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Presentation of the Abstracts of the XXII meeting of the EDTA/EUROPEAN RENAL ASSOCIATON
The abstract of Altman was withdrawn before the meeting; the abstract of Nouiou was not presented.
The material from the following abstracts was presented in Workshops during the Congress:
Ahmad R. Lamperi S. (2)
Albers F, Lornoy W.
Alexopoulos E.
Allen R. Mioli V.
Arrigo G. Mon R.
Ballardie F. W.
Barth H. Neumayer H. H.
Bertani T.
O'Donovan R.
Cosci P.
Crowson M. C. Papadimitriou M.
Pozzi C.
De Plaen J. F.
Egidi F. Rumpf K. W.
Falkenhagen D. Schwarz A.
Fievet P. Shinkai Y.
Fluren C. J. Slapak M.
Sobh M.
Giuliano R. A.
Goodship T. H. J. Taylor J.
Gronhagen-Riska C.
Gutierrez A.
Wauters J. P.
Hassan A. A. Wegmuller E.
Heierli . Williams D. G.
HemmelØff K. E.
Herzog D. Zagornik J.
Hinglais N. Zucehelli P.
These abstracts are published with the help of Gambro AB whom we thank.
NEPHROTOXICITY
ARF AFTER TRIAMINIC®ADMINISTRATION: HIJS OR A NEW
CLINIC ENTITY?
P.Altieri°, A.Barracca°, P.G.Bolasco°, R.Ferrara°,
G.F.Pili°, P.F. Todde°°, A.M.Masia°°°.
Nephrology and Dialysis Department, arid
00 Service of Pathology,
General Hospital of Cagliari, Italy.
000 l5tMedical Clinie,University of Cagliari,Italy.
Two patients (O 2?, 0 40) were admitted to our
hospital both with oligoanuric ARF, haemolitic
anemia, lowered platelet count and dark -- coulared
urine.
About 15 days earlier both patients had been
treated with Triaminic® while suffering influenza.
Initial examinations showed: anemia, reticulocy—
te increase, seric haptoglobiri depletion, platelet
count < 80.000/mm3; aritrocitic fragmentation was
not proved.
The first patient had shown similar episode
6 years earlier after Triaminic® administration
while suffering influenza.
Kidney biopsy examination: in both cases
the immunohistological examination resulted
negative, whereas the light microscope examination
showed spread tubular degenerative a]terations
and no evident glornerular lesions. Furthermore
the ultrastructural examination proved neither
alteration nor deposits on the capillary walls.
In both cases the renal function was back
to normal in about 10 days.
The Authors conclude that the above said
syndrome is probably a new clinic entity different
from HUS.
KIDNEY DAMAGE IN JAUNDICE: DIAGNOSTIC VALUE OF FOUR
URINARY ENZIMES.
G.Bazzenla, P.Amodio, C.Merkel, A.Gatta.
(Intr. A.Iiorsatti)
Department of Clinical Medicine, University of
Padua — Italy.
It is not yet clear which of urinary enzymes
used in clinicai practice is the preferable one to
detect the well—known renal tubular damage in jaun
diced patients. Moreover, it is not yet clear if
there is any correlation between the severity and
the duration of jaundice and urinary enzymes excre
t I OilS
In this research we measured the fractional den
rances of lysozyme (LYS) and of Malato—dehydrogena
se (MDII) —indexes of tubular function— and fractio
nal excretions of —glutamyltrasferase (GOT) and of
—glucosidase (AGE.) —indexes of tubular lesion— in
16 jaundiced patients (bilirubin levels 90—450 mg/i
from more than two weeks) and in 25 controls.
me fractional clearances of LYS and MOO and the
fractional excretions of GOT and AOL were higher
than the upper limit of the range of reference in 2
(P-n.s.), in 7 (P 0.002), in 14 (P 0.001) and in 8
(P 0.001) patients respectively. The levels of un
nary enzyme excretions were not correlated either
with jaundice duration or severity.
In conclusion, among the urinary enzymes we eta
died, fractional excretion of GGT was the most sen
sitive in our jaundiced patients. However, none of
the indexes of tubular damage provided informations
about the severity of kidney lesion, as derived by
serum bilirubjn levels and )aundice duration.
TUBULAR NEPHROTOXICITY AFTER I.V. UROGRAPHY WITH
IONIC AND NON—IONIC CONTRAST MEDIA IN PATIENTS WITH
CHRONIC RENAL FAILURE (CRF)
G. Arrigo, G. Cavaliere, G. DAmico, P. Bernasconi,
G. Schiavina*, L. Dellafiore* and D. Vergnmghi*
Department of Nephrology and Institute of Radiciogy°
San Carlo Borromeo Hospital, Milano, Italy
Potential tubular nephrotoxicity after i.v. uro—
graphy with a ionic (diatrizoate) and a non—ionic
(iopamidole) radiological contrast medium (rem) has
been studied in 18 blindly randomized patients with
stable CRF (mean creatinine clearance = 35.4 mnl/min)
by measunring urinary excretion of 1 lysosomal enzy
me (N—acetyl—13—glucosaminidase:NAG) and 2 brush—bce
der enzymes (gamnma—glutsmyl—tranaferase: —GT and
alanine—aminopeptidase: AAP) in basal conditions
and every 12 hours (hrs) up to ?2 bra after infusion
of rem. Basal enzymuria (Units/g of urinary creati—
nine) did not correlate with basal creatinine clea-
rance or nroteinuria/24hrs. AAP and —GT excretion
increased significantly (p<0.0l) from 13th to 48th
hr in the 9 patients infused with diatrizoate, whi-
le only —GT excretion increased significantly
(peO.05) from 13th to 24th hr in the 9 patients in
fused with iopamidole. No significant change of NAG
excretion and creatinine clearance was observed
with both rem.
In conelusion: 1) urinary excretion of brush—bor
der enzymes AAP and —GT seems to be a more sensiti
vs marker of nephrotoxicity compared with the lyso—
somal enzyme NAG in patients with stable CRF;2) non—
ionic rein appears to be less toxic than ionic rcm;3)
i.v. urography in these patients has no effect onGFR.
INHIBITION OF RENAL GLUCONEOGENESIS BY CY-
CLOSPORIN A (CyA) IN RATS.
W..Beck,K.Schbrer,R.Waldherr,H.Schmidt-Gayk
Depts.of Pediatrics, Pathology and Surgery,
University of Heidelberg, F.R.G.
The study of CyA nephrotoxicity up to
now has been focused on glomerular and ar-
terial lesions. We have studied tubular
morphology, function and energy metabolism
7 days after administration of CyA (10-80
mg/kg/day p.os) to fasting non—uremic Wis-
tar rats. As a sensitive parameter of ener-
gy metabolism renal glucose production(RPG)
by isolated tubules was measured in vitro
after incubation with 7 gluconeogenic sub-
strates (0.1M) , mainly of the Krebs cycle,
for lh at 37°C. Mean RPG from CyA treated
rats was compared with that of untreated
rats (=100%) . Serum CyA and creatinine and
24h excretion of water, electrolytes and
amino acids were determined immediately
before animals were sacrified. After injec-
tion of 20, 40 and 80 mg CyA/kg/day mean
RPG from all substrates combined was signi-
ficantly reduced to 82, 60 and 56%, respec-
tively, with the greatest inhibition in
the presence of pyruvate and oxaloacetate.
The reduced gluconeogenic capacity suggests
that energy metabolism in proximal tubules
is disturbed in CyA treated rats. Changes
of tubular morphology and function may be
related to the disturbance of renal meta-
bolism.
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IS THE NEONATE WITH PHYSIOLOGIC JAUNDICE AT RISK
OF NEPHROTOXICITY ?
Bertotti A., Davanzo R., De Marchi S., Nangiarotti
M.A., Peratoner L., Stormi N.
Istituto per l'Infanzia, Trieste, Italy
The renal involvement in jaundice is known
from several years.
The aim of this study is to evaluate the
nephrotoxic effect of physiologic jaundice in
neonates submitted to phototherapy.
We studied 38 healthy neonates, appropriate
for dates; the mean birth—weigth and the mean
gestational age of the infant were 3399 gr.
(range 2670—4320) and 39.1 weeks (range 37—42).
8 of them had physiologic jaundice (group A)
and 30 were normal (group B).
We measured the urinary escretion of AAP
(alanin amino—peptidase) and NAG (N—acetil
glucosaminidase), two enzymes from different
cellular strnctures of the renal tubule.
Group A(n.8) Group B(n.30) p
NAGOJ/g creat.) 25.OI9.O 29.I2I.6 N.S.
AAP(IJ/g creat.) 85.6±24.0 59.7*33.7 .0.O2
These results seem to enphasize that neonatal
physiologic jaundice has a nephrotoxic effect,
which may be demonstrated by an increased urinary
escretion of AAP,which is an enzyme of the brush
border of the tubular cells of the kidney.
It is still unknown if the nephrotoxicity is
caused by the bilirubin "per se" or by its
photoisomers produced by phototherapy.
Our findings suggest a particular care using
nephrotoxic drugs in such neonates.
RENAl [All ORE DUE TO DIURLT IC THERAPY.
A.M. Castelao, J. lorras, C. Aridrés,X. Sarrias, J.
Ale ma.
(lntr. by X. Sarrias).
Hospital de Bellvitqe. Barcelona. Spain.
Between June 1982 and May 1984 we have found renal
failure (RE) in 48 patients, treated with diuretics
because of arterial hypertension, congestive heart
failure, liver disease or oedema of varied etiology.
Diuretic was proximal in 10 cases, distal in 6 or a
mixture of both in 12, for a period of three to 90
'Ivided our patients in two groups, either becau
se the diuretic was the only factor of RE (Group 1,
31 pat tents) or because there were etiologic factors
as hypotension, dehydration or low cardiac output
(Group II, 17 patients).
lie compared both groups with respect to age (01:
63,9 t 14,1; [ill: 62,3 - 2,9 years), plasma urea (SI:
30,6 12,5; OIl: 14,3 12,2 mmol/l), plasma creati-
rune (CI: 307,6 138,8; CII: 460 298 pmol/1), pre-
vious RE (01: 7; 011:6) or hypertension (01: 16; GIl:
8). We found hypanatremia in 21 cases, hypocalcemia
in 10, hypocalemia in 4, hypercalemia in 25; hyper—
phosphatemia in 25 and hyperuricemia in 33.
RE was considered pre renal (PRF) in 31 patients,
and was oliguric in 17. Three patients with no pre-
vious RE needed dialysis, because of hypercalemis
(2) and severe RE (1). Eight patients (16,6 5) died
of causes other than RE. The remaining patients re-
covered renal function.
We believe that diuretic therapy must be individua-
lized in high risk patients (age 60 years, heart
or liver disease), with sequential monitoring of re-
nal function.
THE EFFECT OF OXALIC ACID ON HUMAN PLATELET
RICH PLASMA.
M.Carnici,M.Raspolli—Galletti,L.Evangelisti.
(Intr. by M.Camici)
2nd Medical Clinic,Pisa Univeraity,Italy.
Patients with renal failure have a bleeding
tendency and the etiology is unknown.In ure
sic plasma Oxalic Acid(Ox.Acjis increased.
++Since high affinity for Ca ,oxalate is an
anticoagulant.Healthy human citrated rich
plasma(cPRP)is incubated for 10' in Born ag
gregometer with Ox.Ac.(2000 gamma% final
concentration)before adding ADF:a control
is studied without Ox.Ac.Platelet aggregati
on(PA)percentage of maximum rate slope of
the aggregation curve and platelet disaggre
gation percentage(PD)following formula
WgE lOO(CAcurve amplitude after
CA
1;MA=maximum amplitude),are evaluated by
ADP 2.5 pN/ml.With Ox.Ac. PA is 30% and in
control 50%;PD is 16% with Ox.Ac. and in
control 48%.The Ox.Ac. concentration for
the in vitro study is higher than in human
pathology,but:1)in vivo thrombocytes chroni
cally are together with plasma increased Ox
Ac. level,2)during anesthaesia by alothane,
Ox.Ac. precursor,there is an impaired PA
and increased bleeding time.We believe that
++Ox.Ac. can bind platelet cytosolic ta and
inhibits cAMP function or blocks some enzy
me of platelet cytosolic metabolism.Further
studies are necessary.
RISK FACTORS FOR AMINOGLYCOSIDES NEPHROTOXICITY.
A.M. Castelao,J. Torras, E. Andrés, J.M. GriOó,
S. GilmJernet, 1. Alsina.
(lntr. by X. Sarrias).
Hospital de Bellvitge. Barcelona. Spain.
Sixty two patients presented acute renal failure
(ARE) secondary to aminoglycosides (AG) nephrotoxi-
ty, between January 1980 and May 1984. Tobramycin(alone in 33 cases or associated with other drugs
in 19), gentamicin (in 8) and amikacin (in 2) were
responsible for nephrotosicity.
We divided our patients into two groups: Group I,
with AG as the only factor for nephrotoxicify (20
patients) and group 11, with other etiologic fac-
tors such as sepsis, dehydration, arterial hypoten—
sion, iodine contrast media or diuretics (40 pa-
tients).
We compared the two groups with respect to age (01:
59,5 — 13, GIl: 63,3 — 14,3 years) duration of the
rapy (01: 10,19 — 3,09k GIl: 9,27 — 4,62 days), to—
AG dose 161: 266 1,54, GIl: 2,63 — 1,63 gr.),
plasma urea (33,9 — 16,15, GIl: 29,28 13 mmol/1)
and plasma creatinine (CI: 585 — 260, 011:538
pmol/1).
ARE was nonoliguric in 13 patients (59%) in 01, and
in 23 patients (57,5 5) in CII.
Five patients (22,7 %) underwent dialysis in 61 and
8 patients (20 %) in CII. Mortality rate was 27 %
(6 patients) in CI and 33,8 % (15 patients) in CII.
We consider as risk factors age over 65, hyponatre—
mia, hypoproteinernia, hypoalbuminemia, sepsis, dehy-
dration, diabetes mellitus and liver disease.
In conclusion there were no differences between the
two groups concerning risk factors. The higther mor
tality rate in CII was due to the associated patho-
logy of the patients.
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NONSTEROIDAI ANTIINFLAMA[ORY DRUGS (NSAID) NEPHROTO
XICITY.
—
A.[l. Castelao, S. Gil-bernet, H. Roveda, [. Andrea
J.M. Cr166, 3. Aisina.
(lntr. by X. Sarrias)
Hospital de Bellvitqe. Barcelona. Spain.
lie have studied 8 patient aith renal tailure (RE)
due to NSAID betmeen October 1982 and May 1984. Se-
+yen mere male and 1 female, aped 54,5 — 2.1,5. Thera
py aith NSAID sas administered because of fever (3
cases), artliralgias and/or arthritis (4), pericardi
tis (1) and gout (1). [he NSAID responsible for RE
ass diciophenac (1 cases), indometacin alone (.5 ca-
ses) or associated to naproxen (I) and to aspirin
(I).
in all cases there ass severe, associated 1 mess
Hodqk lip, furrqs 1 mycos is, mye I urns, amy in i dos i a, syS—
tern ic iripus crythematosus, chronic 1 iver disease. In
no pat imts there ass preexisting HF
The plasma urea ass 24, 5 10,£ cent/i , plasma
crest, in lire 416,8 — 519 ties I / 1, and t here ass hyperka
temia in 4 caves, hyperphosphatemia in 6 and hyperu—
rirernia in 4. in three cases se I ounci liver disease
due F NOAID. HF ass oligriric in I patients, and
FINs 1 in 6.
lie detected p rot minor is 111 4 cases (0,12—0,92 g/d)
and nephrot IC syridrnme in (amy Ioi dos is).
Al 1 pat ents but sire recovered gnod renal I sic lair.
lie curie lode I bat , II trough Nl3AID nept:rotnx ic ity is
nut requuerut and RI a lullS I ly moderate, lb thera—
mw ire care lii! ly preen, mon 11.0 r i rug renal (uric—
I OR iii lii ijh r irk III I
CARBALAZTFIT INDUCD I'PHR0PATHY
R.Cjljberto C.Fede
Istituto di Perliatria iedica Provaritiva
I Sociale,Cattedra di Puericultura —Univsrsit di Messina —
The AA. describe the case of a girl, 9
ysors old,who was submitted to a Carba—
mazerrine theramy (20mg/kg/die) for a
sudden ganralizsd tonic—clonic seizure
occursed chile she was watching televi-
sion.
After fee days the girl shew up with an
irythematous rash urticaria—like ,and
oedema at the femoro—tibial,radio—carp.
and tjbjo—tarsjc articulations.The:refo—
re, the CBZ was discontinued and an an—
tistaminic treatmunt was started.
The laboratory test leaded to a nephro—
tic syrdrome for the dyslipidemic pat—
trrns of the blood;the urine analysis
shvu miasurable albuminuria(g.3,5%),afld
markad eosinoahiluria.
After three days of drug suspension and
imerproteic diet,the general conditions
of the girlgreiatly improved,while the
o•edernas vanished.
This clinic matterns can be esplained
by the drug ndministration,v:ich has
orovoked a carrillaropathic mechanism
of imaunoallergic genesis, as also uro—
ved by the eosinophiluria.
• MITOMYCIN—INDUCED RENAL INJURY.
V. Cattell
(Intr. by B. Hulme)
Dept. of Pathology, St. Marys Hospital Medical
School, London, England.
Haemolytic uraemic syndrome (H.U.S.) reported
in some patients treated for cancer with Mitomycin
is of unknown pathogenesis and evidence inipli-
cating Mitomycin inconclusive. To determine
whether Mitomycin can induce direct renal damage,
left kidneys in Lewis rats were perfused with
Mitomycin (60-4,000iig). Control rats received
saline-only perfusions. Renal tissue was examined
from 1 hour up to 1 month later. Twenty-nine out
of 31 rats, developed left renal pathology: 9
(Mitomycin 1,000-4,000 eg) - severe cortical
infarction; 20 (Mitomycin 40-500 rig) - lesions
indistinguishable froni human H.U.S, Glomerular
endothelial damage was the earliest detectable
abnormality, followed by platelet accumulation and
later capillary wall splitting typical of micro-
angiopathy. Some kidneys had interlobular artery
necrosis and thrombosis. Bizarre tubular cells
witrr giant nuclei simi ar to those reported in
human kidneys with Mitomycin-induced H.U.S. were
seen. Right kidneys were normal. No rats in the
control group (10) developed H.IJ.S.-like lesions.
Thus Mitomycin directly produced renal lesions
indistinguishable from those of human H.U.S.,
suggesting a mechanism for injury seen in
Mitomycin-treated patients, and providing a new
model of H.U.S. in the rat.
CHRONIC MEOCURY EXPOSURE: REFAL FUNCTION AND EX-
TRAPENAL DAMAGE.
C.DellOro, C.Pozzi, R.Ponti, F.Locatelli.
Division or Nepbro]ogy, Hospital of Lecco, Italy.
We studied 21 patients (14 males and 7 females)
aged between 18 and 62 years, exposed to rrrercury
vapours inhalation for 2 to 46 years (rican 20.1),
to evaluate renal and extrarenal darrrage.
All the patients had high serum and urine Hg con-
centrations (serunr Hg: nrean 28.8 mcg/dl, range 17-
53; urine Hg: niean 636.4 meg/i, range 83-1 ,84O).
To search for possible renal danrage creatinine cle
arance, proteinuria with electrophoresis and imnru-
neelectrophoresis, glicosuria, enzyrriuria and TePO4
were evaluated; all these pararuieters resulted nor-
mal.
As for extrarenal damage vie found a peripheral neu
ropathy (evaluated by clinical exanrination and ele
ctronryography) in 15 patients, and C4 reduction in
7 patients. Circulating immune complexes were ab-
sent in all patients.
In conclusion:
1) Chronic Hg intoxication, with serurri Hg values
up to 50 mcg/dl , do not produce detectable renal
damage neither after a very long exposure; we must
think such concentrations are below the thresold
value (not yet definite) for renal toxicity.
2) The only clinical alteration that we found in
chronic mercury vapours inhalation is peripheral
nervous system damage.
3) C4 reduction in 35 per cent of our patients is
unexpected and of unknown significance.
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ENZYMURIA FOR DETECTING CISPLATIN(CDDp) CUMULATIVE
NEPHROTOXICITY(NTX).
M.Giannattasio,F.Petrarulo,B.Buongiorno,
G.Passavanti,P.Coratellj.(Intr. by A.Ainerio).
Institute of Nephrology University of Ban Italy.
In order to assess if enzymuria could detect cu-
mulative NTX of CDDP,we studied the urinary excreti
on of 3 brush border(BB)enzymes(alanin_amjnopeptjda
se,gammaglutamyltransferase,alkaline phosphatase)and
of a proximal—distal tubular cell lyaosomal enzyme
(B—glucuronidase) ,in 18 cancer patients(pts)divided
into 2 groups studied for a total of 40 CDDP—cycles:
Group A:9 pta receiving CDDP(50 mg/sq b.s.ajand cy
clophosphamide;
Group B:9 pts receiving CDDP(70 mglmq b.s.ajalone.
We found positive correlation between urinary ex
cretion of each enzyme measured before every admini
stration of CDDP and cycles number of therapy;it out
lines that pts eliminate a progressively higher amo
urit of enzymes at each new cycles of CDDP—therapy.
Ilowever,covaniance analysis showed no difference
between group A and group B for BB enzyrnes,but a ai
gnificant(p<.Ol)differcnce for lysoscmal enzyme(BG);
namely cycles of CDDP being equal the BC excretion
trends to he higher in group A than in the other one
Our data indicate that enzymuria is a helpful to
01 for detecting chronic tubular damage and provide
evidence of CDDP cumulative NTX;companison of urina
rv enzyme pattern in pta submitted to 2 different
dosages shows that CDDP chronic tubulo—toxicity is
dose—dipendent and that,likely,this damage reaches
distal tubule increasing CDDP dosage.
CORTEX AND MEDULLARY PROTON NMR IN CENTAMICIN AND
GLYCEROL INDUCED ACUTE RENAL FAILURE IN RATS.
A. laina, S. Abrashkin, J. Weininger, L. Grifel,
R. Shneider, L. Lupo, H. Rosenman
Barzilai Med. Ctr., Ashkelon and Soreq NRC, Yavne,
Israel
Acute renal failure (ARF) was studied in Charles
River rats of both sexes. Centamicin ARE was in-
duced by daily i.p. inlection of C 100mg/kg bw for
8 days and then NMR was done on day 9. Glycerol
ARF was produced by an i.m. injectIon of Cly 50%
lOml/kg bw. The rats were studied 24 h later. T1
(spin—lattice) and T2 (spin—spin) relaxation times,
in msec, were measured (BRUKER PC—2O "MULTISPEC" at
37°C), from renal cortex, medulla, liver and
spleen slices. ARE was confirmed by Scr and his-
tology.
GARF
T1 T2
G1yARF
T1 T2
Controls
T1 T2
*1/ *jbCortex 663±50 93±9
Medulla 720±24*# 93±6*#
Liver 289±3 39±2
Spleen 578±26 76±2
e
458±31 65±4
536±21 85±3*
347±10* 44±2
529±22* 63±2
466±6 49±2
636±29 73±3
284±3 39±1
613±22 74±4
* IF
Mean±SE, p<O.O25 vs controls, p<O.O5 vs G1yARF
Significant medullary, liver and spl*en NMR
changes were found in G1yARF. The most striking
changes were found in GARF which is characterized
on NMR by an important prolongation of both cortex
and medulla T1 and T2 times compared with normal
and dy ARF rats, without changes in the liver and
spleen. It is concluded that renal NNR properties
can differentiate ARF of different etiologies.
KIDNEY CORTICAL ACCUMULATION KINETICS OF
GENTAMICIN, NETILMICIN, AMIKACIN AND TOBRAMICYN IN
INFUSED CONSCIOUS RATS.
R,A. Giuliano, G.A. Verpooten, M.E. De Broe.
Dept. of Nephrology—Hypertension, University of
Antwerp, Wilrijkstraat 10, 2520 Edegem, Belgium.
The in vivo kidney cortical accumulation of 4
aminoglycosides (AMG) was compared quantitatively
in rats. Gentamicin (0), netilmicin (N), tobramy—
cm (T) or amikacin (A) were administered to
conscious rats by continuous i.v. infusion during
6 hours. The constant serum levels during the
infusion ranged from 0.4 to 100.tig/ml.
The renal cortical uptake of 0 and N appeared
to follow Michaelis-Menten (MM) kinetics and was
saturable at clinically relevant serum levels. The
uptake of T and A was not saturable when examined
through the whole range of serum levels. A
Scatchard plot showed 2 mechanisms involved in the
uptake of A.
Since in the MM model, at low serum concentra-
tions, the relation between uptake and serum
levels is ssentia1ly first order, the initial
part of the curves (up to a serum levels of 10
ig/m1) was studied separatedly.
Mjchaelis rienten Initial rate of uptake
Km Vmax (serum < lojiq/ml)
ug/ml serum )Jg/g cortex/h
8 15.0 1.5 149.8 9.1 y = 4.84 + 5.32 x
N 23.8 3.5 178.4 17.8 y = 5.01 + 4.10 x
Linear Regression
T y= 9.55 + 1.38 x y = ?.40 + 2.27 x
A y= 11.91 + 1.72 x y = 4.28 + 3.02 x
It is concluded that there are differences in
the renal cortical uptake of the 4 AMO in the
rat. This night contribute to the observed
differences in nephrotoxicity.
PHENYTOIN—INDUCED STEPOID RESPONSIVE INTERSTITIAL
NEPHRITIS WITH ACUTE RENAL FAILURE
A.Khoss,U.Wagner,E.Baizar,G.Lubec,J.Kovanjk
Dept.of Pediatrics,Univ.of Vienna,Vienna,Austnia
Acute interstitial nephritis ,with or without renal failure,
follcwa bacterial infections ,hypersensitivity reacticen to drugs
such as penicillin-reiated,rarely to phenytoin,or rmmy idiopathic
The purpose of this ccsmmxmication is to report a child with epi—
denanlysla builosa dystrophieans who developed a phenytoin—indu—
ced hypersensitivity reactlcn.After five weeks of phenytoth de-
rivative (Epanutin") therapy a 7—year old girl developed a gen-
eralized nmculopapular rash with fever,Jaosdice (seruim bilirubin
6,9 sejdl) with hepatopathy(f7r 97 U/l,cholinesterase 474 U/i),
hepatcaplenamiegaly, lynphadenopathy ,ensinophilia, henolytic ane-
mia(Hb 7,2g/di) and subsequently acute renal failure(BUN 1 mg/
dl, serum creatinine 4,6 meJdl) .Acute hemodiatysis was initiated.
Diagnostic procedures shused high levels of B—2—microglcbulin
(€o.ooo ,ugJi) indicating proximal tubular claisege. On Eti SDS—poly
acrylamlde gel electrophoresis tubular proteinunia was ubserved.
Exmnination of urinary sediment on interference contrast micros-
copy shosed the presence of lynphceytes,trtular cells and cirs—
morphic herentmnia indicating tthulointerstitiaL nephnitis . Rim-
nytoin was discontinued and steroid treatment was started based
upon clinical course and laboratory thta using Co n/sqn and day
Steroid administration caused rapid decrease in eosinophilia,
lyrphadenopathy and hepateeplenamiegaly; laboratory values also
returned to normal after lo weeks
In surrmsry,our patient had interstitial nmephnitis with acute
renal failure due to Epanutin hypersensitivity on the basis of
clinical presentation of fever, exfoliative dermatitis, ecaino—
philia,hermrmlytic anemia and protethunia.The success of treat-
ment with corticosteroids and the siue,but essentially ccmqilete
recovery of renal ftreticns(blccxl urea nitrogen 17 nerJdl ,serumm
creatinine 0,7 mg/dl) upon discontinuation of the offending
drug, further support this diagnosis.
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•DRUG (0)-ASSOCIATED ACUTE RENAL FAILURE (ARE). A
PROSPECTIVE MULTICENTER REPORT.
Société de Nephrologie. Coordinator :D.KLEINKNECHT.
Methodologist : P. Landais. Centre Hospitalier,
Montreuil-sous—Bois, France.
During a one-year period, D-associated ARE was re-
corded in 398 patients (pts)(male : 222, female
176 ; mean age : 56.9 19.9 years), registered in
60 Nephrology Units. D involved were primarily anti-
biotics (136), mainly aminoglycosides (107), glafe—
nm and derivatives (79), non—steroidal anti—inflam-
matory 0 (62), contrast media (50), diuretics (18),
chemotherapy (14), captopril (9), paracetamol (5),
and other 0 (25 pts). 128 pts had received combined
regimen with several suspected D. More than half of
the pts were non—oliguric (55.8 %). Hypersensitivi-
ty reactions were reported in 70 pts, hemolysis in
12, and rhabdomyolysis in 11 pts. According to cli-
nical , biological , and pathological findings (77 pts
had a renal biopsy), ARE could be classified as pre—
renal azotemia (58), tubular necrosis (222), inter-
stitial nephritis (18), tubular obstruction (7) and
other types (93). Factors predisposing to ARE inclu-
ded previous diuretic therapy(135), sodium deple-
tion (85), cardiac failure (83), underlying chronic
renal failure (CRE)(72), diabetes (60), hepatocel—
lular insufficiency (26), hypotension (19), and mye-
loma (6 pts). One or several predisposing factors
were present in 255 pts. Dialysis was required in
114 pts (28.6 %). Fifty pts (12.6 %) died, 217 re-
covered fully, 54 with CRE reqained previous renal
function, 50 had permanent renal damage (PRO) and 3
required chronic dialysis. 0-associated ARE repre-
sented 18.3 % of total pts with ARE registered du-
ring the same period. These results emphasize the
high incidence of D—associated ARE and of subsequent
PRO. They point out the urgent need for recognizing
pts at risk and for directing therapeutic efforts to
prevent this type of ARE.
ANALGESIC NEPHROPATHY AND MALIGNANT TUMORS OF THE
KIDNEY AND THE URETER. VALUE OF URINARY CYTOLOGY.
W.LORNOY, I .BECAUS,V.MORELLE,E.FONTEYNE,
L.Tf-IIENPONT,J.MESTDAGH,P.D'HAENENS,
R.VAN STEENBERGE ,A. ROLLIER.
Department of Nephroloqy, Urology, Pathology,
Radiology, O.L.Vrouwziekenhuis, Moorselbaan,
5-9300 AALST, BELGIUM.
Thirty—nine out of 412 patients with analgesic ne—
phropathy, examined during the last 12 years, deve-
loped a malignant tumor of the kidney or/and ure-
ter (9,5 per cent) in 20 patients a tumor of the
renal pelvis, in 5 a hypernephroma, in 7 a tumor
of the ureter, in 5 a tumor of both renal pelvis
and ureter, in one patient a bilateral tumor of
the renal pelvis and in another a tumor of the re-
nal pelvis and a hypernephroma. The mean serum
creatinin was 4mg oer cent ranging from 1 to 12 mq
per cent. Seven patients were treated with hemo—
dialysis, one with CAPD. There is no direct rela-
tion between the degree of renal failure and the
development of a uroepithelial tumor. On the con-
trary there is a strong relation between the dura-
tion of the abuse of the analgesic mixtures and
the possible onset of such a tumor. This series
contains an exceptional high number of hyoerne—
phromas, which is considerable higher than in the
normal population.
A systematic screening of these patients seems
mandatory. Urinary cytology proved to be of great
value in 8 asymptomatic patients an urothelial
tumor was first detected by routine cytological
screening. False negative cytology occur if ob-
struction is present, in cases of a CA tumor or in
cases of a non—functioning kidney. CT evaluation
is valuable for loco—regional staging. The outco—
poor only eleven patients are actually ali—
• HtIAL INfULiLc.NT JLJLi TO HLriUIN
. J.M.López—Gomez, M.G.Vinuuaa, V.t3arrio, E.Niembro, Igrau, J.Solares, A.Alvarez, A.FranoO ,F.Valderrabano
Hospital Provincial. Madrid. Spain.
e studied 156 heroin addict patients along a pa—
nod of 23 months and 26 of them (l5.5)presented
clinical or laboratory data of renal disease. Percu-
taneous or post—mortem kidney biopcies were perf or—
med in fi?hteen cases and they were classified in
three histological groups:ls)Proliferative glomeru—
lonephritis)GN):five cases showed diffuse and two
focal proliferotive GN associated to Staphylococcus
Aureus endocerditis or sepsis.Clinicel presentation
included proteinunia,frequently in a nephrotic ran-
ge ,microscopic hematuria and hypocomplementamia.
Diffuse forms showed no histological differences
with the poststreptococcal acute GN.2Q)Heroin nephro
pathy in 3 casss.Two of them showed a focal and seg-
mental qlomerulosclerosis and the third case had a
membranoproliferetive SPJ.Nephrotic syndrome was the
most frequent presentation form and one of the focal
and segmental glomeruloselerosis patients showed a
complete remission after cesuation in heroin addic—
tion.32) Acute tubular necrosis because of sepsis
or nephrotoxic drugs, along or acompanning to the
previous lesionc, was found in 11 cases. This pa'—
tients had and oliguric acute renal failure and 10
of' them dead.Ten patients had serus virus 3 markers
but only one of them had positive anti }-t3sAg glome—
rular deposits. 8e conclude that heroin addiction
is increasing in our enviroment and carry out an ia
portent risk of renal disease.Different histologi-
cal findings are present in relation to heroin toxi
City,its vehicles and contaminants or more frequent
ly to sepsis.The heroin nephropathy can improve af-
ter discontinuation of' drug addictior,.The associa-
tion to acute renal failure is frequent end has a
high mortality rate.
MONITORING RENAL TOXICITY OF CIS-PLATINUM
BY URINARY ENZYMES
U. Metz, E. Kurschel, N. Graben
Division of Renal & Hypertensive Diseases
Universitaetskl inikum Essen
0-4300 Essen, ERG.
Acute and cumulative nephrotoxicity are
the main side effects of cis-platinum. Im-
pairment of renal function is manifested
by elevation of BUN and S-creatinine le-
vels, decrease of creatinine clearance and
proteinuria. To detect toxicity more sen-
sitively we analysed the urinary excretion
of LDH, LAP, -GT, N-acetyl-glucosaminida-
se (NAG) and Il-galactosidase (GAL) in addi-
tion to the above parameters.
10 pts. suffering from different cancers
received 150 mg cis-platinum with adaequa-
te hydration and furosemide induced water-
diuresis: 2000 ml saline 0,9 % before and
after cis-platinum infusion.
During 3 - 5 treatment cycles every third
week no elevation of BUN, S-creatinine or
decrease of creatinine clearance were no-
ticed. However 9 of 10 pts. had a rise in
the excretion of all (LDH)r-GT>NAG) enzy-
mes. Maximum levels were found 5 days af-
ter cis-platinum administration.
10 days after the end of each treatment
cycle the urinary enzyme excretion had
returned to normal range.
The pattern of urinary enzymes reflects
that by adaequate hydration the toxic ef-
fects on proximal tubulus cells is limitel
and the defect is reversible.
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MINCXLYSIDE NEPHlYR)XICITY (NTX): A 480 CASES
PERSAL REVIEW.
Mioli V. ,Perilli A. ,Lcnsbardo V. ,Micucci G.,Bibiano
L.,Castelli P. ,Bordoni E.,Palumho P. and Boggi R.
Nephrological Center-Dialysis Unit, Umberto 1St
University Hospital, Ancona, ITALY.
In the last 12 years we have treated 484 pts. by
aminoglycosides for urinary infections: Gentamycin
in 170 cases ,Kanarnicin in 45 c •, Amikacin in 40 c •,
Sisanycin in 39 c.,Tobramycin in 135 c. and Strep-
tomycin in 55 cases. All the pts. were carefully
nonitored for the early detection of N'X. Conside-
ring only the Cr .cl. and the quantitatie proteinu-
na in 449 pts. (Group A) and the U/P Na ,the maxi-
iium concentrating ability and the enzyciuria, besi-
des the previous tv, in 321 pts. (Group B), the re-
suits show a different NIX incidence respectively
of the 5.57 and 18.38% in the to Groups. This un-
derline the greatest importance of the patient's
nonitoning for the early detection of the drug's
NIX. For this aim the major criteria were: r&iucti-
onin the max .conc .ability and increase in the U/P
Na core than 30%; stable increase of the urinary
NAG and MP over than 1(0% increase of the daily
quantitative proteinunia; decrease of GFR.
NIX shows a complete recovery within 90 days of
suspension of therapy in 86.4% of the damaged kid-
neys. in 8 pts. the renal damage was persistent
with the pattern of an interstitial nephritia and
the functional decay in Cr .cl. (observed up to 60
nonths in three pta) was: 0.57 0.14 ml/min/m2b.s.
per rronth. We have found no significative correla-
tions with the total doses of the drugs.
1 ,2-DICHLOROPROPANE NEPI-JROTOXICITY IN MAN.
C.Pozzi
, R.Ponti, P.Marai , F.Locatelli.
Division of Nephrology and Dialysis, Lecco, Itl'.
The increasing household use of several compo-
unds whose renal toxicity is not well known can ex-
pose people to increased risks of renal damage.
We observed two patients with acute renal failure
appeared after exposure (ingestion or sni ff1 ny) to
l,2-Dichloropropane, sold as trilene. Serum creati—
nine on admission was 4.4 and 8.4 mgi respectively.
The first patient (1,2—Dichloropropane ingestion)
underwent forced diuresis, with prompt recovery of
renal function (serum creatinine 1.7 mg% after 4
days); on the 7th day he died because of septic
shock.
The second patient (1,2-Dichloropropane sniffing)
underwent four hemodiafiltration sessions because
of oligo-anuria; renal biopsy findings were consi-
stent with acute tubular necrosis; three weeks af-
ter admission she was discharged with complete re-
covery of renal function.
These patients showed also hemolytic anemia and he-
patic damaae.
In conclusion:
1) 1,2-Dichloropropane is nephrotoxic not only in
animals, but also in man, both by ingestion and
inhalation.
2) The wide 1,2—Dichloropropane diffusion in com-
mercial solvents and trilenes is an unknown source
of intoxication, both because of its household use
and the sniffing practice among young people.
MEFENAMTC ACID NFPIIROPATHY — A SPECTRUM OF RENAL
LESIONS
A.J. Nicholls, J.R. Shortland, C.B. Brown
Royal Ifallamahire Hospital, Sheffield, U.K.
Many non—steroidal anti—inflammatory drugs can
cause renal damage, hut mefenamic acid (MA) is
rarely implicated, We report 7 cases of renal
failure associated with NA to draw attention to
the spectrum of renal lesions which can he caused
by the drug.
The 7 patients, 4 male and 3 female, aged 57—89
had in all hut one case been prescribed MA in a
dose of O.75—l.5g/24hr for 4 weeks or less before
renal failure was found. Four patients presented
as acute uraemic emergencies, (plasma crestinine
(Per) 720—l400umol/l), while the other 3 were
found to have renal failure (Pcr 25O—SSOumol/l)
when investigated for diarrhoea and/or vomiting.
Three patients had been taking thiazide diuretics
for over a year beforehand and have continued to
take them since without untoward effect. No other
nephrotoxic drugs were involved. All patients had
developed at least one, and usually two of the
classical side effects of MA — rash, vomiting,
diarrhoea — before the Onset of renal failure.
Two patients underwent renal biopsy: both
displayed florid acute interstitial nephritis with
additional mild proliferative glomerular lesions.
All patients showed a substantial Improvement in
renal function on withdrawal of MA, hut none
returned to normal (Per 140—33Oumol/l).
Previous reports of MA nephropathy have
described pre—renal uraemla, papillary necrosis,
and systemic hypersensitivity with vasculitis, to
which we add severe Interstitial nephritis. Thus
renal damage by MA can he caused by a variety of
mechanisms.
EXPERIMENTAL LOW DOSE CADMIUM NEPHROPATHY IN
NEWBORN RATS
V Savica, G.Bellighieri, S Rotondo, I.Padovano,
M.Crino, M.Sindoni, v.Magri, F.Consolo
Instituto Pluridisciplinare di Clinica Medice e
Terapia Medica Generale e Speciale, Instituto di
Farmacologia. University di Messina, Italy.
An experimental study on cadmium nephrotoxicity
was performed in newborn rats fron mothers poison-
ed by cadmium chloride during pregnancy, in order
to study the eventual renal lesions after admini-
stration of sublethal and low doses. Eight
female Sprague-Dawley rats were poisoned during
pregnancy with SOppm of cadmium chloride in
drinking water; eight other rats were controls.
The newborn rats were sacrificed at the age of
three months as well as their mothers.
A histological study on the (explanted) kidneys
was performed. The examination showed glomerular
and tubular alterations. The glomerular altera-
tions included intracapsular oedema, glomerular
atrophy and hyaline degeneration. The tubular
alterations were interstitial inflammation,
haemorrhagic areas, infiltration of mononuclear
elements and parietal lesions.
These data show that cadmium is able to pro-
duce experimental kidney changes even at low doses
Accordingly, cadmium nephropathy must be prevented
among factory workers exposed chronically to low
doses of cadmium, especially during pregnancy.
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COMPARISON BETWEEN ANALGESIC CONSUMPTION IN
PATIENTS WITH ANALGESIC NEPHROPATHY AND CONTROLS
A. Schwarz, F. Keller, U. Faber, W. Pommer,
B. Kemmerich, H. Lode, H. Huckauf, C. Offermann,
M. Molzahn
Department of Medicine, Klinikum Steglitz,
Free University, Berlin, FRG
Patients with analgesic—associated nephropathy
(AAN) are strongly advised to stop taking analge-
sics. Compliance with this advise was tested.
Analgesic intake history of 111 ambulant pa-
tients (49 with AAN, 62 controls with chronic pul-
monary disease) was recorded during a routine con-
sultation. Urine taken the same day was analyzed
quantitatively for N—acetyl—p—aminophenol (NAFAP).
a component of many analgesics and the primary
metabolite of phenacetin (method of Welch and
Conney). — Statistically significant differences
between patients with AAN and those with chronic
pulmonary disease (CPD) (AAN versus CPD) were
found: indication of chronic pain (88 vs 53%;
p.O.OO1),cumulative intake of more than ]000
analgesic tablets (71 vs 10%; pO.OOl), and NAPAP—
positive urine test indicating phenacetin or pmra—
cetamol intake no longer than 24 hours preceding
the test (23 vs 2%; pO.OOl). 85% of the NAPAP—
positive patients with AAN and none with CPD denie
having taken any analgesics (pO.Ol2). No sta-
tistically significant differences with respect to
age (54 11.6 vs 55.7 14.9 years) and percen-
tage of women (69 vs 60%) were found between the
groups. — Conclusion: Patients with analgesic—
associated nephropathy suffer chronic pain and
take analgesics more frequently than chronic pulmo-
nary patients. Even after diagnosis of nephropathy
these patients continue to take analgesics and
usually they deny havin done so.
TUBULAN LESIONS SECONDARY 'Ii) CONVENTIONAL UROGRAPHY
A STUDY ON RENAL BIOPSIES BY LIGHT—MICROSCOPY.
Stanziale P., Balletta M., Esposito A., Fuiano C.,
Santopietro A., Andreucci V.E.
Dept. of Nephrology, 2Faculty of Medicine, Naples.
The radiocontrast—induced nephrotoxicity is a ra—
ce complication of urography. Several reports, how—
ever, have recently emphasized that tubular damage
occur with a greater incidence than expected.
We have studied renal specimens of 52 patients in
whom a renal biopsy was performed because of clini-
cal diagnosis of glcmerulonephrites (GHN). Patients
with evidence of metabolic, systemic or hypertensive
disease were excluded from our study. In 42 patients
(group 1) an urographic test, using iotalamic acid
as radiocontrast medium, preceded renal biopsy by 1
to 5 days. In 10 patients (group 2) urography was
not performed and biopsy was carried out under eco—
graphic control. The histological types of GHN had
similar distribution in the t groups.
Ten renal biopsy specimens of group 1 (24%) exhi—
beted morfological signs of tubular damage, mainly
cellular vacuolization and focal areas of necrosis.
These lesions occurred almost exclusively in the
oroxal tubule if radiocontrast administration pre-
ceded biopsy by less than 48 hours and were local-
ized in distal tubular sites when the time interval
Detween biopsy and urography was greater than 3
days. Renal function in these 10 patients s nt
impaired by the urographic test. In group 2, no tu-
bular injury was observed.
These results demonstrate that contrast medium nay
cause tubular lesions even if renal function is not
apparently impaired.
• ANALGESIC NEPHROPATHY AND ALUMINIUM TOXICITY
A. Schwarz, D. Kraft, F. Keller, D. Gawlik*,
C'. Offermann.
Medical Department, Klinikum Steglitz, Free
University, Hahn-Meitner-Institut for Nuclear
Research*. Berlin, West Germany
We investigated plasma aluminium levels in 116
chronic hemodialysis patients treated by reversed
osmosis and in 6 patients with preterminal chronic
renal insufficiency. Patients with analgesic-
associated nephropathy (AAN) (n = 51) were com-
pared with patients suffering from other renal
diseases, who served as controls. Plasma alumi-
nium was measured by atomic absorption spectro—
photometry. Additionally, bone aluminium was
analyzed in iliac crest specimens from 14 of these
patients by measuring neutron activity. Plasma
aluminium levels were significantly higher in AAN
patients than in controls (mean SD = 2.71
1.89 versus 1.7 + 1.13 ljmol/l; p<0.OOl). Bone
aluminium (y) wa significantly correlated to the
years (x) of alujinium hydroxide niedication
(y = 1.28 + 0.45 x ; r = 0.6459; n = 14; p<0.05).
Differences between the 2 groups with respect to
the daily aluminium hydroxide dose (7.7 + 5.5 vs.
6.7 + 5.2 tablets), the duration of hemodialysis
treatment (4.6 3.9 vs. 3.9 + 3.6 years), and
the bone aluminium (2.44 1.41 vs. 2.82 + 1.61
imol/g) were statistically not significant.
However, antacid medication for peptic ulcer
disease was significantly more frequent in AAN
patients than in controls (34% vs. 10%; p.O.OOl).
All 3 patients who died of dialysis encephaio-
pathy were in the AAN group.
Conclusion: Analgesic nephropathy may be
associated with an increased risk of aluminium
toxicity.
• PREVENTION OF GLYCEROL-INDUCEL) ACUTE RENAL. FAILURE
IN RABBITS BY THROMBOXANE-ANTAGONIST EM 13.505
K. Stegmeier, F. Hartig, J. Pill, H. Patscheke*.
(Intr. by C. A. Baldamus)
Dept. of Medical Research, Boehringer Mannheim GmbH,
Mannheim and *Institute for Clinical Chemistry,
Klinikurn Mannheim of the University of Heidelberg,
6800 Mannheim, F.R.Germany.
In glycerol (G)-induced acute renal failure
(ARF) renal function as determined by serum crea-
tinine has been reported to correlate with renal
metabolic potential of thromboxane (TX) biosyn-
thesis of kidneys. This suggests a pathophysiologic
role of TXA2 in ARF. To test this hypothesis in
G-induced ARF the effect of the new TX-antagonist
BM 13.505 (BM) was compared with that of the cyclo-
oxygenase inhibitor indomethacin (I) in regard to
changes in renal function and kidney morphology.
ARF was induced by 14 mi/kg of C (SO % in sali-
ne, s.c.). Five mg EM/kg or 8 mg I/kg were injected
i.v. 30 mm before G-administration. Two and six
hours after C-injection the same doses of drugs were
injected s.c. The median and range of serum crea-
tinine (/umol/l) is given in the table (n = 6-8)
before 24 48 72 hr
C 109(85-158)177( 93-417)l77( 75-506)l70( 89- 434)
C+BM114(97-119)12l( 88-182)lO0( 71-159)123( 89- 186)
G+I l09(96-128)348(l62-62l)221(l20-897)189(121-1049)
The morphological changes in individual animals at
72 hr after administration of C and of C + I corre-
lated very well with serum creatinine. The prominent
pathological findings were necrosis, casts, tubular
dilatations and interstitial edema or fibrosis. In
contrast only minimal changes were seen in some of
the animals treated with G+BM. From the highly effec-
tive prevention of C-induced ARF by the TX-antago-
nist BM 13.505 we concluded that TXA2 may play an
imoortant role i0 the pathogenesis of ARF.
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ACUTE RENAL FAILURE (ARF) AFTER RADIOLOGIC CON-
TRAST (RC) USE.
J. Torras, A.M. Castelao, N. Romero, E. Andrés, J.
Alsina.
(Intr. by X. Sarrias).
Hospital de Bellvitge. Barcelona. Spain.
Acute renal failure due to NC is a know feature
in radiology, but the rate and etiologiea are not
well established.
35 patients who developed ARE after a diversity
of trials with RC were studied retrospectively,
in a four years interval. The risk factors we eva-
luated were age, pre—existing renal impairment
(RI), diabetes mellitus (OH), hypertension (Hy),
arterioesclerotic arteriopaty, high blood uric
acid, proteinuria, diuretic or aminoglycoside ad-
ministration and hepatopaty.
RI was present in 62,8 % of the patients, Hy was
in 57 % and 25,7 % had arteriopaty. Seven patients
(20 %) had ON. ARE was oliguric in 16 patients and
it developed during the first 24 hours. Six pa-
tients underwent dialysis, in a total of 24 sesions.
Two patients died because of their main illness.
80 % of the patients ameliorate renal function to
previous rates.
Results suggest that (1) RI is the most prevalent
risk factor in ARE after RC use; (2) renal arterio—
paty and renal hipoperfusion of several etiologies
(ON, arterioesclerosis) seem to predispose to ARE
sitar RC use; (3) renal function recover to pre-
vious rates in few days.
CORTICAL ACCU?IIILATION KINETICS OF GENTAMICIN IN A
CHPONIC RENAL FAILURE PAT MODEL
G.A. Verpooten, R.A. Giuliano, V.M. Pattyn,
P.O. Hendrix, M.E. De Broe
Dept. Nephroloqy-Hypertension, University of
Antwerp, Bel give.
ninoqlycosides enter the proximal tubular cell
by absorptive pinocytosis. The kinetics of this
uptake mechanism have already been published for
aentamicin (0) in normal rats, receiving a 6h IV
infusion to achieve constant serum levels ranging
from 0.4 to lOOug/mL. It was found to follow
Michaelis—Menten kinetics. The model parameters
determined were the maximal rate of cortical
uptake (Vmax SD) and the 8 serum concentration
corresponding to Vmax/2 (Km SD).
In this study we present the 8 uptake kinetics
in a chronic renal failure rat model (remnant
kidney method).
Km Vmax
(pg/eL serum) (pglg cortex/hour)
Controls 15.0± 1.5 149.8± 9.1
Remnant kidney rats
(creat. 0.9-1.2 mg/dL) 73.9±10.7 213.7±22.0
(creat. i.2-i.8rng/dL) 135.8±49.7 239.2±69.9
Rats with renal failure showed an increase in
Km, proportional to the degree of renal failure.
This reflects a decrease in affinity of G for the
brush border binding site, possibly caused by the
increased tubular flow and increased solute
delivery to the proximal tubule in a hyper—
filtrating remnant kidney. The increase of Veax
can be explained by the hypertrophy of the
proximal tubular brush border in remnant kidneys.
• NEONATAL DIABETES INSIPIDUS DUE TO MATERNAL LITHIUM
THERAPY DURING PREGNANCY.
M.Van Dijck, R.Van Damme-Lombaerts, W.Proesmans.
University of Leuven, Leuven, Belgium.
A newborn premature baby was referred for fai-
lure to thrive, poor sucking and hypotonia. Her mo-
ther had been given lithiumcarbonate from the 28th
week of gestation on. Serum lithium was monitored
at weekly intervals. At 32 weeks, a level of
2.O5mEq/l was measured and the therapy was inter-
rupted for 3 days. At 34 weeks when the lithium
level was l.25mEq/l, a sodium-poor diet was star-
ted because of edema. Two weeks later serum lithium
reached 3.3 rnEq/l; the medicine was stopped. One
week later the baby was born; birth weight was
2.700g. On admission at the age of 4 days the ba-
by weighed 2.300g i.e. -20 per cent. Urine output
was markedly elevated 450ml/24hrs i.e. 200ml/kg
per 24hrs. Urine osmolality was 2OOm0sm/kg water.
A total fluid input of 24Oml/kg was necessary to
make the baby grow. The babys blood contained
still 0.O5mEq/l of lithium at day 12. A DDAVP
test was performed three times maximal urine
osmolality was 375musm at day 13, 61U at day 25
and 74OmOsm/kg water at day 44. In the meantime,
an improving appetite was noted together with
a decrease in fluid needs and urine output. A re-
nal biopsy showed no lesions on light microscopy.
Electronmicroscopy revealed irregularities of the
nuclear shape in the epithelial cells of the collec-
ting ducts and an increased number of vacuoles of
lysosomal origin. Besides the renal concentrating
defect, no other abnormalities of the renal func-
tion were observed.
Our findings show that lithium toxicity du-
ring pregnancy can lead to a temporary diabetes in-
sipidus in the newborn. This diabetes insipidus
seems to be partially central and partially nephro-
• NEPROTOXICITY OF HIGH DOSE METHOTREXATE THERAPY -
A LONG TERM FOLLOW UP STUDY IN 5 JUVENILE
PATIENTS WITH OSTEOSARCOMA
R. Wartha(l), M. Guziur(2), V. Dam,jantschitsch(2),
J. KUhl(2), D. Gekle(2)
(Intr. by D.—E. MUller-Wiefel(2))
University Childrens Hospital Heidelberg(1),
University Childrens Hospital Wurzburg(2), FRG
In the last years therapy of osteosarcoma was
significantly improved by High Dose Methotrexate
(HD-MTX) therapy. According to Rosen s protocols
the patients receive toxic initial doses of MTX
and are rescued by Leucovorin. Nephrotoxic side
effects are reduced by alkalization of urine.
5 juvenile patients (8-22yrs) were studied over
8-18 (mean 14.6) cycles of HD-MTX treatment within
9 months. Clinical investigations and laboratory
parameters were completed by measurement of total
proteinuria (Biuret), 13
-microglobulinuria (ELISA),
and SDS-polyacrylamide el electrophoresis (SOS-
PAGE) of urinary proteins in 24-hours urine
specimens collected during the days 1-4 of each
therapy course. An acute intoxication with tran-
sitory renal failure was seen only in 1 out of 73
treatment cycles. Endogeneous creatinine clearance
decreased in each of he patients at least once
below 40 ml/min/l.73m , but was normal again within
24-48 h after MTX-infusion. A ignificant protein-
uria of more than 100 mg/24h/m was seen only
intermittently. The 13 -microglobulin excretion was
slightly increased wihout continous elevated
values. SDS-PAGE revealed in 36% of 206 urine
specimens low molecular weight patterns; indicating
tubular kidney affection. We conclude that nephro-
toxic side effects in our patients were within
tolerable limits.
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NEPHROTOXICITY OF PARAQUAT AFTER PERCUTANEOUS
POISONING
R.Wronaki1, S.Okonek, W.Niedsrmayer1,
M.Okonek , A4a..r . let Medical Clinic
UnivSreityKiel , lind Medical Clinic niver—
aity,Mainz , Stadtkrsnkenhaua,RendsbUrg
Germany.
A fatal paraquat poisoning can occur when rela-.
tiwely large areas of skin are contaminated with
concentrated aolution of paraquat.
The hitherto unanswered question to what extent
concentrated paraquat can be absorbed by intact
akin and induced renal failure was answered in
animal experiments
Female Wistar rats (n=32) received 25 mg of p.—
raquat p.r kg body weight per os or on shaved
area of akin.
The percentage of renal elimination of peraquat
by daily .eaauraments of cumulative excretion
in the urine was 5 days after:
oral application : 6.6 %
percutaneous application 4.8 %
percutaneous application : 11.2 %
(mechanical damaged akin)
percutaneous application : 8.2 %
(chemical damaged akin).
paraquat was abls to
was controlled by
In the presence of mechanical or chemical 1.—
sions of skin the percutaneous peraquat absorb—
tion is distinctly enhanced and the excretion
delayed.
ENzYMuR]:A AND PROTEINURIA IN EPH GESTOSIS: ARE THEY
CORRELATED?
M Ainato S Bandini, P. Tosi, G.Mello, G.Sensi,
A. Ingenito.
Dept of Npehrology, Florence Italy.
Recent reports have underlined the importance of
LDH,NAG and lysozyme to detect both early renal
failure and mechanisms of proteinuria in pre—eclam—
psia. 36 patients from 26 to 37 weeks of pregnancy
(23 as control group and 13 as EPH gestosis) were
followed for renal function through urea and creat—
mine c:Learance, proteinuria ,urinoculture ,enzyme
activity of LDH and NAG. The analysis of individual
tests is not satisfactory. LDH and NAG have been
studied as associated couples: only if the couples
with both results pathological are considered as
positive the specificty of the tests is 100%. The
proteins and the other mentioned test never revea-
led pathological values. In the econd phase we
have studied 26 patients to deterie whether the
the proteinuria of pre—eclampsia resIllts from a
loss of proteins or from tubular dysfunction. To
confirm that there is no tubular component in pre—
eclapmsia,ie protemnuria, we have tested for urina-
ry kysozyme which was lowest O.8g/ml;in fact when
more than 2g/ml of lysozyme are present, this is
a sign of tubular damage. This study confirms that:
1) The urinary enzymes LDH and NAG proved to be
the only tests to reveal renal failure and 2)
Proteinuria in pre—eclampsia is caused by loss
of proteins through a damaged glomerular basement
membrane, without evident damage of tubules.
KIDNEY IN PREGNANCY
EARLY PRE-ECLANPSIA" PRESENTING AS NEPHROTIC
STNDRO(NS)
R. Allen, R. Gokal,* P. Donnal, N.P. Mallick*
Renal Unit, Manchester Royal Infirmaz'y and
Department of Obstetrics, Saint Mary's Hospital,
Manchester, U.K.
Pre—eclamptic toxaemia (PET) is most likely to
occur in the last 6 — 8 weeks of pregnancy with
good maternal and foetal prognosis. However,
during 1983—84 we observed a clinical picture of
sudden onset, severe NS with hypertension and de-
cline in renal function in 6 pregnant women (mean
age 26; 18—35) in the 2nd and early in the 3rd
trimester. All cases were normotensive and with-
out abnormalities of renal function up to the
development of the syndrome.
-
Mean gest— Protein— Serum Dia— Creatinine
ational uria g/ alb stolic Clearance
age 24 hrs g/l B.P. ml/minute
27 yrs 12.2 22 120 78
(23—31) (8.5—15) (20—25) (100—130) (50—130)
Poetal outcome was poor with 2 deaths in utero
and 3 others requiring an emergency caesa.rian
section. In all cases, proteinuria disappeared,
blood pressure (in 5) and renal function normalised
within 6 weeks post—partum. No renal biopsies were
performed but placental findings in one were not
those of PET.
The clinical picture of fulminant, sudden onset
115 appearing in the 2nd or early 3rd trimester has
a poor foetal outcome but good maternal prognosis
on termination of pregnancy.
EFFECT OF PIIEGNANCY IN THE NATURAL COURSE OF PRI-
MITIVE GLOMERULONEPHRITIS (PC)
P.Barceld, J.L.Lillo, J.A.Ba11arl y G.Del Rio
Clntr. by L.Piera). Fundación Puigvert, Barcelona.
Spain.
The repercusion of pregnancy in the glomerulone-
phritis has been discussed. We have studied the
effect of pregnancy in 48 PG during 66 pregnancies
and their evolution has been compared with 36
non—pregnant women with PG. All of them were biop—
sied and the PG progression was evaluated by the
increase of creatinine, hypertension and proteinu—
rio 'versus time" at 1 and 5 years. The pregnant
group is formed of: 16 membranoproliferative (MP);
13 scierohialinosis (H); 10 IgA nephropathy (Berg)
7 membranous (M) and 2 focal (F) with an average
sue of 28+5 years. Non pregnant by 11 MP, 10 H, 10
Berg and 5 N with an average age of 265±2. The
average creatininemia varied from 083±036 rng%
before delivery to 085+037, 3 months after deli-
very and from 119±057 to 162±104 mg% after 12m.
in the non—pregnant group. The BP of 135+234/867
mrnHg to 127±17/827÷135 in the pregnant
group and from 132±106/828+071 to 132±103/807
+091 in the non—pregnant and proteiriuria, from
114÷163 g/24h. to 103÷149 in the pregnant
group and from 229÷130 to 145÷125 in the non
pregnant group.
At one year, in the pregnant ones, 41% impaired
their function; 87% hypertension and 83% protei—
nuria and in non pregnant 11% impaired their func-
tion; 83 hypertension and 26% proteinuria. At 5
years, 187% impaired their function, 37% hyper-
tension and 24% proteinuria, and in non pregnant,
29% impaired their function, 29% hypertension and
19% proteinuria. These data show that at short and
medium term, in most cases, the natural course of
PG is not affected.
Thereby renally eliminated
induce renal failure. This
enzymological technique.
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INCREASE OF THE RENINE—ALDOSTERONE SYSTEM IN PREG-
NANT WOMEN WITH RENAL DISEASE
P.Barceló, J.Ocón, R.Castellet y G.Del Rio. (Intr.
by L. Piera). Fundación Puigvert. Barcelona. Spain.
There is an increase of the renine-aldosterone
system in pregnancy. In 33 pregnant women with
glomerulonephritis(8c.(PG)lithiasis(14c.(L) hyper—
tension(6c.(H);chronic pyelonephritis(3c.(P) and
renal polykistosis(2c.(P renine, aldosterone, Na,
K in plasma and 24 h. urine, and creatinine clea-
rance were determined quarterly and 3—6 months af-
ter delivery.
'Jut of hypertensive women in all cases there was a
renine-aldosterone increase in the 3 periods with
decrease after delivery. P0; Renine: ll'3+2 to
164+38 ng/ml/h; Aldosterone: 649+9 to 366+144
NMOL/dO. L; Renine 103±2 to 16÷3'8; Aldosterone
244+9'3 to 292÷95. C.P., Renine B'l+3'l to 1l'4÷3'2
aldosterone 164÷29 to 755±131. P; Renine 27÷59 to
5'7±3l; aldosterone 372÷123 to 438±134. The va-
lues of renine-aldosterone were normal after deli-
very.In some H women there was not a refine increa-
se, but there were high levels of aldosterone
There was a wignificant decrease of the plasmatic
Na during pregnancy and an increase of the urinary
Na after delivery in all patients without hyper-
tension. The lineal correlation between aldostero—
ne and renine was not significant but a signifi-
cant increase of the aldosterone levels in the
3rd. trimester compared with the 2nd. trimester
was confirmed.
Our results show a normal response of the reni-
ne-aldosterone system regarding the controls and a
hypersecretion of aldosterone (3rd. trimester) non
related to the angiotensine.
• EFFECT OF PREGNANCY ON AMYLOID NEPHROPATHY IN
FAMILIAL MEDITERRANEAN FEVER (FMF)
S. Cabili, 0. Rabinovitch, D. Zemer, M. Pras,
J. Gafni
Chajm Sheba Medical Center and Tel-Aviv Medical
Center, Rokach Hospital, Tel-Aviv, Israel
The effect of pregnancy on renal amyloidosis
was examined retrospectively in 15 women (26 full-
term pregnancies) with FMF and established
proteinuria.
Three women evidenced renal insufficiency,
defined by a serum creatinine > 1.6 mg/dL, at
conception. In I an elevated creatinine was first
documented 8 months after an apparently uneventful
earlier pregnancy. Two of the 3 progressed to
severe renal failure during pregnancy or immediat-
ely post-partum. The third showed progressive
deterioration to end-stage renal disease after 7
years, probably reflecting the natural course of
the disease.
Twelve women with renal amyloidosis and normal
renal function experienced neither aggravation of
proteinuria nor deterioration of renal function
during a total of 21 pregnancies. After their last
deliveries, however, 5 of them progressed to renal
failure within 4-8 months, 4 reaching end-stage
renal disease within 10-30 months and the fifth
recovering slowly over 3 years. All S were normo-
tensive throughout their pregnancy. All S failed
to show the expected increase in GFR with progres-
sion of pregnancy, suggesting that deterioration
did in fact occur during pregnancy; by contrast,
in 5 of the 7 women whose renal function did not
deteriorate post-partum, such an increase was
documented by a fall in serum creatinine.
These data show that pregnancy imposes a
tangible risk of deterioration of renal function
in amyloidotic FMF patients.
RENAL FUNCTIONAL RESERVE IN PREGNANCY.
A.Brendolan,L.Bragantini,S.Chiaramonte,R.Dell'Aquj]a
A.Fabris,M.Feriani,P.Meritasti,C.Ronco and G.La Greca
Depts. of Nephrology and Obstetrics-St.Bortolo Hospi
tal — Vicenza — Italy.
Glomerular hyperfiltration usually occurs during
pregnancy starting from the first weeks and reaches
an increase to 25-40%.This functional alteration is
constant all over the gestation and lasts till the
delivery.The aim of this study was to evaluatewether,
during pregnancy,all renal functional reserve is to-
tally utilized or not.
In normal healthy subjects an acute oral protein
load increases glomerular filtration(GFR),within 2-3
hours,of about 40-50%.To verifythe wideness of renal
reserve in pregnant women we administered to 8 third
trimester gravidas(mean age 27T5.6)a standard meal
with 80 grams of protein as red cooked meat.To avoid
inadequate collection of urine at low flow rates due
to difficulty in completelyemptying the bladder,awa-
ter load of 20m1/Kg/BW was initially administered and
afterwards urine losses were replacedwithualamoun
ts of water.Furthermore to minimize the variations
in GFR influenced by posture all investigations were
made in sitting position.Creatinine clearance was e-
valuated in 2 periods:2 hours before and 4 hours af-
ter protein load.In our population baseline Creatini
ne clearance was l26.92l.5ml/min and after the pro-
tein load an increase to l482O.2ml/min was observed.
GFR increase resulted significant according toT pai-
red test(n=8;T=4.29;p<0.0I).Thjs studyindicates that
in pregnancy natural glomerular hyperfiltration does
not reach the maximal renal functional reserve.
ACUTE RENAL FAILURE AND NEW TREATMENTS IN
SEPTIC ABORTION
, CA&LA.R. S. UNAL, TURGAN
Hacettepe University Medical Faculty TURKEY
A brief review is given of 50 cases of a-
cute renal failure followed in Hacettepe Uni-
versity Medical Faculty hospital between the
years of 1979—1984. Obstetrical problems emer-
ged as the commonest cause of this disease.
Surgical proce&tres was the second commonest
cause. The most important etiolologic factor
noted with induced abortion seemed to be over-
whelming sepsis in obstetrical group. Mortali-
ty of non—obstetrical group was 42%, obstetri-
cal group was 27% and overall mortality ws
36%. Total abdominal hysterectomy and bilate-
ral salpingo—oofereotcmy is applied to 17 of
22 obtetrjca]. cases because they were the
septic focuses, Positive blood cultures was
18%. All cases were treated with suitable an—
tibiotic and supportive care and additionally
17 cases with peritoneally, 1 case with hemo—
dialysis. P0110w up reports were obtained in
7 patients, They were all in good conditions
and their approximate creatinin clerens was
89.5 mi/mm.
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OUTCOME OF PREGNANCY IN WOMEN WITH LUPUS NEPHRITIS
J.S.Cameron, J.A.Hicks,G.Frampton,D.G.WillLams,
C.S.Ogg.
Renal Unit, Guy's Hospital, London UK.
Until recently, pregnancy in women with lupus
has been thought to be ill—advised, especially in
those with evident lupus nephritis. We report the
Outcome of 38 pregnancies in 22 women,whose ages
ranged from 18—36yrs; 18 had diffuse proliferative,
3 membranous and one mesangial glomerulonephritis.
Proteinuria ranged from 0 (7pregnancies)to 5.lg/24h
at first ante—natal attendance, and GFR from 35 to
105m1/min(<SOml/min in 4). 7 were hypertensive,con—
trol]ed on treatment. 2 women presented with lupus
during pregnancy I suffered a neonatal death and
the other was aborted. 1 other women had an exacer-
bation of cutaneous lupus during pregnancy but
renal function was unaltered. 1 other aregnancy end
ed in therapeutic abortion, and 7 in early spontan-
eous abortions; one stillbirth and the neonatal
death produced a fetal loss of 3/36 (25%) ; 1 woman
with a bicornuate uterus contributed 2 abortions
and 1 live fetus. Of 28 deliveries, 6 were at term
10 prcmaturo and 12 by Caesarian soctLon, B for
emergencies; hycertension was the main reason, and
comolicated 13/38 (34%) of pregnancies. Post—partum
all were gut on elevated doses of prednisorio,taper—
ing over 6 weeks; no "flares" were seen. Of 8 women
tested serially for the presence of anti-cardioli—
pin ontisody ("lupus anticoagulant") only 1 had a
high titre of loG ]hkt not 1gw) antibodyrshe deli-
vered normally at 38 weeks gestation.
We conclude that in women with lupus, even those
with previously severe nephritis,pregnancy is not
contra—indicated in those with quiescer;t disease.
however, the fetal losses romain unacceptably hi gh
and way relate to iramunological sauses.
• EXACCEPATED NATRIURESTS TN CURONIC F)YPPUTEPSTON IN
PRECNANY (CI IPJ.
P Conte, A Dat Canton, M Terrihile, C Fuiano, C F
sposito, VE Andreucci. DPT of Nephrology, Second
Faculty of Medicine. University of Nanles.
In thk study, the way by which Na is handled a
long the nephron, and the ability to excrete a salt
load was investigated in 5 patients with CUP. Five
female, age matched, non—pregnant patients with
chronic hypertension (CH) were used as control.
Clearance studies were performed in a condition of
steadv—sl.:ate water diuresis. After 60—mm baseline
periods, the patients were loaded with hypotonic sa
line, 3mEoJKg h.w. iv., in 80 minutes.C1earreCo of
creatinine, Na+, K+ and osmolar clearance were meas
ured in the baseline periods and during salt load
sverv 20 minutes. The increment in Na+ excretion
was significantly greater in CUP than in CU in the
last period of loading. In CUP, the filtered load
of Na due to increased GFR was higher than in CH,
accountino for enhanced Na delivery to the distal
part of the nepiiron. Free-water clearance (CH2O, an
index of Na reabsorption in diluting segments),
however,was sir'ilar in CUP as CU. Therefore, the ra
tb
CH20/Na
delivery was decreased in CUP. These re
stilts indicate that the pregnancy intensifies the
exaggerated natriuresis of hypertensive patients
and that the diluting segment is the nenhron site
of impaired Na transport. This defect may be due
to the transmission of increased hemodvnamic nressu
re in vasa recta, which is made possible in pregnan
cv by the impaired autoregulation secondary to re
nal vasoclilation.
MAGNESIUM (Mg) RENAL HANDLING DURING PREGNANCY (P).
G.Colussi,G.Rombola,E.Benazzi,M.E.De Ferrari,M.Su-
rian,F.Malberti ,L.Minetti.
Renal Unit,Niguarda CaGranda Hospital ,Milano Italy
Plasma Mg (PMg) is known to decrease during P,
but the cause(s) have not been investigated.
Fourteen normal pregnant women were studied alo-
ng a physiologic P (weeks 6—16:I°;17—26:II°;27—term:
1110) and 3-6 months after delivery (C). PMg and
PMgUF progressively fell: 1.89÷8 and 1.33+12 mg/dl
respectively in C; 1.72+.l6(p<.OOl) and l.27±ll(p<
.05) in 110; l.68+.2l(p<.OOl) and l.22-F.l3(p<.O2)
in 1110. Daily and fasting urinary Mg excretion
(UMgV) remained unchanged, as did filtered load of
MgUF and total tubular Mg reabsorption (TRMg), due
to the increase in GFR. Moreover, fasting Mg excre-
tion and tubular reabsorption per unit GFR (MgE and
TrMg) and MgUF fractional excretion all fell (from
39+17pg/d1GFR, 1 .29+.6 mg/d1GFR and 2.76+1 .2% in C
to 26+ll—p<.O2-, l.l8+.l3-p<.Ol- and l.75+.45-p<
.01- in III), according to a Tm-regulated model of
tubular reabsorption, without any apparent change
in renal Mg threshold (TmMg/GFR). In particular,sin
Ce PMgUF=UMgV/GFR+TRMg/GFR (UMgV/GFR=MgE and TRMg/
GFR=TrMg), it appears that low PMgUF is accounted
for by low MgE and TrMg, and thus (being UMgV and
TRMg unchanged) by the increase in GFR.
In conclusion, it appears that the increase in
GFR is the single most important factor responsible
for low PMg and PMgUF during P.
MATERNAL AND FETAL PROGNOSIS AND LONG—TERMFOLLOW—
UP IN PREGNANCIES(P) WITH HYPERTENSION(H)
P.Cosci, M.Surian, F.Malberti, B.Corradi,G.Colussi,
L.Minetti*.
Rena] Units, Ospedale Maggiore,Indi and E.O. Ca'Ora
nda—Niguarda, Milano, Italy.
The aim of our study was to evaluate the incide
nee of maternal and fetal complications in 43/60 P
with H,whose clinical and laboratory data were aval
lable in P and postpartum(PP),over 8D consecutive
P and the risk of H and/or renal disease in a fo-.
110w—up to one year after PP. H in P was defined as
an average of two consecutive blood pressure recor—
dings>,.140/90, obtained after 10 minutes supine,00n-.
firmed 48 hrs later. H in P was classied into 4 gre
ups,according to the criteria of Am.College of Obs—
tetricians&Gynecologists Comittee(1980): I group(ll
P,25%)preeclampsia_eclampsia; 11(6, 14%)=whatever
cause chronic H; III(6,14%)=chronic H with superirn
posed preeclampsia; IV(20, 46%)=late,transient or
gestational H. The incidence of maternal and fetal
complications was significantly greater in group I
than in IV:severe H(81vs45%,p(O.05),poor response
to antihypertensive treatment(AHT)(18vs65%,p<0.025)
decreasing GFR(54vs20%,p40.O1) ,preterm delivery(81
vs35%,p<O.025),small for gestational age(81vs25%,
p<O.OO1) ,cesarean section(54vs20%,p<0.05) .In group
11,111 and IV the AHT(drugs+bed rest)obtained an a
dequate control of H in 100,66 and 65% of P,respec
tively. After long—term fo1low—up12 months)the
incidence of Hwas 30%(13/43),significantly higher
than that of antenatally H(4/43,pçO.025),renal fun
ction,deteriorated in 20%,normalised in all cases
and the persistence of proteinuria in 6%(3/43)was
suggestive of a renal disease.
Therefore the classification of H in P in groups
selects the high risk fetuses and pregnancies(group
I) and a PP long—term survey detects 30% of establi
shed H and 6% of renal diseases.
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• SALT PREFERENCE IN PREX3NANT HYPERrENSIVE RPTS.
.
Dal Canton A,Altonnte M,Conte G,Esposito C, Romeno
G,Sabbatini M,ticcello F,Veniero P and Ilndreucci yE.
Opt of Nephrology, 2nd Faculty of Medicine, Naples.
This study was carried out in feffale Munich-
Wistar rats in which a silver clip (0.2 ate) was
placed on the right renal artery. Since this nmneu
ver mey raise systolic blood pressure (BP) to a
variable degree, BP was measured daily (tail-cuff)
and only rats with BP steadily between 140 and 180
nsa Hg were included. The rats were allowed to recov
er for 15 days after clipping, then were housed in
individual metabolic cages, in which tap water and
0.41% saline solution were available (2—bottle,
self—selecting test). The rats were allowed to ac
custom to metabolic housing for 1 week. Then, a
group (n=9) were meted (Pregnant Hypertensive rats,
PH). Others were used as Non-Pregnant Hypertensive
controls (n=14, NPH). The rats were fed a chow with
0.12 xtsrcl NaCl/g. Metabolic studies were performed
during gestation (the corresponding period for NPH),
and consisted of daily measurement of saline, tap
water and food intake, urinary and fecal Na excre
tion. Daily introduction of saline averaged 28.1 ml.
in PH and 13.9 ml in NPH (p< 0.01). Daily tap water
intake was 10.8 and 14.1 ml, respectively (NS).
Total Na intake averaged 3.4 mEl/day in PH and 2.3
rnFi/day in NPH (p< 0.01). Total Na excretion was
2.7 mEg/day in PH and 1.6 niEq/day in NPH (p< 0.01).
Daily apparent Na retention was equal in PH and
NPH. These results indicate a nsmrked saline prefer
once in PH, that is secondary to increased urinaryloss of salt.
ILNIN AUIIOTEJ6IN PUX1ERf'E (RAft) SYSTEM fiN) N IiERGIC SYSTEM
IN er&iuy iimD HYPERT9IO' (PIN)CRiITCAI RCFI IL IlL STI-i
14&.AIIVE OITIS N13 CF TIE LABILITY (F ILIXI) P SS1JL IN TIE
P,SSESE){I CF hEIR PA1}mlYSI(IIXIICPL RILE. F IEVE P. FOIJRNICR
5., TRIBIXIT B., C471[A B., COEVOETB CHU Amiens,
Because of the previous conflicting results as regards the evalus
tion of the RAA system and of the adrenergic system in PIP, these
systems were evaluated in 2 studies performed in different condi-
tions of stimulation (basal condition i.e. blood drawn through
iridwelled catheter after 30 miri of lying position and stimulative
'rrrditions I.e. blood drawn Irasedlatly rite, v iprrrrctwe after 5
mm of sitting position), in which the hypertensive patients
(blood pressure . 140—90 ra*lg after the 20th week of pregnancy)
were distinguished Into permanent and labile l'IH according to the
response of their blood pressure to home bed rest. Plasma renir,
activity (PRA) was lower in permanent PIP than in control only ir
basal conditions and higher in labile than in permanent in both
conditions. Plasma aldosterone (PA) was lower in permanent PIP
than labile PIH only in basal condition Plasma epinephrine (Pt)
and norepinephrlne (PIlE) are not different in the - groups in ba—
sal condition but, in stimulative condition. are significantly
igher in permanent PIP than In control and labile PIP, in basal
condition a negative correlation was found between PPm and 10gw-
ritren of PIE when the 2 hypertensive groups are considered (r
..0.457;n=32;p<.01).Conclusjon 1/ The condition o stimulation
are critical in the evaluation of the role of the adrenergic sys
tem which is unmasked only in stimulative condition and of the
role of the RAft system which is masked on the cotrary in the
vane stimulative conditions. 2/ The classification of the pa-
tients according to the response of their blood pressure to home
bed rest is also important since permanent hypertension is cha-
racterized by'a readily reactive adrenergic system arid a low sti.
mulated renin secretion whereas labile hypertension Is characte-
rized by high renin secretion and normal adrenergic system. 3/In
v1p there is an unphysiological negative correlation between plosi-
ma renin activity and plasma norepineprrrine suggesting the role
1 .r factor simultaneously able to stimulate rrsnin secret ion and
tu decrease norepineptirine release or vice—aersa.
VALUE OF ROLL-OVER TEST (ROT) AFTER THEOPHILLINE
(THP) IN THE PREDICTABILITY OF PREGNANCY-INDUCED
HYPERTENSION (PIH).
N.Di Paolo,M.De Mia e E.Gaggiotti.(Intr.by A.Sodi)
Nephrology Department University Hosp.Siena - Italy
In PIH predictions,discrepancies in results are
due to the great number of false positives which we
have attempted to eliminate in this study.
Prostaglandins are known to be involved in the
mediation of vascular reactivity to Angiotensin II
(A II) during pregnancy and this reactivity is
modulated by cyclic nucleotides.To increase
adaptability of vascular walls we administered THP
which is a known inhibiter of phosphodiesterase and
is thus able to increase cellular levels of cyclic
AMP.176 patients between 28 to 34 weeks' gestation,
with no known history of renal disease or
hypertension were given the ROT.36 subjects then
took the A II test. 67 received 500 mg/die Qf TIIP
for 4 days after which ROT was repeated. All 176
were routinely followed throught pregnancy. ROT
was correct in only 44,18% of PIH prediction. A II
test was valid in 80%.
ROT after THP was exact for 85, 71%.
Statistical evaluation showed no difference
between A II test and ROT after THP (P<0,1), while
there was a significant difference between ROT
without and with THP (P<0,001).
EFFECTS (F EVENIP PRII4a] OIL(EPO) (N PLATELET fl.NTIO(S (Ii-
RIMI PR(U1ANY IN PATIENTS WITH HIEM RI1( (F TOXEMIA. F iévet pa
Tribout B. Castier Btm. Diévnl Jaw Capiod 3C", Delobel .Jwtm,
Coevoet B,". Fournjer A. - CPU - eflrifln AMIENS
EPO is particularly rich in lirroleic acid (350mg per capsule)
and ganana linolenic acid (45mg per capsule). Supplementation
with these polyunsaturated fatty acids has been reported to be
associated with a decrease of blood pressure (BP) sod a decrease
of platelets aggregability, possibly through an increase of PIll
production. Therefore the effect of EPO on platelet functions
was studied in pregnant women with "high risk of toxemia" i.e.
ahith anamne of toxemia, in utero premature death,hypertension
or nephropathy. 15 pregnant women were included into the study
and randomised into a treated group (7 pts) receiving 6 capsules
of EPO and a placebo group (8 pts) receiving 6 capsules of olive
oil. They were included respectively after 18.2 and 15+1 weeks
of amenorrhea. Before inclusion and after 7 weeks of treatment
were measured:BP platelet count, bleeding time and various
test of platelet aggregation (AOl', collagen, ristocetin, arachi-
donic acid). Mean PP decreased from 99.4 to 94 rrrsflg in the trea-
ted group whereas it increased slightly in the placebo group (94
versus 96 rrinHg), whereas antihypertenaive treatment was increa-
sed Only in the placebo group. Bleeding time increased in the
treated group (3.60.2 versus 4.AO.6 mn) whereas it decreased
in the placebo group (4.40.4 versus 3.8+tJ.6 sin). No significant
change was observed in either groups for the various tests of
platelet aggregation except as regards the frequency of platelet
desaggregation (after aggregation induced by 0.5'of APP), which
increased in the treated group (from 40 to 50%) whereas it de-
creased in the placebo group (from 62 to 25%). No significant
chanpes were observed in the other parameters VIII related an.
tigen, VIII coagulant activity, platelet factcr 4,ttiromboglobu.
ho and fibrinopeptide A. co'ciUSi : Although preliminary,
these results suggest that EPO may decrease blood pressure and
influence platelet functions mainly by enhancing desaggregation,
a phenomenom which may be valuable in the prevention of toxetnis
and of in utero premature death.
RENIN AMIIOTENSIN A1JX)STERUE (RAR) SYSTEM AN) AtIEtLJGIC SYSTEM
IN PREQ*CY IPUJiED HYPERTENSI(1 (PIH) .CRITICAL R(LE (F TI-F STI-
MLATPIE CIU)ITI(*IS AM) OF TI-F LABILITY OF a0(x) PHESSLUE IN TI-F
ASSES9.ENT OF TI-FIR PA1TIFHYSI(IiXICAL R(LE. FIEVET P. ,FOURNIEP
A., TRIBOLJT B., CASTIER B., COMOY E.— CHIt Amiens,Roussy Villejuif
Because of the previous conflicting results as regards the evalua
tion of the RAP system and of the adrenergic system in PIH,these
systems were evaluated in 2 studies performed in different condi-
tions of stimulation (basal condition i.e. blood drawn through
indwelled catheter after 30 sin of lying position and stimulative
conditions i.e. blood drawn immediatly after venipuncture after 5
mm of sitting position), in which the hypertensive patients
(blood pressure > 140—90 mmHg after the 20th week of pregnancy)
were distinguished into permanent and labile PIH according to the
response of their blood pressure to home bed rest. Plasma renin
activity (PRA) was lower iii permanent PIH than in control only ri
basal conditions and higher in labile than in permanent in both
conditions. Plasma aldosterone (PA) was lower in permanent PIH
than labile PIH only in basal condition. Plasma epinephrine (FE)
arid norepinephrine (PNE) are riot different in the 3 groups in ba-
Sal condition but, in stimulative condition, are significantly
higher in permanent PIH than in control and labile PIH. In basal
condition a negative correlation was found between PRA and loga-
rithm of PNE when the 2 hypertensive groups are considered (r=
—0.457;n=32;p<.01).Conclusion : 1/ The condition of stimulation
are critical in the evaluation of the role of the adrenergic sys-
tem which is unmasked only in stimulative condition and of the
role of the RAP system which is masked on the contrary in the
same stimulative conditions. 2/ The classification of the pa-
tients according to the response of their blood pressure to home
bed rest is also important since permanent hypertension is cha-
racterized by a readily reactive adrenergic system and a low sti-
riulated renin secretion whereas labile hypertension is characte-
rized by high renin secretion and normal adrenergic system. 3/In
PIH there is an unphysiological negative correlation between plas
ma renin activity and plasma norepinephrioe suggestirg the role
of a factor simultaneously able to stimulate renin secretion and
to decrease norepinephrine release or vice—versa.
RENAL RESPONSE TO PREGNANCY IN 5/6 NEPHRECTOMIZED
CHRONIC RENAL FAILURE IN RATS. D.Herzog,A.Iatne, D.
Cohen,I .Serban, S.Gavendo, S.Kapuler,HE.Elia1ou.Dv-pt.
Nephrology,Chaim Sheba Med.Ctr, Tel Hashomer,52621,
1 rael.
The experiments were done in 60 day old virgin rats.
Four days after I6 ncphrectorty, 3 females were put
for 72 hrr with an adult male rat. The fenales were
then placed in metabolic cages for fluid intake
UV , liv , UV , liv determinations. Seven ratsNa K Cr prot
were pregnant(Group F) and delivered normal litters,
1.0 rats were not pregnant (Group C,control). Creat—
mine clearance(Ccr),FE ,FE oH 0 were measured 211hNa T 2
before slating and 21t hrs after delivery.
Cc r
uI/mm
________
GROUP P(n7)
Before 327+72
After 525+70*#
GROUP C(nlO)
Before 338+5l 1.3+0.1 ,8÷0,5I 6,6tu,7
After J76+R(i 3.1+0.7__l2.9+3*j 257+3E3
Mean-+-SE. *p(005 compared. with the before values.
#p(O.05 compared with Group C's respective period.
Before mating, all parameters were similar. After
delivery, Group P had significantly higher Ccr and
lower FEN & PET H20, while protein excretion became
similar when compared with Group C. During pregnan-
cy fluid intake, UVNaUVK were higher from day 3
IJV, UVprot from day 12 when compared with Group C.
CONCLUSION:A very reduced renal functional mass
with an already high work load, is capable of a
significant further increase in its glomerulo—tubu—
lar function in response to pregnancy.
ATENOLOL TO PREVENT PREECLAMPSIA IN CHRONIC
HYPERTENSIVE PATIENTS.
G. Gregorini, R. Majorca, 0. aden, L. Danti*,
1. Frusca, B. Samaja*
Opt. of Nephrology, Spedali Civili; dept. of
Obstetrics and Gynecology, University of Brescia,
Brescia, Italy.
34 patients (pts) (age 32 were perspec-
tively followed during 36 pregnancies (p). Severe
hypertension (PAD 120 rmnHg) was present in 3,
moderate (PAD 110(120 mmHg) in 12, mild (PAD 90<
110 mHg) in 19. Six had nephropathies, 1 renal
failure. Atenolol (50-100 mg daily) was started
before or at the beginning of pregnancy to keep
PAD under 90 mmHg. Hydralazine (50-100 mg/daily)
was added in 9 pts. Preeclampsia (acute worsening
of hypertension, generalized oedema and protei-
nuria) occurred in only one (2%) (our data in
normal population 1.7%, alphametildopa—hydra-
lazine group 5/23, 21%). No intrauterine death
occurred. Mean birth weight was 2.614 533 g, 14
babies (38%) had a weight less than 2500 g., 11
(30%) were small for dates (SGA) (our data in
normal population: mean birth weight 3.300 450,
babies less than 2500 g. 4.5%, SGA 2.3%, alpha-
metildopa-hydralazine group mean birth weight
2.722 691, babies less than 2.500 20%, SGA
8.6%).
We conclude that Atenolol is highly effective in
preventing preeclarnpsia but it does not normalize
or it affects the fetal growth.
ANGIOTENSIN—Il—SENSITIVITY AND PROSTAGLANDIN—
EXCRETION IN PREGNANCY DURING SODIUM—BALANCE.
14.J.M. Jaspers*, A.W. Mulder, P.A. de Jong.
Catharina Hospital, Eindhoven, St.Lucas Hospital,
Winschoten, The Netherlands.
In 6 normal primigravidas (group I) and in 9 pri
migravidas with pregnancy—induced—hypertenstion
(group II), we measured A—Il—sensitivity (effective
pressor dose=EPD, ng A—h/kg/mm) ,tetranorprostandi
oicacid (TNPDA, ng/24h), POE2 and PGF25(ng/24h) and
Na (mmol/24h) in 24h. urine, before and 7—10 days
after a strongly Na+_restricted diet and bedrest.
Results: Group I Group II
+ Na+ — Na+ + Na+ — Na+
Na+ 15
EPD 28.3±10.3
TNPDA 456±167
POE2 875±190
PGF2, 5152±1002
F2jE2 9.9±4.9
EPD increased signif. in group I (pO.OOB, Wil—
coxon) and in group II (p=O.OlO). Na+_excretion and
POE2 were correlated before Na+_restriction(p=0.O3)
Before Na+_restriction no significant differen-
ces were found in TNPDA, PGE2, PGF2,, or the PGF2,(/
/PGE2 ratio between the two patient groups.
After Na+_restriction there was a decrease of
PGE2 in group II and a decrease of PGF2, in group I,
which did not reach levels of significance. The
ratio PGF2/PGE2 became significantly higher in
group II (pO.O3, Wilcoxon).
Concl.: 1.Na+_restriction results in an increase
of EPD. 2.Na+ does not influence EPD by changing
renal prostaglandin synthesis. 3.Na+_balance is re-
lated with PGE2—exc. 4.After Ns+_restriction normo—
tensive primigravidas show a more favourable F2,/E2
ratio with respect to the vasoactive properties of
these prostaglandins than hypertensive primigravids.
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FE xlOONa
1.0+0.
2. 2+0.6#
FETCHP0 I0Tprot mg
xlOO f5hrs.
8.5+2.5 10.5+2
5.2+l*# 208+Th*
97
12. 6±4. 9
4 64± 153
977±2 19
5 884± 1583
6.7±1.1
101
11. 0±5. 2
577± 186
7 14± 132
7 875± 1557
15.0±4.1
15
18.6±5.7
45 1±215
44 7± 139
7 92 2 964
40. 2± 12. 5
RTNAL AFFECTI ON S AND PREGNANCY EVAWA-
TION OF SOME PROGNOSTIC CRITERIA
H. Jbveva, A. Astrug D. Doichinov
Medical Academy, Sofia, Bu.Lgaria
Kidney diseases exert a patho.Log±ca.1-
influence on pregnancy (P) and vice ver-
se. In an attempt to elucidate these in-
terrelationships 722 women with different
renal affections 86 of them with toxemia
of pregnancy (TP were observed before,
during and after P. Detailed cJ.inical,
laboratory and immunological tests (Ig,
C, lymphocytotoxins detrmined by di—
réct cross—matching or donor pannels)
were carried out. Tn 74 women with se—
quelae after renal biopsy was perfor-
med. In 70.2 per cent of them diffuse or
focal—serental mesangia). proliferative
lesions along with 1gM, C and fibrin de-
posits in g±omeruliend inarterioJ.es we-
re found.In spite of these renal damages
the natural course and the outcome of a
next p were usually not adversely affec—
tcd by the underlying kidney disease. In
84.8 per cent of 79 new P supervised by
us took a norml course.
In conc±usion the prognosis of a p
in women with renal affect ions seem to
be not .Lways discourging. D norme± re—
nal function and by negative roll—over
an cross—matching testes next P may be
cuccess:Lul with a :eaterni anJ fete.i.
-ell—bcing. This descnds on a sufficient
aduetment of the -'other's constitution
a careful supervision and trentrw-nt.
ABNORMAL RENAL FUNCTION IN HYPERTENSIVE
PREGNANT WOMEN : REVERSAL BY LTFT LATERAL
DECUBITUS
M.Labeeuw, N.Pozet, A.Hadj Aissa, M.Vincent
Ch.Bizollon, Ch.Rudigoz, P.Zech
Clinique de Néphroloqie, INSERM U 80,
Hôpital E. 1-lerriot, Lyon, France
A comparative study was undertaken in 7
normotensive non pregnant controls (C) and
24 pregnant females : 17 normotensive (NP)
and 7 hypertensive (HP). The following pa-
rameters were measured blood pressure (BP,
mmHg), creatinine and uric acid clearances
(CCr, CUA, mi/a) fractional sodium excre-
tion (FeNa %), plasma renin activity (PRA,
ng/l/min) and aldosterone (A, picoM/1) af-
ter one hour of dorsal decubitus (DD).
Their mean values are
BP CCr CUA FeNa PRA A
C 107/62 2.07 .23 .72 43 296
NP 118/66 2.78 .31 .73 246 638
HP 135/79 2.04 .24 .73 230 673
CCr, CUA, PRA, A are significantly hig-
her in NP than in C. CCr and CUA are signi-
ficantly decreased in HP vs NP.
The relative changes (%, mean values)
induced by one hour of left lateral decubi-
tus (LLD) and compared to those observed
during a second hour of DD in C (Cdd) are
BP CCr CUA FeNa PRA A
C —8/—l4 —18 —9 +22.4 —12.5 —43.6
Cdd +4/+3 —12 —6 +32.6 — 5.9 +15.9
NP —7/—13 —12 —7 +15.3 — 7.3 —30.6
HP —13/—18 +19 +36 +59.8 — 5.2 —38.7
The response to LLD is identical in NP,
C and Cdd. In HP, LLD is associated with a
significant improvement n CCr, CUA, anti
FeNa which reach values identical to those
observed in NP.
ICA NEPHROPATHY (IGA N) AND PREGNANCY
P. JUNGERS, D. FORGET, D. DROZ, M. HENRY—AMAR,
Department of Nephrology, Necker Hospital, France.
Reciprocal influence of I5AN on fetal outcome
and of pregnancy (P) on the course of renal disea-
se was retrospectively evaluated in 34 patients who
had at least I P after the apparent onset of IgAN,
and were followed—up for a mean (+ ISD) duration of
7.2 + 5.1 (range, 1—20) years after last P.
Of a total number of 69 P (including twins), 50
(72 7) ended in full—term and 9 (13 7) in premature
delivery (with 3 perinatal deaths), and II (15 7)
in spontaneous (7) or therapeutic (4) abortion.
Overall rate of livebirths was 80 7, mean birth—
weight was 3200 + 500 g (1900—4800g). Of 5 P (in
4 pts) complicated by renal failure (RF) which pro—
existed in 3 cases or developed in the 3rd trimes-
ter in 2 cases, 2 ended in early abortion plasma
creatinine was 212 and 266.imol/L and hypertension
(HBP) was present in both P. Fetal loss was signi-
ficantly more frequent when HBP preexisted or deve-
loped early in P (5/10 cases) than in P without HBP
(7/42) or when HBP developed late in P (2/17, over-
all Chi—2 pO.Ol). At end of follow—up, 9 pts (26
7) had chronic RF, but rapid progression (within 1
year of last P) to end—stage RF was observed in on—
ly 3 pts, all of whom had RF before index P. Perma-
nent 1-IBP was present at end of follow—up in 17 pts
(50 7), but was significantly more frequent in pta
who had HBP during at least I P (12/14, or 91 7)
than in pts who never had HBP in any P (5/20, or
25 %, pCO.OOI, relative risk 3.7).
In conclusion, P was most often successful in
IgAN and had no demonstrable adverse effect on re-
nal function, but onset of HBP in P was highly pre-
dictive of subsequent permanent hypertension.
NO14P.L PREXANCY AND PBE-EICL?MPSTh: IMMUNOUXIICP.L
PATTEPNS.
S.Ianperi, S.Carozzi.
Division of Nephrology,St.Martin Hospital,Genoa,
Italy.
Some inmunological parameters were studied du-
ring pregnancy in 24 prirnigravidas and these data
were compared with those observed in 28 ccntrol wo-
men who had never been pregnant. In the 14 women wi-
th normal pregnancy (NP) a reduced percentage of ma-
ture T—lynphocytes (Ofl3) and helper cells (OKT4) ,a
fall in plasmatic interleukin 2(p-Th2) and urina-
ry interleukin 1 (u—ILl)activities, in PHA-induced
lyaphocyte transformation index (PHA-LTI) and in dela-
yed hypersensitivty skin test (DHST) positivities we-
re found. Simultaneously ,an increased percentage of
suppressor cells (Oicr8) and of spontaneous lyrtphocytE
transformation index (SLTI) was observed. In 10 pre-
gnant women who showed pre-eclampsia (PE) ,a decrease
of ORP8 percentage and of SLTI ,simultaneously to a
greater decline of p-IL2 activity, PHA-LTI and DHST
positivity,in comparison to NP ,was found. C the
ccntrary ,OKT4 percentage and u-ILl activity in the
same conditions showed a significant increase.
The results show that in women with PE the im-
munological data are opposite to those observed in
women with NP. In the first case, in fact there is a
trt patological immunological pattam,in particu-
lar as regards strcsaal cells such as nonocytes anL
macrophages ,indicating abnormal reactions between
anther and foetus;in the second case, cm the contra-
ry,only an impaired cellular inune—responsiveness
is present.
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HORMONAL REGULATION MECHANISMS OF CALCIUM
METABOLISM IN PREGNANCY
SLorenai,C.Lornbini ,B.Agazia,P.Marchini,F.Angoletta
R.Dittadi°,R.Mione°,M.Gionb,M.Saba*
Div.Nefrologia-Dialisi; Div.Radioterapia; *Djv.Oste_
tricia—Ginecologia,00.CC.RR. ,USSL 16 — Venezia
(Intr.by E.Saporiti)
The A.A.evalueted the calcium(Ca)meta.bolism
with longitudinal study in 15 women during uncompli
cated pregnancy(P)and in 15 volontary unpregnant wo
men,healthy and of the same age as control group.
Ca-tot,Ca,PTH,CT,25—OH-D3,HPL were determined at
the 12th,24th and 38th week of P.During P an increa
se of PTH,ccnsidered physiological by A.A.,doesn't
emerge;The 25-OH—D3 values result higer during the
entire P compared to those of the control group;the
Cavalues are superiors to the control group ran-
ges and more evidently in the last 6 mths of p. 25-
Od-D3 and Caappear to be the most involved ele-
ments in the hormonal homeostasis of Ca metabolism
in P.The increase of 25—OH—D3,pre—hormone,trasfor—
me to 1,25 (OH)2 would determine an increase of the
intStifla] Ca absorbtion.Estrogens with a'water -
salt'retention mechanism would determine,with a o—
therwise trough renin—angiotensin system,a saving
of the urinary Ca loss for the close connection of
tubular transport machanism.The increase of intesti
nal absorbtion associated with the saving action of
the urinary loss,would mantain the Ca vslues wi-
thin)and above)physiological ranges in spite of vo
luaes expansion,the increase of glomerular filtra-
tion and foetal Ca subtration contribute to the re
duction of the Ca pool in pregnant women.
MENSTRUAL DISTURBANCES IN ADOLESCENT GIRLS
WITH CHRONIC RENAL FAILURE (CRF).
K.Schbrer,M.Kratzmeier,G.Gilli,D.E.MUller-
WIefel
Univ.Children's Hospital Heidelberg, F.R.G.
The initiation of regular menstrual cy-
Cles is a precondition for fertility. About
50% of adolescent girls entering terminal
CR1' at 15 yrs fail to have inenarche (M) be—
fore this age which is regarded as the up-
per normal limit (Proc EDTA18:60,1981) .Men—
strual status on conservative treatment(CT)
for CR1' and its subsequent course on hemo—
dialysis (HD) and after transplantation(TP)
have rarely been studied in pediatric pts.
We investigated longitudinally 20 girls
aged 17—22 yrs at last observation who star-
ted CRF at 15 yrs and had an adequate his-
tory of pubertal development. At last as-
sessment 4 pts were on CT, 6 on MD, 2 on
CAPD and 8 after TP. At the age of 15 yrs
M had failed to enter in 2/10 girls on CT
and in 6/9 on HD. Following institution of
MD only 1/15 pts experienced N, in contrast
to 8/9 after TP, although the event was
thereby often delayed. At full puberty
cycles were usually regular in early stages
of CR1' but irregular in more advanced CRF.
Amenorrhea occured in 2 girls with persis-
tent ncphrotic syndrome on CT. Transient
oligomenorrhagia was found in 3 pts on HD.
The mean interval between thelarche and
menarche was normal (2.1 yrs) on CT but was
prolonged on HD. Bone age at time of N was
higher than normal (>'i4 yrs) in 6/13 pts.
The data let assume that later fertility
is severely reduced in female pediatric
pts with CRF.
URIC ACID(Ua) RENAL HANDLING DURING GSTATION(G);
A IDNGITUDINAL STUDY.
F Malberti,M Surian,P_Cosci,B Corradi,E Benazzi*,
G Colussi*, L Minetti*.
Renal Units,Cpedale Maggiore,lodi and Niguarda—Ca
Granda Hospital ,Milan*, Italy,
Eliring early G,plasnia ua(PUa) decreases as a con
sequence of the increase in Ua clearance(C1Ua),pre
dominantly caused by the rise in GFR. It is still
disputed whether alterations in fractional clearan
ce of Ua(FEUa) may explain the increase of PUa,as G
progresses,to values approaching the non pregnant
levels of PUa, Therefore we studied 10 women during
3 periods of a normal G (I:6tFLl6th; II:l7t1_26th;
III:27th week—term)and 3 months after delivery or
the and of lactation(C).
PUa UUa/Ucr FEUa ClUa FLUa
mg/dl mg/g % ml/min mg/mm
C 3.8+0.7 413+82 9.1±2.2 8.8±2.5 4.0±1.0I 2.6+O,6 496±l4cN2.2±4.l* 16÷5.4• 3,91-1.6
II 3.l+0,7 551±148 9.2±4.5 14.2+G.OA 5.4±1.7.III 3.5+0.7 676±l62ll.l±3.6 l4.6÷6.4 4.6±1.0
vsC p •=0.05; a=0.02; •=0.005; * =0.001
GFR is increased dring G(I:l59462 ml/min;II:155
p.O.O5 vs C:lO8+2),PUa decreases
during period I and II and normalizes during period
III. C1Ua and uricosuria(Ua/Ucr) are persistently
increased during G. Luring period I,the high FEUa
values with normal Ua filtered load(FLUa) suggests
that reduced fractional tubular reabsorption of Us
contributes to hyperuricosuria and high C1Ua values;
as C progresses FEUa normalizes and hyperuricosuria
is caused only by the increased CFR and FLUa.
In conclusionsin early C the increase of FEUa and of
GFR determine the increase of C1Ua and the decrease
of PUa.Towards the term of C the normalization of
FEUa is accompained by a increase of PUa.
DECREASED URINARY KALLIKREIN EXCRETION
PRIOR TO DELIVERY IN PREGNANCY INDUCED
HYPERTENSION:
R.Sipila, N.Jalkanen, K.HuotariWihuri Research Institute
Helsinki, Finland
Urinary kallikrein excretion (UKE) was
studied in 10 patients with pregnancy
induced hypertension (PIH), defined as blood
pressure elevation over 140/90 in multiple
measurements, first detected after 24 th
gestational week in previously normotensive
pregnancy. Some patients had also daily
proteinuria over 300 mg (preeclampsia)
The gestational age was determined from bi—
parietal diameter measured ultrasonically
in l7th—l9th gestational week. 24—hour
urinary samples for UKE were collected both
in 32nd-36th gestational week (preterm) and
1—5 days prior to delivery after full 37
gestational weeks. DEE was determined by
using chromogenic tripeptide KABI S—2266
and expressed as nanokatals/24 hours. We
observed a decrease in UKE from 9.7 in pre—
term to 5.75 prior to delivery. The decrease
was statistically significant (p< 0.02) . In
preterm the difference in DEE between norno-
tensive pregnancy (12.6) and PIH (9.7) was
not significant. Prior to delivery UKE is
significantly lower in PIH (5.7) than in
normotensive pregnancy (10.8, p< 0.02).
Decreased DEE probably reflects changes in
renal kallikrein—kinin system caused by
hypertensive pregnancy. It remains uncertain
whether these changes influence extrarenal
hemodynamics or circulatory disturbances
observed in patients with PIH.
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THE ROLE OF INTRAVASCULAR COAGULATION IN ACUTE
RENAL FAILURE (ARF) PREGNANCY RELATED
P. Stratta, C. Canavese, L. Colla, C. Tetta, M.
Dogliani ,A. Vercellone
University Institut of Nephrology, Torino, Italia
To investigate the role of coagulation disorders
in obstetric ARF,25 cases were reviewed: 4 bilater-
al cortical necrosis (BCN), 1 focal cortical necro-
sis (FCN), 18 acute tubular necrosis (ATN), 2 late
post partum hemolytic uremic syndrome (HUS). 5 pa-
tients died (20%); 1 remained on RDT, 2 hsd a par-
tial renal recovery and 17 (68%) full recovery.
Clotting studies showed undetectable fibrinogen
within 5 hrs from partum in 2/2 BCN and 3/4 ATN,
and levels<l5O mg/dl within 24 hrs in 3/3 BCN and
6/9 ATN. Platelet mean values at 48 hrs after par—
turn showed no significant variations (66.2+16.9 in
5 BCN and 69.0+19 in 13 ATN) and no significant
correlation with days of anuria in the ATN group.
AT III values resulted 60% within 48 hrs in 2/3
BCN and 3/6 ATN. FDP were increased in 3/3 BCN and
3/3 ATM. Schistocytes were found between 5—30%,. in
3/4 BCN, 1/2 HUS, 8/10 ATN, and> 30%. in 1/4 BCN,
1/2 BUS, 2/10 ATN. LOU values were > 1000 U/l in
2/2 two H(JS, 2/3 BCN and 4/5 ATN.
Coagulation disturbances owing to placental com-
plications (i.e. abruptio placentae(AP)) don't seem
greater in BCN than in ATN. Predisposing factors
such as endotelial damage of preeclampsia—eclampsia
(PE—E) need to induce irreversible ARF, as support-
ed by the fact that all 4 AP had complete recovery,
while 3 out of 5 AP following PE—E showed BCN. He—
parin doesn't seem able to provide more favourable
outcome (all the 4 BCN and 1 FCN had been given
heparin, 3 immediately after partum).
IlR0VEtNT OF RENAL FUNCTION DURING PREGNANCY (P)
IN PATIENTS WITH A CADAVERIC RENAL ALLOGRAFT.
A.M. Tegzess, S. Meijer, G.H.A. Visser, J.M. Swart,
N.J. van Son, F.J. van der Woude and W.J. Sluiter.
University Hospital, Groningen, The Netherlands.
In a retrospective study the course of the serum
creatinine concentration (SCr), 24hrs creatinine
clearance (CrC1) and 24hrs creatinjne excretion
(CrE) was investigated before, during and after P
in order to evaluate the potential functional re-
serve capacity of the renal grafts. Nine P in 8 re-
cipients (R) 2—7 years after grafting were studied.
All R's were normotensive before P, 3/8 without and
5/8 with antihypertensjve medication. Only 2/5
showed a moderate rise in blood pressure during the
third trimester. One case of an asymptomatic pro—
teinuria did not worsen during P. Rejection episo-
des did not occur. Steroid medication was maintain1
in a dose of 10 mg/day. The azathioprine dose was
reduced from 1.5 to 0.75 mg/kg/day.
A B C 0 E F
Med SCr imol/1 97 80 75 74 89 93
Med CrC1 ml/min SO 91 IOS II3 83 92
Med CrE mtnol/24h 12.0 11.8 12.4 12.7 11.6 11.7
A=preconception, B, C and D= first, second and
third trimester, E and Ffirst and 2—12 nths post
psrtum. ++=p< 0.01, +p( 0.02 in relation to A.
Despite the fact that the median CrC1 before P
of these cadaveric renal grafts seemed to be maxi-
mal, a significant improvement of the CrCl could
be observed during P. The fall of the SCr was also
significant. These changes, as well as the physio-
logical hemodilution (Hc41, are identical with
those observed in normal P. They indicate a pre-
sence of a functional renal reserve capacity and
the absence of a permanent state of maximal hyper—
filtration in these single cadaveric renal grafts.
GLOMERULONEPHRITIS/GN/ AND PREGNANCY.
L,Szalay, Ca.Göndocs, E,Dulka, E.Magyarossy,
.J,Fehór.
II.Dept,.Med.and I.Dept.Pathol.and Exp.Cance
Res. ,Zemnelweis Med,Univ. ,Budapest,Hungary.
Results /x.,.SD/ of 37 GN patients/pta! with
different iTistoiogy having So gravidity has
been analysed.GN was started between 1965—82.
Imaunosuppression was used in l3pts,Tino
elapsed between symptoms and gravidity vard
1—17 /6+4/ years.Clinical forms of GN was
nephrottc my in two cases,others showed asmm—
ptomatic urinary abnormalities.In all but ore
pts kidney function was normnal,snd in only
five cases B? was slightly elevated.
During pregnancy edema in 22 pts,preecc1arnrs
in 5 cases,uririary infection in 7 occassions
woe observed.There were three abortions: in
one of them patient iad an elevated serum
oreatinine value,in the second case a neph—
rotic sy.From the remaining 47 pregnancies
49 alive babies /28 girls,2l boys! were
delivered.Newborns weighted between 175o and
4o5og /3o2o++6l/, in 4 of them weight was
under 25oog.All but one babies are healthy.
There was no maternal death or loss of babi
either,
There is no change in kidney function before
and after pregnancy.All pts are alive and in
only one is creatinine above 3oo uaol/1.
Results show that:l.pregnancios are succes—
ful in GN pta having asymptomatic urinary
abnoraalitiee,although higher incidence of
abortion,edema,preecclampsia was observed.2, pregnancy is not alter progression of GNin these cases.
3. previous insunosppression does not seem
to contraindicate pregnancy in itself.
QUANTITATIVE MORPHOLOGY OF POST PARTUN RENAL
BIOPSIES.
O.Th.Uttendorfsky, Ooms E.C.M. Oort, J. Stolte,L.
(Intr by P.L.Oe)
Department of Obstetrics and Pathological Inst.
Free University, De Boelelamn 1117, 1007 MB
Amsterdam, The Netherlands
Since in eclamptogenic gestosis renal impairmentis a prominent feature, investigation in to the
origin of the disease has frequently been directed
towards kidney function and morphology.
The present study consisted of a histological
examination of renal biopsies, obtained in the
puerperal period, from 17 patients who suffered
from proteinuria and hypertension during pregnancy.
The glomeruli were subjected to a quantitative
morphology examination. On clinical grounds the
patients were divided into 4 cstegories:A)non—
pregnant controls with minimal changes;B)genuine
gestosis with dysmaturity;C)superimposed gestosis
with dysmaturity and 0) superimposed gestosis
without dysmaturity. It is concluded from our
data that eclamptogenic gestoais contributes to
an extensive increase (proliferation) of mesangial
cells, in less degree a proliferation of endo—
thelial and epithelial cells and a marked enlarge-
ment of glomeruli. In case of dysmaturity the
number of endothelial cells is less increased
(p<O.O5).
CALCIUM, BONE, PTH
REVERSAL OF OSTEOMALACIA IN CHRONIC DIALYSIS
PATIENTS WITH HEJiVY IRON AND ALUMINIUMLOADING.
R.Ahmed, P.Ackrill, J.P.Day, J.Denton,
A.d.Freemont, C. Hewitt, H.J.Goldsmith.
Dept. of Nephrology, Royal Liverpool Hospital,
and Depts. of Chemistry and Rheumatology,
University of Manchester, U.K.
5 anaemic patients on haemodialysis for over 8
years received multiple blood transfusions,monthly
intravenous iron, and oral iron. All presented
with severe bone pain and 3 with fractures. Trans—
iliac bone biopsies were examined for iron and
aluminium using Pen's re—agent and acid solo—
chrome azunjne. Bone marrow and trabeculae were
separated and analysed for iron and aluminium by
atomic absorption spectrophotometry.
All patients showed osteomalacia. lron was
demonstrated at the omteoid mineralisation
junction in 3 patients and also within the bone in
2. In all patients the aluminium content of
trabecular bone was high — range k3l — 175 ug/g,
and the iron content very high — range 3772 — 650
ug/g. (dialysed control patients normally less
than 100 ug/g). Trabecular iron content corre-
lated with the serum ferritin which ranged from
1566 to 8020 ug/l.
All patients reannded symptomatically to
Desferrioxanine (DFO) within a few weeks, the rise
in serum aluminium being similar to that in a
group of patients with aluminium accumulation
alone.
Thus iron may accumulate within bone and at the
calcification front in a similar pattern to
aluminium and may be a factor in the development
of osteomalacia in these patients. also heavy
iron 1oadin does not appear to interfere with
aluminium removal by OFO.
lNrWX5X]2 VflNffN D tAaLfam TPE?SMRNF: 1'l'S ITI0r4SHIP
Wrfll SEIUI miuen (F) UNn%1. N4) P BI NDSrTI8.
JB Cannata, J Paniagua, M Galbe, MV Cuesta, M Hoza, V Feral,J Herrera. Hospital General de Asturias. Universidad de
Oviedo. Spain.
It has teen recently suggested that vitamin 0 Wit 0) netainl-
ites(net) cculd inpair serum P control In chronic renal failure,
making necessary to increase the P binders. Hiver, nost of
these studies have teen done with Vit 0 net doses higher than the
sean-dose currently used.
Therefore, the sUn of this study was to evaluate the short and
Icog-terin effect of intrcducing 1.25 Vit 0 (current-dose)cn serum P
ccntrol and P binders necessities in 40 hamninialysis patients
followai-up during last twa years. turing the whole study wa
rnantained the sane dialysis and diet schedule)13.5—lS (is/seek;
12 g/}(g protein) and patients received P binders (Aluminium hydro
xide )Al(CH) 3)and/Or calcium carbaaate) ,cnce or twice daily,
according to their protein intake patterns, to keep serum P
between 1.5—1.8 nenl/l.
As the table shows 2 ntnths (m) after intruduclng 1.25 Vit 0(0)(sean: 0.18 pg/day), serum P had a significant increase. The
Al (OH) intake had a slight (not significant) increase and the
percenage of patients who kept the serum P under control with-
cut using F binders decreased. Patients with high iron stOres had
lower basal values of-serum F, hot after intreducing 1.25 Vit 0
they showed also a significant serum P increase. After 6 a (48)
of 1.25 Vit 0 treatnent ,serum P started decreasing ,reachmg 6 s
later (+12) nearly pre—Vit 0 treatnant values.
Pre—values 0 + 2 + 4 + 8 + 12
2.2902 2:38±02 2.38+02 2.39402
Serum P
(rem/i)
1t
1.25 VitO
(pg/day)
1.1041.1
0.18
X 1.89404
1.2741.2
21%
0.19
1.78405
—
1.2540.9
14%
0.19
1.75±05
1.2410.9
13%
0.19
1.69405
—
1.2640.9
10%
0.19
TRANSIENT HYPEROXALURIA AFTER INGESTION OF
.
FOOD RICH IN OXALIC ACID(OA)AS A HIGH RISK
FACTOR FOR CALCIUM OXALATE CALCULI
P.Balcke,J. Zazgornik,G.Sunder Plassmann,
H . Kopa a, F . Gre mme 1 , L .Wagner, K. De r f 1 e r
I.Med.Clinir,University of Vienna,Austria
Dietary factors are involved in the pa—
thogenesis of idiopathic calcium oxalate
stones.The intake of dietary OA is believ-
ed to be of minor importance since only a
negligible increase of total urinary OA
excretion(E)was noted in 24hour samples
after ingestion of food rich in OA.
We studied in 6 male volunteers the diurn-
al variation of urinary CA E after ingest-
ion of bog chocolate('225n;gCA).The fast-
ing urinary OAK was ),o+o,26mg/h.After
ingestion of the chocolate a striking in-
crease was found.The OAF rote to 2,23+
o,36mg/h withi.n 2 hours and to 2,89+o,6
mg/h within 3 hours(t7,6),pO,ooI,t=8,64,
p(O,00().This peak E was 2892 of the init-
ial value.Thereafter OA S fell rapidly to
the fasting value within l;ours.yhen onl:j
5og of chocolate was ingested the peak 0$
i-: after 3 hours was 254% of the prevaloe.
The administration of ranitidine did not
decrease the S rate.Our data show that
food rich in UA causes a transient hvper—
oxa lot i a ui c h was as S i ;h as i n case s
e'ith primary hyperoxaluria.'fliis liftS risi.
factor is not reflected in 2-i I1rnr sir Its
since in our volunt:eers total Lrinarr' VA
E(4,834,45sigIdsy)eas only -ir hipher
than the fasting value and was litlin tie
norunil r:inge (<4lnig/dav) . ISo roan) Laerr,li
size the strikiii' irportanco dietorviA
reutri cti on in cases tiltS nopicrol i tI; as) s
VITNUI D ?FALr1, HYPEI5PARATH1CIDISM Nt I54 STtES: rrslTIPWITh JliJM WjatL RPrI.
JB Cannata, niriguez-Foza H, F,llende 9W, Gonzalez-Carcedo A.
A De Miguel, J Carrillo. Hospital General de Asturias. Faculta-
des de R'edicina y Ciencias OiImicas.Universidad de Oviaio.Spain.
The risk of aluxsinium)Al) ateorpticsi f ran Al—containing phos
phate binders is alnost warldwide accepted. Recently, several
factors have been blared of enhancing Al, tI-arefore,its study
have a great interest as they wsJ Id help us to recognize the
Al-hyperathorter patients )pts)
The aim of this study was to evaluate the influence of 1.25
vitamin D)Vit D)treatxrent, parathyroid honrnee(PrH) levels anddifferent iron (Fe) stores in Al gastroitestinal absorption. We
studied 29 hamandialysis (MD) pta dialysed with the sane schedule
using low-Al dialysate. Curing tie basal period all pta received
aluminium hsrox1de (Al (OH) in the dose they ware currently (isv
thg to maintain serum phoshorus under control (1.5-1. &mol/1).
In tine 0 ferrcus sulphate was stoped and during seven days all
of then received tie sane dose of Al (OH) (2.8 g/day) skiitbaut
intrcducing other changes.Serurn Al was sasured by ICP in tUco
o and after the seven days of Al (OH)3 Overload.
We did not find any striking influence of 1.25 Vit D treat-
sent or basal senan Ff1 levels. The effect of Vit 0
enhancing Al ateorption,was seen only in those pts with low-
normal serum ferritin levels(table( .Regardthq PTH, pts with very
high basal leves(rrean:6.6 ng/nd; normal values:(i.5 ng/ml) hal
loser basal serum Al concentration, bit after the Al (OH) over-
load they showed the propartionally higher serum Al incrase
areng different PIN grcups,fran 2.1 to 3.7 unol/l(78%) despite
the 2.8 g dose did not sean for then a big change.In respect of
Fe stores we fcund a significant negative)p(O.C05) correlation
between serum Ferritin (sFerr) and serum Al levels pre and past
surcharge. Al: basal valuen 0 Al: Post-overload
whole grcup:2.642.0 wtle grcup:3.8±2.6X sFerrCSO:2.9 sFerr)25O:1.7 sFerr(25O:4.5 sFerr)250:2.O
% Vit D whole grcup:2.8+l.6 whole grcup:3.6+2.7
a p<O.O5
This results suggest the sore ljTortant fector regulating Al
gastrointestinal absorption seera to be Fe stores • Vit 0 rretatolites treatnent and Ff4 levels wa.ild play a sary role as
they cculd increase serum Al only if there is no Fe overload.
Fran cur findings we could think that SFerr might be a gixd pre
dictor of likely Al absorption and maybe a useful index to
select patients at risk of Al hyperatsorpticn while undergoing
Vit 0 netatolites treathent.
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Pt: patients x:pO.Os5 )oC:pu.W4a
Cur results suggest that during the first m of treatment, 1.25
Vit 0 wmild inçiair the serum P ctrol increasing nederately the P
binders necessities. Nevertheless, there is no a clear long—term
effect, likely due to an increased P bane uptake maybe secondary
to changes in (male mineralization induced by the 1.25 Vit 0.
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COMBINED SCINTIGRAPHY AND ULTRASONOGRAPHY
IN THE LOCALISATION OF PARATHYROID ADENOMAS
IN PATIENTS ON RDT.
G. Csppelli, P. Zaniol, B. Talia, 0. Barbolini,
F. Romsni, M. Leonsrdi, E. Lusvsrghi
Nephrology snd Dialysis Unit, Radiology Institute,
University Hospital, Modens, Italy.
Instrumentsl locslisstion of parathiroid
(PT) is up to day a difficult problem in the
diagnosis and treatment of secondary hyperparathy—
roidiss (HPT).
We cospared high resolution ultrssonogrsphy
(US) and scintigrsphy with Technetium—Tallium
subtraction scanning (SC) in 37 patients on
ROT, divided in 3 groups according to biochemical
snd X—ray hone findings of secondary HPT.
PT hyperplssis was detected in 89% and
57% of total patients by SC and US respectively;
in the group with greater severity of HPT
(iPTH > 8 ng/ml) the detection was 100% by
SC and 69% by US. Either SC or US showed an
hyperplssis sostly in the lower glands (72%
and 90% respectively). In the mild HPT group
(iPTH C 3 ng/ml) SC was doubtful in 23% of
patients while US in none. Looking to single
gland detection, SC was doubtful in 19% while
US in 3%; one gland only remained doubtful
combining the two methods.
Therefore the combination of SC end US
can be regarded as the most accurate method
for the detection of PT hyperplasis in patients
on ROT.
MFt*Cfl€NT OF PCIST-PAPATHYROIOECTOMY (Pm)
HYF€CALC8IIA IN HEMODIALYSIS (FE') PATIENTS:
LISEFIJLI'ESS OF 1,25 diCH VITFfIIN D3 (CALCIFRIOL). F.
C1eSr. L. Leenhardt', D. Robert', 3. Zingraff', C.
Oubost' end 1. OrUeke'.
Hâpitaux Necker and F. Widal, Paris, France.
Severe, prolonged hypocalcemia is observed in
scme, but riot all, lID patients after (PTh) performed
because or uncontrolled P4s'perparathyroidism. The aim
of the present study was to investigate whether
calcitriol and Ca supplementation in the ininediate
post—PTX period was of more help in the control of
plasma Ca than Ca supplementation alone. Forteen 14)
patients were enrolled in a prospective, randomized,
double blind and placebo controlled study. From the
dw after PTh seven patients received calcitriol and
the remaining seven a placebo using incremental doses
adjusted to the degree of hypocalcemia (upto4ug/dayfor calcitriol). Pre—PTX plasma Ca, P, alkaline
phosphatases and 1PTH were comparable in both patient
oroups, as was the lowest plasma Ca achieved in the
post—PTh period. The mean decrement of post—PTX (days
3 through 9) as compared to pre—PTX plasma Ca was
hcmever less pronounced in calcitriol treated than in
placebo treated patients (0.25±0.06 561 vs 0.45±0.05
nil, p<0.025). Moreover, treatment with placebo was
interrupted before day 14 because or persistent
severe hypocalcemia in 4/7 patients whereao
calcitriol treatment was continued in all 7 patients
up to 14 days, i.e. the end—point of study. Finally,
patients on calcitriol treatment needed less mean Ca
supplements (days 1 through 9) then patients
receivingplacebo(37.4±3.2vs49.4±3.7g, p<O.O2).
In conclusion, oral calcitriol when given to
dialysis patients during the immediate post—PThperiod is associated with a lesser degree of
hypocalcemia and reduced need for Ca supplements.
ACCUMULATION OF ALUMINIUM DUE TO ALUMINIUM
HYDROXIDE INGESTION IN PATIENTS WITH CHRONIC RENAL
FAILURE (CRF)
*S.N. Channon, **H,A. Ellis, *M.K. Ward.
Departments of *Medicine and **Pathology, Royal
Victoria Infirmary, Newcastle upon Tyne, NE1 4LP.
The aluminium content of iliac crest bone
biopsy samples from patients with CRF was measured
using wet digestion and flameless atomic
absorption spectrometry. A section of each biopsy
was examined histologically after staining with
aluminon (ammonium salt of aurine tricarboxylic
acid). The mean aluminium content of bone biopsy
samples with a negative aluminon stafn wss 18.5 ug
aluminium/gram dry weight (ug/g) (n=45, SD= 10.9
ug/g, range 7.0—61.6 ug/g), while the mean
aluminium content of biopsy samples with a
positive sluminon stain was 81.9 ug/g (n=12,
SD=54.4 ug/g, range 42.0—225.7 ug/g).
Ihere was a significant correlation between the
aluminium conrent of bone (range 7.0—69.4 ug/g)
and the total dose of aluminium hydroxide
prescribed (range 0—5279 g) (n=47, Spesrmans rank
correlation coefficient r5 0.83, p<O.OOl).Patients not treated at any time with oral
aluminium—containing medication had a mesn bone
aluminium content of 12.9 ug/g (n=18, 50=4.4 ug/g)
while patients who had received oral aluminium
hydroxide and had been treated by CAPD and/or
haemodialysis (with water purification — Al<5
ug/l) had a mean bone aluminium content of 29.4
ug/g (n23, 50=14.6 ug/g). In the few patients
studied who had received oral aluminium hydroxide
and haemodialysis prior to water purification the
meanbone aluminium content was 53.1 ug/g (n=6, SD
=13.8 ug/g). Continuous oral medicstion with
aluminium—containing phosphate binders leads to
progressive accumulation of aluminium in bone and
probable long—term pathological consequences.
• SHORT- AND LONG-TERM EFFECTS OF 1,25(OH)2D3 (1,250)
ON BONE GLAPROTEIN SERUM LEVELS IN PREDIALYSIS CRF
G.Coen, S.Mazzaferro, G.Donato, F.Bondatti, A.Landi,
C.Massimetti, A.Smacchi , G.A.Cinotti.
(Intr. by M.Taccone Gallucci)
Div. of Nephrology, Univ. La Sapienza, Rome, Italy
Serum Bone GLA Protein (BGP), produced by the os
teoblasts, is elevated in CRF and increases with
advancing renal damage, in spite of the known 1,250
deficit. The effects of 1,250 treatment on BGP was
studied in 22 pts with CRF. 11 pts (age 48.1±14.9
yrs; Cr1 4.38±1.2 mg/dl, M,SD) received I ug daily
for 2 weeks. 11 pts (age 54.4±14.5 yrs; Cr5 4.28±
1.52 mg/dl) were treated with 0.25 ug/day for 1 year.
Blood for iPTH, BGP and AP was sampled before and
at end of treatment and stored until measured each
in the seme assay. iPTH was measured with a C-term
RIA (n.y. 0.34±0.19 ng/ml) and BGP with a RIA using
bovine antiserum and standard (n.y. 3.9±1.4 ng/ml).
Administration of 1,250 for 2 weeks induced a fall
in iPTH (1.8±1.3 to 1.5±1.1 ng/ml, p<0.02) while
BGP increased (p<O.005) from 24.2±16.9 to 32.2t16.3
ng/ml. AP did not change significantly. Long-term
treatment with 1,250 induced a fall in iPTH (1.9±
1.6 to 1.3±1.0 ng/ml, p<O.O5), BGP (18.0±10.0 to
10.1±8.9 ng/ml, p<0.001) and AP (p<0.002).
In conclusion short—term administration of 1,250
in predialysis CRF induces an increase in BGP lev-
els, probably due to direct stimulation of the os-
teoblasts. Long-term treatment with 1,250 causes a
parallel decline in iPTH and BGP, presumably due
to prolonged suppression of sec.hyperparathyroidism
and reduction in number of the osteoblasts.
COMPARATIVE EFFECTS OF ALFACALCIDIOL AND
PARATHYROIDECTOMY FOR RENAL BONE DISEASE
T. Cundy, D. 0. Oliver, J.G.G. Ledingham, C.G.
Woods, J. A. Kanis.
Metabolic and Renal Units, University of
Sheffield, Beech Hill Road, S1O 2RX, UK.
One of the hopes of treatment of renal
osteodystrphy with alfacalcidiol is to achieve a
medical parathyroidectomy'. Whereas many reports
have documented satisfactory clinical, biochemical
and radiographic responses, the histological
responses of bone, particularly in haernodialysed
(HD) patients, may be less complete. Part of the
problem of assessing the efficacy of alfacalcidiol
has been the lack of data comparing the responses
to surgical parathyroidectomy (PTX). We studied
12 HD patients before and 11 months (mean) after
PTX, and compared the results to those obtained in
14 MD patients similarly studied before and after
22 months (mean) of alfacalcidiol treatment. Only
3 of the PTX patients had previously received
vitamin D. The two groups were matched for age
and sex, mean plasma alkaline phosphatase levels
and prevalence of subperiosteal erosions on
radiographs. All had significant and comparable
degrees of osteitis fibrosa on their initial bone
biopsy. Plasma alkaline phosphatase levels showed
comparable and significant reductions in both
groups (p<O.O05) and subperiosteal erosions healed
similarly. Quantitative histology of trahecular
bone showed that mean values for the active
formation and resorption surfaces and the marrow
fibrosis score decreased significantly after PTX
but did not change after alfacalcidiol. We
conclude that the histological responses in HD
patients are less complete after alfacalcidiol
than after PTX and that alfacalcidiol infrequently
achieves a complete 'medical parathyroidectomy'.
UREMIC THROMBOCYTOPATHY: THE ROLF O
SECONDARY HYPERPARATHYROIDISM tHFT)
D.Docci,F.Turci,L.Baldrati,C.DelVecchio,
E.Pistocchi (Intr. by S.Stefoni)-Servizio
Emodialisi,Laboratorio Analisi,Ospedale
M . Bufalini, Cesena,Italy
Recent in vitro 5tudy suggests that PTH
may play a role in the pathogenesis of ure
mic thrombocytopathy.We tested this hypothe
sis in 42 hemodialysis (HD) patients, i8 of
whom '.ere studied before and 6 months after
treatment with l,25-DHCC.Secondary HPT .'as
evaluated by serum biochemistry PTH,calci
um,phosphorus,al aline phosphatase) and ra
diographic examinations (hand skeleton).
ADP induced platelet aggregation was used
to assess platelet function.1O sex and age
matched normal individuals acted as contra
ls. plats'let aggregation was significantly
altered in HD patients.3 parathyroidectonsi
zed patients had values in the same range
as other HD patients.No correlation between
Platelet aggregation and the biochemical
changes associated with secondary HPT was
found.No difference in platelet aggregation
was observed as to the activity (alkaline
phosph.) and the severity (X-ray findings)
of secondary HPT.Effective treatment of se
condary HPT was not associated with conse
quent improvement in platelet aggregation.
It is concluded that secondary HPT is proba
bly not a major factor influencing platelet
function in HD patients.
ORAL. ACNZHZSTRATIOt OF 1,25 DIHYD)XYCHOLHCAI.—
CIFERDL. DOES DZRECThY SUPPRESS P1'!! SECRETL(I
Ui PATX1TS WITH CHNIC RESAL FAIWRE.
AH Pt !9ngc, J. Hall, RSC Rodger, MJD2Cassidy
JR Gleed , C.J Robinson, b Ward, t(S Kerr
Dept.. of Medicine an Physiology, University of
Mewoastle upon Tyne, D9pt. of Medicine, Middlesex
Hospital, London, and Royal Postgraduate Medical
School, London, U.K.
A.lthough 1,25 dihydroxycholecalciferol
(1, 25( OH )2D ) can effectively suppress parathyroid
gland oveiL,tivity it ie uncertain whether this
effect is due to a direct action on the parathy—
roid glands or mediated indirectly via a rise in
plasea calcium. Thi. study was designed to invee—tigate the acute action of 1, 25(OH)2D3 on PT!!
secretion, independently of changes in plasma
calcium, in patients with chronic renal failure
and secondary hyperparathyroidism.
Six patients in chronic renal failure (plasma
creatinjne a400 umol/L) with elevated serum PTh
levels and histological evidence of osteitis
tibrosa were studied for up to nine hours after a
single oral dose (2 ug) of 1,25(0!!) D . Despite a
significant increase in serum lj5OH)2D3 fromlow/undetectable levels to normal or above normal
levels (pO.O1), serum PT!! levels, measured using
an amino terminal specific assay did not differ
significantly from control values obtained on the
previous day. Additionally serum ionieed calcium,
total calcium, phosphate and magnesium values were
not significantly different from the basal values
measured prior to 1,25(0!!) U3 administration.
Since changes in PTh Jcretion can be detected
within 15 minutes using this amino terminal
specific assay these results indicate that
1,25(OE)2D3 does not have an acute direct effect
on the secretion of PT!! in patients with chronic
renal failure and secondary hyperparathyroidism.
PREVENTI( (F OSTEWYS I RI)'HV BY CaCO3 1W) U'I HYPERCALCEMIC IX)SES
CF 25 (II VITAMIN D3 IN PATIENTS WITH I4TaRATE RENAL FAILIJE.
FOURNIER A1,IDRISSI A,SEBERT JL1,CALY C1,CAROBEDIAN M2,MORINIERE
P1,REANUO H1 -(1) CHU - AMIENS -(2) Hop NECKER - FuRlS - FRAMI -
Prevention of renal osteodystrophy by suppression of diary
products,oral supplement of 3g of CaCO3 and of non hypercalcemic
doses of 25 OH 03 was assessed in 21 uremic patients with an ini-
tial Cr clearance 15—43 ml/mn.For that purpose blood and urine
phosphocalcic parameters and creatinine were measured every 3
months 4 times before starting the treatment and then at least 4
times in all and 8 times in 17 patients.The doses of 25 OH 0 sos
10 pg in group 1(13 patients)and 25 or 50 •ug in group 11(6 and 2
patientsYplasma 25 OH O(norrnal 25—75 mol/1)increased signifi-
cantly from 15 to 24 in group I and from 24 to 102 in group II.
Plasma 1,25 OH O(normal 50—150 pmol/ml)increased non significan-
tly from 84 and 82 to 100 and 98 pmol.Plasma creatinine increaser
from 3.5+1 Omg/dl to 5.0.1.5 the second year.The slope of l/SCr
however decreased from 50 to 3O.1O3dl/mg/month.Plasma PTH(C ter-
minal)increased not significantly from 140÷70 to 180÷70 pg/si the
2nd year. Alkaline phosphatase decreased from 150+70 to 130+40
(p<.05).Plasma calcium remained stable at 2.35 mol throughout
the study.Plasma P04 increased from 1.14 to 1.45 mmol(p<05).Uri-
nary calcium increased significantly from 0.11 to 0.22 nasol/mmoi
of creatinine.TmPO4/GFR increased in group II only.Plasma bicar-
bonate remained stable at 25 mol.A bone biopsy after double te-
tracycline labeling was performed before and after 15±3 months of
prevention in 12 patients.Osteoid voiume decreased significantly
(p<.05)from high values(5.3±3)to normal value(2.8+3% TBV);osteoid
thickness remained normal.Oateoblaatic surface decreased signifi-
cantly from 2÷2 to 1÷1(%TTS).Active resorption surface decreased
from 2.9±2 to 2.1÷2(normal < 1).Mineral apposition rate remained
normal at .45+1 u/d. CONCLUSIONS : 1/The above measures are ef-
fective in the prevention of hyperparathyroidism worsening in
spite of the progressive decrease of GFR since they decrease
biochemical and histological indexes of PTH activity. 2/They
prevent the occurence of osteomalacia and acidosis. 3/They do not
accelerate the speed of CFR decline.
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() PPISSrE EFFECT (F SELLCTIVE ( 101 SELECflW TA-
ODcERS 4 PARATI1y1X HYPERTIc4 IN tJIENIC PATIOITS. GeLY C
COOET ',MP<0ASSI R, COEVOET 8,FOURNIER - CHU - MIENS -
Suppressive effect of betablockers(A)on parathyroid secretion
in uremic patients is controversal.It has been reported mainly
with propranolol a non seiective(i in patients on hemodialysis i.e
with unstable phosphocalcic pararneters.To better answer the ques-
tion,the effects on plasma concentration of C terminal parathyroi
normon(PTH)of propranolol and of betaxolol(a selectiveg)were com
pared at the end of a 1 month placebo period of a 2 subsequent
periods of 2 months during which 12 hypertensive uremic patients
received either propranolol(PR:160 mg/day)or betaxolol(BX 20 mg/
day)and then the otherp, .Their initial plasma creatinine was bet-
ween 142 and 471 iimol/l.The decrease of BP and of the heart rate
was the same with the 2 .PPTH(normal range 20-45 pg/ml)did not
significantly decrease with either(131 under placebo;117 under
PR and 135 under BX).There was either no significant change with
both drugs for plasma creatininemia(262 /jmoL/l under placebo; 278
under PR;270 under BX)and for plasma,calcium,phosphate,bjcarbona—
te,alkaline phosphate or urinary excretion of phosphate and so—
Jium.However calciura significantly increased with BX(.116 to
.136 mol/arnol of creatlnine;p<.05)but not with PR(.120).Statis-
tical analysis with multiple components showed that when the para.
meters influencingpotentially the filtrate load of calcium(plas—
ma concentrations of creatlnine,calcium,protein)are kept Constant,
the cnange of calciuria with BX is still sigriificant,these para—
rnet€rs explaining only 50% of this change.The parameters potentia1
y influencing the tubular reabsoprtion of Ca(PTH,plasma,bicarbo_
nate,natriuresis)eaplained on the other hand only 20% of the chan4
ge and when considered simultaneously with the other factors, did
not increase the explanation of the change of calciuria with BX.
CONCLUSIONS :(1)The suppressive effect of propranolol on PTH hy—
nersecretion in uremic patient is not confirmed.(2)Betaxolol has
neither such effect but increases caiciurja.(3)The increaseofcal,
Ciuria is explained only at 50% by the known parameters potentiai+
sy influencing the calcium filtrate load or its tubular reabsop—
eion.This suggests that BX acts by a mechanism iridepent of these
factors.(4)None of these 2 has a deleterious effect on the glome-
fuIr filtratIO,1
INSULIN RESISTANCE IN PATIFNFS ON C[RONIC HEtDDIA-
LYSIS:A CONSEQUENCE OF LONGSTANDIYC AND SEVEBE
tYPERPRATHYROIDISM 7
Ilraf,J.Kovarik,R.Prager,A.Luger,G.scherothaner,2 Dep. of Internal Medicine,Univ.Vienna,Austria
• In order to evaluate the potential role of para-
thyroid hormone (Fm) on glucose metabolism in pts
on chronic hemodialysis (CEID) a hyoerglycemic clamp
study was performed in 11 pta on CHO with moderate
renal EH(NON—FD(),in 6 pts more than 24 months
nfter subtotal parathyroidectomy because of severe
HPI'H (Prx) and the results compared to healr.hy
controls (CON).
All pts were comparable concerning age,degree of
obesity and plasma Ca and P values.The hyperglyceinici
clamp study was performed after an 12 hours over-
night fast as originally described by DeFRONZO.CHD
pts were studied 48 hours past the last HO.
There was no significant difference in the amount
of glucose metabolized (NI) in either of the groups:
CON: M=lO+3,3;NON—VI'X: M=ll,7+4,8;PTX: M11,3+6,4.
the beta- cell reapoose to hyperglycemia duriflg the
steady state (I) was almost identical in CON
c59,8÷36,1) and in NON-PIX (7l,3÷4,2) wnereas it
the PTX group the values were markedly elevated
(143+133,8).Tissue sensitivity to insulin expressed
as NI7I ratio again was equal in CON (20,6÷10,2) and
'1ON—FFX (19,7÷7,9),prx pta (1l,6+6,7)showed signi-
ficantly lowered NI/I values compared to NON-FIX as
well as to CON.
Pta on CHD with only moderate renal HPTh (=NON-PTx)
show normal glucose nnetabolism.Peripheral insulin
resistance was found in FIX pts suggesting that a
longstanding and severe HE'IH as it is conanonly the
reason for parathyroidectomy is an etiologic factor
of impaired glucose tolerance of chronic uremia
shich can not be reversed by parathyroidectomy.
IS PARATHYROID HORMONE (PTH) AN UREMIC TOXIN?
F. Oiacchino, F. Quarello, 0. Oiraudo, H. Pozzato, H. Borca, 0.
Quattroochio, (3. Piccoli.
Medical Nephrology Institute of the University. Turin.
Dialysis Units. S. Oiovannl Hospital. Turin. Italy.
The effect of secondary hyperparathyroidism on I lymphocytes
in uremic patients was assessed during parathyroidactomy (PIX) in
4 dialysis patients. The capacity of normal lymphocytes to bind sheep
red blcod cells (E—RFC test) and monoclonal antibody (OKT II to E
recaptors - Orthoclone) was studied after incubation with sere
before end after PTX. These results were compared with date from in
vitro tests of E-RFC test when Pill was a1ed. The percentage of
inhibition (P1) of E—RFC with serum, markedly dacreesed after PTX
in 3/4 cases (38±6 vs 70.3*4.4 before PTX); 8-10 days later P1
increased (59±5) and the results were unchanged at weeks
2—3—4—12. The P1 of 01(111 positive cells dacreased after PIX in
4/4 cases(17±5 vs 59±4 before PTX) and no change was found in
the 10110w—up.
The fact that Pill in vitro inhibits the E-RFC capacity of normal
lymphocytes, at concentrations close to those found In uremia (P1
62*7), supports these findings, suggesting a possible role of PIll as
an uremic toxin inducing a lymphocyte impairment in chronic renal
failure.
EXTRARENAL PRODUCTION OF 1,25(OH)203 AND 24,25(OH)2
VITAMIN 03 IN ANEPHRIC PATIENTS.
G.Graziani, S.Casati, A.Cantaluppi, C.Castelnovo,
S.Adami,C.Pontjcefli.
Div.Nefrologia,osp.Maggiore Policlinico,Mjlan and
* Semeiotica Medica,Univ.verona,Italy.
To evaluate the existence of extrarenal loihydro-
xylase and 24—hydroxylase activity in organs other
than kidney, 150 pg of 25(OH)D3 were administered
daily for 15 days to 7 anephric dialysis patients.
None of them received vitamin D3 or derivates in the
previuos 6 months,or assumed vitamin 02 in the last
5 years.Patientsage was 47+14 years and the mean
dialysis time was 12±5 years.Plasma levels of 25(OH)
l,25(OH)2 and 24,25(01-1)2 vitamin D were measured
before and at withdrawal of therapy.patients compliance
to 25(01-1) therapy was confirmed bythe great increment
of plasma levels of the hormone from baseline (5.78±
5.0 vs 64.7±31.6 ng/mi; p< 0.O01).Pretreatment
plasma levels of 24,25(01-1)2 were 0.29 jO.25 ng/mian
increased to 0.99±0.87 ng/ml after therapy(p0,O2)
Baseline plasma levels of 1,25(01-1)2 increased from
6.1±3.6 pg/mi to 11.7±3.9 pg/ml(p<0.01)at with—
drawal,Our results indicate that 25(OH)dc, not accu-
mulate in anephric patients.Moreover,baseline 24,25
(OH)2 and l,25(OH)2 plasma levels were very low and
increased when pharmacological doses of 25(OH) were
given.This suggests an extrarenal,substrate dependeffi
activity of a loi hydroxylase and 24 hydroxylase. The
role of 24,25(OH)2 in the treatment of renal osteo—
dystrophy still remains controversial.However,therap
with 25(OH)D3 might increase the plasma levels of 24,
25(01.1)2 a vjt.03 metabolite not yet available.
. USE OF DIPHOSPHONATES IN POST-TRANSPLANT
HYPERCALCAEMIA
N.A.T. Hamdy, R.E.S. Gray, C.B. Brown, A.T.
Raftery, A.D. Paterson, J.A. Kanis.
Metabolic and Renal Units, University of
Sheffield, Beech Hill Road, SlO 2RX, UK.
Hypercalcaemia following transplantation is
most commonly due to hyperparathyroidism, which in
turn augments renal tubular reabsorption of
calcium and increases bone turnover. We have
investigated the effects of two diphosphonates,
specific inhibitors of osteoclast mediated bone
resorption, in transplanted patients with
hypercalcaemia. We studied 10 courses of
treatment using clodronate or aminohexane
diphosphonate (AHDP) in 8 patients with persistent
hypercalcaemia. The responses to clodronate (1.6g
daily) or AHDP (O.4'-O.8g daily) depended on the
mechanism of the hypercalcaemia. In 2 patients,
hypercalcaemia mediated by increased renal tubular
reabsorption of calcium alone failed to respond to
treatment. In contrast, in the patients with
biochemical evidence of increased bone turnover (8
courses of treatment in 6 patients) diphosphonates
induced a marked fall in serum calcium within two
weeks (2.91 + 0.21 to 2.76 + 0.l2mmol/l; p<O.O2)
due to a decrease in net calcium release from bone
(fasting calcium/creatinine ratio fell from 0.78 +
0.44 to 0.55 ÷ 0.41 mmol/l and urinary hydroxy—
proline from 58 + 27 to 38 + 18 pmol/mmol of
creatinine; p<O.05). These effects persisted for
the duration of treatment. Following withdrawal
of treatment, 2 out of the 4 patients thus far
studied relapsed. No side effects were noted. We
conclude that the use of diphosphonates in
transplant hypercalcaeeia provides an effective
probe for investigating its mechanism, and may
also he a valuable adjunct in the management of
these patients.
INDICATIONS FOR URINARY CITRATE MEASUREMENT IN THE
WORK-UP OF RENAL STONE FORMERS.
Ph .Jaeger,L. Portmann,A. F.Jacquet,P. Burckhardt
(Intr.by J.P.Wauters)
Dept of Int.Med.Univ.Hosp.Lausanne,Switzerland
The reported incidence of hypocitraturia among
stone formers(SF)varies between 15 and 50%.It isnot
known,however,whether this incidence depends on the
type of SF.The recent simplification of the method
of measurement of U—Citrate(Boehringer—Mannheim kit)
led us to adress this issue in 106 male idiopathic
(I)SF,with either normocalciuria(n42) ,or idiopa-
thic hypercalciuria of the renal(n=5),absorptive(n=
16)or dietary(n=43)type.Results were compared with
those of 42 male normal volunteers.7 patients had
hypocitraturia(2l5mg/24h),all of them belonging to
the group of normocalciuric ISF;only this group of
patients had mean U—Citrate (i significantly lower
than controls(43l±28vs 504±29mg/24h,p(0.05,5jSEM).
The cause of hypocitraturia in these patients re-
mains unknown:e.g.there were no significant corre-
lations between U—Citrate (i and U—pH or blood[HCO3]
or[Cl},and none of the patients had urinary infec—
tion;moreover,none of the patients with hypocitra—
tuna had signs of distal tubular acidification dys-
function as assessed by 3—day NH4C1—loading tests.
Extended to our whole population of 1SF whose 65%
have hypercalciuria,2% isolated hyperuricosuria,l8%
hyperoxaluria and 15% no apparent detectable disor—
der,these data lead to the conclusion that measure-
ment of U—Citrate allows to reduce the group of pa—
tients"w.ithout detectable disorder'to 9%.Since by—
pocitraturia can easily be corrected by oral admi-
nistration of citrate,routine measurement of U—Ci-
trate in 1SF without hypercalciuria—hyperuricosuria—
hyperoxaLuria appears promising.
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THE OPTIMAL CHLORTHALIDONE(CT)DOSAGE IN THE PREVEN-
TION OF RECURRENCE OF NEPHROLITHIASIS IS 25MG/D.
Ph.Jaeger,L.Portmann,A.F.Jacquet,P.Burckhardt.
(Intr.by J.P.Wauters)
Dept.of Int.Med.tJniv.Hosp.Lausanne,Switzerland
Thiazides are considered to be effective in the
prevention of recurrence of various types of nephro—
lithiasis,but the optimal dosis has not been defi-
ned.To address this issue,5 idiopathic stone farmers
with hypercalciuria on low Ca diet were administe-
red CT at 3 different oral dosages and were random-
ly assigned either to the sequence 25—50—loomg/d or
to the inversed one(2 months per dosis,monthly blood
and urine measurements).
CT dosis 0 25 50 100
UCaV(mg/d) 372±37 284±20 l82±7** 211*37*
UcitrV(") 621±196 611±165 495±185* 362±96*
Risk index 2.3±0.5 1.1±0.3* l.4±0.4** 1.0±0.3*
*p(O.O5,**p(O.Ol versus O,paired t—test;±SEM
The anti—calciuric effect of CT was significant
on1y at 50 and lOOmg/d at the expense of a dose de-
pendant decrease in U—citrate excretion.There were
also a dose—dependent decrease in blood levels of K,
increases in those of HCO3and urate,as well as in U—
pH,trends for blood levels of Mg and for U-oxalate
excretion to fall,and no change in U—urate excretion.
Therefore,to derive the optimal CT dosis,the Tise-
lius'risk index was applied which is based on the
values of urinary[Ca] , toxalate] , [Mg] ,[citrate] and
volume.CT led to a decrement in risk index which was
similar at each of the doses tested.Conclusion:rai—
sing CT doses beyond 25mg/d does not let anticipate
better protection;this agrees with Ettingers preli-
minary data (Urol Res 1984)showing similar protecti-
ve effect of CT at 25 and SOmg/d despite no signifi-
cant anti—calciuric effect at 25 mg/d.
MEDICAL TREATMENT OF PERSISTENT POSTTRANSPLANT HYPER—
PARATHYRO']DISM WITH 3—AMINO—1—HYDROXYPROPYLIDENE—1,
1-DIPHOSPHONATE. (APD). (Intr. by J.M.V. Mooy)
K.M.L. Leunissen(1), F—J.F.E, Vismans(2), J.P. van
Hooff(1). Dept. of Nephrology( 1) and Gastroenterology
(2) of the University Hospital Maastricht, Netherlands.
Beneficial effects of diphosphonates in lowering serum
calcium levels in primary hyperparathyroidism has been
reported, Moreover improvement of bone pain in some pa-
tients treated with dichlorometylene diphosphonate
(C12MDP) was noticed. APD is a diphosphonate that on mo—
larbase has stronger inhibiting effects on bone resorp-
tion. We want to present the preliminary results of the
effect of APD in persistent posttransplant hyperpara—
thyroidism. Until now two patients are treated with APD
l5Omgthreetimesadayorally, withafollowupof6
weeks. Both patients had a persistent hyperparathyroi—
dism, with bone pain and elevated serum calcium— ,alka—
line phosphatase and PTH levels,(Table I). The bone
biopsies and bone scintigraphies were compatible with
renal osteodystrophy. During treatment with APD bone
pain disappeared in one week and serum calcium levels
gradually decreased to near normal levels. Parathyroid
hormone (tIH: 1—o4)levels decreased considerabie! Af-
ter 6 weeks of treatment alkaline phosphatase levels
were increasing, whereas hydroxyproline excretion de-
creased. (Table I) -__________ __________Table I PATIENT I PATIENT 2
_________ I
2,05±0,05 2,65 93*0,05
A1k,1, phap-
ph.C..e 0/I5,: 30—125)
550±40 545 50*40 350
P,,lhy,±±d
flae.ae. pa1 p /1(,'<O.TO) 5.61 2.42 1.56 0.6
In conclusion our preliminary observations sug ?st an
inhibitory effect of APD on PTH release. Longteru effects
of this treatment especially on bone structure will be
presented.
Abstracts
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• DETERM1N1NTS OF SERUM CALCIUM LEVELS AFTER
RENAL TRANSPLANTATION: THE ROLE OF 1,25(01-4)203
PALUCaS, R.C.Brown.L. B1oodwortfl3.S.Woodhead, G.AColes
Departments of Renal Medicine and Medical Biochemistry,
Uliversity of Wales College of Medicine, Cardiff. U.K
Hypercaloaemia Is relatively common after renal trans-
plantation (RTX) but the factors responsible have not been
well defined.To Investigate the determinants of serum cal-
cium (SeCa) post RTX we measured serum parathyroid
hormone (1PTH), 1.25(OH)2D3, 25(OHX)3 and alkaline phos-
phatase (PIP) in 34 subJects (GFRs 15-90,rnean 46.9 ml,Thln)
after RTX. we also measured intestinal calcium absorption
(oral 47Ca given with 20mg elemental calcium, radioactivity
measured in plasma ten 60 mins later) in 17 RTX subjects.
VItamin 03 metabolites were measured by RIA, after lipid
extraction and HPLC; IPTH. by immunoradiometric assay.
with antiserum recodsing intact PTH.
Significant positive correlations were found between:
1) 125(OH)2D3 and SeCa (r = 1145 p<0.01). 2) 1..25(OH)2D3 and
fractional calcium absorption (r = 0.77 p<0.001).
To gain insight into tne mechanisms involved In determining
SeCa, we compared the levels of IPTH, AP and 1,25(OH)2D3
in RTX and chronic renal failure (CRF) subjects with the
same GFRs, 45-75 and 15—45 mI/mm. As results are similar
at both GFR levels, only GFR 45-75 mI/mm are shown
(mean SEM) CRF (n15) RTX(n14)
GFR (ml/min) 58.5±2.9 NS 54.7±2.1
SeCa (mmol/l) 2.21±0.03 p<11002 2.52±0.06(lu/I) 76.5±16.7 p<0.002 179.4±20.1
1Pm (ng/ml) 1.57±0.22 NS 1.81±0.57
L25(OH)203pg/ml) 27.9±2.9 p<0.05 44.1±5.7
25(OHJ3 (nq/rnl) 17.2±1.5 NS 15.4±3.1
(normal: IPTH. 0.350.21; L25(OH)2D3. 38.0±7.9; mean±SD)
Thus, both intestinal calcium absorption and SeCa were
proportional to circulating L25(OH)2D3 post RTX. Compared
with CRF subjects comparable in GFR and 1PTH, RTX
subjects had higher A?, 1,25(OH)2D3 and SeCa. l,25(OH)2D3
appears a major determinant of SeCa after RTX, increasing
gut Ca absorption and possibly bone Ca mobilisation.
BIOCHIICAL DTTEINAIT FACTORS IN SEROM LEVELS
OF OSTROCALCIN (oc) IN URiIC PATITS.
M H. Martinez,J.L. Miguel,R. Selgas,C. cle Pedro,
G. Blaguer, F. Escuin, L. Sanchez Sicilia.
laboratory and Nephrology Services. C. S. In Paz.
Madrid. Spain.
The osteocalcin is a non—colingenous bone
protein whose synthesis is stimulated by 1—25(OH)D
and can be used as an indicator of osteoblastic ac-
tivity. In order to see the posible influence of
other parameters of phospho-calcium metabolism in
the levels of osteocalcin in patients with urania,
we have quantified the levels of Ca (atomic absorp-
tion),P, PI'H—C tenninal (IRE), 25(OH)I) (protein —
Binding, Bulhmann + B1PLC) and alkaline phosphatase(iF) in 68 patients with chronic renal failure;22
on iTh, 32 on CAPD and 14 with GFR <21 nil/mm. (ciii).
The time on dialysis was greater than six months.
27 patients were receiving oral treatment with 1-
25(OH)D (IF), (O.25—o.5o,L4.g/dar) for longer than 3
months and 41 had no treatment (NTP).ESuVIS: We
find no differences in the levels of (OC),a,P,PTH
an iF in any of the groups studied (,CAPD, CRF, 2'P
and sr).However the CAPD group has a lower level
of 25(OH)D.Considering all the patients, we find a
correlation between (cc) and PTH, r 0.750, pO.OOl
25(OH)B, 0,370, pcO.Ol; AT, r 0.500, pO.Ol.In the (TP) these correlations are manteined, while
(NTP) have no correlation between (oc) and 25(OE)D.
The results are if we consider the groups
of HO and CAP]) separatly. The PPH/(OC) indice was
0.99 for (TP) and 1.25 for (NUP) but without a sig-
nificant difference. CONCLUSION: PTH sena to be the
principal factor on the levels of (oc) in ursis,
but 25 (OH)D also has some influenoe.The fact that(TP) have a positive core.ation, sesm to indicate
that besides of the 1—25(OH)D,adequate levels of 25(Oil)]) are related to this protein synthesis.
• REDUCED 125(OH2D3 MAY BE RESPONSIBLE FOR THE
DEVELOPMENT OF HYPERPPRATHYROIDISM IN EARLY
• CI-PONIC RENAL FAILURE
PALucas,R.C. Brown, C.R.Jones, as. Woodhead ,G.AColes.
Departments of Renal Medicine & Medical Biochemistry,
University of wales College of Medicine, Cardiff, UK..
It is generally accepted that hyperparatnyroidism (HP) may
develop early in the course of chronic renal failure (CRF) and
increased circulating parathyrold hormone TH) levels have
been found at GFRs as high as 70 mI/mm. However, the
precise pathogenesis remain controversial. Plasma levels of
1,25(OH)2D3 are low in advanced CRF ana in theory, a
reduction occurring in early CRF could give rise to HP.
Surprisingly few data are available as to 1.25(OH)203 levels at
the time, early in the course of CRF. when I—P begins to
develop. We therefore measured vItamin 03 metabolites (by
RIA, using antiserum 02282. after lipid extraction and HPLC)
in 52 adults, 11 with early CRF (GFR: 50—90 ml/min/1.73m2),
18 with more severe CRF (GFR: 20—50 ml/min/1.73m2) and 23
normal subjects. PTH was measured (by lmmunoradiometric
assay, using antiserum recognising the Intact molecule) in
most subjects. No subject had been treated with vitamin 0 or
any of its metabolites. No subject had protemnuria of more
than ig/24h. GFRs were measured by single injection of
5lCr—EDTA, avoiding the need for 24 hour urine collections.
(Serum 1.25(OH)2D3. serum phosphate and GFR: mean SD.)
Both CRF groups had normal serum 25(OH)03 levels and
elevated serum P11-I compared with normal subjects (p<11002).
There was a significant correlation between GFR and
1.25(OH)2D3 (rr0.54, p<0.01) from 20—90 ml/min/1.73m2 GFR.
normal early CRF moderate CRF
GFR(ml/mln/1.73m2) 1163±19.7 69.5±9.9 36.1±9.8
1,25(OH)2D3 38.0±7.9 30.9±9.9 21.1±10.9
(pg/mi) p<O.02 p<0.025
phosphate (mmol/) 1.18±0.12 1.14±0.28 1.43±0.61
We found significantly reduced serum 125(OH)2D3 and normal
phosphate levels early in tne course of CRF. Our findings
therefore support the contention that 125(OH)2D3 deficiency
may be a major factor In the development of HP early in CRF.
PROGRESSION OF VASCULAR CALCIFICATIONS IN
HEMODIALYSIS PATIENTS.
R. Matesanz, E.M.Escobar, L.Orofino, R.M.
Heraindez, A.Fernndez, L.Orte, J.OrtuGo.
Centro Ramdn y Cajal. Madrid. Spain.
The appearance or increase of calcifica—
tions of great vessels (GVC) was evaluated
in 342 follow up yearly periods of 155 liD
patients since the start of treatment (1-5
years) . At the start of HD 22% of patients
had GVC. Progression of GVC was found in -
37 periods (18%) , differenciated by an 01—
der age (49±7 vs 37±13, p<O.OOl), longer
hypertension history (75 vs 35 months, p<
0.001), greater Ca levels (9,25±0,6 vs 9,0±
0,9, p(O,05), with similar serum Cr, BUN,
P and AP, Ca C03 and (OH) 3 Al dosis and Ca
dialysate, while they received less vitamin
B (16vs43%) probably because of they were
considered higher risk patients for GVC.
There was no correlation with subperiostal
resorption, bone pain nor fractures, but
there was with pruritus (p<0,05) vertebral
osteopenia (p< 0,001) and small vessels cal
cification. GVC did not correlate with — ——
hypertension control, cardiomegaly nor EKG
changes. Beta blocker prescription was grea
ter in the group without GVC progression --(p 0, 01)
Previous vascular situation (age and hy—
pertension)in the face of slightly greater
Ca levels and some indirect signs of hyper—
paratiroidism seem to conditionate CGV pro-
gression. Beta blockers could prevent them
perhaps through the control of PTH and/or
hypertension.
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• IS UNRESPONSIVENESS OF Al-INDUCED OSTEOMA-
.
LACIA DUE TO CELLULAR 1,25(OH)2D3RESISTENC
MerkeJ., Helbing, F., Ritz, E., Dept.Int.
Med., Univ. Heidelberg, Germany (FRG)
Severe aluminium—induced osteomalacia is
known to be refractory to treatment with
1,25(OH)2D3 (Hodsman,Ann.Int.Med. 94, 629,
1981). This has been ascribed to diminished
bone cell density, i.e. number of target
cells for 1 ,25(OH)2D , but changes of 1,25
(OH)2D3 receptor status of target cells
have not been excluded. To further explore
this possibility, westudied 1,25(OH)2D3
receptors in epidermal cells (as probes for
poorly excessible bone cells) in Al—loaded
rats. Epidermal cells were previousLy shown
to express 1,25(OH)2D3 receptors (Merke,
Calc.Tiss.,in press). Male 379 g SD rats
(n=60) received by i.p.injection either sa-
line or Al (Cl)3 by daily injection for 4
weeks (total Al dose 38 mg). After 4 weeks,
Fib had decreased (15.8÷3.7 to 13.3+4.3g/dl)
as did MCV (65÷7.3 to 56±5.1 fi) and serum
Al levels (AAS) had increased (0.19+0.04 pg/
ml vs non detectable) . Epidermal ceLls were
isolated by trypsination flotation procedu-
re. Calcitriol binding as described pre-
viously (Merke, Eur.J.Biochem.130,303,1983).
Upon Scatchard analysis, KD was similar in
Al and CO (101°M). Maximal binding capaci-
ty (Nmax) was 49.4+6.2 fmol/mg prot. in
controls and 63.1+7.0 in Al. The data indi-
cate that Al intoxication of short duration
does not diminish phenotypic calcitriol re-
ceptor expression on calcitriol taraet
cells.
ALUMINUH COHTAIIiING ORAL PHOSPHORUS Nli,DERS hOD THE
ALUxINUR CONTEHT OF THE BONE
H. Raidt, N. Viscfiedyk, I. Kellinghaus, U. Stein—
hausen, U. Graefe
Oeiizinische Poliklinik der Westtdlischon hlihelms—
Universit3t, Ndnstei, F.R.C.
It has been generally assumed that alumjnui. in
antacids is noriabsorbable in the gut und thus these
drugs are safe in using thec. in high dosages as
ohosphate binders in uremia. However, there is in-
creasing evidence that orally administered aluminum
can be absorbed to a significant extent. Some forms
of bone disease seen in dialysis patients may be
hue to accumulation of aluminum in the bone. be
therefore investigated the impact of total oral el
(Oh) — ingestion(Alo) on the aluminum load of the
borie (PJ.b) in 54 patients on chronic intermit tent
hesodialysis. 19 patients had been equipped with
water softeners (w.s.) (group I) . 35 patients had
been using reverse osmosis water pretreatment(r.o.)
since initiation of dialysis treatment (group
II) . For the whole group of 34 patients a weak out
significant correlation between Ale and Ails car, be
found (r=O.504, p.O. 01) , whereas no correlation is
stated for Ale and Alb in group I (p>O.I). In group
II there was a highly significant correlation bet—
wean total ingested Al(o153 since the initiation
of treatSerit and aluminum content of the bone (r
0.003, p<U.OO1).
Aluminum contamination of the dialysate is the
most important cause in respect of aluminum cumula-
tion in dialysis patients. However, our results de—
montrate clearly that intestinal dose—relatea ab-
sorption of aluminum plays a sajor role in chronic
aluminum contamination as well.
. CALCITRIOL (1,25(OH)2D3) RECEPTORS IN URE-
MIA
Merke, J., Weber, A., Htigel, U., Ritz, E.
Dept.Int.Med., Heidelberg, Germany, FRG
Calcitriol plasma levels are low in ure-
mia but calcitriol receptor status and cal-
citriol responsiveness have not been estab-
lished. In a previous study (Merke,Calc.
Tiss.,in press) expression of calcitriol
receptors on basal epidermal cells and
changes of [HJdT incorporation with calci—
triol were shown. To study calcitriol recep-
tor regulation in uremia, basal epidermal
cells were studied in male NMRI mice 4
weeks after subtot. nephrectomy (NX) and
sham op. pairfed controls (CO). S—crea. was
1.3+0.32 mg/dl in NX and 0.34+0.05 in CO
(n=20 per group). Epidermal cells by tryp-
sination flotation and percoll gradient;
receptors as described (Merke, Eur.J.BioCh.
130,303,1983). Calcitriol binding by nuc-
lear fraction was specific and reversible;
half max. displace. of[H]1,25(0H)2D3 with
8OxM excess of 25(OH)D3 and 200xla(OH)D3.
Binding macrornolecule on sucrose density
gradient 3.5S, distinct from 6S tissue 25
(OH)D3binding prot. K was similar in NX
(1.3x1010M) and CO (B.7x1010M) ns. Maxi-
mal binding by nuclear receptors was lower
in NX (53.8±2.7 fmol/mg protein and 16.1+
1.3 fmol/100 g DNA respectively) than in
CO (82.5+3.9 fmol/mg prot. and 23.4+1.8
fmol/100 ig DNA). Receptor sites in epider-
mis of uremic animals are diminished or non
receptor bearing cells accumulate. Results
warrant closer evaluation of response to
alcitriol in target cells during uremia,
e.i.oarathyroid cells, bone cells
IMPORTANCE OF EXOGENOUS CALCIUM SUPPORT ON
SHORT—TIME BLOOD PARAMETERS OF UREMIC
OSTEODISTROPHY IN DIALYSIS PATIENTS
V.Rivetti,M.Baruffaldi, P.Ghiringhelli, F.
Pecchini
Hospital Division of Nephrology,CremOfla,
Italy.
60 chronic dialysis patients,divided in
six groups(6 to 14 persons),had a change,
different for each series,of osteoditro—
phy treatment: oral calcium supplements(1—
2 g/day)or vit.D(various drugs and doses)
carried out,calcifediol(300 ,4g/week)or cal
citriol(1,5,14g/week)added and finally cal-
cium dialysis fluid 4 mEq/L or dihydrota—
chysterol(0, 15—0,30 mg/day)respectively re
placed by 3 mEq/l fluid and 1,5,4g/week
calcitriol. Phosphorus(P) ,total(Catot) and
jonized(Ca)calcium,alkaliI1e phosphatase
(AP),protidemia and parathormone(PTH) were
valued before and after three months chan-
ged treatment.
PTH,AP(p' 0,05)and P(p -0,01 )increases
and Ca0t_Ca1(pL0,05)redUCtiOfls were se-
en following to exogenous calcium lighten-
ing due to oral supplements withdrawal or
reduced dialysis fluid calcium;while only
lower Ca++ values after calcifediol addi—
tion(p.c-O,05),calcitriol removed(p<0,O1)
or vit.D changed were seen.
Calcium mechanism probably underlies
and goes before metabolic signs.
•
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Q.fi-fi1OTEIN IN FD1J)IALYZED PATIENT A QU) IPX
FtJ4TI&Ruiz .JC,Sebert JL,Morinière Ph,Oe Erémont JF,Caly C,
Marie 6,Fournier 6.(1)Laboratoire LEVYParis.(2)CHU Amiens.
Plasma levels of bone Cia-protein (BCP) were measured in 16
patients on chronic hemodialysis using a radio—imunoassay (INC
Laboratories) with rabbit Sotibody directed against bcvine BGP.
611 patients had a transiliac biopsy for bone histomorphometric
analysis. BOP correlated well with serum alkaline phosphatase
(Alk.Pase) r:.89, p3.001, and with plasma FTC measured with a
radio—imunoas.say specific of the terminal 53-84 region of the
molecule : r:.77, p3.001. Mean values SD of all measured para-
meters and the correlation coefficient ( r between biochemical
and bone histomorphometric parameters (relative osteoid volume
DV] and surface [OS] osteoblastic [OBL.S] and active resorp-
tion [ARS) surfaces expressed in S total trabscular sur+ace)
are reported below
Biochemical parame- BCPAlk.PasePTH
Bone parameters ters (normal mean (1.8-6.6 (60—70 (40—160
(normal mean SD) op/mi) 111/I I pg/all
• SD) mean so 8.6222 345
(16 patients) 1 8.8 216 318
DV 5 (2.5.1) 9.1+ 3.1 .67" .56 45w
OS 5 (16:6) 56.2115.9 .47 .18 .21
1JBLS %(53) 8.6 8.5 75ww 64w
IIRS S (0.5105) 2.31 2.1 .70" 74" •57
Significance of r ; • p3.05 " p3.01 ; " p3.001
CONCLUSIONS 1/BCP is a good index of bone formation as shown
by its strong correlation with osteobls..sts.It is also indirec-
tly a good index of bone resorption because of the coupling bet-
ween formation and resorption in bone remodeling. 2/ Its deter-
mination has the advantages versus 61k Pase not to be influen-
ced by estraosseous product ion which is frequent in hemodialy—
vis because of Depatitis prevalence
VISUALIZATION OF PARATHYROID (LANDS BY ULTRASOUND
IN DIALYZED CHILDREN
P. von Lilien, 0. Mehis, R.B. Dietrich, I.B.
Salusky, H.E. Leichter, M.I. echat, H. Kangarico,
R.N. Fine.
University of California, Division of Pediatric
Neptrology and Rad iolngy, tos Angeles, Cal ill, USA
and University of Heidelberg, Division of Pediat—
nc Neptrolngy, Fed Pep of Germany.
The parathyroid glands (PG) play a key role in
the control of renal osteodystropty. Fbwever,little is kwn about the anatomic status of PG in
uremic children. We, therefore, evaluated the PG
size by real tine ultrasound (US) in 33 dialysis
pta aged 12.4 + 5.4 yrs (SD). Mid—C PIN (Ca 9),
alk phos, Ca and P were measured. US was evaluat-
ed independent of clinical data. In 9 pts ro P3
was seen; 1 PG was present in 9 pta; 2 PG in 13pts; 3/4 PG in 1 pt each. The largest diameter
ranged from 2.0 to 12.2 imi (mean 6.02 + 2.58).
iPrH values ranged between 13 and 1103 ul Eq/ml
(mean 259.2 +279.7).
Serum iPI'H correlated with the largest PG diam-
eter (r0.54, p60.01). In eddition, we found sig-
nificantly higher ?IH levels in pta with 2 or more
visuable PG (P60.01). There was ro correlation
between alk phos, Ca and P and the size of the P3.
Tw pts underwent renal transplant (TX) and we
visualized a decrease in the number of P3 in one
and smaller diameter in both pta.
We conclude US is a safe, effective ron-invasive
method to visualize the anatomic status and loca-
tion of PG in uremic children. This is pDtentially
iinprtant prior to parathyroidectciny, and may behelpful in delineating high risk situations. In
aãlition, PGUS might facilitate better Pt follow—up
when used in cvnj unction with conventional clinical
and biochemical parameters.
ALUMINIUM—INDUCED OSTEOMALACIA — EFFECT OF PRE-
EXISTING HYPERPARATHYROIDISM
G.D. Smith, R.J. Winney'
University Department of Pathology and Medical
Renal Unit', Royal Infirmary, Edinburgh, Scotland.
Aluminium bone disease', occurring in haemo—
dialysis patients with chronic renal failure has
usually been described as consisting of osteo—
malacia without secondary hyperparsthyroidism, the
mineralisation deficit being sometimes of a focal
nature, because aluminium accumulates in pars—
thryoid tissue and suppresses parathyroid hormone
secretion in vitro, it has been proposed that
aluminium—induced (relative) hypoparathyroidimm
plays an important role in the development of
osteomalacia. In this paper we present 13 alumin-
ium—intoxicated haemodialysis patients with osteo—
malacia varying in severity from focal to exten-
sive distribution of thick osteoid along bone
trabeculae. 9 patients (group 1) suffered a
gradual onset of chronic renal failure and of
these 7 had biochemical — radiological evidence of
hyperparathryoidism before dialysis. 4 patients
(group 2) had a relatively acute onset of chronic
renal failure and were euparsthyroid before
dialysis. Within each group the extent of the
osteomalacja tended to increase with duration of
exposure to aluminium. However, the patients in
group 1 developed osteomalacia at a much faster
rate than those of group 2. These results indi-
cate that, with plasma aluminium levels sufficient
to produce clinical toxicity, hyperparathyroidism
at the onset of dialysis does not protect against
osteomalacia and in fact contributes to its rapid
progression by providing a large trabecular
osteoid surface capable of binding aluminium.
• DELENERATIVE OSTEOARTICULAR LESIONS ANDMYLOID INFILTRATION IN LONG—TERN
HAENODIALTSIS (HD) PATIENTS (ptsJ
.1 2irjqrat'f, T Berdin D. Kuntz, M .C . Voisiri.
T . DrUeke"
Nephrol . Department, Necer Hospi tel end
Phumatol - Ciepartffierit. Len bolsiere HospitalParis, France.It becomes increasingly euident that oirlt
problems in pta treated by ND duringaprolongedperiod are not limited to the carpal tunnel
syndrome (CTS) . Wereport on 7 pta (6 females, 1
male), all on HO for at least 10 years (r.snge
10. 5—18 year) di sebled by arthropathies oflarge joints shoulder (/7), hip (4/7) and
knee (4/7] with characteristic X—ravs
narrowing of the articular space associated
with subchondral lacunee. Moreover,
destructive spondylarthropathy was seen in 5/7
pta and erosive arthritis of the fingers in 3
pta. All pts but one had history of CTS
surgical decompression was realised in 5 pts.
Light microscopy revealed arnyloid deposits in
all but one in whom this substance was however
found in a synovial biopsy of her knee. Only 1 pt
had overt hvperparathvroidisrn, all but one were
aluminium overloaded. Complete destruction of
the hip 13 pta) or the knee (1 pt) needed
prosthetic replacement. Massive anlyloldinfiltration was identified in the 3 hips, The
very small sample of the knee, analysed by
transmission electrorl microscopy, revealed ro
amyloid substance but apatite crystals. The
pathoqenesis of these arthropathies remains
obscure and requires further investigation. It
is likely that this pathology will be observed
with increasing frequency in view of the aging
of the population undergoing intermittent HO.
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HYPERTENSION
PRA CIRCADIAN RHYTHM IN HYPERTENSIVE SUBJECTS.
A.Albertazzi, G.Del Rosso, F.Capani*, A.Consoli*.
Institute of Nephrology & Dept.of Internal Medicine*
University of Chieti — Italy.
Previous reports have demonstrated the existence
of a plasma renin activity (PRA) circadian rhythm
but such results were obtained in pts deterred from
their usual way of life. Aim of this paper is to
observe if a PRA circadian rhythm could be obtained
in subjects synchronized only as far as sleep—
awakeness and meal timing schedules are concerned.
In 12 hypertensive pts, aged Lt2.00t17.87 yrs,not
on drug therapy, 214 hrs blood samples were drawn
every ttth hour for PRA evaluation (Le Petit RIA
renin kit). The selected pta were invited to sleep
in the hospital, to attend their jobs during the
day and to be back in our unit at fixed time for
blood sampling. For each pt the mean PRA value on
six points was calculated. The differences from the
mean at single time (espresaed as percentage) were
then evaluated by Cosinor test.
A significant circadiar PRA rhythm was documen-
ted with acrophase ath.11.38,95% confidence limits
between h.10.15 and h.13.09 and amplitude of 6i4.66t
10.06%.
The PRA circadian rhythm persists even in pts
leading a near normal way of life. So a 24 hrs in-
tegrated PRA value (mesor—reninemia) could repre-
sent a reliable parameter in renin profiling.
Further .etudies are in progress to confirm the use—
fullness of mesor—reninesia in diagnosing secondary
hypertensive forms and in primary hypertension
therapy aiming
INFLUENCE OF NALOXONE ON HEAD-OUT WATER-IMMERSION
(WI) INDUCED ENDOCRINiz ALTERATIONS IN HYPERTENSIVE
PATIENTS
5. Baczynski, F. Kokot
Department of Nephrology, Silesian School cf
Medicine, Katowice, Poland.
The present paper aimed to investigate the
importance of opiate receptors on WI induced
alterations of plasma renin activity (PRA) ,plasma
aldosterone (ALD) and AVP in hypertensive patients
as related to the etiology of hgpertension. Ten
patients with I and 15 with II (according to the
WHO criteria) essential hypertension (EN) 10
patients with renovascular (RVH) and 11 patients
with nephr tic hypertension (NH) were examined.
The control group consisted of 12 normotensive
healthy subjects, Changes in blood volume, P51½
plasma ALD, AVP and osmolality (osm) arid blood
pressure (BP) were checked before and 120 mm.
after WI in a) untreated and b) naloxone treated
subjects.
Results: WI was followed by a significant and
similar increase of plasma volume and decrease of
BP, PRA, ALD, AVP and osm in all hypertensive
subjects regardlecs from the etiology of hyper-
tension. Pretreatment by naloxone did not change
significantly the WI induced endocrine reaction
patterns both in normotensive and hypertensive
subjects.
Conclusion: Endogenous opiates do not seem to
play a significant role in WI induced endocrine
alterations both in hypertensive and normotensive
subjects.
HYPERTENSION IN THE HOLOCAUST SURVIVORS
A. Aviram, D.S. Silverberg and A.S. Carel.
Sackler School of Medicine, Tel—Aviv University
and Kupat Holim Sick Fund, Tel—Aviv, Israel.
To examine the effect of stressful life events and
chronic emotional distress in the development of
hypertension, we have compared the blood pressure
of 1150 Israelis (aged 50 to 80)who immigrated
from Europe before World War II to 2159 Israelis
who survived the Holocaust and came to Israel
after WWII. Most of the subjects were examined as
part of a periodical health examination offered by
their employers. There were only minor differences
in age, height, country of origin and level of
education between the two groups. There was no
difference in the prevalence of hypertension
(lying systolic 160 mmHg and/or diastolic 95
mmHg and/or anti—hypertensive medications)between
the two immigration groups and a similar
percentage of both groups were receiving
treatment. ANOVA showed that age, sex and degree
of obesity were the main factors contributing
to the blood pressure. Although the denree of
past emotional and physical stress was much
greater in the Holocaust survivors,there was no
correlation between level of current emotional
distress, satisfaction with life or number of
psychosomatic complaints and level of blood
pressure or prevalence of hypertension.
These findings do not support the opinion that
chronic stress plays a major role in the
development of established essential hypertension.
THE TRUE PROBLEM IN RENOVASCULAR HYPRTE.N—
3ION (RVH): RENAL ISCHEMIA.
O.Chiarini,E.Degli Esposti, C.Lapalombara,
F.Losinno, A.Stella, A.Sturani, P.Zucchelli
Division of Nephrology and dialysis,Malpi—
ghi Hospital, Bologna, Italy.
RVH may be an important cause of uremia
and it accounts for nearly 5% of pta in he-
modialysis. The effect on renal function of
revascularization (R) either by surgery or
by percutaneous angioplasty in 62 pts was
compared to the effect of medical treatment
(N) in 34 pta. Only the M—pts with compara-
ble seriousness in the clinical patterns of
R—pts were included in this study.The mean
period of follow—up was 34 months. The se-
rum creatinine decreased from 1.7 to 1.5 ag
/dl in the R—pts, and increased from 1.6 tc
3.5 mg/dl in M—pts (p< 0.005). Five M—pts
reached end—stage renal failure and under-
went hemodialysis. In this group the worse-
ning of renal function was independent of
blood pressure control. The longitudinal
diameter of the stenotic kidney at angiogr
fic control increased from 11.6 to 12.3 cm
in R—pts (p<O.005) and decreased from 11.7
to 10 cm in M—pts (p<O.OOl). We suggest
that the aim of revascularization is not
only to relieve hypertension, which can
now be controlled by an effective therapy,
but also to improve renal ischemia, regard.
less the effect on blood pressure.
ALCOHOL ASSOCIATED HYPERTENSION: WHAT IS THE ROLE
OF THE KIDNEY?
S. IDe Marchi, F. Cecchin, A. I3asile, F. Grimaldi.
Department of Medicine, Hospital of Codroipo, Italy.
Retween 1983 and 1985 we observed 310 chronic
alcoholics referred for detoxification. Of these 35%
had elevated blood pressure on admission. In order
to investigate the mechanisms of alcohol associated
hypertension we studied 51 random chronic alcoholics
We measured plasma levels of' cortisol (PC) and aldo—
mterone (PAl, plasma renin activity (PRA), 24h uri-
nary excretion of' aldosterone (UA) and metanephrine
(UM)creatinine clearance (CCr) and fractional ex-
cretion of sodium (FFPa) in relation to changes in
hlood pressure during detoxification. On admission
blood pressure was elevated (>160/95) in 20 patients
(39%) (proup 1) and normal in 31 (group 2). PA, PPA,
MA, MM, OCr did not differ between the 2 groups. PC
was significantly increased but we could not find
any difference between the 2 groups of alcoholics.
FFIIa was significantly lower in group 1 patients
(o.s3+O.l vs 0.67+0.3) and it correlated inversely
either with systolic or with diastolic pressure.
Contrarily no relationship was found between blood
pressure and PC, PA, PHA, IJA and (3M. Poring detoxi-
fication FENa significantly increased while blood
pressure fell to normal in most patients. After 1
month of abstinence FFNa did not differ between the
2 groups of alcoholics (0.96+0.4 vs 0.99÷0.4).
In conclusion our results demonstrate that in
alcohol associatd hypertension there exists a re-
versible abnormality of renal handling of sodium
which is closely correlated with blood pressure.
PROGRANMED DESIGN OF POTASSIUM SUBSTITUTION FOR
HYPERTENSIVE PATIENTS TREATED WITH DIURETICS
K. Felsovalyi, E.A. Balas, I. Taraba
Semmeiweis Medical University and Centre of Medical
Information and Computing, Budapest, Hungary.
To keep the plasma potassium level in the normal
range in hypertensive patients receiving diuretics
is etill a problem.
A BASIC programme was written for SHARP calcula-
tor using the following formula:
H2 k d
D — maintenance dose of potassium
— sex and age dependent coefficient
U - weight of the patient
H - height of the patient
k - diuretic specific coefficient: the change
of plasma potassium level caused by 1 mg
diuretic
4 - required dose of diuretic
The programme was checked in 20 hypertensive
patients (9 females, 11 males) . The sublects
ranged in age from 16 to 76 years, in blood
pressure from 150/100 to 240/135 Hgmm, in serum
creatinine from 65 to 115 pjsol/l. They received
different doses of chiorthalidone, clopamide,
furosemide and hydrochiorothiazide for 2 to 16
weeks. The plasma potassium level during the trial
was the following (mmol/1)
0 1st 2nd 3rd 4th 10th 16th
week week week week week week week
mean 4.06 4.43 4.17 4.22 4.31 4.20 4.23
SD 0.336 0.473 0.335 0.268 0.331 0.337 0.252
Our investigation proved that using the above
mentioned formula and SHARP calculator, the plasma
potassium level was kept standard during long—
term diuretic therapy in hypertensive patients.
A RANDOMISED DOUBLE BLIND CROSSOVER TRIAL OF
ENDRALAZINE VERSUS HYDRALAZINE IN PATIENTS WITH
RENAL FAIWRE AND C RENAL REPLACEMENT ThERAPY.J. B. Dibble, D. J. Read, E. J. Will, A. M. Davison
Regional Renal Unit, St. James's University
Hospital, Leeds L39 7TF, England.
Endralazine, a new vasodilator related to
hydralazine, is less reliant on acetylation and may
have advantages with respect to side effects.
22 patients (18m,4f), 12 with renal failure
not yet needing dialysis , 2 on CAPD, one on
regular haemodialysis and 7 with functioning
transplants, were randomly allocated to a cross-
over trial of oral hydralazine 25 mq bd or oral
endralazine 5 mg bd, each for 12 weeks, run—in
period of t weeks, during which their previous
treatment with hydralazine was discontinued.
Patients were umnitored frequently and the dose of
both drugs doubled as necessary to a maximum of 200
mg of hydralazine or 40 mg of endralazine daily,
aiming to achieve a blood pressure of 140/90 in
patients < 50 yrs and 150/95 in patients > 50 yrs.
Four patients dropped out due to poor
xspliance. A further 4 patients were withdrawn
fran the trial, three because of failure to control
blood pressure adequately (2 on endralazine, one of
whan later had his transplant renal artery stenosis
successfully dealt with, and one on hydralazine),
and one for side effects of hydralazine. Roth drugs
controlled the blood pressure equally well in the
fourteen remaining patients. t patient developed a
positive ANF or significant DNA antibodies during
the study.
Endralazine, therefore, appears to be as
effective as hydralazine and during this study was
not associated with any lupus—like syndrane. This
vasodilator uld therefore seem to be a valuable
alternative to hydralazine.
KIDNEY SCINTIGRAPHY AFTER ACE INHIBITION: A POSSIBLE
TEST FOR THE DIAGNOSIS OF RENOVASCIJLAR HYPERTENSION
C. Fommei, S. Ghione, L. Pails, L. Moriconi,
A. Mantovanelli, A. Ragazzini, C. Palombo, L. Donato
Istituto di Fisiologia Clinica, Clinica Nefrologica,
Pisa, Italy.
Recent studies have demonstrated that ACE inhi-
bition may cause an acute decrease of GFR in kidneys
affected by unilateral renal artery stenosis (URAS)
detectable by 99mTc DTPA renography.
Aim of the study was to assess the acute effect
of ACE inhibition on unilateral kidney function in
a comparison between 4 pta with URAS, 7 essential
hypertensives (E) and 4 pta with non—vascular uni-
lateral renal disease (URD). Each patient underwent
DTPA renography before and after oral Captopril (C)
25 mg
GFR ratio between the two kidneys was estimated
from the ratio between the corresponding kidneys
activities over the 2nd minute after the injection.
C induced a marked decrease of the stenotic—to—
non stenotic kidney GFR ratio ( range from 50% to
90%), whereas no appreciable change was observed in
all E and URD pta (always less than 5%).
These results confirm that C may induce an abrupt
GFR decrease in kidneys affected by URAS, presumably
by markedly decreasing glomerular filtration pres-
sure. The fact that the scintigraphic response to C
was positive in all the URAS pts but in none of the
E and URD pts suggests the possible clinical use-
fulness of this test for the non—invasive diagnosis
of renovascular hypertension.
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AO.JIE EFFECt OF ORAL NIFEDIPINE ON BID3D PRESSURE lEVElS AND
URINARY TER AND ELECTREEITES EXCRETION.
E. Fcmnei, C. Palciito, L. Palla, A. Ragazzini, A. antovarielli,
S. Giaconi, S. Ghione.
Clinical Phyaio1o Institute, C.N.R., Pisa, Italy.
The calCiun_antagcnists have been suggested to decrease blcxxi
+
pressure (BP) in hypertensive pta by interfering with a Na —trans
port mechsnisrn.
This study reports our observation stout relationinips between
BP and urinary electrolites changes acutely induced by oral nifedi
pine (N) in 12 hypertensive pta. N was ac¾einistered 3 he&irs after
the beginning of an oral water load, performed in order to allow
urinary collections every hour and protracted until 2 tours after
N adsinistration.
Results: N induced a sigiificant decrease of BP (p < .0)1) and
an increase of heart rate (HR. p .COl), diucesis (U, p< .COl), u-
+ +
-H- -H-
rinary Na (UNa , p <.05), urinary Ca (UCa , p< .05). Before N,
-
+ -H-beth BP and 1-10 directly correlated with UNa (p < .0)5). UCa cor-
related with UNa , but not with BP, before and after B (p < .0)5).
Furtheniore, the higher basal BP and UNa, the greater was fiP de-
crease after N (p< .01 and p< .0)1).
Conclusions: these results conf ins previous observations that
+ -H-
N increases UNa and UCa and that its hypotensive effect is rela
ted to pretreatment BP. The fact that BP and UNa were correlated
each other and beth of them were also related to the hypotensive
effect of N, spoports the hypothesis that N say act by interfering
with a Na -dependent mechaniem of BP regilation, which nay also be
active in control of Na excretion. The fact that ro such rela—
tiara were found with UCa suggests that the observed increase of
UCa could be secondary to that of Wa and not directly related
to N effect.
• HiGH INCIDENCE (42 5) Ut PrtL<i-IAL ILNAL ARTERY
.
LESIONS IN ACCELERATED OR MALIGNANT HYPERTENSION (I-IT)
C. Gudrin, C. Genin, R. Gonthier, d.C. Sahatier,
J. Toulon, G. Leroy, X. Barral, C. Veyret et
F.C. Berthoux.
Service de Nephrnloqie, HOpital Nord, Saint—Etienne,
F rnnre.
The incidence of renovascular hypertension is
below S % in the hypertensive population. Hnsever it
is of particular interest to define subgroups with
a much higher incidence.
From 1979 to 1983, we have prospectively perfoniec
a complete and selective rennl anqioqraphy in all
50 patients observed with severe hypertension
(diastolic blond pressure > 130 mm Hg) associated
with stage III fundi (accelerated HT, 33 patients)
or stage IV fundi (malignant HF, 17 patients).
21 patients (42 5) had proximal renal artery
lesions either unilateral (14 patients) or bilateral
(5 patients). The lesions were as followed
significant renal artery stenosis (diameter reduced
by 50 %) 17 ; renal artery thrombosis 4 renal
artery dysplasia 3 ; primary renal artery dissecting
anevrysm I single renal artery anevrysm IL.
Among these 21 patients with renovascular H.T.,
6 (28 5) were silent and would not have been screened
reconstructive surgery with good results.
These date confirm that accelerated or malignant
HI is a subgroup with higher incidence of reno—
vascular FIT justifying the systematic performance
of selective renal arteriogram.
REVASCULARISATION OF COMPLETE RENAL MRIERY OCCLU-
SIONS (RAO) USING TRANSLUMINAL ANGIOPLASTY (TA)
P.GrUtzrnacher, W.D.Bussmann*, T.Meyer, E.Starck**,
J.Kollath, W.Fassbinder, and W. Schoeppe
Depts.Nephrol., Cardiol. *,and Radiol.**, University
Hospital Frankfurt/M, ERG
Complete occlusion of renal arteries mostly causes irre-
versible cortical necrosis after stort time, leading to re-
nal failure or renovascular hypertension, if kidney sur-
vival is maintained by collateral circulation. Further
therapy depends on residual renal function of the contra-
lateral kidney, and duration of the RAO. Analogous to
treatment of peripheral arterial occlusions, we modified
the TA—technique for treatment of occluded renal arterieS
From 1982-198A 16 patients with 17 complete occlusions of
the main renal artery underwent angiography with the aim of
recanalisation. In5cases theaorticostiumof the renal
arterycould not be localized, so that no attempt was made.
Successful recanal isation of the occluded vessel was
achieved in7of the remainingl2pat., simultaneouslydi—
lating renal artery stenosis of the contralateral kidney in
two cases. Behind the occlusion, intact vasculature was
found. Signsof returning kidney function were already
spparent at the end of TA showing excretion of Contrast
solution into the pyelon in 6 pat. Acute oliguric renal fai-
lure, present in 3 pat. could be reversed (serum—creati-
ninedropped from 4.642.9tol.9+O.1mg/dl (p<O.05,n=7)
Radioisotope controls confirmed function of the recanal i-
red kidneys (4/4). Hypertension improved in 6 of the 7
aat., reaching nearly normal values (187/110 to l55/86mmHg,
p<0O5). No complications were observed during TA.
Our data indicate, that occlusions of the renal
arteries can successfully be treated by TA—technique
however, rate of success in occlusion is lower than
in uncomplicated renal artery stenosis. Transluminal
angioplasty should be tried before decision for
surgery is made, and is an important alternative
for patients with high operative risk
• LOSS OF RBF-AUTOREGLILATION IN OLD SHR WITh NEPHRON
LOSS DURING INDOMETACIN TREATJVITNT.B.M. Ilversen, L.
Mprkrid,I.Sekse and J.Oiatad.Medical departriwnt A,
University of Bergen,Norway.
Frinlier observations have revealed that RBF-aut-ore-
gulation Is well perserved althougt reset in old
SHR with renal danmge.Inhibition of the prostagln-
din system is knoian to effect OFR in kidneys with
nephron loss.We therefore studied the effect of in-
dorestacin on RBF-autoregulgtion in old SHR.LO Young
SHR,indosritacii-i did not interfere with RBF-autoregu-lation.
CalF was measured by an electrorirignetic flowneter.
The perfusion pressure was regulated by an adjusti-tie aortic clamp.Male 00 weeks old SHR were studied
before and after iicdonstacin treatnrint,and age
iritch Wistar Kyoto(WICL)were used as controls.,
WKY SHE
Mean BP(ci Hg) :110+2 (p(O.Ol) 159+7 NS
(rnl/min/g) :3.8±1.2 (p(0.0l) 2.8÷0.2 NS 2.8±0.1
RVR
im Hg/mi
rnin/g) :lB.O±2.2(p(0.o5)57.Q5 NS
Lower limit
of autoregu-
lation(nis Hg):85+24 (p(0.Ol) 116±0 (p(0.02)105+9
OFR
(mi/win) :2.0±0.2 (p(0.05) i.7±O.S(p(0.02)1.3+o.1
Conclusion: During intonstacin treatment
regulation is corrpletely abolished in old SHR with
nephron loss without affecting RBF,but reducing OF'R.
These results indicate that dilatation of the resi—
stans vessels in kidneys of old Slob is prostaglan—din dependent.
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155 ÷0
57.2+0.1
. I4YOCRDIAL BETA ADRENERGIC RECEPTOR RESPONSE
COUPLING IN CHRONIC RENAL FAILIJRE(CRP) RAT
K.Kuinano, S.Yokota, T.Sakai (Intr. by K.Ohta)
Kitasato University Hospital, Kidney Center,
Sagamihara, Japan
It was previously reported that cardiac physi-
ological response to beta adrenergic stimulation
was reduced both in patients of CRF and in uremic
animals. Some investigators explained this low
responsiveness by decreased number of cardiac
beta receptor(—R) and decreased myocardial
adenylate cyclase activity(ACA) in acute uremic
rat. No experiments,however,were reported in the
heart from chronic uremics. To study the possible
biochemical mechanism of receptor response coupl-
ing in the myocardium of CRF rat, —R density
was measured in 40,000 G membrane preparation of
rat ventricle using 3H—dihydroalprenolol. ACA
was also measured in the heart homogenate by the
method of Salomon et al. CRP was induced by renal
ablation with cryosurgery following contralateral
nephrectomy 2 weeks later. No significant change
was observed in cardiac 8—R density and affinity
between sham cunLrl(u=8) and CRF(n=1O, sertun
creatinine: 2.7+0.52 tag/di, Urea N: 180±39.6)
(Bniax: 37.7±7.31 fmol/mg prot. vs 31.9±8.25, Kd:
3.23+0.92nN vs 4.53+0.98). Hormone stimulated ACA
not only by isoproterenol(ISO) but also glucagon
(GLU) were decreased by 65 % in the uremic myo—
cardiuin with no change in basal level(ISO: 26.3
pmol cANP/niin/mg prot. vs 17.1±4.08, GLU:
19.3±1.86 vs 12.5±3.76, p<O.O5). Sodium fluoride
guanylylimidodiphosphate or forskolin stimulat—
ed ACA were also decreased significantly in CRF
ventricle. These results indicated that post re-
ceptor defect(s) was mainly involved in the low
responsiveness of 8—adrenergic stimulation in the
heart of CRF rat.
FAMILIAL AND HEREDITARY HIGH LEVELS OF SERUM ANGIOTENSIN—
CONVERTING ENZYME ACTIVITY
P. Le Pogamp*, A.Le Goff**, A. Le Treut**, D.Chevet*,
J.Y. Le Gall** (Intr. by J. Cledes)
* Nephrology Unit
** Medical Biochemistry Laboratory B.
C.I1.tJ. Pontchailiou 35033 Rennes.
During an investigation on the possible changes of serum
angiotensin—converting enzyme activity (S.A.C.E.) In chronic
renal failure and glomerulonephritis (Path. Biol. 1983, 31
182—185), a very high level of S.A.C.E. (146 nmol mi—i mn—i) is
found in a 22 years-old woman affected of a nephrotic syndrome.
S.A.C.E. was measured by a radiochemical adaptation of a specto—
photometric method (using (Gly—i—14C)—hippuryl-L-histidyl-L-
leucine as substrate), mean enzyme activity for 47 healthy
controls being 20.7 7.6 nmol ml1 mn—1.
This high level was confirmed on numerous determinations. Blood
pressure, plasma resin activity and aldosterone were normal.
The patient was free of all medications. Clinical and labora-
tory investigations including a gallium scan to rule out active
sarcoidosis were negative, as well were investigations for
known diseases elevating S.A.C.E.(hyperthyroidism, hepatic
and lung diseases, leprosy. Gaucher's disease...).
Despite a spontaneous regression of the nephrotic syndrome
within 18 months, a persistent high S.A.C.E. was observed,
between 138 and 172 nmol mi—i mn1. In vitro, a specific
inhibition of this S.A.C.E. is obtained with captopril, as
usually.
A similar elevation of S.A.C.E. is observed in the serum of
the motljr of the patient and of some relatives, suggesting an
autosomic dominant transmission. No Specific associated disease
can be detected.
As far as we know, such isolated familial hereditary elevation
of S.A.C.E. has never been reported.
. MALIGNANT ESSENTIAL HYPERTENSION:COMPARISON WITH
MALIGNANT HYPERTENSION IN IgA NEPHROPATHY.
X.M.Lens,J.Montoliu,R.SubIas,A.Botey,A.Darnell,L.Revert.
Nephrology Service.Hospital ClInic.Barcelona.SpajnIn the last 12 years,lO patients with biopsy
proven IgA nephropathy(9 males,mean age 36.4+3
years)presented with malignant hypertension(mHT).
Their clinical course was compared with that of
10 patients(9 males,mean age 38.5±3.7 years)diagno
sed as essential mHT after appropiate studies,in—
cluding renal biopsy.mHT was defined as:diastolic
BPal2O mmHg,grade ITT or IV hypertensive retinopa
thy and serum creatinine*2 mg/dl.Results were:
Essential mHTmHT in P
IgA nephrKnown duration
of HT(months) 23.3+9.6 11.2+8,2 NS
History of hematurja 2/10 5/10 I NS
Mean arterial BP(mmHg) 177.7+4.7 164+3.2 0.026
Peak serum creatinine
at onset (mg/dl) 8.9+1.2
Proteinuria(g/24 hr) 2.4+0.7
4.6+0.9 I 0.012
3.3+0.7j NS
Follow up (months) 32.4+11.3 11.3+2.4 NS
Need dialysis at end
of follow up 4/10 6/10 NS*
Change in serum creati
nine in the remaining
(mg/dl) —5.4+1.8 —0.4+0.3 0.037
Chi square test with Yates's correction (if
necessary)
We conclude that mHT in IgA nephropathy is com-
moner than previously reported,that in spite of
some differences its clinical presentation is simi
lar to that of essential mHT,and therefore given
a case of 5HT,IgA nephropathy is difficult to rule
out without a renal biopsy.Essential aHT seems to
have a better prognosis for recovering renal func-
tion.
EFFEE7TS OF INCREPSED DIETARY CP.IiIU1 INTAKE AND PA-
R8THYF4DIDEE'BltY (PTX) ON BILX)D PRESSURE AND INI'Rlt-
VASCULAR VOLUME
J.F.A.Mann, J. Bomner, E. Ritz
Dept.Med., University of Heidelberg, FRG
We investigated the effect of high dietary cal-
cium intake on mean arterial pressure (MAP), intra-
vascular volume and serum chomnistry in the follo-
wing groups (n=8) of nornotensive rats: FIX with
high dietary calcium intake (P1K—Ca); sham operat
controls with high dietary intake (CD-Ca); sham op
rated controls with a normal calcium intake (CD).
The dietary regimens started at age 4-5 weeks, one
week after FIX or sham operation had been perform
Success of FIX was controlled by determining S-Ca.
At age 15-17 weeks, i.e. after chronic dietary in-
tervention of 3 nonths (s. table), the folling
results were obtained:
Table
MAP(mrnHg) 108+4* 111+6* 123+3
Plasma vol.(ml/lCOg) 4.7+0.1* 4.6+0.1* 4.1+0.1
blood vol.(ml/lCCg) 7.7+0.1* 7.7+0.2* 7.0+0.1
S—Ca (mt'i)
S—Pi mM)
2.5+0.1
1.9+0.1*
2.7+0.03*2.4+0.05
2,OO.O3*1.6O.08
5-crea (mg/dl) 0.3+0.04 O.2T0.05 0,4÷0.04
S—Na (irt4)
S-K (rrtt)
137+1
4.9O.6
137+1 142+1
5.0+0.7 5.ciO.3
Our results deonstrate that high dietary calciumintake induces a similar fall of blood pressure
and expansion of intravascular volume as does PTX
(as previously reported by us). This may indicate
that high dietary calcium acts via suppression of
endogerous parathyroid hormone secretion.
250 Abstracts
ISOLATED BILATERAL RENAL ARTERY DISSECTION
C. Michel, V. Roger, C. Hdldnon, F. Mignon
Service de Ndphrologie, Hopital Tenon—Paris France
Only 88 cases of isolated nontraumatic renal
artery dissection have been reported, exceptionally
bilateral (13 cases).
A 47—year—old woman, previously healthy, expe-
rienced sudden right loin pain with gross hematuria
and high blood pressure (190/110). An intravenous
urography was normal. Eighteen days later, left
loin pain and recurrence of the right flank pain we-
re noted with persistent hypertension. Serum crea—
tinine was 212 /Jmol/l. The arteriography disclosed
typical findings of dissection involving the two
right renal arteries and the left renal artery with
defect of the superior and infefior poles of the
right kidney on arteriographic and isotopic reno—
grams ; the aorta and other visceral branches were
normal. Treatment by atenolol was initiated. Five
months after onset, blood pressure and serum creati.
nine were normal. Arterioriranhic control showed im-
provement of the lesions on the right inferior and
the left renal artery and no change on the right
superior renal artery. Antihypertensive treatment
was interrupted. Six months later, she is still in
good health with a serum creatinine level of
100 JJmol/l and blood pressure not exceedinf 130/80.
This case is of particular interest because the
dissection occured almost simultaneously on the 3
renal arteries without evidence for any etiology.
Conservative medical management was particularly fe-
vorable with resolution of hypertension and recana—
lisation of two of the dissected arteries as demons-
trated by control arteriography which has been ra-
rely reported.
RENAL ARTERIAL SCLEROEMBOLISATION (RAS) FOR FREAT-
IVTENT OF RENOVASCUIJ\R Fr'PERTENSION (PH).
Russo D.,Fil Canton A,Cofelice E,Conte C,Oliva 0,
Testa A,Iaccarino V,Andreucci VE.Dpt of Nephrology,
Second Faculty of Medicine,Naples.
Theraneutic renal embolisation has proved useful
in preparing surgical ablation of tumors,closing ar-
terio-venous-urinary fistulas,or suppressing heavy
proteinuria in end-stage renal disease. We report or
four patients with RH that were treated with RAS.
?atient l;l3-year old,female,BP 180/120 to 250/140
pmHg.Rx finding:fibrodysplasic stenosis of intrare-
nal branches supplying the upper pole of the left
kidney,Patient 2;48-y.o.,male,BP 170/110 to 240/130
inmHg.Rx:90% stenosis of the right renal artery.This
patient had cerebral ischemic attacks and chronic
congestive heart failure.Patient 3; 20-y.o. ,feinale,
BP 160/110 to 170/120 mmHg.Rx:uniform narrowing of
the right renal artery from the aortic oriwin to
renal hilusPatient 4;68-y.o.,male,BP 180/110 to
220/120 mivHg.Rx:90% stenosis of the left renal arte
ry.This patient had severe congestive heart failure.
In all patients RAS was performed by injecting into
the stenosed vessels a 80% solution of sodium iotha-
laniate mixed with tiny (1 anti) Core-Tex particles.RkS
was followed by persistent normalisation of BP in
ell patients.The only side effects were transient
Lever and rise in LDH.These results show that RAS is
a safe and successful substitute for surgical nephre
Etomy in treatment of RI-LRAS should be preferred in-
etead of surgical nephrectomy in case of intrarenal
arterial stenosis(case l),or in patients at high
surgical risk (case 2 and 3).
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BILATERAL NEPERECTOMY IN CHILDREN WITH HYPER-
TENSION IN HAEMODIALYSIS: A TREATMENT OF CHOICE.
M.Rengel, F.Cómez,A.L.Pablo,M.Prieto
(In-ti,. by J.Cannata)
Pediatric Nephrology. Hospital Provincial.
Madrid. Spain.
One of the most important risk factors in
children (Ch) undergoing haemodialysis (HD) is
hypertension (H).In order to control H,bilateral
nephrectomy (BN) was performed in 8 Ch (age 4 to
12 rears; weight 10 to 30 Kg) whose blood presure
(B?) could not be controlled using either hypo—
tensive drugs or isolate ultrafiltration.Time on
HD before surgery ranged 1.6 te 38 months (X=l8)
and all of whom had severe H with visceral is—
pairment.We did not find any surica1 complica-
tion and as the table shows we findout a fall in
plasma renin activity (PRA) and diastolic blood
presure (DBP);Hb. and Hct. did not change and the
number of blood transfusion (BT) (unit/patient/
month) requirements had a slight decrease. Three
years after BN all Oh thrived adequately.4 Ch
received a renal transplant and they keep easily
B? under control.
PRA DBP Hb Hot BT Weight
Pre—BN 80 10.8 6.2 19 0.7 19
Post—BN 0 7.2 6.3 20 0.5 20
ARP= ng/ml/3h.
Our results suggest that BN would be a treat-
ment of choice in hypertensive Oh in RD as we
achieved a stable and more efficient BP control
than with hypotensive drugs, avoiding all their
side effects.
SERUM LIPOPROTEINS DURING CHRONIC DIURETIC THERAPY
OF RENAL PARENCI-IYMAL HYPERTENSION
H.Schiffl, PSchollmeyer, R.Kluthe
Medizinische Klinik, Universitt Freiburg, West
Germany
Patients with renal disease are prone to develop
hypertension and hyperlipidemia, and both abnorma-
lities tend to occur already at an early stage. In
72 patients with early stage of kidney disease and
hypertension of mild to moderate severity, the
effect of six years of treatment with two differ-
ent thiazide diuretic-based therapeutic regimes
was assessed by a randomized controlled trial.
Compared to placebo, hydrochiorothiazide-ami bride
significantly increased total cholesterol (by 20%
and by 31%, respectively), and LDL-cholesterol
(by 18% and by 27%, respectively) in men or post-
menopausal women, but not in premenopausal women.
Serum HDL-cholesterol and total triglycerides were
not consistently changed in all diuretic treated
patients. The combination of timobol with amilori-
de-hydrochlorothiazide had the advantage of pre-
venting diuretic induced changes in lipoprotein
metabolism. Increased serum levels of the athero-
genic LDL-cholesterol fraction during diuretic
treatment in men or postmenopausal women with re-
nal disease may represent a potentially undesira-
ble effect, particularly since such patients tend
to have hyperlipidemia in the untreated state.
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THERAPEUTIC EFFICACY AND TOLERANCEOF TWO ORALLY AC.-
TIVE ANGIOTENSIN CONVERTING ENZYME (ACE) INHIBITORS
IN PATIENTS UNDERGOING REGULAR HEMODIALYSIS (RHD)J. Sennesael, D. Verbeelen. Akademisch Ziekenhuis
en Vrije Universiteit Brussel, Brussels, Belgium.
The high frequency of side—effects with Captopril
(C) in patients with renal failure prompted us to
compare the therapeutic efficacy and tolerance of C
in RHD patients with enalapril (E), another ACE—in-
hibitor. Eight RHD patients treated with C alone
(mean daily dose 143,8+28,14 mg; range 12,5—75 mg)
or combined withfr—blockers for at least 6 months
were switched to E. After a wash—out period of 3
days 5 mg E once—a—day was given and gradually in-
creased up to 110 mg 0.8. and other antihypertensive
treatment added as long as diastolic bloodpressure
(DBP)> 100 mmHg. E alone (mean daily dose : 19,14
11,6mg; range : 2,5—l4Omg) or combined with ft—bloc-
kers achieved satisfactory BP control in all pa-
tients at the 6 month. Therapeutic response was
estimated using following scale : 1.DBP<90; 2. 90<
DBP<1O).l; 3. 1O)4<DBFK11I4; 14• DBP>1114 mmHg. Individu-
al daily dose of ACE—inhibitor and need for additi—
anal treatment as well as antihypertar.sive response
achieved were highly correlated (Spearman's rank
test : rsO,92; p<O.Ol and rsO,96; p<0.OOl respec-
tively) during both study periods. No clinical side-
effects were observed after 6 months of S treatment.
On the contrary, taste disturbances present in 4
out of 8 patients disappeared 2 weeks after replaee+
ment of C by F. Serum electrolytes, bilirubin, li-
ver enzymes, hemoglobin, white cell and platelet
counts as well as transfusion number per patient
month were identical throughout both study periods.
It is concluded that : (1) RHD patients with hyper-
tension are responsive to ACE—inhibition, F having
the same potency as C; (2) patient compliance and
tolerance are better for F than for C,
THE PREVALENCE OF HYPERTENSION (HT) IN RECURRENT
CALCIUM NEPHROLITHIAS (RCN)
F.Vendemia,E.Rovelli ,L.Luciani ,N.Colleoni ,G.Fellin,
GD Amico,G.Colussi ,M.Surian,F.Locatelli ,A.D Angelo,
E.Valvo ,M. Marangella.
RenalUnits,Milan,Lodi ,Lecco,Padua,Vcrona,Turin,Italy
A relationship between high blood pressure and
increased urinary calcium excretion has been sugge-
sted in essential NT.
To verify the existence of such a correlation also
in other hypercalciuric states, we examined 308 RCN
patients (pts) classified according to 3 metabolic
patterns: 1) 56 pta with Diet Independent Idiopathic
Hypercalciuria (DIIH); 2) 71 pts with Diet Dependent
Idiopathic Hypercalciuria (DDIH); 3) 181 pts with
No Metabolic Disorders (NMD). To limit some interfe
ring factors on HT, we selected those pts with
age<dOyrs,body weight(8OKg, Sr.Creatinine(L2 mg/di
Sr. Calcium<lO.5 mg/dl, Sr. Uric Acid<7.5 mg/dl.
Multivariate statistical analysis was performed.
the prevalence of HT in RCN pts as a whole was 22%,
similar to that reported in the population living
in the same geographic area; when the 3 groups were
examined separately, DIIH pts showed a 25% prevalen
ce of UT, DDIH pts a 17%, NMD pts a 23%; these
slight differences were not statistically signifi-
cant, even when matched for sex, age, etc.
Our study shows that in RCN a decrease of renal cal
cium reabsorption, which underlies DIIH, is not cor
related with HT, whereas in essential HT a very si-
milar abnormality has been emphasized as a cellular
marker of HT.
URINARY KALLIKREIN ACTIVITY IS NOT ALTERED IN HUMAN
ESSENTIAL HYPERTENSION. BM Simonetti, A Pierucci, F
Taggi, S Morabito, A Ghidini Ottonelli, M Di Natale,
G Stirati, GA Cinotti (Intr. by V Andreucci).
Dept. of Internal Medicine, Division of Nephrology,
University of Rome, Italy.
Despite previous reports, a normal urinary Kalli
krein activity (UK) has been recently observed in es
sential hypertensive (EH) patients (J Clin Invest
65:347, 1980). In the present study, the UK of alar
ge series (n=149) with recently diagnosed uncomplica
ted EH (age:20—70, 68b, 81, diastolic BP:90-11O mm
Hg) was compared to the UK of 85 normotensive patien
ts (N)(age:20-56, 42c 43'). The known duration of
hypertension was 12-24 months. The relationship bet
ween UK, age, sex, U—sodium, U—potassium, Plasma Re
nm Activity (PRA) was evaluated. All subjects were
on ad libitum diet and all drugs were withdrawn 3we
eks before the study. UK, U—sodium and U—potassium
were determined in the same 24 hour collection.
UK (Esterase Units/day, m÷SD) was 14.02÷9.8 and
12.83+9.3 in N and EH, respectively. In both N and
EH groups, UK was not correlated with diastolic BP,
U-sodium, age or sex. A weak correlation was obser
ved with U-potassium (r=0.308,p<O.OO1) and PRA (r=
O.235,p<O.OOl) in EH group alone. Using multiple re
gression analysis the evaluated parameters account
for 25% and 17% (N vs EH) of UK variability.
We conclude that, to the extent that the activity
of the renal Kallikrein-Kinin system is reflected by
UK: 1) this system is not appreciably altered in re
cently diagnosed EN; 2) in these patients UK does
not represent a diagnostic marker.
INTERACEION BETWEEN DIETARY SODIUM AND CALCIUM IN
BLOOD PRESSURE CONTROL IN ESSENTIAL HYPERTENSIVES
C. Zoccali, D. lellamo, S. Parlongo, Q. Maggiore(with the technical assistance of S. Crucitti and
n. Postorino)
Centre Fisiologia Clinica CNR, Reggio Cal. Italy.
Epidemiological surveys indicate that dietary
Na and Ca interact in blood pressure control. We
have investigated the influence of oral Ca supple-inentation (lgr/day) on the blood pressure effects
brought about by dietary Na changes in 7 "salt
sensitive" essential hypertensives. Dietary Na
intake was stepwisely increased from low to high
levels during three weeks (1st wk:lO; 2nd wk:l5O;
3rd wk:300mEq/day) . Each patient underwent twice
the sequence of dietary Na changes while receiving
either Ca or placebo, in single blind, randomized,
crossover and balanced fashion.
Mean arterial pressure fell (P<.Ol) on low Na
(-17±SD 8mrnHg) and rose mlight (NS) on high Na
intake (+4+6mrnFlg). Serum Ca was higher on low
Na (2.12+.22 mEq/L) than on normal (2.03-F.17) or
high Na (2.OO+.l8). Overall there was a significant
inverse relationship between Cand MAP (r - .53
Pc02). Calcium supplementation had no influence
on MAP on both normal and high Na intakes, however,it reduced by 54% + 32 (P<.O5) the hypotensive
effect of low Na. The expected changes in PRA and
Aldosterone brought about by dietary Na changes
were unaffected by calcium supplementation.
The results suggest that "salt sensitive"
essential hypertensives are unlikely to benefit
from calcium supplements when on free Na intake.
Actually, high calcium intake may blunt the hypo-
tensive effect of low Na diets in these patients.
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RENAL PHYSIOLOGY
GLIJCAGON—MEDIATED MODIFICATIONS OF GFR INDUCED BY
ESSENTIAL AMINO ACIDS AND KETOANALOGUES.
A. Albertazzi, P. Cappelli, B. Di Paolo, C. Del
Rosso, M.T. Nisi.
Institute of Nephrology & Dialysis — University of
Chieti — Italy.
Glucagon,secreted after both protein ingestion
and amino acids infusions,increases the REF and GFR.
In 8 normal subjects we examined the effects of
oral intake of essential amino acids and ketoanalo—
gues on insulin and glucagon secretion and on mu—
Un clearance(IC])based on the following protocol:
I day:after overnight fasting 3 hours IC1;II day:
after fasting,oral intake of 100mg/Kg of a mixture
of 5 essential amino acids and 5 ketoanalogues(KA),
serum insulin and glucagon after O'—15'—30'—60'—90'
120'—180'and 3 h IC1;III day:after fasting,oral in
take of 100mg/Kg of the same mixture composed enti-
rely of 10 essential amino acids(EAA) , recording of
serum values as in II day,3 h Id.
The EAA determined an increase of insulin arid
glucagon with a peak after 30',the mean IC1 resul-
ted 132.2±12.7 ml/min.The KA did not determine any
hormonal stimulation,the mean IC1 resulted 121.7
20.Oml/min,while after fasting it was 12l.2±10.8
ml/min.
The substitution of 5 essential amino acids with
corresponding Ketoanalogues substracts the glucagon
stimulating activity responsible for the increase
in GFR .Therefore KA represents the most idoneous
supplement of a very tow protein diet in order to
antagonize the glomerular hyperfiltration in survi-
ving nephrons in chronic renal failure.
IFFECTOF INSULIN ON R[NAL SODIUM HANDLING IN
DIABETICS AND IN NORMAL DOGS.
6. f-isrerum, . AZiz, '. Borsourn, U. Aroury, I". His—
Ban, I'. ibou?rir, . ;honeimy, . clirnsn, .
rih, Y Sbcc'l— hmen, A. sebeuI I; . Li—Bacry
131r0 (niversity. [eiypt.
[his tuny aims at cnnfireir,ç, tne clinic 1 jrnpr—
esslon that maul in may hev cii rect tubular effect
on S re asorption. It lncluues ii) normal controls
1 30 newly discnveraci insulin—ciependerit oiabetics.
'f those, 11 were ri—oesiised after insulin ther cpy.
In sli subjects, F sNit tci2' were rietarminerl bafetc-lcd ftcr iii acute i.e. sling load after an oral
stir lia. cur lcci era al,o induced as a conti—
reatory p erimeotal nodal. [heir kidneys CrC ax—
posed by a direct posterior approach. 30th renal ar-
teries were infused at constant rxte by N—saline to
which insulin was intermittently addad on one side
at a tjm. wa I [cH3O sere determined in split
urine collections. F[ja was higher in diabetics &
I CONTROLS DIABETICS DOGS
Before Rx After Rx
sal expen Hasal exoan dasal expsn iali Ins
IroNs 11.20 1.85 1.61 2.00 1.13 1.51 2.57 1.97
ITCH?01 2.45 3.71 3.85 3.92 3.44 3.83 0.72 IO.Og
was reduced by insulin therapy. This was confirmed
by reduction of FeNa with intrarenal infusion ofjn—
sulin in dogs. Its response to expansion, whether
by saline or water, was normal in diabetics irresp-
ective of treatment, indicating the integrIty of rca—
turetic mechanisms. In all clinical and experiment-
al settings, TCH20 correlated with eNs, attributa-
ble to variations in Na delivery to distal tubules.
To conclude, insulin seems to have a direct anti—
naturetic effect on the renal tubules proximal to
concentrating segments. This action seems to be in-
dependent of naturetic mechanisms triggered by vol-
ume expansion. Insulin effect on TcFI2O can be enti-
rely explained by its proximal action on F eNa.
CHLORIDE HANDLING AND HYPERFILTRATION (HF) DURING
AMINOACID (AA) AND GLUCOSE (G) INFUSION.
A.Appiani, B.M.Assael, G.Cavariria, G.Marra and
S.Tirelli. (intr. By L. Minetti)
Dept. of Pediatrics University of Milan, Italy.
Chronic HF is considerated a cause of progressive
glomerular sclerosis. Thus The mechanism leading
to renal vaaodilatstion and HF need to be investi-
gated. Among these there is experimental evidence
that a decrease in chloride (Cl) distal flow inhi—
bitsthe tubuloglomerular feedback mechanism and
permits GFR to increase. Our study was performed in
S young healthy adults in order to determine the
relation between renal hemodinamics (Inutest and
PAH clearance) and Cl handling (UC1V lOOmi GF). The
subject were studied under 3 different condition
l)Saline inf. 0.9% (.4m1/ min/Kgxlh)
2)AAinf. 3.5% (8s1/ min/l.73sqrn)
3)G inf. 5% (2 to 4ml/ min/lOks)
Results (mean and SD) p(.0lt._test paired data
AA C
Basal Load Basal Load Basal Load
GFR 115(15) 1l7(18)118(28)° 180(42) 13O(9)°169(0)
RPF 532(53) 591(96)546(222)°796(1SO)67O(2O)°922(28)
UC1V .16(.l)°.39(.3).16(.O8)°.l(.O3) .17(.O5)°.12LO1)
Saline inf. did not cause chenges in renal Hemodi—
namics while elevation of SF8 and RPF was seen in
the other 2 conditions. These changes were accompa-
nied by a decrease in the Cl excretion rate. Our
study support the hypothesis that a reduced Cl
distal flow may contribute to glomerular HF.
EFFECT OF PROLACTINE ON NA-K-ATPase ACTIVITY IN RAT
RENAL TUBULE
BussiAres L., Laborde K., Sachs C.
Department of Physiology, HSpital Necker, Paris,
France
To test wether prolactine (PRL) has any action
on osmoregulation in mammals, we evaluated the ef-
fect in the rat of this hormone on a major enzyme
in renal regulation of water and electrolyte : Na-K-
ATPase. For this purpose Na-K-ATPase activity was
determined by cytochemistry in specific nephron seg-
ments from rats treated either by bromocriptine (a
potent inhibitor of PRL secretion) , or by PRL. Six
hours after a simple injection of bromocriptine
(0.65 mg/l00 g I.P.) a significative decrease of Na-
K-ATPase activity is observed in both medullary as-
cending limb (HAL) )p<0.001) and distal convoluted
tubule (DCT) (p<O.Ol) enzyme activites are 79%
of control values in MAL, 72% in DCT. This decrease
persist 12 hours after the injection : values return
to normal 24 hours after. Reciprocally, a signifi—
cative (p <0.001) increase in enzyme activity is in-
duced by a single injection of a PRL (123 ig/lOO g
IM) , as soon as 3 hours after injection again in
both nephron segments : HAL 165%, OCT 172% of
control activities. This effect persists 6 hours af-
ter the injection (HAL : 129%, DCT 148%).
A direct effect of PRL on the tubule is auggested
by result from experiments in which PRL, at various
concentrations, is added (20 mm) in vitro before
Na-K-ATPase activity measures on renal slices (8 u)
obtained from rats sacrified 3 hours after the last
injection of bromocriptine (0.5 mg/100 g/12 h.) The
increase in Na-K-ATPase activity exhibit a log.dose
dependancy with PRL concentration (p<O.0l).
More investigation are necessary to confirm and
define the direct effect of PRL on renal Na-K—ATPase
suggested by these results.
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RENAL FUNCTION DURING OROGRAPHY WITH IONIC AND NON
IONIC CONTRAST DIA IN CHILDHOOD.
eC.Pecoraro,M.Usberti,L.Carbonaro,A.Pingo,M.T.Saravo,
F. Leo,V. Bisesti.
'Department of Pediatrics,Chair of Nephrology,II Fa-
culty of Medicine of Naples,Italy.
Several authors suggest non ionic contrast media
(NICM) in performing urography in childhood.Renal
function during urography in 2 groups of children
was compared in this work.Excretory urograrns were
obtained using lopamidol (NICM) at 300 mg I/mi admi-
nistered at a dose of 1. mi/Kg in group A,and Meglu—
mine Diatrizoate (1CM) at 306 mg I/mi at a dose of
1 ml/Kg,in group B.Both study groups comprised 15
children of the same age and body weight;all chil-
dren had normal renal function.The study of renal
function was carried out at time O,at 5 and 60 m'
after injection of contrast material.In both groups
no significant change of plasma creatinine,Kt,Osm
and GFR was observed.pNa and hematocrit decreased
significantly at 5 m' postinjection and returned to
basal level at 60 m'.Vm' increased more in group B;
while FENa and UNaV increased in group B only (p4
O.Ol—p<O.OOl).We observed a reduction of UfpOsm in
group A and a significant increase of Cosm/GFRxlOO
in both groups.Our findings show that 1CM produce
higher urinary excretion of sodium and water,because
of their strong Osmotic effects.NICM have a minor
diuretic effect and therefore reduce the risk of wa-
ter and sodium depletion wich may account for by so-
me increases of creatinine levels.We recommend the
use of NTCM in urographic examinations of children.
DO CALCIUM ANTAGONISTS IMPROVE THE COURSE OF POST-
ISCHEMIC ACUTE RENAL FAILURE IN CONSCIOUS DOGS?
H.-H. Neumayer, K.Wagner, M.Rafelt, V.Achenbach,
A.Distler, M.Molzahn
University Dept. of Internal Medicine, Berlin (ERG)
Calcium channel blocking agents may ameliorate
acute renal failure in anesthetized animals in
some experimental models.
We have investigated the effect of Diltiazem
(D) in a postischemic model of ARF in conscious
dogs. An electromagnetic flow probe and a pneu-
matic cuff were placed around the left renal ar-
tery of 19 uninephrectomized beagle dogs on a high
sodium diet. ARE was induced by inflating the cuff
(180 mm). Group A (n=6) received a continuous in-
fusion of 0.9% NaC1 (7 days)1 group B (n=6) re-
ceived one of 5 g.kg-l.min-1 U (7 days) immedi-
ately after deflating the cuff (post—treatment).
whereas, in group C (n=7), the Diltiazem infusion
was started 3 days prior to ischemia and then also
continued for 7 days (pre- and post-treatment).
Before Ischemia After IscheiiT
Group 1st 3rd 7th day
RBF + A 129 125 120(ml.min) 161_9 B 220* fl3 101
133±3 C 146 100 86
GFR
(ml min)
A 263 212 211
100 B 232 250 122
C 171* 95* 61*
mean, SEMp < 0.05
Thus, we conclude that the protection by Dii-
tiazem pretreatment observed in postischenjjc ARE
is likely to be due to its direct effects on the
ischemic renal epithelial cells and independent of
its partial preservation of renal blood flow.
• EFF1X'f OF ANGIOTENSIN II (All), ADItSNAL1NN (Adr) AN!)
NOICADILENALINE (Nor) ON TUE GLA3I1EHULAU SYNThESiS OP
PROSTAGLtNDIN 1.2 (R1F.2) AND Th OIIBOXANE 82 (TxB2) IN
iSOLATED HAT GLONEHLLI (It.G).
.Podjarny, J.Shapira, M.Rathaus, J.Bernheim.
Dpmt of Nephrology,Meir h!oapital,Kfar Saba and Sack1er
School of Medicine,Tel Aviv University, Tel Aviv.
Synthesis of and TX132 has been demonstrated in
iti;fhe possible physiological importance of these
prostanoids on the GFH leads us to evaluate the effect
of vasoactive substances(VS),All,Adr,Nor, on the syn-
thesis of PGE2 and TX!)2 on Sprague hawley male HG iso-
lated by using graded sieving method.RG were preincu—
beted for 40'.VS were added for 2O'.ftE2 and were
measured in the supernatants by EIA.Phe following re-
sults were found (mean+SD).
mE2(pg/mg protein) T)Ui(pg/mg protein)
All stimulates FOE2 synthesis, a result which is in
agreement with previous studies.TXB2 synthesis is also
significantly stimulated by All in physiological con-
centrations. Adr and Nor had no significant influence
on the synthesis of POE2 and TXB2 in HG. The present
findings suggest that the associated changes observed
with All may be involved in the regulation of the GPR.
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INCREASE OF GFR FOLLOWING ANINOACID (AA) INFUSION
IS SUPPRESSED BY INDOMETHACINE IN NORMAL MEN.
T. Eisenhauer, K. Scholz, F. Scholer
Department of Medicine, Division of Nephrology,
University of GEttingen, FRG
Protein ingestion and AA infusion lead to an in-
crease in GFR.
To elucidate the underlying mechanisms glomerular
function was evaluated in 10 normal human volunteerd
500 ml of a comercial AA mixture (10% Amino—
steril) were administered intravenously for a
period of 2 h. Simultaneous measurements of crea—
tinine, inulin and PAM clearance every 30 minutes
were carried out 2 h before, during and after AA
infusion. One week later the study was repeated
under identical experimental conditions after
blocking prostaglandin synthesis by 150 mg indo-
methacine orally.
As expected GFR rose after AA infusion by about
40% (inulin clearance from 107 3,57 mI/mm. to
145 3,7 mi/mm. P 0.001). Administration of indo-
methacine completely abolished this rise of GFR in
all studied persons.
These date demonstrate that protaglandins may
play a role in the mechanism responsible for the
variation of GFR after AA infusion.
43±3
34±2 C
FEN+ (%)
6 10 10
11 13 15
17* 19 20*
Control 222+ 56
All (2.5. 107N) 520+218
AlI(2.5. Io—811 458±163
All (2.5. 109M) 401±131
All (2.5. url'4i) 319÷ 49
Control 238+ 38
Adr(1OM) 138÷ 85
Adr(108M) 218÷ 65
Nor(1O1) 168+ 56
Nor(108M) 261+ 86
p.02
p< • 02
p.O5
p .05
MS
NS
NS
NS
203÷108
328+168 p
279+111 p.O5
247±191 p.O5
179+77 NS
228±116
231+72 NS
177±73 NS
267÷170 N S
228+116 N S
RED BLOOD CELL He' ,K4 COTRANSPORT DURINO VOLUME S
EXPANSION IN NORMAL SUBJECTS.
Quarello F., Boero R., Guarena C., Rosati C.,Deabate MC, Piccoli 0.
Cattedra di Nefrologia Medica, Université di Torino. Divisioni di
Nefrologia e Dialisi, Ospedele S. Giovanni, Torino. Italy.
The elm of this study was to investigete the acute effects of
extracellular fluid volume ([CIV) expansion on the activity of red
bled cell (RBC) Na ,Kcotrensport in normal subjects, to test the
hypothesis that changes in ECFV may influence this transport system
by means of circulating humoral factors.
In 12 healthy subjects (SM, 7 F), mean age 28yr(20—40),
[CIV was expanded by a three hour intravenous infusion of 2 it
normal saline. Urinary volume, natriuresis and kaliuresis pre and
during the infusion were alsoevaluated.
Furosemide—sensitive Na and K effluxes
cotransport) were measured in fresh RBC taken pre and post the
[CIV expansion, by means of an established flux assay (Garay' R. et
al. Bih.Pharm. 33: 2013,1984). Results(mean±SEM):
HeKc0TRANSPORT URINARY EXCRETION
(i.tmol/l RBC/h) volume Na K
Na4 K (ml/h) (mmol/h)
PRE—LOAD 219±36 243±42 53±9 7.4±1.4 4.4±0.7
PO3T-LfiD 174±31 196±38 160±22 21.3±3.7 6.1±0.7
p VALUE <0.01 <0.06 <0.01 <0.01 <0.05
The changes in RBC Na4cotransport were correlated to the
variations in urinary volume (r=—O.73; p<0.O 1) and Na excretion
(r = -0.55; p = 0.06). Moreover, the degree of inhibition of RBC
Na4 outward elf lux, observed after the saline infusion, was strongly
correlated to that obtained by incubating the RBC of the same
subjects, taken in a separate ecasion, with their autologeus plasma
collected after the [CIV expansion (r = 0.95).
These effects might be due to an encbgenous factor mcxlulating
the No4 ,K4cotransport activity, triggered by ECFV expansion, and
playing a role in the renal response to an acute water and salt load.
5 ND11—Isi'NNDNNT PGE2—9—K £ONEDUCTASE( 9MIJACTIYITY IN
filE KIUNEY OF DIABETES INSIPII)US BRATTLEBORO (Dl) ANt)
LONU DTANS hATS (bE) :ItELATIONSIILFS WITH URINARY HE2 AND
HW2a EXCILTION.
M.hlathaus ,}l.Weher,l).Lis ,N.Kariv, E.Podjarny,J.Bernheim.
0 mt of Nephrology,Heir ilospital,Kfar Saba and Labora—
tory of experimental Surgery,University of Tel—Aviv
Israel,
Previous works have suggested that the renal 9IU1,
which catalyzes the reaction PUE2—kGF2a,might modulate
the relative levels of these Itis in response to changes
in Na balance.The urinary N/P ratio has been conside-
red to reflect the activity of 9K11.l)irect evidence of
the validity of this assumption is still lacking.In
Drder to assess this relationship,we measured 910t ac-
tivity in cortical and papillary homogemetes of DI and
of heterozygote and normal LE.9Kh was measured with a
modification of the method of Weher el al(Nature,266:
'5,1977) and urinary PUs by HIA.'fhe results were as
following:
910< activity
(ng PGF7giir'1n Protj
Cortex Papilla
7.29+2.00k 38.40+3.75
ileterozygote 15.25±2,13 25.20+4.77 1.11±0.10
(n = 5)
Normals(n=5) 13.60+0.89 23.00±5.75 1.64+0.19
*=p<0.O1 when compared with heterozygote and normal
rat,'I'he results suggest that the N/P ratio is a
reliable assessment of papillary 91CR activity.This is
in agreement with the decreased FUR2 in I)I.The decrea-
sed cortical 910< activity is in agreement with the in-
creased PGE2 production in DI rat glomeruli(prostag—
landins 20:349,1980)and is possibly related to the
increased renin production known to occurr in DI.
EFFECT OF POTASSIUN LOA])ING ON URINART PROSThGLANDI}I
2a IXCRETION (PGE2—KIF2a) IN DIABF.IFES INSIPIBtS
BRATTLEBORO (DI) AND LONG EVANS (LX) RATS.
M.Rathaus, N.Kariv, J.Shapira, E.Podjarny, J.Bernheim.
Dnt of Nephrology,Meir Hospital,Kfar Saba and
Laboratory of experimental Surgery,Sackler School of
Medicine,Tel Aviv University.
To assess the possible influence of K on the renal
synthesis of POE2 and POP2a,we measured the 24h urinary
excretion of PGE2 and PGF2a in DI and LE maintained on
a standard diet.The K load was performed for 11 days
by supplying KC1 solution instead of drinking distill-
ed water(O.75gr/l and 6gr/l for DI and LE).Urina.ry PUs
were measured by RIA in the last 3 consecutive 24h
urinary collections.
The relevant results are as follows
Normal IZ(n=10)
x = (0.01
(mean 5121):
High K (n=5)
5.5 0,5 X
''9 0.5 x
88
51.6 7•3
66.2 x
57.3 44 x
1.2 0.4 X
0.9 0.1
The results show that K load induces a significant
increase of 'GF2a excretion,a mild decrease of PGI2
excretion and a significant decrease in the ratio N/P
suggesting that an increased activity of the renal
PGE2—9.-Ketoreductase is present in this condition.The
renal PUs can play a role in K homeostasis (without
influence of ADH).
INFLUENCE OF PROSTAGLANDIN F ON GLU-2 alpha
COSE TRANSPORt IN THE RENAL PROXIMAL TUBULE
I. Samarija , V. Molnar, D. Davila
Center of Hemodialysis and Nephrology, Hospital
"Dr J. KalfeP", Department of Pharmacology, Med.
University, PLIVA— Research institute, Zagreb,
Yugoslavia.
It is well known that renal prostaglandins effect
the reabsorption of sodium and water in a tubule
but the mechanism of their action is not completely
explained. By using electrophysiological method on
the kidney in vivo, we tried to get more information
about the action of PGF,, h on sodium-glucose
cotransport through thg ial membrane. The
cell membrane potential difference with 5 mmol/l
glucose in the tubular lumen was measured. The
results show that PGF does not alter the con—2 alohatrol cell membrane potential but in its presence
the glucose transport inhibited and the longer it
lasts the inhibition is more pronounced. This inhibi-
tion is reduced if the prostaglandin synthesis inhibi-
tor — diclofenac is present in the concentration of
0.1 mmol/l. Diclofenac alone reduces the control
cell membrane potential depending on concentration
and duration of preperfusion. These observations
suggest that PGF shows diuretic effect thro-
ugh intracellular2ces and cell membrane per —
meability changes in the regulation of transport
proceses in the proximal tubule.
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Urine K
(meg/a)
Urine PGE2
(ng/d./lOOg SW)
lirine FGF2a
(ng/d/lOOg BW)
N/F ratio
LE 3.1 0.1
1)1 3.5 0.1
bE 107.6
DI 58.2 6.5
bE 26.1 2.7
DI 22.3 2.2
LX 4.4 0.6
DI 2.7 0.6
Dl rats
(n = 5)
N/F ratio
0.32+0.03*
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EFFECTS C IREASED SPLN'O+JIC RESISTNJIS NI) Al]EM),AW PLASA
TR4PPI3 ON RENAL HEM])YN'1ICS NI) Na EXCRETICt1.
A.Satta, R.Faedda, R.frghi ,G.F.Branca,B.Coritu,E.Bartol i.
InstJ'ed.Pathohxjy and Narolcy,L.h1ivers. of Sassari,Italy.
Experiemnts re jrfonimd on dcs to individuate the determi
nants of the relationship between liver interstitial pressure
(ILP) and Na retenticn.The animals re studied before,during
and after release of increased ILP induced by apply
ing a high hydrostatic pressure to the thoracic duc
(HTDP) or to the choledochus (HCP).
With HIPO, ILP rose from 9.5±0.2 to 21.3+2.Sasfl2O
(P<O.01), GFR fell from 15.4+1.8 to 10.2±1.5 mi/mm
(P<0.02), Na excretion from 19±3 to 9±2 )JEq/min (P<
0.05). With HCP lymph flow in the DT rose from 0.48
to 1.68±1.50 mI/mm (P<0.05), buffering the ri
se in ILP. With HCP of 40 cmH2O and a counterpressu-
re applied to TO of 9.6+3.7 cmH2O, the rise in lymph
flow was prevented and ILP rose from 8.2±0.2 to 15.
cmH2O,urine flow rate fell from 0.17+0.03 to
0.11±0.02 ml/min (P<0.05). In this latter group of
dogs plasma A0H rose from 1.9±0.1 to 1.4±2 ng/L.
These data indicate that the increased blood vo-
lume trapped in the splanchnic district caused a fall
in
"effective" plasma volume. This fall was sufficient
to trigger ADH release and to lower renal hemody-
namics and Na excretion when the ILP was > 20 cml-120,
while only the ADH effect was elicited for pressure
<20 cmH2O.Since ILP reflects sinusoidal resistan—
ces, our data demonstrate that there is a critical
value in sinusoidal resistances beyond which Na re-
tention occurs.
CHANGES OF CYCLIC NUCLEOTIDES AFTER DOPAMINE
INFUSION IN PATIENTS WITH CHRONIC RENAL FAILURE
L. Settas, A. Lazaridis, E. Doxanidis, A. Panalas,
Papadakis, A. Tourkantonis
1St Dept. of Medicine, University of Thessaloniki,
Greece
The effects of dopanine on plasma and urinary
cyclic AMP and c"clic (MP, as well as nephroqenous
cyclic AMP were studied in 8 normal subjects and
19 natients with chronic renal failure. Patients
were divided in 3 groups according to serum crea-
tinine values:rroup A (1.2—3.0 mg%) with 6 natients
group B (3.0—8.0 nin%) with 7 patients and qroup C
(8.0—14.5 riq%) with 6 patients. Patients with hy-
pertension, myocardial ischaemia and arrhythnias
were excluded. Dooaniine was given by I.V. pump in-
fusion in a dose of 3jjq/kci/min for 5 hours. Blood
and urine samples were taken just prior to infusion
hourly durino infusion, and 48 hours after the end
of infusion. Side effects were not observed. Cyclic
nucleotides were measured by radioimmunoassay. Pla-
sma and urinary cyclic nucleotide levels and nep-
hrogenous cyclic AMP values were increased signi-
ficantlv during doparnine infusion in both controls
and patients with chronic renal failure,comnared
to basal values (p<.0.001). In group C there was
less significant difference (pO.01). After the
end of infusion cyclic nucleotide concentrations
fell nearly to pre-infusion values. The results
sugnest that dopamine affects renal function in
both controls and patients with chronic renal fai-
lure by stimulating renal adenylate cyclase.
. EFFECT OF AN AC1JTh NACL LOAD ON ThE UUINAIi! EXCRETION
(U) OF PEOSTAGLANDINS (Pu) 52 AND F2a IN ANTID1URE'TIC
ABH) suPrswssu DOGS.
i1.Schneider, i .Erez , is. Spitz,M.dathaus,J. Bernheim.
tsnt of Nephrology,Neir Hospital,Kfar Sabaand Sackler
ichool of Medicine, University of Tel Aviv.
Previous studies have suggested that changes in Na
balance may influence the synthesis of renal Pus;how—
ever they were performed in presence of an adequate
secretion of ADH,known to stimulate FG.Po eliminate
ADH effect and study the action of an acute Na load on
PG in healthy anest.hesied(nciubutal 25mg/kg IV)and in—
tubated dogs we performed the following protocol:5dogs
(17.8±3.4 kg)were infused with a 0.45g4 NaCl sol (us)
and 2 c of 96% ethanol sol/l until U osmol was lover
than l2Omosm/kg.The xperimental protocol was then
started in 3 periods(P)of 3Oni. PA:HS was continued at
the rate of diuresis; U were collected through a blad-
der catheter.k'B(Na load):isotonic NaCl(1 l)was given
in parallel to HS.PC:1I.S was infused without load.Eah
F was divided in 3 U collections for measurements of
osmol,FGE2,RF2,Na.Dlood was taken at 5,15 and 25mn of
each P(Na,osmol).The main results(mean+SD)are:U osmol
decreased from 131O+2(SO(basal)to 86+l6mosm,'kg.The rate
of HS was 28.8+2.6m1/mn for 162--29 mm until low osmol
was ohtained.tJ Na was 4.344-4.3mmole/3Omn in 1,17.7
.05)in PB and 17.S±13(p .05)PC.PGE2 and PGF2
remained stable 0.86+0.7 and 1.35j).8ng/ml(FA),0.94
and 1.5+O.9(PB),O.98÷U.5 and 1.8+1.14(PC).The
k'GE2/l"2a ratio did not change(O.64÷O.36; 0.86+0.76;
0.83÷0.84).In conclusion(1) a good suppression of ADH
and a significant increase of U Na have been obtained
(2) H are present in U of dogs with suppressed ABH(3)
Na load did not change U 151 in clogs.
THE EFFECT OF VERAPAMIL ON KIDNEY FUNCTION
J. Shohat, G. Boner, 3. Rosenfeld
Nephrolor Institute, Beilinson Medical Center,
Petah Tikva & Sackler School of Medicine, Israel.
The effect of verapamil, a calcium channel
blocker on renal function, was investigated in the
isolated perftsed rat kidney.
In the verapamil group (v) creatinine clear.-
ance and filtration fraction were higher than in
the control group (c) (0.4 0.1 vs 0.22 + 0.1
ml/min (p0.001) and 2.69 9.9 vs 1.53 0.6%(p,0.0O1), respectively). Perfusate flow rate
and total renal resistance were similar in both
groups. Although urinary sodium excretion and
osmolar clearance were hiser in V than in C;
9.62 .. 7.3 vs 3.58 .- O.6peq/min (p<0.O01) and
97e62 + 58 vs 44.4 11.4,&eq/min (pO.001),
respectively-, FE Na was n.milar in both groups.
Similarly urinary potassium exoretion was higherin V than in C (1.79 .s- 0.5 vs 0.99 . O.3jseq/min(p..0,001), but FC was not different. 'Urine
volume was higher in V as compared to C (94.4 +
55.5 vs 40.7 ÷ 11.?1u1/min (p<0.O01)), but
FE H20 and free watr clearance were similar.
As verapamil causes a substantial increase in
glomerular filtration rate, without a sigeificant
change in renal perfusate flow and total renal
resistance, we conclude that verapamil causespreferential dilatation of preglomerular arter..jules. The observed increase In electrolyte
and water excretion is related to the increased
GFR in that the fractional excretion did not
change. Verapamil thus does not seem to have
an effect on the tubular handling of electro-lytes and water.
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• GLOMERULAR & TUBULAR ACTIONS OF ANOIOT1SIN II(AlIJ. Shohat, J.B. Rosenfeld., 0. Boner
Nephrolo Institute, Beilinson Med.ical Center,
Petah Tikva and Sackler School of Ned.ioine, Israel
In the present study the direct renal effects
of All and, the influence of verapamil (v) on theae
effects were investigated in the isolated. perfused
rat kidney. In the angiotensin II group (AG) per-.
fusate flow rate (PFR) was lower and. total renal
resistance (TRR) was higher than In the control
group (c) 7.4 2.2 vs 13.3 + 2.5 mi/mm (p.c 0.001)
& 17.6 ... 5.6 vs 9.2 + 1.6 mnfg/min/ru (p<O.O01).
Creatinine clearance (C.Cr) was not different in
both groups but filtration fraction was higher in
AG 3.81 1.2 vs 1.53 '4. 0.6% (p.O.OO1). In AG,
UNaV, FE Na were higher than in C; 17.58 + 7.3 vs
3.58 ÷ 1.3,ueq/min (p..0.OO1), 45.6 + 8.7 vs 13.9
.. 7.3 (p.,0.001). Urine volume (UV) & FE H20 were
higher in AG; 138.5 .. 55.4 vs 40.7 + 11.71u1/mm(pO.0O1) & 49.4 + 8.7 vs 19.4 6J (p< 0.001).
The maiitude of the difference between C & AG
in UV & FE H20 was similar to that of sodium I.ecre-
ticn (300%). Free water clearance (c.o) was not
different in both groups. In All—V group PF'R
(10.5 + 3.4 mi/ruin) was greater than in AG & in C.
C.Cr (.42 0.2 mi/ruin) was higher in the All—V
group than in C & All, FF (3.84 1.7%) was no
different from that of AG, but higher than C
(p. 0.001). UNaV (24.4,ueq/min) & FE Na (41.8%)
were not different in AI—V as compared. to AG.
Similarly UT, FE H20 were not different in All—V.
We conclude thaL tt.e constrictive effect of All
is confined mainly to the efferent arteriole.
All has a natriuretic effect, but no effect on
renal water handling. V. abolished the giomeru].ar
action but not the tubular effects of All.
EFFECT Oi CI-IOSPHATE (C04) ON THE AUTORECULAT[ON (3
THC RENAL HhMODYNA3ICS.
tiohamed Sohh (M.D.), C. Pet itciere (M.D.) ,G.E.Plantc
((1.0.).
Urology & Nephroiogy Center,Nansoura (in vers.i ty,lgypL.
CjI.1I. Dc Sherbrooke, Quebec, Canada.
The el feeL 01 the tubular P04 on the renal auto—
regu lot ion had been studied in five groups of fema-
le mongrel dogs.
Anaesthesia was couduc Led by nembuta arid the dog
was nieclian lea ily ventilated. Femoral vein and arte-
ry catheters were put. Through a .labarotomy incision
Lhe ureters were catheterised and a nylon Lape put
arround the aorta above the origin of the renal ar-
teries. [riulin aiid PAl! were used as markers for GFR
and RPF deLerminaton.
The Renal Perfusion Pressure (RPP) was reduced Iron'
Lhe mean basal value 103 mm Hg to 90 then 80 and
laSL(y to 75 mm Hg.[ii the First (control group) the CFR was found to
he stable in the face of the decreasing RPP. In gr-
oup two, thyroparathyroidectomy performed 24 hour
earlier resulted in complete paralysis of the auto—
regulation. in group three, infusion of levarnesol
resu I ted in 5 ign .1 leant phosphaturia and failure of
the autoregelation mechanisms, in group four, pret-
reatment with ludomethacin resulted in aggravation
ol the levamesoi eFfect and in group five pretreat-
ment with Saralasin resulted in reversal of the ef--
feet of levamesol.
From this we concluded that P04 play an importa-
nt role in the renal autoregulation, this could be
through an eflect on the Renin—Angiotensin—Prostag-
land inc axis.
PROTECTIVE EFFECT OF VERAPAMIL ON THE ISCHAEMIC AC-
UTE TUBULAR NECROSIS IN DOGS.
Mohamed Sobh (M.D.), M.Mansour (Ph.D.).
Urology & Nephrology Center, Mansoura University,
Egypt.
During renal ischaemia there is increase in mit—
ochondrial calcium ion which could be responsible
for renal vasoconstriction and cellular necrosis
(Schrier, 1983). Verapamil decreases intracellular
calcium ion by decreasing it's inward displacement
during the plateau phase of action potential.
In this work three groups of mongrel dogs had
been used. Each dog was anaesthetised by nembutal
& mechanically veritillated. Normal saline was pumb—
ed through a femoral vein catheter & the blood pre-
ssure monitored through a femoral artery catheter.
Right nephrectomy was done. Urine of the left kidn-
ey was collected through a ureteric catheter. Left
renal blood flow (RBF) was measured by an electrom-
agnetic flow probe. In the first group, si.xity mm
complete renal artery clamping was followed one hour
after release by a significant reduction in GFR,
urine volum/min (UV), the acute tubular cell necro-
sis (ATh) manifested by a significanir increase in
the urinary enzymes activity (Alkalin phosphatase,
L.D.H. andlG.T.) In the second group, following
Verapamil 0.5 mg/kg I.V. bolus there was no renal
hemodynamic or functional changes. In the third group,
pretreatment with Verapamil prior to 60 mm ischem—
ia caused a definit protection againest tubular
cell necrosis (abscent increase in the urinary enz-
ymes). Beside there was marked blunting of the exp-
ected decrease in the RBF, GFR and DV.
This study showed that Verapamil can protect
against the ATN and ameliorate the expected increa-
se in the intrarenal vascular resistance following
the 60 mm renal ischaemia.
THE EFFECT OF DOPAMINE (D) ON RENAL FUNCTION IN
INSULIN DEPENDENT DIABETES MELLITUS (10DM)
P.M. ter Wee, E. van Ballegooie, A.J.M. Donker.
University of Groningen and Free University of
Amsterdam, The Netherlands.
Protein loading fails to produce a rise in GFR
in diabetic subjects, even if the renal function is
normal or enhanced. This phenomenon has been
attributed to an already existing generalized renal
vasodilation in IDDM. Renal vasodilmtion can also
be achieved by infusion of 0. Therefore, we have
studied the effect of D (1.5—2 fig kg°min1) on
renal function in normal individuals (n=28) and in
14 normoglycaemic patients with IDDM. No differences
in age or sex distribution were present between
these 2 groups.
HbA1 in the patients with IDDM amounted to
7.6 GFR and ERPF were determined simul-
taneously using the standard clearances (U.V/P) of
125Iiothalamate and 'I—hippurate, respectively.
Mean blood glucose level of the patients with IDDM
during the renal function study was 7.8±0.4inmol/1.
-D
__________________
GFR ERPF GFR ERPF
Normals 112 461 125 629±20
Patients 130*±4.3 541*±],8 144*±5.8 673±27
* p<O.O1 (patients vs normals); values SEM in
ml/min/l.73 2
Infusion of D increased ERPF and GFR both in
normal subjects and in patients with IDDM
(p<O.OO2). Filtration fraction (FF) fell in both
groups. From these results it is concluded that in
IDDM the enhanced GFR is not due to a generalized
renal vasonijiatjon. Thn normal base—line FF in
IDDM is in accord with this conclusion. More likely
therefore, is the supposition that in IDDM only
afferent vasodilation exists, a condition that
cannot be enhanced anymore by protein loading.
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• EFFECTS (F il-fYROID HOOES C Na DJFF1I(J ACROSS PROXIML
TWUfiR BRUSH BOROER IERANE.
F.Turrini, B.Ccntu, A.Ginanni, AYasala, A.Satta, T.De Nirrra
and E.Bartoli.
Inst..Patholngy and l'phrolngy,1hiivers. of Sassari, Italy.
The influence of thyroid hormnes cn Na uptake nexliated by
the antiparter systes was studied on 88 (brush lyjrrjer vesicles
of the rat kidney) isolated in vitro according to Evers et al.
(Iitr.Bicychen. 11:293-308,1978). t"easurenmnts of kinetic
pareaeters were parformad to characterize the Na -H antiparter
of 88.
Vesicles preequilibrated at -l 6.00 were added to a iffer
at i-l 7.50 containing the fluorescent ccnpcund I1cridine Orange
(AO), whose distribution between vesicles and nBliuil is i-F-de-
pemient (Naenstra W.W. of al. J.Biol.Ches.256:11663-11666,
1981). The entry of AO into 88 vesicles determirs a quencing
of the initial fluorescence
sinal (Q), while Na addition pro-
mates an antiporter-nediated H exit paralleled by a ricovery
tcwards the initial fluorescence (R).
The results obtained in control conditions were calpared to
those neasureci when 3 (0. 1 -1 pg/mi) or 14 (0. 1-1 pg/mI) were
added. The calculated IQn fell frau the control value of 4.33 to
1.14 in the presence of 13, while Vm was unchanged (10.05 vs
10.63). Since 58 vesicles incubated with T4 yielded progres-
sively increasing concentrations of 13 with tine, while the of-
fect was negligeable in other proximal tubular fractions, the
88 contains the nuicxleicdinase enzyre, capable of converting 14
into 13.
Thus, these data demnstrate that physiolngic concentrations
of thyroid honiones similar to those bathing the SB epitheliti
in vivo are capable of influencing the affinity of either Na or
for the antiporter. Th'roid honiones may be part of a jiysi-
olngic system that controls Na penieability of the h.tninal nan-brane in vivo.
.
RENAL RESPONSE TO PROTEIN LOADING AND wODULATING
EFFECT OF PLASMA GLUCOSE IN INSULIN-DEPENDENT DIA—
BETICS WITH HIGH AND NORMAL GLOMERULAR FILTRATION
RATE
Viberti GC, Bognetti E, Wiseman MJ
Unit for Metabolic Medicine, Guy's Hospital Medical
School, London, UK.
In order to determine the influence of dietary
protein on glomerular filtration rate (GFR) in dia-
betes, we measured GFR by constant inulin infusion
before and after a meat meal containing 70-bog prom
tein in 6 male non—proteinuric insulin—dependent
diabetics (IDDs) aged 29+6y and with diabetes dura-
tion 8-i-3y during euglyceemia and moderate hypergly-
caemia, and in 6 age matched non—diabetic controls.
Mean GFR in the control group rose from baseline
107+11 to peak 120+12 ml/min/L73m2 (p 0.05) . In
the 6 IDDs during euqlycaemia mean GFR rose from
137+15 to 151+25 ml/min/l.73m (p 0.05) . This re-
flected a consistent rise in the 3 IDD with the
highest GFR (baseline 148+7 vs peak 172+8 mi/minI
l.73m2), but no change in the 3 with the lowest GF'R
(baseline 126±10 vs peak 124+8 ml/min/l.73m2. During
hyperglycaemia, mean GFR in the IDD5 rose from 138
+18 to 15U2O ml/min/L73m2 (p 0.05); the response
was unchanged in 4 subjects (2 who had previously
shown a rise and 2 who had not), hut was different
in the other 2. One whose GFR rose during euglyc-
aemia showed no change, and the other whose GFR had
not changed previously showed a marked rise from
105 to 123 ml/min/l.73m2. We conclude that animal
protein loading increases GFR not only in healthy
controls but also in some diabetic subjects. In
IDDs, both baseline GFR and level of glycasmia ap-
pear to influence this response.
Intr. by Prof. JS-Cameron
• ROLE OF ENDOCENOUS PROSI'ACLANDINS (POs) ON
TI-IF RELEASE OF AOl-!.
M.Usberti, S.Federico, B.Cianciaruso, C.Di
!'linno, B.Ungaro.
Nefrologia Medica, II Facolt4 di Medicina,
Universit di Napoli.
The influence of exogenous POE2 on AD!) release has
been studied extensively in hypothalanio-hypophyseal
complex in oman colture and in experimental animals
but the role of endogenous POE2 on AW release is
still unknown in normal man. Using captopril (C) to
increase endogenous POE2 and to decrease endogenous
angiotensin II (All) synthesis, we studied the rela
tionship between endogenous POE2 and ADI! release in
6 normal men before and after POs synthesis inhibi-
tion by aspirin (ASA). In the control stud', follo-
wing 100 mg of C, there was a significant increase
in plasma POE2, PEA and urinary PGE2 and 6-keto--
P01 and a decrease in plasma APP. (',FP., RPF and FE
were unaffected by C. Urine outnut, FENa, Cosm in-
creased significantly after C. In the ASA study
POs were undetectable in plasma and significantly
reduced in urine, one hour after aspirin and did
not increase when C was added. Plasma AD1I decreased
and PEA increased, as in the control study after C,
whilst CEll, RPF, urine output, FENa, Cosm and Uosm
were unchanged. These results suggests that endoge-
nous All, rather POs, nlays an inportant role in
APP release, and confirm the suggestion that POs
are the mediators of C-induced diuresis and natriu-
resis.
•
THE EFFECT OF DIETARY PROTEIN QUALITY IN
EXPERIMENTAL RENAL DISEASE (ERD)
A.J, Williams, FE. Baker, J. Walls.
Dept. of Nephrol. , Leicester General Hospital,
Leicester, u_K.
Dietary protein restriction has been shown to
alter the course of ERD and reduce the rate of
decline in renal function in some renal diseases in
man. A reduction in capillary flow and glomerular
filtration rate (GFR) may be responsible. Vegetar-
ians are known to have lower GFR's than omnivores.
This study investigates the effect of dietary
animal protein, casein (Op A, 24%, nll, Gp 8, 12%,
n12) and vegetable protein, soya (Gp C, 24%, nl2,
Op 0, 12%, n11) upon ERD.
Four groups of rats (n46) subjected to a
remnant nephrectomy, consumed one of the four
experimentsl diets for 3 mons. The survival of
animals fed soya (Op ClOO%, Op 0=90.9%) was
significantly higher than those fed casein
(Op A=63.6%, Op B=58.3%) (p O.O5). The
proteinuria (mg/24 hrs) in Gps C and D (30.4 + 5.1,
35.5 + 6.7) was significantly lower than Ops A and
8 (98.7 + 34.0, 63.8 + 17.7) (p o.o2) as were the
weights of the remnant kidneys (p <0.005).
Significant correlation between remnant kidney
weight and proteinuria was found (rO.75, p <0.001).
Histological damage to kidneys in Gps C and D was
significantly less than Ops A and B (p <0.005).
The creatinine clearance in Op A was initially
higher than other groups, (p <0.01), but at 3 mona
no difference was found between the groups. No
difference in serum calcium, phosphate or albumin
was found at 3 mona.
These results demonstrate that the type as well
as the amount of dietary protein can affect
structure and function in the remnant kidney.
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GLOMERULAR DISEASE
PROGNOSIS IN PATIENTS WITH 1gM ASSOCIATED PRIMARY
MESANGIAL PROLIFERATIVE GLOMERULONEPHRITIS
E.J.Acheson, W.Lawler, S.B.Lucas, L.Hunt, R.Gokal,
N. P. Mallick
Royal Infirmary, Manchester, England.
Selected clinical and pathological data from
fifty patients with primary diffuse mesangial
proliferative glomerulonephritis and 1gM as the
sole or predominant immunoglobulin was analysed
statistically to ascertain whether outcome could be
predictive.
Follow—up was a minimum of two years (range
2—35 years, median 7). Patients were divided into
two groups; in Group I were the thirty—seven
patients who did not develop end—stage renal
failure; the thirteen who did were in Group II.
A stepwise linear discriminant analysis applied
to selected data at the time of the index biopsy
gave statistically significant variables for
predicting end—stage renal failure. In order of
importance these were: —
1. the greater the proportion of glomeruli showing
segmental sclerosis,
2. the greater the contribution by mesangial
matrix to the expanded mesangial regions,
3. haematuria,
L• the greater the proportion of glomeruli showing
global sclerosis.
Using these four variables, 36/37 of Group I anc
l3/l of Group II patients could be predicted
correctly.
MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS (!IPGM):
MORPHOGENESIS OF THE TYPE III LESION
0. Anders (Intr. by J. S. Cameron)
Childrens Hospital ,University of Giessen,'—Germany
The diagnosis of MPGN type III can only be estab-
lished by electron microscopy demonstrating a
"disrupted' appearance of the basement membrane
in silver impregnated ultra thin sections of renal
biopsies. This particular type of h.m. lesion
see to be the result of both, subendothelial and
subepithelial deposit formation. Due to this
mechanism the lesion takes an intermediate posi-
tion between HPGN type I and membranous glomerulo-
pathy. Early during the course of the disease the
histological pattern may show marked nesangial
hypercellularity resembling 'IPGN type I. Lateron,
there may be a similar lack of mesangial cell acti
vation as observed in mernbranous glomerulopathy.
In the present study electron micrographs of
silver impregnated ultra thin sections were ana-
lyzed with respect to the evolution of toe type
III lesion. Subepithelial deposits can be shown to
be core solid and more resistent to break down
and removal than subendothelial deposits. They
stay in place and are covered from the outside by
strands of new b.m. material while the former b.m.
is being removed from the inside. Thus they are
gradually shifted towards a seemingly subendothe—
uial position where mesangial cell processes may
gain access to the material - one of the possible
reasons why the separation of MPGN types I and III
is still open to discussion. The type III lesion
can be described in terms of deposit formation -
resistence to break down - lack of removal - assi-
milation and incorporation into the capillary wall
WirY IX) PATIENTS WITS A RENAL VASCULITIS DIE?
D. Mu, A. Asokan, P. Bacon, D.B. Brewer, A. Howie,
P. McGonigle and J. Michael.
Departments of Nephrology, Rheumatology and
Pathology, Queen flizabeth Hospital and
Birmingham University, Birmingham, England.
Despite treatment, the mortality from
vasculitis with rena]. impairment remains high.
We analysed data on 29 consecutive patients with
a renal vaeculitie (polyarteritis nodosa 22 and
Wegeners Granulomatosis 7) to determine the
cause of death. Initial treatment we-a w.th
prednisolone and cyclophosphamids ióh orally
or intravenously. even of the 29 patient.
died. Ten out of 20 patients aged over 50
died as compared with two out of 9 atidt
younger than this. Out of 1 patients with a
serum creetinine in excess of 500 umol/l, 10
died whilst only 2 out of 12 patients with a
lower serum creatinine died. Sixteen patients
were given intravenous methylprednisolone and/or
cyclophosphamide and 10 died and in contrast of
13 patients treated with *j.e agents orally,
two died. The predominant aae of death was
sepei..
From this data it is apparent that intra-
enous methylprednisolone and/or cyclophomphamide
are unsafe in older patients with renal failure
due to a vasculitis.
PREDICTIVE FACTORS 01- RENAL FAILURE PROGRESSION IN
MFJvIBRANOUS GLOMERULONEPHRITES (MGN).
Stanziale P., Balletta H., Esnosito A., Santopietro
A., Fuiano G., j'umendola G., ndreucci V.E.
Dept. of Nephrology, 2°Faculty of Medicine, Naples.
In this study, the possible relation of clinica,
morphological and ijnmunobiological parameters with
renal failure progression was investigated in 27
patients with primitive MGN, treated with Indome-
thacin or Prednisone.
The diagnosis was done by renal biopsy and the
follow-up was carried out for 45±25 months. The
patients were divided in two groups, i.e. those
with (group 1) and without (group 2) renal failure
at the last control. The following parameters were
evaluated to compare the two groups: a)hystological
changes in the basal bioptical specimen; b)immuno-
biological changes during follow—up (Clq,C4,C3A,C5,
C9,KAF,.plH,Pron, ICls,ATIII ,Proteinuria) ;c)therapeu—
tic program. The changes in inimunobiological tests
did not appear influence significantly the renal
function. On the contrary, an high score for tubu-
b-interstitial changes (phlogistical infiltration,
interstitial sclerosis, tubular dilatation and
atrophy) was found in the group 1 when compared tu
the group 2. (p0.Ol). The incidence of renal fai
lure was higher in the patients treated with indo—
methacin (41%) than in those treated with Predniso-
ne.
These data suggest that the tubulo-interstitial
changes are of great value in the prognosis of MGN
and confirm that Prednisone is the drug of choise
in the treatment of this disease.
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SUPERIMPOSED NEPHRITIS: A SEPARATE ENTITY AMONG GLO
MERULAR DISEASES?
T. Bertani. C. Mecca, G. Sacchi, G. Remuzzi
Mario Negri Institute for Pharmacological Research,
Bergamo, Italy.
The concomitant occurrence of twp glomerular di
seases in the same patients was diagnosed in 7 out
of the 105 patients undergoing renal biopsy for
suspected glomerulopathy. The most frequently asso
iated disease was a 'membranous' type glomerulopa
thy. The follow—up was characterized by a rapid de
terioration of renla function and two patients re
quired to start a chronic hemodialysis program soon
after the diagnosis. It is suggested that the obser
sed coexisting patterns of glomerular injury do not
occur on the basis of chance alone and should be
considered as a separate entity in glomerular patho
logy. In all cases clinical and pathological fin
dings were strongly suggestive for two consecutive
disctinct pathological processes, thus justifying
the use of the term 'superimposed nephritis'. It is
reasonable to assume that the mechanisms responsi
ble for glomerular damage and for the evolution of
the disease in superimposed nephritis are different
from those regulating the corresponding glomerulone
phritis when occurring alone. The high prevalence
of 'membranous' pattern in superimposed nephritis
indicates that pre—existing glomerular alterations
might favour an immune reaction in the subepithe
hal space.
.
URINARY COMPLEMENT j3REAXDOWN PRODUCTS IN
MEMBRANOUS NRPHROPATEY - A MARKER OF DISEASE
ACTIVITY?
B.M. Coupes, C.D. Short, P.E.C. Brenchley, S. Boyd,
N.P. Mallick.
Dept. of Renal Medicine, Manchester Royal Infirmary
U.K.
Glomerular C3 deposition is a charcteristic of
membranoum nephropathy (M.N.), though serological
studies have not consistently shown evidence of
significant complement consumption. We propose
that intra—renal activation of complement may be
detected by measuring urinary C3dg, which is a
stable product of C3 activation.
Paired plasma and urines were collected from 41
patients with biopsy proven M.N. and 13 healthy
age—matched controls. C3dg was measured by ELISA,
and levels were correlated with clinical statue
and biochemical parameters of renal function.
Active disease was defined as either declining
renal function (progressive rise in serum
creatinine) or very heavy proteinuria ( 5g/24hrs).
The median (and interquartiles) of plasma C5dg
in M.N. patients was 13 units (11—16) which was
significantly higher than in healthy controls (9
units, 7 — 11) (p . 0.001). There was no
correlation between plasma and urinary C3dg levels.
No urinary C3dg was detected in any individual in
the absence of proteinuria. There was no
significant correlation between the quantity of
C3dg in the urine and the 24hr protein loss. C3dg
was detected in the urine of 2/9 patients with
stable renal function and 5g/24hrs proteinuria
compared with 17/20 patients with stable renal
function and 5g/24hre proteinuria (Fisher Test
p = 0.004). All 5 patients with declining renal
function had urinary C3dg.
We conclude that urinary C3dg may be a useful
marker of active glomerular damage.
• NAY GLUTEN FREE DIET REDUCE THE LEVELS OF igA
IMMUNE COMPLEXES IN PRIMARY IgA NEPHROPATHY ?
R.Coppo, B.Basolo, C.Rolltno, D.Roccatello,
G.Martina, A.Pnore, G.Bonglorno, G.Piccoli.
Nephrolo' Units S.Giovanni Hospital.Turin.Italy.
Experimental arid clinical data indicate a patholo,
gical role of circulating IgA immune complexes (IgA
IC) in IgA nephropathy.Moreover,recent experimental
models tn mice have demonstrated that Ig.A nephro—
pathy can be induced by alimentary antigen challenge
through a product ion of specific IgA by mucosal im-
mune system.
To investigate whether this mechanism is opera-
ting also in human primary IgA nephropathy (PIgAGN),
the Authors evaluated the effect of different diets
in six patients selected as having higri IgAIC le-
vels (detected by a specific conglutinin assay) and
heavy microscopic haematuria or nephrotic range
proteinuria. Patients were longitudinally studied
over 10 months.During 3 test periods of 10 days they
received wheat gluten free, bovine meat, free and egg
free diets. After gluten free diet IgAIC levels sig-
nificantly decreased (pco.0l), whereas they were
unaffected by meat, or egg free diets. IgAIC had a
rebound to very abnormal values after one month of
uncontrolled diet (pO.02), but again significantly
decreased during a subsequent period of 6 months at
gluten free diet (pO.02).
The suggestive evidence of a relationship be-
tween gluten free diet and decrease in IgAIC levels
prompts new insight into pathogenetical mechanism
and perhaps unsuspected treatment, approaches for
patients affected by PIgACN
IgA DEFiCIENCY AND CLOMFRULONEP1IRJTIS
R.A. Coward, M.A.H. French, J.R. Shortland,
C.B. Brown
Depts. of Rena] Medicine, Immunology and
Ilistopathology, Royal Hallamehire Hospital,
Sheffield, England.
Patients with selective IgA deficiency(<O.OSg/i) are predisposed to recurrent Infections,
allergic and autoimmune diseases. It is believed
that secretory 1gM antibody compensates for the
absence of secretory IgA in these individuals.
C,lnmerulonephritls in such patients is poorly
documented. We describe 3 patients with IgA
deficiency and a mild self limiting glomerulo—
nephritis.All patients were male with a lifelong
susceptibility to upper respiratory tractinfections. Presenting features were asymptomatic
proteinuria, microocopic haematuria and abdominal
pain with serum creatinines 85, 96 and 282umo1/l
arid 0.2, 0.5 and 1.85gm protetnuria/24hrs. Within
2 months all 3 had normal renal function with
insignificant proteinuria ((O.02g/24hrs). In all
cases renal histology showed a mild focal messnglal
proliferation with electron dense paramesangial
devosits and granular 1gM in the mesangium and
capillary loops. Two cases also had C3 and
fibrin in capillary loops. Secretory component was
absent from all biopsies. Serum complement was
normal and antibodies to IgA and ES/i were negative.
Although 2 cases had circulating 1gM immune
complexes and one milk precipitans, there was no
clear relationship to the occurrence of
ginmerul onephri ti S.
Though we failed to show.a temporal relationship
between infection and glomerulonephritis, we
propose that respiratory tract Infections were the
stimulus for glomerular 1gM deposition In these
oat ients.
CYCLGI'IICSPIIAMIDI Di PLND1INT NEPIJRITIS
IN 2lG:NER'S G1lAiULCMATLSIS
S.CzeieIski, L.Salwa, J.Zeromski, J.Fle—
dorowicz—Fahrycy, H.Kordecki,L.Majkowska
caOeny of Medicine, Svc'zccln and Academy
of Leciicinc, Pozum /i'oinnd/
Six patients /3F, 3M aged 17—5U years"
with histoloelcaHy proven agener's gra—
eel orntosi s in tie resairatory tract and
kidney biopsy specimens, were treated
with Cyclohosphamide in initial dose of
15C ng daily and corticosteroids. Thistreatment resulted in remission of res-piratory syrsntoms in all patients, in
rrrest of renal deterioration in 5 pa—
tints and in the marked improvement of
renal function /after six week losting
re1uirepent of peritoneal dialysis thera-
py! in one 'aticnt with renal insufficien-
cy. The tapering or disscontinuation of
the Cyclophosphamide therapy resulted in
the relapse of nephritic syisatoms. ei—
estitution of Cyciophosphamide therapy
uns ascciatcd with remission in all pa—
tierits but again the disscontinuation of
the drug administration caused another
rclaise in 3 patients. It is concluded
that in son'e patients mith ezener's
Eranuio:atosis the nephri tic symptoms
are (yci ophosphamide dc;erident
ADULT MINIMAL CHANGE NEPHROTIC SYNDROME: GREAT
CORTICOSTEROID DEMAND, BUT BENIGN FINAL OUTCOME.
P.E. deJong, H. Bijiand, C.A. Goidhoorn, J. Grond
G.K. van der Hem.
State University Hospital Groningen, The Netherlands.
Because definite data on long—term follow up of
adult MCNS are rather limited, we studied the
course of 19 patients with biopsy proven MCNS,with
selective proteinuria, IS years of age or older at
the time of diagnosis and never treated before.
Treatment conaisted of prednisolone 60 mg a day
during 6 weeks, thereafter tapered off gradually.
In normal circumstances this resulted in a
cesaation of prednisolone after approximately 12
months. In 3 patients also cyclophosphamide was
given.
One of the 19 patients was a primary nonrespon—
der. The other 19 reached complete remission: 7
subjects within one month, 7 between one and 6
months and 4 long after 6 months therapy. II of
the 18 patients (=61%) had one or more relapses
and 3 were steroid dependent. At the end of the
89 + 41 months follow up period 6 patients were
still on prednisolone of cyciophosphamide therapy.
None had renal failure, and only one had a creati—
nine clearance less than 60 mi/mm. Two patients
had a proteinuria of 2.3 and 3 g/24 hrs during
NSAID treatment. The other 17 had no proteinuria.
Only three patients had a diastoli.c blood pressure
of 9D—IDO mmHg, for which one received antihyper—
tensive drug therapy.
We conclude that adult MCNS is an entity which
requires rather intensive therapy. Relapses are
frequent, but the final outcome is relatively
benign, with only minimal renal function impair-
ment and rare occurrence of hypertension.
. CHARACTERIZATION OF NEUTRAL PROTEINASES IN URINE
FROM NEPHROTIC RATS WITH A PROLIFERATIVE OR A NON-
PROLIFERATIVE GLOMERULAR DISEASE (GD).
J.C.Davin,M.Davies*,J .M.Foidart,J.B.Foidart,
C.A.Dechenne and P.R.Mahieu.
State University of Liège,Liège,Belgium and *Welsh
National School of Medicine,Cardiff,Waies, UK.
The accelerated model of nephrotoxic nephritis
was used to induce a proliferative GD in A rats.A
non—proliferative CD was induced in B rats by I.P.
injection of aminonucieoaide.A marked proteinuria
(>100 mg/24 h)occurred in most animals from both
groups.In normal rats, the 24 h urinary excretion
of neutral proteinases (NP) ranged from 3.4 to 7.8
Units(mean value+SEM : 5.0+7.1; n=18).In proteinu—
nc rats from groups A (n=21) and B(n=8), this ex-
cretion was significantly increased (mean value +
SEM:27.7+5.35 for A rats and 40.81+10.2 Units for
B rats), and ran parallelly with that of protein,
laminin and type IV collagen. In A and B, as in
normal rats,the urinary NP activity was present as
a latent and an active form, exhibited an apparent
moi.wt.of about 30,000 and an isoelectric point of
9.0 to 9.6, was destroyed by proteolytic digestion
by an excess of trypsin, and was found capable of
degrading GBM polypeptides in vitro.In normal uri-
ne, NP activity was inhibited by Soybean trypsin
inhibitor (SBTI)and aprotinin,but not with EDTA and
cysteine, suggesting that NP activity mainly re—
suits from (a)serine proteinase(s).By contrast, NP
activity of urine from A and B rats was reduced not
only by PMS—F, SBTI or aprotinin, but also by EDTA
or cysteine,which indicates the presence of both(a
serine proteinase(s)and (a)metallo—proteinase(s).
Our findings demonstrate that,in these two models
of nephrotic rats,metailo—proteinases and serine
proteinases are involved in the damage to the GBM
and in the development of proteinuria.
HIGH INCIDENCE OF MINIMAL CHANCE NEPI-IRDTIC SYNDROME
(MCNS) IN ASIANS IN LEICESTER
J. Feehally, NP. Kendell, P.C.F. Swift, J. Walls
Depts. of Paediatrics and Nephrology, Leicester
General Hospital, Leicester, U.K.
MCNS is universally common in children, but
variations in incidence in different racial groups
have not previously been reported. We have
analysed 43 cases of MCNS diagnosed in Leicester
between 1973 and 1982 - incidence 2.3/1D5 children
at risk/yr. 2 1/43 were Asian, but only 11.9% of
Leicester schoolchildren are Asian. The incidence
of MCNS among Asian children (9.4/lD5/yr) was
significantly higher than non-Asians (1.3/1O5/yr)
(p <0.0002, chi squared test). MCNS in Asians
did not differ from non-Asians in age of onset,
sex distribution or frequency of relapse. The
majority of Asians in Leicester are Gujarati-
speaking Hindus, but no particular subgroup of
Asians defined by religion, language or birthplace
(UK, India or East Africa) was at particular risk
of developing MCNS. Cases of MCNS were not evenly
distributed geographically in areas of high Asian
population, although no specific environmental
risk factor could be identified. Much of the
Asian population in Leicester has low socio-
economic status and lives in poor housing. There
was not a high incidence of MCNS in a similar
poor non-Asian population. Both environmental and
racial factors may he important in the
predisposition to MCNS in Asians. Further study
of this high risk population may provide new
evidence about the pathogenesis of MCNS.
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IMPAIRED IgG RESPONSE TO TETANUS TOXOID (TT) IN
MEMBRANOUS NEPHROPATHY (MN): ASSOCIATION WITH
HLA-DR3
.1. Feehally, P.E.C. Brenchley, B.M. Coupes,
NP. Mallick, D. Morris, C.D. Short.
Dept. of Renal Medicine, Manchester Royal Infirmary,
and Dept. of Medical Genetics, St. Mary's Hospital,
Manchester, U.K.
Variations in the IgG immune response may
predispose to glomerular IgG deposition in MN. We
studied the IgG response to TT immunisation in MN
(n=2O) and controls (n20). Total and subclass
IgG responses were measured by RIA and ELISA.
Electrical charge of IgG was assessed by
isoelectric focussing, immunofixation and
autoradiography. Total IgG and IgG subclass
responses were impaired in MN compared to controls,
although this was only significant for IgC3
(p 0.05). Non-responders to TT were more common
in MN (6/20) than controls (2/20). Response was
independent of degree of proteinuria, serum albumin,
serum total IgG and creatinine clearance. Mo
distinctive pattern of IgG subclass response or
IgG charge spectrotype was seen in MM. HLA-DR3
was more common in MN (88.8%) than controls
(26.3%). Impaired response to TT was associated
with DR3 among controls and in MN markedly
depressed responses occurred in the 6 apparent DR3
homozygotes. These genetically restricted
variations in immune response may be important in
the immunopathogenesis of MN and other disease
associated with HLA-DR3.
TGA-NEPHRITIS - COURSE AND PROGNOSIS, WITH
SPECIAL CONSIDERATION OF FOCAL-SEGMENTAL
GLOMERULAR LESIONS.
H. -V.Ghrtner, W. Vetter (Intr. by H.Edel)
Institute of Pathology, TUbingeri, FRG.
In order to determine which parameters
influence the course and prognosis of IgA—
nephritis, we examined 267 cases, giving
special consideration to focal—segmental
lesions.It was found that:1)The clinical
picture at biopsy and the course of the
disease in terms of proteinuria,creatinin
and blood pressure are correlated with the
severity of the glomeruloriephritis;frequen—
cy and severity of hematuria are indepen—
dent.2)The frequency of focal—segmental le-
sions correlates with the severity of gb-
merulonephritis and with benign nephroscle-
rosis and interstitial fibrosis.3) When the
underlying form of glomerulonephritis isof
equal severity,cases with focal-segmental
lesions more commonly show benign nephro—
sclerosis and interstitial fibrosis,thecl
nical picture (proteinuria, creatinine ,blood
pressure) is more severe,and the course is
less favorable.4)In subgroups with equally
severe glomerulonephritis but with neither
benign nephrosclerosis nor interstitial f 1—
brosis, focal—segmental lesions correlate
exclusively with the level of proteinuria.
Thus,these lesions represent a prognosti—
cally relevant morphologic correlate with
unfavorable influence on proteinuria.Fur—
ther prognostically unfavorable parameters
are male gender,onset after the age of thir—
ty,proteinuria or microscopic hematuria withproteinuria as initial symptom,as well as
severe glomerulonephritis, benign nephro—
sclerosis and interstitial fibrosis.
THE NEPHROTIC SYNDROME IN ADULTS AGED OVER
60. Etiological and histological features
of 104 cases.
J. Finaz de Villaine, S. Colon, M. Laville,
Ph. Leitienne, M. Labeeuw, P. Zech.
Hôpital Edouard Herriot, Pavillon P, Lyon,
France.
A study of the clinical, etiological
and histological features of the nephrotic
syndrome occuring in 104 adults aged over
60 was performed. Membranous nephropathy
was the most frequent type (42 %). 35 % of
the cases of membranous nephropathy were
associated with another disease wich was
a malignant one in 20 % of the cases. In 2
cases a renal vein thrombosis was associa-
ted with the malignant disease. Amyloidosis
appeared to be the most frequent cause of
the secondary nephrotic syndrome (13.5 %)
and was often associated with plasma cell
dyscrasia.
The study also showed the importance of
iipoici neptirosis among elderly patients
with the nephrotic syndrome (30.7 %).Focal hyalinosis was observed in 6.7 % of
cases. Indeed the presence in elderly
patients of arteriolar, interstitial and
glomerular lesions of hyalinoscierosis
makes interpretatbn difficult.With cortico
steroid therapy complete remission was
frequent in patients with lipoid nephrosis.
IDIOPATHIC NEPHAUTIC SYNDROME Ij3) A5SIATEU TD
DIFFUSE MESANGIAL PROLIFERATION (OMP) IN CHILDREN.
F.G6mez,E.Niarnbro, ,J.L6pez,A.Luque,M.Rengel.
(Intr. by J.Cannata)
Pediatric Nephrology .Nospital Provincial .Madrid.
Spain.
Twenty three C (2cM,3F) diagnosed of NS with DMP
have been studied.The onset of the nephropathy was
between 9 end 138 m of age and they have been fol
bowed f'or 7 to 129 m.Initially they were all trea
tad with steroids and a renal biopsy was done ito
65 m from the onset due to; Frequent relapses in
5 p, steroid—dependence in 13 p and steroid resis
tence in 5 p.By light microscopy all presented
mild increase in mesengial matrix and cells ,We hs
ye classified the patients in two groups according
to the absence (I_Sp) or presence (Il_iSp) of 5U-
perimposed lesions of focal and sementa1 sclero-
sis and/or hyalinosis.8y direct IF there were in—
munoglobulin deposits in 13 p of both groups (IM)
This group is compared with another with 20 C
(ioM,1OF) of similar ages and followed by a simi-
lar period of time, diagnosed by histologicel cr.L
tens of Minimal changes.A1i patients were trea-
ted with inmunosuppressive drugs. CONCLUSIONS:
The NS associated to DMP is more frequent in ma-
les (7:1 vs 1:1 po.oi) and it is associated mo-.
re often with microhematurie (48 vs 5 po.oo5).
usually associated with steroid dependence
-swsistence end it can progress to renal feilu
re, specielly if it presents a persistent NS.The
re is not relationship between mesangial prolife
ration and total steroid dose received,The pre-
sence of positive If is of not pronostic value.
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HAEMATURIA: INVESTIGATION OF ERYTHROCYTE
MORPHOLOGY IN RENAL DISEASE
R.GUlle, J.Bahlmann
Medical School ,Div. of Nephrology,
Hannover, FRG
The glomerular origin of haematuria was
investigated by phase contrast microscopy
to evatuate the dysmorphic shape of ery-
throcytes(ery) in 76 pts. with glomerulo—
nephritis(GN) proved by biopsy, in 20 pts.
with the clinical diagnosis of diabetic
glomeruloscierosis and 84 pts.with non—gb—
merular renal diseases(NGN). Ery in the
sediment of mid stream samples of morning
urine were classified as dysmorphic,normal
or crenated. Urinary protein concentration
and osmolality were measured.
In GN the frequency of dysmorphic ery
was 86±3%(mean±SE) with 6±2% normal ery as
compared to 8±3% dysmorphic and 70±5% nor-
mal ery in NGN(p<0.001). In diabetics 63%
dysmorphic ery were found. More than 70%of
dysmorphic ery were seen in 87% of SN and
only 2% of in the latter bOi had none
and 45% between 1 and 30% dysmorphic ery.
This distribution was different in diabe-
tics 42%of pts.showed> 70% and 58% between
30-70% dysmorphic ery. No correlation was
found between dysmorphic ery and urinary
protein ,osmolal ity,serum creatinine and
hypertension. Crenated ery correlated to
osmolality. Mainly distorted gbomerular
ery were not only observed in SN but also
in renal amyloidosis and diabetic gbome-
rulosclerosis. The results support the
value of differentiating the haematuria
according to its possible gbomerular
origin.
T LYMPHOCYTES SUBPOPULATIONS IN PRIMARY MEMBRANOLIS
OL'1MERULONEPHRIT 15
Ahmed Aciel Hassan, Christian Oenin, Jean—Claude
Le Petit, Blandine Laurent and François Berthoux
Service de N6phrnlogie — HOpital Nord - COO -
42100 Saint—Etienne — France
We studied the T lymphocytes suhpopulations in
the peripheral blood of 48 patients with NON, at
different stages of their disease, by monoclonal
antibodies OKT3, OKT4, OKTB, with comparison to 45
controls. The data were respectively the followings
— 57.53 + 14.24 (50) % T3 cells in MON vs 62.21
10.31 5 iii controls (P r 0.04) ; — 37.52 ÷ 12.67
T4 cells vs 37.98 + 8.55 (NS) ; — 18.06 + 7.32 18+
cells vs 20.86 5.43 (P = 0.02) ; and T47T8 ratio
(helper/suppressor) 2.40 ÷ 1.38 vs 1.93 ÷ 0.64
(P 0.02). Analysis was done according to the
present clinical stage of the patients nephrotic
syndrome (NS) (29), chronic proteinuria (CP) (9), or
remission (8) (10). The results were respectively
— for 0KT3 cells 59.34 + 14.68 in NS, 57.95 + 15.81
in CP, and 51.93 + 1l.02in 8 (P = 0.1113 vs controls);
— for 0KT4 cells 41.133 + 11.92 in NS, 31.85 + 11.06
in CP (P 0.03 vs controls), and 32.13 + 13.45 in
8 (P 0.04 vs controls) ; - for 0KT8 cells 16.14+
6.92 in NS (P = 0.0008 vs controls), 20.86 + 9.99 in
CP, and 21.10 ÷ 3.47 in R — for the 14/TB ratio
2.93 1.52 in NO (P r 0.0001 vs controls), 1.74
0.75 in CP, and 1.54 + 0.69 in R (P 0.04 vs
controls).
The active phase of MON is characterized by a
marked decrease in the S of siressor I cells and
high 14/18 ratio. The remission phase is
characterized by a decrease of S total T cells, of
% helper cells, and of 14/18 ratio. We demonstrated
clearly an imbalance between the helper and
suppressor I cells subpopulations in the
pathoqenesia of the MON.
IMMUNOGENETICS OF PRIMARY MEMBRANOUS GLOMERULO-
NEPHRITIS (NON)
Ahmed Adel Hassan, Christian Genin, J.C. Le Petit,
Blandine Laurent et Francois Berthoux
Service de Néphrologie - Hôpital Nord — CHU —
42100 Saint—Etienne — France
From 76 to 84, we selected 58 patients with
primary MON (5 SLE excluded). Out of these 58, 53
were typed for HLA—A and B, 50 for DR antigens, and
32 for Bf allotypes, and compared to appropriate
controls.
We established the correlations with the clinical
stages of this disease : nephrotic syndrome or
chronic proteinuria or remission. For HLA—antigens,
we observed : — an increased frequency for B8 28/53
(52.8 5) in MON vs 8/164 (12.8 5) in controls
(X2 = 66.56 ; P0.000O0T) ; — an increased
frequency for DR3 29/50 (58 5) in MON vs 29/126
(23 %) in controls ; (X2 = 19.82 ; P ( 0.00001)
— 24/50 (48 5) in MON group were B8 + and DR3 + vs
12/126 (9.5 %) controls (X2 = 32.57 ; P<<0.0000l).
The Bf gene frequency was respectively for S allele
29/32 (91 %) in MON vs 80/91 (87.9 5) in controls
(NS) ; for F allele 6/32 (19 5) 40/91 (44.4 5)
(X2 = 6.42, P = 0.011) ; for Fl allele 7/32 (22 %)
vs 3/91 (3.3 %) (X 10.94 ; P 0.0009) ; and for
Si allele 1/32 (3.1 5) vs 0/91 (0 %) (NS). Out of
7 Fl + patients, 7 were DR3 +, 5 BiB +, and 1 B8 +.
Most of the patients going into remission (10
out of 50) either spontaneously or under steroids
were 0R3 + 8/10 (80 5) vs 21/40 (52.5 %), X2 = 2.48
but the relation was not significant. So, primary
MON is a strongly HLA linked disease, the most
significant association being with 88 alone, with
BR and 0R3, then DR3 alone, and BfFI.
PLASMA EXCHANGE
S.J. Haworth, C.D. Pusey, C.M. Lockwood
Royal Postgraduate Medical School, London.
We report a retrospective study of 30 patients
with lupus nephritis, treated with immunosuppres-
sive drugs and plasma exchange (PE) . The indic-
ations for PE were: failure of drug treatment
severe systemic vasculitis (12) ; and drug toxicity
(3) . A mean of seven 4 1 exchanges was performed
on a daily basis. Concomitant drug treatment
comprised prednisolone with or without cyclophos—
phamide or azathioprine. Renal function and
immunological parameters were assessed prior to
and at the end of PE, and during follow-up.
The initial response to treatment (at end of PE)
is shown below : NCrest (llmol/l) Patients Improved resp8nse Death
<500 14 11 2 1
>500 6 2 3 1
ROT 10 2 3 5
Follow-up to 6 months showed that of 15 who
1improved, 14 maintained their improvement
2deteriorated (relapse) of 8 non-responders,
remained stable, 3 (all creat>500jimol/l with
glomerular sclerosis) became dialysis dependent and
3 remained on ROT.
Immunological analysis showed that overall there
andwas a significant fall inoçDNA antibody levels,
whichrise in C3 and C4 levels, at the end PE,
was maintained at 1, 3 and 6 months (as compared to
pre—exchange values)
Our treatment regimen produced an encouraging
clinical response in a group of high risk patients
recovery however depended on the severity and
chronicity of the renal lesion. There was a con-
comitant sustained improvement in immunological
indices of disease activity. PE may have a role
lupus nephritis with severe vasculitis, or when
contraindicated.drug therapy is ineffective or
. RAREFACTION OF MEMBRAI4OPROLIFERATTVE GLOMERULO—
NEPHRITIS (MPGN) TN FRANCE.
P. Jungers, 0. Forget, D. Droz, L.H. Nofl,
J.P. GrUnfeld.
Department of Nephrology and INSERM U 25, Necker
Hospital, Paris, France.
We retroapectively analyzed the annual incidence
of the varioua types of primary chronic glomerulo—
nephritia (GN) observed in the same French institu-
tion from 1973 to 1983, of which the diagnosis was
established on the basis of kidney biopsy studied
by light microscopy and immunofluorescence. Among
more than 2000 biopsies, 3231 were classified into
5 groups of primary GM : MPGN, membranous GM,
Berger's disease, minimal change or focal glomerulo—
sclerosis, and other or unclassified. A marked
reduction in the annual number of MPGN wss ohserved
after 1976. Thus, we compared the mean annual inci-
dence of the various types of CM between 1971—76
(period I, 65! pts) and 3977—83 (period IT, 580 pta)
A highly significant decrease between period I
and II appeared for the MPGN group (17.5 to 6.6 pts
/ year, p < D.ODI) whereas the mean annual incideire
and respective proportion of all other types of GN
did not significantly vary. This decrease in MPCN
incidence was only observed in pts born and living
in France (13.4 to 3 pts/yesr, p<O.OOI) whereas
both annual incidence and relative frequency of
NPCN were unchanged in pts referred from Haghreb,
Antilles or Africa.
The rarefaction of MPCN in France parallels the
decreased incidence of rheumatic heart disease ob-
served during the same period, Such data suggest
a possible influence of extensive prophylaxis of
pharyngeal infections in industrialized countries
during the past decades. They need to be confirmed
by similar epidemiologic studies in other countries.
• ABSENCE OF IgA IN THE GLOMERULAR DEPOSITS OF PA-
TIENTS WITH CIRRHOSIS OF THE LIVER AND GLOMERULO—
PATHY.
J.Montoliu,A.Darneil ,A.Torras,X.M.Lens,L.Revert
Hospital Cllnic.Barcelona.Spain.
Twelve HBsAg nagative patients sith hiatologi—
cally documented cirrhoais of the liver of either
alcoholic (8/12) or cryptogenetic (4/12) origin
underwent renal biopsy to investigate proteinuria
hematuris end/or renal failure. Immunofluorescen—
ce wee positive for IgA in two patients with
messngiocapillary glomerulonephritis (MCGN) and
could not be performed in 2 additional patents
with the same diagnoais. However, in the remaining
B patients,iemunofluorescence was negative for IgA
and frequently positive for C3, IgG, 1gM and/or
fibrinogen. These 8 patients without IgA were clan
sified aa follows: MCGN with subendothelial elec-
tron denae deposits 2 cases, IgM—IgO cryoglobuline
mis with diffuse endocepillary glomsrulonephritis
1 case, membranous nephropathy 1 case, diffuse en—
docapillmry proliferative glomerulonephritis 1 ca-
se, and vasculitis with focal segmental necroti—
zing glomerulitis end rapidly progressivc glomeru—
lonephritis 2 cases.
These results show that cirrhosis of the liver
can be associated to a wide variety ox glomerular
disorders. Contrary to previous belief, IgA is ab-
sent in 2/3 of patients with cirrhosis and glomeru
lopathy end therefore the pathogenetic importance
of IgA in the development of lomerulsr disease
in such patients is doubtful.
URIHARY POLAR LIPIDS (SULF0LIFIO5) NEWLY DETECTED
TN PRIMARY CHRONIC GLOMERULAR DISEASE
K.Mlnura, S.Yukawa, M.Mune, T.Maeda, H.Nonoto
Department of Internal Medicine, Wskayama Medical
College, Wakayama, Japan
Dy means of thin—layer chromatography (TLC),
we already detected a fraction corresponding to
phospbatidyl ethanolanine (FE) in urine from pati-
ents with primary chronic glomeruler diseases, and
ascertained a positive correlation between the
fraction area and the urinary albumin excretion
rate (Metabolism, l98t, 33, 882). In this study,
the urinary lipids corresponding to the PE frac-
tions of 21i—hour urine samples from ten patients
with chronic glonerulonephritis (CGN), another ten
with nephrotic syndrome (ES), and ten normal sub-
jects were fractionated into phospholipids and
glycolipids by use of a silicic acid column, and
each of then was subfracticnated by one— and two—
dimensional TLC for the detection and quantifi-
cation of glycoliplde, phospholipids, sterols,
sphingolipids, and sulfolipids (SL).
The phospholipid fraction was primarily com-
posed of PE. On the other hand, the glycolipid
faction nainly consisted of SL, containing small
amounts of glycolipids. The analysis of the ex-
cretion pattern of urinary lipids in each disease
group showed that chiefly SL was excreted in the
CON group, whose level was apt to increase with
acceleration of urinary albumin excretion. It
was further demonstrated that the urinary excre-
tion of PE was marked in the ES group. These ob-
servations suggest strongly that urinary SL and
not FE was common to primary chronic glonerulw
diseases and the high urinary level of FE was
characteristic of ES.
ROLE OF 5—LIPOXYGENASE PRODUCTS ESPECIALLY LEUCO—
TRIENE C4 (LTC4) IN AMINONUCLEOSIDE (AN) NEPHROSIS
OF RAT
M. Mune, I. Goto, S. Morishita, S. Vukawa,
H. Nomoto
The 3rd Department of Internal Medicine, Wakaysms
Medical College, Wskayasa, Japan
The effects of a 5—lipoxygenase inhibitor (AA—
861) on AN nephrosis of rat were studied in an at-
tempt to examine the involvement of LT in the dis-
ease activities of nephrnsis. Wistar male rats wei-
ghing 250 gm were given an intraperitoneal injec-
tion of 100 mg/kg puromycin nminonuclenside to pre-
pare AN nephrosis. On day 7 the animals were in-
jected intraperitoneally with 40 mg/kg AA—86l, and
on day 9 they were submitted for experiments.
A control group was given the same dose of saline.
Urinary protein, electrolyte excretion volume in
urine, plasma protein, blood levels of cholesterol,
creatinine and electrolytes were determined on
every day. As an in vitro experiment, immediately
after rats with AN nephrosis prepared according to
the same procedure as described above end normal
vaLe were decapitated, their kidneys were extir-
pated and washed to prepare slices of renal cortex.
LTC4—relemsing ability due to addition of Ca iono—
phore A231B7 was determined under 95% 02 and 5% CO2
in Erebs bicarbonate buffer, Excretion volume of
urinary protein in the animals treated with AA—861
was significantly decreased as compared with that
in the control group. Improvement of the blood
level of protein and cholesterol was also noted in
the treated animals. LTC4—relewae due to A231B7
was seen in the AN nephrosis group alone. These
findings led us to consider that the involvement of
5—lipoxygenase products especially LTC4 is impor-
tant for acceleration of the permembility of the
glomerular basement membrane in AN nephrosis.
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LONG-TERM PROGNOSIS OF GLOMERULONEPHRITIS IN MAN
H.-H. Neumayer, A. Lies, K. Wagner, W. Pommer, F.
Keller, M. Molzahn
University Dept. of Internal Medicine, Berlin (FRG)
The prognosis of glomerulonephritis can be es-
timated to a large extent by histological classifi-
cation. In a retrospective study (observation peri-
od up to 10 years), the progression of various gb-
merular diseases was assessed on the basis of his-
tological, clinical and laboratory parameters in
182 patients (8—77 years) with the bioptically con-
firmed diagnosis of gbomerulonephritis (classifi-
cation according to Churg). The incidence rate of
the various types of glomerulonephritis and the
occurrence of end—stage renal failure (ESRF) were
as follows:
Patients ESRF (HD)
n
29 15.9 0
29 15.9 23
24 13.2 14
22 12. 69
5 2.7 100
21 11.5 29
19 10.4 47
19 10.4 0
17 9.4 44
GN 2 1.1 0
Total 182 100.0
Advanced age, concomitant hypertension and ex-
tent of proteinuria were additional factors for a
rapid progression of the glomerular disease. Our
examinations show that, in addition to pathomorpho
logical findings, clinical parameters are also im-
portant for the prognosis of glomerular diseases.
KALLIKREIN-KININ SYSTEM INVOLVEMENT IN CHRONIC GLU
MERULAR DISEASE (COD). A Pierucci, BM Sirnonetti , F
Pugliese,M Manzi, P Mend, G Stirati, GA Cinotti
(Intr. by V Andreucci).
Dept of Internal Medicine, Division of Nephrology,
University of Rome, Italy.
Involvement of renal vasodilator factors in nonirn
munologic mechanisms of progressive glomerular dama
ge is still unclear. CGD is associated with reduced
renal Prostacyclin production (N Engl J Med 310:279,
1984);a reduced urinary Kallikrein activity (UK) wa
also reported in hypertension secondary to renal pa
renchymal disease (N Engi J Med 299:162, 1978). The
present study was undertaken in order to evaluate UK
in COD with (or without) mild functional impairment.
UK of 16 norniotensive (N) and 7 hypertensive (H)
(diastolic BP:90—llOmmHg) patients with bioptically
proven COD was compared to UK of 25 healthy subjects
(C) and 24 uncomplicated essential hypertensives(EH
(diastolic BP:90—llOmmHg). All groups were matched
for age, sex and race. Creatinine clearance (ml/min,
n-s-SD) was 93+16.8, 84.8+23.7, 106+5.8, 9.5+4.2, re
spectively. All drugs were discontinued at least 2
weeks prior to the study. UK was measured in 3 conse
cutive 24h urine collections obtained after 5 days
on a fixed 100 mEq sodium intake.
UK (Esterase Units/d,m-s-SD) was 15.7+6.1 (C), 14.5
+5.5(EH), 7.3+3.7 (NCGD), 7.4-1-2.7 (HCGD). No signi
ficant differences were observed between C and EH in
UK. However, UK was reduced (p<0.OOI) in COD unrespe
ctive of hypertension and histological findings.
We conclude that renal Kallikrein-Kinin system
may be involved in the progression of COD.
THROMBO—EMBOLIC COMPLICATIONS IN THE NEPHROTIC
SYNDROME.
N. Pertuiset, D. Ganeval, E. Oksenhendler,P.Jungers
Department of Nephrology, Necker Hospital, Paris,
France.
We retrospectively analyzed the records of 274
adult patients (pts) with the nephrotic syndrome
(NS) in order to assess incidence of symptomatic
thrombo—embolic complications (TEC). Renal biopsy
was performed in all the pta and showed : membranous
glomerulonephritis (MCN) in 77 pts, focal glomerulo—
sclerosis (FGS) in 57, membranoproliferative GN
(MPGN) in 51, minimal changes (MC) in 49 and amy—
loidosis (A) in 40.
TEC were present in 25 pts (9.1%) and revealed
NS in 15. Renal vein thrombosis (RVT) was found in
8 pta (2.1 %) and pulmonary emboli in 6. Albuminemia
was significantly lower in the TEC group (17.4 ÷ 1.8
gIL vs 19.8 -s-O.7 g/L ; p<O.O2). The incidence of
TEC in decreasing order of frequency was 14.3 % in
MGN (11/77), 10.2 1 in MC (5/49), 10 % in A (4/10),
5.3 1 in FGS (3/57) and 3.9 % in MPGN (2/5!). MGN
was present in 7 out of the 8 pta with RVT.
When expressed in terms of number of TEC per years
of exposure to the risk, incidence of TEC (No/pt—
years) was higher in pts with MC (3/10) than in pta
with MON (1.3), A (I.!), MPGN (0.6) or FGS (0.55).
Although a high incidence of TEC (and especially
RVT) was found in pts with NGN, we conclude that
nephrotic pts with MC also are at high risk for
thrombo—embol ic complications.
D-PENICILLAMINE—INDUCED CRESCENTIC GLOMERULO-
NEPHRITIS (CG)
Y. Pirson, J.P. Devogelaer, S. Brichard, J.M.
Vander&broucke, J.P. Cosyns, C. Nagant de Deux-
chaisnes. University of Louvain Medical School,
Cliniques Universitaires St—Luc, Bruxelles.
We observed CG with hemoptysis in a patient
given D—Penicillamine (DP) for scleroderma, a
syndrome previously reported in 5 patients on DP
for other diseases (Wilson's disease and rheuma-
toid arthritis). The rarity of CG and of DP
treatment suggests that this assocation is not
fortuitous.
The 6 patients, aged from 30 to 54 years, were
on DP (0.75 to 3.5 g/d) for 10 to 42 months.
Clinical presentation included : lung hemorrhage
(hemoptysis in 5 cases, dyspnea in 3 cases and
bilateral lung infiltrates in 5 cases) and rapidly
progressive renal failure due to histologically
proven CG. The absence of circulating aflti—GBM
antibodies and of linear IgG deposits in the
biopsy in our and 2 other studied cases suggests
that CG is not mediated by anti—GBM antibodies.
Three untreated patients died from pulmonary
hemorrhage and renal failure; the 3 others in whom
OP was withdrawn and immunosuppressive therapy
initiated survived (one of them on chronic hemodia—
lysis); most remarkable was the evolution of our
patient who, despite severe renal failure requir-
ing hemodialysis recovered a nearly normal renal
function after prednisone-azathioprine therapy.
We conclude that OP may induce a CG with hemo-
ptysis without aflti-GBM antibodies. Prompt recogni-
tion of this complication should allow appropriate
therapy including immunosuppressants and with-
drawal uf OP. Furthermore, a careful search for
etiologic agents such as drugs may reduce the
number of so—called idiopathic CG.
Minimal change disease
Mesangioprol iferative ON
IgA nephropathy
Rapidly progressive ON
Goodpasture syndrome
Membranous GM
Focal glomerulosclerosis
SLE nephropathy
Mesangiocapillary GN
Proliferative exudative
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FAMILIAL GLOMERULONEPHRITIS (GN)
M. Rambausek, G. Hartz, R. Waldherr, E.Rit
Dept.Med. and Pathol., University of
Heidelberg, Germany (FRG)
In the past, the prevalence of familial
glomerulonephritis has been underestimated.
In a retrospective study, we examined pre-
valence, glomerular morphology and clinical
course of familial GN. Between 1960 and
1984, 146 patients with GN which had
gressed to terminal renal failure were
admitted. 23 patients of these had at least
one relative with clinical signs of GN.
Biopsy was available in 13/23 (5 x M. Al-
port; 3 x IgA-GN; 1 x prol. scier; 2 x FSS;
2 x extracap. GN).
Probands of 27 families (14 with renal bioll—
sy) presented with GN which had not
gressed to terminal renal failure in pa-
tients or family members (5 x IgA—GN; 1 x
'ninimal lesions; 2 x uncharacteristic fin-
dings; 3 x GBM changes typical for M. Al—
port and 3 x non—specific GBM changes com-
patible with benign f am. hematuria).
Conclusion: (1) familial GN is common
(15,8% of GN) in GN pat. with terminal re—
.ial failure; (2) next to M. Alport familial
gA-GN is the most common familial GN;
(3) both benign and prognostically adverse
'ourse of GN with the above diagnosis may
e found, but the course tends to be consis•
cent within family.
.
IMMUNOSUPPRESSIVE TREATMENT OF 34 PATIENTS WITH
MICROSCOPIC POLYARTERITIS
C.O.S. Savage, C.G. Winearls, D.J. Evans, A.J.
Rees, C.M. Lockwood
Royal Postgraduate Medical School, London.
Renal vasculitis is generally considered to
have a poor prognosis. We report the outcome of 34
patients with microscopic polyarteritis.
Microscopic polyarteritis is a small vessel
non-granulomatous systemic vasculitis with focal
segmental necrotising glomerulonephritis (FSNGN),
originally described by Davson et al 1. We
studied 34 patients (22 M, 12 F) aged 14—75 years
(mean 50 yrs) who had haematuria, renal impairment
(mean creatinine = 574.imol/1, median = 5781.imol/1)
with histological evidence of FSNGN and clinical
evidence of systemic vasculitis affecting joints
(71%) , skin (62%) , musclea (50%) , lungs (29%)
Thirty-three patients were treated with various
combinations of prednisolone (32 patients) , cyclo-
phosphamide (27 patients) , azathioprine (20
patients) or PE (18 patients). Twenty-seven sur-
vived for longer than 2 months and were followed
for a mean of 47 months.
There was no difference in renal function at 2
months between patients who presented with a
plasma creatinine>SOOpmol/l and those who
presented with a plasma creatinine<5Oc.imo1/l,
suggesting that prognosis for renal function may
be independent of the degree of pre-treatment
renal impairment. The 5 year actuarial patient
and kidney survival rates were 65% and 55%
respectively, despite 19 relapses in 12 patients.
Previous reports of renal vasculitis have given 5
year actuarial patient survival rates of 40%.
1. Davson, J et al. Q.J. Med. 1948; 17: 175—205.
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RECOVERY OF RENAL FUNCTION IN RAPIDLY PROGRESSIVE
GLOMERULONEPHRITIS (R.P.G.) WITH JUICY CRESCENTS
Maher F.Ramzy,M.1J., Magdi R. Francis,D.M.,M.Sc.(path)
Nephrology and Pathology Departments ,Cairo Univer-
sity, Egypt
15 patients with R.P.G. were treated with predni-
solone pulses, azathioprine, dipyridamole and dia-
lysis. Their diagnosis was based on a rapidly de-
clining renal function and adequate renal biopsy
specimen showing extracapillary crescents in more
than 70 % of the glomeruli. Non of these patients
had raised ASO or systemic disease. Deterioration of
renal function continued in 12 cases (80 %)while 3
patients who were oligoanuric at the onset recovered
normal renal function after 2-3 months of treatment.
They had been followed up for three years with nor-
mal creatinaemia. Disappearance of crescents cannot
be confirmed due to refusal of rebiopsy. Reviewing
the biopsies revealed that crescents were present in
80 % of the glomeruli in the material of these three
cases. These crescents were of the cellular type witl
plumpy cells, numerous mitoses and infiltration with
polymorphonuclear leucocytes, no basement membrane
material or collagen was seen in the crescents,Bow-
man's capsules were intact. On the contrary all the
remaining cases had fibrocellular crescents often
with necrosis or the underlying tufts. The lack of
immunofluorescent studies doesn't change the fact
that juicy crescents which might be of macrophage
origin have a favourable outcome.
It can be concluded that juicy crescents what-
ever their prevalence are good prognostic features.
LIGHT CHAIN NEPHROPATHY OR LIGHT CHAIN DISEASE?
Scolari F., Scaini P., Carnpanini M., Movilli E.,
Flanganoni A., Savoldi S., Cristinelli L.,Maiorca
R., *Callea F.,**Sacchi G.
Dept. of Nephrology, *1st and **2nd Dept. of
Pathology - Spedali Civili - Brescia - Italy.
Renal light chain deposition in the absence of
aniyloidosis was found in 4 patients (1 multiple
myelorna, 3 benign monoclonal ganimopathy). Two
patients presented nephrotic syndrome, the
remaining two showed protcinuria and chronic
renal failure. In two cases a rapid terporary
improvement of renal function was obtained with
plasma exchange therapy combined with a cytotoxic
agent and steroids. In all cases nephropathy
progressed to uremia. Nodular glomerulosclerosis
was observed in 3 cases, proliferative glomeru-
lonophritis in 1. Imnunofluorescence studies
showed light chain deposition in all cases (2
kappa, 1 lar•hda, 1 both kappa ned I anhc1 thai ns).
In addition to renal pathology, these patients
presented heathomegaly and two of ther! died
following hepatic failure. Liver biopsy specimens
were obtained in 3 cases; in two of these a
nonoclonal light chain sinusoidal deposition was
demonstrated by iriinunohistocheristry.
Our results lead to the following conclusions: 1)
light chain nephropathy can occur in the absence
of malignant plasma cell proliferation; 2) as for
arnyloidosis, neptiropathy can be the first clini-
cal manifestation of a more generalized tissue
light chain deposition.
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LIFE EXPECTANCY AND GLOMRULONPHRITIS /GN/
L.Szalay, Z.Nagy, E.Dulka, Cs.Gondöca, E.
Magyarosmy, K.Szepesbázy, L.Kopper, K.Lapis
II.Dept.Med. and I.Dept.Pathol. and Exp.Cancer
Has., Seoaelweis Med.Univ., Budapest, Hungary
Life table analysis is a valuable tool evaluating
malignancy and the effect of therapy in different
diseases. By using Cutler and gderer's method1
survival data of 510 patients /pts/ were anabjs.
Statistical occurance rate of different histol-
ogical. forms of GN corresponded well to literary
data. Our results show the best life expectancy
in the case of pta with a histological lesion of
nil disease /n=l4, 100% survival after 8 years!,
focal proliferative GN !n=77, 97% s.a.15 yrs/
or minimal glonerular abnormality /n=45, 94% a.
a. 15 yrs!.
Life table analysis suggests somewhat worse lf:
expectancy for pta suffering from diffuse
membranous GN /MGN n=7O, 85% s.a. 15 yis/,diffuse
nesangial proliferative GM /MPGN n= 206, 84% s.
a. 15 yrsi', diffuse mesangiocapillary ON /MCGN
n=47, 82% s.a. 13 yrs!, and focal aclerosing GN
/FSGN n 32, 77% s.a. 15 yrs/.
According to other's experiences patients with a
diffuse aclerosing GN have a rather short life
expectancy /n=14, 34% g.m. 8 yrs/, and inspite of
imrunosuppression therapy life expectancy of pta
ujth diffuse extracapillary proliferative ON was
very poor !n=5, 30% m.a. 3 yrs/. Our results show
a better life expectancy for pta with histolog-
ical evidence of MGN, MCGN and FSGN than lit.
data suggest, which might be due, in our assumpt-
ion to the developmental change in complex non-
specific treatment of patients. githin the MPGN
group, severity of histological abnormalities
/inild, moderate and serious changes/corre lated
well with the life exuectancy of patients.
• FACIORS INFLUENCING THE PRCXRESSI0N OF IgA
NEPHRITIS
KTW00, RPSEdmondson, AYTWu, GSCChiang,
H S Pwee, C H Lixn(Intr. by B Hulme)
Dept. of Renal Medicine, Singapore General
Hospital, Singapore
The clinical and histological features of 151
patients with IgA Nephritis were analysed to
determine the prognostic features of the disease.
Their mean duration of follow up was 50+1—34
months (range 6 to 168 months). Majority of the
patients were asymptomatic young males detected
by routine screening before induction into national
service. The plot of the reciprocals of serum
creatinine against time in the patients with
progressive disease showed that the patients ran
two different courses when they developed renal
impairment; one was a slowly progressive course
over an average of 7.7 years before reaching End
Stage Renal Failure (ESHF), while the other was a
more rapid decline to ESRF within an average of
3.3 years where severe uncontrolled hypertension
seemed to be the major adverse factor. Hypertension
was present in 23% of patients. Nine percent had
renal impairment at the end of the follow up
period while 5% progressed to ESRF. The cumulative
renal survival was 91% after 6 years with no
further develoçmient of renal failure up to 14 years
Unfavourable long term prognostic indices were
proteinuria of more than 2 gm; hypertension and
presence of crescents on renal biopsy.
PLASMA EXCHANGE IN COMBINATION WITH IMMUNO-
SUPPRESSIUE TREATMENT IN GOODPASTURE'S SYNDROME
B. Winterberg (1), D. Kamanabroo (2), H. Loes (4),
A.E. Lison (1), 0. Knoll (1), Ch. Witting (3),
C. Spieker (1), M. Lockwood (5)
Medizinische Poliklinik(1), Medizinische Klinik(2),
Pathologisches Institut(3), University of MUnster,
F.R.G., Krupp Krankenanstalten Essen, F.R.G.(4),
Hammeramith Hospital. London U.K.(5).
Goodpasture's Syndrome (G.S.) is a combination
of a rapidly progressive glomerulonephritis and
pulmonary hemorrhage mediated by antibodies to the
basement membranes of glomeruli and probably lung—
alveoli.
10 patients with G.S. were treated with plasma
exchange of 3-4 1 per day and immunosuppressive
drugs (Azathioprine, Cyclophosphamide and Predni—
solone). Diagnoses were based on typical radiolo-
gical findings in chest—x—ray examination, on cli-
nical and laboratory findings of renal insufficien-
cy and anemia and on circulating antibodies against
basement membranes (in 8 pat.).
9 of 10 pat. survived, 1 pat. died within 48 h
after admission. Another pat. died 3 months late
because of an Addisonian crisis. The other pat.
revealed a rapid improvement of symptoms and chest-
x—ray abnormalities. In 5 pat. (not anuric at ad-
mission) renal function improved, 4 anuric pat.
showed no improvement. Antibody titers fell rapid-
ly under the treatment and remained normal there-
after.
These results demonstrate that the combination
of plasma exchange and immunosuppressive agents
orovides a satisfactory therapy of G.S., which can
therefore be suggested as the therapy of choice.
CLOMERIJLONEPHRITIS TREATED BY PLASMAPE{E1IESIS AND
I*IUNOSUPPRESSIOH:HISPJLOGICAL CHANGES aND CLINICAL
EFFECTS
Ch.Zielinski,W.Ulrich,G.Syre,Ch.Gisinger,P.Preis,
Mchwarz,E.Ba1zar,H.Eib1,J.Kovarik
Department of Medicine,childrens Clinic,Vienna
Jniversity Hospital and Institutes of Pathology red
Irnunology,university or Vienna ,Aus triaSix patients with histologically proven r1uaru1o4
nephritis (GM) (4 with diffuse proliferative G:
and 2 with focal pro1iferatin CN including one
patient with more than 5O crescents) were treated
With either rorticosteroids (in three cases) or
with corticosteroids and cyclophosphamide (in the
three other patients).After this therapy had failed
in improving kidney function,proteinuria and/or the
amount of circulating imune cocrplexes,the patients
were incli'ded into the plasmapheresis program which
consisted of 9,8÷3,1 plasma exchanges performed
during 1,7+0,5 months,during which the entire
irnunosuppressive therapy which had been instituted
at the begin of the treatment was continued.After
the termination of the plasmapheresis prograrn,labo-
ratory data of either serum creatinine,creatinire
ciearance,proteinuria or the ammount of circulati.nC
immune complexes had improved in five out of the six
patients treated where the responding Eive patients
suffered from an acute form of GM and the non-respon-
ding patient from a subacute form.Moreover, the
histologies of sequential kidney biopsy specimens
obtained from three patients showed a change towards
sclerosizing GM.
Thus,we conclude that the combined treatment of GM
by plasmapheresis and immunosuppression can be a
benificial therapeutic approach in acute cases of
proliferative GN.
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B AND T CELL DYSFUNCTIONS IN PATIENTS WITH PRIMARY
IgA NEPHROPATHY
P.Zucchelli, L.Cagnoli, S.Pasquali, E.Beltrandi
Divisione di Nefrologia e Dialisi e Servizio di La—
boratorfo, Ospedale M.Malpighi, Bologna, Italy.
The Ujn vitro" function of B and T cells was
studied in 16 patients with primary IgA nephropathy
(PIgA—N). The distribution of OKT3+ cells (total pe
ripheral T cells) and of regulatory T cell subsets
(helper OKT4+ and citotoxic/suppressor OKT8÷ cells)
was evaluated in the sane subjects and a testing
for 45 HLA-A,B,C,DQ and DR antigens was carried out
in 15. B lymphocyte IgA production, after stimula-
tion by pokeweed mitogen in the presence of T cells
from normal donor treated with mitcimycin C, was si-
gnificantly greater in patients than in controls.
T lymphocytes from patients with PIgA-N were more
efficient than T cells from controls in providing
IgA specific helper activity for normal B cells.The
analysis of the individual data showed that the
overactivity of B cells and the T cell operational
dysfunction were present in about 50 per cent of
the patients and did not correlate. No ncinerical irn
balance between T lymphocyte subsets nor any asso-
ciation between lymphocyte behaviour, HLA antigendistribution and a nunber of clinical, laboratory
and irsnunohistological findings were observed. Our
data therefore suggest that PIgA-N is an ininunologi
cally heterogeneous disease and that an IgA speci-
fic B cell overactivity and/or overall IgA specific
T cell helper activity may be present in some pa —
tients.
PATHOLOGY AND IMMUNOPATHOLOGY
PERSISTANI QIINERIBI, ANJI-ARSCNATE RFSWRSE AND IMIJNOPAThO-
LCCY AFTER NELXIATAL INLEtTILB OF WANSPLWFATIC IOLERANCE
D. Abrarmwicz, M. Coldnn, C. Bruyns, Y. Thoua and J. Urbain
Cliniques Universitaires de Bruxelles, H6pital Erasne et
Laboratoire de Fbysiologie Aninmie, Université Libre de
Bruxelles, Belgium.
'Die occurrence of ininunopathologic features after neonatal
induction of transplantation tolerance was studied in the Belb/
c—A/J strain canbination with special attention for allotypic
narkers and for the antibody response to azobonzenearsoriate
(Ai), halb/c neonates were injected with 1C (Palb/c x A/J)
Fl hybrid spleen cells ip (or 1.5 jQ7 Fl spleen cells iv), the
Fl mice being either non iimiune or previously hyporiiiiitinized
with ABS—KLH.
Sixteen out of Pt) 6 week-old aniisals displayed significant
anmunts of circulating ininunoglobulins bearing the A/J ailo—
type, indicating lymphoid cell chijierinin. Transplantation
tolerance was denenstrated by the isek of cytotoxic response
against tie relevant ails-antigens after mixed lymphocyte
culture. Circulating inmine ccmplexes sere detected in 40 %
of the tested aninals and were associated with mesangial
deposits of IgG and I'l. Anti—SS DNA and anti-LB LNA were
present in 77 1 and in 26 1 of the mice respectively. The
production of these aitoantiaslies was closely associated with
the persistence of the A/J allotype. Whereas recipients of
naive Fl spleen cells exhibited depressed secondary responses
to ALB—KUI, mice neonatally injected with AI4S—KLJI prime) Fl
spleen cells spontaneously produced significant levels of anti—
ARS antibodies.
Thus, neonatal induction of transplantation tolerance is
associated in this strain ccnnbination with the occurrence of
(1) anti—LBA autoantibedies (2) imazne ccznplexes that are
deposited in glcnniruli, and (3) aboornel immune responses to
ASS. The possible relationthip between these abnonielities
and lymphoid chinerim nuns to be detennined.
PREDICTIVE INDICES OF GOOD PROGNOSIS IN IDIOPATHIC
MEMBRANOUS NEPHROPATIW
P.Zucchelli, C.Ponticelli, A.Aroldi,L .Cagnoli
Divisioni di Nefrologia ci Dialisi,Ospedale N.Maipi-
ghi, Bologna e Ospedale Maggiore, Milano, Italy.
The frequency of 45 HLA-A,B,C,DR and DQ antigens
were studied in 55 Italian patients with idiopathic
nembranous nephropathy (INN) and a nephrotic syndro
me who participated in a long-term prospective and
randomized therapeutical trial based on the admini-
stration of methylprednisolone and chlorambucil for
6 months. The lymphocyte subsets were evaluated by
crmnoclonal antibodies at the beginning of the trial
and at the end of the follow—up period in 18 treat-
ed and in 8 untreated patients. The results of this
study show that 1) INN has a significant associati-
on with the haplotype HLA B8/DR3; 2) the possibili-
ty of spontaneous remission is higher in DR3+/B8—
than in DR3+/B8+; 3) therapy does improve the possi
bility of achieving remission independently on I-LA;
4) nephrotic patients have a "helper—inducer"/"sup—
pressor—cytotoxic" T cell ratio significantly high-
er than normal controls; 5) patients with a high
"helper—inducer"/"suppressor_cytotoxic" cell ratio
before therapy are more likely to respond to treat-
ment; 6) the therapeutical schedule used does not
seem to induce a long lasting abnoniiality on cello.
lar irrmunity.
PLATELETS IN THE NEPHROTIC SYNDROME ARE HYPERAGGRE
GABLE TO RISTOCETIN BUT NOT THROUGH LOW ALBUMIN
OR TxB2 GENERATION.
A. Bennett and J.S. Cameron
Renal Unit, Guy's Hospital, London UK
In patients with a nephrotic syndrome,incranscd
platelet aggregability in vitro to the agents
arachidonic acid, ADP and collagen is well known,
and is associated with increased production of TxA2
we now describe similar hyperaggregabiljty to rist-
ocetin in 20 nephrotics,including patients with
minimal change die ease, As reported previously,
addition of pure albumin to platelet-rich plasma of
4 nephrotic patients corrected the platelet hype-
raggregability to arschidonic acid, but exerted
little effect on the ristocetjn aggregation thresh-
olds. The ability of normal platelets to generate
Thromboxane A2 (measured as TxB2) in response to
arachidonic acid was abolished after incubation
with indoniethacin, but in response to stimulation
with ristocetin, no TxB2 was produced whether the
platelets had been incubated with indomethacjn or
not. Thus, the hyperresponsiveness of iiephrotic
platelets to ristocetin is not dependent on serum
albumin levels, nor the platelets ability to pro-
duce TxB2.
The nephrotic patients had elevated Factor VIII—
related antigen levels, and decreased serum IgG and
platelet—asSociated IgG levels. The serum IgG and
platelet—associated IgG levels correlated signifi-
cantly. Therefore, the hyperaggregability of
nephrotic platelets to ristocetin could be due to
the low platelet-associated IgG levels, since there
may be relationship between the platelet Fe and
VWF receptors. Hyperaggregability to ristocetin end
arachidonic acid was not the result of a low
haematocrit.
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EFFECI, OF ASPIRIN AND SULINDAC IN RABBIT NEPHROTO—
XIC NEPHRITIS.
T. Bertani, A. Benigni, F. Cutillo, G. Rocchi, C. Mo-
relli, C. Carrninati, P. Verroust, S. Remuzzi.
Mario Negri Institute for Pharmacological Research,
Bergarno, Italy and Hopital Tenon, Paris, France.
Frostaglanoins (PC) and thromboxanes (Tx) have been
reported to influence glomerular hemodynamics and cm
pillary wall permeability to macromolecules.To inve
stigate the role of arachidonic acid (AA) rietaboli—
tem in .elomerulonephritis (CU) we studied a model of
rrephrotoxic nephritis (NTN) in rabbits.Our aim was
to establish if tissue damage and hemodynamics were
dependent upon intact PG forming enzymes and to di-
scriminate between the role of gloserular or circula
ting cell AAsetabolites.VJe used two different non
steroidal antiinflammatory drugs (NSAID).In UT3 A—
spirin (ABA) 100 ;ng/kg/dap inhibits by 90% platelet
TxB2 enertion and by 35% renal PG us measured by
urinary excrei ion of their stable metabolites, Su—
lindac inhibits by OOh platelet Txbut only partial—
Iy affects PG and Tx urinary excretion.Treatment of
:iTB rabbits si ASA during autologous phase worsens
rorphologicai expression ml disease and increases tue
frequency of death for renal failure.Sulindac reduces
inflammation arid prevents extracapillary prolifera—
ion.So in a nodal closely resembling human progres-
sive CS a SCAlD inriihi tug oth circular ing cell
and renal AA rietabol i tes aggravates the dioase. A
aru,' shicli inhibi is th el aloliarn of AA in circula
ting cell but spares renal cyclooxygenase reduces
nflomnat ion and prevent a severe renal function de-
art ora Li on
.
rMMUNOCIJEMICAL CHARACTERIZATION OF CATIONIC IgG IN
PATIENTS WITH MEMBRANOtTS NEPHEOPATHY AND
DECLINING RENAL FUNCTION.
P.E.C. Brenchley, B.M. Coupes, C.D. Short,
N.P. Mallick.
Dept. of Renal Medicine, Winchester Royal
Infirmary, U.K.
We have previously reported the detection of
abnormal cationic IgG in the serum of 6 of 8
patients with membranous nephropathy (M.N.) and
declining renal function (1). We are now able to
present some of the imrnunochemical characteristics
of this IgG (p1 8.6, 8.6 and 9.3 in patients BB,
PS and MS respectively). For each patient, the
serum IgG of p1 > 7.5 was separated from other
serum proteins by sequential DEAE and CM—Sepharose
chromatography. This cationic IgG fraction was
then subjected to preparative iso—electric
focussing (IEP) using ampholytes of p1 8.0 — 10.5,
and the relevant IgG band for each patient was
detected by analytical IEF. The purified IgG's
were assayed by ELISA using monoclonal antibodies
to the 4 IgG subclasses, and all three IgG's were
of the IgGi subclass. Anti—idiotypic antibodies
to these abnormal IgCs were raised in rabbits.
One of the antisera showed cross—reactivity with
all three IgG's by ELISA, but did not react with
normal pooled IgG, 4 purified IgGi ( and k)
paraproteins of p1 8.0 — 8.6 or paraproteins of
the other IgG subclasses. These cationic IgGi
antibodies share a cross reacting idiotype not
present in normal serum IgG and yet identified in
patients with M.N. and declining renal function.
This idiotype may be a marker of disease
activity in M.N.
(1) IXth Int. Congress Nephrology (1984) 274 A.
• RITTD V)BI'IONS fl 0L0?1ERULAR PROPERTIES
j M Boulton Jones and Lata Chandrachud.
Renal thit, Royal Infirmary, Glasgow, Scotland
The role of the glomerulus in the pathogenesis
of immune complex nephz'itis has been assumed. to
be passive. In this study we have compared. some
glomerular properties in 2 strains of rats chosen
because one, Lewis, is sumceptible to Heymanns
nephritis whereas the other, Dl, is remiatant.
The density of charge of the polyanion of tine
glomerular capillery wall waustuthed by the
infusion of cationic IgG (IgG ) into normal rats
of the 2 ci rains. The uptake was significantly
less in Levis than Dl rats. Infinsion of a poiy—
cation, hexadi.rnethrine, caused proteinuria in
Lewis hut not Dl rats. These results are
consistent vi. h an inherited difference between
species in the nca :i.ve charge concentration of
the GJ3M. Ilesangi&i upaizo of aggregated IgG was
also examined md uas greater in Di rats, as sian
the uptake of irnal tored. IgG
These results sw-ges'i that Dl rats would be
more liable to mnesangial inimane couplex
nephropalhies wid Lewis rats are hnown to be
susceptible to rnetnbranous nephropatl-y. tOme
differences in irtheri ted glonerular
charac'teraslmcs may, therefore, be of great
i:'pori.mnce in deteruining an individuals
susceptibility to a particular nephropat7rrj and
nay account for the susceptibili ty of D23
patients to meriliranous and D114 tO riesangial
TA disease-
EICOSANOID PRODUCTION IN AN IN SITU IMMUNE COMPLEX
(IC) GLOMERULONEPHRITIS (GN) IN THE RAT
H.T. Cook, J. Smith, V. Cattell, S. Moncada,
J. Salmon (Intr. by B. Hulme).
Dept. of Pathology, St. Mary's Hospital Medical
School, London and Prostaglandin Research,
Wellcome Research Laboratories, Beckenham, England.
Glomerular eicosanoid production was measured in
a unilateral in situ IC model of gn. Left (L)
kidneys of Lewis rats pre-irmiunized x 3 with human
IgG (HuIgG) were perfused with 400 g cationised
HuIgG (p1>9.5). Controls were perfused with
saline. Glomeruli showed marked hypercellularity
beginning by 16 hrs and maximal at 4 days. Sub—
epithelial electron dense deposits were seen.
Right (R) kidneys were normal. Basal eicosanoid
production was measured by direct radioinlmunoassay
in supernatarits from incubated glomeruli isolated
by sieving (3 kidneys/incubation). Separate
experiments measured eicosanoid synthesis by
glomeruli from normal Lewis rats. The results
(eicosanoid production ny/mg glomerular protein)
were: -
6 keto
POE2 PGF1ci
ICON 16 hrs
L) >10 0.7) 0.7 (0.8) 0.7 0.8) 0.06 0.05
R) 1.3 0.5) 1.6 (0.5) 1.7 0.5) 0.07 0.06
ICGN 4 days
(L) 1.9 0.7 0.3 0.10
(R) 0.4 0.4 0.3 0.10
Normal rats (n = 11)
0.7±0.08 0.43±0.04 0.50±0.07 0.11±0.01
Brackets = saline perfused controls.
In this model of in situ ICGN, glomerular TxB2 in
diseased (L) kidneys is increased x 10 at 16 hrs
and remains elevated on day 4. Changes in Tx82,
PGE2 and 6 keto PGFi in the (R) (non—ICON) kidney
suggest functional compensation.
TxB2 LTB,
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INFLUENCE OF FUROSEMXDE /F/ ON THE PER ITO-
NEAL. TRANSPORT /PT/ OF GUANIOINES
K.Czyzewska. I.Pietrzak, K.Antoniswicz.
K. Bczyk
Departments of Pathophysielogy end Nephro-
logy, Academy of Medicine Poznasi. Poland
we demonstr*ted the increase in the
peritoneal removal of guanidine compounds
when F was given intrap.ritoneally during
IPO. Thus we tried to campers the F indu-
ced PT of guaniinosuccinic acid /GSA/ and
guanidinoacetic acid /GAA/ in vivo end in
vitro.
In viva studies were done on 8 urasmic
pts during IPD.IA vitro ones on isolated
parietal peritonea]. sheets derived from $
New Zealand white rabbits. Pta received
80 mg F intraperiton.ally during each of
the 3 consecutive dialysate exchange. In
vitro F was added in final amount of 3.3
mg/dl to the medium /M/ bathing the seso—
thelial /Ms/ side of the membrane whereas
GSA and GAA were alternatively administe-
red in concentration of 5eg/dl to the N of
vascular side. GSA and GAA were determined
according to Cohen St all.
Results of the in viva study with F
indicate increased PT of GAA /
—18%J but
that of GSA was found to be decreased /
—17%/. The in vitro study revealed no
changes in the mean transeesotheijel flux
rate /mg x ct2 x seci/ of GAA contrasti-
ng with its decrease of G /
—3O%/ after
adding F to the N of MS side.
We conclude F increases PT of GAA only
in vivo and decreases that of GSA in vivo
as well as in vitro.
MERCURIC CHLORIDE INDUCED AUTOIMMUNE GLOMERULOPATHY
IN BALB/C MICE.
G.J. Fleuren, E. de Heer, J. Burgers, C.v. Osnabrue—
ge, Ph.J. Hoedemaeker.
Departments of Pathology and Internal Medicine,
State University, Leiden, The Netherlands.
Mercuric chloride qiomerulopathy was induced in
50 female Balb/c mice to study the development of
auto-antibodies to renal antigens and the occurren-
ce of glomerulopathy. The animals received subcuta-
neous injections of 0.02 mg HgC12 three times a
week and groups of mice were sacrified every other
day during the first 4 weeks and subsequently at
5 and 12 weeks after the first disease inducing
inject ion.
In the serum of diseased mice auto-antibodies
could be demonstrated directed against renal tubu-
lar epithelial antigens from the second week on.
Purification of the autoantigen involved, using
SOS—PAGE analysis, revealed several similarities
with RTE-gP, the auto—antigen that is responsible
for the induction of Heymann's nephritis in the
rat. Cross reactivity between the rat— and mouse
auto—antibody was demonstrated by ELISA. Western
blotting, however, showed that autoantibodies from
mouse sera recoanized Only one subcomponent of
RTE—gP. Immunofluorescence demonstrated mesanqial
gM deposits from the second week on. Five weeks
after the first injection of mercuric chloride im-
mune aggregates mainly consisting of IgGi were lo-
calized along the glomerular basement membrane in
a granular pattern. Electronmicroscopy revealed
small subepithelial deposits.
This type of mercuric chloride induced nephrito-
genic Immune response in mice is of special inte-
rest to study the genetic background of dysreaula—
tion of the immune system leading to autoirnmune
disease , since many inbred congenic mice strains
are available with known haplotypes.
TIlE REGULATIONOF THE AUTOIMMUNE RESPONSE IN ACTIVE
HEYMANN'S NEPHRITIS BY T—CELL SUBSETS IN LEWIS
RATS.
E. de Heer, M.R. Daha and L.A. van Es (intr. by
I.M. Schjcht).
University Ilospital, Nephrology Dept., Leiden, The
Netherlands.
The cellular regulation of autoantibody
production was investigated in rats with active
Heymann nephritis (HN). Using an enzyme linked
short term culture assay we measured autoantibody
production in vitro by lymphoid cells directed
against the purified nephritogenic renal tubular
epithelia] glycoprotein (RTE—Gp) (Immunology
52,743,1984). Only the lymph nodes that drain the
site of immunization contained autoreactjve B
cells. Pretreatment with Cyclosporine A (Cy—A) or
multiple iniections of high doses of antigen in
Freund'g incomplete adluvnt markedly inhibited the
development of disease to a subsequent
nephritogenic challenge. In challenged high dose
tolerant (HDT) rats the autoimmune response was
only 5—bE of Immunized non—tolerant animals. This
tolerance could not be transferred by lymphoid
cells from Cy—A treated rats, but could be
transferred by ]ymphoid cells derived from the
thymus or spleen of 1-TDT rats. Transfer of affinity—
column fractionated splen±c T cells from IIDT
rtsdemonstrated that 0X8 helper enhanced sod 0X8
suppressor T cells suppressed the autoijamune
rosponse in subsequently challenged recipients.
These eperimeats indicate that both 0X8 helper
and 0X8 suppressor T lymphocytes are involved in
the induction and suppressioo respectively of the
sutoimmune response in this experimental
neph rops thy.
ALP!-L. CAMMA INTERFERON PRODUCTION OF
LYMPHOCYTES OF DIALYSED CHRONIC URAENIC
AND KIDNEY TRANSPLANTED PATIENTS
Gy.G1, M.Tóh, S,lOh, Eva Kiss
University Medical School of Szeged,Hungar'y
litres of gamma interferon /IFN—7
produced by lymphocytes of 128 patients
receiving regular dialysis treatment
/RDT/ were÷significantly /p.O,O5/
lower /136—56,8 IU/ml/ than that of
140 healthy blood donors /255—61,4 IU/rnl/.
Similarly alpha interferon /IFN— /production was lower in the case of RDT
patients than in normal controls
/p(.O,O1/. Comparing H3 Ag negative
/nlO6/ with HE5Ag posiive /n22/
ROT patients, no significant
difference was found in IFN—r produc
tion. On the other hand lEN_ti.. produc-
tion of the two groups showe a highly
significant difference; 3S63l36GT2
lU/mi for HB5Ag negative and 5535—1574,3
lU/mi for HB5Ag positive ROT patients.
Interestingly the same difference in
IFN—D( production was obtained
investigating blood donors and HO5Ag
carriers, otherwise healthy people.
From these results, it seems that the
presence of HB Ag might enhance the IFN—tI..production of 'ymphocytes. We havefollowed the IFN—&and IFN—rproduction
of RDT patients receiving kidney and it
seems that the interferon productiondid not decreased after transplantation
despite of treatment with immuno-
suppressive drugs,
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CIRCADIAN RHHM OP THE MIDMJE MOLULAR
WEIGHT PEPTIDES CONTENT IN BLOOD PLASMA:
SUBSTANTIATION OP HYSIQLOGICAL ROLE
G.V.Glinaky,A.B. Ivanova,S. P.Zaletok.
R.LKavetsky Institute for Oncology Prob—
1 ems Acad.Sc i.Ukr.SSR, Kiev,USSR.
Cjrcadian rh'thma of the middle molecu-
lar weight peptides(MP)oontent,the polya—
mines(PA)concentration and the hematoorit
(HT)].evel in blood of control and tumour
bearing animals were compared. The analy-
sis of was performed by the oombinatl—
on of the ultrafiltration and HPLC methods
The I? maximwn was registered between 12
and 16 houres(h),that of PA—between 4h and
8h,HT-8h and 1 2h. The minimum of —24ii and
4h, PA—12h and 16h,HT—16h and 20h. In all
the temporal points the PA and ME' contentis higher and HP is lower in tumour bea-
ring animals. ME were found to contain apeptide fraction with its level 2—9 timesincreased in animals bearing different tu-
mours. A peptide of the following amino
acid composition was purified till homoge-
neity in the reversed phase:Gly(3),Ser(2),
Asp(1 ),Glu(1 ),Ala(1 ),Hys(1 ),Val(1 ),Leu(1),
Phr(1).PA and ME' cause the decrease of blo
od plasma proteina(BPP)complex formation
with vasopressin(VP)by 116%,its free form
level in plasma and blood of tumour hosts
is increased by 1.9 and 1.5 times.MF while
conjugating PA change the VP binding to
BPP and raise its free form level.The an—
tidiuretic effect of VP regulates the HP
level circadian rhythm. The ME-and PA—de-
pendent changes in the free form levels
of bioregulators may be a factor control-
ling the balance of substances which
cross the blood—brain barrier.
.
ANTI—BSA ANTIBODY IDIOTYPES IN PATIENTS
WITH IgA NEPHROPATHY.
J.Gonzalez—Cabrero,J.Sancho,J.Egido,
L . Hernando.
Fundacion Jimenez Diaz.Madrid.Spain.
We have recently demonstrated the
existence of high levels of antibodies
against diet antigens in the serum from
most patients with IgA nephropathy.In this
work we have isolated idiotypic antibodies
anti bovine serum albumin (BSA) from a pa-
tient with IgA nephropathy. A heterologous
anti-idiotype was also obtained from ra-
bbits previously immunized with the idio-
type. The heterologous antidiotype was
used to study shared idiotypes in sera
and in immune complexes from patients
with IgA nephropathy in an ELISA assay.
Serum levels of this idiotype were higher
than normal in 14 of 28 patients studied.
These cross-reacted idiotypes were also
found in PEG-precipitated immune complexes
of these patients suggesting that they
could be involved in these complexes. In
this sense these idiotypes were also sig-
nificantly increased in serum from pa-
tients with IgA—complexes by Rail assay.
Concordance was found between idiotype
levels and clinical activity as defined
by the presence of hematuria.These results
suggest that in patients with IgA nephro-
pathy there is a restriction in the immu-
nological response repertoire. In addi-
tion idiotypes might be involved in the
immune complexes of these patients and
therefore be implicated in the pathogene—
sis of this disease.
FACTORS INVOLVED IN THE MESANGIAL DEPOSI-
TION OF IgA IN MICE WITH DEXTRAN-INDUCED
NEPHROPATHY.
Eva Gonzalez, J.Sancho,J.Gonzalez,R.Garcia
Hoyo, L.Lozano,J.Egido and L.Hernando.
Fundacion Jimenez Diaz.Madris.Spain.
IgA nephropathy was induced in ICR-
Swiss mice (n=120) by repeated i.p. injec-
tions of dextran—suiphate. The percentage
of animals with IgA deposits in the mesan—
gium increased along the immunization rea-
ching 85% of them at 24 injections (72
days).Previously to the maximal deposition
of I5a delayed blood clearance of injec-
ted I IgA aggregates (t 1/2 3.9 0.8
mm in immunized mice vs 1.3 ÷ 0.5 in con-
trols) ,a diminution in their uptake by the
liver at 30' of their injection (10.6 -
4 vs 32 + 10 in controls) together with a
progressive increase in the serum levels
of IgA (6.05 2.02 mg/al in immunized mi-
ce vs 3.2 1.9 in controls) and in the
anti—dextran antibodies of IgA class was
seen. The % of isolated hepatocytes with
Fc receptors for IgA, determined by rose-
tte formation with IgA—immunobeads, decrea
sed significantly along the disease (62.7k
16 controls vs 38.5 7.5 in mice after
24 injections). Our results suggest thata
prolonged stimulation of the IgA response
together with a defect in the handling of
the IgA—immunocomplexes by the hepatocytes
are a prerequisite for the deposition of
IgA at the mesangium level.
FINE-NEEDLE ASPIRATICI\J BIOPSY (FNAB) IN RENAL
DISFASE
C.C-ronhagen-Riska, E.v.Willebrand, L.Laasonen,
E.Pettersson and T.Tdrnroth
The Fourth Dept. of dicIne and the Transplanta-
tion Laboratory, University of Helsinki
Analysis of FNAB smears has proved valuable for
the evaluation of cellular infiltration in acute
rejection (Clth.Inffnunol.Isinunopathol.17:309,1980).
This techeique was used sirultaneausly with con-
ventional tm-cut biopsy in 19 consecutive pat-
ients with various renal diseases. Cytocentrifuge
smears were stained with MCG. OKT4 and O}r8 anti-
sera were used to identify T cell subsets. Back-
ground was analyzed fran peripheral blood.Table. Interstitial infiltration evaluated fran
histopatholoqical (HP) and FNAB analysis.
HP+/FNAB+ HP+/FNAB++ HP—/FNAB+ HP-/FB—
7 3 4 4
—= no, += detectable, ++= praninent infiltration
Diagnosis varied fran leA nephropathy (7), acute
focal necrotizing CN (4) to diabotic nephropathy
and renal sclerosis. In one patient only, who had
suspected palyarteritis nodosa, HP indicated sore
infiltration than was detectable by FNAB. General-
ly, FNAB analysis was quantitatively equal, or
more sensitive than HP, and enabled exact classi-
fication of infiltrating cells.
T lymphocyte analysis revealed a decreased T4 /
T8 ratio in IgA nephropathy (0.81+0.41, p<0 .01).
In most patients this was due to an increased a-
mount of infiltrating T8—pasitive lymphocytes.
We conclude that FNAB, when tested in large cli-
nical series, may prove a valuable tool for study-
ing the pathocenesis and clinical course of renal
disease.
ABNORMAL INNUNOGLOBULIN PRODUCTION BY LYMPHOCYTES
AND ITS CONTROL BY ADHERENT CELLS TN IgA DISEASE.
0. Gwyn Williams, S. I. Perl and A. H. Wilkinson.
Renal Unit, Guy's Hospital, London, U.K.
Immunoglobulin (Tg) production by peripheral blood
molecular cells (PBC) was examined in vitro in 29
patients with histologically proven IgA disease and
in 36 normal controls using ELISA techniques. Spon-
taneous production of IgA and IgG was significantly
granter in the patients: igA — mean 629.2 SEN 138.5
ng/ml (controls mean 206.9 SEN 27.83ng/ml) p<O.OOI;
IgG — meao 379.9, SEM 69.9ng/ml (controla mean
216.2 SEN 22.3 ng/ml) p <0.001; 1gM production was
not significantly different. Inculturee stimulated
by pokeweed mitogen (PWM) there was significantly
increased production of all three ig's compared
to unatimulated cultures, but there were no aigni—
ficant differencee between patients and controls.
The role of ancrophages, defined here as plastic
adherent cells(AC), on the increased Ig production
sas examined in PWN—atimulated cultures of PHC and
PBC depleted of AC
Patients(n=9) Controls (n12)
IgA ng/ml PHC 2123.4(707.9) 742.8(202.1)
Sean (SEN) PBC—AC 962.8(275.9) 909.6(210.3)
p = 0.04 NS
TgG og/mi PBC 3352.7(745.71)1872.4(375.6)
Moan (SEM) PBC—AC 1872.4(375.61)1755.2(399.8)
P = 0.04 NS
AC removal did not affect 1gM production.
CONCLUSiONS: (1) There is increaaed spontaneous
production of igA and IgG by PBC in patienta with
IgA diaeaae. (2) IgA and lgG production in patients
is under the infiuence of macrophagea (defined as
adherent cells).
(Statistical tests: Wilcoxon rank sum)
CSb—9 IN DISEASED HUMAN KIDNEYS
N. Hingiais, N. Kazatchkine, S. Bhakdi, C. Nsndet,
J. Grossetete, A. Hariety
INSERN U28, Hop. Brouasais, Paris, France
The presence and localization of the C5b—9 neo—
antigens of the terminal complement sequence, of
C3c and C3d antigens and of Factor H antigens have
been studied by immunofluorescence in 67 biopsy
specimens from pstients with a wide rsnge of renal
diseases with and without renal immune deposits. 7
biopsies were studied by imm000electronmicrnscopy
(EN). Biopsies were classified into 3 groups based
on the pattern of glomerular staining with anti—
C5b—9.In the let group, a apsrse meesngial labeling
was sewn, eimilsr to that of morphologically normal
kidneys. In the 2d group, abundant clusters of CS—
b—9 were seen in enlarged mesangial areas. In group
3, CSb—9 neoantigens were found in the same loca-
tion as immune deposits,EN demonstrated the presen-
ce of CSb—9 neoantigens on cell remnants embedded
in connective matrices in all specimens, the cons-
tant presence of C5b—9 on old and large immune de-
posits and the occasional presence of C5b—9 on re-
cent and amali immune deposits. Thus, the presence
of C5b—9 neoantigena even in large amounts, is not
necessarily associated with immune deposits; some
immune deposits of small size do not activate the
whole complement sequence; the occurence of protei—
nuria, in such caees, is independent of the presen-
ce or absence of C5b—9 on immune deposits (e.g.
membranoue nephropathy, stage I); in situ activa-
tion of the complement system may be documented in
the absence of detectable C3 (C3c) antigen in gb—
meroli; morphological alterations of cells in vici-
nity of immune deposits bearing CSb—9 are sparse
and not constantly observed. The presence of CSb—9
in pathological renal tissue does not have an uni—
vocal pathogenic significance.
CSb-9 IN NORMAL HUNAN KIDNEY
N. Hinglais, N. Kazatchkine, S. Bhakdi, M.D. Appsy
A. Grossetefe, A. Bariety
TNSERM U28, HOp. Broussaie, Paris, France
The presence of CSb—9 terminal complexes of the
complement sequence was observed within connective
matrices of the media of cortical arterioles, gb—
merular basement membranes, mesangium and tubular
basement membranes in morphobogically normal adult
human kidneys by imnunohistochemical techniques
using affinity—purified rabbit antibodies to human
C5b—9 neoentigens sod to the complement proteins
CS, C8 and C9. The C3d and C3g antigens of the C3dt
and C3bi cleavage fragments of C3 and Factor H
antigen were found in similar locations. None of
the matrices stained for immonoglobulins. Immune—
electron microscopy demonstrated that C3d, C3g end
Factor H antigens and the CSb—9 neoantigens were
localized on membranous and vesicular structures
embedded in the connective matrices, which have
previously been observed in normal and diseased
kidneys and in other non—renal connective matrices.
These structures represent cell membranes shed
from adjacent cells as evidenced by their ultra—
structural appearance and by the fact that those
which were in close vicinity to pedicela within
the giomerular bssement membrane expressed the C3b
receptor antigen, a specific marker for podocyte
membranes in human kidney. Formation of CSb—9 com-
plexes in the shielded environment of connective
matrices may explain their persistance over long
periods of time in the absence of apparent imauno—
pathological consequences. Complement activation
on cell remnants could suggest that the complement
system plays a role in the normal shedding process
of plasma membranes from cells.
CONGENITAL C3 DEFICIENCY ASSOCIATED WITH
NEPHRITIS IN A FAMILY
G. Kozma, M.C. Koama - Malik, H.A.
Sheikh, H. Al Mosawi, K.V. Johny.
Dept. of Medicine, Nephrology Unit, Amiri
Hospital, Kuwait.
It has become certain, that comgemita]
C) deficiency may predispose to certain
diseases, such as recurrent infection,
'crasculitis, nephritis, SLE - like
symptoms, fever and arthralgia.
We describe a family in which the
father and five daughters had different
degree of C) deficiency (complete or
partial). All affected members have
associated nephritis proved by renal
biopsy. The severity of renal disease
is not related to the degree of C)
deficiency. The pathogenesis of
associated nephritis is still obscure.
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CIRCULATING IMMUNE COPIII.EXES /CIC/ IN
GLOMERULONEPHRITIC 1GM! PATIENTS WITH
CHRONIC INFECTIONS
M.Krzymasiski. Z.Niemir. A.Oko. K.8CZyk
Academy of Medicine Pozna1. Poland
The influence of chronic infections
/bronchitis. sinusitis, tonsillitis/ on
the level of dC in 57 cases with three
morphological types of glom.rulonephritis
— ii with aembranous Gn /MGn/. 29 with
membrano—proliferative Gn /MPGn/ and 17
with mesangial proliferative Gn /Mes.P.
Gn/ were evaluated. CIC were measured by
means of 125 I — C1q binding and 3.5% PEG
/6000 daltons/ precipitation.
In 501 serum samples taken from pa-
tients without any symptoms of active
infections CIC were detected in 17.5%
/by PEG prec./ and 16.5% /by C1q bind.!.
In 123 serum samples taken during exacer-
bation of chronic infection CIC were
found in 45.5% /PEG/ and 31% /Cjq/. This
difference was significant /p<0.O1/.
The most frequent appearance of CIC de-
tectable by PEG were observed in Mee.P.
Gn — 57.8%. whereas that by C1q in MPGn
— 44.4%. in a group of 18 patients with
chronic tonsillitis the freguency of dC
detection after tonsillectomy decreased
from 44.4% to 28%.
It is concluded that exacerbation of
chronic infections may induce intermi-
ttent appearance of CIC in glomeruloneph—
ritic patients.
IN VITRO NO IZAflC$ OF UREL4IC L'LMPH(XYTES BY
INTERLEUKIN—2 (IL—2)
E .Langhoff ,J .Ladefoged ,K .Olgaard, S .Madsen
Med. Dep. P, Rigshospitalet, Copenhagen.
We have previously demenstrated a decreased re—
sponse to mitogens and an increased sensitivity to
the imaunosuppressive effect of steroid of uremic
lymphocytes. Pa IL—2 plays a key role in lyiiphocyte
activation, the present investigation, therefore, ex-
amined the influence of IL—2 on the reactivity of
lymphocyte cultures obtained from uremic patients.
Peripheral bicod lymphocytes (PBL) were isolated on
lynphoprep in parallel experiments from 30 patients
on HO, 30 on CAPD,and 30 control subjects.The PBL
cultures were mitogen stinulated (PHAand Con A) and
cultured for 72 h followed by 20 h incubation with
C 14 thymidine before harvesting and counting the iso-
tope uptake.Purified IL-2 was added to parallel cml-
tures.The in vitro resistance to steroid was tested
by addition of 0.06,0.3,0,6,1.2, and 3.0 ug mathyl-
prednisolone (NP) per ml culture.
Mitoqen responses to Con A and to optimal PHA stim-
ulation were depressed iii HD patients (p O.O1),while
CAPE) patients responded nommal . At sutoptimal PHA
stirnulation,however,toth CAPD and HD lymphocyte re-
sponses were reduced (p 0.01) .Pdition of IL-2 to
these cultures normalized the response of the CAPD
but not the ND cultures .Both CAPD and HD lymphocyte
cultures were nore sensitive to the suppressive ef-
fect of MP than control cultures (p O.O1).Pddition
of IL—2 normalized the uremic lymphocyte sensitivity
of FID and CPPD cultures and rendered all cultures
resistant to the inminosuppressive effect of NP.
In conclusion,IL—2 inproved the response of uremic
lymphocytes to mitogen stimulation and normalized
the sensitivity to suppression by steroids.It is
suggested that IL—2 is a central factor in the im-
paired uremic inuuneresponse.
ALtI4INIUM (N SOME ACTIVITIES OF EYTHROID AND
LYMPHOID CELLS : IN VITRO EFFT.
Silvano La1Tperi,1ndrea Icardi Silvia Carozzi.
Division of Nephrology,St.Martin Hospital, Genoa,
Italy.
Aluminium(Al) and other netal ions(Zn,M,Co,Cu)
were added in gradual dosages to in vitro cultures
of Burst Forming .hit-erythroid (BFU-e) drawn from
peripheral blood with progressively reduced doses
of Erythropoietin (Ep) to evaluate the effect of
the above nentioned materials on the BFU—e growth
andE sensitivity.Besides the effect of the sama
setal ions on the endoerythrocytic delta aminole-
vulinic acid debydrase (D-ALA-D) activity, T-cell
growth factor ('ICGF) production from peripheral
nononuclear cells and the lymphocyte blast-cell
transformation was evaluated.This study was per-
formad in 10 normal subjects from whom inforned
consent was obtained.
Thc final data showed a decline of BFtJ-e growth
and Ep sensitivity, a decline of LCGF production
and lymphocyte blast transformation in the presen-
ma of Al in the cultures;other netal ions showed
any effect.D-ALA-D activity even decreased in the
coincubation of the red cells with Al. The above
nentioned results were obtained with Al concentra-
tions similar to those observed in patients with
Al intoxication.In conclusion,our in vitro data
show that Al is capable of determining abnormali-
ties of the erythroid and lymphoid progenitors ac-
tivity which could contribute to soma hematologi-
cal and invnunological disorders of uremia.
T LYMPHOcYTE AND MACROPHAGE INVOLVEMENT IN THE
GLOMERULAR LESIONS OF MICROSCOPIC POLYARTERITIS
F. Nolasco, J S Cameron, B. Hartley
Hospital Curry Cabral, Lisboa, Portugal and Guy's
Hospital, London UK.
The pathogenesis of microscopic polyarteritis is
unknown, although a popular hypothesis is that cell
mediated immunity may be involved. We studied T—
lymphocytes and macrophages in renal biopsies from
5 patients with microscopic polyarteritis and
crescentic nephritis, four early in their course
and one late biopsy (lyr) , at a time of stable
renal function. All showed negative immunofluores—
cence for immunoglobulins and complement components
Monoclonal antibodies were used, directed against:
all leucocytes (201) : lymphocytes and their subsets
(UCHT1,UCHT4,Leu 3a,Leu 7 and T0l5) ; and monocytes/
macrophages (FMC32) . The results were expressed as
cells/glomerulus.
Intraglomerular leucocytes were frequent (45.1
+ 27) particularly in histologically active lesions
In the single late biopsy, only 12.3 cells/glomeru-
lus were seen. The lymphocytes and their subsets
gave similar data, there being 5 3.5 T-lymphO-
cytes in early biopsies, compared with 1 in the
late biopsy; 9.4 + 9 suppressor/cytotoxic versus 1;
5.0 -i- 2 helper/inducer cells versus 1 per glomeru—
lus in the late biopsy. T—cells were absent from
control renal tissue. Macrophages were frequent
(23 + 6 per glomerulus) in the early biopsies,with
only 4/glomerulus in the late biopsy.
The presence of T—lymphocytes as well as macro—
phages within the glomeruli early in the course of
the glomerular lesions associated with microscopic
polyarteritis, and the absence of immune deposits
or iminunofluorescence or electron microscopy
supports a role for cell mediated immunity in the
pathogenesis of the glomerular lesions.
. SPECIFIC IMMUNOABSORPTION IN A RAT MODEL OF
G000PASTURE S SYNDROME
C.D. Pusey, C.J. Ryan, M. Aslam, J-J Lioveras,
C.M. Lockwood
Depts. of Medicine and Surgery, Royal Postgraduate
Medical School, London.
In order to examine the effects of extracor—
poreal immunoabsorption on auto—antibody synthesis,
a model of anti-GBM disease was developed in the
BR rat, in which a single IM injection of homo-
logous collagenase—solubilised GBM (without
adjuvant) resulted in sustained anti—GBM antibody
production. At the optimal dosage of 1.0mg/kg it
was found that antibody levels reached a peak
between 4 and 6 weeks (in 25/25 animals) , and were
then sustained for 6 months before falling towards
background. Immunoperoxidase studies of renal
biopsy material confirmed IgG deposition along the
GBM.
A novel system for performing specific immune—
absorption in the unrestrained and unanaesthetised
rat was developed. Whole blood was pumped into a
membrane plasma separator, after which the plasma
was passed over a GBM-coated absorption device
before rejoining the cellular elements on return
to the animal. Blood flow rates ware maintained
at 0.7m1/min, and plasma flow averaged 0.2ml/min.
Single 18m1 (2x plasma volume) perfusions were
performed in groups of 3 animals producing anti—
GEM antibody. Those treated with GEM—coated
devices showed a prompt fall in antibody levels
(3l%—40% of initial values) , whereas controls
(albumin-coated devices) showed no significant
change. Anti-GEM antibody levels in the treated
group remained low for up to one week before
returning to pre—treatment values; there was no
early antibody rebound. If asimilar approach proves
feasible in man,it would provide a more specific and
safer form of treatment for anti—GBM disease.
• MEMBRANE ATIACP COMPLEX (MAC) OF COMPLEMENT IN IGA—
NZPHRITIS AND UENOCR—SCRÜNLEIN PURPURA NPURITIS
E.W.Rauterberp. A.—M.Wingen, M.Lieberknecht, E.Ritz
Institute of Immunology and Internal Medicine,
University of Heidelberg, FRG.
Imxnunohistological studies of kidney biopsy
specimen from 23 patients with IgA—nephritjs (IgA—
GN) and two with Henoch—Schönlein purpura nephritis
(}ISP) were performed in order to check whether the
the membrane attack complex of complement (MAC)
could be detected at sites of IgA deposition.
Antigens of MAC, e.g. C5, C6, C9 and MAC—related
neoantigens were demonstrated in all cases, but
were negative in control specimen lacking immuno—
globulin deposits. Markers of classical pathway
activation (Clq and C4) were observed only in 2/24
and 1/23 cases of IgA—GN and HSP, respectively.
Statistical evaluation of the glomerular distribu-
tion patterns (mesangial versus mesangio—perpheral)
revealed significant correlations between IgA and
C3b (P<O.002), between IgA and properdin (P<O.002)
and between IgA and MAC neoantigens (P<O.Ol). The
pattern of four MAC—related antigens, e.g. CS, C6,
C9, MAC—neoantigen, were uniformly either mesangial
or mesangio—peripheral in 13/14 cases. Amounts of
MAC—related antigen depositions as judged froir
immunof1uorescece microscopy were less in IgA—GN
cases with minimal glomerular lesions than in spe-
cimen with more advanced lesions. Glomerular di-
stribution of IgG and 1gM did not correlate with
that of any of the complement derived antigens.
Detection of IgA, C3b, properdin and MAC in IgA—GN
and lISP with similar patterns suggests a complete
local complement activation by IgA immune complexes
via the alternative pathway. MAC may play a key
role in the pathogenesis in IgA—GN and lISP by an
irritation of bystander cells, e.g. mesangial,
endo— and epithelial cells, and/or a charge altera-
tion of basement membranes.
C3D - A MARKER OF LOCAL COMPLEMENT ACTIVATION IN
VARIOUS GLOMERULAR DISEASES
E.W.Rauterberz. A.—M.Wingen, E.Rjtz
Institute of Immunology and Internal Medicine, Uni-
versity of Heidelberg, FRG.
Absence of glomerular "C3" was reported in Va—
cious forms of immunologically mediated glomeru—
lonephritis. However, tissue bound "C3" may repre-
sent C3b, iC3b or C3d and the latter is not recog-
nized by most antisera against C3. In the present
study we used anti—C3c (reacting with C3, C3b,
iC3b) and anti—C3d in serial cryostat sections.
Intensities and glomerular patterns of the respec-
tive antigens were compared in kidney specimen from
23 cases with IgA—glomerulonephrjtis (tgA—GN), 19
cases with membranous GM CM—GM), and 6 cases witi-
anti—glomerular basement membrane nephritis (AGBM—
N). In all cases anti—C3d gave stronger immuno—
1uorescence (IF) signals than anti—C3c. Globally
distributed granular C3d deposits along the peri-
pheral basement membrane (GEM) were observed in
16/19 cases with N—GM in contrast to only 12/15
specimen with C3c—positive deposits of weaker in—
tensites and similar pattern. In AGBM—GN, one case
with no detectable C3c—staining as well as the
other five specimen revealed extensive linear GBM
staining with anti—C3d. In 3/5 specimen anti—C3c
visualized granular deposits only. In IgA—CN, C3d
was demonstrated more frequently with a mesangio—
peripheral pattern (or even with a linear staining
along the GBM) than C3c—related antigens. Our fin-
dings indicate that IF staining for C3d may be
valuable in order to detect the metabolic products
of local C3 activation, especially in "C3—negative"
specimen. C3d seems to represent a long lasting
"scar" of complement activation in the tissue.
DIET EXA
CERBATES ADRIAMYCIN —(ADE) GLOMERULOPATHY.
0. Resuzzi, C. Zoja, A. Remuzzi, M. Rossini, Bat
taglia end T. Bertani
Mario Negri Institute, Vim Gavazzeni 1l,Bergamo Italy
A iv injection (5mg/kg) of ADR induces in rnt
disease persistent proteinuria that
resembles minimal change nephropathy in humana.Elec—
tron microscopy (EM) shows alterations of glomerular
visceral epithelial cell with foot process fusions.We
studied the effect of dietary manipulation on proteinu
na, clearances and
glomerular 1Group received ABE and
fedwere a diet.Group 2 (n=1O) were fed a low
protein diet starting 7days before ADR.Group3 (n=5)
were feds lowproteindietstartingthedayafter ADR
Group 4 (n=1O) fedwere a high protein diet starting7 days before 5ADR.Group served as control.
Rats lowon protein diet developed less proteinunia
(p.OOl) andratson protein diethadmoreprotej
nuns (p4.001) than ratson standard diet.GFR and 1(PF
both higher in group 4 (p<.OS1and p<.OOl), in
respect to 1 and 5. Agroup significant increase in
RPF (p<.O1) was in group 2.
ExcRgrr99° pp}o
Days 14 21 28 28 213
Group 1 199±61 399±112 6CJ7±l36 0.77±0.16 2.42±0.68
2 6 2 6± 8 3 0.95 0.24 3.73±0.65
Group3 5±3 6±4 7±4 — —
Group 4 378±92 330±177 l122199 1.15±0.39 3.68±0.62
Group5 6± 4 8± 4 8± 5 O.86O.16
Means o(mg/day); 00(ml/miri/100 g).
EM showed marked epitheljalcejl abnormalities in
group 1, more severe damage in group 4,minimal alte
rations in group 2 and 3.Dietary manipulation indu-
ces significant changes in glomerular hemodynamics,
however factors other than changes in RPF and GFR ap
pear responsible for the protective effect of low pro-
tein diet.
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. DEFECTIVE FUNCTION WITH NORMAL EXPRESSION OF CELL—
SURFACE Fc RECEPTORS IN MIXED CRYWBULINA8IA.
D.Roccatello, R.Coppo, G.Martina, F.Malavasi,
B.Basoio, C.Roilino, A.Amore, G.Piccoli.
Nephrolor Units S.Giovanni Hospital .Turin.Italy.
In order to gain insight into the role of Fc re-
ceptors in Essential Mixed Ciyoglobulinaemia (EfU),
we quantified the expression of these receptors on
phagocytic cell surface and assessed their con-
tribution to the clearance of inmune material.
A mouse monoclonal Ab to Fc receptors of human
polymorphonuclear cells (Pbl) was employed to deter-
mine the number of receptor1per cell. Moreover the
phagocytosis of IgG—coated Cr—labelled sheep red
blood cells by PMN, the splenic mgrophage (MAC) im-
mune clearance of IgG—sensitized Cr—labelled auto
logous erythrocytes and the kinetics of phagocytosis
of lgG—coated materials by peripheral monocytes
(MON) were evaluated.
As compared to nomual subjects,six patients se-
lected for the absence of DR3 antigen in their I-LA—
DR patterm, had depressed PNN phagocytosis(O.18+O.04
vs O.57÷O.O8,pO.O5),prolonged MAC inrnune clearance
(61.6+33 sin vs 32.9÷10 min,pO.O5) with reduced MON
kinetic index of phagocytosis (0.4+0.2 vs 1.02+0.2,
p:O.O2). Nevertheless the Fc receptors expressed on
cell surface were found to be quantitatively normal
(31620+5020h-ol 1 vs 32240+3780/cell).
Fc receptors are normally expressed but,
functionally impaired in EMC patients. These dys—
functions are likely to contribute to the tissue
locaiizat[on of imune material.
MANIPULATION OF THE SPLENIC PLAQUE-FORMING CELL
(PFC) RESPONSE IN Hgcl2-INDUCED ANTI—GBM DISEASE
J.A. Savige and CM. Lockwood
Royal Postgraduate Medical School, London.
Repeated injections of HgC12 (1mg/kg) in the
Brown Norway rat results in the development of
anti-GBM antibodies in a model of auto-antibody
mediated glomerulonephritis. A splenic plaque-
forming cell assay for direct and indirect plaques
(that correspond to the development of 1gM and IgG
anti—GBM antibodies respectively) has been
developed in this model and mechanisms of control
of antibody synthesis have been investigated. Both
direct and indirect plaque formation can be inhib-
ited in vitro by the presence of GBM (to lOOpg/ml)
but not by an irrelevant antigen. The addition of
a monoclonal antibody with anti-GBM activity
inhibits the PFC response at l.ig/ml (p=O.O5) com-
pared with an irrelevant antibody. Furthermore,
anti—idiotypic antibody was prepared in a rabbit by
multiple immunisations with affinity—purified human
anti-GBM antibodies (by Dr. C. Savage). After
absorption against normal human IgG, preparations
were affinity-purified either on a human anti-GBM
column cr on a human anti—tetanus toxoid column.
The anti-idiotypic preparation (anti-anti-GBM)
inhibited plaque formation at 1O-3pg/ml lpO.Ol)
compared with the irrelevant anti—idiotype (anti-
tetanus toxoid)
Both direct and indirect plaque formation was
short-lived, and after the peak of the PFC res
ponse, the addition of low concentrations of GBM to
the plaguing mixture often resulted in an increased
number of plaques detected ('augmentation'). Aug-
mentation may reflect the inhibition of PFC by
naturally-occurring anti-idiotypic antibodies that
are subsequently displaced by the low concentra-
tion of GBM. Investigations that examine the
phenomenon of aunmeptation will be dcua,.
ABNORMAL EXPRESSION OF THE GOODPASTURE ANTIGEN IN
PATIENTS WITH ALPORTS SYNDROME
C.O.S. Savage, C.D. Pusey, S. Cashman, M. Kershaw,
B. Hartley, D.R. Turner, D.J. Evans, P. Harrison,
J.S. Cameron, C.M. Lockwood
Royal Postgraduate Medical School, London;
Kingston Hospital, Surrey; Guy's Hospital, London,
Southmead Hospital, Bristol.
Alport'S syndrome (AS) is an inherited condit-
ion associated with ultrastructural abnormalities
of basement membranes within kidney, cochlea and
eye, although the biochemical defect is unknown.
There are reports that auto-antibodies to the
glomerular basement membrane (GBM) from patients
with Goodpasture's syndrome do not bind to the GBM
in AS, but others have been unable to confirm this
finding. We have developed a mouse monoclonal
antibody (MCA-Pl) which recognises GPA and have
used this reagent to investigate basement membrane
structure in AS. We have studied renal tissue
from 10 patients with clinical and ultra-struct-
ural evidence of AS (Group A), from 4 patients
with evidence suggestive but not diagnostic of AS
(Group B), and from 15 patients with other types
of glomerulonephritis (Group C) . Binding of
MCA—Pl to GBM was reduced or absent in Group A,
normal in Group B, and normal in Group C, suggest-
ing alteration or absence of GPA in the GBM of
patients with AS. Further studies have shown that
MCA-Pl binds to the tectonial membrane of the organ
of Corti, the basement membrane of the lens and the
internal limiting membrane of the eye in normal
individuals, demonstrating the presence of GPA in
the other membranes affected in AS.
MCA-P1 may be of value not only in the diagnos-
tic interpretation of renal biopsies from patients
with familial nephritis, but also in more detailed
investigation of the molecular basis of this
inherited disorder.
INHIBITION OF THROBOXANE SYNTHETASE WORSENS
"ACCELERATED ANTI--GBN NEPHRITIS IN RABBITS.
Y.Shinkai and J S Cameron. Renal Unit, Guy's
Hospital, London UK.
Throboxane A2 (TxA2) is a powerful vasoconstnic-
tor and proaggregant whose production is increased
in various forms of renal injury, including anti
GBM nephritis in rats. Therefore, inhibition of
this powerful toxic agent is attractive for the
therapy of glomerular diseases. We studied the
effects of 2 ant i—thromboxane agents in accelerated
form of anti-GBM nephritis in rabbits: an in:idazole
derivative, OKY—O46;and trapidil, which besides be-
ing a thromboxane receCtor antagonist also antago-
nizes the effect of platelet derived growth factor
itself possibly implicated in the proliferation and
cellular infiltration of glomerulonephritiS.
Although OKY-O46 almost eliminated the excess
urinary excretio:i of TxB2 (the product of TXA2) in
nephnitic rabbits one day after injection of anti-
GBM serum, it resulted in an increa in proteinu-
na, worse depression of creatinine clearance and
an increased number of monocytes infiltrating the
glomeruli at day 5; the number of periglomerular
crescents was also increased, but not significantly
Trapidil had no statistically significant effects
on any of these parameters, but all were marginally
worse.
We conclude that these experiments do not pro-
vide a basis for the use of thromboxane synthetase
inhibitors in human nephnitis, and that prostaglan-
din synthesis may have been altered in a deleter-
ious fashion. There was little increase in the ex-
cretion of the vasodilator prostaglandin PGE2,which
did not prevent worsening of the disease. TXA2 may
have a role in healing and reparative processes.
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SERUM AND BIOPSY IgG SUBCLASSES IN PATIENTS WIPE
MENBRANOUS NEPEROPAThY.
C.D. Short, P. Tarpey, K. Wood, P.LC. Brenchley,
B.M. Coupes, J. Peehally, N.P. Mallick, S. Waldek*.
Dept. of Renal Medicine, Manchester Royal Infirmary
and Bope Hospital*, Manchester, U.K.
IgG is the predominant deposited imaunoglobulinin membranous nephropathy (!1.N.). The different
physico—chemical properties of the 4 IgC subclasses
may influence the preferential deposition of one
or other IgG subclass. Using paired specimens,
we determined the serum IgG subclass concentrations
and the glomerular IgG subclass distribution in
renal biopsy tissue from 15 patients with M.N.
Serum IgGl—3 levels were measured by radial immuno-
diffusion and serum IgG4 concentrations were
determined by ELISA. Biopsy IgG subclassdistribution was assessed by a single experienced
observer using an indirect immunofluorescent assay
with monoclonal anti—IgG subclass antisera.
Total serum IgG was reduced in the patients
(5.6g/l patients, 1O.8g/l controls) and was
accounted for by significantly lower IgG1 and IgG2
concentrations (p 0.001). IgG3 levels were
lower and IgG4 levels higher than control values
but neither result was significant. Of the 15
biopsies, 11 showed the presence of 3 or 4 sub-
classes; 4 biopsies showed restricted subclass
deposition (3 cases showing 2 subclasses, 1 case
showing 1 subclass). IgG2 was only found in 7
biopsies together with Ig1, IgG3 and IgG4.
There was no agreement between the rank order
of serum IgG subclasses and the relative
distribution of IgG subclasses in the biopsies in
the individual patients. We suggest that the
deposition of IgG subclasses in the GBM is
unrelated to the serum concentration.
EPIDF4IOJiXW OF IMMJOLCX3ICAJLY MEDIATED GLCt4ERU-
LAR DISFSE1 2 3 2A. Tiebosch , H. 44lolters , W. Grav, J. 4oy
Th. van der jiel , B. Zeppenfeldt and P van
Breda Vriesman
2
Departments of Immunology, Pathology and Inter-
nal Medicine, State University of Liaturg, ?4aas—
tricht, The Netherlands. 3Departments of Intexial Medicine, St. Laurentius
Hospital, Roermond Uspital 'Th QDddelijke Voor—
zienigheid', Sittard; Ce Wever" Hospital, Heer—
lea, The Netherlands.
F4idmmiological field data of glcmerular inf lam—
matory disease are not availableThe epideniology
of ininunologicalty mediated glcerular disease in
adults s examined in a regional sttxly in the
southern part of the province of Limburg in the
Netherlands. 225 biopsies sure taken fran a total
adherent population of 1,6 million inhabitants,
12-65 years of age, presenting with persistent or
recurrent hamaturia (58x), henaturia arid protein—
uria in excess of 1 but less than 5 gr per day
(57,c), isolated proteinuria (30x), nephrotic syn—
drane (SIx) and urenia, seruit creatiriine exceeding
300 umol/l (29x). Incidence per year per million
wee 21,5 for Ig neropathy, 9,8 for matibranous
gicinerulopathy, 1,8 for mambranoproliferative gb—
merubonephritis, 7,4 for minimal change nephrotic
syndrcine and 2, 5 for anti CP4 glanerubonephritis.
These data presented above are in part consis-
tent with data derived fran center studies (eg.
anti-Gli ON) but differ fran those in mthranous
glcinerulopathy and mrbranopro1iferative glaneru-lonephritis. Caution should be exercised in extra-
polating epidemiological data fran center studies
to the incidence of disease in the general popula-
tion.
CI-IASGES IN THYROID FUNCTION TESTS FOLLCMING PLASMA
EXCI-LANGE THEAThIENT;PRELIMINARY RESULTS.
G.A.Sobbrio,R.CatalfaIno,F.pitrone,G.Mi1eto,G.Cost
tino,F.Tr'imarchi.
Clinica Medica Ic UniversitA di Messina,Italy.
A preliminary evaluation of thyroid function
(T?T4FT,FT4,TSH) was carried out in 8 subjects
prior treatment and after with plasma exchange be
cause of different diseases.Blooci saiples were ta
ken 24 hours before,at the end,and at 1,3,7,10,15
days fran the end of plasmapheresis.Afl above men
tioned parameters were measured using cem-nercial
kits.Statistical analysis was performed using the
Student's t test for paired data.
In the present study we observed,canpared with ha
sal values,no evident modification of T4 levels,
but a significant diminution of T3,during the whole
period of folbow-up(values of p between 0.025 and
O.OOl);we also noticed,with regard to the last pa
nod of follow-up,a significant decrease of FT, and
FT3(respectively:6.7+9.3 vs l0--l.3,p 0.025;3.7Th.4
vs S.2±5.6,p0.025).F'inally,a rise of TSH values
could he seen fran the seventh to the fifteenth day
of plasmaphereais,but only significant at the tenth
day,because of large dispersion of data(3.3÷0.0 vs
2.2+O.8,p<0.025.These preliminary studies show irn
por'tant modifications of thyroid homeostasis connec
ted with plasma exchange.A proper evaluation of
such alterations implies the necessity of a canpie
mentary study involving the main carrier proteins
(TBG,TBpA) and mechanisms of peripheral deiodina
tion(rT).
RFNAL DYSPLASIA IN CHILDHOOD:
PROPOSAL OF A NTv CLASSIFICATION
Keriman Tlnaztepe, Behçet Tlnaztepe
Hacettepe University, Institute of Child
Health, Unit of Nephropathology,
Ankara, Turkey
Although renal dysplasia is well knon
pathologic entity,there are a few series
about the incidence,clinical presentations,
complications and associated malformations.
In this study the clinico—pathological
analysis of 32 cases of renal dysplasia (RH)
suggested US a simple and working
classification of the disease.
A retrospective review of 206
nephrectornies excluding primary renal
tumors received during an 8 year period
were done. Applying histopathological
criterias for R which include 1—primitive
ducts, 2—primitive ductules in a cellular
inesanchymatous stroma 3—cartilage; RD oases
were grouped based on the amount of the
formed renal parenchyma as follows;
aplastic dysplasia(ll Oases) ;hipoplastic
dysplasia(9 cases) ;hydronephrotic
dysplasia(8 oases) ;segmenter dysplasia(4 cases). In our classification, the
distributions of major clinical features
and complications correlated with the
amount of the formed renal parenchy-ma and
the associated malformation.
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. CHARACTERIZATION OF TARGET ANTIGENS IN
GOODPASTURE'S SYNDROME
M. Weber, H. Köhler, M. Manns, P. Kurz, K.-H. Meyer
zum Büschenfelde (Intr. by D. Höffler)
1st Department of Internal Medicine, University of Mainz, FRG
Demonstration of anti-GBM antibodies in GP-syndrome is
possible by various methods including ELISA techniques. We
recently presented an micro-E LISA which recognizes anti-GBM
antibodies with high sensitivity, specificity, and reproducability.
The target antigen of the anti-GBM antibodies, however, has not
yet been entirely characterized.
GBM was prepared according to Westberg and Michael (1970).
A collagenase-digest was used as soluble antigen preparation.
SDS-PAGE (5-20%) was performed to separate the basement
membrane proteins. Proteins were then blotted onto nitro-
cellulose paper and bound IgG was detected by immuno-
peroxidase staining. GP-sera (4), sera from patients with various
forn of glomerulonephritis (10), SLE (10) or other immuno-
logical diseases (10) and sera from healthy blood donors (10)
were tested. In addition, stability of the basement membrane
antigens was investigated under reducing conditions.
Reactivities on the nitrocellulose sheets were obtained only by
4 GP-sera and the IgG fraction of one GP-serum eluted from
protein A- sepharose 4B. The serum from one GP-patient in
clinical remission and the control sera were negative. Three
high-titered sera identified proteins of the mol-weights 23.500,
24.500, 41.000 and 46.000 as target antigens. The fourth serum
with an antibody titer of 1:4 (indirect immunofluorescence) or
1:512 (ELISA) did react only with the peptide of 24.500 D.
Reduction with mercaptoethanol destroyed the GP-target
antigen as demonstrated by negative immunoblot and ELISA.
Our investigations showed, that anti-GBM antibodies identified
antigens of different mol-weights in a collagenase- digest of
human glomerular basement membrane. The different reactivity
of the fourth serum might be due to low titer or low avidity of
the anti-GBM antibodies in these patient. Further investigation
should clarify the precise nature of the GP-antigen(s).
RENAL PHARMACOLOGY
THE PHARMPICDKINETIC INTERACTION BETWEEN PIPERACIL-
LIN AND FLUCLOXACILLIN IN RENAL FAIUJRE PATIENTS
CANI9IYT BE PREDICTED FROM RESULTS IN HEALTHY \i'OLUN-
3. Braun, I. Briining, F. Sorgel, K. BrauereiB, E.
Lang and U. GeBler.
institute of Nephroiogy, Niirnberg, F13.,
Carl Korth Institute, Division of Clinical Pharma-
cology, Erlangen, F.
We studied 15 patients with variable degree of re-
nal inpairmant (RF) in comparison with eight heal-
thy volunteers (1W). Both groups received a bolus
injection of a fixed combination of 4 g piperacil—lin (P) and 1,3 g flucloxacillin (F). Plasma and
urine concentrations of both agents were neasured
by high pressure liquid chromatography. The pharma-
cokinetics were analysed by non-conpartmantal ma-
thods. The initial plasma levels of P and F in RE
were very similar to those in HV. However in fly
during the elimination phase plasma levels of F be-
coma higher than those of P, whereas in RF all
plasma levels of P remain higher than those of F.
Ibtal as well as renal clearances were sinnificant—
ly reducec in RF. As a consequence tl/2 was increas-
ed but 1:1/2 of P was stronger affected than tl/2 of
F.
Renal failure patients Healthy volunteers
P F P F
c.p.max 566±90 259±43 436±123 252±70 ig/ml
tl/2 9.57.8 6.3±5.7 1.30.3 1.20.2 h
Cl./tot. 33.5±28 24.9±13 140.7±27 53.510ml/rnin
Cl./ren. 19.723 8.0±9 100.4±33 28.5±7 mi/rein
AUC(103) 183±99 73±45 29±6 25±Spgxrnin/Inl
The ratio of the areas under the curve (AUCP/AUCF)
was 1.16 in 1W but 2.5 in RF. These findings made
us conclude that drug interaction studies in IN -
although frequently done - may not be predictivefor RF as the elimination of the individual coIn-
pound is affected differently.
ABNORMAL IMMUNE RESPONSE IN PATIENTS WITH MINIMAL
CHANGE NEPHROPATHY IN REMISSION.S A. H. Wilkinson and D. Gwyn Williams.
Renal Unit, Guy's Hospital, London, U.K.
The immune response of 18 patients with minimal
change nephropathy (MCN) in remission for 2—10
years (mean 5.6) was studied. Six patients had
been treated with prednisolone alone and 12 with
prednisolone plus cyclophosphamide. The immune
response was examined by measuring (I) IgG antibody
response to dinitrophenol—Ficoll (DNP) on days 0
and 14 and expressed aso—14 of the reciprocal
titres logio; (ii) IgG antibody response to keyhole
limpet haemocyanin (KLH) on day 14 expressed as
reciprocal titres log10; (iii) the skin reaction
to intradermal KLH expressed as +1—. Results were
compared to those of healthy subjects of a similar
age range.
RESULTS: (i) IgG anti—DNP (mean±SE):MCN=1.80±0.11;
controls=2.44±O.06 (n=58); p<O.OO1 (Wilcoxon);
(ii) IgG anti—KLH: response on day 14: MCN=11/18;
controls=49/66; not significant (i). Of the resp-
onders (mean±SE) MCN=2.14±0.2; Controls2.67±0.09;
p<O.Ol(Wilcoxon test); (iii) Skin reaction to KLH
—positive2response; MCN=6/18; controls=52/66;
p<O.OOi (( ).
CONCLUSIONS: The abnormal immune response in pat-
ients with MCN in relapse clearly continues into
remission. Possible explanations for this are (a)
previous treatment with immunosuppressive drugs;
although cyclophosphamide could have long—term
effects on the immune system after cessation of the
drugs, prednisolone will not do so. There were no
differences between patients treated with prednisone
or prednisolone+cyclophosphamide. (b) The nephrotic
syndrome itself affects the immune system long—term.
(c) There is a pre—existing abnormality in the
immune response which predisposes to the develop-
ment of a nspnropatny.
Ff11 -X1(IpTIcS IT ONAL(1AC, A t&W &R STEROID 4TIDFLflI44ATO-
RY E(XS (NSAID) IN LINIC PATIENTS. Dkhissl H, Atik A, Andre-
jak H, Galy C,Morinière Fh,Abdulmassih Z,Fournier A.CHIJ Amiens.
Pharrnacokinetics of Lonazolac was studied in 7 uremic patient6
(5men,2 women,age range 25-69 years) with a creatinine clearance
of 45 to 8.5 mi/mn (mean 19 mi/mn) and osteoarticular pains jus-
tifying NSAID administration. For thatPUrpoie 12 blood samples
were drawn for measurment of Lonazolac and its active metabo].!—
te B 761—15, during the 48 hours following the administration
of a single tabiet of 200 mg first without previous administra-
tion of any NSAIO for 4 weeks (period A) and then (period B) af-
ter 5 days of Lonazolac administration at the dose of 200 mg
t.i.d. The following parameters were then calculated maximum
concentration (C max.mg/ml) the time of maximal concentration
(tmax), half life (tl) and area under the curve (AUC mg/lxh).
The mean results are summarized in the table and compared to
results obstaimed in normal volunteers.
sean
periods
Cmas
A
mg/i
B
teas
A
(h)
B
t 1
A
(h)
B
AbC mg
A
/lxh
B
Uremics
Lonazolac 3.6 3.6 2 1 10.6 13.6 10.6 18.5
8 761—15 2.0 1.9 2 2 14.5 15 8.9 22.8
normals
Lonazolac
1.7 1.8 5.9 6.2
8 761-15 1.4 6.4 I
Clinical tolerance was food except in 1 patient who developped
a rash at the first administration. Glomerular filtration de-
creased in 2 patients during Lonazolac administration but resu-
med its initial level within a week after discontinuation.
cocj.5IcP :, 1/Uremic state induces only a mild alteration of
the pharmacokinetics of Lonazolac, the factor of correction for
Cmax and tI being 1.5 to 2 for Lonazolac and its active metabo—
lite. 2/ As other NSAID, Lonazolac should be given with caution
in uremia because it may worsen renal insufficiency. This wor-
sening is however reversible.
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FACTORS AFFECTING RENAL LITHIUM CLEARANCE
E.H.Dyson, S.Freestone, D.Simpson*, A.T.Proudf'oot,
L.F.Prescott.
Regional Poisoning Treatment Centre and *University
Department of Clinical Chemistry, Royal Infirmary,
Edinburgh, Scotland.
(Intr. by R.J.Winney)
The renal clearance of lithium was studied in
six female patients (age 22—66) with lithium over—
tesage. Maximum serum lithium concentrations
ranged from 2.2 — 7.0 mmol/l. Five patients were
receiving regular lithium therapy and became intox-
icated; three had therapeutic intoxication and two
took acute overdoses. Three were treated with
intravenous saline and dextrose and two with
forced alkaline diureais. The other patient, not
receiving lithium treatment, took an acute overdose
and was asymptomatic. All six recovered unevent-
fully.
Lithium clearance (CLi), sodium excretion
(UNaV), urine flow rate (V), hydrogen ion concen-
tration ([)-tJ) and osmolality were estimated for
each urine collection period (usually 4—6h). CLI
correlated with UNaV in all patients (r=O.51 to
0.98, pO.O75 to (0.0001), There was a significant
correlation with V in three patients (r=O.70 to
0.88) but in these V was correlated with UNSV.
CLi did not correlate with LH] or osmolality in
any patient. The serum lithium half—life varied
(12—35h) and was not noticeably affected by
treatment.
Saline diuresis seems to be of value in the
treatment of lithium intoxication (without renal
failure) but alkaline diuresis was of no benefit.
EFFECT OF FELODIPINE ON RENAL HAEMODYNAMICS, SODIUM
EXCRETION AND RENAL PROSTAGLANDTN METABOLISM.
D.A.S.Jenkins, K. Craig, A.M. Macnicol and M.L.
Watson (intr. by R.J. Winney)
Medical Renal Unit, Royal Infirmary, Edinburgh U.K.
Felodipine (F) is a calcium antagonist which
lowers blood pressure (BP) in essential hyperten-
sion. The renal effects of this class of drug are
unclear. These effects of F were exolored in a
placebo (P) controlled double blind study of 9
normal volunteers. F (0.15mg/kg oral) was given
with and without indomethacin (I), to identify any
role of prostaglandins (Pc). Renal plssma flow
(RPF) and glomerular filtration rate (OFF,) were
measured by PAH and Inulin clearance. I.(50 mgs
oral) was taken 12 hours before and at the start
of the study. After two 30 mm. control urine
collections F or P were given and colletions
continued for 150 mm. at 30 mm. intervals.
Urine volume (fly) and sodium excretion (UNaV)
increased after 60 mm. and returned to control by
150 mm. I. slightly blunted this response.
UV (ml/min)± S.E.M. UNay (pM/min)± S.E.M.
Control 60 mm. Control 60 mm.
F 6.0±0.3 10.0±0.7* 323±26 679±115*
F+T 6.1±1.0 9.4±1.0 321±37 575+97*
p 6.2±1.2 6.3±0.9 371±46 320±40
* P < 0.02
There were no changes in RPF, GFR, urinary 6 keto
PGF1 excretion or plasma renin activity. BP was
unchanged but heart rate increased transiently.
F has diuretic and natriuretic effects that are
not mediated by renal haemodynamic change nor
associated with changes in renal prostsglsndins.
The combination of vasodilator and natriuretic
properties enhances the potential role of this
drug as a useful hypotensive agent.
DIURETICS IN POSI-ISCKEMIC ACUTE RENAL FAILURE (I F).
R.Faedda,A.Satta,G.F.Brarta,F.Turrini ,B.Cc*itu, E.Bartol 1.
Inst.d.Patho1onj' and N hro1ngy,1ivers.of Sassari,Italy.
The protective effect of diuretics co past-ischenic acute re-
nal failure was studied by ccnparing the intra h.ininal acting
drug Furoseiiide (F) with the peritubular agent Muzolinhine (N).
The studies were perfonied on 14 volisie expanded rats: in each a
ninisi the left experine,tal kidney (L) was cceared to the right,
control side (R). After baseline clearance nasuresits,an acute
hydronaphrosis was produced on L and naintained for 20 minutes.
Either N (1.2 eg) or F (4 n) or Placebo were injected during
the last 3 minutes of stop flcni,then both renal arteries were
claiped for 20 minutes. After release of the claips and hydrcoe-
5 consecutive clearance periods were collected frcin ei-
ther side to assess recovery frcn ARE.
Overall,ARF dressed (R to 13% of the control value in the
L, 16% in the R kidney. The speed of recovery in renal function
were higher in the R irrespective of the agent given. There was
rio difference between drngs, since the final values reached were
39 (L) vs 64 (R) with F, 59 vs with N, 62 vs 82% of baseline
CFR with Placebo. Urine ficM rates () were higher in the R with
F (248 vs 144) and with N (276 vs 155% of baseline value,P(0.01,
to the contrary, they were riuch lcwer with Placebo and rot diffe
rent in either side (97 vs 82, P)0.05).Na excretion was parallel
to V. Tissue AlP content was higher with F (459 in R vs 3(X) nWg
in L, P(O.O1) than with N (323 in R vs 322 r'i/g in L,P0.05) and
Placebo (372 vs 349 r14/g, P)0.05).
These data denDnstrate that diuretics do rot protect against
ARE during vohsne expansion, whether or rot they reach the tube-
lar lu'ren,or spare AlP. Idronejiimsis, preswiably throngh redu-
ced urine flcw rate, aggravates the effects of renal ischesia
since the L post-hydronephrotic kidney shcws consistently a re-
duced function.
SHORT-COURSE ANTITUBERCULOSIS CHEMOTHER-
APY IN PATIENTS WITH END STAGE RENAL FAI-
LURE (ESRF) WITH THE REGIMEN OF ISONIAZID+
RIFAMPICIN + PROTIONAMIDE
R. Krause, I. Bennhold, K.L. Radenbach.
GIrd Division of Internal Medicine, Moabit Municipal
Hospital, Berlin, Federal Republic of Germany.
In patients with normal renal function, a short-
course antituberculosis chemotherapy of less than 12
months is Internationally accepted. This progress Is
based on drugs and drug combinations with bacteri-
cidal effect on all fractions of tubercie bacilli: iso—
niazid (H), rifampicin (R), pyrazinamide (Z), strep—
tomycin (5) and protionamide (P). Generally accep-
ted regimens are H+Ri-Z(+S)in an initial intensive
phase of 2 to 3 months and H+R in a continuation
phase of 4 to 6 months. - However, iii patients with
ESRF, therapy is restricted to bactericidal drugs
with extrarenal metabolism (H, R, P). In animals(Grosset et al., 1982) and In a controlled study in
tuberculosis patients with normal renal function(W.A.LL., 1993), the low single daily dose of P of
5 mg per kg of body weight in combination with
other bactericidal drugs was highly effective and
well compatible. — Therefore, the aim of this pro-
spec live study was to investigate efficacy and com-
patibility of the regimen of H(5 mg/kg) +R(IO mgi
kg) +P(5 mg/kg) for 3 months and H+R for further
6 months in patients with ESRF and complicating
hilar lymph node, pericardial, renal or pulmonary
tuberculosis. In 3 patients on hemodialysis treatment(HD), the drugs were given 3 times a week after
each HO, and in I patient with chronic renal fail-
ure, the drugs were given 6 days a week. During
therapy, the regimen of 3 HRP/6 HR was well com-
patible and effective. In I patient with follow—up of
1 year after the end of short—course chemotherapy,
no relapse was observed.
Abstracts 279
KINETICS OF NIFEDIPINE IN PATIENTS TREATED WITH
MAINTENANCE HEMODIALYSIS
H. MARTRE, C. JACOBS, E. SINGLAS, R. SARI, A.M.
TABU RET
Centre Hosp. Bicëtre and Centre Pasteur—Vallery—
Radot, Paris, France.
NIFEDIPINE is widely used for treating angina or
hypertension in patients undergoing maintenance he—
modialysis (HO). The HO cLearance of NIF. was de-
termined in 5fasting patients (residual creatinine
clearance 1,5—0,5 mi/mn) after administration of
10 mg of the drug 4 hours prior to the start of a
HO session performed with a single pass system and
a lsqm surface area cuprophane dialyzer. Arterial
and venous blood samples were drawn 2 hours after
start of HO, QB and QO were 200 mL/mn and 500 mi/mr
respectively. Plasma levels of NIF. were measured
by liquid gas chromatography. The extraction ratio
was 2,3±0,8 ¾ (range 0,2—4,4 ¾) and the clearance
through the dialyzer 2,8±0,9 mi/mn (range 0,2—4,9
mi/mn). This low elimination of NIF. by HO can be
accounted for by its Liposolubiiity and strong bin-
ding to plasma proteins which amounted to 89 ¾ — 8
fasting patients were also given 10 mg of NIF. on
an interdialytic day, their mean residual creatini—
ne clearance being 2,2±0,8 mi/mn. Blood samples we-
re obtained at seven time intervals between 0,5 and
10 hours after NIF. intake. Peak plasma concentra-
tion of NIF. was observed 0,5 to 1 hour after drug
intake and amounted to 124±35 ng/mi (range 29—332
ng/ml). These values are similar to those observed
in healthy subjects, due to the largeiy extra renal
elimination of NIF., which is metabolized up to
95 ¾ in the liver. These data indicate that the
therapeutic dosage of NIF. needs not be modified
for patients with terminal renal failure treated
with HO.
.
THE EFFECT OF PREVENTIVE ADMINISTRATION OF NIFEDI-
PINE (NF) ON ACUTE ISCHAEMIC RENAL FAILURE (AIRF)
IN HYDROPENIC DOGS.
T.Natsheh, E.Alexopoulos, A.Dimitriadis, T.Tsobane
1 Is, S. Kalpakoglou, M . Papadimitriou.
2nd Prop. Dept of Medicine, Aristotelian Universi-
ty of Thessaloniki, Greece.
In previous experiments the favorable effect of
verapamil on the course of AIRF in dogs was demon-
strated. The purpose of this study was to examine
the effect of NF a calcium entry blocker which does
not significanty affect A-V nodal conduction on the
prevention of AIRF in 20 hydropenic dogs.Two groups
of animals were used. The first group (10 dogs) was
used for the study of NF (NF group) and the second
(10 dogs) as controls (placebo group). After clam-
ping on one side (control kidneys), 10 1g/kg BW of
NF or placebo was given IV 15mm later the renal
pedicle of the other side was clamped (NF or pla-
cebo kidneys). The total ischaemic period was 60mm
for both kidneys and thereafter blood flow was ree-
stablished and in the subsequent 120mm renal fun-
ction of both kidneys was evaluated. At the end of
2 hours Vu (M±SE) was higher in the HF group (0.79
ml/min) than in controls (0.31*0,07 ml/min)
(p<O.05). Other parameters measured were as follows:
Ccr(ml/min):O.31±0.O7(C)_0.79±0.24(NF)(p<O.05),
Curea(ml/min):3.16±0.82(C)—5.65±l.21(NF)(p<O.O5),
FENS(%):9.OS±3.43(C)_7.27±l.64(NF)(p=NS), ULDH(U/L):
274.3O±64.89(C)_lOl.6O±2l.77(NF)(p<O.05).
Our results indicate that the preventive admini-
stration of NF had a favorable effect on glomeru—
lar and tubular function in the experimental AIRF.
The differences between HF group and control of
placebo group may be due to the reduction of vaso—
spasm and to the better viability of renal tissue
in this group.
BIOAVAILABILITY OF VER?,PANIL DURING CONCOMITANT
TREATMENT WITH OTHER DRUGS.
J.Mooy, B.Arends, R.Bdhm, J.v.Kemenade, M.v. Baak,
and K.H. Rahn.
Department of Medicine and Department of Pharmaco-
logy, University of Limburg, Maastricht (The
Netherlands).
The calcium antagonist verapamil is now fre-
quently used for the treatment of hypertension. The
drug is extensively metabolized by the liver. Hepa-
tic enzymes can be inhibited by cimetidine and in-
duced by rifampicin. Therefore, the influence of
these drugs on the pharmacokinetics of verapamil
was studied. Six subjects was given a single oral
dose of 40 mg verapamil. Subsequently, the plasma
levels of the drug were repeatedly determined du-
ring 7 hrs. The study was repeated after the sub-
jects had been treated for 5 days with oral doses
of cimetidine (400-1000 mg/day). Furthermore, 40 mc
verapamil was given orally to 4 patients treated
with drugs for tuberculosis (rifampicin:450—600 mgi
day, isoniazid: 5 mg/kg/day, and ethambutol:15 mg/
kg/day), and the plasma levels of verapamil were
determined for a period of 7 hrs. Verapamil was
determined by means of high—performance liquid
chromatography with fluorescence detection. Pre-
treatment with cimetidine didn't change the maximuja
plasma concentration (Cmax), the half—life of the
terminal slope, and the AUC (p > 0.1).
In the patients treated with drugs for tuberculo-
sis these parameters were very low.
The study demonstrates that cimetidine has no in-
fluence on the pharmacokinetics of verapamil.
Treatment with tuberculostatic drugs, however,
strongly reduced the bioavailability of the drug,
probably due to enzyme induction by rifampicin.
THE EFFECT OF VERAPAMIL ON A COMBINED ISCHAEMIC
AND AMINOGLYCOSIDE MODEL OF ACUTE RENAL FAILURE
(ARF) IN DOGS.
M.Papadimitriou, T.Tsobanelis, E.Alexopoulos,
S.Kalpakoglou, A.Kelesi, M.Leontsini, P.Metaxas
2nd Prop. Dept of Medicine, Aristotelian Universi-
ty of Thessaloniki, Greece.
It was shown that verapaail protects the canine
kidneys from acute ischaemic renal failure. On the
other hand, there are reports that calcium intake
prevents the aminoglycoside-induced ARF in rats.We
examined the effect of preventive administration
of verapamil on a combined ischaemic and aminogly-
coside model of ARF in 15 dogs. After clamping the
renal pedicle on one side (control group), 0.5 mg/
kg BW of verapamil was given and 2mm later the re-
nal pedicle of the other side was clamped (verapa—
mil group) . After 30mm of ischaemia clamps were
removed and netilmycin (80mg/kg BW) was infused IV
for 2 hours. During this period renal function was
studied in both kidneys. The results at the end of
the 2 hours study were as follows (M*SE):
Controls
Vu(ml/min) 1.66±0.25 1.46±0.20 NS
Ccr(ml/min) 10.08±0.98 6.40±0.76 <0.001
Curea(ml/min) 8.28±0.96 5.66±0.79 <0.01
Cosm(ml/min) 2.00±0.35 1.27±0.18 <0.01
FENa(%) 23.30±4.07 34.66±8.40 <0.05
ULDH(U/L) 55.00±9.27 179.67±53.88 <0.05
The results indicate that verapamil does not pre-
vent the netilmycin-induced nephrotoxic lesion. On
the opposite, calcium blockade seems to lead to a
greater degree of renal cell damage probably due
to increased intracellular aminoglycoside levels.
.
kidneys Verapami 1 p
. MORPHINE TRANSPORT IN THE ISOLATED PERFUSED RAT
KIDNEY
P.2. Ratcliffe (introduced by D.O.Oliver) , J.W.
Sear, C.T. Hand, R.A. Moore
John Radcliffe Hospital, Oxford
Delayed elimination of morphine in patients with
initially non-functioning renal allografts (Moore
et al, Clin. Pharmacol.Thera. 1984) suggests that
the kidney is an important site of morphine metabol-
ism and that this mechanism is sensitive to ischae—
mia. These observations prompted this study of
morphine handling in the isolated perfused rat
kidney.
Kidneys were perfused with 100 mls blood free
recirculating medium consisting of bovine serum
albumin in bicarbonate buffer. GFR was measured by
inulin clearance. Morphine sulphate was added to
the perfusate to produce a concentration of approx-
imately 60—600 nmol/l which is similar to the
therapeutic range in man. Morphine and morphine—3-
glucuronide were assayed in perfusate and urine by
radioimmunoassay.
Morphine clearance (mean 3.08 0.88 mi/mm/gm
wet wt) was very much greater than inulin clearance
(mean 0.65 0.11 mi/mm/gm wet wt) indicating a
high rate of net Secretion of morphine. Initially
high morphine transport rates were much less well
maintained than sodium transport during 3 hours
perfusion. Morphine secretion was dose dependent
ranging from 256 pmol/min/gm wet wt (clearance 4.7
mi/mm) at a perfusate concentration of 60 nmol/l
to 1099 pmol/min/gm wet wt (clearance 2.5 mi/mm)
at 638 nmol/1. No metabolism to morphine—3-glucuro—
nide could be detected. Thus active morphine
secretion by a system with high affinity and high
capacity in the rat kidney results in very high
urinary clearance rates over the concentration
rouge studied.
ItO ROAI BUMINURIA AND HIGH PROTEIN DIST IN PAI'IFNiS
WITH UNILATERAl NEPHT1ECTONY.
\.Amure, R.Copp, B.Basoio, D.Roccatello,G.Nsrtina,
C.Rii 1 inn, G.Bongiorno, G.Piccci i
NophroloJ Units S.Giovanni Hospitai.Turin.Italy.
Subtotal ncphrectorny in young rats results in
hyperfiltrat ion in the remaining nephrcns and badE
to proteinuria and progressive focal and seentai
glomerulosclerwsis (FSG), which is accelerated by
high protein diet. In humans, FSG seems to be as-
sociated with unilateral renal agenesia, but, It is
ill deb&cd whether adult neptitrect orrmj may promote
a similar prvcoso.Since mtcroalbuminuria,i.e. in-
creased urinary albumin excretion (UAE) undetecta-
ble by rOandard 'echniques, is an early sign of gle
merular hyperfiitrat ion as demonstrated in Inc ipi—
tnt diabetic nephropathy, this parwatter was ap-
p1 ied LA analyse 13 normotensive adults, who had
had unilateral nephrectemy I to 27 years before and
entered this study without, preteinuria detectable
by mutinary assays. By employing a very precise
and reproducible solid phase enzyme irrinuno assay,de
veloped by fhe Authors, detecting UAE as low as 0.91
pg/mi, these patients were found tn have significan
tly higher U.AE (9.7 +9,vs 2.5 pg/mi in 20 con—
trols,p<O.03). In 5 cases microaibuininuria (UAE 7pg
ml) was detectable. Six patients receiving for one
month a high protein diet (1.6 g/Kg) had a signifi-
cant increase in UAE (from 7.8 to 19.8 +18 pg/rn]
p<O.02).These results suggest that unilateral ne—
phrectomy in adults can induce microalbuninurla
possibly due to a mechanism of hyperfiltrat ton
which may be further enhanced by high protein diet.
CLINICAL NEPHROLOGY
FACTORS AFFECTING PROGRESSION OF CHRONIC RENAL
FAILURE.
A. Albertazzi, P. Cappelli, B. Di Paolo, M. Evange—
lista, T. Di. Marco.
Institute of Nephrology & Dialysis — University of
Chieti — Italy.
Chronic renal failure(CRF)usually is characteri-
zed by an inexorable decline of the GFR.
The relative importance of the main factors af-
fecting progression of CR?' was evaluated retrospec-
tively on 136 patients with various nephropathies
presenting a linear decline with time of the reci-
procal of creatinine.The follow—up varied from 17
to 106 months with serum creatinine from 1.6 to
16.8 mg%.The following progression factors were
studied :glomerular hyperfiltratjon indirectly eva—
luated by the patients' compliance to the low
protein diet(LPD),hypertensjon evaluated by diasto-
lic blood pressure(DBP) , high CaxP product, hyper—
uricemia.
The patients on early LPD(serum creatinine 2—3
mg%)presented a significantly slowed progression in
respect to both the patients on late LPD(aerum crea
tinine)t4 mg%)and those following no LPD.In these la
st two groups DBP mean values.1O5smHg,CaxP product
5O, hyperuricemia8mg%,significantly worsened the
course of CRF.
The reduction of protein intake,when started ear
ly during the course of' CRF,improves the control of
CaxP product and of serum uric acid,stabiiizes the
glomerular hemodynamic equilibrium therefore protec
ting the surviving nephrons from damage due to
hypertension.
RELATIONSHIP BETWEEN PHOSPHATE CLEARANCE AND PROX-
IMAL TUBULAR SODIUM REABSORPTION IN LIVER CIRRHOSIS
P. Angeli, L.Caregaro, A.Merlo, M.Rondana, A.Gatta
Clinics Medica II, University di Padovs, Italy.
The precise nephron site of the increased
tubular sodium reabsorption in liver cirrhosis has
not been defined yet. Based on the assumption that
phosphate is reabsorbed proximally coupled to
sodium, phosphate clearance (Cl004) has been
proposed as an index of proximal tubular sodium re-
absorption (PFRNa) in liver disease (Rochman J;
1978; Epstein, M.1982). This study was attempted
to assess the relationship between PFRNa and Cl04
in cirrhotics and in controls. 7 compensated
cirrhotic patients and 6 controls were studied.
PFRN5 was evaluated during maximal water diuresis
as 1—(V/GFRx100) and compared to simultaneously
determined Clp04. Cirrhotics showed sn increased
PFR (88.76±3.45 compared to 82.45±4.28% of
conols; p<O.025). No correlation was found in
all subjects between PFRNa and Cl004. We therefore
conclude that: 1) An increased PFkNa may occur in
the early stages of liver cirrhosis and 2) Clo4
isnot a reliable index of PFRN5, suggesting a
phosphate reabsorption beyond the proximal tubule.
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• 99m Tc-APROTININ UPTAKE TEST AND
.
SEPARATE KIDNEY FUNCTION
C.Aprile,R.Saponaro,G.Villa ,M.Carena ,A. Salvadeo,
F.Lunghi°,V.Piazza and E.Petrella*
Fond.Clinica del Lavoro,Pavia—ltaly
Sorin Biomedica°,Saiuggia VC—ltaly
Scuola Spec.Nefrologia Univ. ,Modena—Italy
The aim of this work is to correlate the sepa
rate net kidney uptake of the renal agent 99mTc
Aprotiriin(TcA)with the separate ERPFs(131 I—OlH,
Meldolesi s method)and GFRs(99mTc—DTPA,Gates
method).
After i.v.injection of 1l0—185MBq of TcA(Reno
cis,Sorin Biomedica)separate net kidney uptake
was calculated according to the method previous
ly proposed(Nucl.Med.23:22,1984)employing a LFOV
camera linked to a data processor.
Correlation between TcA uptake(202 renal uni
ts)with ERPFs is highly significant(p<.001)at
any time(90,l80,36Omin)p.i. ;this correlation was
confirmed in further 25pts studied at 90mm.
In 17 pts with chronic renal failure TcA correla
tion was better than with 99mTc—DMSA. Correlati
on between TcA uptake at 90mm and GFRs in 19
adults(36 r.uJis highly significant(p.00l)as
well as in 12 children(23 r.u.) (p<.Ol).
TcA uptake test is a feasible indicator of
split renal function even in the case of very ad
vanced kidney failure allowing morphologic and
functional evalualion of residual parenchyma.
EFFECT OF A LOW-NITROGEN DIET SUPPLEMENTED
WITH ESSENTIAL AMINOACIDS AND KETOACIDS(AR
TIFICIAL DIET:AD), AND OF HEMODIALYSIS (MD)
ON LIPID METABOLISM IN UREMIA.
G.Barsotti, F.Ciardella,E.Morelli,F.Bianchi
F.Niosi, A.Cupisti, R.Caprioli and S.Gio—
vannetti.
Clinica Medica 1 ,Università.Pisa,Italy.
Hyperlipidemia (HL) is frequent in
uremia, and HD cannot reverse this derange-
ment, often responsible of cardiovascular
disease. AD corrects several uremic endocri
me dysfunctions strictly related to HL, as
hyperparathyroidism and male hypogonadism.
For this reason we studied serum triglyceri
des (5TG) and serum cholesterol (SCHL) in
76 chronic uremics (6lmales and 15 females,
26—73 years) who changed from low—nitrogen
diet to AD. During AD (11.8 months as an
average) renal function, evaluated by crea—
tinine clearance, was unchanged (from 9.1+
3.2 to 8.2+3.6 ml/min) while 5TG decreased
significantly (from 185.6+88.0 to 150.7
66.4 mg/di; p 0.001). The hypertriglyceri—
demic patients (29 males and 6 females,agi—
ng 28-69) had a greater response to AD
(from 252.8+84.8 to 181.1+72.1 mg/dl; p0.001). This reduction wa more evident in
males than in females.
In 27 uremics who changed from AD to
HD, sTG increased significantly (from 168.6to 239.4±187.8 mg/dl; p 0.05) after
12.2+10.7 months.
We can conclude that AD corrects HL,
probably by reversing several endocrine dy—
sfunctions, as hyperparathyroidism and male
hypogonadism, while MD worsens these abnor-
malities and rises sTG levels.
PROPIONHYDROXAMIC ACID (pt-IA) VS ACETOHYDROXAMIC ACID
(AHA)IN URINE UREA—SPLITTING BACTERIAL INFECTIONS.
A.Aroldi,A.Mandressi ,G.Graziani,A.Trinchieri,D.Caimi
C.Castelnovo,0.Decobelli,P.Passerini,C.POflticelli.
Renal Unit,Urological Unit; Osp.Maggiore,Milan,Italy
The antiureasic activity of PHA,a new hydroxamate;,
was evaluated and compared to AHA in urea—splitting
bacterial infections.Twenty—two pta with normal reri
al function and refractory urea—splitting urine infe
ction that persisted after removal of struvite sto
nes,were randomly allocated to receive PHA (O.125g/,
q.i.d. ;llpts)or AHA (0.25 g/q.i.d. ;llpts). Intrave
nous pulses of antibiotics wei'e also associated for
3 consecutive days followed by a 15 days course of
pipemidic acid. Thereafter hydroxamate was given alo
ne for 15 days and pipemidic acid was given for the
next 15 days. Urine (culture,pH,NH)and blood (RBC,
WBC ,platelets, serum aapartate aminotransferase , amyla
se and creatinine)analysis were performed before and
after each treatment period. A significant reduction
in urine pH and NH was achieved both with PHA and
AHA. Urine sterilization was obtained in all pts
after iv antibiotics but infections recurred in 3
Pt-IA and in 3 AHA pta. No significant variations of
blood parameters were observed with both hydroxania
tes. Side effects like tremor(5pts),weakness(5),hair
toss(3)were present only in PHA group, while mild
headache and nausea were present in both groups.
In conclusion: the efficacy of PHA (O.5g/day) is corn
parable to that of AHA (lg/day), but side effects
are more frequent and important with the use of PHA.
I€OAD 1IIP44RY PYRCIMNi-v,it. A LITI-ONIC R19( FN2TtJ IN
IDIPATHIC l-MF)CPLCItJIA tJtED BY DIARY IDXT I5TRICTI(J.
RATAILLE P ,LACOUR B ,RtSJLLET 38 ,ATIK H ,FINET H ,FOURNIER A
(1) CHU AI-4IENS - (2) Hopital Necker - PARIS — FRANCE -
To evaluate urinary pyrophosphate as lithogenic risk factor
and its eventual change with the usual diary product restriction
(DPR),pyroohosphate was measured before and after 4 days of OPA,
by enzymatic method,in the 24 hours urines together with phosphatE
in 12 controls and in 62 calcium stone forrners classified accor-
ding to their calciuria into normocaiciuria(NC),dietary hypercal—
ciuria(DH),and idiopathic hypercalciuria(IH)(defined by a calciu-
na on a calcium restricted diet > 3 mg/kq/day).Plasma phosphate
was measured,in fasting conditions after OPR.
FREE DIET DPR DIET
HEAN+SEM P04 Pyro PU4 Pyro P P04
rarrol/d ,jmol/d rrnsol/d
/jmol/d rsrrol/d
Control
26.1 43*1 22.1' 30*5 0.94.0.03
30.1 30+.3 29.1 28.1 0.90+0.02
H
14
33+2 29+6 28.1 25+5 0.80..0.05
IH
21
33+2 27.0.5 29.1' 22.3' 0.80.0.045
5ignificance of the difference between free and DPR diet p < .05
S significance of the difference between the control and Ca stone
1ormers.
CONCLUSIONS : 1/ Pyrophosphate is decreased only in IN and repre-
sents therefore a lithogenic factor for this group. 2/ DPR furthe
decreases phosphaturia ar-rd pyrophosphaturia in IN.
3/ The decrease in pyrophosphate with DPR may conterart the bene-
ficial effect f decreasing hypercalciuria and may justify in
this group phosphate supplementation.
282 Abstracts
FfrIJ(DUI0THIAZI1F(HT ).€oEASEs OXALATE A8SCPTIClJ IN CALCBII
STtJE fiDt:RS(CaSF) — BATAILLE P,FINET M,LEFLON P,ROGEZ P,
RIBOUT B,FIEVET P,FOURNIER A -. CHU - AMIENS -
Effect of HI on oxalate intestinal absorption is controversial
This may be explained by the fact that both calcium and osalate
Lntskes were not well, controlled Therefore the % absorption of
oxaiste was measured in 21 CalF after a standard load of 1 p of
oxaiate(200 p of spinachs)while the patient is asked to respect a
low calcium and low oxalate diet and to drink the same amount(1,5
l/d)of water in 4 conditions:(l)after 4 days of haitjwater(HW:Ca =
11.25;Mg=2,7 nasolil)(2)after 4 days of soft water(SW:Caw,25;Mg
25 molil)(3)after 3 months of I-T+50 mg daily of HT(4)after 3
months of SW+50 mg daily of HT.Furthermore the probability of b-
ing of a stone former(ROBERTSON index)w8s calculated on the baaia
sf UCaV and UOxV on the 24 h urins collected before the oxalate
load.The results are sumarjzed for the 4 therapeutic perdioHs jn
:he table (mean SEe).
—
HW HW+HT SW SW+tlT
(JCaV mol/d 9.2a.8 B.9t.7 4.9±5 5.3.8
LJNaV maclid 18519 180±18 165±19 190±17
DXV mol/d
.226j.025 .235j.01 .320±031 .293±02
UMpV moliri 4.8±.5 5.8j.2 3.6±25 4.8±.5
UMg/UCa .54.OB .7±08 .75a.t ,95.22
PSF- .55.Q4 63±05 .53±05 .51±02
% Ox absorbed 1.2±17 .5.1" 3.6j.o 2±35"
Singificance of the difference with an without HT:"p<.02.
The only significant change with IT was the decrease in the S
of oxalate bsorhed which decreased with MT both on RW and SW.
here was however no significant decrease ic calciuria,oxahjria
Pit related to thesr factors nor in magnesium or Sodium excre
tion. CONCLUSION 1/The Tact that the long term hypocalciuric
fFect of F-IT is not shown in this study suqgess that the patients
were not folidwing adequately their calcium restricted diet on a
long term basis. 2/This fact is an evplaination for the decrease
in osslate absorption. 3/F-IT effectiveness would be therefore ex-
plained by a higher tolerance to calcium and osalate intake, the
actual higher Calcium intake inducing no increase in calciuria
thanks to HT,snd decreasing the osalate absorption.
• INTRADERMAL SKIN TESTING IN THE LOIN PAIN
.
HAEMATURIA SYNDROME
C.M.Bell, D. Thomson, J.L. Anderton, A.T. Lambie,
A. Doig.
Medical Renal Unit, Royal Infirmary, Edinburgh,
U.K.
The observation of accelerated skin reactions
to intradermal tuberculin in 2 patients with the
loin pain haematuria syndrome (LPHS) prompted this
controlled study of intradermal skin testing in
the LPHS and other forms of glomerulonephritis
(GN). Three age and sex matched groups were
studied, pat.lents with LPHS (Group A, ri 10,
mean age 34 — 8 years), patients with other frms
of GN without loin pain (Group B, n = 10, 31 — 6
gears) and normal subjects (Group C, n = 10, 30
— 3 years). In Group A the following
investigations were normal; MSU and EMUs for
AAFB, plasma chemistry, ANF, DNA antibody, serum
complement and immunoglobulins and IVP. Renal
biopsy of all patients in Group A showed no
significant GM but immunofluorescence revealed a
Consistent granular deposit of C. in arterioles.
All subjects were tested in standard fashion
using 0.1 ml intradermal injections of each of 5
antigens; tuberculin, varidase, candida albicans,
trichophyton, mumps and control. In Group A
severe localised skin erythema-and swelling
occurred in all patients within 12 hours to at
least 2 of the 5 antigens, significantly greater
than the reactions in Groups B and C (p(O.OOl).
Systemic complaints and lymphadenopathy occurred
in 8 patients in Group A and in none of the
patients in Groups B and C (p(O.OO1). This
hyperimmune status of the LPHS suggestive of type
III hypersensitivity may play a role in the patho—
genesis of the renal lesion.
n-usJiic. VlWtPC (F S(V1 VERSUS KARD WATER IN CALCIU4 ST
Ftø.ES(Ca)1WATED WITH HVt1C)UIOTHIAZI((HT)IS [LPOI)PNT L1
tNX4ITTPNT OXALATE RESTRICTIW - BATAILLE P,FINET M,RENAUO H,
LEFLON P,ROCEZ P,TRIBOUT B,FIEVET P,FOuRNIER A — CHU — AMIENS —
HT is a well established treatment of nephrolithiasia as high
fluid intake.The optimal quality of water to drink is however a
matter of controversy mainly because their calcium and magnesium
content are correlated and that oxalate excretion is inversely
borrelated to hardness of the water.To answer the question which
tis the optimal water for Calf a hard one(HW:Ca=11.25 mmol/l;Mg
'3.7 mol/l)or a soft one(SW:Ca=.25 mol/l;Mgw.25 mol/l)21 CalF
tollected their 24 h urin during 2 days while on an otherwise low
calcium and low oxalate diet and while taking 50 mg/d of HT sue-
Cessively after 3 months of MW and after 3 months of SW ingestion
mt a constant daily amount of 1.5 l.Furthermore at noon of the 2rd
urin collection they ingested 1 g of oxalate as 200 g of apinachs
Cor each urin collection,the probability of being a stone former
CRlF of ROBERTSON)linked to calcium and osalate was calculated,as
tell as the Mg/Ca urinary ratio
The results are summarized in the table.
IJCaV ssaol/d
UoxV macl/d
HARD
0X
8.9+7
.235±01
WATER
OX load
86..9
.274+.O2
SOFT
0X
5.3+8'"
.293+02"
WATER
OX load
5..7
.453+.03I
tJMpV msol/d 5.8±.2 5.75.3 4.81.5 4.8*.5
heg/uCa .7j.08 .7j.08 .95±22" .99.21
FSF .63±.05 .64±.O5 .5l±.U5 .72±.05
Significance of the comparisons hard vs soft water(pC05,"p <
.U1)and before versus after ox load(p<.05, §p<.01).
The PSF was the lowest and the UMp/UCa the highest when SW waT
drunk and oxalate restriction observed.However when osalate load
was given the PSF was highest with the soft water because a grea-
er percentage of oxalate was absorbed(2% versus .5%,p(.05).
CONCLUSION 1/ Even under treatment with HT,calciuria is depen-
dent upon calcium intake. 2/ The therapeutic advantage of using
soft water exists as regards a more optimal tR.g/UCa ratio1but as
regards the PSF linked to oxaluria and calciuria1 it exists only
when oxalate restriction is strictly observed.
.
END—STAGE RENAL FAILURE ASSOCIATED WITH
OCCUPATIONAL EXPOSURE TO ORGANIC SOLVENTS
G.M.Bell, A. Doig, D. Thomson, J.L. Anderton and
J.S. Robson.
Medical Renal Unit and University Department of
Medicine, Royal Infirmary, Edinburgh, U.K.
In this study we have investigated occupational
exposure to organic solvents as a possible factor
in the pathogenesis and progression of
proliferative glomerulonephritis of unknown
aetiology. Solvent exposure was assessed by
interview and questionnaire in 50 patients with
biopsy proven proliferative glomerulonephritis
and 100 matched control subjects without evidence
of renal disease. The interviewer did not know
whether the interviewee was a patient with
glomerulonephritis or a control subject.
Exposure scores, derived from the questionnaires,
were significantly greater in the glomerulo_
nephritis group than in the control group
(p<O.Ol). In the glomerulonephrjtjs group
solvent exposure was heavy in 26 patients, the
main agents being paints, degreasing agents,
fuels and printing reagents, whereas in the
remaining 24 patients exposure was moderate or
low. Although both of these subgroups showed
similar renal functions at te time of biopsy,
follow—up for periods of 89 — 30 and 92 — 32
months respectively revealed the development of
end—stage renal failure in 9 of the patients with
continuing high occupational exposure compared to
none in those with moderate or low exposure
(p<'O.02). These findings suggest that heavy
exposure to organic solvents may be a factor of
importance in the development and progression of
proliferative glomerulonephritjs.
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CREATININE CLEARANCE (Ccr) WITHOUT URINE
P. Beranek, R. Gabriel
St Mary's Hospital, London, England.
Ocr is subject to substantial inaccuracies d
to extra- and intra- laboratory errors. Previously
calculations of Ccr based on serum creatinine, age,
sex and weight have been used in order to reduce
such e±rors (Hull 1981). We have modified the form-
ula to the following:
N x (1k5 - age) - 3 x wt (kg) where N is 75 for mefl
ar creat (pmo11) 70 and 88 for women.
Our calculations were compared with Hull's
formula. Ocr in 165 reliable renal unit patients
(78 males, 87 females; aged 17 to 68; weight range
51 to 85 kg) were:
Ccr i+Ccr i Hull's i our nSD formula formula
1—10
11—30
31-60
61-90
91+
1.71.15
22.s:k.55k2.7 8.9k
7k 79k
119.625.7k
6.52.17
28.1k.80**
k9.k 13.k3*
8o.ii8.27
11k.119.3
k.7:1.9k
2k.4k.60
k2.79.20
72.8 12.70
113.321.90
2k
3k
36
kO
ki
where ***<0 001 **<0 002 •<005 Ccr = ml/min;
1SD; j = mean; n = number of patients.
A regression of results using formula against
Ccr gave a correlation of 0.95; pns (0.298 for
165 degrees of freedom) between calculated and mea-
sured clearance. Restrospective monitoring of Ccr
in patients with and without renal disease has sho'-
wn that isolated major changes in Ccr are not refl-
ected in calculated values and hence may indicate
errors. Calculated values have been compared with
Ccr in several patients with rapidly changing clea-
rance and similar results are obtained. The simpli-
city and accuracy of calculatedvaluem arues for
,ts use as a renlacement for urine ccilection for h
RENAL BIOPSY GUIDED BY ULTRASONOGRAPHY
M.v.Bonsdorff,R.Sipilk,E.Honkanen,
L Hortling, C. Grbnhagen—Riska, L. Laasonen
IV Dept. of Medicine,University Central
Hospital, Helsinki, Finland
Percutaneous needle—biopsy of the kid-
ney was performed using 2—dimensional ul-
trasonic real time guidance. The sector
scanner (Aloka Sect.Scan.SSD 710, 3.0 MHz)
was placed in a sterile polyethene bag and
equipped with a sterile needle holder.Fig.
The puncture pathway was displayed on the
oscilloscope with a dotted line. We used
Travenol Tru Cut biopsy needles.
In 100 consecutive biopsies on 89 pa-
tients (mean age 39 years) adequate tissue
for diagnosis was obtained in 92 cases.
Twenty—two complica-
tions were observed.
Macrohaeniaturia was seen
in 1 patients of whom 2
rcquirod blood transfu—
sions.Perirenal haema—
tomas were ulitrasono—
graphically demonstra-
ted in 18 cases.
A 10—20% fall in haeaa—
tocrit was seen in 11
patients and a fall less
than 10% in 9 patients.
_______
• PRCX3RESSION OF CHRONIC RENPL FAILURE (CRF) IS RE-
.
TARDED WITH MDRE FREY,UE?T CLINICPL FOLtL'J-UPS
J. Bergsträn, A. Alvestrand, H. Bucht, A. Gutierrez
Department of Renal Medicine, Karolinska Institute,
Huddinge University Hospital, Stockholm, Sweden
Numerous, mostly retrospective, studies suggest
that protein restriction may retard progression of
renal failure. In 17 CHF—patients (GFR 12—66 mi/mm)
entering a prospective study (obs.time 224-449 days)
clinical and laboratory check-ups including creati-
nine clearance (Ccr) were made monthly i.e. much
more frequently than during the preceding 2 year pa-
nod (average 4.5 times/year). Care was taken tore—
duce blood pressure to <150/95 and correct fluidba—
lance, acidosis etc. The reciprocals of serum crea—
tinine (pmol/l) and Ccr(flll/min) were plotted against
time (days). The progression, evaluated from the
change in the regression coefficients, was slower
(p<O.O5; see table) after entering the study than
before without any dietary intervention having been
instituted.In sane cases the retardation of progres-
sion was associated with improved blood pressure con
trol and in the whole group diastolic pressure waslcr after entering the study.
Regression coefficients (b—values)
l0 Cr- 10 Ccr
vs time vs time
Before 0.198+0.028° 0.280+0.002 93+2
After 0.098±0.033* 0.170±0.028* 90±1*
Omean±S.E. *p<O.O5 by paired t-test
We conclude that the frequency and presumably the
quality of the clinical check—ups may favourably in-
fluence the progression of RF independently of the
protein intake. This may have important implications
for the design of randomized studies, aimed at
assessing whether protein restriction may retard
progression.
Diastolic blood
pressure, mug
EFFECTS OF TROMBOXANE SYNTHESIS BLOCKING
ON HEPATORENAL SYNDROME
M.Buemi ,F.Squadrito,N.Frisina
Ist.Medicina Interna—Un. di Messina—Italy.
The investigate if tromboxane may be irivol
ved in the pathogenesis of hepatorenal sin
dromeNrinary excretion of PGE2,TBX2,6—che
to—PGFlalfa,renal blood flow and glomeru=
lar filtration rate was measurated in 7
cirrhotics with functional renal failure
before and after treatment with indometha
cm or imidazole—2—hydroxybenzoat,who indu
ced selective inhibition of tromboxane—syn
thesys.Indometacin has reduced all parame
ters investigated by us.Imydazole—2—hydro=
xybenzoat did not modify PGE2 excretion et
reduced TBX2 excretion and it increased
blood renalf low and glomerular filtration
rate.
These results suggest that functional re=
nal failure in cirrhotic may be also a
conseguence of abnormal production of TB).
e conclude that the described radiation
free technique for renal biopsy is safe and
reliable.
ENZYME URINE ACTIVITY IN ACUTE RENAL FAILURE (ARE).
A.M. Castelao, F. BarragAn, 3. Fuentes, F.M. Bau-
cells, 3. Alsina.
(Intr. by X. Sarrias).
Hospital de Bellvitge. Barcelona. Spain.
The study of urinary enzymes has been proposed as
a diagnostic aid in renal diseases, specially in
tubular damage.
We have studied the urinary enzyme excretion in
53 patients with ARE. Thirty five were male and 18
female, aged 58 13 years. The patients mere dis-
tributed in two groups: 34 patients with establi-
shed ARF (EARL) and 19 with pre renal failure (PRF).
Specimen were collected in the first morning urine
from all patients.
The enzymes studied were: alanineaminopeptidase
(AAP), alkaline phosphatase (ALP), gammaglutamyl—
transpherase (GGT), n-acetyl B Dglueuronidase (NAG)
lysozyme (LYS), lactate dehydrogenase (LDH).
NAG Lysozyme
EARL
POE
475 564
205 — 401
0,02 < p <
ikat/mol cr 1156±1733 mg
213—460
0,05 p(. 0,001
/mol cr
U
We have found increased excretion of NAG and LYS
in both groups, being superior in EARL (statistical
comparison beig significant). There sere no signifi
cant differences in the excretion of the remaining
enzymes in both groups.
We think that NAG and I YS are good markers of tu-
bular damage, sequential monitoring being useful as
an Index of tubular function recovery.
TLIXDSE INIOLERANCE IN ACUTE UREMIA (AU).
B.Cianciaruso,L.Saccà,V.TerraCciano,F.MmrcucciO,
G.Orofino,A.Petrone,V.E.Andreucci & J.D.Kopple.
Univ.Naples,Italy & Harbor—UClA ?d Ctr,Los Angeles
CA, USA.
There is disagreenant as to the factors which
cause glucose intolerance in acute uremia. To eva-
luate this question, we investigated hepatic uptake
and release of glucose, as well as other substrates
and eetabolites, and the response to insulin in 8
dogs made AU by bilateral nephrectorri and in 8 dogs
sham-operated controls (c). Catheters were placed in
the portal vein during surgery. 24 hrs later,cathe-
ters were inserted iii the femsral artery and hepa-
tic vein,and the dogs were studied while conscious.
L)ogs first received an infusion of normal saline
for 90 mm arid then,for 90 min,an infusion of insu-
lin (5mU/Kg/min) and sufficient glucose to maintain
mild hyperglycemia. During saline infusion, in both
groups of animals there was significant hepatic re-
lease of glucose arid uptake of alanine and lactate.
During insulin infusion in AU dogs, plana insulin
(jU/ml)rose higher (626±2l4(AU) ,255±40(c) ,p<O.CX)l),
and less glucose (rrg/min) was requested to maintain
the sama level of plasma glucose (170±98(AU),304±95
(c) ,p<0.025) . In AU dogs hepatic glucose production
and hepatic lactate uptake were not suppressed nor-
mally with insulin and glucose infusion.
These data indicate that hepatic glucose netabo-
lism is altered in AU dogs and nay explain the glu-
cose intolerance in acute uremia.
• SITES OF DEFIVE REXUIATIC* OF PIOLACrIN
.
SBRFTION IN CHlIC REL FAILURE (CRF).
B.Cianciaruso,A.Capuano, °M. Iodice,A.Auciello,R. Ian-
dolo,D.Bonanno,F.Marcuccio,V.E.Andreucci.
Div.Nephrology, °Div.Hadocrinology, Univ. of Naples.
Hyperprolactinemia and defective regulation of
PRL secretion have been shown in CRF • Aim of this
study was to evaluate the site of the defective re-
gulation of PRL secretion (soprapituitary,pituita-
ry or both) at different degrees of CRF. We admini-
stered to 20 patients affected by CRF not undergo-
ing dialysis and 15 controls, tso drugs stimulating
PRL secretion: Cisetidine (CIM) acting at soprapi-
tuitary site and TMH acting on pituitary lactotro—
pas. According to the response to the tests (PRL >
l(X)% of baseline) 3 groups of patients were obtai-
ned. Patients of the 1st group (N=9) did not respo
ad to any test and 6/9 had abnormal high basal PRL.
Patients of the 2nd group (N=6) responded only to
TRH. Patients of the 3rd group (N=5) responded to
both tests. All patients in 2nd and 3rd group had
normal levels of basal PPL. GFR was significantly
lower in the 1st vs 2nd group (p<O.CxDl) and in the
2nd vs 3rd group (p<0.oS). A significant positive
correlation was found between GFR and plasma PRL %
change from baseline in all patients with both CIM
and TRH stimulation. The results show that a def e-
ctive regulation of PRL secretion is present even
in patients with normal PRL levels. The dissociati-
on of the response to the two tests indicates that
the hypothalamic disfunction seems to precede the
pituitary defect during progression of CRF.
HANTAVIRUS SERO—EPIDEMIOLOGICAL STUDY IN TEE BEL-
GIAN MILITARY
3. Clement (1), R. François (1), R. Van Hoof (1),
S. van der Groen (2)
(1) Military Hospital Brussels, Belgium
(2) Institute of Tropical Medicine Antwerp, Belgium
Military have been described to
be at risk for the rodent borne Hantavirus disease.
Are Belgian military also at
risk for this disease? An acute case of Hastavirus
disease in a young Belgian soldier a few weeks
after open field manoeuvers in 8. Gertiany was des-
bribed previously. Further evidence was obtained
by a retrospective epideoiological study in an
existing computerized serotheque of the Belgian
Army. On a total of 1335 sera examined so far,
0.9 % give a positive titre ( 1/16) on Hantaan
virus infected Vero E6 cells in the indireci immu—
nofluorescent antibody test. There is a statisti-
cally significant higher prevalence of positive
sera in the so—called Fighting—Forces (10 out of
731 sera or 1.4 %) in cooparison to the Depot and
Logistic. ru teS (2 uuL of 334 Or 3.3 ), which
seems to indicate an increased risk of open air
activities. A prospective study, comparing the
two groups during the next years, is under way.
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MODERATE DIETARY PROTEIN RESTRICTION WITH DIETARY
FIBER SUPPLEMENTATION IN RENAL FAILURE
S.L. Cohen, D.J. Betteridge, W.R. Gjbb, T. Gordon,
J. Harding, N.I. McNeil
University College Hospital, London WC1, England
This study was designed to test the hypothesis
that fiber supplementation combined with mild
dietary protein restriction (O.7g protein/kg/body
wt) might be of benefit in patients with moderate
renal failure (plasma creatinine 250-500/timol/li-
ter).
20 patients with a variety of different renal
diseases entered the study. They kept a dietary
diary for 7 consecutive days each month and were
seen monthly by a dietitian and a physician. After
a 2-month run-in period the diet was started and
after 6 months, fiber in the form of Ispaghula
(Fyhogel) i4g daily was added.
Analysis of plasma creatinine values showed no
improvement during the study; patients' renal
function continued to decline at the same rate as
before the study. Although dietary fiber caused
a fall in blood urea levels, it did not appear to
influence the rate of rise in plasma creatinine in
this group.
It is concluded that a dietary protein intake of
0.7g/kg/day was too high to prevent decline in
renal function in this group of patients with a
variety of different renal diseases. Fiber sup-
plementation reduced blood urea levels but did not
affect the rate of rise of plasma creatinine.
Dietary studies in renal failure should concentrate
on diagnostically homogeneous groups whose rate of
decline before the study is well established.
ERYTHROPOIETIC INHIBITORS IN CHRONIC RENAL FAILURE:
CLINICAL CORELATIONS, IN VITRO SPECIFICITY AND
EFFECTS OF HEMODIALYSTS.
F. D1wich, G.M. Segal, J.W. Eschbach, J.W.
Adamson (Tntr. by B. Scribner).
University of Washington, Seattle, Washington,U.S.A.
Many studies show that sera from patients with
chronic renal failure (CRF) impair in vitro eryth—
ropolesis. Some of them demonstrate a correlation
between the degree of in vitro inhibition and the
severity of in vivo anemia. These observations
support the concept that inhibitors play a role in
the anerniaof CRF. Sinmioukopenia and thrombopenia
are not usually observed, we have examined the
effects of 51 uremic sera on in vitro erythroid
(CFU—E), granulocytic (CFU—GM) and megakaryocytic
(CFU—Meg) colony growth in methylcellulose murine
marrow cells cultures.
As compared to the same concentrations of 8
normal human sera, increasing concentrations of
uremic sera induced a dose—dependent inhibition on
CFU—E, CFU—GM and CFU—Meg growth. The inhibitory
effect on CFU—E growth was significantly greater
(p<U.OL) in patients with serum creatinine con—
centrat:ions7 mg/dl but no correlation was found
between CFU—E inhibition and hematocrit. CFU—GM and
CFU—Meg growth inhibition were not associated with
leukopenia or thrombopenia. Sera from 11 patients
were obtained before and after one hemodialysis
session and were assayed on each progenitor type.
As compared to control colony growth with predialy—
aim sera : CFU—E, CFU—GM and CFU—Meg growth increa-
sed of 108 %, 51 % and 70 % respectively with post—
dialysis sera. These data indicate that uremic sera
contain dialyzable inhibitors which increase with
the severity of renal dysfunction but lack specifi-
city. If erythropoietic inhibitors in CRF are rele-
vant in vivo, there must be unrecognized repgir me-
chanisms for granulopoiesis and thrombopoiesls.
• DIURNAL PATTERN OF SERUM CORTISOL IC,
AND ADRAL C RESERVE IN PATIENTS WITH
NEPEROTIC SYNDROME INS!
S.Czekalski, K.Napierala, W.Wieliczko,
J.Lapie, S,Pynka
Academy of Medicine, Szczecin, Poland
Cortisol serum level was determined
by radioimmunoassay in 16 untreated pa-
tients with nephrotic syndrome without
renal insufficiency. Ten healthy volun-
teers served as controls. Blood samples
were taken at: 8.00 a.m., 2.00 p.m., 4.00
p.m., 0.00 n.m., .OO a.m.
Results /Mean — SD! of serum C /ug/dl/
8.00 2.00 4.00 0,00 8.00
.m. p. p.
NS 16.7 16.3 16.4 13.9 16.9
(n=16/
Contr. 14.8 9.2 71X0 42"'l3.T3L_2L
Stgnifieamtly /p <0.05/ lower in compa-
rison with 8.00 a.m. value.
•Significantly /p<0.05/ lower in compa-
rison with NB group. Functional adrenal
C reserve assessed as serum C increament
1 hour after 0,25 mg of 1—24 ACTH admi-
nistration was impaired in NS /5,8±4.0/
in comparison with controls /17.7±8,1/,
The results revealed the disappearance
of normal diurnal patters of serum C and
an impairment of adrenal reserve In pa-
tients with NB.
TANN HORSFALL GLYCOPROTEIN INHIBITS BACTE-
RIAL ADHERENCE TO HUMAN KIDNEY CELLS
J. Dulawa, K. Jann, M. Rarnbausek, E. Ritz
Dept.Immunol., Freiburg, Dept. Medicine,
Univ. Heidelberg, Germany (FRG)
The effect of Tamm Horsfall protein (THP)
of 18 healthy subjects and 14 diabetics on
adherence of E. coli (06:K 13) 2699 strain
to HUK human kidney cells was studied ; iso-.
lation of THP using repeated precipitation
with 0.58 M NaCl. THP pure by SDS PAGE,
Ouchterlony immunodiffusion and isoelectrici
focussing. Adhesion of bacteria (without
additions: 100 bacteria per cell) was re-
duced dose-dependently ty THP, half maximal
inhibition occuring with 250 pg THP/ml.
Maximal inhibition (—84% at 1000 pg/nl) ex-
ceeded inhibition by alpha-methyl-mannosi—
de (—36% at 50 mmol) was specific (not re-
produced by other glycoproteins, e.g. oval—
•bumin, mucin or thyroglobulin) and rever-
sible (abolished by washing THP off HUK
cells). Antiadherence property of THP was
not abolished by neuraminidase treatment.
No significant difference of antiadherence
activity of THP was found between controls
and diabetics despite altered carbohydrate
composition of THP in diabetes (Glucose
content diabetes 2.28÷0.55 g/100 g THP,con-
trol 1.25+0.35; pL0.01; N-acetyl-neuraminic
,acid 3.62÷0.25 vs. 4.96+0.15; p0.0l).
THE INFLUENCE OF FOLIC ACID ON THE ERY-
THROCYTE VOLUME IN CHILDREN WITH CHRO-
NIC RENAL INSUFFICIENCY (CR1)
W.Eggert, R.Bleiber, S.Wolf, K.Zoellner
Children's Hospital, Berlin, GDR
In view of the incidence of hyper—
chromic anemia in CR1 (Helbig 197?) we
studied MCV and the volume distribution
curves (VDC) in children with CR1
(group i: conservative treatment, n
13; group 2: chronic hemodialysis, n =
28; control group, n = 13).
flesults: i'ICV — control group: 83,0
3,6 Cl; group 1: 85,3 + 3,9 Cl; group
2: 89 4 5,9 11 (p 0,01 to control
groups. In 5 pat, of group 2 the Mdv
amounted to 93 — 106 Cl, VDC — There
were no significant differences among
group 1, 2 and control group.e administered Colic acid to 5 pat.
(group 2) with increased MCV and we
could observe a normalisation of NCV.
In 3 of these pat, the VUC also reached
normal, positions. Conclusions: o
suggest to check up MCV and VDU in all
childret4in a chronic hemodialysis pro-gram. In case of macrocytosis a treat-
ment d iii Colic acid is recomniendable
even ihough the serum Colic acid le-
vels are normal.
VIBRATION 2U3CRY TH1L3HOLD (vsT) A3 A LONITCR OF
URAdMIC TOXICITY.
T. G. Feest, V. Trounson
Boyal Devon and Exeter Hospital, Exeter, UK.
Loss of vibration sensitivity is an early sign
of uraemic neuropathy. VST may be reproducibly,
non—invasively measured with a hiothesiometer, and
is abnormal in uraemia. We performed sequential
studies of YST over 3 years in 43 patients with
chronic renal failure (CRF) and 75 on dialysis.
We then compared hasmodialysis (HD) with peritoneal
dialysis (o), and compared different dialyser
membranes. Results were corrected for age and
compared with age, sex and drug catchod cntrois.
VUT deteriorated more frequently and severely
in older natients. In CN.P there is little change
until serum creatinine rises above O umol/l.
VST improves in the first 3 months of dialysis,
related to individual changes in serum creatinine.
Thereafter YST is unrelated to serum creatinine
and is stable unless there are changes in residual
renal function, which was shown to be the most
important determinant factor of VSP in dialysis
patients. k'ollowing transplantation YST returns
to normal within weeks. In sequential cross—over
studies, PD seemed to maintain a better VST than
HD. In CAPD patients, increasing bag exchangesfrom 4 x 2 litres to 5 x 2 litres daily had no
effect. Changing RD patients from cuprophan to
polyacronitrile membranes, which clear more middle
molecules, had no effect if dialysis was adjusted
to keep serum creatinine constant.
Sequential studies of VST in individuals can
help determine the point at which dialysis is
needed, may indicate inadequate dialysis, and can
be used to compare the effectiveness of different
dialysis regimes.
ASSOCIATION BETWEEN PROTEINURIA LEVELS AND
HISTOLOGIC TYPE IN PRIMARY GLOMERULONEPH-
RITIS WITH CLINICAL NEPffiOTIC SYNDROMEE .Erek, K.èteHgçti
Cerrahpaa Fac.of Med., Istanbul, Turkey.In 62 patients with primary glosierulo—
nephritis, clinical expression of the dis-
ease was assessed in it relation to under-
lying histology. Kidney biopsies revealed
a mesangiocapillary glotnerulonephritis (MC
ON) in 31 (50 %), a proliferative type of
glotnerulonephritis (PON) in 18 (29 %) and
finally a menibranous glornerulopathy (MG)
in 13 (21%) of these patients respectively
Clinically 29 cases (47 %) displayed a
nephritic syndrome and 33 (53 %) a nephro-
tic syndrome. Of the 29 cases with nephri-
tic syndrome, 15 (52 %) had MCcN, 11 (38 %)
PON and only 3 (10 %) MG with no signifi-
cant difference between the histological
groups as regards to proteinuria1 glorneru-lar filtration rate, serum albucnln, lipid
and cholesterol levels. Of the remaining
33 cases with clinical nephrotic syndrome
16 (49 %) had MCON, 10 (30 %) MG and 7 (21
%) PGN• There again, no significant differ-
ence was revealed between histologicalgroups as regards tO the above cited par-
ametres with the exception of proteinuria
that was found to be significantly lowerin the PGN group (48.il.8g/day) than in
both the MCGN (83.6g/day) (p<O0l) and the
MG (8.81,8g/day) (p.0.05) groups respec-
tively. It WRS concluded that in patients
with glornerulonephritis presenting with
nephrotic syndrome the level of proteinuria
could be a pointer to underlying histology
s,,rlitively moderate proteinuria (4.8.l.8gday) being especially suggestive of PGN.
A YEAR'S EXPERIENCE WITH A COMPUTER PROGRAM TO SUP--
PLY DIETARY MENUS IN CHILDREN RENAL FAILURE.
N. Fischbach, N. Chrtien, M.C. Burger, M.E. Ritter
A.M. Dartois, 3. Geisert.
Ndphrologie et Dialyse pour enfants.
The purpose of setting up dietary menus for
children with kidney failure is to quantitatively
and qualitatively meet the needs for growth whild
taking into account the state of the kidneys. The
computer program designed for this works from a da-
ta base that contains the qualitative composents of
food (Na, K, Ca, proteins, glucids, lipids, calori-
es. .)which arm listed either in ponderal unitsam
or in units commonly supplied commercially (exp
a single yoghurt portion). The first step in the
procedure is the etablishment of the eating habits
of the child from a discussion with him and his pa-
rents. The computers calculates his quantitative
and qualitative intake and sums it up in units per
weight or surface ares. The computers allows the
access to many parameters including the amount
of oligo elements and vitamins which normally invo-
lve tiresome calculations. The second use of the
data base is the etablishment of a typical menu ac-
cording to a dietetic prescription that is adapted
to the needs and the evolutions of the kidneys. The
speed of this calculation from the data base al-
lows one to make up a variety of different menus
for a single patient. The simplicity with which
such a computer program can be consulted even ena-
bles older children to ask the computer about the
quality of the meal they have taken or about to
take. Thus adolescents who are suffering from seve-
re kidney failure can learn dietetics themselves by
making up their own menus from prescriptions no
longer entirely mandatory. The program of a flsppy
disk can be used on a small capacity personal com-
puter such as Apple II. It is easy to operate even
by children.
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PROTEINURIA IN PATIENTS WITH CANCER: PROGNOSTIC
SIGNIFICANCE.
R. Gabriel, M. Wijnen
St Mary's Hospital, London, England.
Single random samples of urine were collected
from 282 patients with extra—renal malignancies
over a two year period beginning July 1981. Urine
was not collected from patients with renal tract
diseases, systemic disease or malignancies involv-
ing kidneys or those receiving potentially nephro-
toxic drugs. Catheter or ileostomy specimens were
excluded. The age range was 20 to 80 years; mean
57.2 22.7. Urines were assayed for total proin
concentration.
Proteinuria, mean 0.32 gIl, range 0.03 — 9.1
t 0.5k was found in 169. The coefficient of vari-
ation of this assay was 16.9%.
At follow up of 1 to 3 years 10k (61.5%) of
the 169 patients had died of cancer and 50 (kk.2%)
of the 113 without proteinura had died. The
difference is significant; X = 7.1; p < 0.01.
Proteinuria is thus common in patients with
cancer and it appears to affect the prognosis
adversely.
NEUROPEPTIDES AND PEPTIDE HORMONES AS POS-
SIBLE HUMORAL 1VDIATORS OF ENDOGENOUS IN-.
TOXICATION IN CANCER.
G.V.Glirisky,A.B.Ivanova, L.P.Osadchaya,V.BVinnitsky
R.E.Kavetsky Institute for Oncology Prob—lems Acad.Sci.Ukr.SSR. ,Klev,USSR.
The presence of 22 neuropeptides and
hormones in the middle molecular substan-
ces(MMS)fraction of blood plaxna was stu-
died by the RIA and/or the I' — labeled
standards involving methods.All the subs-
tances under investigation were found in
the MLiS which were isolated by the ultra-filtration.The quantitative differences in
the components observed in norm and in ex-
perimental tumours are similar to the in
vitro pol'nmine—induced shifts:the somato—
statin level was decreased by 8.6%,that of
I..
—MSH—by 20.7%; the content of . —endorphin
was increased by 48.4% met—and leu—enke—
phalins — by 21.8 and 12.54, cortisol— by
36.6%,substance P—by 136%, vasopressin—by
87.3%, NP—by 5O..Since the quatity of
bioregulator in MIvL5 reflects its free form
level in plasnia,the above mentioned shifts
will lead to the activation of opioid pep—
tides and vasopressin.The antidiuretic ef-
fect(through the changes of hematocrit)and
the alterations in blood cells acceptor
characteristics cause the chronic increa-
se of the free form level of 11 out of 13
neuropeptides and hormones investigated in
blood of tumour hosts.The multivalent hy.-
perhormonaemia leads to systemic distur-
bances of hormone—receptor interrelations
by the down regulation mechanism.Hemocar—
boperfusion may be selective in the cor-
rection of these disturbances.
LEFT VENTPICtJLP.R FUNCTION BEFORE AND AFTER PI?.SMA-
PBERESIS EVALUATED BY EXH0CPRDIOGBAPHY.
C. Gisinger, C. Punzengruber, K. SiTherbaimr,
P. Preis, C.C. Zielinski
2nd Dept. of mt. td., Univ. Vienna, Austria.Since plasrnapheresis (PP) leads to several nmta—
tolic changes and influences the xnpDsition of
plasma electrolytes and hornones which in turn may
influence cardiac contractility we have investiged
left ventricular pump function as assessed by time
notion echocardiography before and after PP. Conti-
nuous PP was carried out on an IBM 2997 blcod cell
separator. 5% human alburen served as plasma sub—
stituent and ACD-B as anticoagulant. Theatxrent con-
ditions were chosen to prevent any change in pre—
load. 6 pta (with systemic lupus erythematosus,
progressive glomerulonephritis and Grave's disease)
underwent this procedure twice. None of the patient
had any manifest cardiac failure. +
Feslts: No change in mean blod pressue (98-6 vs.101—5 nnnHg) and heart rate (91—4 vs. 93—4 min1)
were found. Left ventricular dmensions wee conpa-
ruble befoe and after÷PP (4,9-0,1 vs. 5.0-0,1 cm
LVEDD; 3.3-0,2 vs. 3.1-0.1 an LVESD). However, a
slight but significant increase of LVEDD has been
calculated using the paired student-t-test. Also
the shortening fraction showe a significant in-
crease from 0.33±0.02 to 0. 37-0.01 while the mean
velocity of circumferential fiber shortening remai
ned unchanged (1 .3±0.1 vs. 1.3±0. 1).Our date indicate that no deterioration of cardiac
systolic function occurrs after PP despite a sini—
ficant reduction of ionized serum calcium (4.51-
0.14 vs. 3.96±0.07 mg/dl). This contrasts to recent
findings obtained in patients on hemoialysis. The
slight increase of shortening fraction observed in
our study might be due to discrete alteration
of loading conditions.
HUMAN CYTOMEGALOVIRUS (HCMV) IN THE URINE
OF PATIENTS WITH CHRONIC RENAL FAILURE
Gmelin, K., Theilmann, L., Wiedenmann, B.,
Klooker, P., Rambausek, M., Dreikorn, K.,
Bommer, J. , Renz, M. , Braun, R., Kommerell
B., Ritz, E., Univ. Heidelberg, FRG
As the diagnosis of MCMV infection can-
not be performed rapidly by tissue cultu-
ring, we established a new method to detect
MCMV using molecular DNA/DNA hybridization.
The J-region insert of a cloned plasmid
pCM 5018 was isolated and labeled to a spe-
cific activity of 1.2x1O9 cpm/itg DNA by
nick-translation. The DNA of the urine was
put onto a nitrocellulose membrane and
subsequently hybridized with the radioac-
tively labeled probe. The autoradiographic
signals of the specimens were evaluated by
comparison with standard samples of cloned
DNA (10 pg-O.1 pg/spot). The sensitivity
as 1 pg cloned DNA/spot. Positive controla
consisted of urine samples positive in cell
culture. 23 of SO urine samples of hemodia—
lysed patients reacted positive in molecu-
lar hybridization. In addition, 10 of 55
pat. after kidney transplantation had posi-
tive urine samples. In transplanted pat.,
high levels of CMV DNA in the urine ( 60 pg
/spot) correlated with elevation of serum
transaminases.
Conclusion: Molecular hybridization for de-
tectiO of CMV DNA enables rapid and
quantitative detection of HCMV infection
in risk groups. Such rapid information is
of great value in transplanted patients
where immunosuppressive therapy has to be
changed in ongoing CMV infection.
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. LIPID ABNORMALITIES IN INCIPIENT RENAL
FAILURE (Rfl
Gnasso, A., Haberbosch, W., Augustin, J.,
Ritz, E., Herzinfarktinst. and Dept.Int.
Med., University of Heidelberg, Germany (Fld
In endstage RF hyperlipemia is common,i.
e. increased serum triglycerides (TG), par-
ticularly VLDL-TG, and decreased posthepa—
rim lipoprotein lipase (LP) and hepatic
triglyceride lipase (HTGL). It has not bea'i,
clearly established at which point in the
course of RF such lipid abnormalities su-
pervene. To further investigate this prob-
lem, patients at various levels of S—crea
(1.5-8.0 ng/dl) who were not on medication
causing lipid abnormalities (betablockers,
diuretics) were studied (fasting, outpa-
tients). Nephr.syndr. diabetes/prediabetes,
elevated TSH, liver disease or body weight
excess/changes were excluded. In fasting
and postheparin (15 mm. post 100 U hepa-
rin/kg bolus) plasma: TG, CHOL, apolipoprot
(imnunediffusion/TEF), ultracentrifugation
(UZ), LPL and HTGL. Controls: 150 healthy
probands of comparable age. At S—creaC3mgt
dl, TG, VLDL-TG (73.2+20.5), HDL—CHOL (48.3
LPL and HTGL ('4.1-'-7.64) were norma],.
In contrast, at S—crea 3—5 mg/dl, while
plasma TG was still normal (VLDL TG 67.4÷
61, HDL CHOL 56.7÷14.2), HTGL was low nor-
mal and significantly reduced compared witl
controls (15.7÷0.16 U; LPL 6.59÷3.37U). On-
ly in pat. with higher S-Crea were TO and
VLDL-TG increased. The earliest lipid ab-
normality in RF is decreased HTGL at GFR
'-'--30%. Total TO and VLDL-TG do not increase
until preterminal renal failure is reached.
URINARY STONES IN CHILDHOOD: ETIOLOCIC AND
CLINICAL ASPECTS.
C Grechi, M.Amato, G F Vichi, D.Villmri
Dept of Urology, Florence, Italy
In Europe, among hoapitalised patients the
occurrence of urolithiasis in childhood is reported
to be between 1/3000 and 1/67D0. All types of
calculi observed in adults also occurred io child-
ren but the distribution is ofter different. Tn the
Urology department of the University of Florence
from 1968 to 1983, 101 patients affected from
urolithiasis have been examined and differentiated
according to the etiopathogenesis of the disease.
On a formal level, pre renal, renal and post renal
causative factors or cofactors are to be discerned
in childhood. However from the clinical point of
view, a different classification is adopted. A
first group of patients suffering from the endemic
urolithiasis can be distinguished (mainly bladder
calculi). In this case a nutritive defect of
unknown origin plays a role in the psthogenesis of
lithissis. A second group included urolithiasis
associated to urinary trsct obstruction. The
third group includes urinary stones caused by
metabolic factors or cofsctors and the so—called
idiopathic calculosis. The role of urinary tract
infection as a cause or a result of urinary
stones is discussed.
. cARDT0vA5cULAR c0MpLTcATT0NS TN ADULT POLYCY5TIC
KTONEY DISEASE
S. Gdtz, K. Schafferhans, R.M. Schaefer, H. Reid—
bredsr, M. Teschner, A. Heidland
Dept. of Nephrology, University of Wurzburg, FRC.
Signs of a multi—organ—disease are frequently
found in adult polycystic kidney disease (APKD):
cystic degeneration of liver, psncrees, spleen,
thyroidea; aneurysmata may occur in cerebral and
visceral vessels and diverticolosis of the colon
are common findings.
In our study 26 patients (pta) with APKD (18 mele,
S female, age 52,9÷ 7,2 ye) underwent non-invasive
examinations (5cc, chest-X-ray, echocardiogrmphy,
abdominal sonogrsphy) and optional invasive investi-
gations (coronarangiogrmphy, atrio— and ventriculo—
graphy).
3 pts displayed cardiomyopathy; - 11 pta had left
ventricular - and septumhyportrophy (4 of them with
normal blood pressure); — 4 pts showed etrial dila-
tation. 1 pt had an atrial-septum-defect and 1 pt s
ventricular—septum—defect. 1 pt demonstrated multip-
le aneurysmata of the coronary arteries, — 1 pt an
aneurysms of the aorta. Stenosis cf thn a. carotis
was found in 1 pt. 2 pts required pacemaker therapy.
These data demonstrate, that APHID is frequently re-
lated with cardiovascular abnormalities. Therefore,
pts with APHID are more prone to cardiovascular com-
plications compared to other hemodialysis pts. Thus,
2 pta died of congestive heart failure, — 2 pta un-
derwent cardiosurgery for valve—replacement, — 2
pts had to be treated with a cardiac pacemaker.
We would like to suggest, that the high rate of car-
diovascular complications in APHID is due to an in-
born error of the collagen metabolism. As a clinical
consequence, pta with APHID should undergo an inten-
sive cardiovascular examination.
.
CORRELATION BETWEEN SERUM PHOSPHATE
CONCENTRATION AND RATE OF PROGRESSION OF CHRONIC
RENAL FAILURE?
N. Gretz, E. Neisinger, N. Strauch,
Clinic of Nephrology, Klinikum Hannheim,
University of Heidelberg, 68 Mannheim, FRO.
In patients with chronic renal failure (CM')
phosphate intake is thought to be a major factor
in the progression of the renal disease. As
serum phosphate concentration (SF04) reflects
the phosphate intake in uraemic patients, we ana-
lysed the correlation betweem SF04 and the rate
of progression of CRF in 133 patients. As indica-
tor for the progression rate we used the slope
of a regression line computed for reciprocal
serum creatinine concepgtiona (SCR)..The.xex
gression lines were based on all 5CR values
(m—167-2) of the patiemts between 6 and 10 mj/l.
The slopes were pd.otted against tbefrcorrespbud—
img median SF04 calculated for the respecti
5CR ramge. A correlation betwem SF04 and slope
was not found: rO.QtQ p—0.7917. ujtetgatify'—
the data according to the mode of diet:
'free diet' and low protein diet (30g) supple-
mented with keto acids, no correlation between
SF04 and slope could be detected('free diet': r=
0.114, p=O.2907; low protein diet: rao.110, pa
0.4950). A difference in slope, but not in SF04,
could be found after further subdividing the two
groups according to the underlying renal
disease. A correlation between SF04 and slope,
however, could not be revealed in the respective
subgroups. In summary: no correlation exists
between SF04 (range: 0.5 to 3.Ommol/l) and the
rate of deterioration of renal function,
irrespective of protein/phosphate intake and
underlying renal disease.
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CHANGES OF PLASMA LIPIDS DURING PROGRESSION OF
CHRONIC RENAL FAILURE (CRF).
P.GrUtzmacher, W.Fassbinder, E.Schifferdecker*,
B.Peschke, J.Riepenhausen, and W. Schoeppe
Depts. Nephrol., and Endokrinol.*, University
Hospital Frankfurt/ti., FRG
Patients with CRF show frequently signs of athe-
rosclerotic diseases when entering maintenance hemo-
dialysis therapy. To elucidate the potential invol-
vement of disturbances of 1 ipid metabol ism, serum
levels of total cholesterol (CHOD—PAP), triglyceri-
des (enzymat.) and their proportions in HDL, LDL
and VLDL (ultracentrifugation) were studied in sta-
ble ambulatory patients with CRF of different crea-
tinine clearances (Ccr). Patients with nephrotic
syndrome, diabetes cell itus, liver disease were ex-
cluded. With progression of renal failure a signifi-
cant increase in total triglycerides was observed
(n=251, p<O.Ol, loglin.correlation analysis) mainly
due to an elevated VLDL—triglyceride fraction. HDL-
and LDL-triglycerides showed only a slight increa-
sing tendency (NS). Total cholesterol concentration.
also increased significantly during CRF (p<O.O1),
due to an 901 increase of cholesterol in the VLDL
fraction (p<O.Ol), whereas the LDL-cholesterol re-
mained constant. HDL-cholesterol decreased during
CRF (p<O.O5). These changes became apparent already
at Ccr between 30-60 ml/min and could be observed
in normotensive as well as in hypertensive patients
We conclude that already in early stages of CFR
basic changes of plasma lipids can be observed.
these lipid alterations may contribute to premature
atherosclerosis observed in patients with CRF. Li-
pid changes should be considered particularly in
individual patients, before a protein—restricted
diet, necessarily rich in carbohydrates and fat,
is advised.
COMPARATIVE TREATMENT OF ACUTE RENAL FAILURE (ARE)
BY HAEMODIALYSIS (HD) VERSUS CONTINUOUS PERITONEAL
DIALYSIS (CPD) IN A NON RANDOMIZED BUT PROSPECTIVE
STUDY.
C. Guérin, R. Gonthier, 0. (lenIn, .1. Toulon,
C. Leroy, J.C. Sehatier, F.C. Berthoux.
Service de Néphroloqie, Avenue A. Raimond, Hopital
Nerd, Li2277 St Priest en .Jarez, France.
During the last three years, me have prospective].'
treated ARt either by HO (16 patients) or by CPU
(23 patients). In the last group, me treated
preferentially patients aged over 70 years (8 vs 1),
patients suspected of gastrointestinal bleeding
(blood hemocjlnbin<7 g/100 ml) (15 vs 2), patients
with septicemia or septic shock (3 vs 1), or/and
patients under immunosuppressive treatment (8 vs 3).
Nevertheless, the two qroups mere not different by
mean ace (55 + 15 y in MD vs 59 ÷ 17 y in CPD), by
sex (11/16 maTes vs 10/23), by post—operative ARE
origin (4/16 vs 6/23), by mechanical ventilation
(2/16 vs 2/23) or/and by overhydrat ion (4/16 vs 5/23)
The initial simplified gravity index is 13.3 ÷ 5.3 (
in the HO group vs 11.2 + 3.3 (SD) n the CPD group
(NS). The overall results are the following
— mortality is 18 5 (3/16) in the HO group vs 17 %
(4/23) in the CPD group (P NS) ; — the mean ARE
duration sos 6 d. on HO vs 14 d. on CPU ; — 3 months
after onset, the mean serum creatinine was 149 jmol/l
on ID vs 191 pmol/l on CPD (P r 0.04) — the
morbidity of the technique was 2 CI bleeding
(2 deaths) on FlU vs 2 peritoneal leakage, 2 cathetei
displacement and 2 episodes of peritonitis (I death)
on CPD.
In conclusion, CPU is an efficient alternative
to ARE treatment by HD in elderly patients with
high—risk factors.
DOES EXIST HYPERENDORPHINISM IN PATIENTS
WITH ACUTE /.ARF/ AND CHRONIC /CRF/ RENAL
FAILURE?
W. Grzeszezak, F. ICokot, J. Dukawa
Department of Nephrology, Silesian School
of Medicine, Katowice, Poland
The present paper aimed to elucidate the
role of endogenous opiates in the patho—
genesis of uremia induced dysfunction of
the adenohypophysis.
Material and methods: 30 patients with
.ARF, 30 patients with CRF and 30 normals
were examined. All examined subjects were
males. ACTH and somatotropin /HGH/ secre-
tion were triggered by insulin induced hy
poglycemia, lutropin ILl!! and follitropin
/FSH/ — by luliberin /Lll—RH/, while prolaa
tin — by chiorpromazine. All stimulatory
tests were performed twice e.g. in naloxo-'
ne untreated and treated subjects.
In patients with ARF blockade of opiate
receptors was followed by an increased re—
sponsivenes,s of ACTH, FSH and LU and sup-
pression of HGII and prolactin secretion.
Endocrine reaction patterns found in pa-
tients with CRF differed only quantitati-
vely from those in ARF.
Conclusion: 1/ A state of hyperendorphi—
nism in patients with acute and chronic
renal failure is very likely. 2/ lts im-
portance in the pathogenesis of endocrine
abnormalities of the adenohypophysis in
acute and chronic renal failure seems to
be dependent upon the etiology and dura-
tion of uremia.
INFLUENCE OF MEAT-FREE DIET ON TUE URINARY EXCRETION
.
OF 3-METHYL HISTIDINE (3MH) AND CRETtTININE (Cr) IN
CHRONIC RENAL FAILURE (CRF)
A. Gutierrez, A. Qureshi, J. Bergsträn
Dept of Renal Medicine, Karolinska Institute,
Huddinge University Hospital, Stockholm, Sweden
3MM, a constituent of actin and myosine in muscle,
is formed by methylation of histidine after its in—
corparation in protein. When muscle protein is de-
graded 3MM is not reutilized for protein synthesis
but excreted unchanged in the urine. In subjects
with normal renal function the excretion of 3MH may
be used for assessing muscle protein breakdown if no
exogenous 3MM (meat protein) is given for 2 days
before the determination. Since 3MM excretion is de-
pendent on renal function CRF patients may require
a longer equilibrium period on meat—free diet before
3MM excretion stabilizes. We have studied the plasma
concentration and urinary excretion of 3141-I and Cr in
10 CRF patients with GFR <10 rnl/min on constant
protein intake (40 g/d) before and after withdrawal
of all meat from the diet. Plasma concentration and
urinary excretion of 3MM decreased continuously on
meat—free diet during 8 days without reaching apla-
teau; only in4patients followed for 16 days was the
3MM excretion stable after day 10-li on meat free
diet. Plasma concentration and urinary excretion of
Cr decreased continuously over the whole period of
observation.
Conclusions 1) A prolonged period (>10 days) onmeat
—free diet must be applied in CRF pat. beforemuscle
protein catabolism can be evaluated from endogenous
3MM production 2) Reduction in intake of meat (exo-
genous creatine) reduces plasma Cr to the extent
that it becomes misleading for evaluation of chang-
es in renal function. This has to be considered
when comparing patients before and after protein
(meat) restriction.
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PHASE—CONTRAST MICROSCOPY IN EVALUATION OF
GLOMERULAR AND NONGIOMERULAR NEMATURIA
Dr. F. NASANOLII, Dr .B .11 ANUEMtR, Dr . A.NASANOILU, Ur. H. UUSUNSEL
ERCtVES UNIVERSITY—MEDtCAL SCHOOL KAYSERI/TURKEV
It has bees postulated Us the litsratsre that the
source of red blood cells is the srine could be detected by
Phase—Cestrast Micrsscupy(PCM) tahisg the shape asd size of
the eucrected red blued cells Lsts consideration.
Is this prelisisary study we esamised 45 urine samples
sbtaised from unselected hemsturic patients by PCM. lhe
examiner was usaware sf clinical diagnosis. The results of
PCM was found identical with the clinical diagnasin in 27
uf 30 samples (% 90) nf glueerular diseases and in 13 of 15
(% fh7) 0C non1lnmpriilnr disnnces,Cnsts in diffxrxst nature
were feusd is % 74 of gisnerelar diseases.
Under the light of this preliminary study we can say
that P01 technique could help clinician during the initial
eoaluatinn of patients with henaturia.
HEPATITIS B VACCINE IN NON DIALYZED UREMIC PATIENTSs
PRELIMINARY RESULTS.
P. Jungers, P. Chauveau, AM Couroucd,B.Mattlinger.
Department of Nephrology, Necker Hospital and
CNTS, Paris, France.
Patients (pts) receiving hepatitis B vaccine
when already on chronic hemodialysis develop a poor
immune response. Thus, we started a prospective
trial in uremic pta not yet dialyzed, using 3 in-
jections of HEVAC B vaccine (Spg/dose) at monthly
interval with a 4th injection 2 months later.
From October 1982 to December 1984,111 pta(6lmale1
SO female) entered the trial. Their mean (+ 2 SEM)
age was 46.5 2.8 years and plasma creatinine (Pcr)
590 + 32pmol/L. Following the 3rd injection. 66
(60 F) had an anti—HBs titere 10 mIU/ml and were
defined as responders (R). Their mean anti—lIEs level
was 219 + 86 mIU/ml (131 + 54 mIU/ml in the whole
population).
Proportion of K was significantly higher in pts
aged<40 years (34/40, 85 F) than in older pta (32/
7!, 45 F, pcO.00I), hut mean anti—liEs titer in R
did not significantly differ with age (209 + 93 vs
230 ÷ 147 mID/mI, respectively). Proportion of R
was higher in pts whose Pcr wasC400pnol/L when
starting vaccination (9/13, 69 F vs 57/98, 58 %,NS)
Mowever, mean antiUBs titer im R was significantly
higher in the former than in the latter (431 + 256
vs 186 + 88 mID/el, pCO.O2), with geometric mean
titers of 277 vs 72 mIU/ml, respectively.
Theme preliminary results suggest that hepatitis
B vaccination in uremic patients should be started
early, before plasma creatinine is in excess of
400 pmol/L, or creatinine clearance below 25 el/mn,
in order to improve immune response.
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CATHETER DRAINAGE OF UREMIC PERICARDIAL EFFUSION
WITH TAMPONADE
H. '.Jungbluth, G. Keusch, 0. Porr, P.C. Baumann,
E. Russi, U. Binswanger
Department of Internal Medicine,
University Hospital of Zurich, Switzerland
Pericarditis with tamponade is known to occur in
patients with chronic renal failure. Of 6 patients
reported here 2 were undergoing hemodialysis and 4
had not yet been dialyzed. The diagnosis of pen-
cardial tamponade was made by echocardiography in
the presence of jugular vein distension and pulsus
paradoxus. Drainage by a percutaneously placed
catheter was performed. Findinbefore and after
an initial drainage of 707 (200-1660) ml fluid were
as follows (M (range));
Catheters were left in place for an average of 61
(23—90) hours until effusions arrested.As suppor-
tive measures non—absorbable steroids were instilled
via the pericardial catheters and dialysis treat-
ment was intensified. No complications were ob-
served and no recurrence of effusion or development
of constriction was noted during 9—35 months after
drainage. Conclusion: Subxiphoidal pericardiostomy
with prolonged drainage and steroid instillation
has been found to be an effective and safe method
which provides imediate and lasting relief.
ABSENCE OF CARDIAC DYSRHYTHMIAS TN CHIL-
DREN ON REGULAR HAEMODIALYSIS (aD).
H.Keller,A.Bosch,K.Bonzel,H.Dlmer,K.Schhrer
University Children's Hospital Heidelberg,
FRG.
Increased frequency of cardiac dysrhyth—
mias has been reported in adult pts on HO
followed by longterm(Holter) monitoring of
ECG. We have adapted this method to urenic
children. We investigated 26 pts aged 1-19
yrs at various stages of chronic renal fai-
lure (CRF). 12 of these were treated by HD
3 times per week for 5 hrs using a dialysa—
te with 2.0 mmol K. Holter.monitoring was
performed twice in each child, once on the
day of HO and once in the interdialytic pe-
riod while pts were fully active in a holi-
day camp. A standardized exercise test was
done during each period. 8 pts were trea-
ted by antihypertensive drugs but none re-
ceived digitalis. Tape analysis under con-
tinuous operator control showed no signif I—
cant dysrhythmias in any pt when compared
to healthy children or pts in the pretermi-
nal stage of CRF or after grafting. Altera-
tions in sinuatrial or atrioventricular
conduction were absent. The incidence of
atrial and ventricular premature beats was
similar in all groups (c100/24h) although
heart rate considerably increased and chan-
ges in P configuration and depression of
ST and T occured during HO. P wave pattern
indicated atrial volume load during HO. The
absence of dysrhythmias is remarkable in
view of the still high proportion of deaths
due to cardiac arrest reported in pediatric
pta (Proc.EDTA 20:79,1983). This finding
may alter the policy of restraining chil-
dren treated by HO.
before after
8P systol. 120 (105-150) 157 (135—180)
(mm Hg) diastol. 74 ( 45—80 ) 79 ( 55—110)
central venous
pressure (cmu2o) 21 ( 14—29 14 ( 8-16
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GLICOPROTEIDS CONTENT OF PLATELETS /GCP/
IN URAEtIIC PATIENTS /UP/,
tl.Komernicki. IPietrzak. K.Bczyk.
M.Zozuliñska
Departments of Hematology and Nephrology.
Academy of Medicine. Pozna?i. Poland.
Decreased GCP were found in Bernard —
Soulier syndrom and in Glanzmann's throm—
basthenia showing disorders in platelets
/PL/ adhesion /AQ/ and aggregation /AG!.
It seems to us interesting whether uraemic
thrombopathy is also connected with this
abnormality.
we studied the GCP in 15 UP treated
conservatively /TC—5 pts/. by chronic
hemodialysis /H0—5 pts/ or intermittent
peritoneal dialysis /IPO—5 pts/. Nine he-
althy persons served as controls. GCP
/Ib,IIb.IIIa/ of peripheral venous blood
were determined accordingqto the method
of Laemmeli and all /,ug/109 of PL/.
The results obtained, showed no chan-
ges in GCP of uP as compared with normals
whereas the PL AD and AG in patients were
found to be evidently deteriorated. The
corresponding mean values for UP were 4,97
—541/lb! 5.69—597/IIb/. 5,9O—6.36/IIIq
Controls—5.14/Ib/. 6,82/IIb/. 6,90/lila!.
This discrepancy can be ascribed to
the determining procedure enabling the
electrophoretic separation and quantita-
tive estimation of gl.icoproteids. This
does not exclude the hampering action of
uraemic toxins upon glicoprotsids as the
receptors for inductors of P1. AD and AG
process.
LOWERED TISSUE—FLUID ONCOTIC PRESSURE PROTECTS
BLOOD VOLUME IN THE NEPHROTIC SYNDROME (NS)
H.A. Koomans, A.B. Geers, [.3. Dorhout Mees
Dept. of Nephrology & Hypertension, University
Hospital, Utrecht, The Netherlands.
We have studied the role of adjustments of
tissue—fluid (wick—method) colloid osmotic
pressure (COP) in the maintenance of the blood
volume (Bid) in 10 (recumbant) patients with the
N5, before and after diuretic treatment until dry
weight. A mean weight reduction of 13.5 ÷ 6.4 kg
was attended by a fall in Bid in 3, and no changes
in 6, but the final Bid was normal: 85.3 ÷ 3.7
mi/kg (normal value 87.6 + 8.8 mI/kg, nz88).
Overhydrated Dry
Plasma AIb (g/l) 10.7±3.4 14.7+5.5
Plasma COP (mmHg) 8.6÷1.6 11.7±3.7
Tissue—fluid AIb 3.4÷4.5 8.9±4.4
Tissue—fluid COP 2.2÷2.0 5.0+2.7
u—COP 6.5-i-l.5 6.2÷1.7
The edema removal brought significant increases
in plasma albumin (Aib) and COP, and parallel
changes in tissue—fluid Aib and CUP. Yet, even in
the dry state Plasma Aib and COP were very low,
but tissue—fluid AIb and COP were also very low.
Thus the transcapillary difference in COP (—
COP), which had not changed by edema removal, was
not much below the value of about 10 mmHg,
normally found with this technique. We conclude
that lowering of tissue—fluid COP is important to
maintain Bid in overhydrated and dry patients with
the NS. In addiUon, this adaption can explain
why the Bid is often normal and not expanded
despite sometimes huge overhydration in the NS.
The absence of a reduced Bid in the dry state
pleads against secondary renal sodium retention
by hypoalbuminemia as long as plasma COP exceeds
12 mmHg.
. BLOOD VOLUME EXPANSION (HYPERONCOTIC ALBUMIN)
DURING SODIUM RESTRICTION REDUCES URINARY FLOW
• AND ENHANCES PROXIMAL REABSORPTION W.H. Boer,
H.A. Koomans, [.3. Dorhout Mees, Dept. of Nephro—
logy, Univ. Hospital, Utrecht, The Netherlands.
Clearance (C) studies were performed during
maximal water diuresis in 7 healthy subjects,
before and after blood volume (Bid) expansion
using 300 ml hyperoncotic (20%) albumin (HA). A
low sodium (Na) diet was prescribed (20 mmol/day)
to induce a state of renal Na—avidity also
present in clinical situations in which HA is
commonly used in attempts to promote a
natriuresis (e.g. surgical patients with edema).
CONTROL ALBUMIN
C—inulin (ml/min) 117±17 110±13 (NS)
C—uric acid (ml/min) 9÷ 4 6÷ 1 (p<O.O5)
urine flow (mi/mm) 14÷ 4 10± 2 (p<O.O5)
C-H2O (mI/mm) 11-i- 4 2 (p<O.OS)
Na-excretion (umol/min) 35±19 30÷19 (NS)
Bid—expansion (690 ml, calculated from a single
plasma volume measurement and changes in
haematocrit ) caused a marked decrease in urinary
flow and a tendency towards further Na—retention.
Fractional proximal Na—reabsorption (calculated
from C-H 0-max) and fractional reabsorption of
uric acig, an alleged proximal marker, both
increased (90.5 to 92.6 and 91.5 to 94.8% reap.),
indicating enhanced proximal reabsorption. Fract-
ional distal reabsorption did not change. These
findings may be explained by changes induced by
HA-infusion favoring proximal reabsorption such
as an increased peritubular cap1llary oncotic
pressure or a decreased renal interstitial hydro-
static pressure. It is conceivable that HA-
i.nfusion likewise does not induce natriuresis in
the above-mentioned clinical conditions and may
he of limited cliniia1 use.
INACCURACY OF 24 HOURS PROTEINURIA ESTIMATIONS FROM
PROTEIN/CREATININERATIOSOF RANDOM URINE SAMPLES.
M.G.Koopman, R.T.Krediet. L.Arisz.
Renal Unit, Department of Medicine, Academic
Medical Centre, Amsterdam, The Netherlands.
Variations of proteinuria during the day were
studied in 21 patients (pts) with nephrotic syn-
drome (NS). Urine was collected per 3 h during a
period of 3 successive days under a regimen of bed-
rest and identical fluid and food intake every 3 h.
Estimated proteinuria (E-PROT, g/24 h/1.73 m2) was
calculated for every sample from the protein/creat-
mine ratio, multiplied by the expected 24 h excre-
tion of creatinine on the basis of
(140-age in years) (weight in kg)
5000
This estimation was compared with true proteinuria
(T-PROT, g/24 h/1.73 m2) of the same patient on
that particular day. The variation of E-PROT in the
course of a day was large when compared to T-PROT:
max range 58-195% of T-PROT, mean range 71-144%.
Correlation between E-PROT and T-PROT was higher
when only samples of identical periods of the day
were used for E-PROT (e.g. r=O.94 for samples from
0-3 p.m). Mean E-PROT (0-3 p.ni) / T-PROT ratio of
3 successive days exceeded 1.0 in 15 of 21 pts and
showed large interindividual variations (0.89-1.70).
Also in most pts this ratio was rather variable
during the 3 days.
We conclude that the observed inaccuracy of
E—PROT is due to variations of urinary protein ex-
cretion during the day and incorrect predictions
of 24 h creatinine excretions. Our patients were
studied under standardized conditions but varia-
tions may even be higher in out—clinic pts. Pro—
tein/creatinine ratio's give only a rough semi-
quantative approximation of 24 h protein excretion.
For accurate interpretation of treatment results
in NS pts 24 h urine collections are mandatory.
ACUTE RENAL FAILURE BY HANTAM VIRUS NE—
PHROPATHY.PIRST CASE IN ITALY.
F.Leoncini, D.Bertolozzi,M.salvadori(member)
M. Lomb ardi.
Dept. of Infectious Disease and Nephrology
USL 1O/D Firense Italia•
P.Versni,
Laboratory of Virology.Istituto Superiore
della Sanità—Roma—Italia.
M,Balducci.
Field epidemiologist for Toscana Region.
C.J. Gibbs
N.I.N. C.D.S.—N.I.H. Bethesda—Maryland USA
The authors report one case of acute re
nal failure following an epidemic nephro—
pathy due to Hentaan virus.This is the fi
rst case observed in Italy even if the na—
tient probably contracted the illness in
Russia.
The illness diaguosis was made by detecting
in the patient's serum specific anibodies
against Hsntaan virus
The man had a diffuse intravascular coa-
gulation which was in part the cause of
the renal failure.In fact a well defined
acute interstitial nephropathy has been de-
scribed in the Hantaan virus disease.
The authors stress the possibility that
from an ecological point,some acute renal
failure would be due to the Hantean virus
also in Italy, in particular in some coun-
tries such as Puscnna region.
SELENIUM DEFIcIEMcY IN CHRONIC URAEMIA AND DIALYSIS
ALeung, I Henderson, C Fell, D Hall, A C Kennedy
University Department of Medicine and Biochemistry,
Royal Infirmary, Glasgow, Scotland
Selenium, being present at the catalytic sites
of the enzyme glutathione peroxidase (GGHPx), is an
essential trace element in human metabolism and
selenium deficiency has been associated with
increased risk of cancer. We measured plasma
selenium level and plasma and erythrocyte
glutathione peroxidase level in 25 patients each
with advanced chronic renal failure (CRF) with
creatinine clearance < 20m1/min, on haemodialysis
(HO) and on continuous ambulatory peritoneal
dialysis (CAPO) . The results were compared with 40
normal healthy controls. Plasma selenium was
measured by electrothermal atomic absorption spec—
trometry and GSHPx by reaction rate spectrophoto—
metry. A significant reduction in plasma selenium
and plasma and erythrocyte GSHPx were observed in
all 3 patient groups. (P < 0.001 by students test.
In over 1/3 of the patients, the plasma selenium
and plasma and erythrocyte GSHPS levels were frankly
sub-normal. Our results suggested a selenium
deficient state in chronic uraemic and dialysis
patients. The cause may be due to reduced dietary
intake and/or loss through dialysis membrane.
control
CRF
1HD
CAPD
* p K 0.001
. TONSILLECTOMY DECREASES THE SYNTHESIS OF
POLYMERIC IgA DY BLOOD LYMPHOCYTES AND
THE CLINICAL ACTIVITY IN PATIENTS WITH
IgA NEPHROPATHY.
L .Lozsno, R.Garcia-Hoyo, H .Blasco,J.Ssncho
J,Egido, L.Hernando.
Fundacion Jimenea Diaz. Madrid.Spain.
Polymeric I9A seems to play an impor-
tant rule in the pathogenesis of IgA
nephropathy. Thus, these patients show ele
vated serum levels of polymeric IgA and
this immunoglobulin is found at the mesan—
gium level. Taking into account that these
patients often present recurrent macrosco-
pic heematuria following upper respirato-
ry tract infections, some authors have
advised tonsillectomy as a therapeutic
approach to this nephropathy.one year af-
ter tonsillectomy (n=8) the percentage of
circulating lymphocytes producing polyme-
ric IgA (measured by seccetory component
binding) mlgnificatively decreased (42.28±
5.54) in relation to basal levels (67.4
7.2, P<O.0O25).Simultaneoumly there was
a significant decrease in the number of
episodes of macroscopic hematuria per year
(2.2±1.2 vs 0.14+0.3) and bf the microhe—
maturia (82j113 vs 16±33).There were not
significant changes in the total IgA syn-
thesis, in the generation of suppressor T
cells by Con A nor in the OKT4 /OKTB ratio.
Since tonsil lymphocytes in these patients
produce high levels of polymeric IgA,com-
pared to the controls, our results suggest
that tonsillectomy may be useful for pa-
tients with IgA nephropathy and recurrent
macroscopic haematuria linked to upper rem
piratory tract infections. —
ACUTE TUBULAR NECROSIS IN RENAL BIOPSIES
OF PATIENTS WITH HEMORRHAGIC FEVER
N.Macanovld, S.Solemac, M.Aangici,
O.Vcrbid, D.HlaCa and F.Cohar
Institute of Nephrology, Sarajevo
Yugoslavia
In 1904, hemorrhagIc fever was
diagnosed in S patients. All the pati-
ants had clinical course characterjsed
by 5 phases: febrile, hypotenaive, oh-
guric, diuretic and convelescent phase.
In three patients, renal failure was
so intense necessitating the dialytic
therapy (peritoneal dialysis in two and
hemodialysic in one).
In the nliguric phase, all the
patients had dense, long lasting nephro-
grams, the characteristic IUU finding
in acute renal failure.
Renal biopsy was done in the cli-
guric phase. On light microscopy, tubu-
lar necrosis was found with no glomeru-
br changes. Immunofluorescence was
negative.
Sarciogically, Haantan virus 75-115
was diagnosed as the causative agent.
Thrombocytopenia, eubconjunct ival
hemorrhages and skin hernatomae were the
most expreesed eigne of coagulation de-
fects.
Low C3 and CHSU indicated the acti-
vation of complement system.
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plasma
selenium
umol / 1
plasma
CSHPx
10/1
Erythrocyte
GSHPx
10/gm Hgb
1.5 0.3*
1.0 0.3
1.2 0.3
1.0 0.3
214 55*
109 36
111 51
a7 34
17 3*
13 4
13 1 2
13 1 4
Abut qL FAILIJ IPIUED BY P4)1 S1EI)IDPL ANTI-IPFLN44Tl)1Y
ttCs (I6AID) — MAKDASSI R, FIEVET P, DKHISSI H, TOIANI M,
ANDREJAK M, FCURNIER A - CHU 80000 AMIENS -
Comparison of 8 cases (4 of which with renal biopsy) to the
litterature allows to stress following coments : 1/ The clinical
onset may be dramatic because of life threatening hyperkalemia
(>7mEq/l in 4 cases) or pulmonary oedem (in 2 cases because of
abrupt decompensation of congestive heart failure). 2/ The etlo—
logical agent may be easily overlooked, being often found only
after an obstinate anamnesis looking for seifmedication.3/ When
no nephrotic syndrom is present, other drugs than indomethacin
nay be incriminated piroxicam ketoprofene, clometacin, diclofe-
nac-, 1en a nephrotic syndrom is present other drug than Fenopro
fen are also involved like Pyroxicam. 4/ The pathogenesis is ex-
plained by 2 main mechanisms working alone on in combination
(a) the vasomotor nephropathy secondary to glomerular hemodynamio
manges directly related to the inhibition of the cyclooxygenase
which induces an inhibition in the synthesis of prostacyclin and
renin—angiotensin II. (b) Interstitial nephritis due to disorder
of cellular mediated innnunity. Whereas the first mechanism may
be always incriminated and even exclusively as in 2 of our cases
with normal renal biopsy (one without urinary abnormality, the
other with heavy proteinuria), the second may be involved in sri—
dition when a cellular infiltration * oedema of tne interstitbin
is found (as in 2 of our cases, 1 with a nephrotic syndrom, the
other with mild proteinuria and hematuria). 5/ Vasomotor nephro—
pathy is favored by concomittant effective hypovolemia such as
congestive heart failure (2 cases), nephrotic syndrom (1 case),
cirrhosis (i case), dehydration (2 cases) and by renal insuffj—
ciency (2 cased. Advanced age is also a risk factor. The age ran-
ge was 62—76 years in our observation. These situations are the-
refore risk factors which should lead to careful monitoring of
blood pressure weight, kalemia, creatininemia within the first
week of administration of NSAIO when these latter are absolutily
necessary. 6/ Nephrotic syndrom occurence is unpredictable and
this eventuality should only lead to periodic chet< of proteinu—
na specifically with propionic NSAID. Its reccurence can be
however anticipated when the same drug is taken again as illus-
trated twice in I patient,
PLASMA CHROMOGRANIN A(pCgA)IN SUBJECTS WITH RENAL
FAILURE:ELEVATIONS FROM BOTH DEGREE OF RENAL INSUF-
FICIENCY AND SECONDARY HYPERPARATHYROIDISM(2°HPTH)
M.S.Mezqer,D.T.O'Connor. (intr. by L.W.Henderson)
Dept. of Med. ,VA Med.Ctr. & Univ. of CA, San Diego.
CgA is the major catecholamine storage vesicle
(CSV) soluble protein, and PCgA may index exocytotic
sympathoadrenal activity. C9A is also structurally
similar to parathyroid secretory protein, which is
stored and released with parathormone. We assessed
the influence of renal dysfunction on pCgA in sev-
eral subject groups: normal controls(NL) untreated
subjects with moderate azotemia(Azo,Scr2.O.7.4 mg/
dL)stratified for hypertension or normal bloodpres—
sure; and subjects with end stage renal disease(ES—
RD,Scr >7.5)stratified for clinical signs of 2°HPTH.
Human CgA was purified from adrenal CSV, and meas—
results are mean value +
pCgA increased systema-
_____
tically from NL-Azo-*
ESRD. Hypertensive and
normotensive Azo subjects
did not differ in pCgA.
In ESRO, 2°HPTH subjecLs
had higher pCgA than
those without 2°HPTH.
We conclude: 1) pCgA in-
creases progressively
with degree of renal insufficiency. 2) The increase
of pCgA in Azo is unrelated to hypertension. 3) In
ESRD, pCqA is increased preferentially in 2°HPTH
subjects, suggesting a parathyroid source. 4) Meas-
urement of pCgA in Azo or ESRD must be controlled
independently for both degree of Azo and signs of
2°HPTH.
DIALYSIS AND VENTILATION IN ACUTE RENAL—
RESPIRATORY FAILURE.
Martin, A.M., McHugh M.I., Millar N.D. Scott S.J.,
Medical Renal Unit and Intensive Therapy Unit,
Sunderland Hospitals, England, U.K.
A review of 36 cases of acute renal failure and
respiratory failure was undertaken to identify the
causes of death, treatment associated morbidity
and to define prognostic indicators.
Over a 5 year period from a total number of
106 cases of acute ischaemic reversible renal
failure, 36 patients were also in respiratory
failure and required both dialysis and
ventilation. Studies were undertaken in relation
to pulmonary function, cardiovascular stability,
biochemical control and bacteriological
complications. Post mortem findings were also
analysed.
33% of patients had evidence of ischaemic brain
damage, cardiovascular instability related to
ventilation and dialysis procedures was observed
in the majority of patients. Bacteriological
complications linked with respiratory support
and renal failure therapy were noted in 60%
of survivors and 48% of non survivors.
Of 12 predictor variables analysed the
development of cerebral complications and the use
of peritoneal dialysis alone were associated with
non survival.
Early mortality was directly attributable
to the precipitating illness. Complications
related to therapy resulted in significant
morbidity and mortality in those surviving
longer than 10 days.
.
IMPRO'.MENT OF IMMUNE RESPONSE IN DIALYSIS PATIENTS
TO HEVAC B VACCINE AFTER MULTIPLE INJECTIONS OF
VACCINE. 1 1 1
Ph MICHEL, G JANIN, S EL-YAFI, Ph CHEVALIER2, C
TREPO3.l.Service d'HAmodialyse CH de MACON-FRANCE,
2.Laboratoire d'Hygiene. FacultO de Médecine,LYON.
3.Inaerm U271 FacultA Alexis Carrel, LYON.
Antibody response in dialysis patients is poor
with the Institut Pasteur Production Hepatitis B
vaccine (HEVAC B). Reinforced vaccinations proto-
cols using HEVAC B improve the immune response,
however 20 to 30 1 of dialysis patients remained
vaccine non responders. In order to obtain active
protection against hepatitis B virus infection
in all our dialysis patients, we have continued
Monthly injection of HEVAC B, Till active anti
HBS response appeared. Before occurence of the
Active response, Passive protection was achieved
by inJecting 4 ml of Hepatitis B immune globulin
(HBIG) every 2 months. 39 patients (25 men,14
women) were enrolled in this study from December
81 to April 84. 28 were hemodialysis patients.
11 were CAPD patients. Blood samples were regulary
tested for presence of HBS Antigen, Anti HBC,
Anti HaS. Active response to the vaccine was defi-
ned if a level of Anti HBS.33 mUI/ml was observed
60 days after the last injection of HBIG. Propor-
tions of vaccine responders were 44 %,67 %,
82 1, 90 1 after respectivly 4,6,10,14 injections
of HEVAC B. Only 2 CAPD patients remained vaccine
non responders after 14 injections.lLepatitis B
viral infection was noted in 2 hemodialysed patients
Tha first one waa contaminated in another center
before vaccination. In the second patient passive
protection was interrupted by error.
Conclusion Multiple injections of HEVAC B vaccne
in dialysis patients Markedly improve Active Anti
HBS response funther studies are needed to deter-
minethe Mc,st efficatiot.ts vaccinations regimen in
urersic patients.
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ured by RIA(in ng/ml) . The
SEM:
Group n pCgA
ML 44 63±7
Azo 18 148±18
Hypertensive 12 135±22
sormotensive 6 173±29
ESRD 30 411±27
2°HPTH 18 473±24
No 2°HPTH 12 318±45
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SHORT-TERM ENALAPRIL THERAPY AMELIORATES THE
HYPOKALEMIA OF BARTTERS SYNDROME.
J.M.Morales, L.M.Ruilope, A.Coto, J.M.Alcazar,
M.Praga, R.Miranda, I.Bello, J.Nieto, J.L.Rodicio.
Servicio Nefrologa.Hospital 1°Octubre. MADRID
The treatment of adult's Bartter syndrome re-
mains a controversial issue, We have had the oppor
tunity of studying three cases (2 males, 1 female
aged 34,36 and 34 years respectively) in whom the-
rapy with Enalapril was started at a initial dose
of 2.5 mg/day and maintained during four weeks
with increasing doses.The results of plasma pota-
ssium (K), plasma renin activity (PRA) and aldos—
terone (PA) and mean arterial pressure (MAP) as
well as the dose of Enalapril are contained in the
table below
CASE 1 CASE 2 CASE 3
I 4w I 4w I 4w
K(mEq/L) 2.5 3.4 2.2 3.1 2.5 3.0
PRA
(ng/ml/hr)22.5 39.2 20.0 30.1 30.2 38.3
PA (ng/dl)62 41 49 32 58 27
MAP(nsnHg) 83 78 91 85 96 96
Enalapril
(mg/day) 2.5 7.5 2.5 5.0 2.5 5.0
I=Initial; 4 w= 4th week
Exogenous angiotensin II infussion did not
show changes of sensitivity before and after [na
1apr11 therapy. The tolerance of the drug was
excellent. These results indicate that Enalapril
therapy can correct, at least partly, the hypoka
lemia of Bartters syndrome when used in very
small dosages. Further studies are needed in order
to see whether better resuTts can be obtained with
higher doses of the converting enzyme inhibitor.
THE EFFECT OF COLCHICINE ON THE NEPHROTIC
SYNDROME OF FAMILIAL MEDITERRANEAN FEVEROIC nen, K0 Serdengeçti
Cerrahpaa Fsc0 of Med., Istanbul, Turkey.
The efficacy of coichicirie was evalua-
ted in 11 nephrotic patients with Familial
Mediterranean Fever(FTvIF) .Renal amyloidosis
was proven by kidney biopsy.The duration
of renal clinical findings were 2 to 16
months .The mean values for proteiriuria,se—
rum albumin and GFR were6s2.5(2.5-l0)g/
day,2o2.iOI4(108_2.8)g/dl arid 56.9(38—68)ml
/cnin repectively.Phe patients ,'ere given
1 ag colchicine per day and followed for 6
to 52 months,fn 3 of these patients follo
ed for 6 to 12 months, the clinical and
laboratory findings did not change and GFR
decreased further.In 5 others followed for
6 to 46 months a partial clinic response
together with an increase in ISFR from a
mea9 of 634(59—66)ml/niin to a mean of 77.
15(63-98)rnl/miri was observed but there wm
o change in proteiriuria and serum albumin
levels.l-Iowever, ir the remaining 3 patien-
ts followed for 36 to 52 months a definite
improvement of clinical and laboratory fin
dings was rioted together with significantincreases of GFR.Their proteiriuria decrea-
sed from 5g,4g and 4.5g/day to
arid g/day, their serum albumin increas-
ed from 29g,2.3g and l.8g/dl to
and .jg/d1 and their GFR increased from
60 ml,53 in]. arid 43 ml/rniri to 148 ml, ml
arid j rnl/niiri respectively.These results led us to conclude that
coichicirie is worth to try for the treat-
merit of the riephrotic syndrome due to IF.
ESTB.1AIION OP EXCHANC PLAA VOIA3L IN
PIASMAF]ITRATION WITH HUMAN ALBUMIN SUB-.
STITION
DJLuskiov, Z.ICirjakov1J.StantchevMedical Academy, Sofia , Bulgaria.
When interpreting the therapeutic re-
sults of plasmafiltration (Pr) we must
stress that the absolute quantity of the
exchanged plasma is riot of such importance
as the percent of the exchanged plasma of
the patient.The latter can not be estimateby the volume of the filtrated plasma be-
cause a certain quntity of it belongs to
the infused substitute solution.
In the development of the present me-
thod we proceeded from the formulation
that considering PP the plasma volume thepatient remains constant(the ntity of
the extracted plasma corresponds with theinfused substitute solution).When human albumin is used as a substitute,the decre-
ment of the globuliz ccai'cntrati-on in pa-
tient's plasma depends on the diluting ef-fect of the retained substitute solution.
The volume of the latter is equal to the
exchanged plasma volume of the patient,That enables us to estimate the percent
if the exchanged plasma volume (EPV) on thebasis of the percent of the decrement of
the plasma globulin concentration.
Practically that can be done on the ba-sis of the initial(Qo) and the differencebetween it and the final(Gf) plsma globu-lin concentration:
% EPV = (Go — Gf) Go x 100
GLYCOSYLATED HA[MOGLOBIN IN URAEMIA
R. Paisey, R. 8nks, M. Rartog, R. Holton,
D. White, R lee, J. Mackenzie.
Southmead Hospital & Royal Infirmary, Bristol, UK.
It has been suggested that glycosylation of Hb
(HbAIc) is an unreliable guide to diabetic control
in uraemia as formation of carbamylated Hb may
artefactually increase HbAIc measured by methods
depending on alterations of charge such as elec—
troendomosis ([EM). Conditions causing persistent
foetal Mb (HbF) also increase HbAIc when measured
by such methods, We have compared the effects of
uraemia on 2 methods of measuring HbAIc in 52
patients with chronic renal failure.
Gp.I; Non diabetics, haemodialysis (HD) n=15.
Gp.2; Non diabetics, CAPD, n—l5.
Gp.3; Non diabetics, no dialysis, n"l5.
Op.4. Diabetics, no dialysis (n=4) and CAPD (n=3).
Mean HbAIc by the thiobarbituric acid method and
EEM respectively were (mean + 1 SD):
Gp.l, 5.5+0,7% and 5.9-i-0.6%; Normal range
Gp.2, 6.5l.0% and 7.0±0.9%; 5.5-7.5%
Gp.3, 6.7+1.2% and 7.6+0.9%; (both methods)
Gp.4, l0.+l.7% and 10:3+1.2%.
Correlation between tTe 2 methods was good in
all groups. HbAIc by [EM was not related to the
level of blood urea, also suggesting that carbamy-
lation did not influence the measurement. Mean
HbAIc was higher in diabetics (p(0.Ol) and lower
in patients on HO (p<O.O5) than any other group.
HbAIc correlated with haemoglobin (r=0.65,
pO.0l) suggesting an effect of haemolysis in
uraemia. Mean HbF was higher in patients on HD
than all other groups (1.4+0.8%, 0.7+0.2%; p<O.O5)
for reasons that are unc1er. This tudy does
not support the suggestion that HbAIc is unrelia-
ble in uraemia except in MD where increased
haendysis may result in low values.
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LEVANISOLE IN THE TRFATI!ENT OF FREQUENTLY RELAPSING
NEPHROIIC SYNDROME (FRNS).
°C.Pecoraro,M.Usberti,B.Cuida,L.Grumetto,L.Carbona—
ro,A.Pinto, M.T.Saravo,A.Gaggiotti.
°Department of Pediatrics,Chair of Nephrology,II Fa—
culty of Medicine of Naples,Italy.
A main goal of pediatric nephrologist is to re-
duce the relapse rate of FRNS.For this purpose 7
children with FRNS were treated with Levamisole (L),
an effective antihelmintic and also an immunostimu—
lant drug.Remission of proteinuria was obtained with
the standardized (ISEDC) steroid regimen.Children
were given L (2.5 mg/Kg/day,orally for 6 months) as
soon as alternate—day prednisone for 4 weeks treat-
ment was started.Steroid therapy was gradually with-
drawn over the next 4 weeksL was ineffective in 1
patient .The mean age of the remaining 6 children at
onset of NS was 3.62 years.The duration of the dis
ease before L ranged from 1.25 to 6.9 years with a
mean of 3.92.3 years .After the course of L the mean
annual rate of relapses decreased from 2.1 to 1.0.
The increase of the relapse—free interval was sig—
nificant after withdrawal of either the steroid (2.4
versuo 8.6 months;p<O.0O5) or L (2.4 versus 5.1
moriths;p(O.O5). 2 of the 6 children are still in re—
mission;the remaining 4 each suffered 1 relapse 3
to 6 months after the course of L.The mean daily
dose of prednisone,before and after L,was reduced
from 12.7 tug to 6.5 tug (by 48.l%).No major side ef-
fects were noted while on L.Our preliminary results
with the use of L in the treatment of FRNS are en-
couraging.
ANTITHROMBOTIC THERAPY IN CHILDHOOD HEMDLYTIC URE-
i41C SYNDROME A PROSPECTIVE CONTROLLED STUDY
W.Proesmans, R.Van Damme-Lornbaerts, R.Eeckels, B.
VD7J.Verrny1en, R.Vlietinck
Department of Paediatrics, University of Leuven,
Belgium
Since June 1976, all infants and children en-
tering our department with HUS, are allocated at
random to one of two different therapeutic schedu-
les : supportive therapy only (CONT-group) on addi-
tional administration of heparin and dipyridamole
(ANT-group).
Sixty patients have entered the study so far.
Both groups, made of 3D children each, are similar
as far as age distribution, prodromal illness and
biochemical data on admission are concerned.
Two children in the ANT-group died in the acute
phase and one patient from the CONT-group; the over-
all mortality rate is 5 per cent. Three patients
in the CONT-group have had an unusually prolonged
course with sevee iypecterision one of thee died,
another one was treated with chronic dialysis and
transplanted. All other patients made a reasonably
quick recovery.
The analysis of the renal biopsies shows statis-
tically significant differences between both groups
in favour of the antithrombotic treatment.
Data on the long term evolution of kidney func-
tion are incomplete. Creatinine clearance values
at 1,2,3,4 and 5 years are not different between
both groups.
RENAL FAILURE IN PATIENTS WITH MULTIPLE MYELOMA
RENAL OUTCOME AND SURVIVAL.
N. Pertuiset, B. Ganeval, M.C. Commare,P. Jungers,
Department of Nephrology, Necker Hospital, Paris,
France.
We retrospectively analyzed renal outcome and sur-
vival of 35 patients (pts) with multiple myeloma(MM)
and renal failure (BY) observed from 1977 to 1984.
MM components were BJ alone (19), IgG ( 8), IgA (7),
IgG + IgA (1). The kappa/lambda ratio was 1.1.
Renal biopsy (15 pta) disclosed myeloms cast nephro—
pathy in 7, amyloidosis in 3 and non—amyloid light—
chain deposits in 5. Pta were classified according
to creatinine clearance at presentation into 3
groups : I (50—80 ml/min,7 pta); II (20—49 ml/min,
8 pta) ; III (<20 ml/min, 20 pts). All pts were
treated with active alkalinization, high diuresis
and chemotherapy. After I month, renal function
improved (19 pts) or was unchanged (12 pts), and
worsened in only 4 pts. Improvement did not depend
on the initial degree of RF. Long—term course was
evaluated in the 27 pta who survived for more than
2 months. In 8 pta, HF progressed either slowly
(3 pts, all with amyloidosis) or rapidly (4 pts,
who were treated by chronic hemodialysis). In the
other 19 pts, RF remained stable (10 cases) or even
improved (9 cases). Subsequent worsening of RF
occurred concomitant with MM relapse. Mean survival
in the whole series of 35 pts was 22.5 months. It
was higher in group 1 (33 mths) than in group II
(18 niths) and III (17.5 mths) pts. Survival exceed-
ed 2 years in l3pts.
In conclusion, sustained improvement in renal
function and substantial survival may be obtained
in MM pts with HF.
ZINC AND LYMPHOCYTE FUNCTION IN CHRONIC RENAL
FAILURE (CRF)
Maher Ramzy, H Habib, N.Hassaballa, I Iskiander,
M.Solomon and N. El Sheemy
Nephrology and Clinical Pathology Departments,
Cairo University, Egypt.
Immune responsiveness may be reduced in some
uremic patients. The mechanisms of this secondary
immune deficiency is unclear.
Our study included 40 patients and 10 normal
controls. The patients were divided into 2 groups:
group A:20 patients with chronic renal failure on
conservative treatment; Group B: 10 patients with
end stage renal failure on regular haemodialysis.
Serum zinc, E.rossette test and leucocyte migra-
tion inhibition tests were done on all cases.
A significant decrease was found in all para-
meters (total lymphocytic count, E—Rossette, mig-
ration—inhibition test and serum zinc)in both
group A and B. After 3 months on regular haemo—
dialysis a significant improvement was observed
in total lymphocytic count and E—Rossette tests,
but insignificant change could be observed in both
migration—inhibition test and the level of serum
zinc.
It can be concluded that both quantitative and
qualitative suppression of peripheral T—lymphocyte
in uremics,together with hypozincemia.Regular
haemodialysis for 3 months could partly ameliorate
the quantitative defect, probably by removal of
serum inhibitory factors, but not by correction
of hypoziacemia.
HYPERLIPIDEMIA AND RENAL FUNCTION IN THE UREMIC RAT.
V .Reichenbe rg,E .Levy ,H . S tank iew icz ,!L Go lds tein
U.Elat,E.Rosenmann and A.Drukker.
Shaare Zedek Medical Center,Jerusalem,Israel.
It has been suggested(Moorhead 1980)that hyperli—
pidemia may lead to renal damage.The present study
was designed to evaluate this hypothesis.
Male,HU—strain rats weighing 200 g were stu—
died.Uremia was induced by 2-stage 5/6 nephrectomy
(U) .Control animals were sham operated(C) .The ani-
mals were divided into 3 groups which were fed ei-
ther a normal laboratory dlet(N),a high carbohy-
drate diet(CH) or a diet rich in fat(F).Three,6 and
8 weeks after surgery renal function(Scr),serum 11—
pids(TG,CHOL) and urinary protein(Uprot)excretion
were determined.At sacrfice(8w) the kidneys were
removed for histology.
At 8 weeks: 5cr
(mfl)
TG
(mgc)
CHOL
(mg%)
Uprot
(mg/214h)
N
—
CH
C (n=5)
U (n=5)
(n=5)
U (n=5)
0.5
1.3
0.7
1.0
186
161
296
331
53
So
62
85
15
78
16
28
F
—
C (n—6)
U (n=6)
0.5
1.1
281
291
127
365
15
139
These results clearly show that a high—fat diet
induces significant hypercholesterolemia in uremic
rats.The hyperlipidemia is accompanied by severe
proteinuria without changes in Scr.The fat loaded
animals also had mild histologic changes involving
glomeruli,tubuli and mesangium,not seen in the
other groups of animals.
We conclude that hyperlipidcniu of rclctively
short duration indeed inpairs renal function in
the rat with mild—moderate (surgical) uremia.
CLINICAL USE OF PROSTAGLANOINS SYNTHESIS
INHIBITORS (PGI) IN SIADH.
RIJBIHSTEINM,OIJCOBU J,SILVERT C,DUPOHT P.
Centre Hospital ier do Tivol i, La Louvière,
BELGIUM.
Prosfsglandins inhibit the hydroosmotic
effect of ADH on the renal collecting duct
but stimulate AOH release at the pituitary
level. The aim of our study was to compare
the relal va value uf alcool and PGI for
causal diagnosis and possible therapeutic
use in SIADH.
14 patients with SIAUH were submitted
to 4 wafer loading tests:
(1) 20 cc water/kg,
(2) (1) with 2,5 cc efhannl 40%/kg
(3) = (1) preceded by 3 days P131
(4 control fesf (1)
The results are expressed in percentage
of the water load excreted aft
SIAOH (1) (2)
87.Corrected by P131 25,6 27,3 35
(2 carbamazepine
4 cerebral atrophy)
Worsened by P131 33 15.3 14.2 31.3
(6 pulmonary disease)
No effect of P131 26.5 33.7 22.5 19.2
(2 cerebraLatrophy)
assays are now in course and may permi
more definitive conclusions.
EPSTEIN—BARR VIRUS (EBV) INFECTION IN DIALYSIS
PATIENTS
H.Roujouleh, J.Carquin, O.Toupance, S.Lavaud,
G.Dropsy, J.Chanard
Centre Hospitalier et Universitaire, Reims, France
The frequency and clinical significance of EBV
infection among chronically hemodielyzed patients
are not well defined. Over a three year period cli-
nical evaluation of EBV—related disease and serolo-
gic teats were measured in 40 hemodialyzed patients
and compared with 38 controls members of the staff.
When possible, EBV was isolated from pharyngeal se-
cretion. In addition, in vitro continuous cell pro-
liferation from patients blood B cells was tested.
At the beginning of the study 30 (95%) patients
had evidence of previous EBV infection with antibo-
dies (IgG) to viral capeid antigen (VCA) from 1/160
to 1/10240, 24 of them having a titer higher than
1/640. Antibodies against nuclear antigen (EBNA)
were also present. 97 5 controls were positive and
had yeA antibodies from 1/10 to 1/160. The diffe-
rence between the two groups is highly significant
(p<O.001l . During the follow up period 7 patients
(17.5 5) had 1gM antibodies to VCA for 6 to 24
months (without rheumatoid factor) . IgN antibodies
were associated in 4 instances with acute hepatitis.
In addition, two of these patients had fever with
mononucleosis. REV was only found in pharyngeal
secretion of 3 of these 7 patients. In vitro epon-
taneous peripheral H cell proliferation was obtai-
ned in 2 of them. All these teats were negative in
healthy controls.
In conclusion, during a three year period only
hemodialyred patients had symptoms of ESV infection4
10 5 with clinical events and 17 % with serological
conversion. In the absence of any KEy—related di-
sease among the members of the staff the results
argue for endogenous EBV reactivation.
S MHAHDOMYOLYSIS AND MYOGLOBINURIA IN 19 PATIENTS
WITH CHRONIC ALCOHOLISM
5 K.W. Rompf, Tb. Henze, H. Kaiser, H. Kiein,
H. Prange, F. Scheler
Departments of Medicine and of Neurology,
University Hospital, Goettingen, FRG.
We report on our experience with 19 cases of
rhabdomyolysis and myoglobinuria in chronic alco-
holics. In these patients myoglobin — measured by
RIA — was monitored serially in serum and urine.
The clinical spectrum of the syndrome was cha—
racterired by a wide variability of the extent of
myolysis. Muscle tenderness and muscle swelling
were rare findings and brown discoloration of urine
was often overlooked. Seirores and delirium were
frequently seen at the beginning of the disease.
CK values up to 96,000 U/l (normal C 70 U/l) and
myoglobin concentrations in serum up to 600,995 ng/
ml (normal C 70 ng/ml) and in urine up to 4.0
million ng/ml (normal C 50 ng/ml) were observed.
Acute renal failure was common, only 5 patients
exhibiting maximal creatinine concentrations below
130 tsmol/l. 9 patients had a maximal serum creatin-
me value above 350 umol/l and S patients underwent
dialysis treatment. All surviving patients recover-
ed their normal kidney function. Other complicat-
ions included respiratory failure, thrombocyto-
penia, and hypercalcemia. 2 patients died from
irreversible shock.
We conclude that rhabdomyolysis in chronic
alcoholism is a well defined entity and one of the
most important causes of atraumatic rhabdomyolysis.
It has a considerable lethelity, especially in
patients presenting with initial shock. Early re-
cognition of the syndrome is desirable, because the
most frequent complication — acute renal failure —
may be avoided, if proper treatment is instituted
as soon as possible.
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sr 4 hourE
So, PhI more than alcool can separate
two kinds of SIADEI. P131 presumably
depress ADH secretion in central SIADP
but on the contrary reinforced hydroosmo-
tic action of ADH ectopic secretion.
rurther studies with appropriate ADH
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. PLATELET FUNCTION IS ENHANCED, NO DEPRESSED
IN URAEMIA
P. B. Rylance, N. P. Gordge and M. 3. Weston
St. Phi1ips Hospital, London, NC2 and
Duiwich Hospital, London, SE22, U.K.
Platelet function in uraenia is reported to be
depressed (which may be corrected by Hasmodialysis(ED)) and bleeding time prolonged. Although this
might be expected to protect against athercina and
thranbosis, cardiovascular mextality in HI) is very
high. Techniques and results of platelet function
testing vary between workers. We have studiedplatelet aggregation with a standardised method and
a variety of agonists and concentrations.
14 undialysed chronic renal failure (CRF) patient(mean plasma creatinine llO3pmols/l) and 14 chronic
HD patients were compared with 18 normal controls.
Turbidanetric aggregation was performed using ADP,
collagen, arachidonic acid (AA), ristocetin and the
calcium ionophore A23187. Rate, maximum amplitude
and threshold for aggregation were measured.
When platelets fran CRF patients were compared
with normals, CRF platelets had a lower threshold
PflP 5flr AA ni ''ere more agcjregrble to la:—doco
AA and ristocetin. When platelets from HI) patients
were compared with normals, aggregation to Alt was
also increased. However, ristocetin aggregation was
no longer enhanced and ADP threshold was normal;
aggregation to high-dose collagen and A23187 was
depressed. Fibrinogen, a risk factor for atherana,
was elevated in CrlF and ED patients.
This suggests that in contrast to previous studies
platelets from CRF patients are hyperaggregable and
that ED depresses platelet function. The differing
response to different agonists and concentrations
may in part explain coexisting bleeding & throistosis
Hyperaggregable platelets and high fibrinogen may
predispose to atheraila and thrombosis and tustifies
a study of antiplate1et therapy.
• BRANCHED CHAIN AMINO ACID (HM) MENSABDLISM IN
CHM)NIC RENAL FAILURE (CIIF) AND DIALYSIS (D).
M. Schreiber, S. Kaihan, A. McCullough, S. Savin
(Intr. by S. NakanDto)
Cleveland Clinic Foundation and Case Western
Reserve University at Cleveland Metropolitan
General Hospital, Cleveland, Ohio, USA
Alterations in M (leucine. isoleucine, valine)
metabolism have previously been described both in
CRF and I) patients. Oral ketoanalogues of' M
have been employed in dietary therapy for CRF.
Considering the importance of further understanding
protein metabolism in uremia we quantified the rate
of leucine (LED) turnover and LED oxidation in 5
CRF patients (mean creatinine 7.8 eg/di, BUN 87
mg/dl), and 2 D patients. Six normal subjects
served as controls. (I—-3C) LED tracer was used
as a primed constant rate infusion for a period of
6 hours. 13C enrichment of plasuia LED and of ex-
pired (D wax measured by nasa spectrailetry. The
rate of production and 02 consumption was
measured by respiratory calorimetry.
Leucine* Protein-f
Turoovor Oxidation Cat abolirm Synthcsis
Normals (6) 86.93 12.42 3.54 3.03
3.29 +0.79 +0.68
CRF (5) 79.35 7.58 3.23 2.92
+16.99 +2.05 +0.69 +0.62
# mean +51) *unDles/kg.hr + gm/kg.dy
The % total body water determined by H2 ('8o
tracer was; normals: 57.2 + 5.8, uremics: 63.4
9.39 S.D.. In the 2 D patients the LED turnover
was 109.85 and 109.99 and LED oxidation 11.5 and
14.7. In CrlF decreased nitrogen excretion results
in decreased net nitrogen loss from LLD and de-
creased LED oxidation. These studies provide a
basis to reexamine the therapeutic effects of keto—
analogues and AA in CrlF and D patients.
SINGLE-DOSE TOBRAMYCIN TREATMENT OF URINARY
TRACT INFECTIONS(UTI).
Sasdelli M,Duranti E,Imperiali P,Bizzarri D,
Vagnoli E.
Divisione di Nefrologia,Arezzo,Italia.
Single-dose aminoglycoside therapy has
been shown effective for the treatment of
uncomplicated UTI,the failure of responce
usually is bound to other upper urinary in,j,
uries.154 adult ambulatory women(average a—
ge 37 years)with apparently uncomplicated
lJTI(clinical symptoms of cystitis and urina
ry colony countlOO,OOO/ml)were treated usi
ng a single dose of tobramycin(150 mg i.m.).
In all,urtnary coltures were performed befo
re,3 days and 1 month after therapy.
In 126 followed pts,104(83%)recovered compi
etely,14(llli)showed recurrence of infection,
while 8(6%)did not responde to treatment.
Ourtherinvestigstions(Urogaphy,.\ntibody_
ated fiacteria etc)were pejfornied in the
t two groups:in Spts(37%)with recurrent inf
ections and in 5 rionresponder pts(80%)we fnu
nd upper urinary lesions:interstitial nephr
itis,staghorn calculi etc.
In conclusion we confirm the efficacy of si.
ngle-dose aminoglycoside therapy in the tre
atment of UTI anda good reliable way of sel
ecting out the pts who require special inve
stigations.
THE CYCLIC ENZYMATIC METHOD FOR THE
DETERMINATION Na,K ATPase IN HUMAN
ERYTHROCYTES' GHOSTS OF HEALTHY MEN
AND OF URARHIC PATIENTS
D. eparovic, S. Milutinovic, V. Molnar
Center for Hemodialysis and Nephrology,
Hospital "Dr J. Kajfes", Zagreb, lugo—
al avi a
The modified cyclic enzymatic method,
according to Schwartz et al. (J Pharmac
Exp Ther l969 i68:31-41), was applied to
assay the activity of Na,K ATPase in hu-
man er;throcytes' ghosts of healthy con-
trols as we].]. as of uraemic patients.
The intra—assay and inter—assay variation
in activity of Na,K ATPase was 3.93 and
21.4 percent, respectively. Optimal con-
ditions of the method were examined, too.
Uraemic patiQits before as well as after
hemodialysi had lower Na,K ATPase acti-
vity (O,i8l—O,1i9..uxnoles NADH/13r/mg pro-
tein, niO, P<0,GOl and O,23L1._O,154
imo].es NAp/)r/ protein, n=6, P< 0,05,
respecive1y) than healthy controls
(O,38?—O,136,umoles NADH/hr/mg protein,
n=14-2). The permanent decrease in activity
of Na,K ATPase found in uraemic patients
erythrocytes could have an important im-
pact on development of various compli-
cations of uraemic syndrom. Addition of
plasma of' uraemic patient to healthy do-
nor erythrocytes' ghosts (n=4) resulted
in a dose dependent inhibition of enzyme
activity; half maximal inhibition was ob-
tained at 1:71 dilution of uraemic plas-
ma, suggesting the role of a circulating
inhibitor of Na,K ATPase present in
uraemic plasma.
MIXED ESSENTIAL CRYOCLOBULINAENIA: CLINICAL
FEATURES AND RESPONSE '10 TREATMENT
D.R.J. Singer, M.C. Yenning, C.D. Pusey, C.N.
Lockwood
Renal Unit, Hammeremith Hospital, London.
The clinical features and response to treatment
with plasma exchange (PX) and immunosuppressive
drugs (ID) were studied in 10 patients referred
from 1979—84 with clinically significant mixed
essential cryoglobulinaamia. Rash (10) , neuro-
pathy (7) , renal diseasa (7) , arthropathy (6) and
liver disease (5) wero tho dominant clinical
manifestations. Of the 7 patients with renal
disease, 2 had heavy proteinuria and all had im-
paired glumerular filtration. Renal biopsy (6)
revealed mesangiu—capiilary glomerulonaphritis (5)
and necrotising vasculitia (1) . Skin biopsy
(leukocytoclastic vasculitis) waa a useful diagnos•
tic feature in 4. Characteriaation of the cryo—
globulins revealed munuclonal 1gM kappa-polyclonal
IgC (9) all with depressed C4 and CMSO, S also with
C3 depression. One patient with oligo-clonal IgG—
IgC had a normal cumpiement prnfile.
Treatment was determined by the severity of
clinical manifestatiuns and ths rate of resyn-
thesis of cryoglobulin: mx (2) , PX and ID (8) . S
patients have persisting mild renal impairment.
One patient with severe renal impairment died early4
from gaatro—inteetinsi. heemorrhage. A further
patient developed acute on chrnnic dialysis depend-
ent renal failure and succumbed tu peripheral
vascular disease. Other significant morbidity
included: brunchiectesla (I) , neoplaeia (2) - 3
patients died, the third from lyaphoma.
Resuiutiun uf cryngiubulineemie occurred in i
patient after 2 years treatment with PX and ID.
The surviving 7 patients are well and syeptomet—
Ically controlled on maintenance treatment: PX (2)
10 and PX (5)
THt EFFECT OF INTRAPERITONEAL (IP) INSULIN RECIMENS
UPON DIABETIC NEFHROPATHY
R.L.Stephen, F.m. Nelsnn, J.G. Maxwell, C. Ksblitz,
S.C. Jacobsen, B. Hsnover (Intr. by V. Parsons).
University of Utah, Sslt Lake City, Utah, USA
Ten patients with clinical diabetic nephrupathy
were followed for 13—49 muntha on multiple—
injection IP insulin regimens, by reciprocal serum
crestinines (100/crest; mg/dl), creatinine clear-
ances (Ccreet; ml/minll.73m2) and fractional pm—
tein clearances (FPCCprotein/Ccrest).
Six patients displayed pre—treatment (SC regi-
mens) serum creatininea of 2.3—3.8, a controlled
mean HP nf 138/87 end a mean glycosylered Mb (HbA1)
of 10.9%. The seen rates of decline in renal
function during SC end I? regimens are:
100/crest n r Range
SC Regimens —O.80t5 51 0.78 —1.2t, —D.46t
IP_Regimenet _D.29t* 130 0.53 D.59t, O.16t
iCumulative tisel6D months 5Pc 0.05; t=months
FPC increased by 19—34% per annum (pa) in 5
patients and by 560% in 1 patient, during IP regi-
mens.
Renal status in the remaining 4 patients, with
pro—treatment Ccrest 45—78, was assessed during IP
regimens only, end: mean Ccreat cr-O.08t, r63,
range —.29t, D.89t; cumulative time 112 months. FPC
decreased significantly in 3 patients and increased
by 16% pa in 1 patient.
In all 10 patients mean HP yea maintained at C
140/go end moan MbA1 decreased by 1.5% during IP
regimens. Thus, slthough ill understood, a postu-
lated improved "metabolic environment" created by
the I? portal route of insulin delivery may
play a major role in stabilizing disbetic
nephropmthy.
S CYTOMEGALOVIRUS (CMV) RETINITIS IN A RENAL TgANS—
PLANT PATIENT WITH RECURRENT OPPORTUNIST INFECTION:
5 TREATMENT WITH FOSCARNET AND CMV HYPERIMMUNE
GLOBULIN.
D R .1 Singer. I J Fallon, W.E.Schulemburg,A S Boyd,
J.Cohen, G.Williams.
Renal Umit end Dept of Ophthalmology, Hammorsmith
Hospital, London.
A white heterosexual man developed renal failure
from focal segmental glomeruiosclerosie. Me was
well during 15 months hsemudialyaia but developed
recurrent opportunist infection after renal trans-
plant: oral and oosophegeal Candidiaaia, herpes
simplex virus I and II,recurrent pneumocystis
carinii pneumonia, primary and reactivation CMV
infection. Antibody to human T—cell lymphotropic
virus III (HTLV3) was also detected. After the
primary CMV he developed unilateral, mecrotieing
retinitis which, untreated, progressed to blind-
ness. CMV retinitis recurred in the unaffected
eye 11 months later; CMV wee isolated from oral
secretions and urine. There wee no response to
6g weekly x 3 iv CMV hyperimmune globulin and
viral excretion continued. The new anti—viral
agent foacernet was introduced (600mg iv bolua,
0.09mg/kg/mm iv infusmon,4 woeks).After 12 days,
the reti:nel lesions progressively reeolved,acuity
increased from 6/36 tn 6/12; viral excretion
abated. Retinitis remained in remission for 12
weeks before e further recurrence, this time re-
solving on foecarnot treatment alone. We believe
that further trials of foscarnet are indicated in
CMV retinitis, which, untreated, in severely
immune—compromised patients, runs a perticulerly
aggressive course.
HYPOCITRATURIA AS MAIN MEIABOLIC RISK FACTOR IN
NEPHROLITHIASIS
F.Susanna,R.Lanaro,M.Oe Luca,R.Arduini ,°P.Manente,
C. Cascone
Renal Unit,°Day Hospital,General Hospital,
Casteifranco Veneto,Italy.
In order to evaluate the metabolic risk's
factors of nephrolithiasis we studied 20 outpa-
tients with documented story of stones,according
to the ambulatory protocol developed by Pak.
Metabolic abnormalities were found in 75% of
patients:Absorbitive hypercalciuria type I (HAl)
in S (25%);type II in 2;Renal hypercalciuria in 2;
hyperuricosuria(HU)in 5(25%);pnimary hyperparathy-
roidism in 1;no metabolic abnormality(NMA)in S.
The most remarkable finding was hypocitraturia
found in 12 patients (60%):in 4 with 8MM (BO%),in
4 with HAl (80%),)n 3 with HU,in 1 with HAIl.
HO was found in 10 cases:in S as the only metabo-
lic derangement,in 4 with HAIl.
Using Regression analysis and Student's t-test,we
found a significant correlation (p'cO.Ol)only bet-
ween urinary Calcium and uric acid,while the curre
lation between citric and uric acid excretion was
slightly above the upper normal limit of signifi—
cance.No correlation between citric acid and the
other parameters.
Our data give a confirmation about the high in-
cidence of hypocitraturia in stone former patients
and its main pathuphysiologic role in nephrolithia
sis. On the basis of the frequent finding of hypo
citraturia in NMA patients,we could postulate a
key role of this inhibitor of crystallization al-
so without the contribution of other derangements,
defining therefore a distinct group in the patho-
genesis of nephroiithiasis.
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LINICAL AND EPIDEMIOLOGICAL EVALUATION OF 70 CASES
DF LEPTOSPIROSIS COMPLICATED BY ACUTE RENAL FAILURE.
2. Teodori, P. Gatti, P. Calzavara, A. da Porto,
4. Baum Rosa.
i2ivisione di Nefrologia e Dialisi — Treviso— Italia
From 1970 to 1983 70 patients were admitted for
Leptospirosis (L.) complicated by Acute Renal Failu--
re. Further 28 patients were excluded (11 of them
died) because the serologic tests for L. were nega-
tive.
The average age was 44.5+ 14 years.
Agricultural workers, followed by factory and
building—site workers, were the most frequently in-
volved categories.
The seasonal trend of the disease was typically
a summer—autumnal one.
In most cases the serologic teats were positive
for Leptospira "ictero—haemorrhagiae".
The mortality rate was 8.5%.
In order to study the main features 01 tne aecea—
sed patients, a series of clinical and laboratory
parameters were compared with those of the survivors
A significant statistical difference was found in
the average age and in the total duration of oligu—
rim wich resulted higher (pCO.OS) in the deceased
patients.
A greater rate of alcoholism was found among de-
ceased patients (p(O.O0l) compared to those who sur-
vived.
Peritoneal dialysis was used for 31 patients: in
4 of these this treatment was withdraws and repla-
ced by an Hemodialysis schedule.
COhPAkIISOR or dOTOL NERVE CONDUCTIOI VELOCITY AED
VIBRATORY PERCEPTION AS LOLG TERM MARKERS OF
URENIC POLYNEIJROPATEY
Ii. Raiclt, R. hachmdller, U. Oracle
Nedizinieche Poiiklinik des Westfdlischen Nilhelms—
Universitt, MOnster, F. 2.0.
Urernic polyneuropathy is a substantial cop1i—
cation of the uremic syndrome. Quality of dialysis
treatment has thus been correlated to peripheral
nerve function. Usually either the motor nerve con—
duction 'e1ocit (MNCV) or the vibratory perception
(VP) have been used for quantification. In this
study we comoared these two methods in view of
their diagnostic value and their sensivity for long—
term follow—up of patients on chronic dialysis
treatment.
Both methods were used simultaneously in 141 pa-
tients on hersodialysis with a oean age of 42 years
and a mean dialysis treatment of 72.u months in 6—
weeks—intervals over an average period of 2o0 weeks(bO—440 weeks). Patients with less than 10 oeasure—
monte were excluded.
MMCV and VP are significantly dependant on sex
and age. e9 patients improve significantly in VP in
the total period, 67 have such a trend over 10 sub-
sequent measurements of VP. There was no case of
VP-deterioration. Most of these trends demonstrate
a coincidence in time with the beginning of the
investigation, but net with the initiation of dia-
lysis treatment. There is only 1 patient with
coincident trends for KNCV and VP. In 10 patients a
deterioration of MMCV was found and at the same
time in 6 of them an improvement of VP, and in the
remaining 4 no trend for VP for the whole period.
In conclusion this prospective longtersr study
raises doubts about the clinical validity of both
methods. Only by comparison with other clinical
data Indicating uremia this dilemma may be solved.
• LOW—PROTEIN DIET INCREASES SERUM ALBUMIN BY
REDUCING PROTEINURIA IN SOME NEPHROTIC PATIENTS
J. van der Meulen, L. Gooren and P.L. Oe.
Free University Hospital, Prnsterdani,
the Netherlands.
A restriction in protein intake is recommended
to retard end stage renal failure in idiopathic
glomerulopathy. This study followed the effect of
reduction in protein intake in 8 such patients with
proteinuria > 3.5 g120 h in particular whether this
regimen causes hypoalbuminemia. Proteinuria, serum
albumin and creatinine clearance were first as-
sessed on a 70 gram protein diet, 12—18 weeks
apart. Then patients went over to a 30 gram protein
diet for 1)6 weeks. Four patients turned back to
the 70 gram because of subjective complaints, but
resumed the 30 gram when it was found that protein-
uria increased again. All 8 patients could then be
followed for 12 weeks at a 30 gram protein diet.
The results shown are expressed as median values.
—18—12 wks 0 wk L wks 8 wks 20 wks
proteinuria
gram/21 h 9.5 9.9 7.2* 5.0/11 6.6*
serum albumin
g/l 25 27 20 27/26 29
creat.ciear.
ml/min 70 61 50 52/50 03
* p < 0.05 Mann—Whitney rank sum test
Conclusion: A reduction in protein intake is
associated with a fall in proteinuria without
lowering serum albumin levels. If onoteinuria re-
duces 25 %, serum albumin levels rise. Uniortu—
nately, the decrease in creatinine clearance is not
mitigated by this regimen.
•
ACUTE RENAL FAILURE (ARF) IN CHILDREN (c)
MRenel,P.Caro,J.Fdez—Llebrez,F.Vargss—Z,
• TPTtmezT
(Inir. by J.B.Cannata).
Pediatric Nepirology, Hospital Provincial,
Madrid, Spain.
Available information about ARF in C is meagre.
We present Our experience on 74 C (46 males and
28 females) with 76 episodes of ARF. The C were
aged 2 days to 14 years, with a major incidence
of ARE in the first year of life (44%).Diagnosis
of APP was established by the classical parrmeter
in the flood and urine. ARM was divided in prere—
nal 8%; renal 78% and post—renal 14%, all of whom
were males with posterior urethral valves. In the
reral group,the major incidence was the heaolytic
uremic nyndrose 30%, followed by hypeanstremic
dehydration (ND) 21%, glomerulonephritis 11%,
sepsis 8%, cardiac surgery 7%, hypertension 6%,
nephrotoxicity 5%, tumors 6%, hypercslcerim 4%,
and acute interstitial nephritis 2%. The non oil—
NDrc ARE rate reached 40%. Early dialysis treat—
sent was started in 59%. The over all mortality
rate ass l9%,during the oligoanurid perioN of RD
and sepsis, Total recovery was achieved in 60%
of C. Only 2 C started chronic hmemodialysis.
In conclusion. ARF in C is more frequent in the
first year of life, with r major incidence in
males. The nonoliguric form of ARE occur more of-
ten than generally recognized. Prognosis improved
with the regular use of dialysis and so the pres-
ent over all mortality rate is lower and the re—
cerery rate is higher.
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INFLUENCE OF RENAL INSUFFICIENCY ON C.ARBO—
HYDRATE METABOLISM DURING PHYSICAL ACTIVITY
E.Rbseler,K.Precht ,F.Priem,R.Aurisch
Humboldt—University,Medical Clinic(Charitê),Berlin,GDR
Disorders of carbohydrate metabolism in
uremia are well known.The aim of our study
was to investigate the influence of chro-
nic renal failure (CRF) on glucose meta-
bolism during exercise..Blood glucose,lac—
tate ,pyrovate ,inorganic phosphate
were determed at rest and during exercise
in 79 patients with CRF and 18 transplant-
ed patients.
There is a correlation between the change
of glucose level and sertmi creatinine
(ro,7o). Glucose level increased by o,38
mmol/I in uremic patients,whereas glucose
decreased by o,8o mmol/l in the others.
The maximal increase of lsctate production
and Pj during exercise was lower in the
uremic patients (3,62 resp.o,o96 rnmol/l).
than in transplanted patients (7,61 rasp
o,21 mmol/l), but there ware no differen-
ces in pyruvate levels between both groups.
(Pyruvate rosa fron 75 to 235Jumol/l).
These data demonstrate that uremic patients
are unable to metabolize glucose during
physical exercise at normal rate. The
different behavior of lactate and pyruvate
suggast the presence of alterations of
anaerobic glycolysis and citrate cycle.
FAMILIAL BARTTER'S SYNDROME: THREE SISTERS LONG-
TERM TREATED WITH CAPTOPRIL.
A.Voipi, G.M. F'errsrio, M.Meroni, A.Sessa.
Servizio di Nefro)ogia e Dialisi. Ospedale di Vimer
cate. Vimercate. itaLy.
Three sisters, 36—34—23 year—old, were found to
have Bartter's syndrome. They showed hypokalesic
metabolic alkalosis, hypochioremia and increased
levels of urinary chloride, hyperreninism, hyper—
aldosteronism, evident hyperplasia of the juxtaglo—
merular apparatus, and normal blood pressure.
We treated tne tnree patients with captopril for
1 year ( 25mg tnree times a day) and with Ed ( 20
mEq three times a day). We performed chemical ana-
lysis every three months.
During the administration of captopril these pa-
tients didn't show consistent changes of blood pres
sure and cardiac rate; their biochemical findings
didn't show significant modifications of kalemia,
renal handling of electrolites, supine PRA and supi
ne plasaa aldosterone. Although we found evident
reduction of upright PRA and upright plasma aldoste
cone concentrations, they were higher tnan normal
levels.
We conclude that long—term treatsent with capto—
pril at the dosage of 75 mg/day, is not apparently
useful in Bartter's syndrome.
THALLIUM 201 MYOCARDIAL IMAGING IN PRE-DIALISIS
PATIENTS AT HIGH RISK OF ISCHAHMIC HEART DISEASE
N.P.Vites, R.Gokal, N.P.Mallick, M.Prescott,T.Testa.
Manchester Royal Infirmary, Manchester, England.
Coronary artery diaease (CAD) is a major
deterainmnt of survival in end—stage renal disease
(HARD). Coronary arteriography is expensive and
carries some risk. Thallium 201 syocardial
iaaging is a non-invasive sethod of detecting GAD,
carrying high sensitivity (8á) and specificity
(91%). Thirty—six patients in or approaching HSRD
considered at high risk for GAD on the grounds of
histnry, EGG or possession of multiple risk
factors, were studied by this method in & pre—
dialysis assessment.
Nine patients were suspected of recent
infarction and were scw'med. Five scans confirmee
infarction, the other four showed no such evidence
and other psrameters proved normal.
Twenty-seven scans were performed on stable
patients under maximal exercise stressed
conditions. There were no ill effects; 77/c
achieved exercise within the normal range of
tolerance. All four patients with stable angina
had abnormal scans; one had triple vessel disease
at angiography. Of twenty—three aaymptosstic
patients, fourteen had normal scans, nine had
abnormal. Exercise tolerance was equivalent in
the two groups. One of the normal group subse-
quently died and had normal coronary arteries at
autopsy.
Thallium imaging is a safe, simple, non-
invasive method of assessing coronary artery
disease in pre—dislysis patients with or without
angina. It may be used to select those requiring
coronary aogiography, and facilitates follow—up of
a progressive disease process via sequential
testing.
THE LIPOPHTEIN AND APOPROTEIN(APO) ABNORNALITIES
IN HYPEHTHIGLYCERTDEMIG(HTG) PATIENTS UNDERGOING
CHRONIC HENODIALYSIS TNEATNENT(CHT)
Y.WAICABAYASHI,N.OKURO,H.SHINADA,N.SATO,F.MARUNO
Oep.Med. ,Kitasato Univ.Sch.Med. ,Sagamihara,Jmpan.
The serum lipid,lipoprotein and spo levels were
exnnined in 20 patients who had been undergoing
CHT for over 2 yenrs.They were divided into 2
groups consisting of 10 HTG patients and 10 normo—
triglyceridemic(NTG) pntieots.Fastiog blood speci-
mens were collected in the morning of dialysis,and
serum triglycerides(TG) ,total cholesterol(T—CHL),
VLDL,LDL,HDL—CHL,and lethicin—cholesterol scyl—
transferase(LCAT) were measured as routine.In ad—
dition,serum ape AI,AII,B,GII and E were deter-
mined by single radial imnunodiffusion method.
Gene of the scm were ultracentrifuged to obtain
VLDL fraction,whese ape CI,CII and CIII were quan-
tified by horizontal sodium dodecyl sulfate—poly—
acrylamide gel electrophoreeis.
The HTG group of patients showed significantly
higher concentrations of VLDL,T—GHL and LDL than
the NTQ group.HDL—CHL concentration was signifi-
cantly decreased and LGAT activity was signifi-
cantly elevated in the HTG grcup.The ratios of
HDL—CHL/T-CHL and apo Al/ape B were significantly
decreased.The serum concentrations of ape B,CII
and S were elevated,while the ratios of ape CII/
VLDL,apo E/VLDL and TG/VLOL were significantly de-
creased in the HTG group.Apo CII/VLDL showed a
strong inverse correlation with the serum TO level
.Apc CII in VLDL fraction showed a significant de—
crease,while ape GIII,n significant inorease.In
conclusion,the patients in the HTO group exhibited
both compositional and functional alterations in
VLDL and a concomitant deranged metabolism of cho—
lesternl.Accordingly,they may be more susceptible
to develop atheromatous cardiovascular lesions.
. ROLE OF ALPHA-1-MICROGLOBULIN FOR THE EVALUATION OF
TUHULAR IMPAIRMENT AND AS A PARAMETER SUPERIOR TO
CREATININE IN THE ESTIMATION OF THE GFR
M.H.Weber, P.Scholz, F.Scheler
Dept.of Nephrology, University of Gottingen,FRG
Urinary alpha—l-microglobulin (alpha-i—M) was
measured in 350 patients with renal diseases to
study its role as an indicator protein of tubular
impairment. It was further evaluated as to whether
its determination in serum is superior to creati—
nine in the estimation of GFR.
Single radial immunodiffusion, endogenous crea—
tinine clearance and microelectrophoresis in SOS—
polyacrylamide gels were used to determine alpha—i—
M—concentrations, GFR and the urinary protein pat-
tern (high/low molecular weight = HMW/LMW).
In 90 patients with LMW—proteinuria, increased
urinary alpha—i—H—concentrations were found, but
serum levels were Only elevated in patients with
renal insufficiency. We also observed that a reduc-
tion of the GFR itself (Ccrea'c70 ml/min) leads to
increasing urinary concentrations of alpha—i—M. In
350 patients serum—alpha—i—H showed better corre-
lation to the endogenous creatinine clearance
(r = —0,9) than serum creatinine (r = —0,72).
Urinary alpha—1—M is a sensitive parameter of
LMW—proteinuria, but conclusions on an isolated
tubular impairment can only be drawn in cases of
normal or slightly reduced (Ccrea70 xnl/min)renal
function. Serum—alpha—i—H proved to be a more sen-
sitive indicator of renal insufficiency than serum
creatinine even in the so—called creatinine—blind"
region (60—100 ml/min) of the GFR.
ALUMINIUM CONCENTRATIONS IN PLASMA, BONE AND HAIR
IN PATIENTS ON LONG-TERM HAEMODIALYSIS
B. liinterherg, H.P. Bertram, S. Remmers, 3. Remmers,
A.E. Lioon, H. Loose and H. Zumkley
Modizinische Polikiinik and Institut für Pharma—
kologie und Toxikologie, University of MOnster,
[.0.0.
Previous findings from our group suqciest that
plasma aluminium levels do not reflect the alumi-
nium burden in uremi.c patients. A better parameter
seems to be the aluminium level in humsn tissue,
particularly in bone shich is not easily accessib-
le, however. Scalp hair, on the other hand, is sn
easily available human tissue; therefore ae studied
the aluminium concentrations in plasma, hone end
hair specimens of 42 uremic patients on lone—term
dialysis in order to test the applicability of alu-
minium determinations in scalp hair for the moni-
toring of the aluminium body burden. The aluminium
concentrations in these specimens mere measured by
flameless atucic absorption spectrophotometry. The
mean plasma aluminium level was 59,7 58,l,ug/l.
The hone aluminium content sas also elevated to
13,6 9,9in/q fresh weight. Analysis of scalp
hair specimens showed an aluminium concentration
of 10,6 ÷ B,24,&jq/g fresh eeight. Whereas plasma
and bone aluminium concentrations are obviously not
related, bone and hair aluminium levels shoe a
sirjnificenl correlation (rr 0,52, p<0,Ol).
Thus, our findings suggest that analysis of
the easily available scalp hair permits a reliable
monitoring of the aluminium burden in patients on
long—term dialysis.
NTER-SPEIFIC VARIATIONS OF ThYIOID }1DRM)NE LE-
VELS IN HF1DDIALYSIS PATIEN . RESTJL'I.OF A MULTI-
cENTER TRL.
M. Weissel,H.K. Sturmvoll, J. Ivarik, E. Ziumr-
nnn, F. Kaiser, I. Fasching, R. Phegger.
2nd Medical Univ.Clinic, 3rd Dept. of Med., Wilhel-
minenspital, 1St Dept. of Wed., Kaiser Franz Josef-
Spital, Urological Dept. ,}Ianusth-Krankenhaus, Vien-
na, Austria.
Recently presented data suggest a high prevalen-
ce of hyçothyroidien in patients with enletage re-
nal failure. Me have therefore investigated the
thyroid status in 118 patients of 4 heandialysis
centers. Clinical investigation .of the patients re-
vealed no palpable geitre and no definite signs of
thyroid dysfunction. Thyroid hornone serum levels
were noasured by radiolninunoassay: (maan SD).
Center Total T4 Total T3 Tot, reverse T3 n
1 6.0±1.7 68±26 24±6 29
2 6.2±1.7 63±15 21±6 19
3 7.0±1.3 8222 3119 44
4 4.6±1.1 56—18 9—4 26
Mermal ug/dl ng/dl ng/dl
range 4.5-13.0 70-2C0 10-30
Thyrotropin serum levels were normal in all pta.
hyroxin-binding globulin was significantly higher(2 3±4 mg/l) in pta of center 3 in comparison to the
other centers (17,20 and 18 rm/l nean valt), but
within our normal range. The presented nean valts
of center 4 were significantly (p ( 0.01) lower than
the values of the other centers. Our data shcM that
hypathyroidism is rare disease in }ID—pts (0/118).
The here observed significant differences in thy-
roid hornone levels seem to be center—spacific.Vari-
ous factors like different dialysis techniques,vita-
mm supplemantation,cceosition of clialysate mayplay a role.Tine on dialysis and of heparin
did not differ siqnificantly between the centers.
OIJBAIN BIlD1NG SITES OF RED BLU(]) CELLS (PEC) IN NGrUIALYZED
PATIENTS (pts) WITh (HCAiiC RENAL FAILURE (CRF) —
C.H. Witteck, R. Brunkhorst, 0. Schoter, C. Bossaller, K.N.
Koch, K. KUhn.
Div. phro1oaj', 1-larinover tdica1 Schccl, I-brnover, FRG
High sodiin content f )BC in rmndialyzed CkFptssnytedJetoan
inhibition of the i43 -K-AWase activity or due to a reduction
of the nuiter of the RBC-ATPase nnlecules. nEasured in 16
nondiaiyzed CAF pts (s.creainne 6(n) - 12tX) (sDi/l)xi in 14
healthy control subjects Na -K -AlPase activity by K uptake
of PBC and REC-H3-oubain binding sites hich correlate with the
rurter of RBC-AIP ase nnlecules.
group n binding sites
of RBC
(b.s./cell)
NaKtATPase
activity
(rrmDl/RBC/b)
CF4 16 319 1.67 0.24
**
Controls 14 333 64 1.92 0.33
p<O.05
Na-K-ATPase activity was significgntly diminished in CPF pts
cciipared to controis(table). -i -concentration was rega-
tively correlated to the REC-Na -K -AWase activity. Qibain
binding sites ware rot significantly different in CRE pts and
cctr2l subjects (table). In 2 of the pts starting dialysis
Na -K-ATPase activity increased iereas cjbain binding of REC
decreased after 4 was of dialysis treatjiont.
Conclusion:
In rondialyzed pts with CRF high scxiiuii ccnterit of RBC is
rather caused by an inbition of the REC-I'i4-K-ATPase activity
than by a reduced ruter of RBC-ATPase nolecules.
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. IMPAIRED POLYMORPHONUCLEAR (PMN) CELLS CHEMOTAXIS
IN UREMIA.I P. YOUINOU, J. CLEDES*, 3.P.
Departments of Immunology and * Nephrology,
University of BREST — FRANCE
The humoral and cellular contribution to PMN chno—
kinesis (OK) and chemotaxis (CT) were studied in 10
renal failure patients (7M/3F,mean age 51.4) using
the under—agarose assay. Cnplement derived chso—
tactic activity (CA) was obtained by activation of
plasma with 1 mg/mi zymosan. To evaluate the possi-
bility of PMN—directed plasma inhibitor, control
PMNs were incubated for 1 hour at 37°C in 10% pa-
tient plasma, and then activated by control plasma.
Motile
function
Stimulant
Solution
Patients
PMNa
N = 10
Control
PMNs
N = 10
1—Chemoki—
nesis (CM)
CM Plasma
ZANP*
ZP,PP
16.2+6.2
16.96.2
14.7+2,9a*** NS*
15.6+3.9 NS
inhibitor
2 —Chem otax is
ZANP ND 147+2.6a
(CT)
CT Plasma
ZANP
ZAPP
23.4±5.9
23.6+5.7
27.1+1.9b 0.02
26.2+2.0 0.03
inhibitor ZANP ND 21.4+3.3b
*ZAN(P) P, zyinosan—activated normal (patient)plasma
ND : not done, WS : non significant ** Mann
Whitney's test ***Wjlcoxons test:aNS,b=0.001.
CT was significantly reduced in uremia, whilst CM
and CA were normal. There was a PMN—directed plamsa
.nhibitor which correlated to CT in ptients(delb=
control PMNs in medium minus control PMNs in pa-
tient plasma VS patient CT:r=O.67, p0.05). This
could well be one of the explanations of CT
impairment in uremia.
A STUDY ON FACTORS RESPONSIBLE FOR LOW CONCENTRA-
TION OF FRYTHROCYTE a—TOCOPHEROL IN CHRONIC RENAL
FAILURE
S. Yukawa, K. Mori, H. Nomoto, N. Nimhikawa,
I. Nishide
The 3rd Department of Internal Medicine, Wakayacna
Medical College, Wakayama, Japan
It is known that in chronic renal failure (CRF)
the level of s—tocopherol (TOO) in erythrocyte
(RBC) is lowered, causing the dysfunction of sur-
face membrane of RBC, but the relevant mechanism is
quite unknown. The present study was performed in
an attempt to elucidate this abnormal mechanism
both in vivo and vitro. In healthy subjects, the
blood level of TOC at 0, 3, 6, 10 and 24 hr after
oral administration of 600 mg/day TOC reached a
peak at 6 hr in plasma and thereafter showed a
time—dependent increase in high density lipoprotein
(HDL) and NBC; in patients with CRF, the TOO level
was delayed in reaching a peak in plasma, and its
increase in HDL and RBC, especially in the latter,
was slight. REC—TOC at 0 hr showed a positive
correlation with HDL—TOC in healthy subjects,
whereas a positive correlation of RBC—TOC with
lipoproteins other than HDL was noted in patients.
Thus, as an experimental system in vitro which is
similar in physiological conditions, the mixture of
REC from patients and plasma with and without
lecithin: cholesterol acyltranmferase (LOAT) ac-
tivity from healthy subjects was prepared and incu-
bated at 37°C fur 30—60 mm. to examine the utili-
zation of 1-(DL—TOC. As a result, the lowering of
HDL—TOC level was found most prominent in the ex-
perimental system containing LCAT. These in vivo
and in vitro findings suggested that a main factor
responsible for the lowering of erythrocyte—TOC
level in patients may be an insufficient reaction
of LCAT.
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TRANSFERS FROM HEMODIALYSIS (HD) TO CAPD AND VICE
VERSA.
S. Acchiardo, M. Datzman, A. Kraus, Jr.
University of Tennessee Center for the Health
Sciences, Memphis, Tennessee. U.S.A.
CAPD is an accepted modality of treatment for
patients (pts) with end stage renal disease. We
evaluated the outcome of pts who were on HD and
transferred to CAPD or those who dropped out from
CAPD and were started on HO. During the last 5
years 17 pts transferred from HD to CAPD, and the
main reasons given were more independence, no diet
restrictions, no needle sticks, and unstable cardio-
vascular conditions. 4 of these pts returned to
ND, 3 of them within 7 m. due to repeated episodes
of peritonitis and 1 due to loss of ultrafiltration
after 32 m. 15 pts transferred from CAPD to HD due
mainly to repeated peritonitis, non-compliance with
exchanges, catheter problems, intra-abdominal ab-
scess and mesenteric venous thrombosis. The mean
values for Hgb (10.0 vs 7.5 gms), Hct. (29.2 vs
21.7%), cholesterol (212 vs 182 mg/dl), and bicar-
bonate (23.3 vs 20.2 mmol/l) were significantly
higher in CAPD pts. The total protein (7.0 vs.
6.4 g/l) and serum albumin (3.8 vs 3.27 g/l) were
significantly lower in CAPD pts. There was no
significant difference in the blood urea nitrogen,
creatinine, calcium, phosphorus, alkaline phospha—
tase and uric acid values. 6 of the 10 pts requir-
ing antihypertensive medications on HD were able to
discontinue on CAPD. Body weight tended to increase
on CAPD but did not reach statistical difference.
Hospital days/yr were greater while on CAPD (22.5
vs 4.96 days/yr) except for those who had non-
dialysis related complications. CAPD offers more
freedom, better control of BP and improves anemia,
but at the expense of poor nutritional status and
more prolonged and frequent hospitalizations.
DIFFERING OPSONIC REQUIREMENTS FOR STAPHYLOCOCCUS
EPIDERMIDIS ISOLATED FROM CAPD PERITONITIS:
CLINICAL S[GN[FICANCE.
D.N.Bennett—Jones, C.M.Gillespie, J.S.Cameron,
C.S.Ogg, D.G.Williams.
Guys Hospital, London, U.K.
Ten isolates of Staphylococcus epidermidis
from the skin and PD effluent of 9 patients
receiving treatment with CAPD were identified
using bio—typing and phage—typing. The isolates
were opsonised with 10% pooled human serum (PHS),
1% PHS, [0% decomplemented pooled human serum
(fr-PHS), 1% 8—PUS and PD effluent after 30mm,
4hr and l2hr dwell—periods. The degree of
opsonisation was assessed by measuring the
chemiluminescent response of normal peripheral
blood polymorphs to the opsonised bacteria. The
findings were confirmed using a semi—quantitative
Acridine Orange assay.
Some isolates demonstrated significantly less
opsonisation when treated with 1% PHS and 10%
—PHS (p<O.OS). However, no correlation could be
found between bio—type, phage—type or virulence
and opsonisation characteristics. When PD
effluent was used as the opsonic fluid, a marked
difference in opsonisation was found between
patients against different isolates over the
time—course of a 12—hr dwell—period.
These results suggest that the host—pathogen
relationship In peritoneal infection during CAPD
is more complex than previously suspected, and
that the ability of the host to respond to a
particular strain of contaminating bacteria may
determine whether peritonitis occurs or not.
USE OF HUMAN INSULIN INTRAPERITONEALLY ADMINISTRA-
TED TO DIABETICS UNDER CAPD
P.Altieri, R.Ferrara, G.F.Pili, P.G.Bolasco, A.Bar
racca.
Nephrology and Dialysis Department, General Hospi-
tal of Cagliari, Italy.
Human Insulin pharmacokinetic intraperitoneally
administrated to 8 insulin—dependent diabetics
(ages 25 to 47 years) under CAPD for at least
6 months was studied.
In all patients insulin was added to the
dialysate.
To compare the traditional insulin kinetic
(Actrapid MC Novo) with the human insulin
kinetic (Actrapid HM Novo) the latter was
administrated one day later. Both insulins
were injected in the first morning bag containing
glucose 1,5 gr.%.
The same doses of insulin administrated
during previous periods of observation were
used in both cases.
Curves obtained from the mean value of
free—insulin and from glicemy assessed in 0, 10,
20', 30', 40', 50', 60', 90', 120', 180',
240' from the onset of the inflow did not show any
statistically significant difference and has
confirmed an equal absorbtion and an equal
metabolic action of the 2 insulin intraperitoneal—
ly administrated.
Further studies are necessary to assess
the long term effects of intraperitoneally
administrated human insulin to diabetic patients
under CAPD.
RISK FACTORS FOR PERITONITIS AND TECHNIQUE
FAILURE IN CAPD: INCREASED AGE AND DIALYSATE lgG
PROTECT AGAINST PERITONITIS.
D.N.Bennett—Jones, A.Eaton, J.S.Cameron, C.S.Ogg,
D.G.Williams.
GuyTh Hospital, London, U.K.
Actuarial survival curves have been calculated
for time to technique failure, 1st episode of
peritonitis, all episodes of peritonitis and
death, for all patients (n'135) treated on our
CAPD programme. The influence of age, sex,
whether CAPD was being used as 1st treatment and
year of entry to the programme was analysed using
the log—rank test. The calculations were
performed using a locally—written programme on a
micro—computer.
The results reveal no identifiable risk
factors for technique failure (47% at 1 year, 60%
at 2 years). However, patients >60 years old are
significantly less likely to develop peritonitis
(p<O.OS). IgG levels from the overnight PD fluid
of 37 patients was measured and a significant
correlation between dialysate IgG and increasing
age was found (p<D.O5). This may explain the
lower incidence of peritonitis in older patients.
A higher rate of peritonitis in any group of
patients was not associated with an increased
rate of technique failure.
The life—table for time to first episode of
peritonitis is not significantly different to
that for subsequent episodes. In view of this we
are using cross—over procedures in the design of
trials investigating methods of reducing the
incidence of peritonitis. This allows a greater
number of patients to be entered into each limb
of any trial, and also reduces the problem of
matching patients on the different treatments.
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CALCIUM TRANSPORT DURING HYPERTONIC PERITONEAL
DIALYSIS
U. Binswanger, K. Vogt, R. Hermann, B. Hess,
G. Keusch
Section of Nephrology, University Hopsital Zurich,
Switzerland
Net calcium transfer was estimated in 17
patients on CAPD based on measurements of total
and ionized calcium in dialysate and serum as
well as ultrafiltrable calcium in serum. The
dialysate contained calcium 2 mmol/l, glucose
220 rnmol/l and lactate 35 mmol/l. Calcium uptake
from the dialysate amounted from 0.01 to 0.76 in
13 patients whereas loss of calcium into the dia—
lysate was 0.12 - 0.92 mmol/l in 4 patients. The
calcium concentration gradient calculated as mean
Ca (total in dialysate) — Ca (UF in serum) was
2.27 + 0.39 and 2.66 0.36 mmol for patients in
positive and negative dialysis calcium balance
respectively. However, ultrafiltration volume was
higher in calcium loosers amounting to 0.98 lt
(range 0.86 - 1.0) as compared to 0.66 lt (range
0.20 — 1.00) in patients with calcium uptake.
These data point towards an important influence
on dialysis calcium balance of convective calcium
transport from blood into dialysate in case of
high ultrafiltration volumes.
LONG TERM EFFICACY OF A V—CONNECTOR ANDDIS1NFECTANT
'10 PREVENT PERITONITIS IN CAPD.
A.Cantaluppi, C.Castelnovo, A.Scaiamogna, L.Guerra,
G.Graziani and C.Ponticelli.
Div. Nefrologia,Ospedale Maggiore,Milsno,Italy.
We have already published (Lancet 1983,ii,642)
the resulLs of a controlled study in two Centres
showing the efficacy of a Y—shaped set,Iilled with
sodium hypochlorite during the dwelling time,for
the reduction of peritonitis rate: 1 episode every
33 pt—months versus 1 episode every 11.3 pt—months
in the control group using the standard method.
During the past two years we continued the use
of the V—connector. All the new pta referred to our
hoaptal for CAPD program were trained to use the
Y—eonnector,while pts already on trestment conti—
nued with the atandard or the V system.
From January 1983 to December 1984,in the 18 non
diabetic pts using the standard bag—exchange method,
there were 20 peritonitis episodes in 13 pts (72%)
during a cumulative period of 250 months— 1 episode
cvery 12.5 pt—months, In the 77 pts using the V
connector,there were 18 peritonitis episodes in 15
pta (19.5%) during 997 months— I episode every 55.4
pt—months. When we exclude from this group the 10
diabetic pts adding insulin to the bags, the mci—
derice of peritonitis was 1 episode every 98.5 pt—
months.
These results confirm that the Y—connector is
extremely effective in reducing the rate of perito-
nitis in pts on CAPD.
PREVENTION OF PERITONITIS: UV—SYSTEM OR FILTER?
E.W.Boeschoten, J,Southwood, R.T.Krediet, L.Arisz.
RiiT1ThT€,epartment of Medicine, Academic
r-ledical Centre, Amsterdam, The Netherlands.
In a group of 60 CAPD patients large differences
were seen in peritonitis incidence (X) between in-
dividual patients. Assuming this to be caused by
external bacterial contamination, we selected seven
high-risk patients to test the efficacy of the UV-
system (Travenol) and the PeridexR filterset
(Millipore). Preceding CAPD experience had to be at
least six months and X at least two episodes per
year. Three patients had the UV-system, three
others the filterset, and one patient had both in
succession. Results were compared with the pre-
viously used (Travenol lIP) system. Mean Xwith the
UV-system was 3.3 episodes/year (previously 2.6
n.s.). Using the filter a decrease was seen from
4.6 in the past to 2.1 episodesJyear (p < 0.01).
Probability (P) to stay free from peritonitis
after six months was calculated as Pexp (- Xt),
where t is period of time. It appeared unchanged
(25%) with UV and improved from 10% to 35% with
the filterset. In case of peritonitis the same type
of bacteria were cultured from filter and dialy—
sate. Interestingly from four of 22 filters Gram
positive bacteria were cultured in the absence of
peritonitis. This suggests that the filter actually
may have prevented peritonitis in these cases. In
the five peritonitis episodes that could not be
prevented by the filter, no obvious cause for
failure of the system could be identified.
We conclude that the UV-system did not produce
a real improvement in high-risk patients. Although
filtersets are expensive and too cumbersome in most
CAPD patients, they may be useful in selected
patients with a high incidence of peritonitis.
PERITONEAL MEMBRANE DEFENSE MECHANISM IN
CAPD.
S.Carozzi, S.Lamperi.
Division on Nephroloqy,St.Martin Hospital,
Genoa, Italy.
In 40 C7PD patients from the predialysis phase,
up to one year after the beginnig of therapy ssne
immunological parameters primarily connected with
the biolcx9ical functions of the peritceeal rnernbra—
ne ,particularly IgG, C3, C3b levels, opsonic and
interleuki.n 1 activities, Inacrophage and neutrophil
antibacterial function were studied.
The results shod a progressive activation of
the above rnantioned parameters ,which sre depressed
in predialysis phase, in 30 CTPD patients (group 1)
with a low incidence of peritonitis. Ce the contra-
ry, in 10 CAPD patients (group 2) with a high Inci-
dence of peritonitis non activation, or even de-
pression of the mama paramaters, has observed.
Eight CItPD pcttienbs of group 2 were LreaLed with
intraperitoneal prophylactic instillation of IgG
fol one year. These subjects showed a progressive
recovery of the defensive peritoneal activities and
a reduction of peritonitis occurrence.
Our rsult de'anstrate that the evaluation of
the biological activities located in the abdaninal
cavity can identify those CPPD patients with a pos-
sibly high incidence of peritonitis, and start a
precocious therapy with the aim of recovery in the
host defence mechanism.
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IRON AND IRON BINDING PROTEINS LOSSES IN CAPD
D.Cassani,M.Martegani,L.Baratelli,G.Frattini,D.D00
ti,A.De Maio,O.Amatruda,L.Gastaldi.(Ifltr.bY R.Rossi)
Ospedale di Circolo—Div.di Nefrologia—VareSe—ItalY.
Iron(I), Albumin(A),Transferrin(Tr)afld Ferritin
(Fe) daily peritoneal losses were studied in 15CAPD
patients on four exchanges regimen. I(spectrophoto—
metric method), A and Tr(immunonephelometry),Fe(RIA)
were determined both in serum and in dialysis fluid.
Total 24 hr.losses and peritoneal clearances were
calculated.
A and Tr 24hr.losses are similar those reported by
others; I losaes,amounting to 338 ,pg(125 mg/year)
represent about an half of the estimated iron losses
that occur by blood rest in the dialyzerm.
Statistical analysis(T test) showed a highly signi
ficative correlation between A and Tr clearances(p(
0.001) and between I and Fe clearances(p<0.OO1).
Furthersore Fe clearance is six fold higher than Tr
clearance. Since Fe m.w.(450.000)is higher than Tr
s.w.(68.000) it can be argued that Fe transfer thro
ugh peritoneum occurs in a different way from simple
diffusion.
The high Fe clearance may be explained assuming an
active transport of Fe through the peritoneal wall
or the release of tissutal Fe in peritoneal cavity
by macrophages and desquamating mesothelial cells.
THE EFFECT OF PERITONEAL DIALYSIS (PD) ON THE
ENERGY TURNOVER
H. Ebel, W. Bereck, H.G. MUller, H. Lange
Dept. of Nephrology, Univ. of Marburg, F.R.G.
The effect of PD procedure itself (duration:
9.5 - 10.0 hrs) on the energy turnover IQmetab =
Qrcc + Qevapi was measured by direct calorimetry
(metabolic scale: evaporative heat loss [Qevapi
temperature computer; heat loss by radiation, con-
vection, and conduction Qrcc] on 16 patients
with ESRF (group P01: 11 female, 5 male; 30—83 yrs;
Ccreat<3 el/mm.). The measurements were performed
under controlled conditions (air temp., humidity,
rectal temp.). a) before (7.00 - 8.00 a.m.) and
b) after PD (6.00 — 6.30 p.m.). 5 patients were
reexamined without PD procedure and formed group
P02 (4 female, 1 male; 21 — 40 yrs.).
7 healthy subjects served as normal controls
(group N).
Qrnetab Qrcc Qevap rectal. temp.
[kcal / kg / dayj OCj
N — 26.6±3.4 20.6±2.5 6.6±1.0 36.5±0.2
** p'0.01
Conclusion: The corresponding increase of heat
loss and rectal temp. (r=0.511, pO.Ol, Spearman—
Rang) under PD-procedure appeared to be due to an
increased heat production rather than to heat
accumulati on.
CLINICAL EXPERIENCE WITH SHORT PERITONEAL CATHETERS.
S. Chiaramonte, M. Feriani, S. Biasioli, L. Bragan—
tini, A. Brendolan, R. Dell'Aquila, A. Fabris, C.
Ronco, 6. La Greca.
Dept. of Nephrology, O.C. S.Bortolo, Vicenza, Italy
The displacement of the peritoneal catheter is an irn
portant complication which requires a surgical cor—
recti on.
To avoid this problem, we modified two convenctional
catheters (Gore-Tex and Tenckhoff catheter) prepa-
ring a short intraperitoneal segment (8 cm) and in-
serting the device 3 cm above the pubis: thus the p0
sition of the catheter tip in the peritoneal cavity
cannot affect the drainage any more.
In two groups of patients comparable for age, sex
and dialysis, we studied 41 short catheters versus
26 convenctional catheters: the total catheter—month
experience was respectively 245 and 259; the skin
exit infection episodes (requiring the substitution
of the prosthesis) were respectively 7 and 9; the
catheter displacements (requiring surgical correc-
tion) were respectively 0 and 14.
All the short catheters have been well functioning,
even during a severe episode of adynamic ileus cau-
sed by peritonitis and after two wide laparotomies
performed without removing the prosthesis.
Our data suggest that the displacement of the pen—
toneal catheter will be no more a problem by the use
of short catheters.
CAPD: A} ALTERNATIVE TIET0D POR TREAT ING
CHRONIC RENAL FAILURE (CRF) IN DEVILOPING
COUNTRIES(DC):TFIE EXPERIENCE OF ONE CENTEL
EL Shahat, Y. El Gammal.
El Mehalla Nephrology Center - EGYPT.
The most important problems facing the
treatment of CRF in DC are soclo—economic.
Phe high costs and lack of advanced techn-
ical facilities prevent the widespread of
iemodialysis(HD)and renal transplantation.
Searching for a better way, 20 CRF pat—
ients(pts)(l3and 7) were treated by CAPD
between Jan 1983 and Jan 1985. At the beg—
Lnning of CAPD, the mean age was 42+7years
and mean creatinine clearance was 4.5 ml,
mm. Causes of CRF were chronic glomerulo—
hephritis in 9; chronic interstitiel neph—
itis in 6; and diabetes in 3. All the ma-
terials necessary for CAPD are rnanufactur—
ed locally. Each patient made 3 exchanges
per day. The evolution of some clinical
and biological parameters was as follows:
Months 0 6 1 24(Patients).... (20) (18) (14) (14)
M S.creat.(nig/dl) 14 8.9 7.8 7.5
M B1.urea(mg/dl) 280 210 180 170
M B1.Press. (nimHg) O _0
M Body weight(Kg) 66 60 61 59
12 pts regain a full—time work. The in-
cidence of peritonitis was 1 episode/12
mnonths—pts.2 pts died, one from septicemia
after peritonitis and the other from rnyoc—
ardial infarction. 3 pts were transferred
to HD. Economically CAPD costs about S4000
While HD costs about $ 12000.
So, CAPD can represent a better way for
treating CRP in the DC.
.
.
Daily losses
I = 338 + 91 )g.
A = 5253 + 2129 mg.
Tr = 340 + 13b mg.
Fe = 97 78,Lg.
Clearances
0.4311 + 0.028 ml/min
0.1059 + 0.045 mI/mm
0.1133 + 0.054 ml/min
0.7768 + 0.073 mi/mm
PD1 a 27.O±4.7** 20.4±3.1 6.6±2.5
b 30.5±3.9** 23.0±2.5 7.5±2.0
PD2 a 25.7±2.6b 26.9±2.8
20.5±2.4 5.2±0.3
20.5±2.4 6.3±1.6
36.6±0.3
37.2±0.3
36.6±0.2
36.8± 0.5
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SUBSTITUTION OF SODIUM BICARBONATE FOR SODIUM ACETA
TE/LACTATE IN THE CARD FLUID.
N. Feri ani ,S.Biasiol i ,L .Bragantini ,A. Brendolan ,S. Chia
ramonte,R.Dell tAqulla,A.rabriscRoncoGLa Greca
Dept. of Nephrology St.Bortolo Hospital Vicenza
A preformed HCO3 solution for CARD is difficult
to prepare,steriljze and store.When an acid solution
(acetic/lactic acid)reacts with NaHCO3 a high CO2
content is generatecj,thus preventing the precipita-
tion of CaCO2 salt. C02,which is volatile,tends away
from the solutjon.Thj risk can be prevented prepa-
ring the final solution just before its use.
We solved this problem by designiq and realizing
a specially shaped bag(SIFRA SOLUBAG ) for CAPD.
Thanks to a partition walI,this bag is divided into
2 parts,one for the acid and one for the basic solu-
tion.The bag is sterilized by autoclave and can be
stored for 1 year.Only before the use,a special va}e
placed in the partition wall,is broken by a gentle
external pressure and,as the 2 solutions mix,the fi-
rial dialysate is ready.
After several"in vitro"experiments,a clinical
trial with 4 CARD patients was started using the fol-
lowing final composition: Na=l39,K=l,Ca=4,Cl=l04,
HCO3=35,CH3COO=5 mEq/L;Glucose=16.5 g/L;Osmolality=
=368 m0sm/Kg/H20;pH7.l5;pCO2=34 mrnHg.
The HCO3 transfer from dialysate to blood is stri
ctly related with serum HCO3;the difference between
serum and dialysate HCO3(N=l4) were:3.6l.4(r=O.6l)
2.O±l.O(rO.74)and l.6±0.5(r=0.99)mEq/L after 4,6,12,
hrs dwell time respectively.The lack of technical
problems and the easy correction of acidosis confirm
that HCO3 can be used as a buffer in CARD solutions.
PERT!IONHtJN WINNER OF PERI!JNEAL INFECTIONS ?
R, Guiberteau, D, Le Chapois, A. Nony, A. Talin
(Intr. by D. Benevent)
Dep. of Nephrology, Bourges, Prance.
In CAFD, the instillation of large volumes of
dialysate disturbs the natural defenses of the
peritoneum against infections.
Since Nay 1982, in order to avoid nutritionnal
problems and to Save peritoneal membrane, we have
stopped instillation of the night bag for all pa-
tients. So, they stay with empty abdominal cavity
during the night. We call this method "Intermittent
Ambulatory Peritoneal Dialysis" (IAPD).
After this change, the rate of Peritoneal
Infections (pi) has decreased and the clinical
aspect of the P1 was less serious. We explain this
phenomenon by an improvement of the natural
peritoneal defenses due to the nocturn peritoneal
rest.
So, in the case of P1 we decided to increase
this rest upto 48 K. We have the following
schedule
— single injection of 500 mg Oxacillin dilutedin 10 ml to avoid bacteriological proliferation
into the catheter,
- stop of exchanges during 48 II.
During 1984, 25 P1 in 17 IAPD patients were
treated with this method.
16 Fl treated with success (no relapse during
the 4 following weeks). The method failed in 7
cases and the patients were after wards treated
classically.
The stop of exchanges during 48 B is an easy
and atoxic way of treating P1, because we can use
effioiently the natural defenses of the peritoneum.,
INFERIOR RESULTS FOR RENAL TRANSPLA1TATJON IN
PATIENTS ON CAPD VS HEMODIALYSIS
N. Gelfand, J. Role, B. Quillao, N. Meihorn,
J. Winchester, 8. Helfrich.
Georgetown University Hospital, Washington,o.C.USA
Although the outcome for transplantation in pta
receiving CAPD has been reported to be equal to
that of pts receiving ND, data from our center do
not confirm these results. In 22 transplants per-
formed in 17 CAPD pts, we found transplant survival
was Inferior in CARD compared to ND pta. Graft sur—
vial at 1 yr was 33% for CAPD vs 76% for ND (p<
0.05). At 2 yrs, only 2 transplants continued tofunction in CAPD pts (10% 2—yrsurvival) vs 655 for
HO (p<O.05). To explain these results, we studied
changes in I—cell subsets in CASO ad ND pts swait—
ing transplant. In contrast to MD pts, there was a
rise in the ratio of T4:T8 (helper:suppressor) T—
cells from.an average of 1.3 0.3 during the 1st
6 most of CAPD to 2.0 1 from 7 to 24 mos on CAPD(p<0.05). 14:18 ratios of pts on CAPD 26 or more
moe returned to baseline (T4:T8=l.6 0.3, PNS).
Consistent with these findings is the observation
that pts on CAPD 5 mos had a 40% rejection rate
whereas those on CAPD 6 to 27 sos had an 80% re-jection rate. In addition, 5 of 25 CAPD pta
studied developed high titer (4+ at 1:16 or greater
dilution) warm anti B—cell Abs. Only 3 pta of more
then 100 on HD had warm anti B-cell Abs at thistiter. This was interesting since CAPD pta in
general required fewer transfusions tha HO pts.
Perhaps these immunological changes reflect under-
lying enchancement in immunocompetence in CAPD pts
or immunostimulation during CAPD thus predisposing
CAPD pts to a less favorable outcome for transplan-
tation. Alternatively, pts in our program may re-
ceive their transplants during the sos on CAPD
during which they may be more immunocompetent.
EFFECTS OF TIME, DIABETES AND HYPERTENSION ON PERI—
TONEAL TRANSPORT
!lanneiore Main, Ramesh Khanna, Harold Moore, Karl
Moiph
(Intr. by M. T<essel)
Univ. of Mo.,, VA—Hospital and Dalton research center
Columbia, Mo./USA
in 27 patients treated with CARD peritoneal tran-
sport was assessed during the first week and at
varying intervals thereafter. Initial and later
measurements have been analyzed seperately in pat-
ients with diabetes mellitus, patients with 5 years
of totally controlled hypertension prior to CAPD
and in non—diabetics with normal blood pressure.
Transport measurements were determined during 2 C
long—dwell exchanges (200—300 mm) with 1.5% dex-.
trose solutions. Measurements included ultrafiltra-.
tion (liE), urea clearance (CON), creatinine clea-
rance (CCH), inulin clearance (CIN), dialysate pro-
tein (DPR), dialysate glucose (DC) and glucose ab-
sorption per exchange (CABS). The results overall
are shown in table 1.
ml mi/sin mg/di ng/ml mg/ex
mit.
-
238 8.3 5.8 2.1 79 648 16
last 94 7.5 5.5 1.9 65 605 18
p 0.025 .01 .001 MS MS MS NS
The mean time on CAPD between studies was 11 1.3
SEM months. The findings do not suggest any signi-
ficant changes in permeability or peritoneal area.
Decreases in OF explain changes in filM and COB and
may relate sore to mechanics or compliance than
membrane alterations. In diabetics OF was sigrjifi—
cantly decreased after one year. However, a history
of hypertension suggests no significant effects on
peritoneal transport or UP.
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PLRITQN4L MEMBRANE rAILuRE (Pp) AS A DETERMINANT OF
THE CAPO FUTURE (A EPIDEMIOLOCICAL,F0NCTIONAL AND •A—
THOLOGICAL STUDY)
£.Huarte,R .Sel 1aa, A .R—Csrmona ,M . P—Fontan, 0 .Ortega ,M .E
Martinez,J.Li9Iiiel,L.S—SiciliaL.S.La Paz, MADRID. SPAIN
Perjteneal functional survival could be limitec since
some CAPO patients(pts) should be transterod to demo—
dialysis,because they present PE • Pr i has been defi
ned as a severe decrease of ultrafiltration capacity(UF); Pr ii is PF I. decrease of ditfusion capacity
U1TC)-. 12 pta on CAPOlactate),among 55 treated atleast 1 year,presented Pr (I:7;II:5); S should have
been transfered to HO. Control aroup for functional
measurements (C) was constitutod by 18 pta commencinç1
CAPO therapy,no vascular disoase,never peritonitis(P)
MTC's were determined through nathernetical modelling
thecniques; 4 pta were examined(MTC)under Nitroprusel
de(N) i.p.(4.Smg/l).Epidemiologicai features 11 we-
re women,9 high blood pres-ure,6 were under beta—blo—ker therapy(4 Pr I); no differences were found in age
(mean)arnd renal disease distribution; slightly greater
P incidence as a group than the rest of pts( 1 p re-
quired surgery; 2 pta never P.Man duration of episo-
des: 2.5 days.In scram pta sever1 P were concentratod
in small periods of tine) .MeanJCAPD treatment 16 m,
3 pta suffered hemoperitoneura( s the only known fac
tor in one Pt). Functional stues: UI (both groups)
was 5O with respect to C(l0 in one case) ; hyperto—
nic(4.25%) employement 2—3 times more than C. MTC's:'
P1 I showed a mean % increase with respect to themse
yes and C,respectivaly,for urea S7—5b3.,creatinine 132
—llO,uric ac. lO5—35,inulino 102—92 and i—PIH b5—53
P1 II : mean o decrease for urea 66—66,o,craatinine
65—79,uric Sc. 70—41 and PTh 35—l9. N—test PF I (3
pta) RIO's increases slightly more then C P1 II (1pt) MTL's do not change . Patho1pgge1 features : PrI I4 pta) showed partial sclerosis of peritoneum. P1
II (4 pta) showed extense sclerosing peritonitis.
Conclusions : It seems that not only acetate md P
duce PE: gender,hemoperitoneum and beta—blokers are
also factors that play a role in P1 induction. P1 I
could be the initial form of the PF II,or both may br
different degrees of the name phenomenon. IIIC s and
JI help to define the type of PF. In PF I,creatinine
djfussjon is more affected than that of urea.
IS THE Li1ALYmATE EytLUENT lflhILr. CI:LL COUNT (EWC) A
khLIAI3LE INDICATOR OF ItmIII1TONITIS (P) IN PATIENTS
TMEATEI) 131 PEIIITONEAL DiALYSIS (PPD)?
Z,Korzets, S.Kovatz, N.Jasensky, J.Bernheim.
Opmt of Nephrology, Meir Hospital, Kfar Saba and
Sackler School of Medicine University of Tel Aviv.
P1) is a useful treatment for end stage renal failure
its major complication remaining P.Early diagnosis of
P is essential for prolonged success.EWC above 1O(J/mm3
associated to cloudy effluent and signs of peritoneal
inflammation is considered as an indicator of P.To eva-
luate the value of EWC,a prospective study was perfor-
med during a year in 15 PPI) on IPD.729 IWC were perfos'
med.Mean individual patient INC was calculated under
basal condition and in presence of P.m every case of
P and 8 P1'!) without P(44 evaluations)a polymorphonu—
lear cell count(PMN)was obtained.The results(mean+SD)
are as follows:The total EWC,with no P,is 74+132/sin3
implying that above 338(m+2 SD)should INC be considend
abnormal.individual patient EWC showed a wide scatter
(range 35±20 to 143-i-8(nm3).1'athologic EWC can this be
hown to vary from 75 to 313/mm3.Absolute PMN ranged
from 14±3 to 85+44nm3.individual patient F?IN varied
from one dialysis to another(6 to 75) of total wBC).
Cloudy ffluent was not infrequently seen with normal
EWC.In culture positive F, INC and l'tN were 1300 and
1150/sin3 respectively (k'NN 90%).In sterile P INC was
830±1550 and PEN 643±148/nin3.The tremendous SI) suggests
overdiagnosis of }'.ln conclusion INC above 100/mm3 as
an indicator of P leads to overdiagnosis.The basal EWC
(no F) should be determined for each PPI).EWC above
nean+2 513 is probably a more reliable indicator of P.
"MN above 9Ofe of EWC is present during P although in
some FF13 without P PMN may be as high as 75i.
INTRACELLULAR SURVIVAL OF CANDIDA ALBICANS IN
PERITONEAL MACROPHAGES FROM CHRONIC PERITONEAL
DIALYSIS PATIENTS.
W.F. Keane, D. Lee, 51.3. Suh, M. Develon, R.D.
Nelson, P.K. Peterson
(Intr. by C. Kjellstrand).
Hennepin County Medical Center, and the
University of Minnesota Health Sciences
Center, Minneapolis, Minnesota.
Candida peritonitis is a tenacious
infection in patients undergoing chronic
peritoneal dialysis. Since little is known
about host defenses of the human peritoneal
cavity against fungi, we investigated the
interaction of peritoiieal macrophages (PMO)
from uninfected dialysis patients with C.
albicans blastospores. Chemiluminescence
techin.iques were used to assess the repiratory
burst activity of these cells, and
candidacidal activity was evaluated with a
fluorochrome inicroassay. In sharp contrast to
peripheral blood polymorphonuclear leukocytes
(PMNs) from healthy donors, which gave a brisk
Juminol—enhanced chemiluminescence (CL)
response to opsonized blastospores and killed
35% of cell—associated organisms, PMO produced
barely detectable luminol—enhanced CL and
killed only 13% of intracellular Candida.
These findings appeared to be related to
relatively poor triggering of superoxide
production during phagocytosis of viable
blastospores. The CL response of PMNs to C.
albicans was opsonin—dependent, and peritonesl
dialysis effluent was devoid of opsonic
activity. Tue studies suggest that local
cellular and humoral mechanisms of defense are
inadequate for protection of peritoneal
dialysis patients against Candids peritonitis.
5 YEARS PERITONEAL DIALYSIS
M.C.Kozma-Malik, Q. Kozma,M.Al Mosawi, K.
V. Johny (Intr. by G. Kozma)
Dept. of medicine, nephrology unit, Amiri
Hospital, Kuwait.
Peritoneal dialysis (P.D.) as a mode
of renal replacement therapy started in
1979. From 1979 to 1984, 166 new patients
have been taken on both intermittent and
continuous peritoneal dialyais. In our
cosmopolitan country 48,2% of the patients
are citizens. The age varies from less
than 10 years to up than 70 years.
Chronic pyelonephritis is the major cause
of renal failure. The reasons for termi-
nating P.D. include death (23.5%), renal
transplant (19.3%), hemodialysis (29.5%).
The shifting to hemodialysis is due for
the majority to peritonitis (59.2%) and
blocked catheter (22.4%). There was 0.47
peritonitis and 0.28 blocked catheter per
patient in 1984. The patient survival is
72% at 1 year, 63% at 2 years. The
peritoneal catheter survival is respecti-
vely 65% and 58%.
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• PERMEABILITY OF THE PERITONEIJM TO PROTEINS IN CAPO
.
PATIENTS WITH SYSTEMIC DISEASE.
R.T.Krediet, E.W.Boeschoten, F.M.J.Zuyderhoudt,
L.Arisz.
Renal Unit, Department of Medicine, Academic
Medical Centre, Amsterdam, The Netherlands.
Peritoneal protein loss (PL) and protein clear-
ance (PC) were determined in 13 CAPD patients with
renal failure due to primary renal disease (PRO),
15 with diabetic nephropathy (ON), 4 with SLE and
4 with amyloidosis (AMY). The patients collected
all dialysis bags on 3 successive days. None of
them had peritonitis during the study. Proteins
measured in dialysate and serum were albumin (Mb),
transferrin (I), IgG, C3 and ct2—macroglobulin (aM).
Alb. was quantitatively the most important dia-
lysate protein. P1 of Mb (mean, g/24 h) was 3.3 in
PRO, 4.0 in DM, 2.2 inSLE and 4.6 in AMY. PCwere
found to be lower, the higher the molecular weight
of the protein. This relationship was linear when
plotted on a double logarithmic scale. The observed
restriction in transport of high molecular weight
proteins was much more than could be attributed to
differences in free diffusion in water.
No significant differences in PCs were found
between PRO and SLE patients, but OW patients had
higher PC of Aib, T, IgG (all p<0.05) and C3
(p<O.01) than PRD patients. The highest PC's were
found in the AMY patients: Aib, 1, 1gB (all p<0.O1
versus PRD). C3 and m2M (both p <0.05 versus PRD).
In conclusion SLE patients on CAPD have similar
peritoneal permeability to proteins as PRO but
patients with DM or AMY have higher permeability
than PRO. This may be a consequence of vascular
basement membrane alterations in ON and amyloid
deposition within peritoneal capillary walls.
• (DIPLICATIONS (T RENAL TRANSPLP.N1'ATION IN CHILD—
PEN C CAPD/CCPD: A CCMPARISON 'lD HEMODIALYSIS
• H. E. Leichter, LB. Ettenger, I.B. Salusky, T.
Lilien, S.C. Jorxlan, T. Hall, J. Marik, R.N. Fine.
University of California, Division of Pediatric
Nephrology, Ls Angeles, California, 90024 USA
Little is known rlDout the safety and outccne of
renal transplantation (Tx) in CAPD/CCFD (PD)
patients (ptm). We, therefore, canpared retro-
spectively the outccjne of 44 CA.PD/(XPD pts who
received 48 Txs (32 cadaveric, 16 live related) to
41 hseodialysis (ND) pta in whom 49 Txs (39 ca:Ia-
veric, 10 live related) were performed. Twenty—
five PD pta (57%) and 23 HD pta (56%) received a
primary Tx. IXiration of dialysis was 17.1 + 11.5
and 18.6 + 11.5 nonths in PD and ND pts, reipect—
ively. BDth groups re cunparable with regard to
sex, age, original disease, nber of pre—Tx blcod
transfusions, HLA—A,B, Dr—matching and cytotoxic
antibody levels. Post—Tx dialysis was necessaryin 57% and 71% of the PD and ND pts, respectively,
Five P1) pta (11%) developed peritonitis, which
responded to antibiotic (ATB) therapy. Exit siteinfections occurred in 9 pta (20%). In 3 pta ATh
led to improvenent, whereas in 6 progression to
tunnel infection ma3e catheter removal necessary,
Ascites developed in 12 pts (27%); drainage led to
isrovement in all instances. Catheter removal
was performed electively with stable renal func-
tion in 34 pta after 17 + 14.2 weeks post—Tx. The
cunulative overall graft survival was significant-
ly better (p<O.O32) in the PD pta. One pt death
occurred in each group. In conclusion, CAPD and(XPD can be used safely in the post Tx period.
Graft survival rates seem to be better in the PD
group, but further ininunologic stedies are needed
to evaluate this finding.
COAGULASE NEGATIVE STAPHYLOCOCCI (CNS) in CAPU
K.G. Kristinsson, B.C. Spencer, J.G.M. Hastings,
C.B. Brown.
Department of Bacteriology and Renal Unit,
Royal Nallamshire Hospital, Sheffield.
Patients undergoing CAPO are susceptible to
peritonitis. The commonest causative organisms
are CNS and in our hospital they accounted for
65% of isolates between 1981—84. It has been
suggested that strains of CNS producing slime are
more likely to cause peritonitis in CAPD and that
the slime may protect the organism from efficient
opsonisation.
To determine whether slime production is a
major virulence factor we looked at 118 CNS
strains isolated from the dialysis of 43 patients
undergoing CAPD. Using API—STAPH 91 were
identified as S.epidermidis, 13 S.haemolyticus,
9 S.hominis and 5 others. There were 45 slime
producing CNS (SP—CNs) responsible for 34
episodes of peritonitis and 73 non—SP—CNS
responsible for 59 episodes of peritonitis. All
the slime producers but one were S.epidermidis.
There was no significant difference between the
white cell counts in the effluents from the two
groups. Lumino 1—dependent neutrophil
chemjlusjnescence was used to assess the in—vitro
opsonisation of SP—CNS and non—SP—CNS, Initial
results indicate no difference between the two
types of organisms. However clinically the slime
producing strains appear sore likely to cause
protracted peritonitis.
• tRACE Mm$L ABNOIfIALITIES fT COIT2fIUOUS ULALORY
FEDITONEAL DIMXSIS (cAn)).• A Leung, I llenderagn, D Hall, 0 Fell and A Kennedy.
Renal IJItjt and Department of Pathological
Chemistxr, Royal Infirmary, Glasgow, Soot land.
tTo studies trace metal profile in the serum,
plaSma and whole blood in 25 CALD patients and
compared the results utIli those in normal controls
Blood samples were taken through a plastic cannula
and placed in nitric acid washed polystyrene
t-tibe. Serum and plasma wore separated from red
cells as soon as possible nfter blood collection.
ioiiic absorption speotrometry was used for trace
metal measurement.
P.DSULTS
Trace Metal Normals CAPD
Alumirium*
Cbromium*
Selerjium**
.nc*
Copper*
Leed.***
Cadr6iuni***
umol/l
nsol/l
cniol/l
umol/l
umol/l
uxnol/l
nmol/l
0.7
4*3
1.5±0.3
14.5±1.8
15.0± 3.1
O.47±1.r
13±2
1.3±0.3 P40 01
99±49 p<o,o
1,0±0.4 p0.OQ112.7±2.6 P<0.O
16.9± 3.6 nO.o
O.43±O.27 N.S.
8.(±5.9
J
P(0.O0l
* Serum ** Plasma *** tThole blood concentration
Our resul a showed. tba in CAPD patients,
there tiers significant accumulation in the blood
of potentially toxic metals like aluminium and
Chromium and depletion of essential trace
elements like zinc and selenium. Contamination
of dialysate, medications especially phosphate
binders, dietary deficiency and loss through
peritoneal membrane all may contrtbute to
these abnormalities.
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• IMPORTANCE OF THE ROLE OF BLOOD TRANSFUSIONS (BT)
IN OELAYED HYPERSENSITIVITY (OH) AMONG END STAGE
RENAL DISEASE (ESRO) PATIENTS
F. Louis, P. Ruedin, 0. Frei, M. Jeannet, H. Favre
Oepsrtement of medicine, Geneva, Switzerland
The depressed OH observed in ESRO patients is
poorly understood. 15 hemodialysed (HO) patients
matched with 15 continuous ambulatory peritoneal
dialysis (CAPO) pstients for sex, age and duration
of treatment were evaluated for OH with a skin
Multiteat (Merieux) and with in vitro lymphocyte
stimulation (IVLS). Number of BT and nutrition
state (triceps fatfold) were recorded. In ESI-(O
patients nutritional state was 33 5 lower than that
of normal independently of the mode of treatment.
Multiteat score (MS) was 8.0 mm in CAPO
patients versus 4.6 1.3 em (p 0.02) in HO
patients (control: 16.5 2.1 ran). Lymphocyte
stimulation was expressed as the percentage of the
values obtained in controls: HO patients had a
score of 54 5 versus 83 5 in CAPO patients. Among
15 HO patients, 5 received less than 5 BT and had
a MS of 7.5 2.4 m; the 10 remaining submitted
to an average of 53 12 BT had a MS of 2.3± 1 mm.
Aaong 15 CAPD patients, 10 received less than 5 UT
and had a MS of 10.04 1.6 mm (group A) whereas
the 5 remaining received more than 5 BT and had a
MS of 2.0 1.2 ran (group 8). The incidence of
peritonitis was 0.07 0.04 month/patients in
group A and 0.16 0.02 month/patients in group B.
Conclusions: 1/ All the ESRD patients preaented
a malnutrition state and a depressed OH evidenced
both by the MS and IVLS. 2/ Among HO and CAPD
patients the degree of suppression could he related
to the number of 81. 3/ In CAPD patients, the more
depressed OH, the greater is the incidence of
peritonitis. These data call for limitation of 81
in ESRD patients.
NETILMICIN (N) AND VANCOMYCIN (v) IN TEE TREAT-
MENT OP PERITONITIS IN PATIENTS ON CAPD.
C.D. Mistry, P. Salgia, J. Manos, A. Tooth,
R.T. Rameden, A. Marsderi, R. Gokal, Manchester
Royal Infirmary, Manchester, U.K.
The efficacy of N and V as a combined 'first—
line' antimicrobial regime in the treatment of CAPD
peritonitis was compared to a single agent,
Cefuroxime (c).
Twenty consecutive episodes of peritonitis in
18 CAP]) patients were allocated randomly to either
NV or C treatment groups. The NV group underwent
6 exchanges on the first day and 4 thereafter with
the antibiotics added to alternate bags. One of
the two antibiotics was discontinued as soon as an
organism and sensitivity was available. Blood and
dialysate levels of NV, auditory and vestibular
functions were evaluated daring the treatment.
Daily Dose Therapy
in days
(mean
sem
Episodes
of pen-
tonitis
-. Outcome —
Re- Pai-
Cure lapse lure
Day 1 Day 2
on-
wards
N 1mg/kg
V 4mg/kg
C1.Sgm
0.75mg/kg
1.5 mg/kg
1.5gm
5.6±0.8
8.0±0.3
85±O.9
10
10
9.0
5.0
0
2.0
1.0
3.0
C group received 200 mg/l in each exchange
throughout the duration of treatment: Steady state
levels in serum for N (1.8 mg/l),V (3.0 mg/l)were
achieved within 3 days and were maintained through-
out therapy. Dialysate levels of N and V followed
a peak and trough pattern but remained within the
therapeutic range. No auditory or vestibular toxi-
city was observed.
In the doses used, the combination of NV appears
to be a safe and effective treatment
of CAPD peritonitis.
• THE ADVANTAGES OP GLUCOSE POLYMER (GP 20,000) AS
AN OSMOTIC AGENT IN CAP]).
• C.D. Mistry, N.P. Mallick, R.
Manchester Royal Infirmary, Manchemter, U.K.
We previously reported significantly superior
ultrafiltration (UP) and solute clearance charac-
teristics of 1GP (average MW960; GEk) compared to
glucose (G) . The usefulness of GPA wae limited
by high levels of serum maltose, derived from the
infused dialysate and systemic metabolism of ab-
sorbed small MW fractions. A modified preparation
of GP, consisting of polymer chains greater than
12G units (average MW 20,000; GP B) was studied
for UP and solute clearance characteristics in 3
non—diabetic CAPD patients. Each patient underwent
2 separate 6—hoar studies with 2 litre peritoneal
dialysis (PD) fluid containing 5% GP B (2.5 mmol/l)
and 1.36% G (76 mmol/l).
Although initial osmolality of GPB (304.7 4.2
moan/kg) was considerably lower than i.36%G (334
1.5 moan/kg, total UP were comparable for both
solutions. The dialysate/plasna ratio of creatin—
me, phosphate, uric acid was significantly greater
for UP compared to U. At the end of a six—hour
dwell only 36.8% of UP was absorbed from PD fluid
compared to 65.5% of U; the rise in serum maltose
(0.66 mnol/l) was 74% lower than previously ob-
served with 5% UPA solutions (2.6 minol/l).
UP, MW 20,000, is a useful osmotic agent capable
of providing sustained UP and superior solute
clearance characteristics as compared to glucose.
1. C.D. Mistry, N.P. Mallick, R. Gokal:
Glucose polymer as an osmotic agent in CAPD:
Pent. Dial. Bull, 1984: Supp. 4: 5 42.
ANTITHROMBIN III IN NEPHROTIC SYNDROME AND CAPD
PATIENTS: A COMPARATIVE STUDY.
Mon R., Triolo L., Giusti B.P., De Sole pt,
++ ++
De Stefano V. , Leone 6.
Istituto di Clinica Medica, Istituto di Fisiologia
Umana, Istituto di Seseiotica Medica
Universita Cattolica del Sacro Cuore, Rosa, Italy
Plasma antithrosbin III (ATIII) levels were
seasured as antigen concentration (radial issuno—
diffusion) and as ATIII heparin cofactor(amidolytic
method) in 7 patients with nephrotic syndrome and
in 9 patients on continuous asbulatory peritoneal
dialysis (CAPD). Peritoneal dialysate and urinary
samples, collected from subjects on CAPD or with
NS respectively, were investigated every 3rd day
for one month and the mean daily loss of total pro-
tein, albusins, ATIII antigen and ATIII biological
activity was calculated.
Plasma mean levels of ATIII antigen and activi-
ty in CAPO patients wore cisilnr tn thnce nf a dnn-
trol group of 20 healthy subjects,_whereas NS pa-
tients showed a significant reduction with a large
variability (ATIII antigen 77.0±23%, ATIII activi-
ty 71 .6±22.8%). Nevertheless, the daily loss of
ATIII antigen in CAPD patients (19.6±10.5 mg/die)
and NS patients (16.5±6.8 mg/die) was similar; the
loss of ATIII antigen in both group paralleled to
the loss of albumin and protein. It is noteworthy
that 76% of ATIII in the peritoneal dialysate from
CAPD patients was still active (130.7t69.8 U/die),
whereas in NS patients only the 14% of 41111 is
excreted as a functionally active(13.7±3.6 U/die).
The differences could be explained suggesting ae,
additional loss due to renal metabolism or to a
passage in the extravascular space.
INITIAL ANTIBIOTIC THERAPY FOR UNDIAGNOSED CAPD
PERITONITIS.
G.\, Orane, 1.5. Henderson, A.C.T. Leung.
(Intr. by A.C. Kennedy)
Depts. of Bacteriology and Medicine, Glasgow Royal
Infirmary.
A recently published U.K. survey of practices in
CAPD units revealed a wide range of antibiotic
regimes used for the initial treatment of undiag-
nosed peritonitis. 41 adult renal units were
questioned and twenty two different single anti-
biotics or antibiotic combinations were used. The
majority of units use a cephalosporin either alone
or in combination.
The organisms isolated from fifty—four
consecutive episodes of bacterial peritonitis were
tested against the range of antibiotics found to be
used in the survey. Vancomycin in combination
with an aminoglycoside was the most effective
in vitro combination.
There is a strong case for rationalising initial
treatiiient of CArD peritonitis, and the combination
of Vancomycin and an wninoglycoside would be
appropriate therapy.
INCEEASI1 ULTRaF1LTkflIUN (UP) IN PERITONEaL (Ps)
THEA IIIENT BY 55155 A LOC IIYDRUSTATIC PRESSURE DMA INAUL
SISTI14(LPS).
A.Pomerantz,J .Shushan,Y .Agami ,Z.Korzets ,J .Bornheim.
Dpst of Nephrology,Meir Hospital, kfar Saba and
Sackler School of Medicine, University of Tel Aviv.
Adequate LI" is mandatory to obtain satisfactory
results in long term P1) treatment.Several factors are
Imown to influence UP in PD.Dialysate osmolality is
one of the most important.Regular Pt) is performed with
2 liters dialysate bags(DB).Current draining systems
achieve an UP fluid capacity of 3—3.1 1 with a high
intrabag hydrostatic pressure above 60cm1120.To evalu-
ate the possible influence of this fact on the UP
efficacy of PD,particularly with hyperosmotic solution
of 4.25 G/dl glucose(HOS),we performed the following
protocol: 5 patients treated by intermittent PD for a
meantime of 2y(mesn age:73),without any relevant comp-
lications, participated in a 2 weeks(W)UP investiga-
tion progrsm.During Wi ,IPI) was performed with usual 1)8.
During W2 patients were treated with a LPS.Ur'/W was
measured for each one,for the group,pereycle end per
HON cycle.209 cycles were done with 1)13 and 188 with
LPS.HUS were used 52 and 51 times.The results are as
follows:UP increased in each patient with LI'S without
any exception;as a group UP increased from 34.6 to
38.6 liters(the cycles decreasing from 209 to 188).UF/
cycle increased from 164±36 to 203÷29m1(p <.U2)with a
Aof 39+3±15.4m1.UP/H0S cycle increased from 354÷51 to
573±113m1(p'C.02) with aaof 218±T7ml.These data de-
monstrate that UP is increased with a LPS particularly
when 1108 is used.3—3.5 liter bags containing 2 liters
of dialysate will be mandatory to obtain maximum
efficacy of UP on patients treated by PD.
FLAME-LOCK CAPD SYSTEM — LONC ?'ERM RESULTS AND
IMPROVEMENT OF THE JOINT —
K. Ota, and Flame-Lock Study Group
Kidney Center, Tokyo Women's Medical College,
Tokyo, Japan.
Flame—Lock CAPD System has a special joint con-
sisting of metal and ceramics for bag exchanges.
When the joint is heated by a flame of alcohol lamp
ceramics part (male type) which remains in its
original size can be inserted into metal part
(female type) which is enlarged by heating. Meat
sterilization is completed simultaneously. At the
time of disconnection, the joint is heated again
to loose the connection. No sterilized gloves and
other instruments are necessary throughout the
procedures.
Since Sept. 1981, 66 patients were treated with
cApo using this system, of these 66 patients, 48
remained on and 18 dropped—out from the program.
The main causes of drop-out were peritonitis:8,
tunnel infection:5, transplanted:2, died:3 (sepsis:
1, apoplexy:l, general malaise:l). Incidence of
peritonitis on all cases including those caused by
tunnel infection was 1/18.8 paticnt-months. If
cases caused by tunnel infection were excluded,
the incidence decreased to 1/25.5 patient-months.
Until June 1984, the material used for ceramics
part of the joint was zirconia, thereafter, it was
changed to silicon nitride which is known to be
more heat resistant. Aftet this improvement,
troubles of the joint such as crack and break have
been decreased and the incidence of peritonitis
also decreased to 1/40.6 patient-months although
the observation period is short.
From these results, it is concluded that Flame—
Lock CArD System is fail-safe, easy for training
and less expensive procedure compared to other
systems available at present tine.
sunnzn, nwcmntnrrs or UFRAFWFRAflCN
CAPACttT AND PERZWNEAL CLEANANCE SNOW ND LOSS OF
MDBRANE FUNCTION IN PATZflVFS TREATED BY CAPD.
LSCS Rgdgcx, T.B.J. 000dship, N. Nikolakakis
R. Ashcroft, a. Wilkinson, N.E. Ward.
Depth, of Wadicine and clinical Biochemistry,
University of Newcastle upon Tyne, UK.
Ultrafiltration capacity and peritoneal clear-
ance were measured in 56 stable CAPD patients in
an attempt to identify those factors prosoting
peritoneal membrane failure. Follow up measure—
ments were obtained after 10 n)nths in 72% (31/43)
of those patients still being treated by CAPD. 13
patients had discontinued CAPD because of trans.-
plantation( 6), peritonitis( 3), loss of ultrafil—
tration( 1), pelvic inflanmiatory disease( 1), or
volvulus( 1). All patients used lactate dialyeate.
A single hypertonic exchange with a four hour
dwell period was used to measure ultrafiltration
capacity and peritoneal clearance, precision stud-
ies showed these measurements to be reliable with
an intra individual coefficient of variation (5%.
Ultrafiltration values were independent of clear-
ance levels and multiple regression analysis
showed no effect of patient age, sex, BSA, serum
albumin, peritonitis history or dialysate brand
on these indices of peritoneal function. Follow
up data showed no decline in peritomeal
clearance or ultrafiltration capacity (Fig 1).These sequential data support the findings of
the International Cooperative Cross—sectionalStudy that the duration of treatment per se does
not adversely affect peritoneal function.
fig 1. Sequential Values in 31 Pts. NeanfSD
Deration of CAPD Ultrafiltration Clearance(scnths) (ml) (mi/sin)
27*15 974j19l 8.23±1.08
37±16 932±179 8.60*1.04
Student paired t test Ns 115
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FUNGAL PERITONITIS IN CAPT. WHICH IS THE BEST
TREATMENT?
J.C. Rodriez—Prez,; C. Plaza.; L. Palop.;
3. Arrieta.
HOZFI'AL NTRA. ERA. DEL FINO.— LAS PALITAS DE SEAN
CANASTA. SPAIN.
Among 43 patients in our CAPD. program, over 683
patient—months, 6 cases in 5 patients (3 males, 2
female) of fungal peritonitis were found out of a
total 117 peritonitis episodes for a 5,l incidence
3 episodea have ocurred following antibiotic the—
rrpy for Gram (+) peritonitis and one case thiring
training. 1 patient have a racurrOri episode.
The dir ice]. features were sirS ]..r from those bac—
tonal perHonitis. with increase in leucocytes —
count.
The c.rlhre revenlod Candida species grow in the3 giisrts iithin 5 clays. Canclio.a albioans (4 pts)
Candtda pzirapsilosio (1 pt), Candida Torulopsis —(i pt).
The 3 patients were -treted ith amphotericin B
died. The other 2 w1.o were trated with 5 Fluorocy—
tosine (5Fc) and oral Netoconasole, still alive in
the CAPT programme.
To recommend ile next therapeutic plan to treat
funi peritonitis in CAPD.:
a) an1y catheter reova1.
b) Intrapenitonoal lvae with 5—Fe (100 mgs/1)
through a tenporary catheter resinserted.
c) 5—Fe i,v.: 40 rngo/kg/2 davs 30 mgs/kg/2 days
15 mçcs/kg/31 dads.
d) Oral Ketoconasolet 450 mgs,"day,
In spite of low Ketoconasolo concentration in —
;he neriteneal fluid, we think in a ainergietic —
action K'?toconazOle 5—Fe.
EVOLUTION OF THE ULTRAFILTRATION RATE DURING CAPD
ROLE OF ACETATE AND LACTATE BUFFERS.
J. Rottembourg, B. Issad, H. Mehamha, M. Legrain,
Depart, of Nephrology.Hôpital La Pitid.Paris.France
Ultrafiltration (UF) is required to maintain ade
quate water balance in patients treated byCAPD. To
test the action on net UF of solutions containing
either acetate or lactate as a buffer,the UF in ml
per exchange during a single hypertonic standardi-
zed 4 hrs exchange was investigated every 6 months
(M) in 101 patients with a mean age of 58.2±13.4 y.
Four different brands (Br) were used : two (A,B)con
tamed 35 mmol/l of acetate,and two (C,D) 35 mmol/l
of lactate.Glucose (G) composition varied from 210
(D) to 250 (A) mmol/l.The mean UF values are
Br. iPts. 0-6 M 12 M 18 M 24 M
A 35 750 170 580 480 460 210
B 17 700 150 620 520 520 140
C 13 840 170 850 900 850 180
D 36 840 190 840 900 890 120
Although UF at start was not statistically diffe-
rent in the 4 groups,therafter acetate buffers (A,
B) yielded to significantly lcier UF values (p<O.cOl)
compared to lactate buffers (C,D).There was no dif-
ference between A and B,C and 0 respectively.26 pa-
tients exclusively treated with acetate buffer dia-
lysates during a mean period of 19±6 M were trans-
fered to lactate buffer solutions from the same Br:
Mean UF and G concentrations in the drainage,12 and
6 M before switch () and 6 and 12 M after are
Acetate Lactate
12M 6M 6M 12M
UF (ml) 618 (1) 452 (2) 535 (3) 611 (4)
G (mmol/l) — 36 (5) 43 (6) 46
1-2 : p(O.0Oi, 2-3 NS, 3-4 : p<O.cXDl, 1-4 F'S, 5-6 p(O.O01
Recovery of UF is obtained 1 year after switch from
acetate to lactate.Use of acetate buffer could ex-
plain loss of peritoneal ultrafiltration.
311
SCLEROSINGENCAPSULATING PERITONITIS (ssp) IN CAPD
J.C. Rodriguez — P4rez; C. Plaza; L. Palop;
3. Arrieta.
HOSPITAL NTDA. SEA. TEL PINO.— LAS PALrikS BE
SEAN CANARIA — SPAIN.
Peritonitis due to infection remains the most
common complication and, drop—out from a CAPT pro-
gram. A severe complication represent SEP. The —
small bowel becomes partially or totally encapsu-
lated by a neomembrane resulting in vomiting, mm—
laise, abdominal pain end loss of ultrafiltration.
Over 638 patient—month among 43 patients, one
case of SEP were found of a total of 117 peritcni
tie episodes. He was 69 years old previously trea
ted with hemodialysis and. begining CAPT in October
1.982. Twenty month later he staed, with ultra-
filtration loss end abdominal pain, He Irns had —
recurrent episodes of peritonitis (staphilococci
epid.; pseudomorias, }O.ebsiella, acinetobacter).
He never be with beta—blocking agents. He always
were cianaged with lactate containing fluids, tita
niuin connector and. povidone—iodine like antiseptic
agent. SEP was suspected on clinical grounds and
was confirmed by laparatonr.
Te remove the catheter, and. sureJ fail in
release the bowel. The patient died eigtheen days
later. The etiology of SEP remains unclear but —
recurrent peritonitis, antibiotic treatmen, anti-
septic agents, peni-toneal fluiftz are suggested —
like causative factors.
PWFHYLAXIS ' SFAE4{YILXIXflE PIE prmirris (Stth.A.
.
Pent) IN (XWPINJI PHJLAItEY F1RrI1EAL DIALYSIS (CAI'n)
AT172I A., NIIItPH)LI P. -Rmial I,hit (.Reg.
". ANUZIATA" U.S.L. TA/S TARANIt) Italy
Altci the irxie ofPent eara to be decri.r
with ircrethg experi of CAll) prograle I r ijuva-
ticz, it still rir a freqit cxiilicaticn. 11 arii
nant freamitly ie1aied fran CAll) Petimite (Pts.) are Stsçi'i
idermidis l Stii a,ra.
In order to ariiieve tin prq*tylads of' St*uA.Per'it in
CAll) Pta., , beve vaxdmtai air CAf V Pts. with a ecific
S1knA.vaccix (SrAHTIF'AN 1) ornthinir St*i.A.toxix.
Our fifte&t Pts.beve sfwi oiring the first three nerilin
after varcine, a sig1ificat irnsse in plia a'itist4ilylo-.
lisine levels, nired by HI!WE netkl, axi netivi—
saticri of In tterial ailthres of dn—edt site, vi,ith
re previaly positive frr Stx.A.. In tin ne penied
In levels of the canifly-ative proteine (I—I—I—
03-Cd) in th peritcneel ef'fln..,t varfi',nd to be increneed
in &% of the os. caiparative grosth rate of' Sth.A.
in the ied dialysis fluid betwe the varciriated axi rKt
vaccinated t a'i alr grrwth rate in tin vaxinated.
1re beve beee ro ee of St*i.A. Pelt derirg a
cAervatian a qi.a& rvexy in l os of St.*i.A.tuiie1
infectlcn.
Our eqele aKi air thta s&eets tint aitislylccmc—a a1r vaccine cculd be a i.eflul rovath to tin prev-
ticn of'St1i.A. Pent. axI a txxster tse ntt be aidniste-
red a ey ree nxnIn.
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EN000ENDUS SYMPATHETIC ACTIVITY IN CAPD PATIENTS .ITS
RELATIONSHIP WITH PERITONEAL DIFfUSION CAPACITY AND
BLOOD PRESSURE CONTROL
ft,Selgee,1 .M—Muiioz,E.Huarta,J .Conesa,C.de Pedros,R.Ma—
dero,M.P—Fontan,O.Ortega,F.Escuin,L.S—Sicilia
C,S,La Paz . MADRID • SPAIN
Endogen005 agents,athcathecolaminma (CA),could inf'lumr
cm poritoneal permeability through inducing modifica-
tions in peritoneal. blood flow. Sympathetic activity
has boon related with blood premaure(8P)control in ma-
ma patientm(3te); it seams that CAPD helps to control
OP battsr than Hemodialymia . 27 CAI-'D pta have been
studied : we have examined thair paritonmal diffusion
capacity(through mathematical modelling techniques to
determine MTC for urea,creatinine,wric and PTH) and
their CA plaama(P) and diaiyaate(noctwrnal)(DY)valuea
(pg/al ; adrenalino(A),noradrmnaline(NA) and dopamina
(D): radioenzysatio method "Upjohn Diagnostics"
P Renin Act.(PRA)and Aldomtmrone (Al) were determined
(RIA) in P and DY after 2 h.of bed rest. Dopaninm—be—
ta—hydroxilaae(UBH)waa also determined. 30 healthy
aubjects constituted the control group(CG). All drugs
that could influence remults worm aupremmed during th
previous week
RESULTS : Mean values (±5CM): PRA 4,*4+D.gng/al/h (CC:
0.6±0.1) ; DY lenin Act.not detectable • P AlSSO±22l
pg/al(both significativoly elevated) . DY Al 268±108
pgJml . CA : P A 32+4.7 (CC 264.3,N3),DY A 22±3.S
A % asturation%l±W(DD—3b,range). P NA 411±46 (CD:
253+ 9,NS), DY NA 482+54 , NA , sat. l.2±0.l2(3lD—bD)
P D 94+15 (CC:66+5,N17, DY D 924.7 , D . mat. 1.2±0.1
(257—3U%). P DOfl: 12.7±1.4 (ll.9±2,NS), DY DBH intar
ferencea(,not valid)
Linear reoremmion analysis ( r values ; &— statistics-
ly significant): PRA: P Al D.7& , DY A 0.61 ,P CA air'
MTCs NI • P Al — DY Al 0.991 • PRA and P Al with sr
rum Na—K 85 • PA1—PCA NI .Al —NTV5NS
P A : DY A(D.68&) P NA(D.S&) P D(NS) DY NA(NS)DY DçD.t
&) NTC'e(NS) . DY A : DY NA(D.47) DY D(D.56&)MTC-s
(N5) . A saturation without correlations
P NA DY NA(D.58&),reat NI • DY NA : UF(0.55&) HTC'a
(urea D.47,craatinine 0.64&,uric D.78&,PTI-1D.Sl&)
NA satur.: UF(D.5S&)MTC s(only urea 0.49) . P and DY
D,NS . DBH and BP showed nona correlation uith others
Conclusions : P CA levela arm normal. Renin—Al axis
stimulated in some pta.Thc relationship batwaan axis,
CA and OP control seems scanty. PlC's and DY NAralati
A WMPUTER BASED DATA REI'RIEVAL SYSTEM IC) EXAMINE
INFEI7rION AND TEEAThEWP IN CDNTINIOUS AMUULAIORY
PERIIONEAL DIALYSIS (C.A.P.D.)
M.Schreiber, J. Fuchs, J. Leathenaan, 0.0. Vidt
(Intr. by S. Nakannto)
Cleveland Clinic Foundation, Cleveland, Ohio, USA
From August, 1979 io December, 1984, 160
patients have completed CAPD training at a major
medical referral center. A computer based thta
retrieval system was developed to examine multiple
characteristics of CAPD catheter exit site
infections and peritonitis. Specific attention was
given to patient characteristics, catheter types
and insertion techniques, organisms identified,
culture techniques, hospitalizations, class and
length of antibiotic treatment, organism sensi-
tivities and in vivo treatment responses. The
results indicated that infections were not signif-
icantly higher in diabetics compared to non
diabetics. Patients who were peritonitis free at
one year maintained a low peritonitis rate overall.
18.b/0 of peritonitis episodes recurred within 21
days of standard treatment regimens. A number of
patients developed recurrent infect ion warran Li ng
alternate antibiotic programs despite in vitro
sensitivity to the previously employed antibiotics.
Only 4 cases of methicillin resistant staph were
identified with current culture techniques. Hos-
pitalization was required for the treatment of
peritonitis in 23.9% of cases. Since 1979 an
increasing number of patients have developed
cepthalosporin resistant peritonitis. Identifying
causative factors in resistant or recurrent CAPD
infection is essential in decreasing the dropout
rate in CAPD programs. Re—evaluating existing
treatment programs and improving organism ident-
ification should be carried out in patients with
multiple infections on CAPD.
. USE OF AMINO ACID CONTAINING SOLUTIONS IN
CAPD PATIENTS AFTER PERITONITIS: RESULTS
OF A PROSPECTIVE CONTROLLED TRIAL
H. Schilling, G. Wu, A. Mitwslli, G.M.
Anderson, a.Ogilvie, D.G.Oreopouloa.
University of Toronto, Toronto, Canada,
Because of increased protein losses
during peritonitis, the use of amino acid
(AA) containing solutions for one month
after peritonitis may be beneficial.
Twenty—two CAPD patients with peritonitis
entered this study. The controls (n=1O)
were dialysed with standard glucose
solutions while those on AA were given 2
exchanges of 1% AA alternating with
glucose solutions. Four patients in the
AA group and none of the controls
discontinued the study because of poor
appetite. Seven controls and 5 in the AA
group completed the study.
During peritonitis protein losses
increased and dietary protein intake
decreased leading to negative nitrogen
balance. These ahnormalities lasted only
for one week. Serum alhumin which
decreased significantly during
peritonitis was restored to baseline in
the controls but not in the AA group.
Even though average dietary intake was
not different in the two groups, more
patients reported a decrease in appetite
in the AA group than in the control
group. We conclude that peritonitis
causes only a transient negative N—
balance and decrease in serum albumin.
CAPD with amino acid instead of glucose
solutions offers no significant benefit
after ,,ncomplicated peritonitis.
.
TUE HIGH MOPRIPITY OF FUNGAL PERITONITIS IN CARD
•
W.G.J.Smith, P. Tsskiris, 3.12. Rriggs, M.J.R.
Junor
Renal Unit, Western Infirmary, Glasgow, Scotland
Fuagal peritonitis (FR) is uncommon hut
important in view of its poor response to treatment
and high morbidity. In a 3 year period, 8 episodes
of FR occurred in 7 patients (6 female, I male).
Mean age 37 years and duration of CAPD 17.3 months.
FR represented 5% of the total number nf
peritonitis episodes in our CARD population. All 7
patients had multiple previous episodes of
bacterial peritonitis and 6 of the 7 had
antibiotics within one month prior to the onset of
PP. Rersistent fever and peripheral blood
leucocytosis were common. Repeated positive fungal
cultures revealed the following organisms: Candida
alhirans (2), C. g)ahrata (2). C. parapsilosis,
Aspergilius fumigatue, Verticillium sp.,
Rhodotnrula sp. Treatment initially consisted of
catheter removal alone (3 cases), catheter removal
followed by antimycotic drugs (3 cases) and
antifungal agents without catheter removal.
Antifungal agents did not relieve symptoms without
catheter removal. In all hut I patient extensive
iotrm—ahdominel adhesions confirmed by laparotomy
were found. This late complication ranEed from
loss of peritoneal space to small bowel obstruction
and eclerosing peritonitis. The outcome was that
all patients were transferred to haemodialyeis, 1
returned to CARD and 2 subsequently died from small
bowel obstruction and sclerosing peritonitis.
We would suggest 1. prolonged and frequent use of
antibiotics may predispose to fungal peritonitis,
2. persistent fever and blood lmucocytoais despite
antibiotic therapy should raise a suspicion of F?,
3. treatment by prompt catheter removal and
ayatemic antifungal therapy.
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. PANCREATIC B CELL FUNCTION IN NON DIABETICS WITh
RENAL FAILURE
W.G.J. Smith, D.G. Johnston*, C.B. Brown
Dept. of Nephrology, Royal Hallamshire Hospital,
Sheffield, *Dept. of Medicine, University of
Newcastle upon Tyne, U.K.
The effect of continuous intraperitoneal
glucose in CAPI) on pancreatic B cell secretory
function is unknown. This study investigated the
B cell response to T.V. glucagon measuring
peripheral blood insulin and C—peptide. As plasma
insulin and C—peptide are elevated in renal
failure non diabetic patients with similar serum
creatinines were compared. Subjects were grouped
as C.R.F. (on conservative treatment), haemo—
dialysis, new CAPD ( 6/12) and established
CAPP ( 1 year). Each group (n=5) fasted for 10
hours and peritoneal dialysis was omitted
overnight prior to the study. Basal samples were
taken pre—glucagon and serially over l hour.
Results showed basal glucose (range 4.12 — 4.58
mmol/l), insulIn (10.2 — 13.8mU/l) and C—peptide
(1.39 — 2.64mmol/1) were similar between all
groups. Peak glucose (6.9 — 7.88), insulin
(45.7 — 65.6) and C—peptide (2.39 — 5.11) were not
significantly different between the groups. The
increment from basal to peak levels for glucose,
insulin, and C—peptide was significant within all
groups. The rate of rise from basal to peak for
glucose, insulin and C—peptide was similar in all
groups.
We conclude that there was no impairment of the
insulin and C—peptlde response within any of the
groups to I.V. glucacon, and therefore CAP)) has no
significant effect on pancreatic B—cell secretory
function In non diabetics.
EVALUATION OF TSH RESPONSIVENESS TO TRH ThROUGH IN
TRAPERITONEAL WAY.
G.A.Sobbrio,R.Catalfalno,F.pjtrone,G.Mileto,Epelle
grino,L.Li Calzi,F.Trimarchi.
Clinica Medica 10 Università di Messina,Italy.
Synthetic TRH is available,as lyophilized pow
der, for subcutaneous, intramuscular, intravenous, in
traspinal administration and,as a tablet,for oral
use. In our study we evaluate TSH responsiveness to
distinct TRH doses(200 and lOOcig) through the in
traperitoneal (I. P.) way,hitherto never investigated,
in 8 patients on CAPD.Preliminarily,we evaluated
the response to i.v. administration of TRH(2OcLig)
in the same subjects.Blood samples were collected
at time 0 and 15,30,60,90,180,240 mm. after TRH
injection.I.p. administration of TRH,both at two
different doses,resulted,ccmpared with i.v. con
trols,in a later,slower,more progressive increase
of TSH,whose levels were still rising at the end of
4 hours sampling.
The present study shows that I.P. injection of TRH
is able to evoke a release of TSH in man.The under
lined modality of response seems to be connected
with the distinctive features ob absorption of pen
toneal membrane;this pattern of release,similar to
that obtained by constant i.v. TRH administration,
suggests a ccsiinon site of action for both stimula
tion ways,that is on the pool of TSH requiring lon
ger TRH stimulation(Brermer et al.,1977).
ThYROID FUNCTION TESTS AND EVALUATION OF BASAL AND
TRH STIMULATED LEVELS OF TSH,HPrL,GH,IN PATIENTS
ON PERITONEAL DIALYSIS.
G.A.Sobbrio,R.Catalfamo,P.Princi ,F.Pitrone,G.Mile
to,L.Li Calzi,F.Trimarchi.
Clinica Medica 10 Università di Messina,Italy.
A variety of thyroid function tests abnormal
ties,as well as alterations of basal and TRH stimu
lated TSH,HPrL,GH,are reported in patients with
end—stage renal disease(Czernichow et al,1976;Her
shman et al,1978;Weissel et al,1979).
In our study,l3 patients,with chronic renal failu
re,8 on continuous,5 on intermittent peritoneal dia
lysis,performed a preliminary thyroid scan,eviden
tiating in 10 of them(76%) a marked alteration of
uptake and distribution of the isotope by thyroid
gland.An evaluation of basal thyroid function could
evidentiate values of T4,T3,significantly lower
than controls,with normal rT ,FT ,FT ,TBG and TBPA
3 3 4hinding capacity to T .Basal TSH concentration was4
normil,with blunted reaction to TRH.Basal I-IPrL vu
lues were significantly higher than controls,but
A max after TRH was not significantly different
frcxn controls.A paradoxical response of GH was sti
mulated by TPH with a peak occuring 30 mm. after
injection.
Our studies have focused the important role played
by the kydney on thyroid metabolism:that is,clea
ring iodide,T ,T ,as well as TSH and TRH.Moreover
the shape of response to TRH seems to indicate an
important alteration of hynophyseal—hynothalamic
axis in patients undergoing hemodialysis.
GLYCEMIC AND METABOLIC CONTROL IN CAPD
DIABETIC PATIENTS. 0 S 6D. Spotti, G. Slaviero, A. Cantaluppi, A. Bertin, C.
Castelnovo, L. Monti, P. Micossi, G. Pozza,'C.
Ponticelli.
Istituto Scientifico S.Raffaele e Nefrologia Osp.
H aggiore—M ilano,Italia.
Twenty—four hours metabolic profiles for blood
glucose (EG), free insulin (Fl), lactate (La), butyrate(Bu),and glycerol (Gy) were carried out in 6 uremic
Type—i diabetic patients who had been in CAPD for
more than 6 months (group 1),in 6 nondiabetic uremic
patients matched for age sex and duration of CAPD(group 2), in 6 nonuremic diabetics treated with
continuous subcutaneous insulin infusion (CSII) (group
3) and in 6 matched normal subjects (group 4). During
the study four daily dialysis exchanges with 1.5 g/d
dextrose concentration were performed in CAPD
patients; in group I insulin was added to the bags.
Mean BG was higher in group I than in groups 2 and 4
(162±15 mgfdl vs 117±6 and vs 89±3; p<.01), while did
not differ from group 3 (141+10). Mean Fl levels were
higher in groups 1, 2 and 3 than in group 4
(respectively 25±3, 29±4, 27±3 vs 13±2; p<.OO1 for each
comparison).In CAPD patients (groups 1—2) plasma La
and Gy levels were higher than in groups 3 and 4
(p<.OOl and p<.O05 respectively) while Bu levels were
lower (p<.O1). In conclusion, the control of BG by
intraperitoneal insulin administration in CAPD
diabetic patients is comparable to that achieved in non
uremic diabetics whith CSII. Hyperinsulinemia in group2 reflects a continuos stymulus to insulin secretion
due to the glucose contained in the bags and accounts
for the low levels of Bu found in CAPD groups. The
unexpected high Gy levels would suggest an increase
in peripheral lypolisis in CAPD patients. La absorbed
from the dialysis fluid may contribute to the higher La
levels during CAPD.
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EFFECT OF PROSTAGLANDTNS ON PERITONEAL
PROTETN PERMEABILITY TN CAPO—ASSOCTATEU
PERT TO NT TT S
N.B.Steinhauer, A.Frei and P.Schollmeyer
Department of Medicine, University of
Freiburg, Freiburg i.Br., ERG
Protein loss is one of the main disad-
vantages of continuous ambulatory perito-
neal dialysis(CAPD). The present study was
performed to investigate whether prosta-
glandins (PC) are involved in the patho-
physiology of increased protein permea-
bility during peritonitis. The local gene-
ration of PGE2, 6-keto-PCF1s, PCF2cz and
thromboxaneB2 was measured during peritoni-
tis and in infection-free periods in 12
patients (42.6 3.4 years) undergoing CAPU
(23.9 2.6 month). Protein permeability was
determined by measurement of total protein
(TP), fl2microglobulin, albumin, IgG and 5-
macroglobulln in serum and dialysate.
With peritonitis an increase of dialysate
prostanoids occurred with predominance of
the vasodilative PCs E2, and I determined
as its metabolite 6-krto-PCF1a(pcO.O0l).
Simultaneously an unselective rise of per-
meability was observed for TP and all indi-
vidual proteins (PC 0.001). In the earTy
phase of peritonitis (0 — 12 hours) the
augmented peritoneal PC synthesis correlated
positively with the increased permeability
for proteins (r=O.5970—O.884l). Inhibition
of local cyclooxigenase activity reduced
both the generation of PCs and the loss of
proteins.
The present results demonstrate a link bet-
ween peritoneal PC generation and protein
loss in the early phase of peritonitis.
REVERSAL OF LEFT VENTRICULAR HYPERTROPHY
(LyE) IN NORMOTENSIVE UREMICS ON CAPD
M.Timio,M.Ronconi,S.Venanzi,C.Pippi ,S.Gen—
tili(Intr. by L.Giombini)
Dpt.of Medicine and Nephrolor_Fo1igno_I_
ly
LVH is quite common in normotensive endS-
stage chronic renal failure patients(pts),
Haemodialysis(HD) although produces an impr9
vement in cardiac function, may leave uncha
nged or increase LVH,To determine the role
on LVH,we randomly amsiied 22 pta with LVI
defined as a left ventricular mass greater
than 215 g(LVM—Penn Cube formula)to receiw
treatment either with ED or CAPD.The two
groups were comparable for age,sex,weight,
normal blood pressure.Echoes were obtained
pre and post 40 weeks mmnteinance dialysis
and measurements of end—diastolic interven
tricular septum(IVS)and posterior wall(PW)
thickness and LVM compared.Mean results
(a sn) were (*pc0.5;**=pco.OO1):
IVS(mm) Pw(mm) LVM(g)
Pre—HD 14*2 13*2 237*12
Post—ED 14±1 12±2 231*11
Pre—CAPD 13*1 13*3 233*14
Post—CAPD 10*2* 3*1w 176j10**
In front of identical metabolic changes,
RD brings no modification on LVH,while C.API)
reduces IVS,Pw,LVM.The mechanisms responsi-
ble for different behaviour are only conje-.
ctural;it seems likely that poor hasmodina-
mic imbalance inCAPD plays a role.
IS CAPD THE OPTIMAL TREATMENT FOR END STAGE RENAL
FAILURE IN THE DIABETIC?
N.M. Thomson, E.G. Atkins, S.R. Holdsworth,
D.F. Scott.
Prince Henry's Hospital, Nelbourne, Australia.
Controversy still exists as to the optimal
treatment of the diabetic with end—stage diabetic
nephropathy (ESDN). In the last 7 years we have
treated 40 insulin—dependent diabetics with ESDN
(mean age 42 years: 22—65). All patients were
initially treated with CAPD (mean time 14.2
months: 3—39 months) and patients less than 55
years were offered renal transplantation.
The clinical course of these patients when on
CAPD has been compared to that of 134 non—diabetic
patients on CAPO. Patient survival at 1 and 2
years was 83% and 67% respectively for diabetic
patients and 92% and 84% respectively for non—
diabetice. (N.s.). Adequacy of dialysis and
incidence of peritonitis was comparable for both
groups as was quality of life if vision had been
retained. Significant deterior.stion in diabetic
retinopathy was seen im nnly 3 patient-c.
Excellent control of blood sugar was attained by
intra—peritoneal insulin (n=34), superior to that
obtain by S.C. insulin (n=40).
Renal transplantation was performed in 16
patients. Cadaveric graft survival at 2 years was
56% compared to 51% for 122 non—diabetic patients.
(N.S.). Patients survival post—transplantation
was 78% at 2 years for diabetics and 86% for non—
diabetics (N.S.).
It is concluded that CAPD is a very effective
dialysis treatment for diabetics with good patient
survival and excellent control of blood sugar an
retinopathy and that transplantation is associated
equally good patient survival and a graft survival
comparable to that in non—diabetics,
LOCAL OEFENCE PLAYS INPORTANT ROLE IN PREVENTION OF
BACTERIAL PERITONITIS (BP) IN CAPD
J.van der Neulen*, J.A.Verbrugh**, P.L.oe*,
W,C,F.T.N.van Gestel*, D.M.NacLaren*.
* Free University Nospital Amsterdam
** Academic Mospital Utrecht, the Netherlands
In CAPD, BP (presumably a sequel to breaches of
aseptic technique during bag exchange) manifests
itself as cloudy, culture positive peritoneal efflu
ent dialysate (POE) .Me have studied prospectively
how often accidental contamination of peritoneal
cavity occurred without subsequent BP.In 18 CAPO
patients,followed for at least 6 months,P0E was ex-
amined every 2—3 mnnths.Patients with more than 1
BP per 6 months were called peritonitis prone (PD),
patients with fewer episodes peritonitis resistant
(PR).PDE was examined by culture and a total and
differential WBC was made.Only the results in BP—
free periods (no cloudy dialysate in prev.2 weeks)
were analysed. This study covered 234 patient treat
ment months (PTN) with 28 SD episodes.83 POE were
examined, and 21 were culture positive.The NBC was
always less than 100 per cumm.However,in only 5 of
the 62 culture neg.PDE, but in 7 of the 21 culture
pos.PDE did the percentage of polymorphonuclears
(PNN5) reach B (p <O.01),we used this criterion to
subdivide culture—pos.PDE5 into false— and true
positive.
n=8 PTM=90 n=IO PTN=l44
19 43
4 10
5 (2) 2
)number of poa.culture foll.by clin.peritonitis.
These results suggest that during 83 bag exchanges
contamination of the peritoneal cavity occurred 7
times,but resulted only twice in clinical perito—
nitis.Local host defences seemed important.
POE
culture negative
false pos.
true pos.
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INFLUENCE OF CHANGES IN PLASMA AND RED
CELL VOLUMES ON HI IN CAPD AND HO
PATIENTS
Viachojannis J, Fink M, Werner E, Bähnert U,
Roth P, Hahn W, Hoppe 0, Schoeppe W.
St. Markus Hospital Frankfurt/Main FAG
The course of HI, plasma and red cell volumes in
10 CAPD patients (group I ) end a control group
of 8 HD patients (group II) was investigated in
ferrokinetic and erythrokinetic studies before
and ten months after the start of dialysis.
Results
HT
%
laai
l/kg
red cml
voham
mi/kg
red cell
life spa
days
I syn-
thesis
rate
g/d
BlcaxI
loss
mild
26.1tj4 54.1*3.6 17.1* 1.4 25.3t 0.7 5.11* 0.24 6.9* 1.0
P o1 o5 ns th
26.5 56.9 12.2 22.3 5.C3
P1?
8.0L
after 28.4 54.1 18.7*1.0 19.3t 0.8 6.87*O. 12.3*2.7
p n.s. n.s. n.s. 0.05 o.o5 n.s.
Our findings indicate that the significant im-
provement in HI found in CAPD patients compared
to HO patients is due to a decrease in plasma
volume and the result of combined changes in the
heme-synthesis rate, red cell survival time and
exogeneous blood loss.
PREVENTION OF PERITONITIS DURING CAPD BY
V—CONNECTED DOUBLE BAG SYSTEMS
J. WUst, U. Binswanger, G. Bichsel
Section of Nephrology and Microbiology,
University of Zurich, Grosse Apotheke Interlaken,
Swi tzerl and
A low rate of peritonitis observed with doubic
bag systems is thought to be the result of out-
ward flushing of bacteriae entered in the tubing
lumen during connection. To test this hypothesis,
dialysate movements were performed in vitro as
occurring during patient treatment. Connection
sites were inoculated with coag1ase negative
staphylococci amounting to 51O , 5.lO and 5.106
germs in a volume of 10/il of boullion. After
flushing the inoculation site with 2 lt of dia-
lysate, a new charge of 2 lt was counterpassed
and collected in a dialysate bag. 1 lt out of
this bag was filtered through a milipore filter
which was cultered. Colony counts (M; range)
amounted to 50 (0 - 190); 436 (22 — 670) and
5484 (160 — 14140) for respective inocula. —
V-connected double bag sets decrease the number
of contaminating bacteriae to about 1/10 and
therefore might contribute to the prevention of
peritonitis during CAPO.
18.9
* 1.5after 32.21.4 47.33.8 27.0t 0.9 5.11* O. 4.6* 0.5
DOES CONTINUOUS PERITONEAL DIALYSIS (CAPD) ALTER
IMMUNE FUNCTION?
D.B.Webb*, C. Smith**, C. Lee**, T.B. Wallington*
(Intr. by G.A. Coles).
* Department of Renal Medicine, Cardiff, UK.
** Department of Clinical Immunology, Bristol,
There is evidence that contrary to haemo-
dialysis (1W) CAPD may improve the impaired immune
response seen in uraemia. 27 consecutive patients
were entered into a serial study. In vitro tests
of immune status were made at the start of CAPD
and at two weeks, 1, 3 and 6 months and at 1 year.
In 5 patients CAPD was discontinued by 1 month.
21 have been followed for 3 months, 6 for 6 months
and 9 for 1 year. No patients were transfused.
Lymphocyte proliferation was measured by the
hanging drop technique. PHA response which was
initially subnormal increased to near normal by
6 months but peak responsiveness was seen in 5
day cultures rather than 4 days as in controls.
The response to Con A was similar. Responses to
PPD were subnormal and did not alter. Total
peripheral blood lymphocyte counts were normal.
B lymphocyte numbers (surface immunoglobulin)
were low throughout CAPD. Serum immuno globulins
were normal. Total T lymphocyte numbers (OKT3)
remained within the normal range. Numbers of OKT4
reactive (helper) cells increased within one
month. Levels of OKT8 reactive (suppressor) cells
were low/normal throughout CAPD.
These results show that certain in vitro
measures of CMI, deficient in uraemic patients
improve with CAPD. This is perhaps due to a change
in proportion of helper to suppressor T lympho-
cytes. This could prove important to the outcome
of kidney grafts in these patients.
DrALYSANcE OF ADRENOCORTICOIDS DURING CAPD
PGZag, HJ Frey, CT Spalding, MD Nevarez
University of New Mexico, Albuquerque. USA
Significant quantities of circulating adrenocor-
ticoids, unbound to plasma proteins, may be re-
moved during CAPD. To assess the effects of ster-
oid—plasma protein binding on dialysance, a series
of double equilibrium dialyses were performed in
vitro. Labeled steroids were added to plasma and
dialysate at the end of 4h exchanges(n=6). Per-
centages(%) of bound and unbound cortisol. aldo-
sterone(aldo) and l8-OH-B(l8-OH-B) were determined.
Plasma cortisol aldo 18-OH-B
% albumin bound 13±0.5 30±3
% transcortin bound 78±0.8 27±2 34±4
% unbound 9±0.3 39±1 36±1
Dialysate
% bound 21±4 3±1 4±1
% unbound 79±4 97±1 96±1
Heat treatment of dialysate(6OC for 20 mm) was
done in !jtrg to inactivate transcortin. This re-
duced the bound fraction of cortisol(p<.0l)but not
aldo(ns) or 18-OH-B(ns). Approximately 10% of
dialytate corti sal was transcortin—bound.
Endogenous levels of bound and unbound steroids
were measured in the same samples. Results are
expressed as dialysate/plasma concentration ratios
(D/P ratio).
DIP ratio cortisol aldo 18—OH-B
Total steroid 0.06 0.31 0.28
Bound steroid 0.02 0.04 0.02
Unbound steroid 0.53 0.80 0.76
Large amounts of cortisol(63±l0ig), aldo(2±Jug)
and 18-OH-B(4±2g) were detected in 24h collections
of dialysate effluent.
Conclusion: CAPO removes significant amounts of
unbound steroid from plasma. Albumin and transcor-
tin bound steroid do not readily enter dialysate.
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HEMODIALYSIS
itIOUt r€goa (F PATIENTS 04 DWIIC DIALYSIS TO IWLLENZA
vAcdD€( Iv) (F IPFLLOIX (F IPITWWSLLAR 1450C511149
A&UJ4ASSIH 7,, IXJVE9LIE !, INIERE PhJ ATTN !, HAM014 C.,
PtM1OTTE C0ANIEL Ph (1)C14i Amiens — (2)Instltut Pasteur, PARIS.
In normal humans h,..moral response to Iv has been reported to
be inversely correlated to intracellular magnesii.aii (Magnesium Bul
letin 1982, 2, 135). Since altered magnesium metabolism is anticii.
pated in patients on chronic dialysis the humoral response to IV
(Pasteur MJTAIP) was stusdied before winter 1983 in 21 controls
and 47 uremica on chronic dialysis (79 hemodialysis, 5 CAPO, 3
hemofiltration) in relation to plasma and erythrocytes concentra-
tions in magnesium. The antibodies titers were estimated by the
hemagglutination inhibition method for the 4 strains of the vac-
cine A/143N2 PhIL A/N3N2 BAMI ; A/HiNt and B. Magnesitan con-
centrations were measured by atomic absorption spectrophotometry
in the plasma (normal 1.9. 0.ng/dl) and in the erythrocytes (nor)-
sal 5.3O.5mg/dl). The dialysate magnesium concentration was
1.amg/dI and none of the patients were taking Mg(04)2. The mean
50 plasma 4g was 2.5+Jmg/di and erythrocyte Mg was 7.451.2mg/dl
.e. significantly higher than in controls. One month after the
first shot, husoral response was lower in ureeic patients fcr
the strains A/H3N2 PHIL(titer 1/40 In 40% in uremlc versus 76%
in normals),and tbt.strain HiNt (titef> 1/40 in 47% of uremics
versus 76% in normals). The results were comgarable for the 2
other strains. The non responder to A/H3N2 PHIL received a second
rhot and their hunoral response one month later was positive in
66% for A/H3N2 PHIL and in 55% for A/H1N1 i.e. with a frequency
comparable to controls. No correlation was found between the hu-
moral response to i.V. and the magnesium parameters.
cflC..tGIO6 : 1/ Humoral response to IV. is lower in ureeics
onchronic dialysis than in controls at ieast for 2 strains,
,nich justifies a systematic revaccination one month later.
2/ Contrarily to what has been found in normals, there is no
correlation between the Iumnrai response to I.V. and erythro-
:yte magnesium concentration.in this snail uresic oopulstion.
MAGNESIUM INDUCED NEUROPATHY IN PATIENTS
GOING REGULAR HAEMODIALYSIS TREATMENT
N. Ahmad, C. A. Pickin, H. J. Goldsmith.
Renal Unit, Seftun General Hospital, England.
With the advent of efficient dialysers and
reduction in the hours of dialysis, scant
attention has been paid to magnesium (Mg) kinetics
in patients on regular haemodialysis treatment.
Three adult patients (2 female) who had been
on regular haemodialysis treatment for X6years,
developed symptoms of neuropathy. Their pre—
dialysis plasma Mg concentration was X 1.73 mmol/l.
(normal 0.7 to 1.1 axaol/l). These patients had
been dialysed for 3 X 6 hour sessions weekly using
la' Gambro dialyaers 250 ml/ain, g 500 ml!
mm). The dialyaate Mg concentration ad been
0.85 mmol/l. Prolongation of hours of dialysis
produced no improvement but dialysis with Mg free
dialysate proved beneficial not only in removing
neWUopathic symptoms but also in shortening motor
nerve conduction velocities. Time taken for
improvement of symptoms wee X 10 weeks. In one
patient the symptoms re-appeared after she was
inadvertently dialysed again, against a Mg of
0.85 mmol!l: they cleared, however, with
resumption of Mg free dialysis and she remains
well.
Hypermagnesemia may play a role in the neur-
opathy of pationts undergoing long-term dialysis.
• FACTORS INFLUENCING THE HYPERMAGNESEMIA OF CHRONIC
HAEMODIALYSIS
N. Aebiacher, P. Aebischer, 0. FelI', ,J.P. Wauters
Dialysis Units, Cantonal Hospital, Fribourg, University
Hospital, Lausanne, Switzerland
Hypermagnesemia, a frequent observation in chronic
haemodialyzed patients, can induce gastro— intestinal,
cardio—vascular and neurologic disorders. We therefore studied
the relative importance of factors affecting plasma magnesium
(Mg).
Eighteen patients aged 60.7* 11.5 years and dialyzed for 551t 83 mm per week were considered. There was no significant
difference of pre—dialysis Mg in mMol/1 between patients
dialyzed against dialysate containing 0.5 mMol/L of Mg (1.43 s
0.43; n = 8) and those dialyzed against Mg-free dialysate
(1.55 0.57; n = 10) (p >0.5). The mean Mg loss in mMol
per hour of dialysis, measured by collection of total spent
dialysate, was slightly lower with Mg—containing dialysate
(2.43 * 1.39) then wIth Mg-free dlalysate(3.46 1.11) (p
0.2). Amongst all the patients, Mg intake due to the use of
Mg—containing phosphate binders varied from 2.1 to 64.5
mMol/d. Mg drug deily intake was 20.7 * 12.2 mMol in the
Mg-containing dialysate group and 24.8 19.6 mMol in the
Mg—free dialysate group (p 0.5). There was a strong positive
linear correlation between drug Mg and pre—dialysis Mg (r =
0.85; p 0.001). This correlation was not stronger when only
the group with Mg—free dialysate was considered (r = 0.86).
Nine patients then received non—Mg—containing phosphate
binders. Pre—dielysis Mg in mMol/L decreased from 1.55
0.87 to 1.05 0.15 (p 0.05) after one month already,
Conclusion: in order to attain normal magnesemia, the use of
Mg—free dialysate is inefficient when Mg-containing phosphate
binders are used,
THE RE-USE OF BLOOD LINES AND MEPARIN
RATION SETS (BLHA) IN REGULAR DIALySIS TREATMENT
(EDT).
R. Ahmad, B. Large, P. Livesley, D. Redman and
H. J. Goldsmith.
Renal Unit, Sefton General Hospital, England.
In the management of patients on RDT, dialyser
re—use is now a common and accepted practice.
However, BLHA which together with tho dialyser
form the extra—corporeal circuit (ECC(, are
infrequently re—used. BLMA are expensive items arsil
re—use can result in substantial savings.
In Liverpool, for the past iO years, we have
routinely re-used the ECC. All home (70),
satellite (28) and Centre RDT patients (24) , are
trained to re—use the ECC with the aid of a semi—
automated dialyser re-use machine which can be
coupled to any existing dialysis machine. Follow-
ing dialysis it sequentially rinses the ECC with
0.9% saline, 1% sodium hypochlorite, 09% saline
and finally primes with 4% formalin. Before
commencement of dialysis the ECC is flushed with
0.9% saline and the formalin is dialysed out by
the dialysate of the dialysis machine. Patients
are encouraged to re-use the ECC up to five times
but a mean re—use rate of 4.0 is obtained. HLHA
sets can cost up to 80% of the cost of the dialyser
and therefore its re-use makes economic sense. The
cost savings per freguency of ECC re—use are:
In our experience the financial saving
achieved by re-use of the 8CC beyond five times
is negligible.
ECC Re-Use
Relative Cost I
1 2 3 4 5
66 53 47 53 40
. USEFULNESS OF MULTI—ENZYMATIC INHIBITOR NAFM{STAT
MESILATE (NM) IN HIGH BLEEDING RISK HEMODIALYSIS
• (Ho) 1) 2)T. Akizawa, S. Koshikawa, Y. Asano
,
Y. Hirasawa
4) 5) 6)K. lids
,
N. Mimura , K. Nakamura , K. Ota
1) 2)Showa Univ., Jichi Univ.
,
Shinrakuen Hosp.
Osaka Metro. Toranomon Hosp.4, Teikyo
Only.51, Tokyo Women's Med. Coll.6, Yokohama,
Japan.
NM strongly inhibits in vitro, the multienzyma—
tic systems including the coagulation cascade and
the coisplement pathway. We examined clinical ef-
fects of NM as an anti—coagulant for HD in 66
pat ienl:s.
NM infusion of 30mg/hr prevented coagulation in
the extracorporeal circuit as well as heparin did.
The anticoagulant effect of NM was mostly limited
to the extracorporeal circuit because of its prompt
metabolism. This was the beneficial feature of NM
in treatment of patients with high bleeding risk.
Differing from heparin, NM had neither lipolytic
nor osteoporotic activities.
Although NM prevented leucocyte depletion at
very high doses during HD in animal experiments, it
could not suppress the elevation of activated com-
plements (C3a and C5a), during MD with cellulose
membrane at clinical dosages. Few adverse effects
were noted throughout the clinical studies.
These results indicate that NM baa several pre-
ferable characteristics as an anti—coagulant over
heparin, and that it should be widely available for
HD, especially in cases with high bleeding risk.
LEUKOK:[NErICS IN IØ1G-TEPM TEE (LTU) OF CUPIOPFThNE
HEMDDIALYZEI
F. Albors, A. Rhiout, M. Kessel
Neproicqy, Free University of Berlin, F .R.G.
It has been reported that LTU of cuprophan
dialyzers results in a decrease of pre-dialysis
(PD) neutrcphil (PRN) counts and a decrease in the
chenDtactic response and phagocytosis of PRN.
By a cytochanical automated count (up to 1 cxsco
coils/ran3 blond) we analysed kinetic profiles of
the main types of white blond cells (WBC) during
hanoclialysis (MD) in patients with the very first
use and suds with LTU of cuprophan membrane (1 ,1m2)
Results:
Maximal relativ fall (%) WBC (15 mm MD):
LT1N rrno Jica baso LymphoFirst use (n=lo) 83 81 73 25 40
LTU (n=63) 86 83 59 63 35
PNN—kinetic (cells/nm3 blood)HD-treatjannt n PD 15 mm MD Post—MDFirst use 10 6129 837 7034
1 year 18 4981 867 5799
2—3 years 2o 4493 8o5 49P4jears 2o 4152 656 4251
+ (means as antilog of mean log values)
Similar results were found with nonocytes and lym-phocytes, but their post-MD-values renamed stable.
These results indicated that the very first
blco5—manbrane interaction, cciiipared to those on
routime—HD, MDC shcwed the same kinetic profile.
Our datas sujgested that all main types of MDC tookpart in the MD-induced leukopenia, but with a
Sistinctive cell-sensitivity to the factors
provoking HD-leukopenia. Cuprophan in LTU did not
lead to a significant reduction of ID—PMN—values
but to a significant (p.co,o5) decrease of the
rebound response at the end of each HD.
LEUKOKINETIC IN LCt'JG-TE14 WE (LTU) OF CUPRDPHNE
IDDIALYZES
F. Albers, A. Nahiout, M. Kessel
Nepro].ngy, Free University of Berlin, F .R.G.
It has been reported that LTU of cuproLthan
dialyzers results in a decrease of pre-dialysis(PD) neutrophil (PM) counts and a decrease in the
chemDtactic response and phagocytosis of P1t.
By a cytocheiacal automated count (up to 1 cooo
cous/nrn3 blocd) •. analysed kinetic profiles of
the main typos of white blocid cells WBC) during
hrcdialysis (MD) in patients with the very first
use and suds with LTU of cuprophan membrane (1,1m2)
Results:
Maximal relativ fal] (%) MDC (15 mm MD):
PMJ Mno Ecs Baso Lympho
First use (n=lo) 83 81 73 25 4o
LTU (n=63) 86 83 59 63 35
V-kinetic (oslls/rmrrt3 blcod)
MD-treatmant n PD 15 mm MD Pcst-HD
First use lo 6129 837 7o34
1 year 18 4981 867 5799
2—3 years 2o 4493 DoS 4984
5 years 2o 4152 656 4251
+ (means as antilog of mean log values)
Similar results were found with rrcnocytes arid lym-
PnDcytes, but their post-MD-values rairied stable.
These results indicated that the very first
blcod—menbrane interaction, ccimpared to those on
routire-HD, MDC shcwsi the same kinetic profile.Our datas sigested that all main types of MDC tookpart in the HD-indted leukcpen.ia, but with a
distinctive cell-sensitivity to the factors
provoking HD-leukopenia. Cuprophan in LTTJ did not
lead to a significant reduction of TD-PMN--values
but to a significant (p<o,oS) decrease of the
rebound response at the end of each HD.
INTRAOCULAR PRESSURE (TOP) CHANGES INDUCED BY REGU-
LAR DIALYSIS TREATMENT (ROT).
A. Albertazzi, B. Di Paolo, C. Spisni, L. Mastro—
pasqua°, P.E. Gallenga°.
Institutes of Neph. & Dialysis and Ophthalmology0,
University of Chieti — Italy.
It has been known that uremia and ROT could al-
ter the Central Nervous System. We previously demon
strated the persistence of a delayed P100 wave evo-
ked by Visual Potentials (VEPa) in ROT patients.
Our present study evaluates changes in lOP during
ROT and possible correlations between electrophysio
logical and tonometrical modifications.
In twenty patients undergoing ROT (12 hrs/weeks,
mean age 42.05t10.80 yra) we performed, just before
and immediately after the dialytic session the tono
graphic recordings (Tg) and serum osmolarity.
The predialyais lOP of all 20 pta ranged from
9.00 to 27.19 mmHg with a mean of 16.40±7.20. The
outflow resistance was 0.107±0.06; the flux 5.43±
3.14; outflow facility before dialysis was 0.22±
0.26 and after four hours 0.21±0.27. Serum osmola—
city pre—dialysis was 320 mOsm/l and post—dialysis
293 mOam/l.
Our studies suggest a correlation between decrea
se in plasma osmolarity and increase in lOP during
dialysis. The elevation of lOP should be due to a
decrease in post—dialysis outflow facility inducing
an osmotic influx of water into the eye because of
hyperosmolarity of intraocular fluids. These
continuous modifications should be partially respon
sible for the defective propagation and the slowed
transmission documented by VEPs.
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SPINAL—RECORDED (ESG) SOMATOSENSORY EVOKED POTEN-
TIALS IN UREMIA.
A. Albertazzi, B. Di Paolo, T. Di Marco, L. Varane—
me.
Institute of Nephrology & Dialysis — University of
Chieti — Italy.
The visual,eornatosensory and auditory brainstem
evoked responses have shown a close Correlation
between the degree of electrophysiological abnorma-
lities and the clinical "uremic" follow—up.
Thirty—one uremic patients were examined once
during a conventional low nitrogen diet treatment
and repeatedly after the start of a regular dialy-
sis treatment. Percutaneous or needle lumbar recor-
ding electrodes were applied over the 3rd and 2nd
spinous processes to record the ESG of the right
peroneal nerve stimulated at the popliteal fossa.
On diet, peripheral conduction and the lumbar
compound action potential resulted delayed and
polyphasic in 16 out of 31 patients (51.61%). On
dialysis, the slow peripheral conduction and propa-
gation time persisted, moreover we found a disper-
sion of the central volley due to axonal degenera-
tion in 19 out 31 pta (61.29%).
Our data confirm a defective neural conduction
in uremia due to a breakdown of axonal transport in
the supply of essential components to peripheral
fibers. The electrophysiological parameters worsen
during RDT, implying the role played by the meta-
bolic derangement and the "unphysiology" of dialy-
tic therapy.
.
OBJECTIVE ASSESSMENT OF A LOW MOLECULAR WEIGHT
HEPARIN IN HAEMODIALYSIS
• E. Anastassiades, D.A. Lane, U. Ireland, A. Flynn,
J.R. Curtis.
Charing Cross & Westminster Medical School,
London, England.
We have compared different regimes of a low
molecular weight heparin(LMWH) KBI 2165, with our
standard regime of unfractionated heparin(UFH) for
haemodialysis (n=16) . We routinely inspected the
bubble—trap for clot formation and, uniquely, we
also measured fibrinopeptide—A(FPA) plasma levels
at hourly intervals during dialysis as an objec-
tive measure of fibrin generation. Our UFU regime
completely inhibited clot formation and fibrin
generation with heparin levels of O.7—O.9iu/ml.
LMWH administered subcutaneously (5000 or 10000
anti—factor Xa U) 4hr before the start of dialysis
failed to prevent clot formation in the bubble-
trap. Anti—factor Xa levels in the first hour of
dialysis were low and there was a marked rise in
FPA levels. A single i.v. bolus of LMWH 5000 anti-
factor Xa u at the start of dialysis, after prim-
ing tOe extracorporeal circuit with LMWH 1500 anti—
factor Xa u in saline, allowed dialysis for up to
6hrs. The mean FPA levels, however, rose after 4
hrs. Further addition of a continuous infusion of
LMWH(1500 anti-factor Xa u/hr until the lest hour
of dialysis) completely suppressed clot formation
and mean FPA generation but there was a progres-
sive rise in mean anti-factor Xa levels to l.5u/ml
with a consequent risk of bleeding. From the dose
dependent effect of plasma anti—factor Xe levels
on the inhibition of fibrin clot formation and FPA
generation, we suggest that infusion of this LMWH
at a dose of 4000 anti—factor Xe u bolus plus 750
anti—factor Xa u/hr should result in optimal hep—
arinisation for prolonged dialysis.
DISEQUILIBRATION OR ACUTE CAFFEINE WITHDRAWAL ?
P Altmann, J Barnes, JA Henry, AJ Williams.
The London Hospital, and The Poisons Unit, Guy's
Hospital, London, England.
Transient headache, irritability and malaise are
common after haemodialysis (HO), and often attrib-
uted to "disequilibration". Caffeine withdrawal
causes similar symptoms.
The aims of our study were to determine:
1. Is caffeine detectable in blood of RD patients
before dialysis ?
2. Are their caffeine levels similar to those found
under comparable conditions in normal subjects 7
3. Do caffeine levels fall markedly during ND ?
7 HO and 7 normal subjects drank 4 cups of
coffee (and took no other caffeine containing
substances) on the day before study, the last 'dose'
being before 2200 hr. At 0900 hr a fasting blood
sample was taken for plasma caffeine (gas—liquid
chromatography analysis)
Results:
[Normals CN AP DR JB KB PA AW mean
caff. mg/l 0.98 0.60 0.58 0.22 0.18 0.12 1.50 0.60
Patients RH DA TE SB TW PS PD mean
mg/l 37.0 16.0 2.50 44.0 5.50 1.30 5.701 16.0
Caffeine concentrations in patients were higher
than in normal subjects (p < 0.001). The two
patients with the lowest levels passed much more
urine.
In separate experiments plasma caffeine fell by
60% during haemodialysis (p < 0.01) . Acute caffeine
withdrawal may, therefore, contribute to post—
dialysis malaise.
A P14X3RA6MED REM)VAL OF FLUIDS QDNSIDERING
PATIrS WITh UNSTABLE HEMDDYNANICS DUPIN.
HEMDDIALYSIS.
S
.Zntonov,S.Krivosh jev, Z .Kirjakov,V.Kuleva,
E
.Vazelov, Z .Velkovski.
Medical Academy,Henodialysis center,Sofia,
Bulgaria.
The dialysis related hypotension often
creates cbsticles when fluid removal (in order
to reach optibal ostdialysis ight/OPW/) is
concerned.Aiining to avoid hypotonic accidents
and to reduce the number of the applications s
use "Prcmjranuid Dialysis" (PrD) for 7 anuric
patients on RUT .me duration of the dialysis
treatmant is 36—72 months. In programming we stick
to the basic principle:in the first half of the
dialysis tin-a we reach 2/3 to 3/4 of the fluid
removal acquired parallel to high Na-concentra-
tion in the dialysis fluid(l48nmol/l) .In the
second half the rest of the ultrafiltration is
reached parallel to gradual diminishxtant of Na—
concentration till the optimal level for the
patient is found.We carry out the following
laboratory tests—serum and red cells'K,Na,plasna
omlTo].ality arterial pressure(AP) ,body mass (EM),
drugs outgo .We don't find any significant dif-
ferences between standard and PrD for the serum
and red cells'K,Na,plasma osrrolality,AP.By PrD we
acquire greater dimninishmant of EM-i .6%(p4.OOi)
with decreased drugs outgo:NaCllO%-6tins less,
peripherial vasoconstrictors—2 .4 times less. In-fusion solutions are not applied,We don't notice
subjective ccznplaints of thirst ,abnormal over-
weight.we are not forced to discontinue the PrD
before reaching OPW.
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A NEWLY DISCOVERED LIFE—THREATENING SYNDROME:
MALIGNAHT PROTEINURIA. MANAGEMENT OPTIONS
Avram MB, Gan A, Pahilan AN and lancu M.
The Long Island College Hospital, Division of
Nephrology, Brooklyn, New York, USA
Three patients who presented with massive pro—
teinuria (>25mg/day in 24—hr urine sample) were
found to have hypoproteinemia, reduced oncotic
pressure and massive edema, with life—threatening
hypotension and shock in 2 of the 3 cases. Dia-
Lytic therapy was required for severe azotemia in
all cases. A'though the creatinine clearance was
below 3m1/min, large protein amounts, paradoxically,
were still lost through the non—clearing kidneys.
This was probably due to a few, overactive re-
maining glomerull. Ablation of remaining nephrons
with metallic salts was followed by cessation of
massive protein loss and restoration of blood
pressure.
Other studies have identified massive protein
losses (>25gm/24 hrs) in uremic and non—uremic
patients such as post—transplantation and have
attempted to reverse this life—threatenine state
with a variety of therapeutic modalities such as
metallic salts, gelfoam embolization of renal art-
eries, stainless steel rings, uninephrectomy and
binephrectomy (in dialysis—ma intained pat i.ents)
Focal so torus is was found to h the les ion in
most cases (inc I id ing the pist—transplant patient)
a I though a ri l range of minima change ti complete
histoioica I sclerosis of the ncphiroii is encoun—
tore d.
We have deser thud the mat Lgri;Int prite heir in
syndrome; a new, ile—thruitening 1 inial entity
and its management • in our hands, with medical
nephrectomy usLng ncphrotoxins such as metal I ic
as I is.
ETO-INDUCED IgE-MEDIATED DEGRANULATION OF
BASOPHILS OF DIALYSIS PATIENTS
Barth, H., Boxnmer, J., Wilhelms, H., Ritz,
E., Department Internal Medicine Heidelbeic'
and Boehringer Co. , Mannheim, Germany,FRG
Untoward reactions on dialysis have been
ascribed to reagenic antibodies against ET
conjugates demonstrated by PAST (Dolovich,
J.A11.Clin.Imm.62,3O,1978). To further eva-
luate the role of ETO Ab, dialysis pat.
with such reactions were examined for pre-
sence of cytophilic allergen—specific IgE
Ab against ETO haptens on pat. own basophi-
les. The test detects allergen—induced re-
lease of proteolytic activity coreleased
with histamine and quantitated using an
artificial substrate (TOS-GLY-PRO—ARG,
chromozyme-CH). Buffy coat was isolated
from non—uremic controls and dialysis pat.
with anaphylactoid reactions. Test was
started by addition of ETO-BSA-conjugate
(prepared at different pH) and human IgE
antibody as specificity control; exclusion
of cytotoxicity by measurement of LDH. Pro-
tease colorimetrically (405 nM) as p—NO2—
anilide release. With the exception of 1
control (who had cardiac surgery 10 years
ago with exposure to gas-sterilized equip-
ment) no ETO ab were detected in non-dialy-
sed pat. All dial.pat. with anaphylactoid
reactions had degranulation in response to
ETO conjugate. Results confirm with an in-
dependent method previous results using
RAST and document important role of ETO
hypersensitivity in genesis of anaphylac—
toid reactions on dialysis; they further
support histamine release in genesis of
such rea.tions
. HIGH DOSE VITAMIN C ADMINISTRATION IS
HARMFUL IN PATIENTS ON RDT
P. Baicke ,J. Zazgornik ,P. Schmidt ,H. Kopsa,
A. Haubens tock
I .Med. Clinic,University of Vienna,Austria
Vitamin C supplementation is recommend-
ed in chronic haeniodialysis patients.Since
ascorbic acid is a metabolic precursor of
oxalic acid,we studied the effect of vita—
minC administration on plasma oxalic acid
levels.In 9 chronic haemodialysis patients
Ig vitaminC was given intravenously after
each dialysis session.Mean plasma oxalic
acid level(normal rmnge i6,8+6,o1umolIl)
rose from 79,6+18,I1umol/l to l9,l+29,6
umol/l within 2 weka(mean increase 24o%,
=9,78,p<O,ool).After 3 weeks the level
was 2o6,3+39,9,umol/l,after 4 weeks 21o,5
+27,2 umol/l.W1-ien vitaminC supplementation
was discontinued plasma oxalic acid levels
fell approximately to the pretreatment val-
ues within 2 weeks.Plasma oxalic acid—
creatinine ratios—evaluated to exclude dif
ferences in dialysis efficiency—showed a
similar behaviour.
Our data show that secondary hyperoxalaem—
ia,as a consequence of renal insufficiency,
is aggravated when vitaminC is given.This
is probably due to an increased formation
of oxalic acid from accumulated ascorbic
acid.It is likely that aggravation of hyper
oxalaemia causes an enhancement of calcium
oxalate deposits,found in a high percentage
of dialysis patients in kidney,myocardium,
pancreas,bones,cartilage and joints.
VitaminC supplementation should therefore
be restricted to the minimal dosage neces-
sary to correct vitaminC deficiency.
SNUFFBC FISTULA OR CLASSIC BRESCIA -
CIMINO FISTULA — A COMPAEIATIVE STUDY
V. Brtovd
Department of Internal edicine, Charles
'Jniv. iedical School, hemodielysis Unit,
Prague, Strohov, Czechoslovakia
Sinple subcutaneois arteriovenous
fistul still remains the best vascular
access for patients treated by regular
hemodialysia. The first fistul should
be constructed as distally as posoible
to enable the possibility of constructing
a new one more proximally on the sane
arm in case of thrombosis.
Two hundred and six ond—to—side
arteriovenous fistulas were constructed
at the distal forearm (classic 3rescia —
Cimino fistul) between a. radialis and
v. cephalika antebrachii from Uarch 1l72
to December 1934.
Sixty five end—to—side arteriovenous
fistulas were constructed in the snuff—
box area between a. radiulis and v.
cephlika pollicis from June 1982 to
December 1984.
The long term curnuniulative patency
of both types of fistulas is compared,
showing no statistical difference.
The advantagof the snuffbox fistula
are presented.
Abstracts 319
PHOSPHATE (Pi) REMOVAL IN UREMIC PATIENTS: EVALUA-
TION OF DIFFERENT THERAPEUTIC MODALITIES.
C. Sazzato, U. Coli, S. Landini, P. Morachiello
Nephrology and Dialysis Opt., Umberto I Hospital,
Vanice—Mestre, Italy.
Pi accumulation is one of the main biochemical
derangements in uremic patients. The available de—
purative technique still appears inadequate to mal
otain normal Pi balance. We have evaluated differe
nt therapeutic approaches to obtain better Pi remo
val in chronic uremic pta: 1) plasma perfusion
(PP) with activated alumina cartridge; 2) actived
charcoal hemoperfusion plus hemodialysis (HP+HD),
3) standard dialysis treatment (Hi)) with acetate
(Ac-HO) and bicarbonate buffers (Si—HO). 5 pta on
conventional HO have been treated with PP once a
week, over 6 moe period. A similar study period w
as performed in 3 pts with combined HP+HD. A gro-
up of 5 pta were treated 3 taos with Ac—HO, and 3
mos with Si—Hi). Plasma Pi level and its Red Blood
Cells (RSC) content were monitored during the dif-
ferent treatments and 4 hours after. PP lowered p1
asma Pi from 10.5+1.1 to 6.3+0.7 mg% (PC 0.001) wi
di no univocal trend for RBC Pi content. During
HP—HD plasma Pi changed from 7.25+1.5 to 4.15+0.5
(P<O.Ool). Si—HO resulted more effective than Ac—
lID in preventing Pi rebound at the end of HO sess-
ion. RSC Ui content remained stable (my 3.5+0.3
mg%) with Si—HO while during AcHO increased from
2.6+0.3 to 5.9+0.9 mgi 4 hours following HO treat
meot. PP and Hi—HO scem more effective on Pi remo-
val likely because these two modalities don't pro-
mote a marked P1 shift from extra to intracellular
compartment leading better plasma P1 availability
for depuration.
CLINICAL EVALUATION OF THE VOLUMETRIC ULTRAFILTRA-
TION MONITOR UFM 10-2
J.H.N. Berden, J.N.P. Mokke, R.A.P. Koene
Ocpts. of Nephrology and Physiology, University of
Nijmegen, The Netherlands
Uniform and controlled ultrafiltration (UF) de-
creases dialysis aide effects. The best currently
available method for UF measurement is volumetric
monitoring of the dialyaate flow. Recently Gembro
(Lund, Sweden) introduced the HEN 10—2 which mea-
sures OF volumetrically wiLh two electromagnetic
flow Lrensducers. We tesLed this UFN in various
dialysis modalities mod compared it with bedsealea
body weight monitoring at hourly intervals.
Using hollow fiber dimlyeere the mean percentu—
ml error of the absolute difference between both
methode was 3+4% and the correlation coefficient
between hourly HF measurements by both methods
0.987 ln=100, p<104). If parallel flow dialyeers
were used this error was 13+9% and the correlation
coefficient 0.95) ln=SS, p<1O4) . During single
needle dialysis with a parallel flow dielyser the
error was 10+10% and e correlation coefficient of
0.962 )n=69,pc104) was obtained. The lower accu-
racy of the UFN 10—2 in parallel flow dialysers is
doe to the greater compliance of this dialyser
leading to pulsetile changes in dialysate flow.
Besides measurement of OF, the HEN 10—2 can also
adjust the trans membrane pressure of the dialyser
to obtain a given OF/hr. In 10 dialysis treatments
the mean percentuml error of the absnlute differ-C
ence between planned and obtained OF was 3±4%. The
corrolation coefficient between ilanned and ob-
tained HF was 0.992 (n61, p<lD).
The results show that the UFN 10—2 is clinically
useful but its accuracy is dependent on the type
of dialyser used.
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LIPIDS AND HAEMAIUCRIT AFTER LONG TERM L—CARNITINE
TREATMENT IN HAEMODIALYSIS.
C. Sellinghieri, V. Smvics, A. Msllsmace, B. Riccisr
di, F. Iorre, S. Rotondo, C. Ranerl, C. Liosi, N. I—
lscgua
Istituto Pluridieciplinsre di Clinics Medics s Term—
pie Medica Generale a Speciale — OniveraitA di Mes-
sins —.
Literature data and preceding our data refer use-
ful effects of L—csrnitine treatment in hsemodisly—
zed patients, specially in regard to the so—called
post—dislysis syndrome. The present study regards 11
pids and haemmtucrit vslues of 15 msle sod 25 femsle
subjects undergoing periodic haeeodialyais from 12
to 96 months under controlled diet. The patients,
after a baasl evaluation of colesterolemia, trigli—
ceridemis, HOL colesterolesia, HDL colesterol ratio
and haeeatocrit, were followed for tao years. During
the first yesr s placebo was sdainistered while du-
ring the second year L—cernittne sac sdministered at
the dose of 2g/die/os. Every month the parameters
considered were evaloed. The results showed that hse
matocrit )pO,OOO4) and HDL colcsterol (pcO,05) in-
creased. While trigliceridea decreased after L—car—
nitine treatment. In conclusion our data revealed a
therapeutic utility of long term L—csrnitine treat—
sent in haersodialysis patients.
CAROTiD ARTERY ATHEROSCLEROTIC DISEASE
OETFRMJ NEO OY VELOCITY WAVE FORM ANALYSI S
IN HEMODIALYZED PATIENTS
O.Oernardi, A. Ferreri, P. Marctti,
ti . A. Urti , I . lionechi(lntr. by R. Polls).
Oivieiorie di Medicina lnterna, Ospedale di
San Miolato-Pisa, Italy.
Cerebrovascular accidents are vary com-
mon in oremic patients on long—term home—
dialysis. In order to characterize asymto—
matte carotid atherosclerotic diseana (CAD)
in hemodialyzed patients (H), doppler velo-
city wave form of common carotid artery aas
analyzed. 10 H, aged 48—62 years, and 10
healthy controls (C), cross—matched for sex
and age with H, mere studied, Al) were non-
smoker, without diabetes, hypertension or
cardiopathy.
The five mont capable of discriminating
different degrees of CAD wave form dimen-
sions are: peak systolic velocity, peak dia
stolic velocity, cod diastolic velocity,
width of the systolic peak at midhei ght, my
stulic mccellerstion (Bernstein, 1982). The
we parameters were determined and used in
an equation dcrivered by discriminant ana-
lysis. The conseguent score of H Lracingm
resulted overlapping to that of C tracings.
to conclusion the carotid artery veloci-
ty wave form analysis does not reveal a dif
ferent degree of CAD in dialyzed patients
compared to matched controls.
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YERSINIA ENTEROCOLITICA BACTERAEMIA IN HABMODIALY—
S's.
J.Boelaert, Y.Valcke1, D.yandenbroucke2,2W Lornoy3
Y.Waterlot , H.Van L?nduyt , J.Vandepitte 2
A.Z. St. Jan, Brgge , Cath. Univ. of Leuven , OLV
Ziekenhis Aalst , H6p.Univ.St.Pierre, Bruxelles,
Belgium
Eight patients, on maintenance haemodialysis
since a mean of 6 years, developed a Yersinia en—
terocolitica (Y.E.) bacteraemia. All presented
with high fever. Two complained of severe abdomi-
nal pain, leading to laparotomy in 1. No patient
had diabetes, liver cirrhosis, malignant or here-
ditary haemopathy, nor was treated with immunosup-
pressive drugs. In no patient did the symptoms ap-
pear during or immediately after a blood transfu-
sion. In 2, the Y.E. bacteraemia occurred within 1
month after the onset of desferoxamine treatment.
The serotype of Y.E. was 0 : 3 in 2 and 0 9 in 6
patients. Agglutinins against Y.E. appeared in on-
ly 1 of 4 examined patients. In each case, cure
was obtained with antibiotic treatment. One death
was unrelated to the ifectjon.
All patients had iron overload, as indicated by
1) the previous administration of iron—dextran
and/or packed red cells, corresponding to an ave-
rage iron load of 20 g (range 6—58); 2) a serum
ferritin (in 7 patients) increased to a mean of
2300 ng/ml (range 629—8000, normal < 300);3) a posi-
tive bone marrow iron stain in 4/4 cases; 4) a com-
puted tomography of the liver (in 5 patients, ex-
cluding 1 with polycystic disease) giving an atte-
nuation coefficient increased to a mean of 74
Hounsfield units (range 66—82, normal(60).
Conclusion : haemosiderosis, acquired on dialy-
sis predisposes to Y.E. bacteraemia.
ALUMINIUM CONTAINING PHOSPHATE BINDERS AS
POTENTIAL SOURCE OF TRACE ELEMENTS IN
PATIENTS ON REGULAR DIALYSIS (RDT)
D. BrancaccioR. PietraE. SabbioniF.Mousty
M.GallieniI .BiscegliaA.Berlin".
Renal Unit,Ospedale S.Paolo,Milano,Italy
Radiochem.&Nuclear Chem. ,CEE,JRC,Ispra,
"Conlm.Europ.Comm. ,Health Dir.Luxeinbourg.
The regular oral administration of Al-corn
pound to patients on RDT is believed to be
responsible for progressive encephalopathy
and osteomalacic osteodystrophy.
However,as several trace elements were also
found in patients on ROT with Al intoxica-
tion and are though involved in this syn
drome,we evaluated the content of 37 trace
elements in phosphate binders by means of
Neutron Activation Analysis.
Our results confirm that these drugs are
relative pure in terms of trace metals;
howeve:r,assuming an intake of gels of 2—6
gms/day/patient, the contribution to the
total dietary intake,espressed in %,is
high for As(lO%) ,Ba(l5—30%) ,Cd(7—42%) ,Ce
(l7O%),Cr(lO—30%),Ga(llOO—24000%),La(l7O%)
Sc(20—5O%),Sr(30—225%),Th(6—l2O%),w(6_45%).In conclusion,althougi-i poorly absorbed,
the continuous use of phosphate binders
may represent a potential hazard in terms
of positive balance of several trace me-
tals. In spite of the fact that their toxi
city is still unclear,the clinical use of
Al—based gels should strictly be reduced
in patients on ROT.
VERAPAMIL BLUNTS U[MODIALYSIS—INDUCED LEUKOPENIA.
F.Bonet, C.Caramelo, R.Bosch, M.Sarichez Crespo, S.
Casado, L.Hernando.
Servicio de Nefrologia.Fundacion Jimenez Diaz.Macirid.
A imber of reasons indicates that antagonists
of the Ca +_channels could be a useful therapeutics in
HD patients, since they frequently have hypertension
and angina. In addition, recent evidence suggests the
involvement of extracellular calcium entry as a major
mechanism in polymorphonuclear leukocytes activation.
A study was performed in 10 HD hypertensive
patients. They were treated With 240 mg of verapamil
per day divided in two doses. Prior to verapamil they
were for 7 days without antihypertensive therapy, HO
was done2with a hollow fiber cuprophan hemodialyzer
of 1.1 m surface. Blood samples were taken prior to
the beginning of HO and at 15 and 30 mm thereafter.
Blood pressure at the end of the period prior to vera-pamil was 180 7 22/99 7 6mmHg, and was reduced to
152 7 13/86-p 8 (p<0.05) at the end of verapamil
treatment. Intradialysis angina disappeared in the two
patients with angina. HO—induced leukopenia was signi—
ficently reduced (p<0.025) during the period of vera—
pamil treatment as compared to the values found prior
to the starting of this drug. In this table these values
as shown.
Leukopenia (percent reduction)
Initial 15 mm 30 mm
Verapamil 100 73 T 18 59 T 15
Control 100 55 7 16 45 7 16
In short, verapamil could be a useful antihyper—
tensive drug in hemodialysis patients, that in addition
has the interesting property of blunting the magnitude
of HO induced leukopenia.
SPINAL FLUID ALUMINIUM LEVELS IN HEMODIA-
LYZED UREMIC PATIENTS.
O.Brancaccio",O.Bugjanj,L.pacjni,
I.Bisceglia",N.Gallieni",M.surjan',
C.Costantini",R.Giordano',M.Rjzzjca".
Renal Unit,Ospedale S.Paolo,Milano,Italy
lstituto Neurologico C.Besta,Milano, Italy
Renal Unit,Ospedale di Lodi,Milano,Italy
"Istituto Superiore di Sanità,Roma,Italy
Aluminium is considered as the causati-
ve agent for a progressive syndrome which
mainly features Encephalopathy (EP) and
Osteomalacic Osteodistrophy (00). However
it is not yet understood why a small group
of patients may develop EP,while others
present OO,assuming that all of them are
on the same dialytic treatment in terms of
Al—gels and dialysate purity.
In order to elucidate the possible pathoge
netic factors in inducing EP, 16 informed
patients on RDT,presenting evidence for
Al intoxication,were admitted to an in-
vestigative neurological protocol which in
cluded: spinal fluid and serum Al measure
ment,Blood-Brain-Barrjer (BBB) permeabili
ty to Albumin and IgG,EEG,motor and senso
rial nerve conductivity,CT brain scan and
a clinical neurological examination.
The comparative analysis of all data allow
us to discriminate a double population of
patients (5 vs 11) in which thosw who pre-
sent clinical neurological impairment and
altered EEG also have higher spinal fluid
Al levels ( 5 ug/L or more ). Our data
are suggesting a BBB derangement as patho
genetic factor in inducing Al encephalopa
thy in patients on RDT.
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2 29 3 days PD
3 29 2 years RD
4 48 2 months RD +
5 32 IyearHD —
And. HtZ Treatment Outcome
+ 25 Antalgics+ Impotency
Salbutamol
— 28 Venous bypss Impotency
surgery
+ 34 Antalgics+ Recovery
Atropine
31 Antalgics
35 Csvernnsal
inj ection
Age (years)
Sex
Yrs, from 1st dialysis
Yrs. from transplant
Physicslat now
activity J 1.5 yrs. ago
Hospital admissionab
Severe joint diseass
Carpal tunnel syndrome
Skin problems
TRANSPLANT (2;
29—63
13M: bE
10—1 g
2—17
1.3± 0.1
1.3± 0.1
5
0
Cancer 2
Keratoses 7
136±6/82±2
11
SIMPLE TEST COMBINATION TO LOCALIZE LESIONS OF TNE
AUTONOMIC PATHWAY IN HYPOTENSIVE HEMOOIALYSIS PATI-
ENTS.
N.R.8UERKLE, W.BRECH, P.PIAZOLO
Center of Memodialysis, Friedrichshafen FRC
Severe volume—unresponsive hypotention in chro-
nic MD-patients appears to be related to autonomic
neuropathy. To test this hypothesis, 11 such hypo—
tensive patients (yroup II) treated under standard
MD regiment over more then 5 yrs were investigated
and compaired to 11 normotensive MD—patients
(group I) as controls.The following tests were used:
Valsalva maneuver (VM),amyl nitrate inhalation (AN)
ECC RR-interval variation (an),hand grip test /110).
piassaconcentrations of epinephrine (E), norepi-
nephrine (NE) and dopamine (0) were measured
before and after NC.
Table I: Plasmacatecholamine concentrations
group I group II
before NO after MC before NC after MC
HE ng/l 180±63 261±46 339±75 340±73
E ng/i 45±11 62±13 90±31 92—28
0 no/i 39± 7 41±16 54±11 45tl9
Table II: Results of autonomic testing
ES VII bc Os ANSHR/AMPB HG4MBP
normal >3 05 05 .o.6 t15
group I 2.8o.5 neg pos l.35o.6 182.6
Group II 1.5±0.2 neg neg o.3-o.1 6±1.2
P £o.ool <o.ool C000
volume unresponsive hypotention seems to be due to
a defect of the afferent and efferent limb of the
parasympathetic and of the efferent limb of the
sympathetic nervous system. Longterm normotensive
ND-patients showed a lesion in the efferent para-
sympathetic pathway.Simple tests of the autonnmic
nervous system may predict patient 's stability on
ND treatment and contribute to a rational treat-
ment.
MACHINELESS DIALYSIS.
U. Buoncristiani, C. Sparano,° L.Ciombini
Dialysis Units — Psrugis & Campobasso°-. Italy
TO overcome having to uae machines we set up
a machineless dialysts system enngtsting simply
of; a container for the fresh dialysate,another
for the discharged dialysate, an heater,a filter,
the blood lines.Keeping the filter at the same 1!
vel Os the patient's arm,the fresh dialysate con
tainer at top and the other at bottom,the blood
flow is maintained by the spontaneous Arteroven
ous blood pressure gradient of an external shunt
or of an extemporarily cannulated femoral artery
(respectively in chronic and acute patients),whi
le the dialysate flows by gravity.The dialysate
has the same composition as in the peritoneal di!
lysis. By varying the surface and the hydraulic
permeability of the filters,the glucose concentr!
tion of the solutions, the dialysate flow (vary
ing the levels of the containers or clamping the
dialysate lines), a wide range of depuratiwe eff!
ciency and ultrafiltration can be obtained.Thanks
to the extreme simplicity of the system,suitable
also for unattended and/or home dialysis,a high
flexibility of application is possible so that by
varying the length and the frequency of the ses-
sions we can satisfy the depurative requirements
of a wide range of patients, Fresh I
as in our clinical experience diaiysatj
consisting, of 3 acute and 5
filter
chronic patients treated for
1— 6 months.
Discharpe
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INTRACAVERNOSAL NETARANINOL INJECTION A NEW
EFFECTIVETREATMENT OF DIALTSTS ASSOCIATED PRIAPISM.
B._liBANGER, R. OULES, P. RAMPEREZ, JP BALDUCCHI,
C RIO?, S. SHALDON,
Nephrology department, Nines, Montpellier, FRANCE
Dialysis associated priapism (OAF) is a rare
but often catastrophic complication of long term
dialysis in young adult males. In our area, the
incidence of DAt' is 5 cases of 677 males since
1968 to 1985 (3385 years dialysis patients (1.4%))
The cases and their course are analysed on the
following table
N' Age Time on
dialysis
I 50 2 years RD
Abstracts
HOW WELL ARE PATIENTS AFTER 10 YEARS OF DIALYSIS
AND/OR TRWSPLANPATION?
E A Brown, I R Arnold, P E Cower
Department of Medicine, Charing Cross Hospital
London, UK
All patients treated for end—stage renal
failure were studied using a questionnaire to
establish their current symptoms, were fully
examined and had routine blood tests plus
estimation of parathyroid hormone (PTH). 31
patients were on dialysis (3 had had a transplant
for 3-4 years) and 26 had a transplant (3 de-
faulted) . 5 patients who had changed treatemnt
status within the last year were excluded.
DIALYSIS (31)
29—67
24M: 7F
10—18
2.1± 0.1
1.6±0.1
26
1 1c
10
Pruritis 19
Impotency
Recovery
And. Androgen administration, Ht% haematocrit.
In 3 cases potency definitely failed to return
and in case N° 3 recovery was delayed for 3 years.
In case 5, we used a previously unreported treat-
ment in OAF with 1mg metaraminol injected into
corpus cavernosa and penis was massaged.Within mm
complete detumescence was obtained, normal erec-
tion within 36 hours and normal sexual intercourse
after nne week. tleparin blood level at time of
treatment was significantly higher in cavernosa
(.26010/mi) than systemic blood (.020 lU/mi). The
relevance of an hyper—heparinemia in cavernosal
blood will be discussed. In view of the cost
effectiveness and ease of the intracavernosal
metataminol ioiectiun its systematic evaluationin usv seems jnstitteà.
Blood pressure l42±S/84±3e
On antihypertenaives 5
Creatinine <140 nmol/l — 17
PTH>0.S ug/l 7 1
a—i (normsl)—5 (bedridden); b—in last year; c—
only 2 hadtPTfl; d—both occurred when patients on
dialysis; e—pre—dialysis
It is concluded that the main complication of
long term dialysis is a disabling srthropathy and
recurrent carpal tunnel syndrome. In contrast,
long term transplant patients are fitter but may
have hypertension and may develop keratoses and
skin cancer.
DOUBLE LUMEN SINGLE NEEDLE: LONG TERM CLINICAL
TRIAL IT11 DAILY DIALYSIS.
U.Buoncristiani, C.Quintaliani, M.Cozzari,
R.Ragaiolo,° L.Ciombini.
Dialysis Units, Perupia — Ascolie, Italy
The feasibility, efficacy and safety of long
tern dialysis with double—lumen single needle
(DLSh) have been evaluated in 10 patients (pts)
undergoing daily ultrashort dialysis for periods
lasting 4 to 37 months (mean 22.6) and a cumula
tjve experience of 226.5 ( being the total number
of sessions = 6,795 and the maximun per single pt.
= 1,125). Mean recirculation, calculated from
96 determinations at e mean blood flow af' 250m1/
mirl, was 7.2+3.7, only slightly higher than that
ohtined with two needles in the same pts. under
identical conditions. The great majority of his
chemical and clinical parameters behaved steadi
ly better than during previous standard dialysis,
hut only the hematocrit incresse reached statisti
cal significance. Regarding the vascular access
itself, the results were much better than expec
ted: no fistula closure, no dialysis loss hecau
se of vcnipuneture problems or unsatisfactory
flow; two pts. regularly performed ad f—veriuoc
ture. Such rood rcs'.ilts support the feasibility,
efficacy and safety of long—term <iiaiysis with
L)LSS over; in condi t ions or iriteni; lye use.
LONG TERM BICARBONATE (BD) VERSUS ACETATE DIALYSIS
(AD):NO SIGNIFICANT DIFFERENCES IN THE TREND OF LI
PlO PATTERN AND OF URAEMIC OSTEODYSTROPHY.
A.Castellani,F.Lonati,M.Innocenti,D.Bonucchi and
F.Fasciolo.
Nephrology and Dialysis Service—Umberto I Hospi
ta 1 —Bresc is—Italy.
It is matter of debate if RD improves the trend
of lipid pattern and of uraemic osteodystrophy.
In an attempt to elucidate this controversial ar
gument we prospectively studied two groups of urse
mic patients,formerly on AD:group 1,13 patients who
were swichted toBD;group 2,l4patients whocontinued
AD.The groups didn't differ for age,former dialysis
duration,M/F ratio,phsrmacologic treatment.The fol
low—up was performed for a mean of 24 months.
Serial measurements were made of pN,HCO3,calcium,
phosphate,alkaline phosphatase,COOH—PTN,NH2—PTH, tn
glycerides ,cholesterol, HDL—cholesterol . At the start
and at the end of the trial films of the hand skele
ton were performed with a mammographic film.Acroste
olysis ,subperiosteal resorption, intracortical resor
ption,endosteal resorption were scored according to
Jensen and Kliger (l977)and Ritz et al.(1978).
Before the trial no significant differences were
detected between the two groups in the abovementio
ned parameters.Duning the trial an improvement of
pH and of NCO3 was observed in group 1 but not in
group 2.A slight worsening of the serum and radiolo
gical parameters of osteodystrophy was observed in
some cases of both groupa,without significant diffe
rences between the two groups.Serum phosphate levels
didn't change.Lipid pattern remained unchanged in
both groups.
It may be concluded that,at least in our hands,
RD has no evident beneficial effects on lipid pat
tern and on uraemic osteodystrophy.
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LONG TERM EXPERIENCE IN THE PREVENTION OF DIALYSIS
INTOLERANCE BY BICARBONATE RECIRCULATING DIALYSIS.
S. Casati, P. Passerini, A. Citterio, G. Graziani,
C. Ponticelli
Div. Nefrologia,Dsp. Policlinico,Milsn,Italy.
Four uremic patients(dialysis age 76.8±38 months)
suffering from hypotension,vomiting,headache and
cramps with standard acetate single pass dialysis
(ASP)were switched to bicarbonate single pass(BSP)
and,later,to bicarbonate recirculating dialysis
(BRD)±n order to compare their tolerance to these
different techniques.The study compared clinical
and biochemical data of 390 ASP,308 BSP and 1824
BRD sessions.The incidence of symptoms was:
ASP 8SF BRO
HYPOTENSION 83% 80.1% 15% (*) (**)
HEADACHE 60% 42.0% 2.7%(*) (**)
CRAMPS 5.7% 6.5% 5.O%(ns)
VOMITING 78.7% 57.5% 4.O%(*) (**)
(*) p<O.OOl BRDvs ASP;(**)= p<0.OOl BRD vs 8SF
Vascular stability was expressed as the maximal
variations of systolic(ASP 40%,BSP 32%,BRD 23%)and
diastolic(ASP 34%,BSP 32%,BRD 18%)blood pressure.
Blood chemistry showed no significant variations
except for increased Ht%(p 0.002) ,K(p . O.00l)and
BUN(pO.0O1)in BRD versus single pass treatments.
No underdialysis symptoms were observed in the 40
months of BRD follow up.In conclusiorr:BRD by offe
ring an excellent clinical benefit can be conside
red the cost—benefit treatment of choice for pz
affected by severe dialysis intolerance.
CORRELATIONS BETWEEN VISUAL EVOKEI)
RESPONSES, EEC AND BIOCHEMICAL 1NDEXE
IN DIALYZED CIIILDREN.
D .Cattarelli , A. Edefoni I, L .Capitanio , A ..Ducati°
A .Lajidi°,M .Cenzato°,M .Arguellcs°(intr .hy L
\iinetti)
Centro Dialisi Cl .Pedi trica 11 Università di I'vrlanc
°lst .di Neurochirurgia Universith di Milano Italia
Pattern reversal visual evoked potentials(V EPa
have been recorded in 18 children, aged 5- l5yrs ,un
dergoing llemodialysis or Ilemofiltration for Ternir-
nal Renal Failure .Regi .strations ,carried out before
treatnreiit (721i since last dialysis),were normal in
4 patients, moderately or severely impaired in 14
Tb ree hours after treatment 12 children showed nor-
mal responses (4 persisted normal, 8 normalized);
4 improved but not enough to fall within normal limits
2 were unchanged ;no one worsened .Correlation li-
ne a have been calculated between the a bsolute latr, -
cy of the F' 100 and urea, creatinine , P PIE, al himiniun
and protein metabolism indexes both before and often
treatment; in no case statistical significance was a-
chieved . Finally,in 14 out of 18 patients a traditional
EEC trace was recorded before dialysis: it appeared
that all patients with a path ological EEC showed an
anormal VEPs response as well,while 5patients
whit normal EEC presented with altered VEPs.
It is concluded that no single factor is responsible
for VEPs delay inuremia and that VEPs are more
sensitive ameans than EEC in identifying a CNS
involvement.
Abstracts
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EFFECT OF HEPARIN—FREE DIALYSIS (HFD),
REGIONAL HEPARINISATION (RH) AND LOW DOSE
HEPARIN (LDH) ON THE HEMOSTASIS.
Cavagna H., Cerutti M., Caloprisoo G,
Casol D., Tessarin C., Capelli S
1-lernodialysis Service — Immunohematology
City Hospital — Belluno (Italy)
The effect of HFD, RH and LDH on the
hemostasis was tested in 6 chronic uraemic
patients, treated by the three techniques
in different times.
The data show that Platelets, PT, TT,
Fibrinogen, FDP, Soluble Fibrin—Monomer
Complexes (FM), AT III, j TG and PF4 were
unchanged. On the contrary, PTT was signi-
ficantly increased in RH (p<O.05) and in
LDR (p<O.05), but does not show any chan-
ge in HFD. These data suggest that RH and
LDH induce a hypocoagulability state, whe-
reas HFD does not induce any change in
hernocoagulation tests explored.
HPD moreover does not activate intrinsici
coagulation, as it is shown by lack of cha-
nges in AT III, TG and PF4; and lack of
FDP and FM.
So, heparin—free dialysis seems to be
the most reliable technique in preventing
haemorragic risks during hemodialysis.
• CUTANEOUS HYPERSENSI1ITY REACTIONS TO DIA
LYZER EXTRACT (DE) AND ETHYLENE OXIDE (ETO)
IN HAENODIALYZED PATIENTS
C.Ciancioni ,C.Naret,A.Picot,J .L.Poignet,S.Delons,
N. K. Man
Centre Medical Rist, Necker Hospital, Paris, France
Hypersensitivity reactions in haemodialyzed pa-
tients might be the result of various factors, in-
cluding cellulose derived material, additives from
the manufacturing procedure and ETO used for the
sterilization process.
In order to detect potential hypersensitive pa-
tients, skin prick tests with DE and ETO were per-
formed in 37 stable unselected patients currently
treated with Cuprophan° hollow fiber dialyzer.
Serum samples were collected for IgE and IgE speci-
fic to ETO antibody determination.
Three skin prick tests were done with 0.1 ml of
0.9% NaC1 solution as control , 0.1 ml containing
2 ppm ETO in 0.9% NaC1 solution, and 0.1 ml from
1 liter of 0.9% NaCl rinsing solution of Cuprophan
hollow fiber dialyzer.
Positive skiii reactions were lound in 8 piients
(22%) for both DE and ETO, and in 10 patients (27%)
for DE only. All patients showed negative skin test
for normalsaline solution. No correlation was found
between skin test and either serum IgE and IgE spe
cific to ETO antibodies levels or clinical symptoms
It is concluded that long term exposure to
Cuprophan° hollow fiber dialyzer enhances delayed
cutaneous hypersensitivity against cellulose deri-
ved material and/or additives from the manufactu-
ring procedure and/or ETO, without subsequent pro-
duction of IgE or IgE specific to ETO antibody.
STUDY OF Na AND H20 KINETICS IN HEMODIALYSIS
PATIENTS.
S.Chamoiseau : C.H.U.Ranguei.1;L.BerttOU,J.M.PUjo
Clinique St.Exupéry,France:R.Elsen : Brussels.
(Introduced by J. Pollini)
A 24h. coupled study of IV injected 24Na and HTO
kinetics has been performed in 5 stable anuric pa—
tients,immediately following an HO session. Each
curve was fitted to a sum of 2 exponentials by the
least square method and was consistent with an open
linear and stationary bicompartmental maznillary
sodel including a rapid exchange compartment VI, a
slow exchange one V2 and a loss L •Transfer proces-
ses were assumed to be of first order kinetics.
exch.
Na
mmol
TBW
1. 1
L
mmol
mm—I
VIH2O
1
VH2O
1
LHO
1 mm—I
2387 31.5 9.7 4.2 0.37 16.2 14.7 26 1O
2928 32.6 10.2 6.12 0.34 16.7 12.03 23 l0
2199 27.1 8 6 0.29 13.6 10.9 20 1O
2490 28.7 8.8 5.3 0.37 14.3 13.1 28 lO
2517 33.6 7.7 4.8 0.2 16.4 16.4 2O.lO
Our analysis shows that the intercompartmental
exchange rates could be time limiting factors. It
is thought that optimal mntradialytic management
of body Na and H20 transfers should take them into
account in order to adjust dialysis duration and tc
adapt exchange through UFcontrol and manipulations
of Na dialysate so as to avoid non proportional Na
or H20 removal.
• LOCAL EXPERIENCE OF REGIONAL ANTICOAGULATTON (QITH
SODIUM CITRATE(C)FOR HAEMOVIALYSIS(I-IV) IN PATIENTS
• (PLo)AT RiSK OF SLEEVING.
F.Cot,C.TLeLemctn,s,R.Wevi,M.Vn.atwa. (Intn..by P.Vexee'tn).
HCptaL Un eiLoLtaL'Le BnLLgmann,Snua eT6, BeTgwn.Sine Pnuiclz and Duncan p'wposed Ln 1982 Lo wse
'egLona anti coaguLation wLth C Ln,tectd o hepatLn
o& anticLoagaLation £n HO pta ot o bTeedTng,
we wed thLa tnchnlqae Ln 310 HV 4eon £n 159 pto
wLtk active bTeeding on at kLi!z o bLiecUng)po4t
opeUv pelrLod, pe/tLcandLtLo , hepaLc une).
To maintcuTn a enAiaL and venota Line,6 aVET above
200 and 100 c.nepecLiveLy,a 0. I M C o&tion was
,inu,aed in the ajrte,'iiat Line at a mean 1ow nate o
4.38(521÷60 cc/h)o the bLood tLow 'tate(2O0 ccJmn)
and a 5% caEcLw?1 chZonLde 6oLition in the uenow
Line at a mean low n.ate o 10% o Lhe. C toe, nate.
A caTcLwn- 'tee bLccuthonate diaLyate wa wsed £n
aLL patLent.
The C {Low n.ate aten. one houn. o (-IV wc conne-
La:ed with The pne-KD Ca TeJs('t.533;n=5l;p<.O0fl;
the'Le was a sLighL nctectoe n eaLeaemLa(8.3+1.0
mg/dL beone I-ID to 8.6+1.2 mg/dL avt HD;n34,
p<.O5);-thene. wane no yrnp-tovns o hypocaLcaemLa n
any paLLent.No change4 Ln p teLat coun-t,Leucoc(-te
cow'tt on QT Lptte'tvaL we/ta obanvad.None o The pa-
Lieitts expe/tLencad any bTead-Lng on. necwvtance o
bLeedLng du to C duning on. aften. The pn.ocedwte.
In aoncLuaLon:1)negLoncJ anticoctguhttLon wLth C
L4 an ay,e -c-ent and nae eahaLqae.2)C STow
n.a,te can be pke-deta/unined (znowin0 pne-HV Ca LeveL.
3)venow5 Line aPTT howLd be monLto'ied Lhnougkowt
The pitoaedwte and maLntaLned neat 100 ac.4)to
avaLd hypocaLcaemLa caLcLu.m Low-nate munt be
adjw,Led whenevan. LEe C SLow 'taLe has to be changed
Lo maLntain a /Low 'tate tatLo C/caLcium o 10.
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REGIONAL CITRATE(C)ANTICOAGULATION IN NV PATIENTS
(Ptj)AT RISK OF BLEEPING AFTER PARATNVROIVECTOMV
(PTX).
F. Colic t,M.Vac wa,C.TLeIeman4,R.OJen4. (Ivt't.by P.
Vetee'stmae-ten).
NôpLføi Uhe' taie Bnitgmann,B'waa aLa, BetgLwn.
Aa any pot-opaMlive peicLod La aa4oc-1a-ted wlih
a ga-tea 'cLalz o bliedng due to hepae-n Ln NV pa-
tnLa,)Leg-ona-C avcticoagu&Z-tAiOn wlih cLtmc.-te(a caSt-
cAam hendng compound) ha.a been uaed euith good 're-
ia.The pwmpoae o ;the pa.eaent tudy toaa to eva-
Lactli he 4aety o that techvsLqae and the aLa Ia
a wctheii. d'wp -Ln ccttcAium n NV pLa wlih poiSound
hypocacctem-La atex PTX.
C a oagoLlionhiniuaLon o 0.1 M odiwn c-
t&ate and 5% Ca Cli Ln the cteicLa and uenou4 £-t
ne.4 pcttve2y)waa uacad 1n 4 p-ta(l1 NV 4eaaLon4)
in -the La4t 4 daya a{te/t PTX.
The conount o C(cacw&vted 0.4 The {ow hate o
the Lnwaon nequL'ted to mainta-Ln a coakect( a 200
aec(aPTT -n The aa-te'cLa2 £,Lne)wa4 towe't than ,cn
o-thnt -Lndicc.-t-on(365÷4O mL/h,n=l1 ueaawa 521÷60
mL/h,n=51;p<.O2) .No pcitievct deoa-toped hypocaaem-I.ct
due -to C and NV waa even a occ.ted wi.-th neUe7 o
hypoccicaevnc 4ymptorna and dectecaoe £n FT Lvtte'tva-t
togethe't wLth a auight LncJteaa ie calcaam-La
(6.2÷0.2 rng/dL beoke NV lo 6.4÷0.2 mg/dL a-te't;
p<.O3j.Mo bleedLng wa.a obacvwecIdwcLng o't a(tea. C
NV.
In eoneiithon,a4 The iiequJtemen-ta o cLtmccte oflL
aicoaqutalion -din NV palienLa atvt PTX a&e £oweA
Than no)tma due ;to pocaliaemea L-t6eII, liLa tech-
nqae,Ln addLtoe to Lta p'teventLve eecf on ooat-
opeAa-tLve bliacUvig,cctn be aaeA?y waed in -thoae pa—
liena ivlihowt any aLala o woaaening OS hypocatcae-
mLa.
CORRECTIVE EFFECT OF ACETATE OR BICARBONATE
jCL'Y1ATE ON INTACT RED BLOOD CELL ph.
P HIGH RESOLUTION NMR STUDY.
A. CREVAT, A. MUPISASCO, J.P. MONTI, P. CALLICE,
M. EL MEHDI, C. DURAND, R. ELSEN
Laboratoire de Biophysique and Service de
Ntphr'ologie Univorsité Aix Marseille
31P high resolution NMR allows the study of
phosphorus coinunds in intact red blood cells.
Intracellular P chemical shift is dependant on
pH, ionic strength, protein binding and several
other factors. Therefore chemical shift variations
can be used to evaluate changes in intracellular
pH. We have standardised pH in function of
changes in chemical shift in order to apply this
technique to study the effect of hemodialysis (HO)
on intracellular erythrocyte pH in 11 stable HD
patients pre- and post dialysis. We also compared
the effect of bicarbonate and acetate HO.
Our results show that in uremic patients pre
dialysis intraerythrocyte ph is significantly lower
than in healthy subjects (0.2 pH units, p 0.05).
After dieyeie intea red blood cell p1-i increases
(0.1 pP unit) ard approaches normal value.
There seems to cc no difference between acetate
nd bicarloale -ID (73nd 4 patient.s respectively).
We coicl udo thet P chemical shift measurement
is an excellent prche to study intracellular ph
variations. It is well known that a decrease in ph
value slows down enzymatic activity and therefore
our results are consistant with the decreased
enzyratic activity typical for ureniic cells.
PTH AND LEFT VENTRICULAR FUNCTION IN HO—pATIENTs.
P.Coratelli,E.Buongiorno,M.Giannattasio,F.PetrarulO.
(Intr. by A.Amerio).
Institute of Nephrology.University of Ban. Italy.
The role of PTH as a uremic toxin and its influ-
ence on left ventricular function(LVF)has been sug-
gested. 21 patients(pts),aged 22—70 years,on HD(ti—
me: 53.6+38 months)for primitive nephropaty,actuslly
normotensive,in sinus rhythm and without history of
coronaropathy,were studied for 2 years. Echocardio—
graphic(ECHO)parameters by M—mode were performed 14
18 h after HD,at the start of the study and every 8
months;serum PTH,calcitonin(CT),250HD3,calcium,phos
phorus ,magnesium ,alkaline phosphatase were determi-
ned at the start of the study and every 3 months.
7 out of 21 pts were treated with 250HD3 for 2 years
Four pts had normal ECHO parameters,8 pts(4 treated
with 250HD )had reduced Ejection fraction(EF)and con
centric hyertrophy,9 pts(3 treated with 2SOHD )had
normal EF and septal hypertrophy. EF(O.64+0.l6Lin—
dex of LVF,independent in our experience by the age
and by the pre—HD illness peniod,shows a significant
(p<.OO1)progressive decrease as the time on HO in—
creases,in all the pts. On the contrary,in the 7pts
treated with 250HD3,EF remains stationary increasing
the time on HD. We found a significant fall in serum
PTH(7.9+1.2 vs 2.9+1.2 ng/ml)and a rise in serum CT
(64±22 vs 171±120 pg/ml)and 250HD3(15.8-F8 vs 58+19
ng/ml(only in pts 250!1D3 treated.
Our data suggest that pharmacological parathyroidec
tomy makes slower and sometimes stops the progressi
ye decline of LVF and support the role of' PTH as a
cardiomyopathic uremic toxin.
1 IlUl; (uli'fICUTUOPIN /ACTJi/ NB CUllTISL
/cORT/ CHJSNGI.S INI2IJCLI) BY flAt 1-UDIALYSIS
IN PITI NTS \lTI1 CIIUCNIC ILl NAL 1AILULLL
/criF/
iiLi±i1E1, L.Mnjisorsler , L.flcri ols,'i,
A .Ioronieckn
Academy of ieciicine, Uzezecin, Poland
Seruni ACTII and COIIT, levels mere rae—
nsured in 10 patients with UHF in non—
Glai.yri s and die lynis Caym. :CTE and CrILT
were ieterr-inec by rrdioiaunorrsey after
e':traetion of annles. Llood ors taLon at
F. re.r nO 2. ru n.m. in the doy price—Oinp- dir lywie and in din lysim day hefore
md at the end of hmemodiaiysis. Control
group coneisted of lU healthy rubjects.
Chronic renal failure
ACTII/ng/dl/
S
8.OOc.m. 41.01T16.S 5O.O23.4 8O.0!26.'°
c oi17A7d —
8.00 m.m. 13.0±4.0 18.44:4.0° 17.7± 2.7°
2.00 p.m. lO.2i3,5 138±22X0 18.9± 5,30
XSignificantly different /p<O,O5/ from
the value at 8.00 a.m
Significantly different /p<0,05/ in
comparison with healthy subjects respe-
ctively at 8.00 a.m. and 2.00 p.m.
Haemodjalysjs induces the changes in
the pattern of ACT!! and CORT serum le-
vels: ACTH increases to upper normal
limit and CORT does not decrease in the
early afternnon.
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ACUTE a- AND -ADRENOCEPTOR REGULATION IS IMPAIRED
IN HYPOTENSIVE PATIENTS ON MAINTENANCE HAEMO-
DIALYSIS.
A.DauI, N.O'Hara, X.L.Wang and O.-E.Brodde
Med. Klinik & Poliklinik,University of Essen, FRG
In hypotensive patients on maintenance haemodia—
lysis(MHD) reduced sympathetic activity due to di-
minished a- and -adrenoceptor(R) responsiveness
has been described. To gain further insights into
a- and -R changes in hypotensive MHD-patients we
studied the effects of acute stimulation of sympa-
thetic activity by dynamic exercise on lymphocyte
2-R density (assessed by (-)-i25iodocyanopindolol-
binding) and platelet cx2-R density (determined by
H-yohimbine binding) in 10 healthy volunteers(aged
21-29 years) and in 7 hypotensive MHD-patients(aged
24-48 years). In control dynamic exercise on a bi-
cycle (80% of maximum heart rate) for 15 mm in-
creased lymphocyte (2- density by about 100%.This
effect seems to be due to f32-R stimulation (by ex-
aggerated endogenous catecholarsines), since it was
markedly attenuated by propranolol (5 mg i.v. 45mm
before exercise), but not affected by the (31-selec-
tive blocker bisoprolol (2.5 eg i.v. 30 mm before
exercise). In platelets dynamic exercise decreased
o2-R density by 15% (immediately after) and 20%
(T h after) exercise,presumably due to endogeneous
down-regulation by enhanced catecholamines. In
hypotensive MHD-patients platelet cx2—R and lympho-
cyte (12-R densities were significantly less than in
control. In these patients dynamic exercise increa-
sed f3,-R density only slightly (25%) and did not
affect crp-R density. It is concluded that in hypo—
tensive MHD-patients acute regulation of °2- and
132-R is impaired.
EFFECT OF CaCO SUPPLEMENTS ON SERUM OXALATE(sOx)IN
PATIENTS(pts)ON REGULAR DIALYSIS TREATMENT(RDT).
M.Gonella,G.Vagelli,S.Lupettj,C.Cajabrese,c.pratesi
Service of Nephrology and Dialysis,Casale Monf.to,
and Ciinica Medics I,University of Pisa;Italy.
In ROT pta hyperoxalemia seems to be severe enough
to induce calcium oxalate deposits in many tissues
determining lesions in the involved organs.As an in
crease of urinary Ox excretion was shown in atone
formers on low Ca diet,the effect of oral Ca supple
mentation changes on sOx was investigated in ROT pta
After a basal determination of sCa(by atomic absor
ption spectrophotometry)and sOx(by specific enzyma
tic method) ,oral CaCO3supplesentation was kept un
changed in 6 pts,interrupted in 3 and increased in
lO;in all pta dialysate Ca level(dCa)was reduced
from 2 to 1,75 mmol/l.After a 4 months period on a
new drug schedule,the above parameters were evalua
ted again.
Hyperoxalernia was confirmed in the Studied pts,and
the CaCO3supplementation increase or decrease was
found to be directly correlated to the percent de
crease or increase of predialytic sOx,respectively
0.89, p<O.OO1).
On the basis of the postulated binding action of
Ca upon Ox in the gut and the behavior of sCa and
serum Ca—Ox product(sCaxOx)in the 3 groups of pta,
it seems advisable to increase oral CaCO3aupplemen
tation and to lower dCa in order to keep a positive
Ca balance and to reduce sOx end sCaxOx in RDT pta.
HIF1XJII'PIC AND FU)C1'ICt'(AL ALIERAUC OF T LYNlCYl 24THE
FRLY PHASE (F HFM)DIALYSIS
M. Goldnan, L. diandene, M. Idard-ial, E. liupant, JL Vanherweghmn
HOpital Erasim, Université Libre de Bruxelles, Belgliin
hjor changes in polynorphonuclear leukocytes and in the
ccinplmsent systes occur inirmdiately after initiation of the
hEmudialysis session. We were interested to investigate whether
circulating T lymphocytes wauld be simultaneously affected.
In 12 patients on long—tens naintenance dialysis with cuprophane
nseibranes, the following counts were made inisediately before, 15
and 18) minutes after beginning of a dialysis session : periphe—
al bleed cells reacting with OJ(T3, (KU4, (KU8 antibodies, and
with a imanoclonal antibody directed against the interleukin—2
(11—2) receptor. In addition, the capability of circulating T
lymphocytes to release 11—2 after phytohmimgglutinin (FIIA)
stimulation was evaluated in a biological assay using the rmwine
CILL T cell line. Whereas values at 181) minutes did not differ
significantly fran starting values, the following changes were
observed at 15 minutes
0mm 15mm
01(13+ cells (/mmnn3) 99 1tO 89) 120 N.S
Q}(14 cells (/nin3) 670 ÷ 110 710 1(X) N.S
cells (/nrn3) 310± 43 D+20 O.O1
OK14101C18 ratio
11—2 recept± cells(nin3)
2.12±0.15
31) + 9
4.19+0.57
31) + 6
O.01
N.S
11—2 release (stinmula— 1(t) 17 5 O.O1
tion index %)
* SEan + SF14; as assessed by Wikoxon's rank sun test
Thus, initiation of dialysis results in (1) a significant
decrease in (11(1F8 (suppressor/cytotoxic) cells leading to an
increased (Kr4/CKU8 ratio armang circulating lymphocytes and (2)
an impairnEnt in FIIIA—driven 112—release suggesting functional
alteration of helper T cells. These data indicate that pheno—
typic and functional analysis of circulating lymphocytes Should
be included in the assessnont of dialysis bicaxanpatibility.
DIALYSER REUSE IN THE UNITED KINGDOM.
THJ. Goodship, NA. Hoenich, ME. Ward.
Department of Medicine, University of Newcastle
upon Tyne, NE2 4HH.
In recent years it has become apparent that
there is a decline in dialyser reuse in the United
Kingdom. Using a questionnaire based survey we
have examined the current extent of dialyser
reuse, methods of reuse and reasons for
discontinuing this one-time popular practice.
Sixty one dialysis centres in the IrK were
approached and replies received from Si. Of these
15 were currently reusing, 10 had stopped in the
previous year and 26 had stopped prior to this.
In the centres reusing a total of 1166 patients
were being treated compared with 2175 in the
centres not reusing. Of those reusing, 456 (39%)
and 710 (61%) were treated in the hospital and
home respectively. In the hospital group 48% were
reusing compared with 73% of home patients.
In hospital 41% of the centres were using
ani-omated mpthnd of reuse and 59% manual methods.
At home 50% were using an automated method and
75% a manual; 25% using both.
Formalin remained the preferred method of
sterilisation in all centres; however, only 2
routinely checked for anti—N antibodies. Residual
testing kits were used in six centres, four of
which used Clinitest tablets for residual
formaldehyde monitoring
In the Centres which had recently stopped
reusing, reasons given for discontinuing the
practice were—inconvenience and the reduction in
dialyser cost (8 units) ; time taken for reuse
(6 units) ; cost of reuse (3 units) and the
formation of anti—N antibodies (1 unit).
pS*
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ORAL COLD THERAPY IN A PPTIEtff WJJTI iHE1JMA1OID
ARTUR1TIS AND PREEXISTING URENLA
.Jrartinger,J.Kovarik,G.seidl,J.Smoien ,W.Pinggera2 Dep.of internal Nedicine,Univ.of Vienna,Austria
Recently,an oral gold cornpourd,muranof!n,has been
developed.In contrast to parenteral 2old prepare-
tions,it is excreted primarily via the feces rind
should therefore be especially useful in patients
with impaired kidney function.Iri this report us pre-
sent the results of auranofin therapy in a uramic
patient with rheumatoid arthritis who received
the drug in a reduced dosage of 3rg/doy.Clinicsi
and laboratory examinations nerforned every weeks
did not reveal any abnormality end subjectively tne
patient tolerated th druz very ;,eli.Serun gold
levels rose progressively, reaching a level of 585
ngJml after 8 weeks and 850 og/mi after 5 conths,
when medication was reduced to 3 mg every other day
When th dimlysate fluid and the ultrafiltrate eec
exaniined,gold could not he detected.The assay em-
ployed has a sensitivity of 50 neJml.This indicates
that using hemodialysis,euranofin-gold is either
non—dialysable cr diclysable only in very low
amounts. Tree tneut in this patient induced maciced
clinical improvement sod did not cause adverse r ide
effects.Using a reduced dosage of 3mg./day the cram
gold level rose to a similar extent when compared
to patients iithout kidney failure on 6 ncg/day.Thus
accumulation of gold apparently occured in this pa—
tient,indicating that normally it is mcnally excre-
ted to a certain extent.
We believe that more patients similar to the ore
described will have to be studied in order to fully
determine potential hazards of auranof in therapy in
urenic patients ;hoeever, from the observations repor-
ted -here we conclude that auranofin,elbeit in a re-
duced dosage,ruay be the romisslon inducing dniz or
choice in patients with rheumatoid arthritis and
impaired kidney functIon.
BIOCOMPATIBILITY OF CUPROPHAM AND CELLULOSE ACETATE
MEMBRANES DURING HEMODIALYSIS
D. Grekas, C. Syrganis, 0. Zegla, S. Koutoupi,
H. 'Jasileri, A. Tourkantonis
1st Medical department, University of Thessaloniki,
GREECE
Leukopenia, hypoxia, complement activation and
formation of platelet microaggregates occur in ure-
ale patients during hemodialysis with cuprophan
membranes.The aim of this study is to determine
whether leukopenia and related phenomena occur also
during hemodialysis with Cellulose acetate membra-
nes. We studied six patients, aged 30 to 70 years
(3 males and 3 females), who were dialysed before
with cupronhan membrane and then with cellulose ace-
tate membrane. While cell and platelet count, PH,
P02, PCO2, and complement C3c were measured at the
beqining and 15,30,60, 120 and 240 minutes during
hemodialysis. All blood samples were drawn from thf
arterial line. t'Iithin thefirst 15 mm of hemodialy-
sis there was a marked drop in leukocyte count with
cunrophan, which was less dramatic in hemodial\'sis
with Cellulose. The difference between the two mean
values of leukopenia was significant (p(O.OO1). A
slight drop in platelet count during the first 60
minutes of hemodialysis was observed with both mem-
branes. PD2 decreased significantly at 60, 120 and
240 minutes of hemodialysis (pO.Ol) with both meni
branes, but it was unrelated to the leukopenia. The
increase of arterial PH at the end of hemodialysis
was similar for both membranes, while no change of
PCO2 was observed thorughout hemodialysis. C3c was
activated at 15 mm of hemodialysis with both mem-
branes and was significantly related with the con-
current leukopenia (p0.Ol). It is suggested that
(1) leukopenia is less marked in hemodialysis with
cellulose acetate membranes (2) leukopenia and hypo-.
xia are concurrent but unrelated ohenomena.
• ASSESSMENT OF A11'ERIOVENOUS FISTULAE FROM PERSSURE
AND RECIRCI3LATION STUDIES • CLINICAL EXPERIENCE IN
• 186
H N Greenwood, C Aldridge. I. Goldstein,
L H I Baker and W H Cattel].
Dept. Nephrology, St Bartholomew's H., London, UK
Using a new technique to measure basal intra—
fistula pressures (BIFP) and useful fistula flow
— the maximum blood flow available
dialysis within acceptable pressure limits and
without recireulation — we rerently reported our
preliminary experience in 9 forearm fietulae.1
We now report our experience in 162 forearm ann
24 upper arm '.is+u]ae.
In satisfactory fistulae (UER> 400 ml,/min) nan
BIER (intrafistula pressure with zero circuit
blood flow) at the A arid V needling sites was
22.2 17.1 Hg (mean SD) and 19.2 12.9
respectively. BIER exceeding 60 mmHg suggests
proximal obstruction. Fistula studies id€ntiftei
problems where none were upocd. Thus in
patientS with 'good' fistulae (96) UER<400 was
recorded in 16. In patienkm with poor
biochemistry 8 of 78 fislu]ae showed recirnulatio.
In patier.+s with needling diffirultiem only 11 n
2P f1gtulae had 1]FF4 400. In some fi.eti,lae with
TIFF < 400 the problem was solved by sirnr'y changing
needling 1tes. Surgery was performed fr the
majority.This tstula assessmen+ technique is now
f'mly estahl ished as a inopt valnab' P G'i' to
fitu1 a oerfor"iance arid to causes for moor
furnicion. It markedly rducPs thc reri or
angiogmaphy and surgery.
1Gremnwnri5 et ml... Olin. Nephro'. Vol 23, . 198
ULTRAFILTRATION (OF) QUANTITY AND MODE AND CARDIO-
VASCULAR STABILITY IN HEMODIALYSIS (ND).
M. Grosoli; A.M. Savazzi*; E. Petrella; G.C. Orlan—
dm10
Beilco Laboratories, Mirandola; *Nephrology Unit,
Modena; 0Nephrology Unit, Leno - ITALY.
Influence of UF quantity and mode on some cardio
vascular parameters was evaluated during HO in 13
chronic uremic, anuric and normotensive patients (10
males, 3 females) , ageing 42 to 75. Four—hour sin-
gle pass acetate HO were performed thrice weekly us
ing 1 sqm CuprophanR filters. The patients under-
went 3 HO eeasions (linear OF-ND) with linear weight
loss (25% of total weight gain/hr) and 3 non linear
OF-HO sessions having 40% of total weight gain lost
at the end of the 1st hour and the remaining 60% dur
ing the following 3 hours.
Heart rate (HR) , systolic (5P( and diastolic (DP)
pressures, mean arterial pressure (MAP) were record
ed at dialysis start and every 15 min.using a DYNA-
MAP 845 (Critikon) monitor. Six patients presented
a total OF below 4% (Group I) and 7 ones a total OF
above 4% of body weight (Group II). Group I showed
MAP, 5P and DP significantly lower in linear than in
non linear OF-HO. HR did not change significantly.
Group II showed SP and MAP significantly lower in
non linear OF—ND. OP did not change significantly
and HR increased in non linear UF-HD.
Cardiovascular stability seems to be negatively
affected by non linear OF only in patients with
total OF above 4% of total body weight.
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OIALYSI$.-INDUCEO CHANGES IN URIC ACID
/UA/ CONCENTRATION /C/ IN RED BLOOD
CELLS /RBC/ OF URAEMIC PATIENTS
A,Grzegorzewska, M.Wanic—Kossowska,
I.Krysi,iske, K.8czyk
Dept. of Nephrology, Academy of Medicine1
Poznañ — Poland
Changes in UA C in plasma during dia-
lyses are well documented in contrast to
those in RBC. So we decided to determine
UA in RBC of urmemic patients during 5—
—bre haemodialysee /HO, n — 17/ and 24—
—bra peritoneal dialyses /PD. n — 11/. C
of H in arterialized blood was simulta-
neously monitored as well as free end
bounded water in RBC and plasma of HD—
—patients.
Mean RL3C/plasma UA C ratios at the
beginning, 1 hr and 5 hrs after HO were
0,44, 0,37 and 0,44, reap. The fall in
R8C/plasma UA C atio after 1 hr of i-ia
could not be directly refered to the
decreased content of free water in RBC
/f rom 58,0 to 56,1%!, however we were not
able to establish whether increased con-
tent of bounded water in RC influenced
IJA protein binding. The RBC/plaema UA C
ratio immediately after PD was signifi-
cantly lower than at the PD beginning
and progressively increased in post—pa
period. Changes in UA C in RBC were
connected with decreasing of H+ C in
blood,
we conclude the 5—bra HO and 24—hrs
PD are very effective in decreasing UA C
in RBC. This effect is more pronounced
after HO.
ACUTE CHANGES IN PLASMA PREE PATTY—ACID
CONCENTRATIONS DURING HAEMODIALYSIS COMPARING
HEFARIN WITH EPOPROSTEROL As ANTI-COAGULANT
SJDavies, S M Hohson, U A Young, .1 H Turney
General Infirmary, Leeds LS1 3EX
Heparin affects free fatty—acid (FPA)
metabolism. Acute changes in plasma PPA (and
theIr metabolites) during the early stages of
haemnodiatysis may play a part in the aetiology of
cardiac arrhythmias. We have atudied PFA arid
t"iglycerides during haemodlalysis using Heparin
or Epoprustenol (PG12) as ariti—coagulants.
Six patients (5 men) were studied whilst
receiving routine haemodiaiyIs, Each patient
was investigated during two dialyses, one week
apart, which were identical in every respect
except anti—coagulant used. Heparin was given as
a bolus dose (50 lU/kg) followed by an infusion
at 25 lU/kg/hr. P012 was infused at 5 ng/kg/min
throughout the prucedure. On both occasions the
ant t—cuagulant was commenced 15 minutes prior
to dialysis.
There was a sharp rise In the mean FFA
concentration following heparin, from 0.L11 to
1.19 mEq/l at the commencement of dialysis
(P <0.001) which was not seen with PG12, (0.15 to
0.2 mEq/1). A further rise in the FFA to a peak
of 1.42 mEq/l (Mg) occurred after 15 mine of
Heparin dialysis. A gradual fall in the plasma
triglycerides following heparin from 283 to
243 mg/100 ml (P <O.u2) continued throughout
dialysis, but was not seen with PG12.
P012—dialysis is a model for 'heparin free'
dialysis, suggesting that the changes obeerved
are due to Heparin rather than dialysis itself.
BIIX)D-MFIvIBRANE IbTERZCTION WITHOuT DIALYSIS INDUC-
ES INCREASED PROTEIN CATABOLISM IN NORMAL MAN
A.Gutierrez,A.Alvestrand,J.Wahren,J.Bergstrcth.
flpts of Renal Medicine and Clio.Physiology,Karo-
linska Inst .Hurldinqe Univ j-losp. Stockholm. Sweden
Henmdialysis patients have higher protein requi-
rements than normals; morbidity and mortality in
such patients are associated with protein malnutri-
tion. The dialysis procedure seems to be a strong
catabolic stimulus, but the mechanisms for this are
incompletely known. m explore whether blood—mem-brane interaction triggers protein catabolism in
muscle we investigated free amino acid balance a—
cross the leg in 7 fasting subjects before and after
sham-dialysis, i.e. in vivo passage of blood through
a cuprophane dialyzer (Gambro plate 11.5 ,u) 100 ml!
mm for 150 mm, but with no circulating dialysate.
Blood access for dialysis was obtained by catheters
in a ferroral and a cubital vein. Plasma A-V amino
acids were determined in blood from a fernoral vein
and artery. Teg blood flow was measured by occlusion
pletysriography. The net release of free tyrosine,
an amino acid not metabolized in muscle, increased
by about 100% (from 7.lFl.C to 14.64.0 nmel/min/
100 ml tissue;p<0.05) at 345 mm after start of sham
dialysis, indicating enhanced catabolism of muscle
protein. In 5 fasting subjects not undergoing sham—
dialysis the net release of tyrosine was unchanged.
In 3 additional subjects indcisetacin was administer-
ed before (100 mg) and at the end (50 eg) of the
sham—dialysis. In these subjects no increase in
tyrosine release was observed. Our results indicate
that blood interaction with cuprophane in man leads
to accelerated protein catabolism. This response
was prevented by indometiacin, suggesting that the
enhanced protein breakdown, induced by blood-mem-
brane interaction, is mediated by prostaglandins.
001 TO FVALUATF TIF r5pn(arvpn4'g I5T°LPACF IN
¶JPF'iTA: IG ppg r r'3 (LTtTCALLV ligiL?
'le 'srchi, fl. feechin, F. Tesio.
r)epartment of gericine, lorpital of Codroipo, mit
of Nephrology, Hospital of Pordenone, Ttsly.
In end stage renal failure glycosylated hsernoplo—htn are not useful indices of long term carbohy-
drate metabolic control. The aim of this study is to
investigate the poeshimy that serum reverse T3
a peripheral metaboflte of thyroxine, may
have a clinical information value as indicator of
carbohydrate metabolic control in these patients.
We measured serum levels of thyroxine (T4), triiodo—
thyronine (T3), rT3, TSI!, insulin and glucose in 44
uremic patients enrolled in a chronic dialysis pro—
ram. 3(1 received haemodialysis (group 1) and 14
were on peritoneal dialysis (group 2). An oral glu-
cose tolerance test was performed in all patients.
12 in group 1 and 3 in eroup 2 had an impaired pit,—
cose tolerance (IPT). 2 patients in group 1 ant) 3
in rroup 2 had an overt diahetes mnellitus (NIPS).
Serum rT3, rT3:T4 and rT3:T3 molar ratios were sig—
n-ificantly increased in uremics with NIDr) and in
those with 1(11. Furthermore rT3 showed positive
correlations with pre—dialysis glyceemie and insuli—
lemia, glycoerric and insulinernic peaks, ylycsemic
and insulinemic areas.
We con conclude that serum rT3 assay provides
information about the degree of carbohydrate tnto—
lerance in end stage renal failure in which it might
he a clinically useful index of blood glucose con-
trol instead of glycosylated haemoglohins.
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THtLIUM 2o1 MY(X'.ARDThL S'IUDY IN HHIJDThLYSIS
PATIENTS (HD) AND TRANSPLANT REXLIPIENrS (TR).
K.Derfier,J.zazgornJjc, P.Baicke, K.Kopsa, L.Marosi
K.Fletter and R.Dudczajc.
I. d.Univ.Kiinflc, Vienna,Austria.
The aim of this study was to evaluate the oc-
curance of coronasy heart disease (CHD) in RD (n=
33) and TR (n=23) noninvasively by Ti 2o1 perfusior
sziritigraphy after dipyridasol stress and coxrpari—
son to risk factors irrplicated in pathogenesis of
CR1), overrepresented in both groups. 55% of RD pa-
tients (n=18) (group 1;aged 58+11 yrs) had abnormal
and45% (n=15) (group 2; aged 45+11 yrs) normal Ti
2o1 szintigranis, whereas only 33% had clinical
signs of CR1). ration of treatrrnt was similar in
both groups (1/2;38+15/35+26 isonths) but prevalence
of risk factors was different (group 1/2; hyperten-
sion 94/80%; diabetes nellitus 22/13%, hypertrigly-
ceridaemia 89/9o%; elevated serum cholesterol le-
vels 39/53% and hyperuricaemia 83/8o%). In TR pa-
tients (n=23) 17% had clinical signs of CUD, but
39% (group 3;aged 52÷ 4.7 yrs) denonstrated an ab-
normal and 61% (group 4;aged 42+lo.6 yrs) a normalTi 201 szintigram. fliration of haeriodialysis treat-•
nent was shorter in RT patients especially in group
4 (16÷23 nonths) as conpared to group 3 (21+ 22
nonths). Within group 3/4 hypertension was present
in 89/64%; diabetes nellitus in 22/14%, hypertri—
glyceridaemia in 44/36%, hypercholesterolaemia in
44/21% and hyperuricaemia in 56/29%. conclude:
1) Tl 2o1 pharmacological stress szintigraphy is
useful in RD and TR patients to evaluate CR1),
which otherwise is underestimated by clinical syap—
tons. 2) Beyond age,risk factors like hypertension
and hypertrigylceridaemi.a are of main inportancefor occurance of OlD. 3) Early diagnosis of CR1)
initiated with nedical treatnent including risk
factors may increase survival.
THYROID FUNCTION IN HEPATITIS B VIRUS (HEy)
CARRIERS ON MAINTENANCE HEMODIALYSIS
V.Djorcijevió, S.Kostié, V.Stefanovié
Institute of Nephrology, Faculty of Medicine,
Ni, Yugoslavia
The effect of chronic HBV carrer state upon
thyroid function was studied in 16 HBs
antigen positive and 23 HBe antigen positive
hemodialysis patients. 53 HBs antigen negative
patients served as controls, however all but one
had a previous 1-R1V infection. Thyroid hormones,
triiodothyronine (T3) and thyroxine (T4), and
thyroxine binding globulin (TBG) were determined
radloimounologicaly in the sera droe in the
morning before hemodialysis. Any statistically
significant difference was observed between the
groups investigated. Most of the patients
exhibited a low T3 with a nonmal T4. TBG was
increased in 43.2% HBe antigen positive patients,
but in only 1 out of 16 F-R1s antigen positive
patients. It was also increased in 45.2% of
HBs antigen negative patients. Senim GPT values
were increased in HBe antigen carriers only.
This study shows that crhonic HBV carriers
state does not significantly affect concentration
of thyroid hormones. Howerer, an increased TBG
as observed in some HBetma.tigen positive
patients, and in some patients who cleared
HBe antigen, possibly as a result of inmunological
events.
EVOKED POTENTIALS (EPs) IN UREMIA: BASAL AND
FOLLON-UP DATA.
B. Di Paolo, P. Palrnieri, I. Nisi and A. Albertazzi
Institute of Nephrology & Dialysis — University of
Chieti — Italy.
Various EPs have been employed to disclose even
early central nervous system damage in uremia. This
approach allows also the possibility to follow—up
alterations of many sensory functions during the
sequential stages of uremia.
Fifty—three subjects (35 ?and 18 c, mean age
42.20t7.50 yrs, conventionally low nitrogen diet
treated, on dialysis or transplanted) were follo-
wed—up by recording the EPs every year for seven
years.
The P100 wave's latency and amplitude of visual
EPs were recorded and found abnormal in about 70%
of the examined visual systems; the auditory EPs
were abnormal in 53% of the cases for the peak la—
tencies, interpeak times and peak ratios; the soma—
tosensory EPs showed in 75% of the cases an alte-
red latency and morphology of the waves registered
in the lumbar, cervical and cranial loci.
The persistence of abnormalities disclosed by
EP5' follow—up confirm the faithfulness of this
technique in evaluating pathologic uremic situa-
tions and in apprompting different uremia thera-
pies.
BICARB()IATE I1xDLALVSIS (-O) : AN PLT@ATIVE TO OICII(JOACETA
IF (tEA) IIl'USIft IN TI-F TIAIWNT (F LACTIC ACIDOSIS (LA) WITH
-icx IN DIPTIGS TIATEO WITH &WH4II'F (W) OKHISSI H, LALAU
3F, DEBUSCHE X, TOLANI H, FOURNIER A - CHU 80000 AMIENS -
OCA infusion is now proposed as the best treatment for LA
with shock since contrarily to massive bicarbonate infusion, it
does nor worsen but improves cardiac function.BHD may be however
an alternative treatment since it may improve cardiac function
by lactate clearance and stop lactic production by decreasing HF
plasma concentrations. Therefore we report 3 cases of LA with
shock in diabetics treated by MF which improved dramatically
their shock after RHO. HF doses per day and etiological circums-
tances were respectively : case : 1700mg and a dehydration
case 2 : 5800mg and an acute renal failure due to excretory pye—
lography ; case 3 : 3400mg and a septicemia with acute renal fai.
lure. Arterial parameters are shown in the table (lactates and
bicarbonate mmol/l ; t hours after starting first dialysis).
CASE 1 BHO:4h
to t2.30h
pH 7.15 7.39
Lact. 18 9
Ric. 3 12
CASE 2 RHO : 2.40h
_________ _________
tO t2.45h
___________
pH 7.11 7.22
Lact. 20 18
Ric. 8 10
CASE t -9h
pH 7.14
Lact. 13
Bic. 15 25 31
In case 2 the 2 first RHO were shortened because of coagulation
problems. In case 3 ME plasma concentrations fell from 25 to 15
iig/ml during RHO. cXlllLJSIO6 : BHO is an efficient treatment of
LA observed in diabetics treated with metformin since it
corrects rapidly acidosis and shock. It represents therefore a
good alternative to dichloroacetate infusion.
t 60h
7.51
2
29
HO 3.30h
t12h
7.37
13
HO : 5h
to ts
7.43 7.48
6 2
RHO 4h
t25h
7.47
19
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• HEMOVIALYSJS(HV)-TNVUCEV ACUTE CHANGES TM T LYMPHO-
CYTES I LY)SUSSETS.
N. Vxatwa,F.Co/la/ct, F. Masscatct-LemonèL.Ve ('ettex,°C.
T-LeJLe,nana, R, OJens , 1.Vucha.teaa)Tn2&. by P. Vexeeicot'tae-
ten).
S/utgmann and St PZevte' Un.Luen.oLty Ho4 pAlal4,
&tu46 814, SetgLwn.
HV-Lnduced neuttophil(Meut,to) deplttton £4 welt
known but the £n6luence o5 HP on TLy 4ub4 €26 ha4
neuen. been 4LadLed. We meadwted and corn pa'ied (USC
and dl fiexen2Lo24,TLy 4ub4et6 a44844ed by rnonocto-
ncr! antibodle.o and complement acttvatLon by C3d to
C3 n.atLo(Ln ULn II pa.tienfl dIalyzed once on cii-
pxophan(Cu)and once on polyaexylon.Lttile(PAN)mem-
bxaneo.SLood 4ample4 wexe dAawn beoxe and 15,60
and 180 mLn.a6tex 4tWctlng HP.
A4 the mo4t 4t'cIitLng changeo we&e ob4e&ved a!
15 mln.,onty Lhese axe xepon.ted hvte a mean4÷SEM.
TIme O(Cu.J 15(Cu) 0(PAI4) 15(PANT
(i/SC 8953÷997 3048÷498' 8742÷886 7485÷612
Meutxo 51751775 10851317' 48501602 40901503
Ly 25251596 15571/87' 21801283 18811116
OKT3÷ 15981476 12761212 15011179 14651203
OKT4÷ I 1037T735 194187 810÷78 850÷17
OKT8÷ 7821187 474T94 7031175 sv11ioi'
T4/T8 1.5810,23 1,9210,21' 1.5710.25 1,9110,79'
C3d/C3 671
÷
874' C 576
'p<.OO1;'pc.01; pcOZ,°pc.025 when compaxed to
ua/ue, at tIme 0.
In concla4Lon,HV on both Cu and PAN membtaneA
Inducts a cornpaxable aLgn 6lcant pkog&e44Lve. de-
c&eae In 0KT8+(4upp/te44ot-cytotox,Lc)Ly whIch £4
atn.eady maxIma! at 15 mln.OKT3÷(tota!)and OKT4÷
Ihelpee-InducenjLy axe not aected,Tha4,thLs
phenomenon seem4 Independent o complement act!-
cation and thexeo'te mu4t Inuotve mechanLom4 d--
6exent fleom tho'3e ee4pondlbte dolt HP-Induced nea-
ttopenAia.
PRIMARY HYPOTNYROIDISM AND ANYLOIDOSIS IN
HAEMODIALYSED PATIENTS
P Dupont, B.Carlier, J, Docobu, M. Rubinstein and
J Hainaut
centre Hospitalier de Tivoli, La Louviere Belgium
In chronic renal failure, carpal tunnel syndrome
scapular pain, bone tumors and endocrine involve-
ment (particularly thyroid) can be attributed to
secondary amyloidosis. Recently it has been
shown that CRP dosage are related to SAlt levels.
In 38 patients haemodialysed since 3 months to
14 years, free T4 index, cRP values and dialysisduration were measured. Primary amyloidosis,
hypothyroidism and inflammatory diseases were of
course excluded from our study.
We observed no significant correlation between
CRP and FT4 index and between these two values and
the duration of dialysis. However, in 15 patients
where ClIP was greater than lmg% (n<0.6), hypo-
thyroidism was found 4 times (26%) . These hypo-
thyroid patients were haemodialysed since 2,3,10
and 14 years respectively.
So, in chronic renal failure, thyroid tests
must be regularly asked to search insidious
thyroid involvement which may be due to amyloid-
Osis infiltration. In our experience, primary
hypothyroidism occured in a quarter of patients
with elevated cm!' ( ) 1), all of them being
haemodialysed since more than 2 years.
DESFERRIOXAMINE (DFX) OCULAR TOXICITY; ABOUT TWO
UNUSUAL CASES
P. Dupont, H. Rubinstein, J. Ducobu, 2. Hainsut
Centre Hospitslier de Tivoli — La Louviere
(Belgium)
Long term DFX chronic treatment has been
shown to cause cataract snd reversible retinal
abnormalities in some thslsssemic pstients but
very rarely in chronic renal failure.
Recently, we observed unusual DFX ocular
toxicity in 2 haemodialized patients with
aluminium (Al) osteodystrophy.
The first one, with relatively poor ophthalmic
status (bilateral keratokonus and central corneal
opacities), previously parathyroidectomized,
received DFX st usual therapeutic doses (SO mg/K
IV) 3 times a week during one month. DFX must be
stopped becsuse of sudden fall of visual acuity
(< 1/10) with dyschromstopsy and night blindness
only partially regressive after 3 months dis-
continuation.
The second one, after a single DFX test,
became totally blind within two weeks secondary
to severe bilateral cataract. Fortunately,
ophthalmic surgery was successful and restored
reading sbility. Spectro—photometric atomic
absorption analysis revealed that the Al content
of the lens wss 100 times more elevated than
normal control.
So, ocular toxicity of DFX must be cautiously
tracked down, now DFX is widely used for Al
osteodyatrophy diagnosis and treatment.
LONGiTUDINAl.. COMPARISON BitTWEE ACETATE AND
BICARBONATE IIEMOB1ALVS IS.
E.Duranti ,E.Vagriol I ,D.Rizzarri ,P. imperiali
M. Sasde ii i
Divihione di Nefroiugia,Arezzo,ltalia,
Vascular Instabi I.ity(Vl )stili remains
the moat frequent pr ohlcm on maintenance he
modilalysis .The aim of the work was I u stir—
By the clinical —biochemical eftects of I3ica
rhonate Nemodialysis(BFI)in pts.with high VIbefore treated by Acet ale Flemodia I ysis( All)
I I pts . (age from 32—53 yeara; ) wi Ui high V I
on maintenance hemodi a) ys is or Syeara( 2—1 2
years )we re stud ioil. in all we evalual ed the
ci in ical and biochemical param' I cr 5 at the
end of a pcried(Smenths)on All compared with
a similar period on BIT, in 3 pts.with serio-
us Vi ,BII did not show statistical diCleren—
ces I n comparison with All as regard5; the in
cidonce of symptomal Ac hyootensjnri 'nisndrs
(SHE) and the fluid rcpLacenent(iR)pcr ses-
sion,which signitirwntly decreased inS pf:s
with moderate V1(SHE:AH=fl,44+o,2 vs Bil—O.23
tO.6 p(O.005;FR:AII=lii+5?ml vs 53438mi pLO.
005) .Nn difference was present between the
two treatments as regards hi nchemt.cal para-
meters.In conclusion,RH offers geod results
as regards clinical pnrameters,in comparis—
en with AH,only in pts.with moderate intra—
dialytic VT.Tho problem is still opened in
pta .with serious Vi and difficult t0 salve.
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COMPARISON BETWEEN MEASURED AND PREDICTED INTER AND
INTRADIALYTIC 8Na IN RD PATIENTS.
R.Elsen:Brussels,L.Bertrou:Clin.St.Exupéry;S.Cha-
moiseau:C.H.U.Rangueil;J.L.Lacombe:Clin.St.Exupé;
A.Bru:C.L-I.U.Rangueil,France.
(Introduced by J. Pollini)
We use a model which calculates inter and intra—
dialytic changes of Na1-body content (Na) during an
interval as AMa = Na (t).V(t)—Na (O).V(O) where Na
(t),V(t) and Na(O),V(O) represent Nay plasma con—
centrat:Lon and the total body water at time t and 0
resect:Lvely. Comparison of both measured and pre-
dicted intradislytic ANa has been performed in 7
stable RD patients.
ANa(mn
rmeasur.
teodel
01)
—512
—483
— 5
—15
—187
—193
—154
—151
—161
—153
—269
—205
—3l
—3211
The same comparison has been performed during
the interdialytic period with a strict Na intake
diet control and free fluid intake (V).
+A Na (mmol)
dietetic 323 253 303 305 285 283 300
node1 626 410 450 255 310 256 390
/ (1) 4.6 3.4 2.7 2.7 2.3 2.4 2.6
There is excellent correspondance between measu-
red and predicted values during the intradialytic
interval. During the interdialytic period it can be
seen that more is made available in the body
water pooi than the quantity corresponding to the
dietetic intake in those patients with a high fluid
gain. This can be explained by the mobilisation of'
Na from no body water compartment, probably bone,
to counteract excess dilution. This also shows how
HD can be used to quantitatively correct total ex-
changeable Na, since Na(modeU—Na(dietetic) is
an extra quantity of Na made readily available for
the next RD session.
GA%IllliI)!'uUI:NAl, V l:Ai-11 IN tlIflMIC PATIENTS
1)1111 I NI; IIEMOI) I AlYSI S THEATMI:NT (linT)
$.Ieii ne I I i , V Nlrlecarne , Ii. lIre inn] Ii , Il.
F/tn I i I'. 01 1 I i , 0. Tnt irann i , 0. Gun] itndi
S. Ante tool) i it] , Ferraro, I itly.
(lo•;t r c lunet i nfl shows oft en contttsnci
resolt n 1101 pitt tent -i. We studied banal
not eir) Ieveli-i itt 82 net ients; meet test
(MI) It tnilet or irsIein (0—17 I1IJA:pp/mI)
(eeoc ri :1) pIn; in 211 cases beset and pent;icii-Irtn -it tnt teil ecid seeeet ion (I-'SAS
itilq/tr sIn sI tint tent; 13 rir)deeweet nest ric
noose It pnv
INoenI.tr J\enlpr.I, iivpochl .5 ovpoecrr.38 II . 1 Or-. t . 03±.08 .08*. 1 1 . 5 + I .N') .9+3.I .9+1.9 3.8÷1.5 26.4±14.63—' 7 Ill 27 '41 5+1111)2 133.6+33.8 57. 6÷1 6.6
V—I 7 '10—140 140—220 240—500 600—101)0 )i 00(
II 51(5I') 1I(13') I](]3%) 4(5") 4(5")
'ISA 01)1 10-1 lotir responses : flOr'fiul 1 I1C i
ttvnroi rI 0111111' j C, achlor'hydric afld hypeichlo
i vu ii e .Ac Ii I orhnolr Ii' pitt tent s have hiCher
-oiler) rst F II levels; hyperchl orhydrics he
IC low—iror'in,r! 3,1st rio le cIa. Acid so—
I 'e I i OF) 1-O I I s I I et i 0 er Ii 11) rhydi' i c and
or'1edr'i i 3rocrpo. Seirim Itllstrin ('Or'—
st tin I del by MI FISt) II 1)111 iii cases
o i I I I 0 —tIc) '111111 1)11 I 1 Fill 1 1) I he Iii 411 e 51
'it level. itiol o!o4rcai Iitndirn,tzs show
pt I rirro w1ler''- 'OF tIre 1 Fill r\pen'plasia urd
iiori,'ritir I ciii' nI2i 1 tiet ion pI'evei 1 .We propo-
se eo,ts 11cr' rt)eor'mIll iisttic secretory re—
411111 lOll 10 ch,rred dastrlt, feed—hack: hy—
pO—1011I or'llvdr'ie ot 111CC stimulate inet'fi—('lent 310111101 lOt) its well as hvperchlor'hy—
riot c sI t'p5 011)11 Iii) 5OCI'et ion wi thout coon-I or l'c'spOtlse
A MODIFIED CELLULOSE MEMBRANE (MC) WITH
REDUCED COMPLEMENT ACTIVATION
D. Falkenhagen, G. Zinner, U. Falkenhagen,
P. Ahrenholz, M. Holtz, E. Behm, H. Klinkmann,
Klinik für Innere Medizin, W. Pieck University of
Rostock, GDR
The aim of this study was to clinically investigate a
newly developed modified Cellulose membrane (Enka
AG/FRG). The dialysis efficiency and blood compat-
ibility of 1 m2 MC dialyzers was evaluated in 8 chron-
ic hemodialysis patients. Clearance measurements of
low and middle molecular weight substances were used
to assess dialysis efficiency. Blood compatibility was
assessed by studying blood cell and complement behav-
iour during hemodialysis.
The initial drop in WBC counts during hemodialysis
was significantly decreased from 76 % for a Cuprophan
dialyzer (1 ml) to only 24 % with the MC. This result
correlated with the C generation rate. Mean C3
levels increased by 16 % for a Cuprophan dialyze
and only 300 % for the MC dialyzer. This biocompar-
ibility trend was also observed for other complement
factors and total hemolytic activity.
The investigation of dialyzer efficiency demonstrated
good clearences for urea (140 mI/mm), phosphate(122 mI/mm) and creatinine (125 mI/mm). The contin-
uously measured clearance of 99 m-Tc-DTPA (Diethyl-
triaminopenta acetic acid) with a molecular weight
of 560 showed a high efficiency for middle molecular
weight substances.
No side effects or other clinical complications were
observed during hemodialysis.
In conclusion the modified Cellulose membrane clearly
demonstrates a highly reduced complement activation
combined with high clearance efficiency for low and
middle molecular weight substances as well as a rea-
sonable ultrafilrrarion rate (3.6 mI/h x mm Hg x m2).
PLASMA REFILLING RATE(PRR) DURING ULTRA—
FILTRATION(UE) IN CARDIAC AND NEPHROTIC
EDEMA AND IN PATIENTS ON MAINTENANCE
HEMODIAL VS IS.
P . Faucha id, 3 . Stenst rem.
Rikshospitalet,OsIo,Norway.
The aim was to compare changes in plasma
coiloid osmotic pressure(AIIp) and PRR
during UF.PRR was calculated from measure-
ments of plasma volurne(PV)(125—I—albumjn
space) and lIp before and after UF in 7
patients with diuretic—resistant cardiac
edema(14 IIF—sessions(UFs), mean OF—volume
(0Ev) 3893 ml),6 patients with therapy—res-
istant nephrotic edema(12 UFs,UFv 3730 ml)
and 6 patients with chronic renal failure
(12 UFs,UFv 2956 ml).lIp was greater in
- + +heart fai.lure(13.2—6.9 mmHg)(mean-SD) andin renal failure(9.64.6 mmHg) compared to
nephrotic syndrome(3.l÷L9 mmHg)(p<0.Ol).
In heart failure ultrafiltration rate(UFR)
+ +
was 17.3—LB mi/mm and PRR 12.8—1.7m1/min,
in nephrotic syndrome UFR 2l.Bt4.5 and PRR
19.9L4.8 mi/mm and in renal failure UFR
and PRR l7.02.3 ml/min.PRR inrel-
ation toIlp(PRR/IIp) was reduced in
heart failure(L3t0.9 ml/min'mniHg) compared
to nephrotic syndrome(9.6±4.A mi/mmn/mrnHg,
p<O.Ol) and to renal failure(2.2t1.3 al/mm
/mmHg,pKO.05)
Conclusion:Due to the disparities 1nPRR
and PRR/IIp UF led to substansial reducti-
on in PV in heart failure,less reduction in
renal failure and with the present UFfivery
little reduction in PV in nephrotic syndro—
me.The findings can be caused by differenc-
es between the groups in capillary filtra-
tion coefficient and in interstitial tissue
compliance.
ACUTE RENAL FAILURE (ARF) IN OLD AGE
J.C.FernAndez,S.Aguilera,E.vasta,D,Brana,J.L,do
Pico,N.Castro,R.Pantano and C.Chena.
Servicio de Nefrologia,l-lospital Sirio-Libanés
Buenos Aires,Argentina.
The evolution of all 36 patients over 70 (ave-
rage 76.4 years) with ARF and requiring hemodia-
lysis between 1/1/82 and 31/l2/84,was evaluated.
7 patients showed an obstructive ARF (DARF) and
29 fulfilled the criteria accepted for acute tu-
bular necrosis (ATN).8 of these had a post surgi-
cal ATN and 21 had a medical or traumatic cause.
Patients were hemodialyzed daily with systemic
heparinization and filters were reused at least
3 times.Nobody was prescribed i.v.hyperalimenta-
tion and fluid was restricted to the minimum
in order to .maintain steady hemodinamic patterns.
The number of dialysis per pat ientaveraged538.
12 of the 29 patients suffering of ATN (4l,4)sur-
vived and 6 of them were discharged with a serum
creatinine below 1.5 mgf.There were no differen-
ces in the rate of mortality according to etiolo-
gy,ol iguric or non ml igurig ATN or the patients'
mental state (aiert,disoriented or comatous) at
the beginning of the treatment.1O of the ih patie-
nts who showed signs of sepsis died .The 7 patients
with OARF survived.These results seem to support
the assumption that to treat elderly patients
with ordinary methods and reusing hemodialyzers
does not modify the survival rate significantly
from that currently reported.
EFFTf OF 1101 OVERCOAD 06 SUPIXIXIUE ANION IIUIXCTICXI By
GRANUIJTCYI136 IN IIEMJOIALIZEO PATIENtS
J. l"lamunt, N. Goidrian, I. Waterlot, E. Dupont, 3. Wybran,
I. L. Vushenveghasi
Erasne Hospital, Brussels University, Brussels, helgium
Bacterial infections are frequent in heewsiuslyzed patients.
In order to inveatigste the possible influence of iron overload
on the phsgrcytic function of 36 patients on chronic maintenance
dialysis, we sessured the generation of auperoxide anion (Or) by
granulocytes in whole blood after stimulation by opsonized
zymsssan particles or phorbol myristil acetate (NA). Iron
overload (18 patleuLs) sass defined by a serum ferritin level
aixive 1011 ag/mi in polytrsnsfosed patients.
Results are expressed as nnoles mm/b6 granuiccytea
(sean SEll).
iron overloaded others
Stimulating agent n = 18
c—zynosaa 85.9 7.5 120.9 8.3 0.02
89.0±7,5 142.2±11.9 <0.891
Thua, iron overload in hewsudislyzed patients is associated
with decreased netabolic response of granulocytes to phagreytic
particles as well as to a soluble activating agent (EllA).
These dsts are consistent with previous atudiee about iron
effects on phagocytic functions and suggest that iron overload
could he involved In the susceptibility of hairdialyzed patients
to bacterial infections.
FACTOTS WHICH INTtTFEAE TN THE TtPROCESSING OF DIALYZERS TN A
AUTOMATIC StAGE PROGRAME — C. Ferreira, 8. Martins, L. Olisci—
ra, H. Paz and I. Pratas.
EOTODIAL — LETTTA— PORTUGAL
This data is based on eeperiesce in the total aateeatic repro-
cessing of hollow fiber dialyzers, a technigae we started al-
most two years age. tsperimests were carried sot with am asera—
ge weekly dialysis af 12W 20Mg AM, a cotal dose of heparin of
1.053 0.1. 1.023 and with tn area of the dialyzers being
i.231s'r 5.11.
More than 16.000 reprscessings were carried oat with the
Henatrsn AS 8300 and A) the dialyzers with less than 85% of
normal solace 5) pressare drops C) with more than ten sisible
clstted fibers were rejected. Issignificast, irrelesast casses
sach as machinary problems, fractores and labelling mistakes
etc. were not isclsded,
A total somber of 11.4% rejections wers checked being for
A) 2.59%, 5) 0.48% and C) 8.2Gb. There rsisted sariatians be-
tween the sariass technicians of 9.50% to 13.95%.
Csld atmosphere temperatares before the repracessieg,sn in-
crease of waiting time, the presence sf air in the fibers, a
law qoantity of administrated heparin, the inefficient resti—
tatism of blood at the end of the dialysis, a lswering sf the
speed of Lhe bloed pamp, the large areas and the nos—circalar
dialysers, are factors which ispaired significantly the rease
program. The correction of same of these Factors can imprese
sabstantially resalts in the fstsre.
•
EFFECTS OF IJRAEMIA AND DIALYTIC TREATMENT ON ADNENO-
CEPTOR RESPONSIVENESS.
Fuiano C., Dal Canton A., aMa) M., Tests A., °Ariano
M.O., Conte C., Cuarriello L., Memoli B., Pacchisno
C., Andreucci V.E.
Dept. of Nephrology, 2Faculty of Medicine and aDept
of Psychiatry, F Faculty of Medicine, Nsples, Italy.
The effects of uremia and of a dialytic sessionos,
sdrenoceptor responsiveness were evaluated from the
changes in plasma AMPc 1AMPC) caused by s.c. Epine—
phrine (E) administrstion. In fsct, the AMPc C a
reliable index of the AMPc release rate from the
adrenoceptors and, in turn, of their functional inte-
grity. The test consists of E edminietration (7pg/kg
bw) followed by blood sampling for AMPc every 10—
minutes for 70 sin. The test was carried out in 4
groups of subjecte:(l)Normal; (2)Oremic in conserva-
tive treatment; (3)Oremic in regular dialytic treat-
ment (RDT) by acetate—dislyeis; and (4)Uremic in RDT
by bicarbonate—dialysis (o—o). In groups (3) and (4)
the test wss performed immediately before (Sd) and
after (ad) a dialysis session. The increases OFPAMFc
as % of control value are summarized in the follo—
sing table: MINUTES AFTER S ADMINISTRATION
10' 20' 30' 40' 50' 60' 7O'T
T1AMPc (% control)
— 8 63 go 59 63 45 25Or.2 3 52 63 59 67 40 12
Or. 3 (Sd) 16 46 64 60* 64° 36 9
Gr.3(ad) 13 35 44 52° 40* 31 7
*2  0.025
Or. 4 (Ld) 18 — 44 Sb 60 50 — 44 — 19 —Or.4(ed) 10 60 50 57 Si 44 15
These results indicate that adrenoceptor respon-
siveness is unaffected by uremia, but is impaired
by dialytic treatment, probsbly due to an acetate—
associated effect: the bicarbonate—dialysis, in fact
prevents such reduction.
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DIALYTIC SYMPTOMS:SHORT HYPERTONIC HEMODIALYSIS
VERSUS CONVENTIONAL HEMODIALYSIS (HD).
M.Garcia,M.Carrera,J.M.Pons,P.Arrizabalaga,J.Monto
liu, E.Merola, L. Revert .Hospital ClInic .Barcelona.
Spain.
Previous reports(Proc.EDTA 20 1984)showed that
hypertonic HD(HHD)allowed intracellular dehydra-
tion and maintained better volemia during HD.The
aim of this study was to compare dialytic symptoms
between conventional HD(CHD)and MMD.
In 10 patients,clinical symptoms on CHD for 3
months and on HHD for 5 months were evaluated.Pa—
tients were divided in 2 groups of 5 patients ac-
cording to dialysate buffer:Acetate(A)versus bicar
bonate(B).CHD was done 4 hr x 3/week,using a dialy
sate containing NaC1 139 mEq/L.The same patients
of each group underwent HHD,3 hr x 3/week,using
a dialysate containing NaCl 130 mEq/L with an osmo
lality of 305 m0sm/L and perfusing into the venous
return—line NaCl 342 mEq during the first hour of
MD and Ma 60 mEq for the last 2 hours.The parame-
ters recorded were:hypotension(H) ,nausea,vomiting,
cramps(C) ,headache(Md) ,post.-HD asthenia(A) ,increas
ed thirst,weight loss(W)and fluid rep1acment(F).
Statistical analysis was done by the x analysis
and the studentst test.Results were:
Groups MD H (%)Hd(%) A(%) C(%) W(Kg) F(ml)
A C-MD 252 27.8 7.5 32.5 5.9 2.45±0.12 105±92
A H-MD 320 37* 9.3 18.4 6 2.48±0.05 57±31
BC—HO 194 8.229.332.6 10.9 2.18±0.36 13393
B H—MD 341 6.4 15.5* 9.4 15.5 2.31±0.15 135±17
P0.0Oi Nausea,vomiting and thirst did not show —
significant difference.
We conclude that hypertonic HD improves dialy-
tic symptoms in Spite of rapid ultrafiltration.Mo—
reover the incidence of' hypotension,headache and
post—MD asthenia is reduced without an important
change in interdialytic weight gain.
• INTERLEUIZIN— 1 IN HYPERSENSITIVITY REACTIONS
DURINO HEMODIAI.YSIS.
F. Oiacchino, N. Pozzato, S. Landulfo, A. Oeretto, C. Oangemi, 0.
Giraudo, 0. Piccoli.
Medical Nephroloqy Institute ad the Umversity. Turin.
Drnlysis Units. S. Giovanni Hospital. Turin. Italy.
The interleukin— I (IL— 1) produced by peripheral monocytes of
23 dialysis patients was studied to evaluate the role of mononuclear
phagocytic cells in the mechanism of allergic reactions during
hemodialysis sessions.
Sixteen patients were dialyzed with cuprophan membrane (CU)
and 7 wIth polyacrylonitrile membrane (PAN). 11-1 actIvity,
measured on the basis of IL- I production induced by E. Coli
lipopolysaccharido (LPS) from blood monocytes, was significantly
higher in CU patients than In PAN patients (stimulation index [SI] =
3.48*0.3 vs 17*005; p < 0.05), because of greeter monocyte
activation by CU membrane.
CU patients I lymphocyte response to 11—1 from normal
monoc'ytes (E-Rosette test) did not differ from PAN patients (E% of
E-Rosettes 29.4*5 vs 26.3*3.3: n.s,).
The fact that IL- 1 induce by LPS, from circulating monocytes
studied during allergic reaction to hemodi&ysis sessions with CU,
was much lower (SI = 1.1±0,2; p <0.02 vs 11—1 in CU patients)
confirms these results. It suggests that a chronic activation of blood
monocytes by CU membrane, may be involved in hypersensitivity
reactions during dialysis sessions.
. LINK BETWEEN HLA-B40 AND
.
DIALYSIS ENCEPHALOPATHY
Peter Garrett, Susan Spencer,
David Mulcahy, Patrick Hanly, JS Hanson,JF Donohoe, M Carmody, WF O'Dwyer
Department of Medicine, Nephrology, and
Transplantation, and Tissue Immunology
Laboratory, Jervis Street Hospital,Dublin, Ireland
Not all dialysis patients exposed to
significant aluminium loading developdialysis encephalopathy (DE), suggesting
that constitutional factors may play a
part in the clinical expression of this
disorder. Using standard microlymphocyto—toxic techniques we determined tissue
types for A and B loci in 37 patients with
BE diagnosed on strict criteria.
Frequencies of individual antigens were
compared with their occurence in 453
healthy control subjects using chi—squaretest with Yates' correction. The incidence
of HLA—B40 was significantly elevated in
the DE group, implying involvement ofgenetic factors in the pathogenesis of BE.
EC"OCDIOGRAPTTTC/ECT'O ASSSIr:T Of' CdTIDLkC SIPE
AJ\ID PIJITcTIOM IN PEMO)LkLYSIS/TT' PIPET$/P'S/
K.Gockowski, B.Putkowaki, J. a.:<tis, '1.Krfia:,
A .Mmnitius.
Institute of Internal hd4cine, ITedicv.l 3.r.c(9omv-,
Gdadgk Pol'nd,
Metabolic and hernod,nainic disorders encountered
in chronic renal failure/.r.f./ induce eativeinfluence unon the cardioc :izer fn-nction. In
order to acoesa the s+.ruoturcl and functional
changes, as well as the effect of D on cardac
performance, echo studies were oerorned in 29 PD
uremic otr. Marked. enlarCement of the left at,ri,a'e
was noted in 19 ptc/6/ and the increaoe of the
Lk/Aortic root index to 1,25 or more was found in.
1D casea. Left ventricular dilatation, with the
lue of LVEd. exceedinf 5,5cm was accessed in 14
rts/4/;wherereas LVTDs exceeding 3,5cm was noted
in 15 ptr. In 7 cases/24%/ zvstolic shortening ofthe LV was lees than 2,Septal hvpertron.'aodetected in 6 aic/f5/ b'a- onl in 5 cases IVS/PT
ex exceeded 1,3. Concentric }renertrophv, without
ventricular dilatation was observed in 10 pts/34/,
The decrease of the mean rate of circ:unferential
fiber shortening /VcC/ below 1,02 circ./sec, was
noted. in 7 cases. In 17 pts/5/ a pericardia],
effusion was observed.Pollowin.g PD left ventricular
end—diastolic volume /DV/ decreased from 1o,,ic +
64,4 to 152,72 + d2,O /p< 0,001/, while einction —fr'ction jF/ "rich overared 0,70 + 0,11 before,
remained at 0,71 + 0,10 after PD.Fi'T and. NP showed
a significot coxelatinn before PD / r — 0,47,p<O,02/; after PD t1ii correlation
inzifnificant. In con.trast,there was a iific-mt
increase inircf/from 1,16 ÷ 0,77 to 1,2 + O,,
p<0,001/. It is concluded aat PD iufucea
a sIgnificant chanCes of cardiac I ncion in ptswith c.r,,
) RISK FAOPORS AFJ'EOT LIFE SATISFACTION OF
DIALYSIS PATIENTS?
H. Cokal, J.P. Stout, J. Auer, J. Kincey,
V.F. Hillier, D. Oliver, G, Simon, H. Yu.
Manchester Royal Infirmary, Churchill HoBpital,
Oxford, United Kingdom.
A large scale retrospective study of all pa-
tients starting CAP]) and haemodialysis (aD) from
January 1981 to April 1984 was undertaken in 2
units to assess the role of treatment mode, age,
physical and social risk factors on a variety of
psychosocial parameters of life satisfaction and
stress. A standardised self—report question-
naire incorporating existing and specially adapted
scales was used to assess outcome.
159 patients (941't, 65P; mean age 49 years
(18—73) 81 CAPD, 78 (aD) were studied. Of these98 patients were deemed to have risk factor(s)(medical, social,psychiatric) at onset of therapy.
For assessment 4 groups (below 60 with or without
risk factors and above 60 the same) were identi-fied. On Cantril's life satisfaction "ladder
scale" there was no significant difference between
the groups, the average score being compatible on
a scale of 0—10 with that of a normal population.
The life stress scale revealed that both groups
< 60 years found life more stressful than those
over 60. On further life satisfaction and happi-
ness scales, only the<60 year with risks group
scored significantly less than a normal population.
This groups also was less satisfied with life as a
whole arid standard of living.
Overall life satisfaction for all dialysis
patients appears to be compatible to that of a
normal population except for those <60 with risks
who scored less well. High risk patients, es-
pecially those over 60, do have a reasonable
quality of life and shcmld not necessarily be de-
nied treatment on these grounds.
SUCCESS RATE OF ONUFF—HOX FISTULA
N. Haberal. Z. Oner, N. Cakmakci, H. Gulay,
. Pilgin
Hacettepe Univ. Flosp. TX. Center & Turkish
Transplantation and Rum Foundation, Ankara
From March 15, 1982 to Dec. 31,1084,324
chronic renal failure patients have been
applied 444 vascular accesses. The ages
of these patients ranged between 13 to 62
years, with 214 (66.1%) males and 110(34.
9%) females, with 38 (8.5%) having 2nd, 22(4.PT.) 3rd, 9 (2%) 4th, 3 (0.7%) 5th and 2(.45%) 6th fistulae. Of the 444 A—V fjsf-
lae performed, 298 (67%) were snuff—box
with 230 (77.2%) on the left hand and 68(22.8%) on the right hand. Of the 298
snuff—box fistulae 3 (12%) did not func-tion at all and 22 (7.4%) functioned from
10 days to 360 days. 240 (80.5%) are stillfunctioning well at the present.122 (27.5%) of the 444 vascular accesses
were performed on the wrist area. 24(5.5%)
of the 444 vascular accesses were to the
anticubital fossa.
We found that "snuff—box" vascular access
can be performed on all patients includingjuveniles and geriatric patients with a
"High Success Rate" and for patients in
need of immediate hemodialysis, we were
able to use the fistula within the 1st 24
hours without any complications.
Therefore, it is our belief that a dis-
tally placed snuff—box fistula should be
the primary choice in preparing the patiert
for hemodialysis, providing that it is per-
formed with extreme caution in preserving
the fragile vessels of the patients.
MTTLTICENTRR STUDY OF O1TCOME OF CAl']) MiD
HA$DIALYSIS (m) P&TIRNTS (PTS)H. Gokal, . Jakubowei, L. Ew4, J. Jeacock, *H. Bailod , F. Maeh , M. Ward , R. Wilkinson
C. Ogg , D. Olive?'.
+
Manoe.ter (R8yal Infirmary); London (Royal reeGuys , London Hospitals)4 Oxford (Churchil' );Newcastle (Royal Victoria and Freeman Road
Hospitals) U.K.
In a multi—centre study by 7 large renal unite
in the United Kingdom, the morbidity and mortality
of all patients starting CAPD and RD during a two-.
year period (1983—84) has been monitored prospect-
ively and related to reasons for choice of therapy
and potential risk factors.
Over this period 339 new pta (mean age 48; 3—77)
started OAPD. 17% had diabetes mellitus (DM) and
25% had cerebro—cardiovasculaz disease (CVI)).
177 pta (45; 5—73) started liD: 6% had I)?! and 14%
had CV]).
The Kaplan Meler actuarial pt survival estimates
at 2 years was similar for HI) (84%) and CAP]) (83%)
whilst technique survival at 2 years was not signi-
ficantly different (HI) 9, CAP]) 80%).
No
DROP—OUTS Hoap. Periton—
Change to days/ itis ep/
PP Died RD/PD pt/yr pt year
CAPD 339 86(25%) 24(7%) 35(10%) 14.8 1.7
B]) 177 60(34%) 17(10%) 9(5%) 12.8—Age, D and DM were significant risk factors
for survival. There was preferential use of CAPD
in patients with these factors, and as a prelude
to transplantation (TP), which was the major cause
of 'drop—out' in both groups.
CAPD was used twice as often as RD for managing
new patients. After 2 years hospitalisation, tech-
nique and patient survival were comparable in the
two groups.
A NEW EXPERIMENTAL MODEL OF VASCULAR ACCESS FOR
REGULAR NEMODIALYSIS TREATMENT
4. Hajibaloqlou, C. Papaconstantinou, I. Sapikas,
0. Kiskinis, 0. GFk, 0. Aletras.
1st Surgical prop, department, University of Thes-
saloniki, GREECE
The most imr,ortant prerequisite for the regular
hemodialysis treatment is a good vascular access.
Brescia-Cimino fistulas do require time to nature,
but often one patient with end-stage renal failure
needs to buy time while the fistula matures. In
order to accomplish this goal a new technique has
been developed on 18 dogs in our experimental theat
re. A regular fistula was created first and the
scribner shunt was connected to the fistula inulta—
neously.mis mixed vascular access (fistula—shunt)
was studied hemodynamicall" by recording the blood
pressure and blood flow rate at different points
of the vascular lines. The results showed that the
hemod'namic conditions existing at the various
points of the mixed vascular access provide satis-
factory blood flow rate and patency throunh both
parts of this experimental model. The transfer of
this technique to uremic patients would provide a
new way of vascular access for short-term as well
as for chronic treatment with hemodialysis avoiding
a second operation. Also, two important vessels are
saved, which should be probably used in the future
for a new vascular access.
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MIXED VASCULAR ACCESS FOR REGULAR HEMODIALYSIS TUBERCULOSIS IN DIALYSIS PATIENTS IN 3ORDAN
TREATMENT
A. Hajibaloglou, C. Papaconstantinou, I. Sapikas,
D. Grekis, H. Fronis, 0. Aletras.
1st Surical prop. Department, University of Thes-
Y.S. Flamzeh
Department of Internal Medicine/Nephrology
lordan University Hospital - Amman Jordan.
saloriiki, GREECE In a retrospective study over 5 years 1980-1984
Brescia-Cimino fistula is still the gold stan
dard of vascular access for bng-term hemodialysis
treatment. In order to start the hemodialysis
treatment while the fistula natures we developed
a new method on 34 uremic patients compinin) the
fistula with the Scribner shunt. A regular fistul
was created first and the Scribner shunt was con—
nected to the fistula simultaneously(Mixed vascular
access),. 15—45 days after operation the Scribner
shunt was disconnected from the fistula, while the
treatment with hemodialysis was continued by the
fistula. Thrombosis and hemorrhage were the main
conplfcations,which apeared in two and five cases
respectivel". It is suggested that this new tech-
data from our hemodialysis unit were reviewed, seven
patients with active mycobacterium tuberculosis were
identified in a population of 110 adult patients under-
going long term hemodialysis, the mean age was 39
years, the incidence of tuberculosis was 16 times
greater than that previaling in the general populations.
Extra pulmonary disease occured in 4 of 7 patients,
failure to diagnose tuberculosis resulted in the death
of 2 patients with disseminated disease (Autopsy) while
the remaining 5 patients responded satisfactorily to the
drug therapy. Tuberculin sensitivity was present mire-
quwntly, and examination of sputum for acid fast
bacilli was unrewarding, but fluids were helpful.
The present study indicates the seriousness of
nique of mixed vascular access provides a new way
for immediate and chronic hemodialysis, siniulta—
neouslv avoiding a second operation to the patient.
active Mycobacterium tuberculosis among chronic
dialysis patients in the developing countries, so an
aggiessive evaluation should oe take Ill f SpiCiOuS
Also, two important vessels are saved, ihich should patient from these Countries.
be probably used in the future for a new vascular
access.
Does dialyzer re—use improve membrane
biocompatibility ?
C. Heierli, M. Markert, J.P. Wauters and
THE PERFORMANCE AND COMPATIBILITY O A
NEW COPOLYMERIC MEMBRANE - GAMBRANE -
FOR HEMODIALYSIS
P.R. Lambert. K.E. Hemmeløff, G. Riede, P. Koristantin,
Division of Nepheology, Clinical Chemistry H. Göhl
Laboratory, University Hospital, Lausanne, GambroResearch, Lund, Sweden
and WHO Immunology Training Unit, Geneva,
Switzerland.
The neutropenia and complement activa—
tion observed at the initiation of an he—
modialysis session (HD) seems linked to
the chemical nature of the dialyzer mem
brane and become less important by re—
using the dialyzer. Ten patients were stu—
died successively on Cuprophan (CU) and
cellulose acetate (CA) membrane (re—use
with formaline 4%). Neutrophil counts were
(% SEM):
CU 1 CU 2 CA 1 CA 2
0' 100 100 100 100
5' 75±4 84±2 49±9 52±8
15' 6±1 66±12 63±6 36±8
60' 10 112±9 115±9 111±8
Complement activation measured by C3d
fragments was evidenced with CU at first
use exclusively, while with CA, it was ac—
tivated both during first and second use.
Thrombocytes decreased slightly at 5 and
15 mm. on CU at first use only. With CA,
The performance and biocompatibility
properties of a new flak—sheet polycarbo-
nate membrane (Gambrane ) (G) was inves-
tigated. UFR, urea and creatinine clea-
rances were in the same range as for Cup-
rophan flat—sheet membranes (Cup) of a
similar effective surface area, while vi-
tamin B12 clearance was twice as high (80
ml/min at QB 200 ml/min). Complement
activation, WBC, and platelet counts wer€
compared to Cuprophan. A minor transient
C activation to a maximum of 16 ng/ml
w found during the first 15 mm of HD,
after which it disappeared. For Cuprophan
the maximum was 40 ng/ml and measurable
during the rest of the dialysis procedure.
CJd measured during the dialysis showed
a 40% lower level with (G) compared to
(Cup). WBC showed a transient drop to 30%
with (G) compared to 65% (Cup) of initial
values. Platelets appeared unchanged with
(G) , while a 15% transient drop was no-
ticed during (Cup) dialysis.
thrombocytes remained normal at first use The patients tolerated the (C) dialy—
and slightly decreased with re—use.
Conclusion : our observations suggest that
dialyzer re—use does not uniformly improve
zer extremely well and even patients who
had suffered from severe reactions with
(Cup) dialyzers showed no clinical symp—
membrane biocompatibility since neutrope— toms with (C) dialyzers.
nia, complement activation and thrombocy—
topenia were aggravated during second use
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HYPERCHROMIUMEMIA IN CHRONIC DIALYSIS PATIENTS
I Henderson, A Leung, 0 Hall, G Fell, S Dobbie,
A C Kennedy
Department of Medicine and Biochemistry, Royal
Infirmary, Glasgow, Scotland
We measured serum chromium level in 28 patients
each with advanced chronic renal failure (CRF) wjth
creatinine clearance < 20 ml per mm, on haemo—
dialysis (HD) and continuous ambulatory peritoneal
dialysis (CAPD) . The results were compared with 14
healthy normal controls. To prevent contamination,
all blood samples were withdrawn through a plastic
cannula and stored in nitric acid washed tubes.
Chromium level was measured by atomic absorption
spectrometry. A striking elevation of serum
chromium level was observed in ND (81 42 nmol/l)
and CAPO (99 49 nmol/l) patients compared to CRF
(11 4 nmol/l) patients and normal controls (4 +3
nmol/l) (P < 0.001 by Student's t test).
Chromium transfer studies were performed in 8 ND
patients during a 4 hour haemodialysis. The mean
dialysate concentrate chromium level was 426 nmol/i
and the water chromium level was 3.3 nmol/l. Blood
and dialysate samples were taken for chromium assay
before and after passage through the dialyser.
There was a trend for the serum chromium level to
rise during the hoemodialysis procedure (71 + 29 at
0 sin and 98 27 nmol/1 at 4 hour) . This was due
to transfer of chromium into the blood from the
dialysate, The mean chromium concentration in 10
different batches of CAPD dialysate was found to b
43 nmoi/l ie 10 times > the normal serum level. We
conclude that hyperchromiumemia occur in dialysis
patients because of contamination in the dialysate.
• PLASMA LEVELS OF GRANULOCYTE ELASTASEDURING HEMODIALYSIS: EFFECTS OF DIFFERENT
DIALYZER MEMBRANES AND STERIL11TION PRO-
CEDURES.
W.H. Hor), H.B. Steinhauer, W. Riegel and P.Schollmeyer
Department of Medicine, University of Freiburg, FRG
Plasma levels of granulocyte elastase in complex with
. 1-proteinose inhibitor (E- .x P1) during hemodialysis were
investigated in 15 patients (37.4 3.2 years) undergoing
maintenance hemodialysis (47.0 12.9 months) with diffe-
rent hollow fiber dialyzers. Cellulose hydrate membrane
caused a maximal increase of E-1PI (1,659.0 256.8ng/
ml). Patients dialyzed with polyacrylonitrile dialyzers
failed to exhibit comparable plasma E- P1 levels (237.8
22.9 rig/mI). During hemodialysis plasma E- 1Pl values
rose to a peak 643.0 . 174.7 ng/ml in patients on poly-
methylmethacrylale diolyzers, to 557.5 - 120.0 ng/ml on
cuprophan dialyzers, but to only 381.9 54.0 ng/ml on
ethylene-vinyl alcohol copalymer dialyzers.
The effect of gamma vs. ethylene oxide sterilization of
different dialyzers (polyocrylonitrile, cellulose hydrate)
and blood lines on plasma levels of gronulocyte elastase
was investigated in 17 chronically uremic patients.
P1 was not influenced by the way of sterilization.
We conclude that the degree of PMNs stimulation de-
pends on the nature of the dialyzer membrane material.
The following membranes induce a reaction of increasing
intensity; polyocrylonitrile, ethylene-vinyl alcohol copoly-
mer, cuprophon, polymethylmethacrylate, and cellulose
hydrate. Granulocyte activation during hemodialysis moy
occur independent of the sterilization procedure of dia-
lyzers and blood lines.
LONG TERM SINGLE NEEDLE DIALYSIS USING
SUBCLAVIAN VENOUS CATHETER (SVC)
E. Honkanen, M.v. Bonsdorff, R. Orko
IV Departments of Medicine and Surgery,
University Central Hospital, Helsinki,
Finland
SVC is used extensively for short—
term vascular access (VA). In certain
occasions, however, cathetrization of a
central vein for long periods is the only
wat to save the patients (PT) life.
Two PTs who had undergone various
dialysis (including CAPD) and transplant
therapies started hesnodialysis (HD)
through SVC. Vas-Cath SC-100 (inner
diameter 1.8 mm) or Vaccess 2 (only the
outer lumen, inner diameter 3.1 mm) were
used with Ganibro AK 10 monitor (with
clamp or double pump). Svc was not
tunnelized and it was heparinized only
after HD. The first PT was treated for 6
months until he got a cadaver transplant.
The SVC was changed every 2-3 weeks. The
second PT is, after 21 months, still
dialyzed through the SVC which ham been
changed infrequently; the longest interval
has been 7 months.
The efficiency of the treatment has
been satisfactory. Complications include
one bacterial sepsis (caused by Staph.
aureus) on both PTS. Occasional episodes
of skin exit site infections haoccured.
Conclusions:Long term HO through SVC
provides an acceptable control of renal
insufficiency when peripheral VA or
CAPD are not possible.
RE-ACTIVATION OF' TUBERCULOSIS IN RENAL FAILURE:
A HIGH iNCIDENCE IN ETHNIC MINORITY GROUPS.
B.llulme, F.Cu and D.Carmichael,
Renal (Init,S±illar;'s Hospital ,London W2, England
11 cases of tuberculosis (TB) have been
found in 132 patients with end stage renal
disease(ESRD) in the past 2 years compared with
only 1 in the prior 10 years. 44(30%) of our
ESRD patients were born abroad and TB sits seen
in 25% of such patients with no cases in other
groups. 7 patients had adenitis,1 reiliary TB
1 TB peritonitis and 2 cases of pulmonary TB
with positive sputum; 2 patients were diagnosed
before starting dialysis, 7 on haemodiaiysis and
2 on CAPD. Diagnosis is difficult as the apathy
malaise,tiredness and weight loss are common to
either renal failure or TB but A high index of
suspicion is required since late diagnosis is
associated with a poor prognosis and 3 patients
with widespread disease died despite aggressive
therapy. Physical examination may reveal
lymphadenopathy or hepato—spienomegaly. Chest
X—Rays are usually normal; culture of biopsy
material giving the highest diagnostic yield.
Chemo—therapy with rifonpicin,isoniasid (IN/ill)
and pyrasinamide is safe if used carefully and
is effective if given early enough. We have now
introduced a trial of INAH in such patients
during their first year of dialysis in an
ottempt to reduce the incidence of this serious
disease.
Re—activation of TB should always be considered
in any uraemic patient who deteriorates
inexplicably if they have a history of TB or
were born abroad.
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HEMOCATH VASCULAR ACCESS DEVICE.
Hurst.L3. Jesson,L. J. Booth,D. C. Dukes.
Renal Un., Wsiwgrave Hospital, Coventry.
Where the arterio—venous fistula fails
to provide vascular access for
haemodialysis, alternative methods are
necessary. One such alternative route is a
single—i umen central venous catheter
(Francis et al,1983), but this demands the
use of single—needle dialysis equipment.
The Quinton Hemocath is a dual—lumen
silastic catheter, implanted perrnanentl
into to th central venous system, and
connected to a conventional dialysis
machi re.
We present our experience in the use of
this device in three patients. The first
case had multiple fistula failures, the
second was an elderly diabetic and the
third had a pathological fear of needles.
In all cases the catheter was inserted
into the left external Jugular vein via a
subcutaneous tunnel. The main
complications of infection and clotting
were all successfully managed without
resorting to catheter removal.This rnethod of access has been in our
use fr over nine months and has proved
highly successful in all three cases. It
is now planned to move one pati ent to home
haemodi si ysi s. We conclude that where
primary methods of access fail, the
hemocath is a viable long—term
al tern at i vs.
Francis,D.M.A. , Arze,R.S.
Dialysis L Tranaplantatlon.
Number 3- March 1983,.
COMPARISON OF ADJUSTMENT OF HOME DIALYSIS TO CENTER
DIALYSIS PATIENTS
A. Kaplan De—Nour and V. Soskolne
Hadassah University Hospital, Jerusalem, Israel.
All reports indicate that home hemodialysis
(HHD) and probably also CAPD patients achieve
better adjustment than hospital/center hemodialysis
(CD) patients. However, so far no study has compar-
ed the adjustment of matched groups of patients.
Our aim was to investigate whether adjustment of HD
patients is indeed superior.
32 HRD patients and 34 CAPD patients were match-
ed to CD patients in terms of sex, age, education
and time on dialysis. All pat-ients were married.
Adjustment was assessed in a structured interview
and by two scales: the Brief Symptom Inventory
(BSI) and the Psychosocial Adjustment to Physical
Illness Scale (PAlS). The data was analyzed separ-
ately for the HHD group and its controls and the
CAPD group and its controls.
The main findings are that the HHD patients
perceive their health as better than the control
groups and are more satisfied with that method of
treatment. On the BSI the HHD patients reported
significantly less psychological distress than the
control group. A similar tendency was found in the
CAPD group except that they did not differ signif-
icantly in psychological distress from their
control group. On the PAlS neither group (HHD and
CAPD) differed substantially and significantly from
their control group.
The impression is that the reported superior
adjustment of HD patients is due to their back-
ground and probably also to their personality and
support systems. Once this adjustment is compared
to that of a matched group of CD patients, many of
the differences disappear.
GLUTATHIONE PEROXIDASE ACTIVITY IN RED BLOOD CELLS
OF DIALYSED PATIENTS.
A. laina, H. Rosenman, E. Iscovici, R. Schneider.
Department of Nephrology, Barzilai Medical Centre,
Ashkelon, 78306, ISRAEL.
Superoxide anions generation in uremia and red
blood cells lipid peroxidation in hemodialysis
patients, were already published. Glutathione
peroxidase activity were measured in red blood
cells of hemodialysis patients and normal controls
(by a modification of Beutler, 1975) using
t-butyl-hydroxyperoxide as substrate. The
results are given separately for different ethnic
groups, Ashkenazi Jews (AJ) and non-Ashkenazi
Jews (NAJ group).
GLUTATHIONE PEROXIDASE ACTIVITY IU/g Hg.
Dialysis patients normal controls
AJ + * NAJ AJ * NAJ
25.8—2.6 21.8±1.4 26.6±1.4 20.9±2.4
Mean + SE * < 0.05 vs NAJ group
Significant differences were found in glutathione
peroxidase between the two ethnic groups. In
the presence of high membrane lipid peroxidation
in uremia, a "normal" glutathione peroxidase
level represents an inappropriate intracellular
antioxidative state, suggesting pentose phosphate
pathway disturbance Cs) in the red blood cells
of dialysis patients.
Concentrations of selenium in serum of haemo—
dialysis patients & matched healthy controls"
S. Karayannopoulos, K. Adam, A. Gririanis & H.
Vassilaki-Griniani.
(1) Piraeus General Hospital—Renal Unit.
(2) Radioanalytical Laboratory—Nuclear Research
Center "Democritos' Athens—Greece.
A case—control study was conducted to investiga-
te the association between serum selenium in pa-
tients in chronic haenodialysis and in healthy
population.
Case—control pairs cans from persons of the pa-
tient's family who eat in the sans household.
Case-controls were aged 15-59 years and had beenin reasonable health over the last years.
Controls were matched for sex, age, daily tabac—
co consumption, serum cholesterol and history of
angina.
The mean serum selenium concentration for 24
cases was 63,3iaj/l and that of controls was 75,6
ugh. These differences were found to be stati-
stically significant (t=2,36, p(O,OS)
In view of the fact that both epidemiological
and experimental studies have established an
association between low serum selenium and ra-
pid progress of atherosclerotic cardiovascular
diseases the question to supplement the diet
of haenodialysis patients with selenium may
arise.
Heat on, A.
Volume 12
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WORKING CAPACITY IN PATIENTS TREATED WITH HEMO—
DIALYSIS (HD) AND CONTINUOUS AMBULATORY PERITONEAL
DIALYSIS (CAPO)
G. Keusch, E. LUthy, T. Jenni, R. Tartini,
H. Rölli, W. Steinbrunn, U. Binswanger
Sections of Nephrology and Cardiology,
University Hospital of Zurich, Switzerland
In order to evaluate the degree of physical
activity in patients (pts) treated with HD and
CP,PD we assessed the working capacity (WC) by
bicycle ergometry (BE) in 16 pts on HO (mean age
47 + 12 (SD) years) and 18 pts on CAPO (mean age
44 + 10 years. In CAPD pts WC was measured in
addition to BE with treadmill exercice (TE).
Results (mean SD):
_________JHD
BE BE
WC (Watt
WC (% of
[ffation
normal values
of exercice(Min)
58+31
4F24
4.92
69+40
5225
6.l2
67+52
56133
5.23.2
In 27/34 pts WC was 25 % and in 14/34 pts.50 %
of age and sex matched normal values, respectively.
There was a significant correlation between BE and
TE in CAPD-pts (r = 0.73; p O.OOl). There was no
significant difference in WC between HO and CAPO
treatment. Exercice testing had to be discontinued
because of the following reason (ND-pts/CAPD-pts):
leg fatigue (10/10); reaching max. heart rate
(2/3); claudicatio interm. (0/2); others (4/3).
Conclusions: An acceptable degree of WC (- 25 % of
normal values) was found in most dialysis pts
(27/34) either treated with RD (12/16 pts) or with
CAPD (15/18 pts).
TRANSVENOUS DIGITAL SUBTRACTION ANGIOGRAPHY (T-DSA)
IN A-V FISTULAS -- A CRITICAL APPROACH
K. Konner, J. Tantow
Medizin. Klinik I,Köln—Merheim and Strahleninstitut
Prof. Hoeffken, Köln, West-Germany
In recent years T-DSA has become a widespread
angiographic method to examine a—v fistulas in
haemodialysis patients. Too widespread ?
We tried to find out the indications for T-DSA
in comparison with the commonly used angiographic
techniques, avoiding arterial access in any case.
54 patients underwent T—DSA since 1982. 0.6 mi/kg
contrast medium (CM)-TELEBRIX 380, OMNIPAQUE 350 -
were injected intravenously in the contralateral
forearm. Dialysis treatment followed angiographic
examination for elimination of CM.
DISADVANTAGES : 1. high amount of CM in functio-
nally anuric patients; 2. high costs; 3. visuali-
zation of only a limited area, sometimes requiring
a second series.
ADVANTAGES : 1. visualization of the arteries
after intravenous injection of contrast medium;
2. reliable information about the real haemodynamic
situation of a—v fistulas, especially of the anasto—
mosis itself, including morphologic and functional
alterations; 3. no falsification by issure cuff;
4. no superposition by bone structures.
Thus indicationfor T-DSA should be restricted
to investigate : 1. morphologic and functional alte-
rations of the arteries involved in the anastomosis
and of the anastoniosis itself (anatomic variations,
steal-syndrome, poor arterial outflow); 2. niorpho-
logic alterations within the first 3-5 centimeters
of the fistulated vein (stenosis, aneurysm).
Regarding these indications, the results will be
excellent, giving a reliable basis for surgical
rei nterventi on.
NEW SORBENTS FOR BLOOD DETOXIFICATION:
A MICROSCOPICAL STUDY
M.Kiremitci,E.Pjskjn(Intr. by M.Haberai)
Hacettepe University, Ankara, Turkey
In this study,the surface and the bulk structures,
and the bloodcompatjbjljty of new sorbents were in-
vestigated by microscopical techniques in order to
prepare a suitable sorbent system for blood detoxi-
fication.These sorbents were obtained by following
a radiation -induced polymerization procedure deve-
loped by us.Granular sorbents containing powdered
activated carbon,polyhydroxyethylmethacrylae and
polvethyleneglycol were prepared by i'-irradiatjon
technique applied at supercooled media. Sorbents as
black elastic spheres with different properties were
obtained by changing the relative amounts of ingre-
dients and the radiation dose.The surface and the bulk
characteristics of the sorbents prepared were studied
by means of a scanning electron microscope and an
optical microscope.Blood-material interactions were
also analyzed by following the same techniques. It was
found that the surface and the bulk properties such
as hydrophilicity,cross-ljnk density and porosity can be
controlled by changing the type and the relative
amounts of the ingredients and the radiation dosp,thus
sorbents with high sorption capacities and high blood-
campatjtjiljties can be obtained.
SERUM B2-MICROGLOBULIN IN PATIENTS ON HEINTENANCE
HEMODIALYSIS. THE EFFECT OF DIALYSIS I'IEMBHANE
S,Kostié, V.Djordjevié, N.Leió,V.Stefanovié
Institute of Nephrology, Faculty of Medicine,
Ni6, Yugoslavia
32—microglobu].j.n was found markedly increased
in serum of hemodialysis patients. The
aim of this study was to compare the
effect of dialysis membrane upon serum
B2—microglobuiin. Two types of dialysis
membranes were compared: cuprophane and
a highly permeabie_polyacrilonjtriie
(PAN) membrane. A group of 12 patients
was dialysed for 3 months on PAN membrane
1 - 1.2 sq.m. and then on cuprophanè
membrane for one month. Serum 82—
microgiobulin was 18.6 1.o and 22.7
1.3 mg/l, respectively (p<o.o5). Another
group of 12 patients was dialysed first
on cuprophane and then for one month on
PAN membrane, with B2-microglobuljr
values of 21.4 1.7 and 15.9 1.3 mg/i,
'espectively (p<o.o2)
This study has shown that serum B2-
microglobulin level was significant]y
lower in end—stage kidny disease patients
dialysed with PAN membrane than in
patients dialysod with Cupropharie membrane.
The biological implication of such a
finding remains unknown.
LPF'U
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ASP3ICX3RAPHY IN A-V FIJLAS AND PTFE GRAFTS FOR
H1DDIALYSIS
Z.Kraev,V.Hadjidekov*,E.Vazelov
dica1 Academy,Hezrodialysis center,Depa.rtnnt
of RadiologySofia ,Bulgaria.
We used angiography for visualization of the
anatomy of malfunctioning A-V fisthias and grafts(insufficient blood flow,aneurysms of the drai-
nage vein,for control of the grafts desoblitera-
tion) and preoperatively (underdeveloped vessels,previous attenpts for blood access).In oder to visualize the vessels s used several
riethods for introduction of contrast substance:
puncture of the vein close to A—V anastomDsis-1O;
retrograde arteriography by the mathod of Sel-
dinger-3 ;direct puncture of the artery-5;puncture
of the graft-9 and anterograde phlebography-32.The choice of the mathod depends on the expected
norphological changes.
We perforiied different imaging nethods 1OOnm
spot fiLTa,cinefistuiography,w fluomosccic
control in various proections .The application
of low ositic contrast substances reduces the
nuirber of the conplications and corrplaints of
the patients. 32 of all 60 investigations are
carried cut as preoperative phldographies .From
the remaining 28 investigations in 26 the angio-
graphically ascertained diagnoses-stenosis of
A-V anasthnc>sis ,aneurysm of the drainage vein,
stenosis and aneurysm of the anastonosis ,stenosis
of the anastorrosis beten the graft and the vein
and pulsating hernatoma close to the arterio-
grafts anastonosis prove correct in the course
of the surgical treatnent.
IS THE PDLC1GED Qr-INrERvAL IN THE EX33 DF
PATIHETS ON REl3ULl,R DIALYSIS TRFAThENI A
MANIFESTATION OF UREMIC LYNEU)PATHY ?
S.Krivoshiev, Z .Kirjakov,Sd½ntonov, S. Zlatarska ,E.
vazeiov
Idical Academy, Helmdialysis center, Sofia,
BulgariaIt is sell known that nost of the patients with
chronic renal failure (CRF) on regular henodialy-
sis treatnent exhibit a prolonged Qr-interval in
their E113. The investigation includes 38 patients
(24 males, 14 females) with CRF treated by henodia—
lysis with a nean age of 48,6 years. The average
duration of the henodialysis treatnent is 50,8
nonths. In 26 of the patients the c—interval is
longer than 0,425 sec.There is no statistically sig—
nificant difference in serum Calcium,Potassium,
MAgnesium, systolic and diastolic pressure between
the groups with prolonged and normal QTc. Prolon-
ged QT-interval in combination with hypocalcexnia
is detected in tvQo patients. Electrophysiological
investiqations of notor and sensitive files cif ii -
ulnaris and fibularis are carried out in all of
the patients. In 25 (I group) the nerve conduct-
ion velocity and distal latent tine are delayed
arid in 13 (II group) - normal. In the first group
only 3 patients show normal Pc-interval sthile in
the second group the arc-interval is normal in 9
of the patients. The nean duration of Qrc-interval
in the first group is 0,450 002 sec. and in the
second group 0,413± 0,026 sec. (p'0,001
The analysis of the results shows that elonga-
tion of the Q'rc-interval in the Eas of the pati-
ents with end stage renal disease treated by he-
nodialysis can be attributed to uremic cardio-
neuropaty.
COMPLICATIONS OF THE REVERSE A-V FISTULA
FOR HEMODIALYSIS
Z .Kraev, Z .Kirjakov, T .Velkovskj
Medical Academy,Hemodialysis center,
Sofia ,Bulgaria.
The reverse a—v fistula as a seconda-
ry vascular access for hemodialysis is
indicated in obese patients and
obliterated veins after previons vas-
cular access procedures in the forearm.
For the period of 3 years we
performed 51 reverse a—v fistulas
between branchial artery and basilic
vein.The following complications can be
mantioned:venous hypertantion in 2
fistulas,which resulted in liquidation
of the fistula in 1 case and a
reconstruction in the other;anevrisma].formation in some of the veins in the
forearm—4 ; internitent oedema—3 ;Hematoma
owing to wrong puncture—9;early tram—
bosis—2 :late trombosis—3 ;Steal syndrom-2
and infection-i.
Four(7,8%)fjstulas were liquidated—i.
Because of stasis dermatitis and
ulceration,1—bleedry from the anasto—
mosis,1—steal syndrom and 1 because of
anevrism.For this period 8 patients died
from complications of the essential
disease.
HYPERSENSITIVITY REACTIONS (HSR) DURING
HEMODIALYSIS (ND) IN FRANCE
F.Kuentz, M.Forat, T.Hachache, M.Christollet,
R.Milongo, H.Meftahi, E.Dechelette,O.Cordonnjer
A.G.D.U.C — BP 28 — LA TRONCHE — FRANCE
On the occasion of a retrospective survey into
112 HD units, 111 patients have presented one or
several HSR in the first minutes of HD session.
From this analysis, we can establish several points
— HER appears at any age, sex or MD treatment
duration.— Allergy previous history and/or hyper—
eosinophilia are more frequently noted in severe
reactive patients.— HSR can be reparted into three
groups : — minor (31/111) — medium (54) and severe
(26), four of them have been deadly dull.Treatment
of severe HSR is very urgent as like as anaphylac—
tic shocks.— Several mechanisms are evocated
(component activation, ethylene oxyde specific IgE,
leaching, shearing stress). The two first give
biological data with a variable proportion (12 2
ETO specific IgE in 33 reactive patients, versus
6,5 2 out of a group of 45 non—reactive patients).
(Biological investigation by H.LEMKE, ENKA AG).
But for the moment, we aren't able to conciliate
the importance of each mechanism. Since 1977, the
annual frequency of HSR seems to have been increa-
sed and was comparable with US—FDA in 1983—1984.
They occured with all the commercialized membranas.
Meanwhile, the frequency is more high with Cupro—
phan hollow fiber capillaries.— Material using
particularly the rinsing procedure have a determi-
ning effect since as 75 2 of HSR occured with an
insufficient rinsing procedure, untrue to the manu-
facturer original patterns. —HSR recurrence is pos-
sible with the same mode or with an aggravation
calling to be particularly careful into the choice
of the techniques and the checking of a dialysis
session with such patients.
LYNPHOCYTE FUNCTION IN CHRONIC HEIIODIALYSIS
P. Run, H. Rohler, T. Hlltteroth, N. Ueber,
IC—H. Neyer sum BOmchenfelde
Department of Internal Nedicine, University
of Naina, ERG. (Intr. by 0. HNffler).
Patients on maintenance hemodialysis show an
impaired immune response. 441 of the
patients do not show anti—HBs production
following vaccination with Hepatitis B
vaccine. In this study the in vitro immune
response of peripheral blood lymphocytem
(PBL) from uremic patients was compared with
normal controls.
PBL were differentiated into T4— and
TB—positive cells by immunofluorescence
technique with monoclonal antibodies, PBL
were stimulated uith lectins (ConA, PHA and
PUN)and allogeneic cells (NLC). Supernatants
of unfractionated cells stimulated with PUN
and PHA were tested for their IgG— and IL-2
concentration respectively.
Uremic patients had a marked lysphopenia
(1460 cells/pl) with a reduced number of T4+
and T8+ cells (802 and 492 cells/ul respec-
tively). The T4/T8 ratio was normal. Proli-
ferative responses to lectins and in NLC
were significantly reduced in the patient
group. Stimulation Index was 12 ye 46 for
ConA, 37 vs 88 for PHA, 13 vs 24 for PUN and
8 vs 23 for allogeneic cells (p < 0,05).
Normal B cells produced significantly more
IgG when stimulated with PUN (22 vs 240
ug/ml). A tendency for a diminished 11—2
production yam found hut this difference did
not reach statistical significance.
Our data demonstrate that in addition to a
pronounced lymphopenia functional
abnormalities in T cells exist accounting at
least partially for the observed immuno
deficiency in hemodialysis patients,
.
THE EFFECT OF THE EXTRACORPOREAL HEMOOIALYSIS
(HO) ON THE ENERGY TURNOVER
H. Lanqe, E. Krautwald, 0. Krautyald , H. Ebel
Tept. of Nephroloqy, Univ. of Marburg, F.R.G.
The effect of HO procedure itself(duration 2.75
- 4.5 hrs, 3.4 hrs; ultrafiltration: 0.3 - 2.0
kg, F = 0.96 kg; dialysate temyerature (temp.):
37°C) on the energy turnover [Qmetab Qrcc +
Qevapj was measured by direct calorimetry (metabo-
lic scale: evaporative heat loss LQevaP4; tempe-
rature computer: heat loss by radiation, convecti-
on, and conduction [QrccJ) on 14 patients with ESRF
(8 female, 6 male; 47—78, g = 62.2 yrs; Ccreatc
3 ml/min,). The measurements were performed
a) before (7.00 — 8.00 a.m.) and b) after HO
(2.00 - 2.30 p.m.). 7 healthy subjects (21 - 40
yrs.) served as normal controls (group N).
Qmetab Qrcc Qevap rectal
tem
[° C[kcal / kg / day]
HO a 28.9±3.1* 22.7*3.0 6.3±0.8 36.2±0.5
b 31.4±3.5* 24.5±3.3 7.0±1.0 36.8±0.4
N - 26.6±3,5 24.5±2.5 6.6±1.0 36.5±0.2
Conclusions: *pCO05
1. The hemodialysis procedure led to 10% increase
of heat loss.
2. An increase of the rectal temperature occured
simul taneously.
3. The increased heat loss calculated to be due to
an increased heat production rather than to
heat accumulation.
4. The energy turnover before HO in these ESRO pa-
tients was above that of normal controls.
INNUNE STATUS IN THE EARLY STAGE OF CHRONIC
RENAL FAILURE (CRF)
?_Rurg H. Rdhler, T. HUtteroth, N. Weber,
IL—H. Neyer sum BUschenfelde
(Intr. by 0. Hbffler).
Department of Internal Nedicine, University
of Nsinz, ERG.
Clinical and in vitro observations clearly
demonstrate an immune defect in patients
with end—stage renal disease, but little im
known about the immune status in patients
with the early stage of ORE. Uremic toxins
are unlikely to be responsible for the
observed immune defect in this stage of CRF.
We therefore studied the in vitro immune
response of peripheral blood lymphocytes
(POL) in 11 patients with impaired renal
function (creatinine 2—S mg/dl) compared to
normal controls.
PBL were stimulated with lectins (ConA, PHA,
PUN) and allogeneic cells. Proliferative re-
sponses were measured by 3H—Thymidine uptake
into the DNA of the cells. To measure B cell
differentiation as a result of T-B cell col-
laboration, IgG secretion by PBL in response
to PUN triggering was investigated. On stim-
ulation with ConA and PUN FBI. from patients
show a reduced proliferative response. Stim-
ulation Index (SI) was 42 vs 56 for ConA,
and 17 vs 22 for PUN (p(0,05). No signifi-
cant difference was found when PHA and allo—
geneic cells were used. There was a tendency
for a diminished IgU production on stimula-
tion with PUN (n.m.).
The data show that an immune defect can be
found very early in the development of ORE.
This supports the notion that other factors
than uremic toxins, like an intrinsic T— or
B-- cell defect, might be responsible for the
immunodeficiency.
URETHANES AS ETHYLENE OXIDE (ETO) RESERVOIRS TN
HOLLOW FIBRE DIALYSERS
F.F. Lee and E.F. Leonard,
(Intr. by N. Nedev)
Artificial Organs Research Laboratory,
columbia University, New York, USA.
Hypersensitive reactions during hemodialyaia
have been strongly associated with sterilsnt ETO.
Following the suggestion of Henne et sl (Artif.
Org. 8: 306 (1984)) that polyurethane potting
compound (PUPC) is, in hollow fibre dialymera, the
principai reservoir of ETO residues, we measured
diffusivity (U) and solubility (N) of ETO in 7
PUPC'a, at three different temperatures. We used
thin PUPC films in a permeation apparatus.
Results ahow ideal behaviour of ETO in PUPC's and
substantial variation in both D and H among the
different PUPc's. D's range from 0.6 to g aquare
microna per second. N's range from 0.05 to 0.16
reciprocal atmospheres. Results with Gambro PIJPc
used in computer simulation completely match
elutios curve reported by Henne. Study has
major implications for schedule of sterilisation
and holding before use of hemodialysers, as well
as for device design and choice of PUPC. Alter-
ation of sterilisation conditions and choice of
PUPC (so as to minimise H and temperature
coefficient of D) can strongly affect ETD reten-
tion. Reducing PUPc maaa and altering device
geometry ia less effective. Most long—term ETO
retention ia very near the surface of the part of
the PUPc mama not perforated by fibres.
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• PSYCHIATRIC MORBIDITY AND PSYCHOSOCIAL
ADJUSTMENT AFTER TEN YEARS OF DIALYSIS
C.M. i.e Feuvre, E.A. Brown, P.E. Gower
Departments of Medicine and Psychiatry,
Charing Cross Hospital, London, U.K.
R. baser, Department of Psychiatry,
Middlesex Hospital Medical School and
University College, London, U.K.
All haemodialysis petierits who started
treatment before 1975 were studied
(excluding those who had a functioning
transplant for more than a year). These
patients (age 29-67 years; 23 male, 5
female; years since 1st dialysis 10—18)
were studied using a standardized
psychiatric interview (Goldberg Clinical
Interview Schedule) and a measure of
psychosocial adjustment (Psychosocial
adjustment to illness scale — P.A.I.S.)
29% (8/28) were psychiatrically ill,l2
(3/28) of marriages had broken up. 64%
(16/25) were working of whom 48% (12/25)
were working full time.
In terms of psychosocial adjustment in
various areas, 95% (21/22) showed some
impairment in work, 86% (24/28) in leisure
activity, 84% (21/25) in sexual
relationships, 31% (8/26) in marital
relationships.
The point prevalence of psychiatric
illness in this group compares closely
(using the same interview method) to that
in a dialysis group on treatment for 1—5
years (31%) and to that of a population
attending a G.P.'s surgery (30%).
Although many patients experience
impairment in psychosocial adjustment, a
high proportion have intact marriages and
are still able to work.
.
EXTRA CELLULAR VOLUME (E.C.V.) AND BLOOD PRESSURE
IN 82 HAEMODIALYZED CHILDREN
Leroy D., Dechaux N., Guest 0., Broyer N., Sachs C.
Department of Physiology and Pediatric Nephrology
Necker Hospital, Paris, France.
Since 1979, 108 E.C.V. measurements have been
performed in 82 haemodialized children, 17 month to
18 year old (mean 10,4 + 3.9 years). Fourty five
determinations were performed in normotensive chil-
dren 31 in patients without Intolerance Signs (I.
S.) such as hypotension during dialysis, Group Ia,
and 14 in children with I.S., Group lb 63 E.C.V.
determinations were performed in hypertensive chil-
dren 14 in children with no hypotensive drugs,
Group II, 29 in children with high blood pressure
in spite of hypotensive therapy, Group III, and 20
in groups IVa and IVb corresponding respectively
ro treated children with normalized blood pressure,
without and with I.S. E.C.V. was evaluated by mu—
un distribution volume and was measured between
dialysis periods after I.V. administration of 50
mg/kg of Inulin. Mean E.C.V., expressed as percent
of body weight, are reported on the table.
Group Ia Tb II III IVa IVb
n 31 14 14 29 16 4
E.C.V. % 25.2 19.9 32 30.6 23.8 18.3
SD 1.8 2.3 4.0 5.5 2.1 1.3
Significant increase (p O.O01) of E.C.V. was
found in Group II and III when hypertension was not
controlled while E.C.V. was significantly decrea-
sed (p .0.OO1) in children who had I.S. during di-
alysis whatever the blood pressure level was.
From this study we can conclude 1) that the
'normal" E.C.V. values in haemodialyzed children
range between 22 and 29% b.w. 2) that this easy to
perform determination, can help the pediatricians
to manage the arterial blood pressure problems
often encounterred in haemodialyzed children.
SEPTICEMIA IN HEMODIALYSIS PATIENTS:CURRENT STATUS
X.M.Lens,J.M.Gatell,J.Montoliu,V.Araujo,J.A.MartI—
nez,J.López Pedret,L.Revert.
Dept.of Medicine.Hospital ClInic.Barcelona.Spain.
Over an 18 month period we carried out a pros-
pective study of sepsis(2 or more nonsimultaneous
positive blood cultures in an apprqriate clinical
setting)in patients on chronic hemodialysis(HD).
Thirty six patients(5.3 cases per 1000 treatment
months)were included.The same microorganism was
isolated from the suspected source in 55% of cases
Two groups emerged:A)Twelve patients developed
sepsis within 2 months of initiation of HD(repre—
senting 11.4% of patients entering HD during this
period).Eleven of these cases originated from a
subclavian catheter and most often involved S.Au—
reus(6/ll)or S.epiderrrddis(3/1l).B)24 patients deve-
loped sepsis after 2 months of initiation of HD.In
12 of these the source was the arteriovenous fistu
la(1.5 cases per 1000 treatment months)and in 5
additional cases the source was a subclavian cathe
ter implanted for mechanical problems.S.aureus(lO/
17)and S.epidermjdjs(4/l7)were the commonest isola—
tes.E.Coli(4/7)was the predominant cause in the
remaining,originating from the urinary tract(3/7)
or other sources unrelated to the vascular access.
Staphylococal septicemia was randomly assigned
to treatment with vancomycin or vancomycin÷gentamy
cm and no differences in outcome resulted.Others
were treated according to the suspected source and
sensitivity of the isolate.Overall mortality was
low(2/36,5.5%),and serious complications were limi
ted to S.aureus endocarditis(2 cases)and pneumonia
(1 case).
The vascular access,either temporary or perma-
nent remains the sajor cause of sepsis in HD pa—
tients.The prognosis is nowadays favorable in most
cases and vancomycin is a safe and effective thera
peutic alternative.
COMPARISON OF PSYCHOSOCIAL ADJUSTMENT IN
DIFFERENT FORMS OF DIALYSIS M.Blumenfield,
N.B. Levy, M. O'Brien, A. Goodman,
S. Weseley, NY Medical College, Valhalla,
NY, U.S.A. & C. Charytan & B. Spinowitz,
Booth Memorial Hosp. Queens, NY, U.S.A.
(Intr. by M. Strauch)
The psychosocial adjustment. of patients
on different forms of dialysis was ex-
amined by administering the Brief Symptom
Inventory (BSI) , Psychosocial Adjustment
to Illness Scale (PAlS) and Help and Daily
Living Form (HDL) to 200 randomly select-
ed patients treated at 2 medical centers
by center hemodi.alysis (CH), continuous
ambulatory peritoneal dialysis (CAPD) and
home dialysis (HH).Depression is significantly greater Inpatients on all forms of dialysis for
longer than 34 months compared to thosefor less than 34 months (p .01). Depress-
ion correlates positively with time on
dialycic irrospcctivo of gc (p .Cl).
Sexual adjustment is better for those on
all forms of dialysis less than 34 months
compared to those treated longer (p .02).There are significantly lower depression
scores of patients on HH as compared to
CH (p .04) . CAPD patients at Center B
have lower BSI scores than CH patients at
the same center (p .04)
This study shows there is less depress-
ion in HH as compared to CH and demon-
strates the influence of time on dialysis
in affecting psychological adaptation.
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ANYLOID DEPOSITS LOCALIZATION IN CARPAL TUNNEL
SYNDROME OF CHRONIC }IENODIALYSIS PATIENTS.
M.Lillo—Ferez, M. Petrover, P. Prieur, B. Allain
C. Dupommereulle. Cl.de l'Orangerie 93300 FRANCE
The last years, amyloid depomits (AD) has been
frequently reported in carpal tunnel syndrome(CTS)
of chronic hemodialysis patients (1,3,4,9.14).
These deposits are localised at flexor tendons and
synovium in the carpal tunnel.
CTS diagnosis was settled in 14 patients(5.5%)
among a group of 256 (140 males, 96 females) under-
going chronic hemodialysis between 1979 — 1984.
Sex, 11 females, 3 males, age 57 (range 6—174)
duration of treatment before symptoms 65,6 months
(range 6—162). Cause of chronic renal failure:
interstitial nephritis 3, polycystic renal disease
3, glomerulonephritls 3, hydronephrosis 1, others 3.
In operated patients, biopsies of flexor tendons
(IV or V), synovium and transverse carpal liga-
ment were performed. Pathological specimens were
studied with light microscopy which included
Congo red and Van Gieson stains for amyloid.
7 patients (50%) underwent 13 operations, 4
presenting bilateral CTS, 3 presenting unilateral
CTS and 2 recurrences. Among 13 flexor tendons
and synovial's biopsies we found AD in 11 of thea
(84.6%), in 5 of 9 biopsies (55.5%) of transversal
carpal ligament the identification of this sub-
stance was also positive.
We conclude that AD are a frequent finding in
CTS patients undergoing chronic hemodialysis,
they can be localised not only at flexor tendons
and synovial level but also very frequently at
transversal carpal ligament.
THE Efl'C./I V CESS OP DI'?REJT DIALYSIS
TflATMEIiT /folosiing by ee chrotatogra—
phy and mass epectrometry/
L.Lôcsey ,Z.Dinya ,ancl N.hauck
I.Dept.Ned.Univ.r4ed.Debrecen and Res.
Group and Antibiotic of Hungarian Acad.
Sd.
The authors studied the effectiveness
of the detoxification of uresic serum du-
ring haernodialysis,peritoneal dio13rois,ra
pid proressive ultrafiltration and hae—
rnoperfusion the combined utilisation of
the methods.
The composition or profile of uremic
serum was determined by ges chromatogra-
phy—mass spectroinetry /VG 7035 GC/NS sys-
tem/ before and after usinirn different
dialysis form.A dialysis ratio was estab-
lished for each dialysis form by the chro-
matogram of the patients.The ultrafiltra—
te and the peritoneal fluid was also pro-
filing by these methods.Comparing the values of dialysis ratio
and the gas chronmtographyd profiles of
ultrafiltrate and peritoneal fluid the
authors evaluated the effectiveness of
these different dialysis treatments.Ac—
cording to their investigations the most
effective treatment was the combination
of haemoperfusiOfl and haeodialysis /Ad—
sorba 300 0 and 1,3—1,5 m hollow fiber
kidney/ for the detoxification of urenjo
serum.
USELF(JLNESS OF ELECTROMYOGRAM IN CARPAI. TUNNEL
SYNDROME DIAGNOSIS IN PATIENTS UNOERGOIN() MAINTE-
NANCE HEMODIALYSIS.
M.LiIlo-Ferez, M.Petrover, P. Pricur, B.Ahlain,
C. DupOmmereulle.
Carpal tunnel syndrome (CTS) is a common
complication in chronic hemodiaIyss patients (CUP).
Its incidence fluctuates from 2% up 30% according
to differents authors (1,2,3,6,7,8,9,12,13,14).
A group of 256 patients (140 males, 96 females),
treated by chronic hemodialysis between 1970 and
1984 was studied. Elements of diagnosis were
a) nerve conduction study - electromyoqram (AIVAP.
average), sensory conduction velocity (SCV)440 if/s
distal motor latency (DML)4,5 rn/s h) symptoms
and signs : wrist pain irradiating to the radii]
side of the hand, paresthes i as, numbness, 1heriar
atrophy, Tinel's sign and Phalens sign. Cause of
chronic renal failure : (Jlomerulonephritis 3, inter-
stitial nephritis 3, polycystic renal disease 3,
hydronephros!s 1, others 3.
CTS was diagnosticated in 14 patients (c.).
11 females, 3 males, mean age 57 (range 4h-/,
duration of hemodialysis 87,2 months (rang h-I/ti),
duration of hemodialysis before symptoms f5,h rnnritti
(range 6—162). CTS was bilateral in 1? patients
85,2%). 13 surgical decompresslons were performed
in 7 patients (50%), 4 bilaterally, 3 unilaterally,
recurrences. CTS was confirmed in all eases by
anatomic compression, at dilferents dires, it
median nerve at carpa I tunnel level
In all cases tested, electric fund oil wa
affected several months before clinical manifes-
tations, 3,7 months (range 1-11).
We conclude that eleetrics alterations founds
t electromyographic study of CTS in CUP is a
ljseful element in early diaqnosis ni Ui syndrome.
POLYMORPHONUCLEAR LEUKOCYTES( PMN) CHEMILIJMINESCENCH
(CL) AS AN INDEX OF MEMBRANE BIOCOMPATIBILITY(BIo).
L. Luechi, M.A. Acerbi, C. Cappelli, M. Leonmrdi,
E. Lusvarghi.
Nephrology and Dialysis Unit, University Hospital
Modena, Italy.
Various methods have been used to evaluate
RIO i.e. white blood cells count, complement
assays, PMN aggregability adherence and degranula—
tion, coagulation assay. We used PMN phagocytic
uctivity evaluated by CL to study 810 of Cuprophmn
(Cu), Cellulose Acetate (CA) and Polyacrylonitrile
(AN69—S). Resting PMN CL and maximum response
after opsonized zymosan addition have been
examined before (A) and after 1 hour (B) of
dialysis. 10 patients on chronic haemodialysis
were studied during a single treatment with
each membrane. With Cu there is a significant
increase of resting value in B (A = 54 6 cpm
x 103/106 PMN, B = 75±18; pO.Ol) and a signifi-
cant decrease of maximum response (A 990
B = 786 51; p 0.01). With CA there is
n increase of resting value (A 53 5,
B = 93 p .O.Ol) and no difference in maximum
response. With AN69—S there are no significant
variations in both determinations.
Obtained data represent an evaluation of
an intracellular metabolism alteration which
can be due to: dialysis membrane—blood cells
interaction, particles released from dialyzer,
or a soluble stimulus particularly GSa. Our
study points out CL as an usefull test in 810
evaluation of dialysis membrane.
Abstracts 343
CALCIUM CARBONATE(CC) AS PHOSPHATE BINDER IN CHRO-
NIC HEMODIALYSIS(CHD) IS IT OF BENEFIT ?
A.J.Luik,P.E.de_Jong,W.Geerlings,G.K.van der Hem
State University Hosp.Groningen,the Netherlands.
CC as phosphate binder has been advocated,not—
withstanding the potential risk of hypercalcemia
(EDTA 19;784,1982).Since we were forced to with-
draw CC frequently because of hypercalcemia,we
studied retrospectively whether it could be predic-
ted which pat, will develop hypercalcemia and
which will not. 15 Subjects were included on the
following criteria:1.in CHD since 2 months or more
;2.no change in aluminiumhydroxide(A1OR3) and di—
hydrotachysterol(DHT) at least 2 months before the
start of CC,till the end of the study;3.one or
more determinations of sCa,sPO4 and AF before the
start of CC. A1OH3 dose was 3.8(med,range 0.0—15.5
gr/d);DHT dose 0.25(0.0—1.0 mg/d);CC dose 3.0(1.5—
3.0 gr/d).Only one pat. did not use DHT.sCa rose
from 2.32 ÷ 0.13 to 2.72 + 0.44 mmol/l and sPO4
fell from 2.73 -f 0.80 to 2.19 + 0.75 mmol/l after
one month CC. 8 Pat, had a rise in sCa of either
twice the SD or to more than 2.75 mmol/l.There
was a significant correlation between the reduction
of sF04 and the rise of sCa (r=0.72,pco.0l).The
reduction of the Ca x P product was significant
(pO.O5) but small(10%).The subjects who had hy—
percalcemia were not different from those who did
not,with respect to age,time on dialysis,sex,sAF,
sCa and sPO4 before CC therapy or dosage of CC and
DHT.
We conclude that Calcium Carbonate in this dose
has only a small,although significant,effect on
both sPO4 and Ca x P product.Since moreover this
effect on sPO4 is frequently accompanied by hyper—
calcemia and since this rise in sCa is observed in
particular when the fall in sPO4 is more pronounced
we consider the use of CC of little value in the
'reatment of hyperphosphatemia in CHD.
INHIBITION OF ANAPHYLATOXIN ( ) RELEASE DY COOLI
HG THE BLOOD WITHIN THE DIALYZER.
!4aggiore Q., Enia C., Catalano C., '4isefari '1,, Nun
do A., Creazzo 0., Zaccuri F.. Centro di Fisiologia
Clinica del C.N.R. Reggio Calabria . Italy.
During Cuprophan HI) the cellulosic rnemhrane cau-
ses activation of' the comp]ement alternative path —
way(CAP)wjth A release(C3a,CSa). Since activation
of CAP has been shown to be tempèrature(T)depencjent
investigated both in vitro and in vivo the effect
of low T on A release, C3a and C5a were determined
by RIA(Upjohn). Plasma of normal subjects was incu-
bated in vitro with Cuprcphan membrane at T ranging
from 23 to 37°C. C3a and C5a release was strongly
related with T changes(r 0.00) ,being markedly blun
ted at 23°C. In vivo atudies were performed in 7
pts on regular I-ID. Cool HD was accomplished by ma—
nipilating extracorporeal blood and dialysate T
such as blood T within the dialyzer averaged 25°C.
C3a and C5a release and WBC count were measured bo—
th during cool and standard HO in the same pts.
Maximal changes in WBC count (arterial line) and
C3a and C5a (venous line) occurred after 15 of HO.
Standard—HO Cool—HO
Pre 15'
WBC x 103mm3 8.40 2.98
C3a pg/mi 0.20 3.60 0.16 1.59 *
C5a ng/mI 7.00 49.00 5.5 8.1
Standard vs Cool HO at 15'. Student's t test
** p<O.Ol * p<O.05 °p(O.005
Arterial Pa 02 decreased less in cool HO,the dif
ference being significant after 1 hr( —10 va —27 mm
Hg;p(0.05), while PaCO2 was simiiar.We cortcludethat
cool HI) attenuates A release and leukopenia.
INCREASED DIETARY FIBRE INTAKE IN PATIENTS WITH
CHRONIC RENAL FAILURE
S.I.McKenzie, A.Turner, I.S.Henderson(Intr. by A.C.Kennedy)
The Queen's College, Glasgow and Glasgow Royal
Infirmary, Glasgow, U.K.
Chronic renal failure patients are
traditionally treated with a diet which is low
in both protein and fibre and high in fat and
refined carbohydrate. This diet probably
contributes to the high incidence of cardio-
vascular and intestinal problems which occur in
these patients.
We investigated the effect of changing the
standard diet for chronic renal failure to
include a higher fibre intake. A total of 30
patients were studied, 10 each on haemodialysim,
continuous ambulatory peritoneal dialysis and
undialysed chronic renal failure (creatinine
greater than 700 umol/l), and received a high
fibre diet for 6 weeks followed by a 9 week
post study period.
There were no significant changes in routine
biochemical parameters although some individual
subjects had lower serum ureas during the fibre
period. Lipoprotein profiles were unaffected.
Constipation, which affected al the patients,
was abolished by the extra fibre and a higher
fluid intake was possible.
We conclude that a significant increase in
dietary fibre can be a useful adjunct in the
dietary management of chronic renal failure.
DIALYTIC TOLERANCE AND METABOLIC ASSESSMENT
OF ELDERLY PATIENTS ON BICARBONATE RECIRCULATING
DIALYSIS (BRD)
G. Malmusi, 0. Cappelli, S. Fantuzzi, L, Furci,
M. Leonelli, L. Lucchi, A.M. Savazzi, E. Lusvarghi
Nephrology Unit, University of Modena, Italy
In 10 patients aged 57—76 years, in acetate sin-
gle pass dialysis since 4 to 67 months,we evaluated
dialytic tolerance and metabolic assessment before
and during a 12 months period of 40 liters BRO.
Dialysis time was reduced from 12 to 10.5 hours
weekly and dialysate was regenerated by an activa-
ted charcoal and allumosilicate cartridge.
We observed a marked and stable decrease (p<O.Ol)
in vomiting and collapse, a decrease in dry body
weight (from 57.2+17 to 54.3+17), together with
an increase in pre (from 91,7 to 106.2) and post
(from 86.4 to 101.2) dialysis mean arterial pressu
re. The lowest intradialytical mean arterial pressu
re rose from 68±15 to 88 Muscle cramps were
unchanged. The need of hypertonic infusions was mar
kedly reduced. Biochemical data showed a temporary
increase of urea, creatinine, uric acid, albumin,
colesterol and triglicerides, which returned to ba-
seline within the observation period. A steady in-
crease was observed in alkaline phosphatase and
total proteins. Serum Ca and P remained unchanged.
RBD allows also in elderly patients a good intradia
lytic vascular stability while metabolic pattern
remains unaffected in a long—term evaluation,
Pre 15'
8.20 6.13 **
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EFFECT OF BICARBONATE HEMODIALYSIS ON CARDIAC RHYTHM
C.Manno,M.Stella,C.D'Agostino,E.Squiccimarro,F.RSchena
2nd Medical Clinic, Polyclinic, Ban, Italy.
Cardiac arrhythmias(AR) in hemodialysis(HD) have
been related to rapid changes of blood pressure and
ion concentrations. We studied 82 patients(pts), 33
normotensive(NT) and 49 hypertensive(HT),on acetate
HD.According to the Lown classification,AR were divi
dad into low and high risk;furthemore,AR were divi
ded into dialysis—associated AR(DAA) and non—diysia—
dependent AR(N]JDA). 24 hour dynamic ECG Holter was
recorded on the day of RD. An average follow—up of
5.1±2.7 months was executed in 10 pta put on bicarbo
nate RD and in 12 pta treated with antjarrhythmic
therapy.High risk NDDA and DAA were more frequent in
HT(242 and 16%) than in NT pts (12% and 3%)(p<O.Ol).
Low risk NDDA and DAA were found in 27% and 24% of
NT pts, in 6% and 16% of HT pts. Furthermore, NDDA
was mainly represented by high risk AR(6l%),while
DAA were characterized by low risk AR(69%)(p<O.05).
The follow—up in 10 pta with cardiovascular instabi
lity and DAA(high and low risk), who were put on bi
carbonate MD, showed an improvement of AR, acidosis
and dialytic tolerance. By contrast, the follow—up
in 12 pts with high and low risk NDDA, who received
drugs alone, showed an improvement in only 7 pta.
These findings suggest: a) high risk AR are more
frequent in 1-IT pts, b) high and low risk DAA may be
caused by cardiovascular instability, c) bicarbonate
I-ID may improve DAA without using antiarrhythmic
drugs.
T I 11 Tlfl
u:- . ( :L))
:rt± -Tatao, A. Fochsr :iartin
S. 3uataonte Bustanante.
Gervicin de PefroloGia. os)iercl ilniversitarin.
soul t:oi Ge i icjaa, Talilaciolid. is-ada.
:raco elocentc; 'DiaOmStjc levels in PG have
been studied in numerous occasinnu. Put it
binding to the pleamatic proteina in PG has not
been ifer. reortel, In this parer the proteinbinding of cadmium, copper mnci leaP (Gd.Cu.?b.)
and its plasmatic levels in PG will be studied.2 atier.ts in HG with an average age of L2 13
years old, being 36 11 veeks in iii) have been
dialyzed, during 4 hours 3 times per weeic with
a 1,2 m' cunroehan rnembrane.l7 healthy tersons
yearn old are the control groun. I'he Cd.Cu.Pb. valorations have been done by atomi ab-
sorption spectromotometry with graphite cham-ber. The plasroatic protein distribution were
studied by eromatogranhic, froctioning of serum
in Gerhadex 0—150 treated with BH4Tia and follow
by an analysis of trace elements in the frac-
tions obtained. HO
Controls p before p after
Cdg/dl 0,50,l<0,Ol 0,i±C,2 n.m. 1,00,3
Cu Lg/dl lC729 <0,01 131—22 <0,501 134—47
Pbg/dl 233 <0,001 114±17 n.m. 116±14
Cd binding appears in 3 peaks of the fractions,
being 60% in the albumin. Cu appearsin 4 peaks,
being the moat importaat the one corresonding
to the ceruloplammine with 60% and the others
corresponding peake with lC)d,20% and 10%. The
Pb appears in the peak corresponding the pies-
antic components of proteins of low molecular
weight. These results suggest an increase in
the Cd, Cu and Pb values in SD and Pb binding
to low molecular weight proteins with the pos-
sible toxic effects of these oligoelements.
Modification of neutrophil metabolism
during hemodialysis.
M. Markert, C. Heierli, J.P. Wauters.
Division of Nephrology and Laboratory of
Clinical Chemistry, University Hospital,
Lausanne, Switzerland. -
To define the role of oxygen radicals
in hemodialysis (HD)—induced neutrope—
nia, chemiluminescence (CL) was used to
assess the oxidative metabolic potential
of neutrophils collected at 0, 5, 15 and
60 mm. after the start of an RD ses-
sion. Twelve patients were studied. Du-
ring HD with a cuprophane membrane, the
cells remaining in circulation at 15
mm. (6%±1 SEM) showed when isolated a
significant decrease in CL as compared
to predialysis values, while they res-
ponded to opsonized zymosan (68%±13),
phorbol myristate acetate (49%±14), or
zymosan—actjvated plasma (41%±11). With
dialyzer re—use the CL responses were
normalized. Dialyzed cells in autologous
plasma without stimulus showed increased
resting values with a maximum response
at the nadir of neutropenia. The same
pattern was seen when control cells were
incubated with dialyzed plasma.
Conclusion RD with cuprophane alters
the oxygen radical production of neutro-
phils at the cellular level and simulta-
neously produces plasma factor(s) stimu-
lating the chemiluminescence responses
of dialyzed and control cells. Since
dialyzed neutrophils show an impaired
response to zymosan—activated plasma,
these plasma factor(s) appear to be dif-
ferent from C5.
HIGH EFFICIENCY HAEMODIALYSIS.
F.Mastrangelo,S.Flizzelli ,C.CorlianA,L.Alfonso,V.De
Blasi ,M.Napoli ,M.Aprile,A.M.Montinaro.
Nephrology Dept. "V.Fazzi Hospital. Lecce,Italy.
It has been calculated in the last years that
the optimal goal should be the greatest removal of
uraersic toxins performed in a limited period of ti-
me,It has been also affirmed that these goals can-
not be obtained either with traditional short dialy
sic or with efficient short dialysis (problem of
the vascular stability).
In recent years(1975—l983)we have performed on 113
patients a program of heHD characterized by l)mhort
(10.5—12 hours a week) dialysis time, 2) shortened
dialytic interval (48 hours), 3) high dialyzers sun
faces(S /S ratio 0.8—1.2). High efficien
cy has rid on the basis of Sargents in
dcx and Dialysis index (D1) that was 1.3—1.7 (short
HD D1 1). The vascular stability was corrected by
bicarbonate—dialysis performed extensively (on 57%
of patients). The favourable clinicel results are
the following: 1) Very good compliance (diet free-
dom, short dialytic sessions); 2) Low mortality; 3)
Very poor incidence of ischemic cardiopathy or
heart death; 4) Good control of hypertension, anne—
rnia and neuropathy.
In conclusion, short dialytic sessions with grea-
test removal of uraemic toxins may be performed and
are well tolerated by the patients. Such treatment
represents an alternative to hemofiltration owing
to the satisfactory clinical results and a more re-
duced cost.
IS REDUCED DIALYTIC PROGRAM RESPONSIBLE FOR ISCHE—
MIC HEART DISEASE IN UREMICS 7
F.Mastrangelo, S.Rizzelli,C.Corlianô,L.Alfonso,V.De
Blasi ,M.Aprile,M.Napoli,A.M.Montinaro.
Nephrology Dept. °V.Fazzi" Hospital. Lecce, Italy.
An increase in coronary disease and myocardial
infarction is reported in patients on ROT. Glucose
intolerance, hypertriglyceridemia and hypertension
are considered responsible factors. Recently, the
short HID program has shown a high incidence of mor
tality owing to myocardial infarction.
113 patients on high—efficiency HO (heHD)(3 hours e
'ery other day, 1.4—1.6 mq dislyzers), 15 patients
on standard dialysis and 10 patients on ultra—short
dialysis (2 hours every other day) were mtudied.The
incidence of coronary disease was evaluated on the
basis o:t the following parameters: 1)Clinical trou-
bles (episodes of infarction and angina pectoris);
2) Analysis of the electrocardiograms (a monthly e—
lectrocardiogram was performed for 2 years at
least); 3) Helter study for 48 hours. The adequacy
of the dialytic treatments was evaluated by Babb In
dex and Sargent's single—pool urea model. The pa-
tients on heHD show a more reduced incidence of co-
ronary disease in comparison with the patients on
ultra—short dialysis: myocardial infarction 1.8%,
angina pectoris 1.8%, ischemic cardiopathy 8.3% (by
electrocardiographic study) and 12% (by Hotter stu-
dy). Deaths owing to heart disease represent 20% of
the total causes of death. On the basis of these re
suits, it can be hypothesized that the reduction of
the diaytic progral could be responsible for the
high incidence of coronary disease.
SUB-CLINICAL CNS INVOLVEMENT IN HAEMODIALYSIS
PATIENTS EVALUATED THROUGH NULTIMODALITY EVOKED
POTENTIALS.
C. Meloni, N. Taccone_Gallucci*, M. MorOsetti*,
M.G. Marciani*, P.M. Rossinio*, M. Caramia**, G.L.
Gig1i* and C.U. Casciani.
Istituto CUB L'Aquila, Clinica Chirurgica* and
Ilinica Neurologica 2nd University of Rome, Italy
The presence of sub—clinical CNS involvement in
14 haemodlalysis patients (mean age 38.8 years;
range 15-57 years) has been evaluated through mul-
timodality evoked potentials (EPs) recording. All
patients were dialyzed three times weekly for an
average of 51.2 months (range 6—145 months) each
session lasting 4 hours, with cuprophan membranes.
Visual evoked potentials (VEP5)were alterated in
6/28 eyes (21.4%). Brainstem acoustic evoked poten-
tials (BAEPs) were abnormal in 4/28 ears (14.3%).
Median nerve somatosensor'y evoked potentials (MN—
SEPs) were aiterated in 7/14 (5CF/o). Peroneal nerve
somatosensory evoked potentials (PN—SEPs) recorded
at spinal and scalp levels were abnormal in 2/14
legs (14.3%). Altogether multimodality evoked po-
tentials displayed a defective nervous propagation
in at least one of the investigated sensory path-
ways in 10/14 patients (71.4%) despite the absence
of clinically evident neurological deficits. The
various degree of involvement of different sensory
pathways, gives some information on the possible
mechanisms of uraemic encephalopathy.
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HPLC STUDY OF CUPROPHAN HOLLOW—FIBER DIALYSERS EX-
TRACTS DETERMINATION OF AN OPTIMAL RINSING PRO-
CEDURE
H.Meftahi, J.C.Renversez*, M.Fort, T.Hachache,
F.Kuentz, R.Milongo, M.Christollet, E.Dechelette,
D. Cordonnier
A.G.D.U.C. - BP 28 — LA TRONCHE
* BIOCHEMISTRY LABORATORY A, Pr EM.Chambaz,C.H.R.U.
GRENOBLE
Different procedures were used to rinse Cupro—
phan hollow—fiber dialysers. Eluates were obtained
from 62 dialysers from 7 manufacturers and analy-
zed by high pressure liquid chromatography using a
T.S.K. 125 G.2000 column, calibrated with dextran
polymers — Several peaks were obtained. Those cor-
responding to substances with a molecular weight
between 1000 and 20.000 daltons, or over 20.000dal—
tons were studied.
A. Comparative study showed quantitative differen-
ces between dialysers from different manufacturers
or between different batches from the same manufac-
turer.
B. Different rinsing parameters such as duration,
static or dynamic mode, temperature and volume were
studied — 1° Extraction of the peaks studied incre-
ases with duration, temperature and volume and was
higher when a static mode was used — 2° The effect
of these parameters was additive — 30 The parame-
ters that were the most effective on extraction
were the temperature and a Static mode — 40 After
an apparently complete rinse had been obtained, a
new prolonged Contact with fluid was able to extra-
ct more substances (release or regeneration?).
C. These findings led us to propose a rinsing pro-
Cedure for hollow—fiber dialyser, using the para-
meters that appeared to be the most important, i.e.
a high temperature (37°C) and static mode.
OTONEUROLOGICAL ANALYSIS OF BRAIN-STEM AU-
DITORY FUNCTIONS IN HEMODIALYZED IJREMIC
PATIENTS.
B.Flemoli, E.Cassandro°, A.Dal Canton, L.Sequino°,
C.Saulino°, G.Fuiano and V.E.Andreucci.
Dept of Nephrology and °Dept of Metodology of Com-
municative Sciences, II Faculty of Medicine, Univer-
sity of Naples, Italy.
While uraemic damage to peripheral nerves is
well known, the effects of uraemia on central ner-
vous system are not well understood. In this study,
the effects of uraemia on both peripheral and brain-
stem auditory pathways were evaluated in 12 nomal-
ly hearing patients under regular dialysis treat-
ment. The patients underwent the following tests:
pure tone audiometry, speech reception threshold
and speech discrimination (SSI of Jerger and accele-
rated tests), masking level difference, computeri-
zed acoustic impedance measurements (tvmpanograms,
acoustic reflex threshold), electronystagmography
and auditory brain-stem evoked potentials (ABR) to
11 and 51 pps frequency rate (this test is specific
for central auditory function). The results were
compared with standard data obtained from normal
hearing subjects. Analysis of results showed a re-
duction of the performances to SSI test and a slo-
wer central conduction time evidenced by an increa-
se of ABR wave V latency (p<O.O5) and ill-V inter-
wave (p<O.Ol) to 51 pps frequency rate.
These results indicate that uraemia may cause
damage to central nervous system, which may be evi-
denced, even in the absence of overt symlptoms, by
highly sensitive tests.
Abstracts
CARPAL TUNnEL SYNDROME IN HEMODIALYSIS PATIbNTS.
A.NichelottiP.Argentiero,G.Coccio1o,P.Paparatto,
R.Bigazzi and G.Baldari.
Servizio di Nefrologia e Dialisi,*Divisione Neurolo
gica, Livorno.
Cai'pal tunnel syndrome(CTS) has been observed fre
quently in patients on chronic hemodialysis (ND).
513 patients(20F,361:) had been treated with lID for
periods ranging between 5 months and 12 years, 4—5
hours three times per week,thrcugh an en—to—side pa
dial a—v fistula, and were asked about tIre occurren
ce of symptoms suggesting CTS. One patient,(dialytic
age ii years)roferred these symptoms on the fistula
side, and CTS diagnosis was confirmed by neurologi
ccl examination, including nerve conduction studies
showing bilateral involverient of median nerve. Of
55 psi tents referring no symntomstic evidence of CTS
only those undergoing ID for longer than C yearn on
d,r:wenl detailed nerve conduction study.11 patients
oly ic sean age ti.2+1 .7 'ears)entered the study.
;us3 1 out of ii patients showed a oerangernet only
on the uistuls miLls. line nerve conduction wrrs nor'
ri rtnd per] pheral neurooeliiy war: clinically exclu
itoh. in coIrciuston 1) Suhjcc ive symptoms of CiT
shows ii low occurrc:'rco( 1. 371) in gc'nersi population
and o ego og ID . 5) Dersogernri of' wed i at nerve con
hoc jOlt a lud jew unrein ted :.o peripheral neuropattry
oh se 'yen 1 27 of ;r nyn ':000] Ic pat 3 en a subr U ted
:0 loop— len: 57. 3) her"re COLhoc ori a miii as should
ire nerfornea in oil pst ion a undergo jog long-- l,e't,i
in order' Lu exel UriC tire OCCUrrenCe of 0Syriiiufll0
in 7Th.
ELECTRON MICROSCOPY IN BIOCOMPATIDILIT' SThDY OF ThE
DIALYTIC MEMBRANES.
V.A.Mioli,R.Tarchinj,p.Castelli,E.Bordonj,A.Sbarbati
C.Balicchia and S.Cinti.
Nephrological Center and Human Normal Morphology Dpt,
Umberto 1st University Hospital, Ancona, ITALY.
The present study was carried out to evaluate the
biocompatibility of the dialytic membranes (DM) by
the scanning electron microscopy (SEM), by the chan—
gem of the white cells and platelets count, and by
the behaviour of the C3, C4, Clqb complement frac-
tions. A 1 cm2 wide section Cut from the initial,
middle and final site of each DM was observed.
48 samples from capillary (3 cases) and linear (4 c)
PAN, capillary (3 C.) and linear (3 c.) Cuprophane
and capillary Cuprananoniurn rayon (3c.) were observed.
The technical dialytic parameters (time, rinsing,
volume, ThIP, QB, QD, heparin protocol) were the sa-
nte in all patients. We report and discuss some pre—
liminarv observations: A) there is no significant
changes (Student t test and p) in the blood parame-
ters; B) all the DM revealed debris consisting of
platelets, fibrin and blood cells, but hollcM fibers
had much less deposits than the linear DM, and the
surface free from debris is higher in Cuprananonium
rayon and PAN than in Cuprophane; C) the study of
the degranulation of the platelets sticked to the
membranes (observed by trasniission electron micro-
scopy) do not seem to suggest a "real incompatibi-
lity.
RYPERPROLACTINET"IIA IN UREMIA: THE ROLE
OF HEMODIALYSIS AND P.tRATHORMONE
S.Milutinoviá,D.Ornié,V.Grljui,
B7N'adiniä ,K.Stilinovié ,V.Molnar
Center for Dialysis,J.Kajfe Hosp,
Zagreb, Yugoslavia
To investigate factors underlying hy—
perprolactinemie and menstrual disturban-
ces on hemodialysis(HD),plasma prolectin
(Prol),LH,FSH,oestrediol,progesterone and
C—terminal parathorrnone(PTH) were follo-
wed throughout the menstrual cycle as
well as before and after 5—hour—dialysis
in 27 female regularly dialysed patients
(pts)(age:2o—45 years). 14 women had re-
gular menses (C)(only one with an adequ-
ate Prog rise), 6 had menstrual irregula-
rities and 7 secondary amenorrhoea(A).
Pts with A bad higher Prol level when corn
pared with those with regular menses
(49,ll vs.39+9,p<o.o5).HD induced an
acute rise in Prol for 2o% (46+22 post—
vs.38÷18 predialysis,po.ol)being more
marked in pta with A than in those with C
(29 vs. l29),p<o.o5). There was a corre-
lation between Prol and PTH predialysis
(r.O.8o8,p.(o.ol) as well as between FPH
and the proportion of the pts having A.
Conclusion: HD—induced rise in Prol con-
tributes to hyperprolactinemja and is
involved in menstrual disturbances on RD.
There is a link between hyperprolactirie—
mia and hyperperethyroid ism in pta on
regular dialysis.
EFFECT OF ULTRAFILTRATION RATE ON NEUTROPHIL
METABOLIC ACTIVATION
Mon R., Triolo L., De Sole P."
Istituto di Clinica Medica, Fisiologia Umana
Iiniversitä Cattolica del Sacro Cuore, Roma, Italy
During hemodialysis circulating polyrnorphonuclear
leukocyte(PMN) undergo several kinds of stresses
with secondary activation measurable by means of
chemiluminescence(CL). After an early complement
dependent phase(l), a more prolonged activation is
promoted as a consequence of ultrafiltration(2).
Only during complement activation leukopenia isob-
served. In this communication the effects ufstepise
increase of ultrafiltration rate(QF) on PMN-CL are
reported.
5 uremic patients have been dialyzed with increa-
sing values of QF during the dialytic session.
A proportional increase of PMN-CL has been observed:
time QF resting activ.
sin mi/h cpm/1000 PMN
0 0 68±19
20 0 241±49
45 0 75±24
75 200 117 28
105 700 165 19
135 1200 225
This behaviour reminds the observation by For—
strom et al.(3) of a correlation between the amount
of hemolysis and the ultrafiltration rate.
The clinical importance of the observed pheno-
menon remains unsettled.
1. Craddock et al.,N.Engl.J.Med., 83(1977) 769
2. Mon et al., J.Europ.Soc.Art.Org.,1,suppl.1,
(1983) 154
3. Forstrom et al., Trans.ASAIO, 21(1975) 602
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stimul. activ.
cpm/l000 PMN
1075 188
1324 - 283
1534 242
1509 391
1822 278
2009 786
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EFFECT OF 1st HAEMODLALYSIS AND RENAL TRANSPLANT
ON SERIAL MULTIMODALITY EVOKED POTENTIALS.
M. Morosetti, M. Taccone—Gallucci, C. Me1oni,
P.M. Rossini**, M.G. Marciani**, M. Cararnia**,
F. Zarola** and C.U. Casciani.
linica Chirurgica and Clinica Neurologica ** 2nd
Jniversity of Rome, Istituto CNR L'Aquila , Italy
The nervous propagation characteristics along
different sensory pathways (visual, acoustic, upper
limb and lower limb somatosensory) was investigated
by means of serial multimodality evoked potentials
recording before and after the 1st haemodialysis (6
patients) and renal transplant (2 patients).Pre—
treatment recordings were compared with those
obtained after dialysis (24 hours and 30 days).
°ost—transplant tracings were recorded after
normalization of plasma creatinine levels (<.1,3
mm). Alterated pro—treatment evoked potentialshave been found in 4/8 patients. At 24 hours after
dialysis control, multimodality EP5 returmed to
normal values except for sciatic nerve conduction
velocity. In 1 case a worsening was found at 30
days fellow—up. More remarkable ameliorations were
found after successful renal transplant. Multisy—
naptic sensory pathways as tested by visual, andbrainstem acoustic evoked potentials showed the
higriest sensitivity to variations of perineuronal.
environment provoked by the 1st haemodialysis and
successful renal transplant.
LACTATE/ACETATE BUFFER BASE COCKTAIL FOR
HEMODIALYSIS. Z.M. Nawab, J.T. Daugirdas, T.S. Ing(Intr. by P.T. Ivanovich). Hines—Loyola Medical
Center, Hines, IL, USA.
It has been suggested that if dialysate aoetate
concentration is limited to 20 mM, high plasma
levels of acetate do not occur. In this study,
seven stable hemodialysis patients were dialyzed
(1$—hour treatments) in a double—blind fashion using
isonatric dialysate buffered with 140 mM acetate (A)
140 eM lactate (L) or a 20 mM/20 mM mixture of
acetate and DL—lactate (LA). Each patient served
as his own control. Results were as follows
lh 2h 3h 14h 5h 148h
APO2 (A) — 8.1 —14.7 —7.5 —8.6 —5.2 +1.2
(LA) —5.0 —6.0 —1.6 —14.6 —2.14 —1.2
(L) ÷2.14 +0.14 —2.6 +1.14 —1.14 +14.0
PCO2(A) —2.14 —1.8 —0.9 —0.7 —0.3 —1.14
(LA) —1.5 —0.9 —14.8 —1.5 —0.9 —3.0
(L) —3.0 —3.2 —1.9 —3.1 —1.9 —1.5
pH (A) .02 +.0I4 s..O5 +.O7 +.07 .00
(LA) .00 +.O1 +.O14 +.O1I +.07 .00
(L) —.01 —.01 0 +.02 ÷.014 —.05
HC03(A) +0.6 +1.3 +3.0 +14.3 ÷145 —0.8
(LA) —0.8 +0.3 +0.3 +1.9 +3.9 —0.3
(L)
—2.3 —2.0 —1.1 —0.7 +1.1 —2.3
The pH and HC03 values at hours 2—4 were signifi-
cantly higher for (A) than for (L) (p < 0.05), but
these differences were less apparent at 5 and 148
hours. The pH and HCO3 values for (LA) were bet-
ween those ror (A) and (L). A trend (non—signifi-
cant) toward lesser hypoxemia with (L) was noted.
The results suggest that lactate, or a buffer
base cocktail of lactate/acetate might be a useful
substitute for acetate as a bicarbonate—generating
base. Base gain might be adjusted by appropriately
tailoring dialysate lactate levels, while either
completely eliminating acetate, or limiting the
amount of acetate to 20 mM.
K MODELING IN ESRD PATIENTS TREATED WITH CHRONICAL
HEMODIALYSIS
A.Murisasco, Y.Boobes, R.Elsen, M.El Mehdi, M.Baz,
C.Durand, A.Crevat, J.P.Monti, J.Fondarai
(Intr. by J. Pollini)
C.H.U Hôpital Ste-Marguerite . Mapeille. FRANCE.
We developed a 2 comparment K model describing
intra- and interdialytic K kinetic in order to
quantify individal adaptation of K dialysate
concentration (K Di) during hemodialysis (HD). Our
goal is to avoid intradialytic appearane of non
phsio4ogical intra— to extracellular K gradients
(K'i/K e), normalis ormaintain total body K
(K t) and .improve K homeostasis.
We have done a clinical study on 21 stabe H.D
patients measuring K 'balance, taking into account
dietetic K and oral exchange, resin intake. With
numerical and regression techniques we evalute the
parameters entering into the kinetic equtions of
the model .Therefore we+can now predict K e in
function of time and K Di using a simulation
program. This technique allows H.D to roced
without intradialytic early or late (K iK e)
related arythmia, avoids intradialyti K t
depletion and eliminates iatrogenic K surplus or
deficit. It also helps to understand K
distribution in insuline dependent diabetic H.D
patients, control on dietetic K intake and
adapt oral exchange resin. +
We conclude that a better K homeostasis wish
minimum variation of intra- to interdialytic K e
can be obtained through an asociation of
intradialytic adaptation of K Di 'based on a 2 pool
model and interdialytic ietetic measures to adapt
oral exchange resin to K intake with the model as
a 'control.
IATROGENIC CARDIAC DAMAGE DURING HAEMODIALYSIS
V. Nikolov, Z. Zepcevska and L.J. Veterova
(Intr. by Dr. G. Masin)
Clinic for Nephrology, Faculty of Medicine,
Skopje, Yugoslavia.
We want to indicate the possibility of damage
of cardiac function during chronic intermittent
haemodialysis. 45 patients were analysed with
chronic renal insufficiency who were treated by
means of chronic intermittent haemodialysis at
the Department for chronic haemodialysis at the
Clinic of Nephrology at the Faculty of Medicine
in Skopje. In our conclusion we emphasise that
in spite of an improved haemodialysis and
monitoring, the unwanted effect on the cardio-
vascular system could not be avoided, especially
in older patients and in metabolic diseases.
There existed a correlation with the effective
blood volume, coronary blood vessels, electrolitic
disbalance, blood picture. It is necessary to
check the parameters of haemodialysis through
the individual protocol in each patient.
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S HYPERPHOSPHATAEMIA IS CONTROLLED BY ORAL MAGNESIUM
CARBONATE WHILE ON ZERO MAGNESIUM DIALYSATE WITHOUT
ALUMINIUM BINDERS
O'Donovan N, Monitz C, Baldwin D, Rogerson M,
Parsons V
Renal Unit & Department of Chemical Pathology,
King's College School of Medicine and Dentistry,
London, 5E5 9RS, UK
Twenty six patients on haemodialysis were
switched from aludrox to magnesium carbonate for a
year. To prevent hypermagnesaemia the patients
were dialysed against the dialysate containing no
magnesium. Monthly samples were taken for analysis
pre—dialysis.
Dialysate Mg 0.S0mtnol/L 0.Ommol/L Sig.
Plasma Mg 1.02±0.02 1.08±0.2 NS
Plasma P04 1.92±0.2 1.92±0.8 NS
-,
.-4
Plasma Ca
Plasma Al
Plasma K
Plasma Cr
2.47±0.12
2.23±l.9x10
5.69±0.5
1.214
2.2±0.3
l.26±0.3x10
6.2±0.3
1.194
NS
0.001
0.1
NS
Hyperphosphataemia is difficult to control and
the first trial of magnesium hydroxide was
unsuccessful because of diarrhoea. 5, 7.5 or lOg
of Mg(C03)2 is better tolerated and is not absorbed
to any extent as shown by no more excessive
concentrations of magnesium in the plasma than when
the patients were on aluminium hydroxide. The long
term effects are slightly higher plasma potassium,
probably due to displacement from intracellular
pools by the magnesium. Aluminium concentrations
have fallen and in some patients haemoglobin has
risen over a six month period. Parathyroid hormone
status is still being assessed.
THE EFFECTS OF LARGE DOSES OF BIOTIN ON ANEMIA
AND DRY SKIN IN REGULAR HEMODIALYS1S(HD) PATIENTS
K.Ono and S.Doi
Ono Geka Clinic & Fuso Pharmaceutical Industry
Fukuoka and Osaka, Japan
Biotin deficiency is rare in clinical medicine,
but may be important in the treatment of chronic
ND patients. This study was performed to clarify
the effects of biotin supplementation on anemia
and skin humidity in 10 MD patients. Plasma biotin
levels have been measured by bioassay and skin
humidity by a dermal humidmeter before, duting &
after treatment with oral biotin, 6 mg daily for
11 weeks. Ten unsupplemented HO patients and 10
healthy subjects served as controls. In treated
patients, plasma biotin levels were significantly
increased as shown below: (ng/ml)
Biotin Pre—treatment 11 weeks
6 "s
Pre—HO
Post—RD
2.7 0.4 233.2 55.8
148.7 37.2
Pre—HD 2.2 0.5
none Post—ND
Healthy controls 0.4 0.1
Pre—treatment mean Hct of the supplemented group
(27.4+1.7%) gradually increased to 31.4+3.1%
(p(O.05) after treatment for 11 weeks, while un—
supplemented patients showed no change in Hct. The
mean skin humidity score of HD patients(0.5±0.Ol)
was markedly lower than norxnals(8.2±l.5) and not
improved by biotin supplementation. Although the
mechanism of action needs to be further clarified,
these results suggest that biotin supplementation
could be a useful method of improving the anemia
of chronic MD patients.
3 Y.RB EXPERIENCE 0 HaBll40DLLYBI3
T.L. 0d.utola, S.B. Ositelu, 0.B.C. Onuzo, A.F.B
Maba4ae, La.s University Peohig Hospital/
o11egs of Med.ioine, ieria.
The dialysis Centre at UJTH was incerted in
November 1981. Between then and November 1984,
we have dialysed a total of 148 cases (85 males,
63 fenlos and 3 cases of barbiturate intoxication)
Chronic renal failure cases totalled 78 and acute
cases 70. Chronic cases invariably presented in
ESRF with creatinine clearance 5 mis or less per
minute. Renal biopsies in 6 cases showed EZRD in
4, chronic glomerulonephritis in 1 and focal
glomeruloscierosis in 1. All the CRF cases
presented with moderate to severe hypertension
lmea B? 24/16 kPa supine, 24/17 kPa erect) grade
I to II retinopathy and mild to moderate degree
of cardiac decompensation. aeptioaemia was
responsible faD 43.5% of Primary and Seoorid.ary
causative factors of ABP.
The dialyming machine is ixtracorporeai DM201
positive pressure batch tank system using coil
dialyzer 1z23, 1x25, Rx29. 1 Gaaibro Parallel
plates and hollow fibres are also used with
Gambro negative pressure adapter AK—z1RM. Femoral
vein eanriulation and shunts are used for PRF
whilst shunts rnd fistulae are used for CRF as
access routes.
Dialysis associated complications are shunt
infection 5%, peritonitis 2%, bu-rst membrane 5%,
suspected pyrogen reaction 2%, fernnrai vein
perforation 2%. Our mortality for ARF is 34.5%
and CRF 67.)6 as compared to 7t and 105%
respeotively before the inception or the Centre.
RELATIONSHIP BETWEEN ABSENCE OF ANAEMIA & RENAL
CYST FORMATION IN HAEMODIALYSIS(HD) PATIENTS
K.Ono, K.Kikawa, T.Okamoto, & H.Matsuo
Ono Geka Clinic, FUkuoka Tokushukai Hospital &
Fukuoka Univ. School of Medicine, Fukuoka, Japan
This study was undertaken to try and elucidate
why 5 out of 60(8.3%) chronic HO patients main-
tained a normal Hct(44.$jl.l%) over 2 consecutive
years. Various clinical & biochemical parameters
were compared with the 5 MD patients with the
lowest Hct(23.3*O.8%). In addition,renal & splenic
size were measured by computed tomography(CT) &
sonography. These investigations also allowed an
evaluation of the number and size of acquired
renal cysts. The size of the kdieny was calculated
by multiplying the three longest dimensions of the
organ on CT scanning or two dimensions on sono—
graphy. All patients are anuric and liver enzymes
are normal. Some of the results are sununarized:
Both CT scans & sonography demonatrated increased
volume of contracted diseased kidneys in the high
Rct patients. In conclusion, these findings
clearly demonstrated that patients with normal
Hct have an increased level of erythropoiesis
secondary to high erythropoietin output which may
originate from kidneys enlarged by cyst formation.
4.5 + 1.2
4.2 1.1
Groups High Hct
Rticu1ocyte index(%) l5.S±2.l**
PTH (ng/ml) 7.0±3.2
Aluminum (MCG/L) 53.6±7.0
Erythropoietiri (MICU/mi) 73.8±11.0*
Size of kidney (on CT) 209.2±32.6*
(on sonography) 44.li4.6**
*.p<005 **:p<OOl
Low Hct
6.5±1.0
13.1±6.7
56.0±13.8
35.8±7.0
134.0±12.0
26.4±1.4
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EVIDENCE FOR ARTERIAL HYPERTENSION (HT) AS
ISOLATED CARDIOVASCULAR RISK FACTOR IN
HEMODIALYSIS (HD).
L. Orte, F. Garcia, R. Matesanz and 3. Ortudo.
Centro Raxndn y Cajal. Madrid. Spain
In order to ascertein the role of HT on
mortality in MD population a comparative clinical
study was carried out between 17 cardiovascular
dead patients on HD —group A (10 m. and 7 f.; mean
age 46 14 y.; mean time on HD 29 19 m.); and
a control group (B) selected similar in sex, age,
time or MD, and nephropaty. At entry, the
percentage of previous hypertensives and smokers
was analogous. There were no statistical
differences in biochemical cardiovascular risk
factors at any moment. We evaluate all over MD
evolution: sistolic (BPs), diastolic (BPd) and
mean blood presure (BPm) at the beginning and end
of all sessions; interdialysis overweight, and
need of antihypertensive medication.
Predialysis session BPd and BPm were lower in
group B (p<O.ol), nd with a lesser significance
(p(0.O5) predyalisis Bps and final BP records;
differences confirmed all over MD evolution.
Thirteen group A patients (76%) needed
antihypertensive drugs and only 9 patients (53%)
from group B; nominotension was achieved in 70%
group B patients, and 23% group A (p(O.Ol) . No
statistical differences were found in overweight.
Arterial hypertension in HO, and specifically
predialysis BPd and }SPm, is identified as the
most important factor in cardiovascular
continuous risk evaluation of these patients, and
its control need priority.
BIOCOMPATIHILITY STUDY OF COLLODION COATED CHARCOAL
HAEMOPERFUSION (HP) VERSUS CUPROPHANE MEMBRANE
HAEMODIALYSIS (HD).
R. Oulès, C. Granolleras, 0. Treissède, B. Brsnger,
JP Balducchi, M. Trellis, J. Fourcade.
Nephrology Department, CHRU Mimes, France.
HP has been proposed as an adjunct for HO and
collodion coated activated petroleum charcoal is
claimed to have a good biocompatibility and a
highly efficient extraction of organic compounds in
uraemia, In view of a longer use we compared one
single 3 hrs HP to 3 hrs HO in 10 patients on
regular dialysis treatment. Results for bio—
compatibility study will be presented.
HP was performed with 255g charcoal (3 Diakart
cartridges in series) after the longest week inter—
dialytic interval and HD study was one week before
or later. Total heparin dose was 149±35 lU/kg for
HP and 09±32 lU/kg for HO. Blood samples were
drawn for blood cells and platelets counts,
complement CHSO, C3 and C4 at time 0, 5, 15, 30, 60
and 180 mn. White blood cell counts (WBC) were
perfornwd on 520 cells.
After 15 mn, HO was associated with a sharp
decrease of WBC (—70*11%) which was not observed
with HP (—5±7%)(p<O.0O1)—Neutrophils exhibited the
same pattern, eosinophil count increased after
15 mn HP but decreased with HO. Thrombocyte count
decreased by 9.6% (p>O.05) and by 40.1% (p<O.OOl)
respectively after IS and 180 mn HP, compared to
4.4% and 16.1% increase with HD (p> 0.05). No
correlation was found with heparin dose. Complement
CH5O levels changed slightly : —10.4% and —4.6%
after 15 on, —9.6% and +12.7% after 3 hrs with HP
and RD respectively, with a similar pattern for
C3 and C4.
These data suggest a dffeent blood surface
intersetion related to eitheit the membrane—
corloolon vs cuprophane— or its steriiizing agent.
HIGH DOSE NANDROLONE DECANOATE THERAPY ON
THE ANEMIA OF HEANODIALYSIS PATIENTS
— A muiticenter double—blind comparative study —
K. Ota*, N. Mimura, S. Koshikawa, H. Mizoguchi*
* Tokyo Women's Medical College, Tokyo, Japan.
Many reports on the clinical efficacy of
anabolic hormones on genal anemia have been
made in the past however none is available on
studies addressing the relationship between the
dose of androgens and clinical efficacy.
Therefore a multicenter double—blind comparative
study was performea on 190 patients on
heamodialysis to determine the differences in
the effects on hearnatocrit level, heamoglobin
concentration and RBC following the administration
of nandrolone decanoate 100—200mg/wk to one proup
and 25—SOmg/3wk to a separate group. Alter 14
weeks of treatment all three parameters were
significantly (p<O.OO1) better in the high dose
group, with no significant increase in the
incidence of adverse effects.
We concluded that the effect of nandrolone
decanoate is dose—dependent, however adverse
effects are not, therefore, the use of the
drug in high doses is desirable.
EVONED RJTINPIALS IN DIALYSED AND TRANSPLANTED PATIENT'S
Pagani C., Zoorle C. , Ojaita MC., Altxjnico G., Bazzi C.
Fellin G., Sorgato C., DAnico
Lathratory of Clinical Neurophysiology, Nepartoont of Neurology
and Nepartnwnt of Nephrology and Dialysis, S. Carlo Borrcxneo
Hospital, Milan, Italy.
Uremic Encephalopathy (U.E.) has been investigated with Brain-
Stern Auditory Evoked Potentials (BAEPs), FLASH Visual Evoked Po—
tentials (FLAS VEPs) and LED Psttern—Reversal VEP5 (PR VEP5) in
iCa pta in Regalar Dialytic Treatment (Rtlr) since 4—192 moths;
16 transplanted pta have been studied with the sane methods.
There are only respectively 22.4% and 33.3% of norsol audiograrra
among dialysed and transplanted pta; hearing loss is mostly (84%)
perceptive, coohlear in type. BAEP5 latencies and interlatencies
are normal in transplanted and in normal hearing herrodialysed
pta, without any difference in relation to dialytic age. Inclu-
ding the pta with hearing loss too, BAEP5 are on the average
still in the normal range but the pta in RDT> 82 moths have
BAEP5 slightly sore impaired than the pta in ROT < 82 moths: this
difference is probably caused by the peripheral pathology (mostly
cochlear), slightly sore severe in the sdsgroop of older dialytic
age. BAEPs are proper to showing brainsters damage (and particu-
larly brsinsters auditory tracts damage); they are almost nonmal
in our pta and this excludes brainstern damage in U.E., contrary
to same other previous studies that seamed to suggest it.
Flash and LED PR VEP5 are sigeificantly and markedly inpaired in
dialysed pta ccrnpared to controls and transplanted pta that are
ronral.
VEP5 are sigeificantly sore carprossised in long term dialysed pta
carpared to short term dialysed ones.
VEP5 are a fairly good index of U.E.
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ThIPrE1VE.lENF c*' FiST—DIALYSIS GUKI38E IRIOIERANE BY CAiIfl(c)
NJPPIEIATIc'I IN DLSLYSIS FLuID.
Panzetta G. ,Tessitore N. ,Valvo Enrico,Lupo A. ,Ioschisvo C. ,Ol—
drizzi L. ,Fabris A. ,Gmrnoro L. ,Rugiu C. ,Bellotti Z.and schio
G.
Divisione di Nefrologia. UniversitA di Vervna.Veroria,Italia.
It has been reported that carnitine (C)adndnistration to dia
lysis patients inproves the synptcme of the "post-dialysis syn—
drc*ne'in seem of thmn.To elucidate the biochemical mechanisew
of C action, we sindied glucose metabolism in 15 stabilized dia
betas-free patients(9 F. and 6 N. aging fran 32 to 65 years)in
basal conditions (pre HD)and at the end of tan different 4—hours
acetate (38 rrNoJl) dialysis, one performed without (post ND),
one with 35 n*bl/ml C (post Car HD)in the dialysate.
I.v.glucose tolerance tests (0.33 g/kg b.w.)gave the follo-
wing results:
pre HI) post HE) post Car ND
K: 1.93+0.87 1.01+0.32 1.38+0.8
Nene of the patients, but one, had glucose intolerance in
pre ND (Kw 1.2). Glucose tolerance in post HO was sigificant1y
reduced (p O.COl), with a diabetes—like pattern in seven pa-
tients (K< 1.0). Glucose tolerance in post Car ND was sigifi—
cantly irrproved aben conpared with post ND (p0.O1).
Or sthdy deeonwtrstes that the hecradialysis session causes
a sigpificant sorsening in glucose metabolism, which can be im—
proved by the supplementation of the dialysis fluid with C.This
suggests that the C losses during dialysis tony be partially re-
sponsible for the observed glucose intolerance. We provide evi—
dence of a positive biochemical effect of c in dialysis, which
alt be related with the iccproveciwnt of the dialysis syiptocra.
REGULATION OF THE PLASMA PHOSPHATE CONCENTRATION
IN ANURIC PATIENTS
H. Pogglitsch*, W. Estelberger**, W. Petek***, E.
*Medical Clinic,** Institute of Medical Chemistry,
Institute of Biochemistry, University of Graz,
Austria.
During hemodialysis or hemofiltration, the
concentration of inorganic phosphate does not fall
below the normal range, irrespective of its initial
concentration or the duration of the dialysis
treatment. From the behavior of the phosphate con-
centration we concluded (Proceedings EDTA 1984)
that ist must be the result of two separate me-
chanisms: passive diffusion and active mobiliza-
tion from a phosphate pooi which prevents the in-
organic phosphate level from falling below a cri-
tical value.
In order to confirm this hypothesis, a mathe-
matical model was fitted to the phosphate con-
centration tiwe courses clinically observed in
patients during and after dialysis. The system
characteristics indeed revealed two principally
different kinds of behavior: constant phosphate
delivery dominating at high levels, whereas at le-
vels below a certain threshold a concentration-de-
pendent mechanism comes into operation.
The regulation of the plasma phosphate con-
centration is apparently a basic physiologic pro-
cess which becomes evident in (normophosphatemic)
dialysis patients. The independence of phosphate
regulation from calcium homeostasis was demonstra-
ted by the simultaneous determination of the para-
thyroid hormone and calcium concentrations.
• THE EFFECT OF CALCIUM CARBONATE ADMINISTRATION ON
NITROGEN METABOLISM OF PATIENTS ON HEMODIALYSIS
Papadoyannakis N.J. ,Stefanidis C.J. ,Patrikarea A.,
Kotsovasilis K. and Georgiopoulou A.
Division of Nephrology,Athens General Hospital —
Athens 156 69 — Greece
It has been suggested that one of the responsi-
ble factors of increased protein catabolism in ure-
mia is metabolic acidosis.To study the effect of the
correction of metabolic acidosis on protein metabo-
lism various parameters were compared before and
after a period of calcium carbonate supplementa—
tion(CCS).
During the initial 3 week period of observation
the nutritional status of eleven patients on chro-
nic hemodialysis was assessed from home food recor—
ds,anthropometric and biochemical measurements.
Only 3 patients had a low protein intake(<lgr/
kg/day)and 2 of them had inappropriate calorie in—
take(<80% of the ideal).To spite of this,9 out of
the 11 patients had a mean value of protein catabo-
lic rate(PCR)greater than that of their protein in—
take(PI).A rositive correlation of P1 and PCR was
found(80.61t,p0.O314)indicating reliability of the
assessment of home food records.The mean values of
pH,serum bicarbonate and calcium increased signifi—
cantly(p=0.0002,0.002 and 0.001 respectively)after
8 weeks of CCS(2— g/2)4hr).In addition,predialysis
serum urea and PCI) decreased significantly(pO.11t
and O.32)despite the fact that P1 remained unchan—
ged.During the CCS period,a significant increase of
serum pseudocholinesterase(pO.0O3) ,transferin
(p=O.O1) and albumin (p=O.03) was documented.
These findings suggest that the correction of
metabolic acidosis in patients on chronic hemodia—
lysis improves protein utilisation.
DIGOXIN-LIKE ACTIVITY IN CHRONIC RENAL FP.ILURE(CRF)
INFLUENCE OF H[MODIALYSIS(HD).
M.Prga, J.Arenas, J.Estenoz, B.Miranda, C.Saenz
deT5Calzada, L.Ruilope, I.Santos, J.M.Morales,
J.L.Rodicio, A.Martinez.
Hospital 12 de Octubre. Madrid. SPAIN.
The presence of digoxin-like activity has been
described in CRF(1In the absence of treatment with
dipitalis derivatives the radioimmunoassay(RIA)for
diroxin canshow positive results that have been
iiterpreted as due to the presence of an inhibitior
of Na-K ATPase in plasma. lie have measured the le-
vels of diqoxin in a group of 17 patients without
digitalis treatment in ND, before and after a RD
session. The levels of dinoxin were measured by
two methods: RIA and immunofluorescence polarize—
tion(TOX—Abbott)IP). Detectable levels of dipoxin—
like activity were found by RIA in 12/17(70.5f) na—
tients(ranqe 0.10—1.15 ng/ml) and in only 2/17
(11.7i) patients by IP(1.14 and 1.75 ng/ml), before
HD(ri3.01). After the ND session was completed,
the RI/\ showed undetectable levels of diçjoxin—like
activity in 8 out of the 12 initially positive
cases and sirmificantly decreased values ii the
remaining four (rc<0.O1). These findings were accom-
panied by a sianificant loss of body weight during
the ID session(1.6±O.9 kg, p<0.O1). In the 2 cases
with diqoxin—like activity by IP one had similar
levels after dialysis and the other showed unde-
tectable values. These results indicate that:
1) II' is a more reliable method whenever digoxin
levels have to be measured in HO patietns.
2)Digoxin-like activity decreases after HO proba-
bly as a consequence of volume contraction.
(11; Ann.Intern.Med.: 1983; 99: 604-603.
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TREATMENT OF LIFE-THREATENING OVER-
HYDRTION IN CHILDREN WiTh RENAL
DISEA(3ES BY ISOLATED ULTRAFILTRATION
Z. Puretiô,A. Smetiko,S. Phurie,J,Grgas,S. Glava—Boras,Lj. Ceuk,
Z. Bratelj,M. Puretió
Dialysis Unit,TJrologic Clinic of
Nedical Faculty Zagreb,Yugoslavia.
Despite the development of power—
full diuretics,conditions of severe
overhydration in renal pediatric
patients present still a difficult
therapeutic problem.By classical method
of haemodialysis (lID) combined with
ultrafiltration it is not always easy
or is even impossible to remove
adequately excess of fluids.In recent
years the technique of isolated
ultrafiltration (IU) has been developed
which enables rapid elimination of
retained fluids without serious side—
effects.We have performed IU by
hollow fibre dialysers using standard
equipment for RD and negative
pressure aspiration pump.3l procedure
of ID have been experienced in lo
children whose age ranged from 2—15 y.
7 have had terminal renal failure and
3 other renal diseases.All had signs
of life—threatening overhydration.
Velocity rate of ultrafiltration has
been 14,3 ml/min mean,and previous
body weight (B) has been reduced
for l4,5 on average per patient
(at each procedure l,7—8,4c of Ri).
During the treatment there have been
no accidents,except temporarilly drop
in blood pressure,that could he
easily managed.
S VALUATI( (F VASCIJJR CILCI1)SIS R19( FACT(S IN I-LJ.WIPLYL{D
PATIENTS.Lpi)( (F IWL(LMI (F CALCIU4 CPRBGIATE IX)SES. RENAUO H,
611K A,BENELMOUFOK S,HERVE H,MORINIERE P,FOURWIER A —CHU - AMIENS
High doses of CaCO3 has been advocatedto control both hypocal_
cemia and hyperphosphatemia.Its influence on vascular calcinosis
is controversial.Therefore in 24 patients on chronic hemodialysis
taking variable doses of CaCO3(O—20 g/d mean 4,5 g/d)but no vita-
min D,profile radiographies of abdominal aorta and anteroposte—
nor radiographies of the pelvis were performed just before star.
ting hemodialysis and then 3 times every year.Vascular calcifica-
tions of the aorta and of the iliac and femoral arteries were
measured in mn 3 times by each of 3 independant observers.Calci-
fications were initially present or occured during the survey in
7 of 8 men and in 7 of 16 women.Simple cavariance analysis was
made to assess the link between various potential risk factors
and the relative increase of the calcifications during 3 years.
This analysis shows that male sex is alone a determinant factor
(Cc = 1.97,p<.01).Age is a risk factor significant only in the
male sex (Cc = 1.99,p<O.O1),whereas the covariance is bordereline
for female (Cc = 1.54,p<.06).Diastolic blood pressure(p<.05),
triglycerides(p<.05),plasma calcium(p = .08),glucose(p<.1O) and
phosphate(p = O.12)were covariant with calcifications extension.
However closes of CaCO3 were not covariant,nor the blood choleste-
rol or uric acid.Multiple covariance analysis shows that the mul-
tiplication factor of calcification increase was the following
when 3 significant risk factom were associated 3.25* for dias-
tolic * P Ca'cius * triglycerides;2.9 for diastolic * P Cal-
cium * glycemia;2.98w for F Calcium + triglycerides * glycemis.
For the association of the 4 factors it is 4.54(p<.002).
CONCLUSICNS : 1/Arterial calcinosis of hemodiaiyzed patients is
favored in both sexes,independently and therefore cumulatively,by
diastolic preisure,triglycerides,plasma calcium,glucose and phom—
ohate.Maie sex is an independant factor,age being a risk factor
Only in this sex. 2/CaCO3 is not per se a risk factor since its
doses are not covariant with calcinosis. Only hypercalcemia even-
tually md ced by CaCO3 is harmful.
CLINICAL RELEVAIiCE OF PLASMA ALUMINUM LEVELS IN RE-
LATION TO BONE ALUMINUM CONTENT
H. Raidt, H. Kellinghaus, M. Vischedyk, U. Graefe
Medizinische Poliklinik der WestfAlischen Wilhelms-
UniversitEt, Münster, F.P..G.
The impact of Al(OH)3 in oral phosphorus binders
on the development of encephalopathy and bone disea
se and the clinical relevance of plasma aluminum
(Alp) has been discussed quite controversially. The
half life of Al(OH)3 is prolonged in urenia.
We therefore investigated the correlation of Alp
and bone aluminum (Aib) in 56 hemodialyais patients
with a mean dialysis time of 69 months (Group I).
21 of them used reverse osmosis water pretreatLent
(r.O.) and ingested a mean of 3g Al(Oli)a/d up to
the sampling of bone and plasma (group rI). Another
16 patients used r.o. and did not take oral Al-con-
taining drugs for at least 20 days prior to the
sampling (group III) . Iliac crest bone biopsies
and plasma samples were obtained simultaneously.
l determinations were perforrred by atomic absorp-
tion spectrometry.
In Group I and II weak correlations are found
between Alb and Alp (r=0,73, p<0.01 and r=O.522,
p<O.OS). For group III, however, a significantly
stronger correlation is stated between Alb and Alp
(r=0.925, p<O.OOl).
These results reflect the necessity of sufici—
ently long intervala between the last oral Al-inta-
ke and the blood sampling. The intestinal absorp-
tion and the prolonged half-life of oral aluminum
compounds might otherwise interfere with the inter-
pretation of plasma aluminum levels. Only provided
that the different body cormaartments are in a
steady state, Alp levels are helpful to determine
the deor of Al—contamination.
INCIDENCE AND OUTCOME OF MALIGNANCY (N) IN PATIENTS
ON DIALYSIS PROGRAM (POP)
E. Riambau. J. Roma, E. Marcuello, J. Aubia, J. Llo—
veras, J. Masramon, J. Torrents and E. Rius
Hosp. Gral. Mollet, Hosp. Gral. M.D. L Esperanca
(Barcelona), Hosp. Gral. Igualada and Hosp. Ste Te—
cia (Tarragona), SPAIN.
In ord&r to determine the incidence and outcome
of M in POP we studied 404 such patients (224 males
180 femaLes; mean age 51.7 years) over a 6 years pe-
riod. They underwent either HO. IPO or CAPD during
an average of 34.2 m. The expected incidence of M
Tor the same number of indiviouais of tie smc uc
in non uremic spanish population is 4.86 cases whe-
reas we observed 11 N in 11 POP. 7 males; 4 females.
Age average 56.7 years. Average time on dialysis
37.9 m. Average time on dialysis previously to 1 di-
agnosis was 28.1 m. We excluded N appeared previous-.
Ly to the inclusion on dialysis or after transplan-
tation. Besides, none of them received immunossupre-
ssors. r-i diagnosis were: 1 kidney adenocarcinoma
(ADO; 1 orostate ADC; 1 bladder escamous carcinoma:
1 mixoid liposarcoma; 1 lung oat—cell carcinoma; 1
ovary ADC; 1 lymphocytic lymphoma; 1 escamous carci-
noma of vulva; 2 gastric ADC and 1 colon ADC. Exten-
sion of N when diagnosed was: localized in 3 cases,
regional in 2 cases and methastatized in 6 cases.
Treatment was carried out in 6 cases (3 surg: 2 surq
+ chem; 1 rad). 9 of 11 patients died (7 due to can-i
cer, 2 due to therapy complications) 1 to 22 m (ave-
rage 9.22 m) after diagnosis. The 2 other patients
are alive 8 to 17 m (average 12.5 m) after diaqnosi
Conclusions: 1) The N incidence in POP is 2.26 time
higher than that of spanish general population. 2)M
groups are difficult to compare but POP survival ra
tes seems to have a trend to poorer short term out-
come than general population. 3) Cancer therapy in
POP is associated with poor results and a high rateO comolication.
VL;OuLAR ACCCi3LJ COil rIE5IODILY i5 • TRC cL.SITT OF
STCNC:IC LECI0IL ITY P TTAIIECCT.3 TRMILUMIyAL
MlGIOPLJS°Y (PTA).
3.0, RodHasezP&ez;C.plaza;LI.lsrnsr;L.Pa1op;
II. Arrieta.
110 CPI'mAL lJ°tA. •.CA. DTI P120.— L.l PLTU2 J GRA!H
tAi;ARIA.— 38A1!T.
We set up a study in presence of failure from the vaz
oular access for hemodialysis, Cimino—Tirescia fitu—
O.ae (CB—V),Polietrnfluoroe±hylerue :rafts (l'rIY), Sa—
phena yrcofte ($0), The angioraphic study tIirouh bra
uia1 artery canalization, the use of ioxaf].ic acidiko a nesT contrast media as a diagnostic test, and
on the treatment of stenotic 1esios. Cle present
PTA results in 13/18 patients repulajly diallrsed —
over a peridd, of 9 months, duriny 1.984. 4 pttient
rerents with a poor peridalytic blood flow (( 200m1/
min). 8 patients presen4od Teith hidh venous blood pre
tjsure SaTiny henofialysis, and 2 ps:tionts had a diffi
tsult fistulae canalization. Tie coamsidered sapheniouso
Crafts within Cinino—Brescia fistulae roups. The an—
giorarhic findiny reveals: a) 'Tencu side otenoe
,f the ansstomoss in3 cases (03—F), and 2 cases —
PTFCT). b) Venous stenoses 1—5 cm. froor the anastonno—
in 10 canes c3—F) aid 3 coenes (F]TPD). c) Venous
ternooes rnor thar. 5 ore. irs 2 cares (03—li'). a) Venous
fleurisnso in 2 c-ores (03—F) e) Asymptornatic break—
blood synSrore is 2 cases (03—F). Alsre.ys length of —
snosesrere 0,5 to cr. 2 patients had succenive
tenose ins OLe vsaoua jde f areasLosrsors and. at 1—5
boo. 3 p.List: hLci r,Tore -Cisaus one oLoxsose located. 1—5
ton. fron t'su asstono s. PTA was performed smith —
trntzig as-nc5 OTheri 'nallooss cat}oeer inflated liw-to-reen
—10 tine succesively, 10—TO snccndc • P2A yarn sucoes—
fesi in 9/13 tenose, no chanyco in 2 end no serious
omp1iea-tcrs in f. PT is Cr effinorsi. therspy for ste
tsoo'as os vans' r rcoee:s inolisdir PT'' rafi ansci —a.la 0-5 T 1sere eo555 risc; sLurery.
AMALOID DEPOSIIS IN CARPAL TUNNEL SYNDROME 01 CHRONIC DIALYSIS
PATIENTS
U. Aotnlo, Ii. fisconti, S. Pinto
(Dna by A. Vercelione)
Istitute of lJrology, University of Palernu, Italy
Among 81 patients 5 developed a carpal tunnel syndrome (C(s),
mainly recognized on the hand with vascular access for chronic
h050dialysis. An other patient with clinical picture resembling
CTS was included for involved venous ref Due in the hand of AH
fistola. Six patients, vi chronic ialysis treatment for more
than five years received a suigical operative.
Clinical and electrosyvgrophic CIS was always discovered uni-
laterally, eecept in one case with three All fistolas in either
arms. After the incision of carpal ligaoent a dramatic inpra—
veriest of pain and parestheoiae was observed. Histeingical sec-
tions of epineuriem of the median stretched nerve and fibrous
connective tissue, stained with moon congo , showed a deposi-
tion of amyloid in three cases under fluorescent light
Furthermore a patient suffering from pain and paresthesiae
showed dystrophic cutoneaus lesions and functional impotency in
the hand with Al fistula. An electroneurographic ievestCgation
was normal. A simple legatare of dilated and congested dorsal
corpal vein healed the lesions described by stopping the venous
ref Ion.
In conclusion our results showed that n close relationship
exists betweea ITS aed the presence of an HA fictula, reopnmsi—
bin far segmental ischaemia of the median nerne from perfusianal
redistribution and that amyloid deposition was demonstrated in
three cases olong the epioenriun of the median nerve.
In our spinien secondary amylnidosis was probably due to
chronic infectian depending on persistant HBsAg eirus infection
in one old dialyved pt and scapala—hoineral periarthritio in tee
cases. lsteodystrophy and neurepathy were associated in all pta.
. HEMODIALYSIS: ONLY 6 HOURS ONCE A WEEK.
K. Roteliar, Nl E. Martinez, A. Plans, A. Ferragut.
Clinica Renal, Barcelona, Spain
With our device supporting surface of 5 2 of
hemodialysis, using sessions c: 6 hours per week, we
have obtained the following cearances:
Urea 156.960 mi/week
Creatinine —— -— 124.200 mi/week
Phosphate 110.880 mi/week
Uric Acid 158.400 mi/week
In conventional hemodislysis (a surface of 2.5m2
at 12 hours per week) the clearances are:
Urea 132.480 mi/week
Creatinine ———— 110.880 mi/week
Phosphate 100.800 mi/week
Uric Acid 106,560 mi/week
The 6 patients began in the program with this
device from 114 years to 6 months ago.
The average residual renal function was 4.4
mi/mm, the age between 23 and 69 years, and corpo-
ral surface was between 1.45 and 1.88 m2.
All followed a free diet, with a sodium restric-
tion in the hypertensive patients, and lead a nor-
mal life.
Clinical and analytical results are analogous
with conventional hemodiaiysim.
Surprisingly, the blood level of urea and crea-
tinine after 168 hours without dialysis are similar
to those for the interval of 72 hours after conven-
tional dialysis.
The quantity of creatinine and urea extracted is
more than that total which the patient has at the
beginning of dialysis.
The freedom and comfort for the patient is
greater, and the savings of program coat, transpor-
tation and worktime represents $ 8.500 per year
per patient.
EOSINOPHYLIA (El ,ELEVATED IDE AND ANTIBODIES TO
ETHYLENE OXIDE-ALBUMIN COMPLEXES (ETO-AB) IN
PATIENTS ON REGULAR DIALYSIS TREATMENT (RDT)
K.W.Rumpf, S.Seubert, A.Seubert, H.Ippen, F.Scheler
Departments of Medicine and of Dermatology,
University Hospital, Goettingen, FRG.
Hypersensitivity phenomena ranging from pruritus
to anaphylactoid shock during dialysis have been re-
ported.
We examined laboratory evidence of hypersensitiv-
ity in a group of 56 patients with end stage renal
d.ssease testing for E, serum IgE (ELISA) , and Eto—
Ab (RAST) and comparing patients on hemodialysis(HD)
and patients on hemofiltration(HF).
The incidence of E (eoainophils > 400/mm°) was
high (22.8%). Eoeinophiis were significantly (p<
0.051 higher in HD (n-45) than in HF (n=l1l patients
No relation existed between the extent of E and the
duration of treatment. IgE was clearly elevated in
8 patients on RD but only in 1 in HF.It was highest
in a patient with an anaphylactoid reaction during
RD. This patient also exhibited a very high activi-
ty of Eto—Ab, which were also found in 3 other
patients on RD (8.0% of patients tested)
Our results confirm the high incidence of
allergic phenomena in patients on RDT. In particu-
lar, the occurrence of Eto—Ab does not seem to be
a rare event and it may play a greater role than
hitherto suspected. The reason for the higher
incidence of hypersensitivity indices in RD
patients as compared to HF patients remains to be
elucidated.
352 Abstracts
Abstracts 353
SIGNIFICANCE OF HYPOXEMIA DURING ACETATE DIALYSIS.
SalvadeoA.; Segagni S.; Galli F.; Villa G.; Poggio
F.; Piazza V.; Sovio G.; Picardi L.; Grosoli M.*;
Petrella E.
Dialysis Dept. • Fond. 'Clinica del Lavoro", Pavia
* Beilco Laboratories, Mirandola Italy.
Some Authors hold hypoxemia during acetate dial-
ysis (AD) to be associated with peripheral tissue
hypoxia leading to intradialysis vascular instabili
ty. A previous study showed that hypoxemia follows
hypoventilation mediated by CO2 loss across the dial
yzer (30 ml/min/sqm). Here we verified how FaQ2
decrease affects 02 transport and consumption.
Nine patients were studied during three AD. The
following were evaluated t dialysis start, after
30 and then hourly: Pa02 behaviour (mmflg) , satura-
tion Hb02%, 02 content (volume/lOO ml), Nb (gr/dl)
oxygen consumption (V02 — ml/min/sqm) and external
ventilation ('1E - l/min/sqm)
LU2 loss across the dialyzer arid consequent pa02
drop (83 + 9.7 to 75.2 8) does not cause reduced
Hb02% saturation, which remains constantly around
93%. 0) absorbed from alveolar air remains constant
even with reduced 'E, as seen by the increased
ratio (39.2 + 10.4 to 49.2 + 9.9).
Our clinical results indicate that reduced yE and
PaO do not affect °2 transport and consumption; V02
and2respiratory quotient do not change significant-
ly.
PTH: PATHOGENETIC ROLE IN UREMIC AUTONOM]IC NEUROPA—
THY
V. Savica, 0. Vita, S. Rotondo, R. Cslabrdw, I.
Padovano**, L. Manna*, A. Toscano, G. Bellinghieri
Istituto di Clinica Medica, Neurologia a Farmacolo—
gia — UniversitA di Messina —.
Disturbances of parasympathetic heart control ha-
ve been demonstrated in patients with chronic renal
failure undergoing haemodialysis.However, the patho-
genesis of ureaic autonomic neuropathy is not known.
A debate exists in the literature about a postulated
role of parathyroid hormone (PTH) in the development
of the uremic peripheral neuropathy. Accordingly,
this study was designed to verify whether abnormali-
ty of cardiac parasympathetic function in uremica
may be correlated with plasma PTH levels. 9 haemo—
dialyzed patients from 3 to 121 months but without
other systemic diseases known to influence autonomic
pathways, examining changes in heart rate )Valsalva
manoeuvre, 30/15 ratio, 5—8 interval variation at
rest an6 during deep breathing) were stuiBied PTH le-
vels determined by 814 using anti—N—teroinal anLibo_
dy, and serum calcium, phosphate, alkaline phompha—
tase, choleaterol and triglycerides, were determined
PTH level appeared above normal range in 3/19 pati-
ents. Changes of autonomic control were noted in 20%
on Valmalva manoeuvre to 70% of subjects on deep bro
athing. PTH was found to be significantly correlated
with the dialytic age and with serum alkaline pho—
sphatase levels, while PTH levels did not show any
correlation with either mach autonomic teat or the
other serum parameters studied.It is concluded that
parathyroid hormone does not seem to play a role in
the etiology of oremic autonomic neoropa.ithy.
EFFICACY OF DILTIAZEM IN THE TREATMENT
OF DIALYSIS—ASSOCIATED ISCREMIC: HEART
DISEASE
P ..Salvini
Servizio di Cardiologia,Ospedale san
CamilloRoma, Italia.
we have used a new calcium—channel
blacker,4iltiazem,in the treatment of
dialycsis-associa ted ischemic heart di—
sease-(angina pectoris) in ten symptoma-
tic patients(.foux' men and six wonteni)...
of ten patients studied,eight were using:
short or long—acting nitrates associated
with others calcium—channel blockers or
beta—blockers,but they were still syinpto—
matic.Aftez' the use aE diltiazein alone
at usually recommended doses;,eight pa-
tients became soon asymptomatic whereas
two had to stop the treatment owing to
its adverse reactions or ineffectiveness,,.
We think that diltiazem is in a better
position to ef.icaciously remove the
hemodia].ysjs-induced events that mayprecipitate symptoms of ischemic heart
disease,than others calcium antagonists
are,owing to its mechanism of action on
myocardial contractility, increasingi
heart rate and coronary artery spasm,and
to moderate side—effects.
.
LEUKOCYTE ELASTASE - A NEW MARKER OF BIOCOMPATI8ILI-
TY IN HAEMODIALYSIS
R.M. Schaefer, A. Heidland, N.H. HOrl
Department of Internal Medicine, Universities of
Wurzburg and Freiburg, FRG
During haeaodialysis (ND) an activation of leuko-
cytes occurs, resulting in enhanced aggregation, and
augmented secretion of proteinases. Aim of the pre-
sent study was to evaluate the effect of different
HD—membranes on the release of granulocyte elastase.
Elastase was measured as an elastase—1—proteinase
inhibitor complex: E—1PI, using a higi1y sensitive
enzyme—linked immunoassay. 10 mm after starting RD
there was a marked fall of leukocytes with Cupro-
phan (—68%) , Polymethylmethacrylate (-16%) and Paly—
sulfon (—19%) . Polyacrylonitrile caused no reduction
in white cells. During RD there was a significant in-
crease of E-1PI with all membranes used. Cuprophan
(+420%) and Polymethylmethacrylate (+620%) displayed
the highest levels of E—. P1 whereas Polyacryioni-
trile (+280%) and Polysu1one (+200%) liberated mar-
kedly less E-1PI. Furthermore, the degree of leuko-
penia is not correlated with the increase of E—1PI
during RD. Thus, polymethylmethacrylate induced only
a modest fall of white cells, whereas the amount of
elastase liberated was highest compared with the
other membranes. In conclusions, these data demon-
strate:
1. The release of granulocyte elastase depends
strongly on the membrane used.
2. Different leukocyte functions (aggregation, libe-
ration of protminases) may be stimulated by diffe-
rent membranes at a different degree.
Therefore, the measurement of E—1PI during ND can
be used as a new and important parameter in the
evaluation of biocompatibility of dialysis mem-
branes.
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COMPARISON OF LOW MOLECULAR WEIGHT HEPARIN AND
STANDARDHEPARIN IN HARMODIALYSIS PATIENTS IN A
LONG-TERN MULTICENTRE TRIAL
J.Schrader1,U.Hildebrand2,H.—J.Tannis3,R.Va].entjn4,
V.Armstrong1 ,M.Kant1,E.Quellhorst2,F.Schelerl
1Med.Univ.—Clinic Gdttingen,2Nephrol.centre Hann.—
Münden, 3StAdt.Clinie Kassel, 4Sarepta Bielefeld,FRG
Antithrombotic activity,necessary doses and the
long term effects on coagulation and lipid parame-
ters of the low molecular weight heparin (LMW) Kabi
2165 were compared to unfractionated standard hepa—
nfl (OF) .On the basis of pie-studies in 49 patients
(pta.) including a group of 14 pts with bleeding
isk a long—term multicentre trial has been started.
To date 26 pta have been treated with LMW for 1/2
year and subsequent a second 1/2 years treatment
with UF was followed.
OF and LMW doses were used that lead to snti—FXa-
Levels of 0,5—1,0 U/mi (measured with S—2222).Ooaes:
LMW:initial dose:25—35 anti—FXa—U/kg;dose/hour: 10—
U/kg.UF:35-70 lU/kg; 14-25 IU/kg/hour.During LMW
PTT and thrombin time were oniy increased by 5-8
sec,while OF increased PTT by 90—120 sec and throrn—
bin time by 230—260 sec.Surpriainglv there was a
strong decrease in the elevated levels of factor
VIII during the 1/2 year LMW—period but during the
renewed UP-treatment FVIII increases again. Fibrjn
monomers also decreased during LMW but not during
OF. In contrast to UF,LMW caused only a small re-
lease of lipoprotein lipase.There were no different
changes in other coagulation parameters,in lipo—
proteins ,creatinine,urea and hemoglobin.Bleeding and
thrombotic compitcations did not occurr.
LMW—heparin therefore oroved to be a good alter-
native to IJF—heparjn in dialysis with favourable
effects in long—term use.By effective anti—FXa—acti—
vity and by sufficient antithrombotic activity LMW—
heparin will probably present loss of a bleeding
risk because of its reduced effect on PTT,thrombin
time and throabocytes.
• IMPAIRED TRANSPORT OF THE IRON—TRANSFERRIN COMPLEX
.
AND MIC000YTIC ANEMIA IN HEMODIALYSIS PATIENTS WITH
ALUMINIUM INTOXICATION
SIMON P., ARC ICS., CAM C.
La Beauchée Hospital SAINT—BRISUC 22 000 FRANCE
Three HO patientS with aluminium osteosalacia had a
microcytic anemia (MA) despite oral iron. Their
microcytosia was reversible with treatment by DFO.
In order to investigate a role of trsnsferrin in
aluminium—induced anemia we studied 32 ND patients
with Al intoxication (group A). All developed a MA
despite oral iron or transfusions. Control group(B)
was 36 age and sex matched HO patients who were not
Al intoxicated. In each group iron stores were a—
valuated by serum ferritin (ng/ml) group A1 (l6pts)
22,7+1,4, group A3 (i6pts); 114,3+18,5, group 81
(l3pts); 20,0+2,7, group B2 (26pts), 188,1+31,4.
Hematocrit (Ht), Hemoglobin (Rb) mean corpuscular
volume (MCV), serum iron (SI), transferrin (T) were
measured, Total iron binding capacity (TIBC) and
transferrin saturation (TS) were calculated. Each
parameter was measured before (Ti) and 48 H after
(T2) infusion of desferrioxamine (DFO). In patients
cith low serum ferriti (A1 81), at Ti, HL, HO,
MCV, I, TIBC, ST did not differ between two groups.
Only SI was significantly higher in group A1 than
in group 1 (71,0±4,5 vs 56,8+5,0, p(O,05). At T2,
I increased in group A1 (p(O,001). SI arid TS decre-
ased in group A1 (p(O,OO1). IN patients with normal
serum ferritin (A2 and B2), at Ti, Nt, Hb, T, TIBC,
SI, ST did not differ between two groups, Only MCV
differed (89,O+i;1 vs 95,8+0,7, p(O,000i). At T2,
SI and TS increased in two groups (pO,Ol). 1180
was higher in group A than in group 2 (306,5±12,1
vs 268,4+12,1, pK0,05. In conclusion, in patients
with Al intoxication 1) serum transferrin is the
best marker of impaired iron transport 2) DFO in-
crease T and TIBC and improve microcytosis 3) mi—
crocytosis is a good reflect of impaired iron trans-
port by aluminium bound to tranafarrin.
CHANGING TRENDS IN THE MODALITIES OF
THERAPY OF END STAGE RENAL FAILURE ESRF)
PATIENTS IN CANADA. A Shimizu, C. Posen,
Present and McMaster University, Hamilton and
Ottawa University and Statistics Canada,
Ottawa.
The number of patients accepted for
ESRF treatment in Canada is still rising
as in other countries. It was 52.8 per
million population in 1983. There was a
marked reduction of chronic glomerulo.-
nephritis and a rise in diabetic nephro—
sclerosis and renal vascular disease as
primary renal disease from 1975 to 1983.
Mean age of new patients rose from 42.7 to
49 years over this period. 46.3% of the
new patients were 55 years or older in
1983. Point prevalence of patients with
functioning transplants has risen steadily
from 31.2% in June, 1972 to 4.31% in Dec
1983, a pattern showing reverse trend from
that of Australia's. A special Canadian
ICâ. ULC that 23.3% cf .he Jiatis
patients,carried out peritoneal dialysis
in their homes in 1983, a marked increase
from the 7.4% in 1976. A similar increase
in hospital hemodialysis was noted during
the same interval. 45% of all dialysis
patients performed their dialysis outside
the regular dialysis units. There has
been a steady increase in the rate of
transplants performed from 15.1 in 1976 to
26.1/million population in 1983. Despite a
high rate of new patients commencing
dialysis each year, Canada has utilized,
the most cost—effective modalities of
therany for its management of ESRF
patients.
HIGH-PERFORMANCE LIQUID CHROMATOGRAPHIC (IIPLC)
STUDIES ON THE NONMERCAPT MERCAPT CONVERSION
OF HUMAN SERUM ALBUMIN BY HEMODIALYSIS
M. Sogami, S. Era, S. Nayaoka, K. Kuwata,
J. Shigerni, K. Kids, K. Miura*, E. Suzuki*,
H. Inouye*, S. Hayano**, M. Tokuda** and S. Sawada
(Intr. by S. Nakagawa)
Dept. of Physiology, *3rd Dept. of Internal Medi-
cine, School of Medicine, Gifu University,
**Hayatoku Hospital and ***Sawads Hospital, Gifu,
Japan
Human serum albumin (HSA) is the mixture of
mercaptalbumin (HMA) and nonmercaptalbumin (HNA).
While conducting HPLC studies on HSA using various
kinds of gel-exclusion chromatography columns, we
found a covenient HPLC column (Asahipak GS-520, 4
columns of 0.74 X 50 cm, 0.10 M Na phosphate
fer, 0.30 M NaC1, pH 6.86 (chloride buffer)) for
the resolution of HSA into HMA and HNA. Using a
new HPLC system (10 p1 of serum or plasma), mean
value of fraction of HMA (fHMA) of healthy male
adults was 0.76 0.025. In hernodialysis patients,
HMA before dialysis and mean value of [(HMA after
dialysis for 5 hours)-(fHMA before dialysis)] were
0.45 (n = 112) and 0.16 0.05 (n = 100),
respectively, in chloride buffer. We recently
found that HPLC profiles in 0.03 M Na phosphate
buffer, 0.15 M NapSO, pH 6.87 show tha good reso-
lution of HMA and HNA. We found the nonmercapt
-*mercapt conversion during hemodialysis and the
mercapt — nonmercaptconversion after hemodialysis
in hemodialysis patients. So, HMA might be "a co-
valent carrier protein' for sulfa—containing amino
acids in hemodialysis patients, resulting decrease
in free concentrations of cystine, homocysteine-
cysteine mixed disulfide and glutathione-disulfide
in plasma.
ULTRASOUND OF THE UPPER ABDOMEN IN PATIENTS ON RDT.
DIMINUTION OF THE SPLEEN VOLUME AFTER HEMODIALYSIS—
A NOVEL FINDING?
G.Sommer, H.Kopsa, N.Gritzmann, J.Zazgornik, P.Bal—
eke, C.Herold.
I.Medical Clinic and L.Boltzmann—Institute for rad.
tumor diagnostics, Univ. of Vienna, Austria.
Ultrasound was performed prospectively in 22 pa-
tients on RDT immediately before and after dialy-
sis (ATL—Mark 600, 3.5—7.5 Mhz applicator). Struc-
ture, density, volume, and frequency of organ alte-
rations were assessed. Patients aged from 22—67
years, mean dialysis observation time 25 months
(4—66). Dialysis was performed using capillary kid-
neys 3 times per week, 4 hours each. Basic renal
disease was glomerulonephritis (11), diabetic ne-
phropathy (4), interstitial nephritis (3), polycys—
tic disease (2), tuberous sclerosis (1), and Prune
Belly syndrome (1). Splenomegaly could be demons-
trated in 16 patients (73%) by assessing the size
of the spleen in 3 dimensions. In 15 of them (68%)
a mean diminution of the spleen volume of 28% after
dialysis was observed. This finding correlated well
to the sean loss of body weight of about 2.8% after
dialysis. Liver alterations (10 patients with hepa—
tomegaly, 2 of them with signs of diffuse liver di-
sease) could be demonstrated in 45%, gallbladder
alterations (4 patients with cholecystolithiasis,
3 with recent cholecystectomy, 3 with thickened
galibladderwall) in 68%. The pancreas appeared nor-
mal in all cases. Alterations of spleen, liver and
gallbladder were significantly more frequent when
compared with 100 normal controls.
We conclude that 1) variation of spleen volume
is a good parameter for changes of body fluid ba-
lance, 2) for assessing the spleen size the status
of hydration has to be considered.
PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY (PTA) IS AN
EFFICIENT THERAPY FOR STENOSIS OF ARTERIOVENOUS
FISTULAE (AVF).
C. Stamatakis, A. Kanfer, F. Cornud, F. Haddoum,
V. Delmas, A. Sibert, J.Ph. Méry.
Hpital Bichat, Paris, France.
Fourt:een stenoses of radial AVF which occurred
over a period of 24 months in 11/56 chronichemodia—
lyzed patients (pts) were treated by PTA. Eight pts
had one stenosis ; 2 pts had 2 successive and dif-
ferently located stenoses of the same AVF, and in
the last Pt stenosis occurred in the course of 2
successive AVF. Twelve stenoses were proximal (1 to
4 cm from the anastomosis) and 2 were distal (10 cm
and 15 cm from the anastomosis respectively) ; the
length of 13 stenoses ranged from 1 to 4 cm while
the last one was 10 cm long. All pta presented
with a poor dialytic blood flow (< 200 mi/rain) bet-
ween 4 and 172 wks ( 26 wks) after creation of
the AVF. PTA was performed with an Oibert balloon
catheter inflated up to 12 BAR during 45 sec, from
2 to 10 times. PTA induced an immediate improvement
in 12/14 stenoses with restoration of an intradia—
lytic blood flow > 300 mi/mm and an angiographi—
cally—proved correction of the stenosis. PTA failed
in 2 cases. Late results were assessed from 16 to
61 wks after PTA. AVF remained patent in 4/12 easer( folios up 48 wks) with a mean AVF—blood flow
(pulsed Doppler) of 560 mI/mm. In 1 case, a defi-
nitive AVF thrombosis occurred 17 wks after PTA. In
the remaining 7 cases, stenosis recurred in situ
16 to 50 wks after PTA, leading to a 2nd PTA which
was successful in 5 cases and failed in 2. On the
whole 9/14 stenoses were patent and still used for
HD by the end of the study. Conclusions 1) PTA is
an efficient therapy for stenosis of radial AVF
2) late in Situ recurrence of stenosis, can also be
successfully treated by PTA ; 3) PTA should be per-
formed before considering surgery.
ECOCARDIOGRAPHIC STUDY OF THE RIGTH VENTRI÷
CULAR FUNCTION IN PATIENTS UNDERGOING MAIN-
TENANCE HEMODIALYSIS.
Splendiani G.,Acitelli S.,Marsili P.,Corri—
doni C.,Mdssaro G.,De Blase L.,Campa P.
S.Salvator University—Hospital.L 'Aqulla—Ital)
To get the aim of researching on the
right ventricular function in hemodialyzed
patients,an ecocardiographic and poligraphic
study,joined with arterial blood gases and
ventilation test evaluations,has been per—
formed.3Opatients,aged within 22 and 73 ye-
ars and hemodialyzed three times a week,ha—
veheen examined.THS parameters analyzed with
ecocardiography M—mode were:the right ven-
tricular diastolic diameter,the interventri
cular wall motion,the left ventricular—end—
diastolic and systolic diameter,whoe ven-
tricular function by ejection fraction ([F),
th "eloolty of croumferento] fbcr chor-
tening (VCF),the ratio PEP/LV[1 (pre—ejec—
tion period/left ventricular ejection time)
and the ratio left atrium/eorta.We often
found out that anomalies of the parameters
of the right ventricular function could be
referred both to the overloading of the vo—
lume subordinate to the A—V fistula and to
the overloading of pressure that shows a le-
ft ventricular insuffieiency.We did not ob-
served any cardiac alterations to be correla
ted to disorders of the breathing functions,
nor to different kinds of the membranes used
PARATHYROID HORMONE AND GONADAL FUNCTION IN MALE
PATIENTS ON MAINTENANCE HEMODIALYSIS
V.Stefanovié, M.Bogiáevió, S.Kostié,
V.Djordjeviá, 3.1116
Institute of Nephrolo,', Faculty of Medicine,
Ni, Yugoslavia
The aim of this study was to evaluate
the gonadal status and a possible effect
of parathyroid hormone (PTH) upon
pituitary—testicular axis in hemodialysis
patients. PTH, follicle stimulating
hormone (FSH), luteinizing hormone (LH),
prolactin (Pr) and testosterone were
determined by radioimmunoassay in serum
of 3o healthy men and 39 male end-stage
kidney disease patients on maintenance
+hemodialysis. The concentrations (mean —
SUN) of FSH (lo.8 1.0 rIU/l), LU (19
2.o mIU/l) and Pr (787 127 mIU/l)
were fonud to be significantly increased,
while testosterone (4.9 o.3 ng/ml) was
significantly decreased in comparison
with the corresponding values in healthy
persons. PTH was markedly increased
(range l.2—2o ng/ml) in all hemodialysis
patients. The obtained results suggest
that some clinical signs of hypogonadism
could be based on hormonal disbalance
and that PTH could be one of the factors
affecting pituitary—testicular function in
male patients on maintenance hemodialysis.
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ANTI-DNA ANTIBODIES IN END-STAGE
KIDNEY DISEASE PATIENTS
V.Stefanovió,V.Savié,N.Laiá,M.Polenakovi6
Institute of Nephrology, Faculty of Medicine,NiA
Urology Ciinic,Faculty of Medicine,Skopje,
Yugoslavia
Antibodies to native, double stranded
DNA were studied in 15 pre—terminal
chronic renal failure patients, l7o
patients on maintenance hemodialysis and
12 grafted patients. Fifty healthy
controls and 15 patients in an incipient
renal failure were also studied. SLE
patients were excluded from any group.
Anti-DNA was determined by a commercial
radioimmunoassay (Amersham). An increased
titer (over 25 u/mi) was found in 38 (22.4
%) hsmc1isl'reia oationt but only In
few other patients. Patients on hemodialysis
were analysed according to the age, dur-
ation of hemodialysis,underlying kidney
disease and hepatitis B virus carrier state (HBs—,
HBS-1- and I-IBe+). None of these was found to
influence significantly the titer of serum anti—
DNA. Thus, an increased titer of anti—DNA,
found in patients on maintenance
hemodialysis, could probably be attributed
to the uremic state. An increased titer
of anti-DNA in end—stage kidney disease
patients cannot be used for SLE diagnosis.
.
MICROCYTIC ANEMIA: A MARKER FOR THE
DIAGNOSIS AND TREATMENT OF ALUMINUM
TOXICITY.
R. Swortz, J. Dombrouski, M. Burnatowska-Hledin,
G. Mayor.
(Intr. by F. Port)
University of Michigan, Ann Arbor MI, USA, and
Michigan State University, East Lansing MI, USA.
Screening of chronic dialysis patients for aluminum
toxicity revealed 8 patients with microcytic anemia in
the setting of high serum aluminum, bone and/or
neurologic findings typical of aluminum toxicity, and
no evidence for iron deficiency. Seven of 8 patients
received deferoxamine (DFO), all with marked
increases in serum aluminum level after initial
infusion. Treatment was continued in all 7, the lost
follow-up ranging from 3 to 13 months. Signs ond
symptoms of bone disease improved early in the course
of treatment, and neurologic findings improved in 2
affected cases after more than 6 months. The
erythrocyte abnormality was the best objective marker
for improvement, with normalization of microcytosis
over 2 to 4 months in all patients and increases in
hematocrit of 4 to 20 vol% at latest follow up.
Although serum ferritin level was reduced by more
than 50% in all DFO treated cases, anemia still
improved. Free erythrocyte protoporphyrins were
elevated in 6/7 cases prior to DFO, normalizing in 4
cases and improving in the I other to signal the
improvement in hemoglobin synthesis.
In conclusion, some patients with aluminum
toxicity have abnormal hemoglobin formation with
microcytic anemia which responds to DFO therapy.
Thus the hematologic abnormality in aluminum
toxicity represents an objective indicator which aids in
the diagnosis and therapeutic follow up.
ESSENTIALS OF SODIUM MODELLING
S. Stiller, I-I. Mann
Dept. Internal Medicine II and III, Technical
University of Aachen, Germ. Fed. Rep.
Sodium modelling means calculation and maintanance
of a time dependent concentration profile in the
dialysis fluid to obtain a defined concentration
profile in the plasma of the patient during dialy-
sis. Sodium modelling is done to enhance vascular
stability, to avoid osmotic stress of the brain,
and to remove surplus of body sodium and water.
Dialysis monitors for sodium modelling have to
provide a time dependent sodium concentration in
the dialysis fluid. Additionally, a suitable model
and methods for accurate measurements of the sodi-
um concentration in plasma and dialysis fluid are
absolutely essential. The paper presents a compu—
tensed sodium model and data about the precision
of sodium measurements by flame photometry and 10-
nometry, data about precision of sodium concentra-
tion in dialysis fluids depending on different
proportioning units.
Sodium gradient between plasma and dialysis fluid
can be determined to an accuracy of about 2 mmol/l
under optimal conditions, but standard measure-
ments may lead to an error of several times this
value. Between different charges of the same type
of concentrate differences of up to 5 mol/l have
been measured. Errors in the proportioning units
are found in the same magnitude. The accuracy of
prediction by the model is 3 mmol/l.
It is concluded that sodium modelling has to be
based on very careful measurements of the sodium
concentration in plasma and dialysis fluid, other-
wise sodium balance may be more disturbed than
controlled.
MONONUCLEAS CELL (MNC) MEMBRPNE LIPID PEROXIDATION
IN HEMODIALYSI5 PATIENTS (HP)
Taccone—Gallucci, M. Giardini 0, Valeri M, Lubrano
N, Bandino D, Migliardi A, Piazza A, Mazzarella V
and Casciani C_U.
Clinica Chirurgica, 2nd University of Rome, I din—
ica Pediatrics , 1st University of Rozne,Instituto
C.N.N. L'Aquila, Italy
In previous studies (Nephron 1984), we observed
in hemodialysis patients an increase of red blood
cell (NBC) malonyldialdehyde (MDA), a short chain
aldehyde which is an intermediat.e product of the
oxidation of polyunsaturated NBC membrane fatty
acids. Concomitantly we observed a significant
decrease of RBC vitamin E and its deficiency
could be explained by its increased consumption
as an antioxidising agent. It is known that an in-
creased peroxidation of the polyunsaturated fatty
acids (PUFA) in the membranes leads to formation
of fluorescent chromolipids from phosphatidylserine
and phoephatidylethanolaminc together with high
molecular weight protein aggregates from spectrine.
To verity if peroxidation of fatty acids takes
place in peripheral blood MNC, we studied the MNC
BOA and the MNC vitamin E levels in two groups of
subjects: ten comparable hemodialysis patients for
an average period of 30 mths (r 6—B4mths) 3 times
a week and ten normal subjects as controls.
Controls Patients (mean+SD) p<
MNC BOA 11.39+3.28(A) l8.68±9.30(B)AvsB 0.025
(up/mg prot)
—
MNC Vit E 4.o4+o.39() 3.00+l.67(D)CvsD 0.05
(ug/mg prot)
These data suggest that in HP increased peroxida—
tion of PUFA takes place also in MNC membranes and
it could interfere with the immune response,
impairing the MNC membrane phenotypic markers.
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PLATELET CYCLO—OXYGENASE (PCO) IN HEMODIALYSIS
(HD) PATIENTS: WHAT SUPPRESSES ITS ACTIVITY?
H. Tanaka, K. Umimoto, N. Izumi, T. Maekawa, T.
Kishimoto*, N. Maekawa*
Tadaoka Municipal Hospital and Osaka City Univ.*,
Osaka, Japan
PCO activity is suppressed in hemodialysis (MD)
patients. In this study, we examined whether this
is caused by the platelet itself and/or the
uraemic plasma, by observing the PCO activity
before and after HO.
Normal and uraemic platelets were incubated in
both normal and uraemic plasma. The PCO activity
was then evaluated by measuring the platelet
malondialdehyde (MDA) production rate with the TBA
method. The PCO activity index of the uraemic
plasma (Plasma Index) and uraemic platelets
(Platelet Index) were calculated by MDA production
rate of normal platelets in uraemic plasma/MDA of
that in normal plasma and MDA of uraemic platelets
in normal plasma/MDA of those in uraemic plasma,
respectively. In order to obtain the same number
of platelets for both the normal and uraemic
plasma, the platelet rich plasma was divided by
volume.
The Plasma Index before RD was 90.3 4.0%
(N10, mean S.D.), and that after MD was 99.8
4.5% (N1O) with a significant difference between
the two. The Platelet Index before MD was 101.4
6.6% (N10). As for the uraemic platelets before
and after HD, the MDA production rate in the
normal plasma was comparable.
The above results suggest that the uraemic
plasma contains a suppressing factor which can be
removed by MD, but the PCO activity in the uraemic
platelets remains low, and it cannot be improved
by HD. Therefore, the low PCO activity is mainly
caused by the platelets.
ANION GAP(AG):ITS RELATIONSHIP WITH ACID—BASE STA-
TUS AND DIALYSIS TREATMENT IN UREMIC PATIENTS (PTS).
N. Tessi tore, G.Panzetta ,E .Valvo , A. Lupo ,C. Loschiavo,
L.Oldrizzi ,A.Fabris,L.Gammaro,C.Rugiu,V.Ortalda,V.
Bedogna , B.Panebianco ,G .Maschio.
Divisione di Nefrologia,Università di VERONA,Italia
An increased AG is associated with uremic metabo—
lie acidosis,due to retention of inorganic acid an!
ons.In order to investigate the relationship betwe-
en acidosis & AG in dialysis,we studied 54 pts.(27
F,27 M,aged 18—67 years),treated with CAPD(n=8),bi—
carbonate hemodia1ysis(nlO)(BHD)& acetate hesodia—
lysis(n=3622 tolerant,AHD,14 with clinical intole-
rance to acetate,AIHD).Acid—base & AG(Na * K)—(Cl +
HCO3)were evaluated predialyais in arterial blood.
Protein catabolic rate(PCR)was calculated from urea
generation rate in hemodialysis pta.
AHD AIHD BHD OAPD
HCO3(mEq/1) 18.2+.4 19.8+.7 2l.3±.8 21.4±.5
AG (mEq/) 23.O±.4 26.5±.8 24.8-i-.8 21.3+.5
All hemodialysis pts.had high AG,in spite of dif
ferent HOC ,which were higher in BHD(p<.005). CAPD
pts.hsd lower AG than hemodialysis pts.(p.Oi), but
HCO3 similar to BHD pts.The highest AG was observed
in AIHD(p.OO1 vs AHD).AG showed a significant cor-
relation with PCR(r=.74,p<.O1),while HCO3 did not.
Our data show no correlation between the degree
of metabolic acidosis & AG & suggest that AG is a
better index of Hgeneration rate than HCO3 in hemo
dialysis pts.CAPD provides a more adeguate correct!
on of both acidosis & AG,due to the continuous treat
ment.The relationship between high AG & acetate in
tolerance needs further investigation.
HOW HEMODIALYSIS (MD) AFFECTS PLATELET VOLUME
DISTRIBUTION (PVD)?
H. Tanaka, N. Izumi, K. Umimoto, T. Maekawa, T.
Kishimoto*, M. Maekawa*
Tadaoka Municipal Hospital and Osaka City Univ.*,
Osaka, Japan
Platelets change in number during MD. In this
study, we observed the platelet count, PVD and Hot
in 12 MD patients, 6 of them on the dialyzer, 2—
150 (PMMA, bray, Tokyo, Japan), and the other 6
on H12—1O (AN69, Hospal, Basel, Switzerland).
Blood samples were collected periodically, and
analyzed using the Sysmex E—5000 (Sysmex, Kobe,
Japan). The platelet count during MD was
corrected according to the change in Hot, and the
ratio of the platelet was calculated by dividing
the corrected platelet count by its pre—HD count.
The ratio of the count for the small platelets
(less than 12 fl) significantly decreased at the
beginning of MD with B2—15O, but later recovered.
On the contrary, no changes were seen in that with
H12—10. As for the ratio of the count for the
large platelets (more than 12 fl), it decreased
significantly with both dialyzers, and was 0.90
0.07*, 0.84 + 0.10* and 0.84 ÷ 0.08* at 15 mm, 30
mm and 60 mm, respectively with 82—150 and 1.00
0.06, 1.00 0.10 and 0.83 0.12*, respectively
with H12—10 (Mean SD, * means statistical
significance). The decrease in the ratio was
slower with H12—10. What's more, there were no
changes caused by platelet aggregation in any PVD
during MD.
These results suggest that the large platelets,
which are regarded young and active, were mainly
affected by MD rather than the small platelets,
but that this was not due to platelet aggregation.
As for the dialyzer, H12—10 was more suitable to
the platelets than B2—150.
CARDIAC PARASYMPATHETIC ACTIVITY IN HAEMDDIAL1OIS
PATIENTS.
B J Thomson, B McAreavey, J N Neilson
and B J Ewing,R.J. Winney.
Royal Infirmary and University of Edinburgh,
Edinburgh, United Kingdom.
Abnormal autonomic function has been found in
up to 50% of haemodialysis patients using estab-
lished clinical tests. The incidence of changes o4
>50 ms in successive R—R intervals, which occur
frequently but irregularly in normal subjects,
is a more sensitive index of cardiac parasympath—
etic activity. This can be assessed using 24 h
electrocardiographic monitoring and expressed as
a total 24 h or mean hourly count rste.
28 chronic haemodialysis patients aged 19 — 66
(mean 46.3) years on dialysis for 1—21 (mean 3.9)
years were studied. None was diabetic. All were
in sinus rhythm with few ectopic beats (<5/h) thus
allowing satisfactory analysis of R—R interval
variation.
Mean hourly heart rate was 9O 13.7 (SD)
beats/mm awake and 79 11.8 asleep. In 23 (82%)
of patients, the total 24 hour count of R—R
interval variation of 50 ms were significantly
lower than the previously established normal
range. In addition, their mean hourly count
rates were 40 awake (normal range 150—250) and
38 asleep (normal range 350—430) . These findings
are similar to those in cardiac transplant
patients and diabetics with sutonomic neuropathy.
Our results suggest that the majority of
chronic haemodialvsis patients have cardiac
parasympathetic damage.
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FACTORS INFLUENCING ACQUIRED CYSTIC DISEASE IN
A DIALYSIS POPULATION.
B J Thomson, P A S Jenkins, P L Allan and
R J Winney.
Royal Infirmary, Edinburgh EH3 9YW, U.K.
Acquired cystic disease (AGO) hs been reportea
in longserm haemodialysis patients and may
preCiapose to renal turnouTs. We accessed the
prevalence of cysts in our dialysis population,
excluding only anephric patients and those with
polycystic kidneys. lie investigatad the relation-
ship of cysts to age, duration of chronic renal
railure (CRy), nature of underlying disease,lurstion and type of dialysis and haemoglohin (HO)
81 patients aged 20—78 (mean 50.5) yrs, on
dialysis for 0.5—21 (mean 4.96)yrc, were scapned
using real time ultrasound. 28 were on CAPD.
Ultrasonography was performed and assessed blind
by one radiologist who graded the number of cysts.
Ii patients (63F) had ACD, No o1id lesions
were identified. No correlation was found between
the number of cysts and the patient's age or
duration of CRF (known in 357). Patients with
glornerulonephritis (n—25), pyclonephfitic (N-2O)
and CRF of uhknown aetiology (N—21) were equally
likely to develop cysts. There was a significant
eorrclation (p 0001) betwcen the number of
cysts and duration of haemodjalysis, but not with
duration of CAPI). There was no cnrrIation
between the numbcr of cysts and -lb.
We conclude that duration of haemodiplysis is
the only variable investigated which significanti
uenccd the extent of AGO, and that cystic
d isase had no elct on anaemia in our
opal at ion.
RESIDUAL CREATININE CLEARANCE IN PATIENTS ON
HEMODIALYSIS AND SOME ASPECTS OF EVALUATION OF
THE TREATMENTjjTrpenoski, V. Tomanoski, S. Kovaceski,
B. Kratanoski, S. Muharemj, L. Piposki
(Intr. by K. Cakalaroski)
Centre for Dialysis, Struga, Yugoslavia.
Dialysis treatment was evaluated in 47 patients
(pta) on regular hemodialysis (HD) for a mean
period of 3 years. Following criteria were
considered:— residual creatinine clearance (RCC),—
Bab—Scrjbner's DI hematocrjt (hct), — present
complications and physical condition.
Majority of pta had RCC below 2m1/min, 5 pts
from 2—5, 8 pta from 5—15m1/min. One had RCC
34m1/min. He ceased HD. DI below 1 had 5 pts,
from 1—2 35 pta, and above 2 had 7 pts. Hct in
3 pta was lower than 20, 30 pta had Hct from
20—30, and above 30 had 14 pta. Coefficient of
correlation between DI and Hct was positive
(r—O,74). Pericarditis was detected in 2 pts(in
both DI below 1), and bone alterations in 3 pts
(in two DI below 1). Physical condition was
estimated as bad in 4 pts, good In 26 and very
good in 17.
RCC should be taken into consideration in
assessment of RD treatment, DI was confirmed for
adequate HD but additional demand must be made in
exceeding clinical states as infections, trauma
etc. Determination of RCC confirms the terminal
progression of renal failure or giving a possibil-
ity for changing or rarely for ceasing RD treat-
ment.
THERMOGRAPHY USE POR VASCULAR ACCES IN THE
HEMODIALYSIS PATIENTS
P.Tosi, M.Axnato, A.Attardi, S.Bsndini,M.Sel—
vadori. (member).
Dept. of Nephrolor—USL 1O/D—Firenze
Berni D.
Dept. of Radiology—USL 1 O/D—irenze.
Hemodialysis patients are often affe-
cted by intensive pain referred to the up-
per limbs.
We have studied 22 patients with a dia-
lytic age of 10 years or rnore.All the pa-
tients with a painful syndrome due to a
bone or neurological disease were discar—
ged.All the 22 patients were submitted to
a thermographic study of the upper limbs.
We found a siiificative relationship
between the degree of hypothermia and pain
intensity studying the hsnds.A less signi—
ficative relationship was found for the
forearms and the arms.This is probably due
both to the higher thickness of the muscle
mass at this level, or to the presence of
some arterialized vein who may cause a hy—
nothermia of the skin.
According to this experience,the use of
the thermographia is in particular suita-
ble for the dialysis natients screening.
In fact this method is easily performed,
not invasive and easily reDeaible and of
low cost.Pherrnograrthic studies offer a ye-
of the urn
TIPIIEOSORT CELl ACTIVITY P118 INC RAEMO—
)11.TYGIS /m/ IN CH1ICIJIC TrnAErdicN
Y.Trznodel, H.Tchdrzewski, M.Iuciak.
2nd Dept. of Int.T-ied. and Dept. of Batho—
phyaiologv, WAN, i6d, Poland.
Tn 10 patients with chroni.c uraemia sup—prescor P cell activity was measured durirg
lID as nercentage of hiastoenic stimula-tion
of autoloCcus responder /R/ cells inhibited
by Cnn1,rnitomycjn C—pretreated T /CnnA—NC—
—T/ cells in a two—step cu]turo.Blood sam-ples were taken for investigations before
I-ID and. at 20,60 and 180 sin, of ND from ve-
nous line of the Tundi.a Optima 11 .b u /(iam_bro/ tilalyzer. At 60 sin, of lID in 3 pa-
tients suppressor T cell activity was alsodetermined in blood from arterial line of
the dialyser.
Before HP ConA—MC—P cells did not in—
hihit,hut stimulated R cell mitogenic reD—
oonse to 46.1%.fluring RD this stimulation
decreased to 15.2% at 20 sin., 15.5% at
60 sin, and rose ain to 40.9% at 180 mm.
At 60 sin, of RD in 3 patients this stimu-
lation lowered from 41.7% before the dia—
lyzer to 8.4% after the dialyzer.
The results indicate that in chronic
uraemics on regular dialysis treatment
/RDT/ increased Th ce3l activity or depres-
sed Ts cell activity is observed. Hi) tran-
siently depresses Tb cell activity or in—
creasos Ta cell, activity and that seems to
take place within the dialyzer possibly
due to release of neutrophil granule pro—
ducts.These changes may play an important
role in autimmune phenomena observed in
some chronic uraemics on EDT.
EFFECT OF LONG—TERM TREATMENT WITH L—CARNITINE ON
THE LIPID PATTERN OF CHRONIC URENICS UNDERGOING
HEMODIALYSIS.
G.M. Vacha, G. Giorcelli, M. Corsi, S. D'Iddio
Department of Nephrology and Dialysis, Ospedale
Mmuriziano "Umberto I", Turin, Italy
In a previous study the efficacy of L—carnitine
(20 mg/kg/i.v. at the end of every dialysis session
for 4 months) was evaluated in the treatment of
hypertriglyceridemia in 29 uremic, hernodialyzed
patients. From an examination of the results a
dramatic reduction of values was noted in only 12
patients who presented, in basal observations,
hypertriglyceridemia accompanied by low levels of
HDL—choiesterol. In the present study we have
instead evaluated the effect of long—term treatment,
2 years, with L—carnitine, using the same procedure
as mentioned above, in 15 of the 29 patients previ-
ously described. All the patients (9 of whom did not
present modifications in the parameters in the
preceding study) show a significant reduction in
triglyceridemia values during the entire observation
period, accompanied by an increase in HDL—cholesteroL
The cholesterolemia values, which were already
within normal limits ad basal observation, undergo
no modification.
We therefore believe it opportune to utilize long—
term carnitine therapy in the treatment of dislipi—
demia in the dialyzed, eventually adapting the po—
sology and method of administration to the individual
requirements of the patients.
COMPARISON OF ALIJMINTUM REMOVAL BETWEEN AN AN 69—S
MEMBRANE AND A CHARCOAL FiLTER
B.M. Valentiln M.D., P. Batavier R.N., T.N, Schicht
H.H.
Dept. flemodialysis, Univernitv Hospital, Leideri,
The Netherlands.
Aluminium (A]) intoxication is a well—known
complication of hemodialysia. The use of
desferrioxamine and a dialysate with low Al
concentrations are important therapeutic measures.
The use of a charcoal filter to remove additional.
amounts of Al has been advocated, but leads to high
costs and several gide effects. The Al clearance of
a (70 Cr1 charcoal filter (in combination with a
capillary filter) was compared with that of an
artificial kidney with an AN 69—S membrane (Biospal
2400, flooal). Aluminium levels were determined in
24 dialysis sessions in 3 patients with Al
intoxication. Al levels were determined by atomic
absorption spectrophotometrv in pTa— and
postdialysis serum samples ard all results were
corrected for total protein content.
Results were as shown in the table;
Predialysis
Mean Aluminium
Charcoal
(n=14)
186 21
levels (mol/i)
AN—69
(n=1O)
194 30
Postdialysis 91 25 109 34
A Aluminium 91 17 84 15
The results show the similar efficacy of the AN
69—S membrane in Al removal compared to the
charcoal filter. We conclude that in Al—
intoxication the use of an AN 69—S membrane is
preferred over a charcoal filter for its lower
costs, fewer side effects and high aluminium
c1earance.
SIMULTANEOUS PASSIVE AND ACTIVE VACCINATION AGAINST
HEPATITIS B.
R.M. Valentjjn, C. Clemens, I.M. Schicht.
University Hospital, Nephrology Dept., Leiden, The
Netherlands.
Twenty—two hemodialysis patients (pts) and 23
healthy dialysis staff members were vaccinated
against hepatitis B with hyperimmune ganmnaglobulin
three times in 6 weeks followed by active
vaccination using H—B—Vax® (MSD), 3 times 40 ig at
0, 1 and 6 months. Blood samples were drawn at 2—3
week intervals for 32 weeks and antibody titers
against hepatitis B were determined. The table
shows the percentage of pts and staff members with
a protective antibody titer 10 mIU/ml at various
times after vaccination;
Week 0 5—6 12 16 32
Patients (n=22) 100 33 33 40 bO
Non—responders (n=9) 100 22 0 0 0
Staff (n=23) 95 100 94 94 94
Age and years of dialysis treatment were negatively
correlated with responsership in pta. The 60% and
94% responders at 32 weeks in reap. pts and staff
is not different from published studies using only
H—B—Vax®, suggesting that passive vaccination does
not interfere with the efficacy of active
vaccination. At week 5—6 only 33% of all patients
were adequately protected against hepatitis B,
while in the non—responders this was the case in
only 22%. However 100% of staff members had titers
2 10 ir.IU/ml at week 5—6. Our results show that
protection from passive vaccination in dialysis pta
is considerably shorter than that observed in
healthy persons and should possibly be given at 2—3
weekly intervals, until a response to active
vaccination has occurred.
LONG TERN SURVIVAL OF HbsAg POSITIVE (Ag+) HEMO—
DIALYSIS (HD) AND TRANSPLANT (Tx) PATIENTS.
P.C.T. van Aanholt, P.E. de Jong, A.M. Tegzess,
W.J. Sluiter, G.K. van der Hem.
State University Hospital Groningen, The Netherlands.
We studied survival by logrank test of 66 Ag+
pat. compared to 55 Ag— pat.,who started renal re-
placement therapy between 1967 and 1978 in our
units. All 121 pat. were treated in similar HD and
Tx protocols. Data of survival after 5 and 10
years is: prim.
overall RD alone
-
HD+Tx
neg P05 neg pos meg pos neg po
n
age
5yr
p
55
37+14
78%
ns
66
41+14
67%
18
45+15
44%
ns
33
48+11
58%
37
33+11
95%
ns
33
33+10
76%
33
59% 367
(0.05
lOyr 66% 45% 19% 29% 88% 60% 49% 36
..i__ fl5
-
ns (0.01
-
nS
Both the overall groups ann theHD and rx sub-
groups were not different with respect to age, sex
and diagnosis before therapy. Age in the Ag— and
Ag+ MD groups was higher that in the respective Tx
groups.Overall survival was somewhat better in the
Ag— group, although the difference never reached
sign. In the Ag— Tx group the survival was sign.
better from 70 months on. Graft survival also was
sign. better in the Ag— group from 16 to 112 months.
In contrast the Ag+ pat. did better inHD, although
the difference did not reach sign. The Ag+ Tx pat.
did better than the Ag+ RD pat.(<O.025 at 10 yr).
After correction for age this difference disap-
peared.
We conclude that survival in renal replacement
therapy in Ag+ pat. is not sign. different from
Ag— pat. However, the Ag+ group did much worse in
Tx programs that the Ag— group. Finally, in compa-
rable age groups of Ag+ pat. survival after Tx is
not better than in MD.
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EXPECTATIONS AND DESIRES CONCERNING COMPUTER
EMPLOYMENT IN DUTCH RENAL UNITS
A, van Berlo1 and A.P. Roodvoets2
1. Eindhoven University of Technology
2, St.Elisabeth's Gasthuis Haarlem, The Netherlands
A study has been made in which an inventory has
been listed of desires and expectations concerning
computerapplications in renal units in The Nether-
lands.
A questionnaire with three sections was sent to
all units: (1) employment of computers as data base
system, (2) other applications, choice of system
and function in the unit and (3) financial facili-
t I es.
The questionnaire was returned voluntarily by
three—fourths of the renal units. Some results:
Two—thirds to three—fourths of the renal physicians
require data of the common daily dialysis on a com-
puterized medical record; 50% desire a manual out-
put, 1Q% the data on a screen, one—third desire
both, J40% would have all data stored from the mo—
ment of computer presence, 50% computerstored from
the First dialysis. Three—fourths desire data in
graphics, 50% in tables and 50% both. Three—fourths
would have a computerized output of transplantation
data, two—thirds of holiday—dialysis data. Approxi-
mately half of the physicians desire kinetic model-
ling for treatment optimization. All would rather
manage the computer themselves. Two—thirds want to
be involved in the procuration of computers, but
on1y one—third know what they really want; 50% ex-
pect improvement in patient care and more insight
in dialysis therapy when using computers. It is ex-
pected that in 1985 and 1986 most of the Dutch re-
nal units will apply for computersystems.
Conclusions: Renal physicians demonstrate inrea—
sing interest for computer employment. A majority
wants them as data base system, but does not know
the detailed facilities as yet.
TRANSLUMINAL ANGIOPLASTY FOR VENOUS STEWOSIS IN
PATIENTS DIAL YSED WITH HEMASITE* VASCULAR ACCESS
SYSTEM.
B. VIRON*, B. LUKACS**, C. MICHEL, F. MICNON*
Services de Ne'phrologie* et durologie**
Hopital TENON 75020 PARIS (FRANCE)
Hemasite, a vascular prothesis for hemodialysis
providing direct access to the vasculature without
needle puncture, was implanted in 6 female patients
aged 21 to 65. These prothesis included GoreTex*
P.T.F'.E. grafts and were implanted in the upper arm
Total time of use is, at present, 30 month-patient
(1 to 10 months). Venous stenosis occurred in 2
patients and revealed itself by complete thrombosis
respectively 2 and 6 months after insertion. Local
infusion of thrombolytic drugs through the double
cannula access set proved efficient in both cases.
An angiography performed immediately after desobs-
truction, through the same access, disclosed a
short venous stenosis just beyond the graft-venous
anastomosis. Both patients, then, underwent trsns—
luminal angioplasty, a painless and easy procedure:
after removing the septum of the Hemasite, a bal-
loon dilatation catheter was inserted at the site
of the stenosis through the well of the prothesis
dilatation of the stenosis was obtained by intloa-
ting the balloon under radio control, Subsequent
assessment of the blood flow through the prothesis,
evaluated by the Hemasite flow monitor showed nor-
mal values. Angioqraphy confirmed near total re-
gression of stenosis.
Venous stenosis seems therefore to be a frequent
complication of Hemasite as of every vascular graft
used for hemodialysis. However, this system offers
the interesting facility to perform easily safe
and painless angioplasty through its removable
septum.
CAPSULO SYNOVIAL AND BONE ANYLOIDOSIS (CSA)
COMPLICATION OF LONG-TERN HEMODIALYSIS (ND).
J.M. Vandenbroucke, J.P. Huaux, Th, Guillaume, H.
Noel, B. Maldague, C. van Ypersele de Strihou.
University of Louvain Medical School, Cliniques
Universjtajres St—Luc, Bruxelles.
Localized ainyloid deposits within the carpal
tunnel synovium have been described in long—term
HO patients with carpal tunnel syndrome.
We have observed multiple amyloid deposits
within articular synovium end adjacent bone in
three patients dialyzed for 7 to 13 years. No
other organs were involved. A carpal tunnel
syndrome, requiring surgery, developed in all
three. Amyloid deposits were documented outside
the carpal tunnel, either after (2 and 3 years) or
before (3 years) the onset of carpal syndrome. The
following joints were involved : shoulders (3
cases), hip joints with spontaneous fracture of
the femoral neck (2 cases) and carpal bones (2
cases).
X—Rays are pathognomonic : thickening of
articular soft tissues with synovial hypertrophy,
bone erosion at the insertion of ligaments and
defects in the adjacent bone corresponding to
amyloid deposits. A similar X-ray picture without
histological documentation was observed in a
further two patients (after 12 and 14 years of
ND). Primary renal amyloidosis and multiple
myeloma were excluded for all patients.
Although unfamiliar, CSA represents therefore a
not uncommon complication of long-term HO, with a
typical X—ray picture, requiring ditferential
diagnosis with hyperparathyroidism and osteo—
malacia.
PROXIMAL FOREARM FISTULg: A NEW APPROACH IN VASCU-
LAR ACCESS FOR HEMODIALYSIS
K.Wagner, F.Keller, H.J.Bauknecht,Th.Lenz, 1.-H.
Neumayer, M.Molzahn, A.Distler, R,Haring
Klinikum Steglitz, Free University Berlin, F.R.G.
An upper arm a-v fistula or an artificial vascu-
lar graft is frequently used after irreversible oc-
clusion of Ciniino Brescia (C—B) fistulas and fail-
ure of a high" C—B fistula. We want to report a
method for generating an a—v fistula of the fore-
arm under these circumstances.
Patency of the a.radialis is checked either by
palpation or by Dopper ultrasonoqraphy, Through
the cooperation of a vascular surgeon and a neph-
rologist, the artery is exposed below the m.brach-
ioradialis under local anesthesia. After ligation
distally, the artery is placed subcutaneously
through a tunnel in the muscle. For the termino—
terminal anastomosis, the old shunt vein or a new
vein is used. We have now applied this technique
in 10 patients. The procedure failed in only one
patient due to proximal stenosis of the a.radialis
with subsequent low blood flow. When the old shunt
vein was chosen for anastoniosis, the new forearm
fistula could be used very soon thereafter. The
appropriate indications for the proximal forearm
fistula are: 1. C—B fistula clotting with partly
open shunt vein, 2. impossibility of primary C-B
fistula, 3. low blood flow in C—B fistulas due to
stenosis proximal to the anastornosis, which is
verified by angiography. This technique requires
the intensive cooperation of a vascular surgeon
and a nephrologist. The nephrologist establishes
the indication for the new fistula, while the
vascular surgeon decides the operative strategy
in cooperation with the nephrologist.
• DOES DESFERRIOXAMINE INDUCE ALUMINIUM LOAD IN PA-
TIENTS ON CHRONIC HEMODIALYSIS?
• K.Wagner,T.Lenz,F.Keller,
1J.Piepenhagen,H.—J.Dulce,A.Distler,M.Molzahn
Freie Universität Berlin, F.R.G.
Desferrioxamine (desfer.) is used in the treat-
ment of aluminium(alu)—induced encephalopathy and
osteopathy in patients on chronic hemodialysis.
We have studied the effect of desfer. on alu-
kinetics in 9 patients on maintenance hemodialysis
(mean duration of hemodialysis 28 months; no overt
sign of alu-intoxication). Total plasma alu was
measured by atomic absorption before and 48 hrs
after application of 1000 mg desfer. In addition,
the alu content of 3 different charges of the corn—
mercially provided desfer. (Desferal®, Ciba) was
measured.
The preinfusion plasma alu level was 1.77±0.53
ijmol/i (, SEM) and increased significantly to 3.67
prnol/l after dosing. The alu content of Des—
feral® ranged from 0.15 to 1.4 jmol/2000 mg desfer.
(mean: 0.8 pmol).
From the presented data, it can be concluded
that the commercially provided desfer. contained
high amounts of alu. At an estimated plasma volume
jf 2.5 1, the plasma alu level can be elevated up
to 0.5 imol/l by the application of 2000 mg desfer.
The marked elevation of the plasma alu level after
the desfer. infusion is not only due to the bind-
ing of body burden alu but is also the result of
the administration of alu—containing desferriox—
amine.
DEVELOPMENT OF THE NEW UREA ADSORBENT ANDDIALYSATE
REGENERATION SYSTEM ARTIFICIAL KIDNEY
T.Watan, O.Otsubo, N.Iwadate,
G.Satn ', S.Saitou*, N.Takai* (Intr.by I. Takahashi)
Inst. of Med. Sci., University of Tokyo
* Inst. of md. Sci., University of Toiyo
As a step toward the wearable artificial
kidney, we have dgveloped the dialysate regene-
ration system artificial kidney with the new urea
adsorbent.
The most important problem is urea removal
for the development of portable or wearable
artificial kidney. All charcoals and other
materials known as yet have a low adsorptive
capacity for urea.
We succeeded in development of the new urea
adsorbent. This materialis made of functional
siliceous adsorbent, and its diameter ranges from
0.5 to 1.0 mm. This new urea adsorbent indicated
high adsorvability (7OmgIg) for urea in vitro
shaking and column perfusion tests using solution
of urea.
The dialysate regeneration system artificial
kidney is composed of the oem urea zdorbeot,
activated charcoal, ammonia adsorbent and ion
exchange resin. We performed dialysate regeneration
system on an adult mongrel dog with both ureters
ligated under the following conditions: blood
flow 100m1/min, dialysate flow l5Oml/min.,dialysate
volume 1L. ,urea adsorbent weight 200g. ,charcoal
weight 50g.
Within 3 hrs, effect of treatment with this
system indicated a decrease of the urea—N level
from 125mg/dI to 7Omg/di and the creatinine level
from 9.Omg/dl to 5.ômgldl with rejection yield
of 40—452.
The result of this experiments seems to indicated
a step forward in the development of wearable
artificial kidney.
THE COMPOSITION OF DIALYSATE FLUID IN
BICARBONATE DIALYSIS.
5. Wagner, G. Decker, K. Zuber, M.Strauch,
Clinic of Nephrology, Kliriikum Mannheirn,
University of Heidelberg, Mannheim, FIIG.
Six commercially available bicarbonate
concentrates were compared with regara to
pH, pCO2 and TCO2. Substantial differences
were observed: pH 7.109—7.508, pCO2 41.8—
96 smOg, TCO2 30.70—36.65 mval/l. Loa p11
and a corresponding high pCO2 may in-
fluence security and effectivity of bi-
carbonate dialysis, especially if pts. are
not able to eliminate high concentrations
of generated C02 vie respiration. In order
to get an indication for an optimal con—
centration of bicarbonate in the dialysote
5 pta. were diolysed each against dif-ferent bicar'bonate concentrations (24.6—
'41.6 mvirl/l). Significant differences In
p11, pCO2, 01003—, plasma potassium anu fed
blood cell potassium during dialysis arid
prior to toe consecutive oialysia werefound. It is proposeu that the bicarbonate
concentration in the dlnlysate has to be
us high us to nilow the following predia—lytic plasma hicarbonate concentration to
ho n a normal range: about 35—40 aval/l
The potsesi rio of SOC in oicarbonate di sly—
sad pirs. is much higher than lit pta. on
regular ulaitsis containing acetate. For
thi s reason bicarbonate dialysis coal i ae
a means for tite prevoltion of intrnicellu—Ian potas:iurri Loploilort in the long tori
clironi c lie'oiiilvsis
BIOCOMPATIBILITY OF HAEMODIALYISIS MEMBRA-
NES: ACTIVATION OF COMPLEMENT AND LEUKO—
PENIA.
E. Wegmbller, C. Descoeudres, J. Hodler
(Intr. by A. Blumberg)
Med. Polikilnik, Univ. of Berne (Switzerland)
The ability of three hollow fiber dialysis mem-
branes, cuprophane (CU), polymethylmethacrylate
(PMMC) and polyacrylonitrile (PAN) to activate com-
plement and to induce leukopenia was studied pros-
pectively in 6 chronic haemodialysis patients and
in an in vitro experiment. All patients were dialy—
sed consecutively for one week with each type of
membrane under similar conditions. C3a, Cl-ta, C5a,
the C3d fragment and blood leulcocytes were measured
on predialysis blood samples and at 5,15,30,60,120
and 2140 sin after begin of dialysis.
CU membranes caused a marked complement activa-
tion by the alternative pathway with C3a, C3d and
C5a levels peaking 15 sin after begin of dialysis.
(<O.OOl,<O.02,<O.005). Cl-ta concentrations did
not change. Blood leukocyte counts decreased simul-
taneously by y6,% (pO.OO5) and the decrease in
leukocytes correlated inversely with CIa, C3d and
C5a concentrations (p<O.O0l). In contrast, P11110
membranes lead only to a slight complement activa-
tion with an associated fall in leulrocyte counts of
29,1%. PAN membranes induced very little complement
activation without leukopenia. The in vitro studies
incubating each type of filter with NI-IF corrobora-
ted these findings. Thus, the results indicate that
the biocompatibility of non—cellulose membranes
such as PMMC and PAN is superior to cellulose CU
membranes, although from the clinical point of view,
all patients tolerated the 3 filters equally.
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URGENT DIALYSIS - A THREE YEAR PROSPECTIVE SURVEY
C.G. Winearis, F.W.Ballardie, P. Mason, B. Singer,
O.K. Peters
Renal Unit, Hammersrnith Hospital, London
A prospective survey of patients referred for
urgent dialysis (required within 24 hours) was
performed between 1982 and 1984. The causes of
the dialysis emergencies and the outcome in the
167 cases were as follows
Cause n % Survival % *
CRF 19 11 95
Acute on CRF 24 15 62
RPGN 15 9 80
Obstruction 9 5 78
ATE 100 60 25
TOTAL 167 100 46
* Discharged from hospital
Late referral of CRF appears to be diminishing
as a cause of the uraeeic emergency for the 19
patients who presented with ESEF requiring urgent
dialysis represented only 20% of the new patients
entering the dialysis programme. The majority of
cases were of "ATE" and the most common clinical
settings were: post—operative (48%) , sepsis (18%)
and following marrow transplantation (12%). The
mortality in this group was high (8O%) and
contrasted with the survival of nine of the ten
patients in whom ATE, caused by pigments or pois-
ons, was the primary problem. The requirement for
intensive care management, implying major
dysfunction of another system, predicted a very
poor prognosis. Survival in this group was 10%
compared to 57% in the group managed on a general
ward. This survey illustrates the changing pattern
of renal failure emergenciosand emphasises the
poor prognosis of those patients who develop renal
failure after high risk treatment procedures.
THE INFLUENCE OF INOOMETI-IACIN PRETREAT-
MENT ON HAEMOOIALYSIS/HO/-INDUCEO GRA-
NULOPENIA
H.Wyaocki, R.Czarnecki. B.Wierusz—wysocka
A.WykrtowiCz, K.bczyk
Academy ad Medicine — Poznañ — poland
HO—induced granulopaflia related to in-.
travascular complement activation is a
well known phenomenon. It is particularly
evident in patients/pte/ dialysed with tha
use of cuprophane membranes. Because of
the known relations between aractii.donic
acid metabolites and polymorphonuclear na—
utrophils JPMN/ activatton. we performed
the studies concerning the effects of in—
doethacin on HO—induced granulopenia.
This cyclooxygenase inhibitor was admi-
nistered arally /50 my/ in O pta, two
hrs before start of HO. In all cases indo-
methacin led to the significant reduction
of following granulupenia. plasma of pts
did not manifest there activity inducing
PMN aggregation whereas activity augmen-
ting PMN adherence and chemotactic acti-
vity appeared similar to dialyses perfor—
med in routine wanner.
The obtained results suggest indometha—
cm pretreatment is useful for the dimi-
nution of HO—accompanying metabolic and
circulatory derangements.
• CHARACTERIZATION OF "UREMIC CARDIONYOPATHY BY LEF'r
HEART CATHETERIZATION WITH SERIAL ANALYSIS OF PRES-
SURE-VOLUME RELATIONS AND MYOCARDIAL 02-CONSUMPTIONV.Wizemann, W.Krawer, J.Thormann, J.Kindier
Medizinische Klinik Giessen and Kerckhoff—Klinik
Bad Nauheim, F.R.G.
Pre—testing of 131 pta on chronic dialysis (MHD)
by echocardiography revealed in 57% left ventricu-lar (LV) hypertrophy. Traditional tests of LV func-
tion in pta on MMD do not distinguish derangements
in loading conditions from abnormalities in con-
tractile state. After coronary and ventriculography
we, therefore, used serial computer—assisted pres-
sure—volume relations (PV), which is independent of
loading conditions and highly sensitive to contrac-
tile st5te to assess LV function in 29 pts on MElD
with normal LV resting function.
Results: 1) Beta-stimulation (dobutamine) in—
creed contractility (PV-Ioops, dP/dt ejection
fraction) without improvement in LV eficiency (4.9
vs 5.3, p)O.OS). LV diastolic filling pressure in-
creased from 17 to 22 mmHg (p<O.Ol). In 70% of the
pta an impaired diastolic compliance (PdV/dt, dP/
dtmiri elastic stiftness constant) was aggravated
(p<O.OO1) during beta—stimulation. 2) LV after—
load—increase (phenylephrine) resulted in an in-
crease in dlasto).ic stiffness in all pts and in de-
pressed contractility in 42%, not evident from
resting LV data.
Conclusions: tiremic cardiomyopathy, it any, is
characterized by disturbed diastolic compliance and
appears to be a variant of hypertrophic cardiomyo—
pathy. Beta- and alpha adrenergic responsiveness
depends on contractile reserves and/or severity of
diastolic dysfunction. Pressure-volume—relations
identify preclinical dysfunction. In those pts
rapid volume removal and inotropic stress should be
avoided.
ANALYSIS OF A LIMULS—PO5ITIVE S6BSTANCE Ii THE
CUPROPHANE MEMBRANE
S. Yamagaiai1, H. Niws11 T. Krshimoto1, ri. Uneda1,
S. Tanaka2, S. Iwanagai, Osaka City Univ. Med.
School1, Seikagaku Kogyo mat.2, Kyushu Univ.3
A Limulus Lysate—positive substance has been
found in dialyzers with Cuprophane membrane which
may be endotoxio. The cascade reaction of the
Limulus Lysate assay consists of the Factor C
system which is specific to endotoxins and the
Factor 0 system which is activated by —glucan.
We developed a new method to analyze the two
systems separately in order to determine whether
the substance is endotoxie. Pyrogeneticity was
also tested using rabbits. Dialyzers with
Cuprophane, Cuproammonium and
polymethylmethacrylate (PMMA) membranes were
tested. They were washed with 100 and 500 ml of
pyrogen—free saline, and the solutions were used
as samples.
As a result, a high concentration of' the
Limulus—positive substance was found in the
Cuprophane membrane dialyzers, but not in the PMMA
membrane dialyzer. The Factor C system was
negative in both the Cuprophane and PMMA membrane
dialyzers, but the Factor C system indicated a
high positive reaction Only in the Cuprophane
membrane dialyzers. In fact, pyrogen tests of the
samples using rabbits revealed no pyrogeneticity
in both the Cuprophane and PMMA membrane
dialyzers.
These results suggest that the Limulus—positive
substance from the Cuprophane membrane was not an
endotoxin but a )3—glucan—like substance. Whether
it has any pathophysiological effect suCh as
compliment activation is not yet clear.
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RELATIONSHIP BETWEEN HYPOTRIIODOTHYROXINEMIA AND
HYPER—INTERMEDIATE DENSITY LIPOPROTEINEMIA IN
CHRONIC HEMODIALYSIS PATIENTS
S. Yukawa, A. Maeda, T. Abe, H. Nomoto, N. Kodama,
I. Nishide
The 3rd Department of Internal Medicine & Neph—
rology Unit, Wakayama Medical College, Wakayama,
Japan
The incidence of hyper—intermediate density
lipoproteinemia (hyper—IDLemia) is high in chronic
renal failure. Neverthless, its pathogenesis
remains to be clarified. In this work triiodo—
thyroxine (t3) and postheparin hepatic triglyceride
lipase (H—TGL) levels were studied in relation to
hyper—IDLemia in 25 patients under chronic hemo—
dialysis (HO). Total IDL or IDL—triglyceride (TG)
had a significant inverse correlation with H—TGL
which showed a weak positive correlation with T3.
With a view to studying the relations between them
in more detail, serum lipids, lipoproteins (Lps),
HDL—cholesterol (C), postheparin lipoprotein
lipase (LPL), and H—TGL were measured before and
after 2 months of oral treatment with 25 ng/day of
T3. Serum TG and C levels were significantly
lowered by the treatment. HDL—C levels remained
unchanged. Very low density lipoproteins (VLDL)
and IDL, especially IDL, were decreased, while low
density lipoproteins (IDL) were increased and the
chemical composition of LDL was concomitantly
normalized. H—TGL was increased but LPL remained
unvaried, These observations showed that hyper—
IDLemia in patients with HD is associated with an
impairment of H—TGL which could be affected by
hypotriiodothyroxinemia.
HEPATITIS B VACCINATION OF PATIENTS ON
HEMOD IALYS IS
P.Zabel, G.Leimenstoll, D.Proppe, W.Nieder-
mayer
Dept. of Nephrology, University of Kiel,
Kiel, F.R.G.
We investigated the immunogenicity of
hepatitis B vaccine (HB-Vax) in patients
on hemodialysis (n=28) and in age-matched
non-uremic controlls (n28). After the ad-
ministration of three doses of vaccine
(lo 1ug each) , 43 "a of the uremic patients
were antibody-positive (radioimmunoassay
technique) as compared to 93 % of controliB,
the antibody levels of the dialysis pa-
tients being significantly lower (p.o,ol).
Thus, we changed the vaccination schedule.
Dialysis patiemts were given double amounts
of vaccine (20 1ug each dose) . After three
doses of vaccine, 88 % of the uremic pa-
tients were antibody-positive, and the
antibody levels were now in normal range.
Our data suggest that patients on dialysis
are low responders to hepatitis surface
antigen. Increment of vaccine amount allow
to obtai:n normal antibody levels also in
uremic patients.
THE EFFECTS OF FISH OIL ON THE LIPID METABOLISM
IN CHRONIC RENAL FAILURE
M.Yurtkuran, Y.Taga, A.öbek, K.özkan
Uludag University, Medical Faculty.Depsrtnient
of Nephrology and Biochemistry
The effects of fish oil on the lipid metabo-
lism ware investigated in 3 female and 7 male
chronic renal patients who have volunteered and
who were receiving maintenance hemodialysis.
High density lipoprotein (HDL) cholesterol was
% 41.3 1.5 mg before fish oil ingestion (BFO)
and 1 34.2 2.4 mg after fish oil ingestion
(AFO), (peO.O2).In the lipoprotein electropho—
resis a—lipoproteins were % 29.76 ; 2.4 BFO and
23.51 ; 1.7 AFO (p<O.Ol).On the contrary 8—lipo—
proteins were % 55.8 3.2 BFO and 67.7 ; 4 AFO
(p<O.O2).There was an insignificant decrease in
the HDL—apoprotein A—I and there was a signifi—
can decrease in the HDL—apoprotein A—Il AFO,
(p<O.Ol).Fish oil in chronic renal failure
appears to increase atherogenic risk factors
as a result of our findings.
REUSE OF POLYSULFON CAPILLARY FILTERS
N. Zbinden, U. Binswanger
Section of Nephrology, University Hospital
Zurich, Swi tzerl and
Reuse of capillary dialysers F 60 (Fresenius)
was evaluated during 68 treatment sessions in 4
patients. Reprocessing included cleaning with
3 % peracetic acid followed by filling with 5 %
formalin by means of an automated system (Rena-
tron). Before reuse, filters were flushed with
3 lt of sterile saline resulting in a negative
test for formalin. A decrease of the filling
volume of the blood compartment by more than
12 % served as guidline for disposal of a dia-
lyser. Reuse was possible 19 times, 6 — 11
times, 4 times and 3 - 5 times in one patient
each. Dialyser clearances remained stable until
disposal amounting to 145 10 mi/mm for creati-
nine and 154 ÷ 6 mi/mm for inorganic phosphorus.
No side effects could be observed.
Reprocessing of polysulfon dialysers by pera—
cetic acid and storage with formalin results in
a variable rate of reuse with stable filter per-
formance.
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HEMOFILTRATION AND HEMODIAFILTRATION
SEMI-CONTROLLED MULTIINSTITUTIONAL STUDY OF DOUBLE
.
FILTRATION PLASMM'HERESIS(DFPP) ON SYSTEMIC LUPUS
ERYTHEMATOSUS (SLE).
Agishi,T. ,Takuina,T. ,Amemiya,H. ,Ito,K. ,Kawaguchi,H.,
Hashimoto,H.*,yamagata,J.*,Koga,N**& Yamagata,Y.**
Kidney Center, Tokyo Womens Medical College, Tokyo
Internal Medicine, Juntendo tJniversity* & Koga
Hospital**, Kurume, Japan
DFPP applying differential filtration principle
with two filters of different pore sizes has become
an established technique in Japan. Clinical trial
for DFPP on SLE patients was performed in a semi—
controlled manner. All of 22 SLE patients were
diagnosed according to the ARA criteria, and showed
either one of high anti-DNA antibody, low comple-
ment or high immune complex level. Further-more,
they had rapid deterioration of kidney function and
some other serious symptoms even on conventional
drug therapy, or were difficult to be treated by
conventional drug therapy because of the untoward
effecta. Two to 6 times of DFPP were performed for
2 to 4 weeks. Plasmacure as a plasma separator and
Evaflux as a plasma fractionator were used. In
most of the procedures, 1,000 to 3,000 ml of the
plasma was processed by the plasma separator and
200 to 600 ml was discarded by the plasma frac-
tionator. S—creatjnine level decreased after the
DFPP treatment in 20 out of 21 cases. Anti—DNA
antibody and immune complex levels also decreased
in all of 14 and 6 cases, respectively.
Erythematous eruption and arthralgia improved in
all of 10. Hair loss observed in 6, Raynaud's
phenomenon in 4, serositis in 4 and mental dis—
order in 1 ameliorated in all cases. High fever
disappeared in 5 of 6 cases. DFPP is a useful
modality of the treatment for SLE patients intrac-
table to conventional drug therapy as saving blood
products to 1/10 to 1/5 compared to standard
plasma exchange.
ACID—BASO IMBALANCE CORREC11ON AND DIALYSIS HYPOXE—
MIA IN HYPERTONIC HEMODIAFILTRATION(HI-IDF).
8asile C.,Di Magglo A.,Scatizzi A.
Dept .Nephrology, Toronto Hospital,Taranto, Italy.
We studied the blood acid—base changes(by nieasu—
rements effected every 30 minutes) in 7 uremic patients
during:A)standard hemodialysis (I-ID) with acetate con
rent of dialysate (Ac)38nmo1/I; B) HHDF with high
'Iux dialyzer and a postdilution hypertonic reinfu—
sion containing lOOnisoI/l of bicarbonate (B),and with
Ac=38u1501/I; C) HHDF like B), but with Ac28ninol/I.
The B reinfusion rates were accurately pair—matched
during B) and C).
In HO there was a significant PaCO2 drop and no
increase of blood B,whereas in booth HI-IDE tr'eatnvrta
no decrease in PaCO and a significant increase of
blood B occurred; b'ood B and pH were significantly
iigher in B) than in C),4rem blood pH was not si9ii
ficantly different ri A) and C). Dialysis associated
hypoxemia occurred only in A) and B), at 60,120 and
180 minutes.
In conclusion,dialysis hypoxemia in acetate HO is
caused by alveolar hypoventilation due to extracorpo-
"-eal loss and/or decreased production of CO ;hypoxe-
'ha is minimized in HHDF with 28ninol/l Ac tanks to
8 reinfusion,whereas it is produced in HI-IDE with 38
ainol/l Ac owing to the higher rise in blood piLThus,
dialysis hypoxemia may be caused by different fa±rrs
and our study shows separately the effects of PaCO2
nd pH changes on alveolar ventilation.
. LONG-TERN EXPERIENCE WITH HYPERTONIC HEMODIAFIL—
.
TRATION (H HDF).
C. Basile, A. Di Maggie, A. Scatizzi.
Division of Nephrology, Taranto Hospital, Italy.
More than 3500 runs of H HDF, in which a conven-
tional acetate hemodialysis (ND) is combined with
a high flux dialyzer (polyacrylonitrile membrane
S, 1.2 sqm.), a high ultrafiltration flow rate and
a postdilution hypertonic reinfusion containing Na
(220 mEq/l) and bicarbonate (B) (100 mEq/l), have
been performed in our unit: 11 patients are being
treated routinely (3 x 3 h/wk) with H HDF (blood
flow rate..L,400 mi/mm) since 24.5 2.9 SEM months.
Our results show: 1) an improvement in dialysis
tolerance and cardiovascular stability by means of
the increased effective osmolality, which mediates
an adequate vascular refilling; 2) no fluid over-
load or arterial hypertension, thanks to an accur-
ate Na modelling, which will be described; 3) no
deterioration of the routine blood work, when com-
pared to the previous HD period (3 x 4.5 h/wk): in
fact the removal of small molecules is comparable,
whereas that of middle molecules is largely greater
in H HDF: the percent amount of netilmicin (N, m.w.
"-450) and inulin (I, m.w. ..3OO0) removed are
(* P 0.001) : N
T
HD 42.0 2.4 27.0 4.9
* *
B BDF 56.6 1.7 57.4 4.1
4) a persisting blood B improvement; furthermore,
no significant dialysis hypoxemia develops during
H HDF, at variance with MD, thanks to B reinfusion:
HD 9.8 mmHg (P.c 0.05)
Pa 0 (Pre—Post)
H HDF 6.2 mmflg (P NS)
In conclusion, in our experience H HDF has all
the requisites necessary to become the routine
method of the long—term treatment of uremia.
SMALL AND )4IDDLE MOLECULES IEMOVAL IN ITYPERTONIC fW—
MODIAFILTRAJION.
Bosile C., Di Magymo A., Scatizzj A.
Dept. Nephroioqy, Toronto Hospital, Taranto, italy.
Hemodiofiltration seems to be an effective alter
native to hemofiltration and hemodialysis(l-ID),as re
qarda sisal and middle molecules removal
.We studiei3
small molecules(urea,creatmnjne, uric ocid,phosphorus)nd middle molecules(nctilm,cin_N,and inulin—I—)c
erances and removal in 7 uremic patients underyoin&j
A)staridard HD of 270 mmnutes,with cuprophan men*mrars
(lsqrim); B)o peculiar model of hemodiaf I trot ion(HHDF
of 180 minutes,with poIiicrylonitrjle membrane(1.2
sqm),LIF=ôOml/min and postdi lot onal hypertonic rein
jection.l(MW=5200) and N,an aminoglycoside with ne-
gligible protein binding, (MW45O),were injected i.v.
4' minutes before the heqmnnincj of each session. In
all cases 0 and Q0were:400 and 530 mI/mimi retjvsl>
As expected, clearances(calculated on plasma
were greater in HI-IDE for al I molecules considered.
-Dveral I rermioval(measured in the col lected ultrfi I—
trate and oialysate)was greater in HHDF for I and N,
slightly greater in I-ID for urea,not significantly
different for creat nine, uric acid,phosphorus.
Extraction index( initial pool x IOU/removal) was
calculated for urea an I
HO HOE
urea 67% 61% (P<O.05)
43% 62% (P<o.o!)
In conclusion,HHDF allows a 30% reduction in the
dialysis treatment time,ach,eving a similar smolIm
lecules removal(except for a slight difference for
urea),but a greater middle molecules removal,coimpa—
red to HO of 270 minutes.
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HEMOFILTRATION WITHOUT HEPARINISATION IN 111GB BLEE-
DING RISK UREMIC PATIENTS
A.Bourdais, J.M. Klein, J.Drudi
Service d'Hémodialyse du C.H.T. Papeete — Tahiti.
High bleeding risk in 5 urernic patients was the
result of surgery (2 cases) ,renal biopsy (2 cases)
and gastro intestinal bleeding (1 case). In these 5
patients we assume 9 sessions of hemofiltration
without heparinisation (HFWH) using the principes
of hemodialysis without heparinisation (HDWH) : 1)
maximal blood flux (600ml/min). 2) complete filling
of the drip chamber with blood to prevent air blood
interfaces. 3) Periodic rinsage of the hemofilter
with reinfusion solute while clamping the ultrafil—
trate outlet of the hemofilter. We use a system
with an electric sequential timer activimg succes-
sively a blood pump during 3 to 8 minutes (average
5) (with electroclanp on the ultrafiltrate outlet
of the hemofilter open) ,and a reinfusion pump du-
ring 1 Shinute (with electroclamp closed), an hemo—
filter (ASAHI PAN 200), an air detector (Gambro
LV2A) and a manometer (SN 10). The total weight of
ultrafiltrate and reinfusion solute was maintained
constant on a scale by action on reinfusion flux
and duration of activation of each pump. Result
were excellents in 8 sessions with exchanges of 201:1
in 5 sessions, 12/1 in one and 10/1 in 3. In one
session only, coagulation in blood lines and hemo—
filter lead to stop HFWH. Most frequent incidents
were partial coagulation in the drip chamber and
progressive diminution of the ultrafiltrate flux
through the hemofilter. The blood coagulation tests
suggest a partial consumption of coagulation fac-
tors in blood lines and the heiuofilter.
Conclusion HFWH is more easily feasible than HDWH
in high bleeding risk uremic patients, but partial
consumption of blood coagulation fractions in blood
lines and hemofilter is inevitable.
ARGUMENT FOR THE REUSE OF PLASMAFILTER (pt')
Ii. DECHdL6TI'i:. Cl. LANBERT, 1. BESSOUD, F. KUENTZ,
CI.JURKOVITZ.
Unite dHémodialyse .C.H.U.GRENOBLE — FRANCE.
The reuse of plasmafilter Kuraray SA hasbeenstudsd
because of its performance (Gurland aod personal data)
and the ease With which itis cleaned and sterilized
METhODOLOGY: 161 plasma exchange sessions,22PF for
14 patients. PF were only used on the same patient.
We analysed the following criteria : possbiljty of
reuse; tme consumption for the team, patient's re—
actons, heparin need, hemolysis, bacterial samples
filter performance.
RESULTS: .1.percentage of PF whi'h were reusable
was 100 % for up to 4 sessions, 87 % for up to 9
seasons, 66% for up to 16 sessions2.Each procedn
takes abiut 20—30 an, but it should be noted that
except for an immediate start to washing, the procedure may be carred out when the nurse has free tire
.3. The patient did not exhibit any not cable adver-
se reactions. One patient died a few minutes after
the beginning of the 9th seas on with the same PF.
No explication ould be founded even after autopsy.
.4. The need for heparin remains stable. Hemolysis
is obvious only during the beginning of the first
sessions wth a PF,
.5. 136
baTterial exams were done on the rinse fluid,3 were
positive (epiderrnidis staphylococcus) without clini.-
al symptoms.6. We compared the results of PF per-
formance obtained during the first 3 sessions and
the sessions taking place after the 6th reuse of t1filter, The relative filtration flow (quF/qp
decreased from 48±11.4(l8cases) to 45±16(5cases
the fraction of filtered molecule (cUF/Cinlet plas-
ma) increased from 77±21 (8cases) to 8O5±25(4 case
for IgG and from 56.5+29 (8cases) to 75.8*4 (4 Ca—
ses)for 1gM. In a patient with essential hyperchole
sterolesnia, decreases of cholesterol involved from
64.8 % i 4% to 54.7% during the sessions.
BIOFILTRATICI'1 (HF) VERSUS HJFILTEATIC1'I (HF) IN
THE ThEI!4ERT OF CHRC1JIC URE24IA.
G.Cae11i, A.Icardi, S.Lanperi
Division of Nephrology, St.Martin Hospital, Genoa,
Italy.
HF, a new depurative heno-diafiltration errploy-
ing a high efficiency nembrane (acrylonitryle and
netallilsulfcnate of sodium) and a reinfusion of
4-8 liters of fluid,as an alternative nethod to HF,
has been tested.
8 uremic patients ,who shcd circulatory insta-
bilities during traditional henodialysis (HE)) ,have
been treated with HF (270+20 no/session) or with
HF (210 nm/session) for 12 ncmths.
low and middle nolecular weight netabolyte wee-
kly clearances ,Calcium, Phosphorus and bicarbonate
serum levels in HF and HF have not shown any sta-
tistically significant difference. Leuccx2yte count
and CH50 dosage have dennstrate in HF and in HF a
similar behaviour. With HF the incidence of ayiphe
matic lypotension events and the orthostatic chan-
ges of blood nean pressure have teen lower than
with HE), but little higher than with HF.
Our results show that HF is capable to cause a
satisfactory depuration of low and middle nolecular
weight rietabolytes in a shorter period of tine
than HF. With the sane aethods either an excellent
bioccxipatthility or an inprovenent of Autonomic
Nervous System abnormalities are cbserved.
.
RLIJ(INILJ4 (XWTENT NL) HTST(L(EY IN 00€ (F PATIENTS 04
IE)O)IPLYSIS NI) IILTRATJ01. A COQP.RATIVE S1U)Y. Dkhjssj H
Galy C., Fohrer P., De Fremont iF, Morinière Ph, Leflon P,
Sebert 31, Atik H, Fournier A. CHIJ Amiens.
In order to compare hemofiltration and hernodialysis as re-
gards the risk of aluminium overload and renal osteodystrophy,
double bone biopsies after oouble tetracycline labelling and a
desferrioxomine teat were performed in 12 patients on hemofil-
tration and 15 patients on hernodialysis. Aluminium concentra-
tion was low (<.6 'mol/L) both in the dialysate and in the subs'
titution fluid. The duration of treatment (about 2 years) and
the cumulative doses of A1(OH)3 and CaCO3 were comparable in
the 2 groups. None were taking bhydroxy1ated vitamin 0. Alum!.
ni,jn balance during a hemofiltration run ranges from -22 to
v 1.8&stol, the balance being positive only when plasma alum!—
niun was <.5)jmol/L. Basal plasma aluminium and its increase In.
duced by desferrioxamine( Desf. PAI)were comparable in the 2
group's. Bone aluminium content was also comparable but about 10
times higher than in 7 non uremic controls. The bone aluminium
content andAoesf.P Al were correlated to Al ('l)3 cumulative
dose. None of the patients had florid osteomalacia with increa-
sed osteoid thickness and Only one in each group had traces of
stainable aluminium. Mineralization front was decreased in 8/12
patients on hemofiltration and in 9/14 patients on hemodialysis,
The predominant histological picture of the bone of the pa-
tients was osteitis fibrosa which was present in 10/12 patients
on hemofiltration and in 13/15 patients or, hemodlalysis. Mean
osteoclast count and active resorption surface were comparable
in the 2 groups but increased (5 to 10 tines the mean of con-
trols). The severity of osteitis fibrosa was correlated to pbs
ma concentrations of PTH which were increased in both groups
(about 19 times the upper limit of normal). (DCJSIO6 : alum!
nium overload exists at a comparable degree in hemofiltration
and hemodialysis. It is dependent upon the cumulative dose of
Al (Q1)3 not upon the procedure per Ce. After 2 years of treat-
ment it is not severe enough to induce florid osteomalacia. At
this stage the main histological lesion is osteitis fibrosa in—
&ceci by hyperparathyroidism. This latter has the same severity
to t fIIt,fnn.55. ¶n
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BACTERIAL INFECTIONS AND POLYMORPHONUCLEAR (PMN)
FUNCTION IN CHILDREN ON SUBSTITUTIVE TREATMENT
L.Ghio°, A.M.Plebani+, M,Piccao, M.Glan1°,A.Biolchi-
ni+, E.Viola÷, M.Bardare+, A.Edefontio,(Intr, by L.
Minetti)
°Pediatric Dialysis Unit, University of Milan
+First Pediatric Clinic, University of Milan
An increased incidence of' infectious disease and
PMN abnormalities have been reported in pts on
chronic renal failure and hemodialysis (HD). Data
are lacking for hemofiltration (HF). For this purpo#
se the rate of bacterial infections and PMN functiort
(Chemiotactic index (CI), Candids Aibjeans (CA)
phagocytosis (phF) and CA Killing) were studied in
lo children , mean age 11.4 3.4 yrs, treated with
HF and in 7 children , mean age 12.6 3.5 yrs,
treated with HD. The infection rate was evaluated
during a 18 mo. period. Results: the incidence of
bacterial infections was 1 per 21.5 pt—mo. for the
pta on HF enri 1 per 21 .-8- p-t=ino for tftm p-ta n ND.
The data (mean -4- SD) about PMN function are sum-
marized in the table.
Patients CI CA (phF) CA Killing %
HF 59.8+ 21.2* 0.24÷ 0.05 25.5÷ 4.2
HO 47.4÷ 26.7* 0.16÷ 0.05* 23.6÷ 2.5
Controls 117.9÷ 8.7 0.25÷ 0.05 24.2+ 3.3
*p <0.001
In conclusion, despite of the impairment of CI on
HD and HF and CA (phF) on HD, the incidenee of
bacterial infections in our population is low, ir-
respective of the depuration method,and less than
that reported for hemodialyzed adult patients.
SUCCESSFUL TREATMENT WITH HENOFILTRATION FOR UREMIC
NEUROPATHY CAUSED BY MANGANESE INTOXICATION
S.Hosokawa, H.Nishjtani, K.Sawanishi, O.Yoshida,
K.Umemura, T.Nishio, T.Tomoyoshi
Utano National Hospital, Kyoto&Shiga University,
Kyoto & Shiga, Japan.
Manganese (Mn) is one of the essential trace elements,
however abnormal accumulation of Mn can cause uremic neu-
ropathy in chronic renal failure patients. We measured
serum Mn concentration of 10 chronic hemodialyzed patients
iith uremic neuropathy (A group), and 20 hemodialysis pa-
tients without neuropathy (B group). We examined whether
hemofiltration (HF) method can remove serum Mn or not,
since approxymately 55% of total- serum Mn binds to pro-
tein and is not unable to remove by hemodialysis. Our 30
patients were received 3 times a week, 5-hour dialysis
using various kinds of dialyzers. Mn levels were measured
by flameless atomic absorption spectrophotometer (Hitachi
K.K., Japan). The average serum Mn levels in A group were
0.63L45/dl and 0.21 in B group. Normal subjects: average
0.51.usfdl). There was a significant difference (p<0.001)
in serum Mn levels between A group and B group. We
treated A group pat ients by using post mode of HF(each HF:
5-hours using 20 liters replacement fluid (Sablad A; Fuso,
Japan); 3 times a week) during two month, We used various
kinds of hollow-fiber hemofilter for HF. We made a diag-
nosis of ureaic neuropathy with electromyogram (E.M.G.)
and neurological examination. After 2 months HF treatment,
the serum Mn levels in A group patients significantly de-
creased to 0.22 ,zgjil. Six of ten patients with uremic
neuropathy were recovery completely after two months HF
treatment, and in four other patients, muscle pain was im-
proved with decreasement of serum un levels. We conclude
that HF treatment was very effective for uremic neuropathy
caused by manganese intoxication. Serum Mn levels were
low In chronic hemodialysis patients without uremic neu-
ropathy. and were very high in hemodialysis patients with
uremic neuropathy.
DRU6 REMOVAL BY AMICON_20e4 DIAFILTER IN CAVH.
itier, A—M Saad, WM Bennett.
Oregon Health Sciences Univ., Portland, U.S.A.
Hemodialysis membranes are more restrictive tc
drug passage than the Amicon—20® Diafilter poly-
sulphone membrane, Drugs listed below are <3500
daltons and their passage through polysuiphone is
limited only by drug—plasma protein binding, the
unbound fraction being 100% filterable.
Below is our data on the filtration of several
drugs through the Amicon-2O' Diafilter, presented
as the ultrafiltrate level/plasma water (UF/Pw)
ratio. Each number represents a single observa-
tion in one patient, unless otherwise noted.
Drug IJF/Pw Drug liF/Pw
Pmphotericin .4 tronidazo)e .88, N3
Ampicillin 1.13 Nafcillin .39
Cefoperazone .27 Phenytoin .51
Cefotaxime .50 Procainamjde .80, N=2
Cephapirin 1.21 Streptomycin .30
Clindamycin .98 Thiocyanate 1.07
Digoxin R 1.0, N=4 Tobramycin
.83, N3
Erythromycln .37 Vancomycin .62, N=4
Gentamicin .85, N4
Uremia, bilirubin, free fatty acids, heparin,
other drugs, acidosis and molar ratios of drug
and plasma proteins all may alter protein bind-
ing. Because of these limited data, we have been
unable to relate these factors to our observed
JF/Pw ratios. Protein binding data of drugs are
cited in Bennett et al (Am J Kid Dis 1983;3:155).
To determine the unbound fraction, subtract the %
bound from 100. The fraction unbound times the
total Pw drug Concentration should approximate
the iF drug concentration. The UF concentration
times the UF volume equals total drug removed.
For practical clinical purposes our data supports
this approach.
SUCCESSFUL TREATMENT WITH HEMOFILTRATION (HF) FOR
UREMIC DERMATITIS
S.Hosokawa, H.Nishitani, K.Umemura, T.NIshio,
T.tomoyoshi, S.Sawanishi, O.Yoshida
Utano National Hosp., Shiga & Kyoto Univ.
Kyoto & Shiga, Japan
Many chronic hemodialysis patients have been
suffering from uremic dermatitis despite adequate
hemodialysis (HO). It is well-known that uremic der-
matitis were caused by uremic toxins with middle
molecular weight (500 — 5,000), We treated fifteen
chronic HO patients with uremic dermatitis using HF
treatment. Fifteen patients (average ages 52 years
old, H male, 7 female; BUN levels 10'fmg dl, serum
creatinine levels 12.5 mg/dl) were received 5-hour
HF, three times a week, using hemofilter with PMMA
membrane (produced by Toray, Japan). Each HF treat-
ment were used twenty liters replacement fluid (Sab-
lad A, Fuso, Japan), After three months from the be-
ginning of HF treatment, 12 patients of 15 patients
were completely recovery and the symptom of itching
were improved in three other patients. The average
of BUN and serum creatinine levels decreased to 92
mg/dl and 10.1 mg/dl. Amino acid analysis showed the
improvement from 580sM/L to 660MM/L in essential
amino acid levels (EA)totalled; and from 1,BHOuM/L
to 1,?4O4M/L in non-essential amino acid (NE) ave-
raged, however the tyrosine /phenylalanine ratio in
plasma was not corrected by HF treatment from 0.58
to 0.59. Serum zinc (Zn) levels significantly ele-
vated from 58 ig/d1 to BH4ug/dl. Serum nickel (Ni)
levels elevated from 0-21 ig/dl to 0.34g/dl. We
conclude that 12 of 15 chronic HO patients with ure-
mic dermatitis were completely recoverd by HF in
order to removal uremic toxins with middle molecular
weight; improvement of amino acid abnormality and
trace metals abnormality (such as serum Zn and Ni)
caused uremic dermatitis.
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SPONTANEOUS HEMOFILTRATION BY GRAVITY (SHFG) FROM
SINGLE VENOUS ACCESS.
S. Landini, U. Coli, G. Bazzato.
Nephrology and Dialysis Dpt., Umberto I Hospital,
Venice—Mestre, Italy.
Continuous arteriovenous hemofiltration (CAVH)
has been demonstrated to be effective in the treat
ment of ARF or overhydration. Nevertheless the ne-
ed of an arterial access and the long duration of
the session make CAVH of difficult application for
chronic treatment. We propose a new procedure for
spontaneous HF which needs a very simple device wi
th only a single venous access. The set for SHFG I
ncludes a high permeability hemofilter and two col
lecting bags for blood (250 ml) and ultrafiltrate
(3000 ml). The system is connected to an electric
supporting arm which provides to the set the diffe
rent heights for the inlet—outlet phase. The ultra
filtration is obtained by transmetnbrane gravity
and negative suction pressure. The blood flow can
be derived from central or large peripheral vein.
Epar:Lnization (5000 Ui) is performed at the sta
rt of the session, followed by in line ACD infusi-
on during the withdrawal phase. After the connecti
on to the blood access the system is completely ma
naged by the patient himself acting the electric
arm which lowers and elevates the hemofilter set.
With this device we have performed 42 sessions in
5 overhydrated patients. The blood flow was 67+6
mI/sin from peripheral vein, and 103+11 mi/mm fr-
om central vein obtaining an ultrafiltration rate
of about 700 el/hour. The main advantages of SHFG
appear the semplicity of apparatus, the single ve-
nous access and the minimal medical assistance whi
ch make this procedure feasible also in unspeciali
zed Departments.
CCNTIN0003 .RT!HIOVNOU.;' INOFILTPATION — A
'PEATIENT OPTION FOP KIDIJEY FAILUTIE IN
NON—PENAL UI: ITO.
Onuzo, T.Odutola, S.Ositelu, A.Mabadeje
Nephroiogy Unit, Lagos University Teaching
Hospital, Lagos — Nigeria.
The purpose of the study wam to show that
CAVH is a treatment concept that can assist
the average clinician especially in the devel-
oping world to cope with the exigencies of
kidney failure, and so reduce the number of
moribund patients that are referred to
tertiary health care centres.
All the patients evaluated had clinical and
biochemical evidence of kidney failure, either
acute or chronic. A Gambro FIt 101 haemofilter
was used in the study. Vascular access was
through the femoral route. Fluid substitution
was with normal saline or a modified Ringer s
lactate solution. Ileparinisation was by the
intermittent bolus method using 500—750 lU/hr.
The patients were treated for between 7 and
36 hours continuously, and between 7 and 26litres of fluid were exchanged. Mean arterial
pressure ranged from 70—120 saNg and ultrafil—
trate generation rate was between 6 and 12ml/
mm. Patients were supervised Dy non—rena].
physicians on routine ward call.
The results showed a 17—39 fall in the
pre—haemfi1tration levels of urea and creati—
nine, and an impressive clinical improvement
as judged by levels of consciousness, tremors,
tachypnoea, and a fall in the mean arterial
pressure as well as peripheral oedema.
NAG.I.NT OF ACUTE HdNAL FAILURE aITH CUNTINUUW AR
TIQ\Jc.N[JUb }4jtFILTrtATIQN IUAVFF).
J.M,Lopez-Gomcz, S.B .Vxnuesa, V.Barrio, M.SancheZ, E
dunco, J.Luno, M.A.Alvarez, A,Fr'anco, F.Va].derrabano
Hospital Provincial. Madrid. Spain.
tie have treated 12 oliguric acute renal failure
tients with CAVIF using an Amicon hemofilter of 0.25
m2.Cardiovescular instability or' hypotension were
the selection criteria to treat patients with this
mathod. The most frequent vascular access vere femo.
ra]. artery and Buselmeier external shunt. Continuous
heparine infusion in the arterial line at a rate of
500—1000 U per hour was used. Protainine conhinuous
infusion puap as used in the venous line in two
high bleeding risk patients. ith the aim of increa-
sing the ultrafiltration rate, ultrafiltrate line
was connected to a vacuum system. Total treatment
ranged from 31 hours to 20 days (mean: 97 h.) with a
mean duration of hemof'ilter device of 51.8 h. Mean
ultrafiltration rate was 8,499 al/day. No signif i—
cant differences were found betasen venous, arterial
and ultrafiltrate samples for urea, creatinine and
elec trolites except for an leveted calcium concen-
tration in the venous line and for chloride and to-
tal 2 in the ultrafiltrate. Fluid reposition con-
sisted of peritonea]. dialysis solution, hypertonic
glucose and aminuacicls. No patients needed hemodia—
lysis during the treatment with OAVF No changes in
blood preaaure or were produced and only one
tient prsunted a gastrointcstinal bleeding +hich
required discontinuation of the procedure.
ie conclude that is effective in the manaGc
meet of acute renal failure pati-nts.It allows a
continuous fluid removal perssrvinq hemodinamic eta
bility and a total perenteral nutrition without
fluid overfloa.Treatmcnt +ith only JIP can cmpen
sate th oliquric i'mral ailure and no other dialy-
sis treatmont is nmccsary.
DECR EASED RISK OF IRON OVERLOAD IN
CHILDREN TREATED WITH HEMOFILTRATION
It' .Picca, M .Bacchini, A .Saccaggi, L .Chio, It' .Ca—
sati, A .Bettinelli, M .G iani, A .Edefonti
Pediatric Dialysis Unit,University of Milan
Anemia is commonly present in uremic patients .Td
prevent symptoms ,periodic blood transfusions are
required ,that results frequently in iron overload.
We studied hematologic values, serum fe rritin(S F)'
as index of body iron stores,blood transfusions
(BT) rate,iron supplementation (IS) in 11 children
(lO.2+4yrs) treated first with hemodialysis (HD)
for 12 mo .and afterwards with hemofiltration (HF)
for the same period .The results are summarized
in the Table
BT/mo SF/ng/ml Pts on IS
RD 0.43+0.19 442.7+467.7 2/11
HF 0.35+0.21 241.1+221.2 5/11
p n.s. O.Ol
In HF, despite of the number of BT is not signifi
cantly changed, SF is significantly decreased and
the children on IS are increased.
In conclusion,HF considerably reduces the risk
of iron overload in pediatric patients .Furthermo
re , iron supplementation may be required in chil
dram on HF with low BT rate to avoid a worse
fling of anemia.
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IONIZED SODIUM (Na+), THE ACTIVE PLASMA SODIUM: KI-
NETICS DURING ISOLATED ULTRAFILTRATION (UF).
R. Ponti, C. Ripamonti, A. Citterio, F. Locatelli.
Division of Nephrology and Dialysis, Lecco, Italy.
Since Na+ is the active portion of plasma sodium
and hence is more directly involved in the transpo-
rt across dialysis membranes we wanted to get a de-
eper insight into sodium kinetics by comparing the
behaviour of Na+ and plasma water sodium concentra-
tion (Nap) during UF.
3 patients underwent 6 UF each, using hollow fi
bers 1 sq.m. cuprophandialyzers, Qb 300 ml/min, IMP
200 mniHg. Ultrafiltration rate was 14.55+1.0 ml/min.
Na+ was measured by an ion-selective electrode (di-
rect potentiometry), NaP was calculated from flame
ohotometer plasma sodium and plasma proteins.
IN OUT Uf SC
NaP 150.51+2.22 150.92+2.13* 143.01±2.45° 0.949
Na+ 143.30+2.68 143.8O+2.86** 137.50+2.500 0.958
p <0.01 <001 <0.001 <0.001
IN= blood inflow; OUT= blood outflow; Uf= ultrafil—
trate; SC= sieving coefficient ((IN÷OUT)/2Uf).
*p<0•02, **p<0.001 vs. IN; °p<O.0O1 vs. IN and OUT.
The fact that Na+ is significantly lower than NaP
both in blood and Uf indicates thata portion of so-
dium is bound by anions and therefore is not active.
During UF both NaPandNa+ significantly increase
in blood and are significantly lower in Uf than in
blood because of the Donnan effect. The difference
between blood and Uf is significantly greater for
NaP, so that Sc calculated from NaP is significan-
tly lower than SC calculated from Na+: this reflec-
ts the portion of sodium bound by proteins.
ART[RIO-VENOUS HEMODIAFILTRATION (A—v HDF): A POSSI-
BLE WAY TO INCREASE UREA REMOVAL DURING C.A.V.H.
c.Ronco,A.Brendolan,D.Borin,L.Bragantinischiaron
Creca.
Departments of Nephrology and Intensive Care Unit -
St.Bortolo Hospital — Vicenza — Italy.
Continuous Arterlo-Venous Hemofiltration(C.A.V.H.)
in the treatment of critically ill patientswithA.R.F.
is often limited by a severe catabolism;an increase
of ultrafiltration (UF),a complete replacernent,ml/nil,
of UF and the use of parenteral hyperalimentation
may improve the efficiency of C.A.V,H. When a fur-
ther solute removal is required we suggest a system
called Arterio—Venous Hemodiafiltratjon (A-V HOE).
For this purpose we use a modified Amicon D—20,pro—
vided with an extra UF port.The system maintains the
C.A.V.H. simplicity and offers higher clearances
thank to Convective + Diffusive solutes transport cb
tamed with a countercurrent dialysate flow (Qd).
We treated a patient for 21 hrs. with C.A.V.H,a-id
then 3 hrs.with A-V HDF.Successively the C.A.V.H.was
continued with the same filter,just clamping dialy—
sate port.The following parameters were obtained
C.A.V.H. C.AVH, - A-V
-IDE
TIME 24 hrs. 21 hrs. + 3 hrs.
Qb (el/nun) 60 60 60
Qd (ml/min) I / 300
Qf (el/mm) 10 10 3
UN Clearance (mi/mm) 10 10 + 38
These data show that a dialysate flow added to
C.A.V.H.inuproves the solutes removal and therefore
a daily session of A-V HDF may be scheduled in the
severely catabolic patients.
• TREATMENT OF ACUTE RENAL FAILURE(ARF)IN THE NEWBORN
.
BY CONTINUOUS ARTERIOVENOUS HEMOFILTRATION(CAVH)
C. Ronco ,A. Brendolan ,S. Chiaramonte,M.Ferianj A Fabris
L.Bragantini,L.Menicantj,G.La Greca
Department of Nephrology,St,Rortolo H.Vicenza—Italy
The treatment of ARF in the newborn with hemo
or peritoneal dialysis is technically difficult and
may even be contraindicated.As in the adult CAVHmay
be an alternative therapy.We have treated with CAVH
4newbornswith ARF of different etiologies.2brachja],
1 fenuoral an 1 umbilical arteries were cannulated
arterial access,while 3 jugular and 1 umbilical vein
were used as venous return.An AMICON 0.1 m2 polysul
phon hollow fiber hemofilter was connected to the pa
tient with shortened pediatric hemodialysis lines.
Heparin was administered at a rate of 5-7 u/Kg/hr.Hy
peralimentatjon and/or buffer solutions were used as
replacement fluids and were administered according
to the patients fluid balance.Mean data in the 4
pts.are shown:
Patient n°i n°2 n°3 n°4
Age (days) 4 2 2 12
Plasma flow(mlJmin) 19.6 18.7 9.8 14.3
Ultrafiltration rate(ml/min) 1.1 1.0 0.8 0.7
Treatment Time (hrs) 86 78 30 48
The treatment was well tolerated (Pts n°1,2 re
covered and Pts n°3,4 died due to complications un-
related to the treatment).Arterial pressure remained
stable during the procedure.Metabolic acidosis,when
present,was corrected by increasing the amount of
buffer administered.BUN was maintained below 60 mgI
dl in 3 patients.In e patient catabolism waf severe
and CAVH was discontinued due to high levels of BUN.
SUPERIORITY OF HAEMOFILTRATION IN THE ELIMINATION
OF PORPFIYRINS IN A PATIENT WITH SEVERE PORPHYRIA
CUTANEA TARDA (PcT)
K.W.Rumpf, S.Seubert, A.Seubert, H.Kiffe, H.Wagner
J.-M.Beyer, H.Ippen, F.Scheler
Departments of Medicine and of Dermatology
University Hospital, Coettingen, FRG.
PCT is not infrequent in patients on RDT. Treat-
ment by phlebotomy or chloroquine used in non ur—
oemic patients is not applicable. Comparative data
on the effectiveness of different forms of renal
replacement therapy on the elimination of porphyr—ins are lacking.
Using HPLC we measured porphyrin elimination in
a patient on RDT with severe mutilating PCT and ex-
cessive plasma total porphyrin concentrations ( 2_n
mg/i; normal < 0.02 mg/i; patients on EDT (n50)
without PCT 0.016-0.071 mg/i) , comparing Convent-
ional haemodialysis (ND) , haemofiltration (HF) , and
plasmapheresis (PB).
HF (cellulose acetate; 20 i) was 6-fold more
effective in eliminating porphyrins from plasma
than MD (cuprophane; S hrs) and 4-fold more effect-
ive than PP (2 1). HF was most effective in the re-
moval of uroporphyrin and heptacarboxyporphyrin -
the 2 major metabolites in POT —, whereas it was
lesa superior in the removal of the hexacarboxy—
and the pentacarboxy compounds, respectively, and
of coproporphyrin.
After 1/2 year of treatment by HF porphyrin
levels in Our patient had decreased dramatically
0.39 mg/i) and the cutaneous laesions had im-
proved.
We conclude that in patients with end stage
renal failure and PCT HF is far superior in remov—
ing porphyrins from plasma and that it should be
prefered to ND in such patients.
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ON-LINE PREPARED HEMOFILTRATION (HF) SUBSTITUTION
FLUID VERSUS COMMERCIAL INFUSATE: MICROBIOLOGY AND
PYROGEN CONTENT.
Schäffer J, Brunkhorst B, Bahlmann J, *Shaldon S,
Eisenbach GM
Hanover, West Germany; *Nimes,France
On—line batch blending preparation of HF substi-
tution fluid carries the risk of microbial and py—
rogen contamination. Our system consists of tap wa-
ter treatment (5pm filter, softener, charcoal, 1pm
filter, ultrafilters, RWO), mixing of the product
water 31:1 with a dialysis concentrate in a closed
plastic bag and two ultrafilters before the infu—
sate enters the patient. Microbiolog. quality of
infusate was tested by the full stream filtration
mode (total of 2—32 1 infusate; O.LlSpm disc fil-
ters jr Swinnex holders located before the final
ultrafilters in the on—line system and before the
patient in conventional HF; 7 day 22°C incubation).
For pos. plates (one or more CFUs) germs were iden-
tified. Pyrogen concentration was measured by a
chromogenic substrate method, sensitivity 5 pg/al.
Membrane filters were positive in 25/222 (12.8%)
on—Line and (/'44, IO.%) conventional ht treat—
merits; in most positive samples (60% in on—line and
56% in conventional HF) coag.neg. staph. was iden-
tified, indicating contamination by handling. Pyro—
gen concentration in on—line as well as commercial
infusate was always below 5 pg/ml.Spot samples from
processed water after ultrafilters before the RWO,
and from infusate before and after the final ultra—
filters were negative for bacteria and pyrogen. No
adverse reactions were observed in either patient
group. The data proves on—line preparation of HF
substitution fluid to be as safe as the use of com-
mercial infusate. Further improvement is expected
from continuous in—line preparation avoiding fluid
storage and reducing contamination by handling.
(X)NTINWUS PUMPDRIVEN VE)VEJUS HEr4)FILTPATION
(cwHF) USING IX)UBLE LUMEN CATHEPER IN fl1E TREAT-
MENT OF ACUTE RE5L INSUFEICIENCY.
H.K. Stumivoll, J. Kovarik, A. Luger
2nd Capt. of mt. tdicine, Univ. Vienna, Austria.Since 1982 122 pts were treated by continuoushenofiltration (cliP) in our intensive care unit.
102 for treatment of acute renal failure, 12 for
congestLve heart failure and 8 for acute respi-
ratory distress syndrome alone.
Blood access and blood transport:
Whenever possible (limited by the availability of
pumps) punpdriven venovenous cHF was applied usirj
Mahurkar double lumen catheter inserted into V.
cava sup. via V. jug. mt. Thus, in 74 pts cvvHF
was perforned, in the remaining 48 pts arterio-
venous henofiltration (CAVH) was carried out usin
Kraners original method. One retroperitoneal blee-
ding necessitating surgery occurred in CAVH, no
serious catheter complications occurred in cvvHF.
Henofilter, antbcoagulati, biocorrpatibility:
Low dose heparinization was aimed (usually 5ooU,'h)
Tine until filter clotted ranged from hours to 7
days with a mean of 48 hrs, being longer in cvvHF
vs. CAVH with no correlation to coagulation tine.
Bioconpatibility was excellent, especially no
thrombecytopenia occurring in long term.
Filtrate and substituate:
Filtrate volume could be augmented almost inde-
finitely limited only by the speed of substitute
infusion. Thus, every desired steady state crea—
tinine could be achieved. Miinoacids vre filte-
red unrestricted and a loss of 2coo unol AA/l fil-
trate had to be accounted for in nutritional sup-
port.
Thus, cvvHF is superior to CILVH with regard to
complications of blood access and sufficiency in
blood purification even in hypercatabelic states.
EFFECTS OF DIFFERENT HEMODIALYSIS PROCEDURES ON
BLOOD FIBRONECTIN (FM) CONCENTRATIONS.
F.P.Schena,G.Pertosa,A.Pastore,C.l4anno,V.De Mitrio.
2nd Medical Clinic, Polyclinic, Bar Italy.
Low levels of FN may be the cause of reticuloendo
thelial system dysfunction and decreased resistance
to bacterial infection in chronic uremic patients(pts)
We analyzed the influence of three different
dialyzer membranes (cuprophan,PAN,cellulose acetate)
on FN levels in 57 pts undergoing periodic hemodialy
sis and in 8 pts treated by hemofiltration. Pts with
sepsis were excluded from the study. FN was measured
by single radial immunodiffusion technique. Since FN
binds to fibrinogen and fibrin, its concentration
may be influenced by a possible activation of the
coagulation cascade; therefore, fibrinogen concentra
tions and its split products and aichool test were
estimated.
Our data showed significantly low levels of FN in
uremic pts who received periodic hemodialysis(p<O.O])
by three differenL dialyzer membranes. FN fell more
significantly after the use of PAN and cuprophan.
Moreover, moderate activated coagulation was present
in 57% of pta dialyzed by PAN. A significant improve
ment of FN was found in subjects who received hemo
filtration(p<0.Ol).These findings suggest that con
ventional hemodialysis does not improve the low
levels of FN in chronic uremia, rather, a probable
activation of the coagulation cascade may worsen the
initial FN values.Hemofiltration may contribute to
increase FN levels in the blood and consequently
improve the pts defence mechanism against infections.
REMOvAL OF MIDDLE MOLECULES(MMs) WITH HEMOFILTRA-
TION. (HF>
I Taraba, M. Idei, Gy Simon
Semmeiweis University, Budapest, Hungary
It is supposed that uremic intoxication can be
beneficially influenced by removing 1045 from the
circulation. 7 regularly dialysed patients were
subjected to HF on two successive occasions, both
plate (Sartorious SM 40003) and capillary (Gaxnbro
FH202) filters with cellulose propionate and
polyamide membrane, respectively. Serum
samples were collected both before and after HF
and from the filtrate as well. Quantitative
analysis of the small molecules (EMs) and MMs were
accomplished by Sephadex G-25 chromatographydetection 280nm; conc. values calculated from
the peak areas were expressed in g/L albumin equi—
velant units.
Predialytic conc of SMs and MMs were found to
be 13.86+ 8.69 and 44.09+16.32 respectively.
values changed after HF to 0.31+ 0.82 (EMs) and
23.73+ 11.59 (14145) if plate filters were used, and
to 1.63+ 3.78 (SM5> and 17.37+ 5.99 (MMs) using
capillary filters. Although SM5 removing capa-
bility of the cellulose membrane appeared to be
superior compared to that of the polyamide mem-
brane. The reverse was true for 14145 removing
capacity of the two filters. Based on these
observations, it is assumed that putative 'MMs
dependent complications might be treated more
efficiently with polyamide membrane based than
with cellulose propionate membrane based
filters.
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INHIBITORY NECHANTON OF TJREMTC TOXIN ON LTPOPNO-
TEIN LIPASE
S. Yokawa, T. Naeda, T. Mlyai, 0. Nishikawa, M.
Kinoshita, N. Nomoto, N. Nishikawa, I. Nishide
The 3rd Department of Internal Nedicine, Wakaya—
ma Nedical College, Wakayaiea, Japan.
The responsibility of uremic toxin for lipo—
protein lipase (LPL) impairment in chronio renal
failure has not been fully elucidated. The present
study was undertaken to clarify the mechanism of
LPL impairment by the inhibitor extracted by ul—
trafiltration. The filtrate obtained by both
heaofiltration (HF) and hemodialysis (HP) was
lyophilized, end about tO times cocentrated so—
lotion of the filtrate in O.03N emmonium acetate
buffor was prepared. The specimen so prepared
was fractionated by Sephndex 0—15 column chroma-
tography, then the fraction revealing LPL in-
hibition was subjected to subfrartionatiun by
Bio—gel p—1r column chromatography using the name
buffer. Lit was purified froa human postheparin
plasma by Heparin- Sepharoee affinity chromato—
grauhy. The inhibitor waa detected in the lith
fraction for HF arid 3rd fraction for HP elated
by Sephadex column chromatography and in the 3rd
frartion (Fr,3) by Die—gel p— gelfiltration.
The inhibiiory action was dependant upon ureair
toxin sonrentration in the Fr.3 only. In order
to clarify the mechanism of LPL impairment, a
aixtore of the eubntrate, very low deneity lipo—
protein (VLOL), and LPL wee filtrated through
His—gel A—Sm column at C with and without the
addition of the Fr. 3. Fraction between VhDL nod
LPL wan inhibitud in the prescore of that frar—
tino which was elufted with LPL. These results
suggested that urraic toxin, exteurted as a
relatively pure substance, exerted an Lit
inhibiting action hr binding to Lit.
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TRANSPLANTATION
MEMBRANOUS GN (MGN) "DE NOVO" IN TRANSPLANTED
KIDNEYS IN CHILDREN.
Wnac N.Hinglais, M.C.Gubler, M.F. Cagnadoux,
M.Broyer, R.Habib.
INSERM 0.192 H8pital Necker, Paris, France.
The incidence of MCN de novo in transplanted
kidneys is around I to 2 %. In our series, of the
257 patients (pts) transplanted (263 grafts) who
underwent a renal biopsy, 22 developed a MGN "de
novo' (8 %). Renal biopsy had been performed in 3
pts with isolated proteinuria (Pu) in 13 pts for
suspected rejection and in 6 aaymptomatic pta.
In all cases the lesions were identified by irn—
munofluorescence. Granular deposits of IgG were
diffuse (12 pts) and segmental (5 ts). In the re-
saining 5 cases, the deposits appeared linear but
electron microscopy disclosed typical continuous
subepithelial deposits.
There were 15 boys and 7 girls and in none of
them was MGN the original nephropathy.Age at trans-
plantation (lx) ranged from 5 to 14 years. Grafts
were from cadaveric donors (20 pta) and from living
related donors (2 pts). One pt had been treated
with captopril and 6 were HBs Ag chronic carriers.
4 pts, fol]owed for 20 to 47 months (ms), never had
proteinuria (Pu). In the remaining 18, Pu develo-
ped 2 to 70 ms after lx,essociated with a nephrotic
syndrome (NS) in 6 of them. At latest follow—up (13
to 98 ms) 7 pts, 3 of which with a NS, have lost
their graft, all from chronic rejection ; 6 have a
decreased GFR with a moderate Pu (5 pts) or a NS (1
pt) and 9 have a normal renal function with no Pu(6 pts), mild Pu (2 pta) or persistent NS (I pt).
In conclusion, the prognostic significance of MGN
"de novo" is difficult to assess. Graft loss does
not seem to be related to the development of MGN,
which in many cases may he asymptomatic.
LEUKOCYTOTOXINS AND RHEUMATOID FACTORS IN RENAL
GRAFT EEC TP I LETS WITIT CMV.
1411 Baldwin, TILT Cloas, (31 van Geniort , ML 1lestedt
FC Denny, LC Paul - MR l)aha and LA van Es.
Nephroiosv Dept. Univ ITosnital , leiden, The
Netherlands (ii'tr. 1w 111 Schicht).
Renal graft recipients who develop cvtoniegalo—
virus (CMV) disease produce 1gM immune compi exes as
measured by polvethvlenegivcoi precipitation (FEC
ppt). IgIl immune complexes initially increase when
1gM antibodies to CMV are first detected and
persist for 1—6 months. The PEG ppt from 31 of 59
patients wIth CMV deease contaIned IgH leuko—
cytotoxins that reacted with 50—100% oF a panel of
lymphocytes Fran 10 random donors at 2?C, as well
as m000cytes, grarulocvtes and separated T- and
IT—lymphocytes, hut not platelets. Cytotoxicity was
not directed to HIA antigens because it was not
blocked by inonoclonal antibodies against ITLA—A,B or
PS and t was not abrogated by "stripping" HlA from
the Jvmphocvt;cs with monoclonal anti —micro—
globulin. In contrast, sera from N of 15 control
patients undergoing acute graft relection without
CMV diseaae and from 15 of 15 hvperinnnune patients
contained pririsrilv IgC lvmphocytotoxins that were
rot precipitated by 3,5% PEG. These IgG antibodies
were directed to liLA because their activity could
he abrogated by 'stripping off" PLA. 1gM rheumatoid
factors (1(F) were detected in 22 patients with CMV
disease hut no controls. Circulating RF coincided
with the onset of fever and with increases in IgG
antibodies to CMV. RF disappeared within 3—8 weeks.
All RF reacted with the Fc portion of IgG but at
least 8 also reacted with Fab. The Fc and some Fab
reactive RF were precipitated by 3,5% PEG. The Fab
reactivity of some RE raises the possibility that
they have anti—idiotypic activity snd could
modulate the cellular as well as the humoral
imsunity to CMV antigens.
EFFECT OF VERAPANIL (V) ON PRESERVATION OF RENAL
FUNCTION AFTER ISCHEMIA. N. Atuk, L. Rudolf, S.
Turner, C. White and F. Westervelt, Jr., Univ. of
Va. Sch. of Med., Charlottesville, U.S.A.
Preliminary studies in our laboratory in non—
transplantable human kidneys using V in perfusate
showed improved perfusion (P) characteristics, and
less LDH release and ultrastructural damage (Clin
Res 30:440A, 1982). To define this apparent pro-
tective effect, we perfused 8 dog kidneys for 24 h
with V. The contralateral kidneys perfused without
V served as controls (C). We measured P pressure
(PP), P flow rate (PFR), resistance (Res), P renin
(PR), norepinephrine (NE), LUll, and calcium (Ca).
At 24 h, V kidney P characteristics were not signi-
ficantly different compared to C: PP, 26.5±2.0 vs
24.3±3.8; PFR, 62.6±11.3 vs 63.4±5.6; Res, 0.53±
0.10 vs 0.39±0.06. P LDH and Ca++ levels were not
significantly different between the two groups.
With V perfusate, PR levels showed a rise at 6 h
and became greatly higher at 24 h compared to C
(150.8±49.3 vs 79.6±29.2, p <.02). V and C kidney
NE levels were equivalent at 6 h. V kidney NE be-
gan to decrease and at 24 h NE showed lower levels
(0.49±0.11 vs 0.75±0.13, p = .01).
These results suggest that decreased calcium
influx, together with decreased NE release, play
a role in the protection of kidneys perfused with
V.
RECIPIENT SELECTION, TECHNIQUES AND FIRST
RESULTS OF PANCREAS AND KIDNEY TRANSPLAN-
TAT ION
V. Barto, I. Vanèk, P. Pavel, K. Vondra,
V. Kodandrle
Institute of Clinical and Experimental
Medicine, Prague, Czechoslovakia
On the basis of examination of 20 insu-
lin-dependent diabetics with renal insuf-
ficiency criteria for the selection of can-
didates for pancreas /PTx/ and kidney
transplantation /KTx/ were formulated.Iso—
lated KTx was indicated in 7 patients.Four
and 9 patients were classified for both
PTx and KTx as potential and urgent candi-
dates. PTx and KTx was performed in 6 of
them. Segmental pancreatic graft was oc-
cluded with Ethibloc using the technique
of interposition in arterial anastomoses.
One patient died with functioning grafts
due to cardiac death 10 days after Tx.Pan-
creas graft was removed due to ischaemic
necrosis 3 days and renal graft due to re—
jectios 14 months after TX in another pa-
tient.In 4 patients pancreas graft survi-
val was >l,4,>7 and l2 months, renal grt
survival >l,5,7 and l2 months. Out of
3 recipients followed up for more than 5
months, visual acuity improved in 2, neuro—
logic findings in 1, no progression oc-
curred. Four patients developed an exter-
nal pancreas fistula. It is concluded, 1/
PTx in diabetics normalizes metabolism
hampering progression of angiopathy,
2/ technique of interposition reduces the
risk of thrombosis, 3/ exocrine secretion
of the graft represents a problem.
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. STUDY OF PRESENSITIZATION BY FL(M CYTOMETRY IN
CABAVERIC KIDNEY RECIPIENTS.
J. P. Bernhardt, C. Stabile, B. V. Colombe,
W. Amend, F. Vincenti, J. Melzer, N. Feduska,
0. Salvatierra, N. R. Garovoy.
University of California, San Francisco.
The flow cytometry (FACS) crossmatch 1),
which is up to 250 times more sensitive than
current cytoxicity tests, was used retrospectively
to investigate presensitisation in 117 cadaver
kidney recipients transplanted in 1°83. Although
all patients were T cytotoxic XM negative at the
time of the transplant, 34% were FACS T cell
positive. Overall, the graft survival at 6 months
was 70% with a negative FACS T KM and 59% with a
positive FACS T ZN. Among the presensitized
recipients (PeA 10%) a positive FACS T ZN was
associated with 53% graft survival at 6 months vs.
73% for FAGS T negative patients. Among patients
with B warm cytotoxic antibodies we could detect
by FACS, at least 2 types of antibodies in these
sera: one binding to I cells, and one binding to
B cells oniy. The Table below shows the graft
survival at 6 months:
FACS T meg. 77%
B warm Ab positive FACS I pos. 51%
FACS T neg. 63%
B warm Ab T 55%
Therefore, among panel reactive individuals
(PRA > 10%) PACS crosamatching appears to detect
an adverse state of presensitization, while
distinguishing those patients with B warm
cytotoxic antibodies who have an enhanced rate
of graft survival.
THE BENEFITS OF ELECTIVE TRANSFUSION TO 10
UNITS WHOLE BLOOD BEFORE 1st CADJIVERIC RENAL
TRANSPLANTATION OUTWEIGH THE RISKS OF
SENSITIZATION.
J.M. Bone, A.N. Hillis, G.T. Taylor,
R.M.R. Barnes, R.A.Sells. Royal Liverpool
Hospital, England.
From 1981, 135 patients referred for 1st cad-
averic renal transplantation Mere given up to 10
units of whole blood electively at rates from
1-3 units weekly to 1-2 units monthly depending
on place of dialysis. Blood was transfused sub-
sequently according to clinical need.
Lymphocytotoxic antibodies (LCA) to random
panel lymphocytes developed in 12/92 men against
42±26% cells (10-93%) after 12±11 (2—39) units
of blood. By contrast sensitization was commoner
in 16/43 women, (X2_10.6,p<0.01) who developed
LCA against 57±23% (13-90%) panel cells after
only 7.8±3.5 (1-14)units. In most patients LCA
were transient, and not detectable after 3
months in over half, even when highly sensitized.
Graft survival after 0, 1—4, 5—9, and >10
units in 21, 41, 12, and 18 patients given
azathioprine (A) and prednisolone (P) rose from
38%*** to 76*,68***, and 88% at 1 year. In 18,
12 and 62 patients given Cyclosporin A (CyA)
alone as first choice maintenance irmsunosupp-
ression, and transfused 0-4, 5—9 and >lOunits,
graft survival at 1 year rose from 71%** to 83
and 91%. Thus the risks of transfusing 10
units electively appear small compared to the
chances of enhancing graft survival both with
CyA and with A & P.
*p<O.O2,**p<0.Q1,***p<O.001:c.f.>lOunjts.
INFLUENCL OF DIALYSIS DURATION VERSUS NO DIALYSIS ON
KIDNEY GRAFT SURVIVAL IN ONE-CENTER PROSPECTIVE
ANALYSIS.
F.C. Berthoux, C. Genin, C. Guérin, B. laurent,
.l.C. Sabatier, 3. TOulon, 0. Leroy, X. Barral.
Service de Néphrologie, HOpital Noid, 42100 Saint—
Etienne, France
During 1983 and 1984, we developped a program of
renal transplantation (Tx) before effective start
of chronic dialysis. Patients with end—stage renal
disease (ESRD), serum creatinine > mg/dl, .zist
usual pretranaplantexaminations, a transfusion
program (2 units of RBC every month x 5 times), and
were put on our waiting list. Depending on cadaver
kidneys availability, and compatibility, these
patients mere eventually grafted with only a single
heniodialysis before surgery. During that period, we
have done 46 cadaver and first grafts, and me
excluded 2 livtnq related donor qrafts and I second
cadaver graft : 11 Tx done without previous dialysis;
5 Tx sith dialysis duration < 6 a ; 14 with dialysis
duration between 6-12 m and 16 with dialysis ckiraticii
> 12 a. Immunosuppressive treatment was conven-
tional in all cases : Prednisolone, Azothioprine,
and prophylactic ALU during the first 14 days.
Pat)ent survival is exccllnnt with 100 % at 3 a
(46/46), lOU % at 6 m (40/4U), and 100 5 at 12 m
(23/23). Kidney survival is respectively at 1, 3, 6
and 12 months — 98 5, 96 5, 90 5, 65 5 for the
ahole group ; — 100%, 100%, 91 5, 50 5 for the
subgroup without dialysis ; and - 97 %, 94 5, 90 5,73 % for the subgroup with dialysis. ihese data are
not statistically different, and we confirmed the
possibility of grafting ESRD patients without a
necessary step on chronic dialysis. The social and
economical advantages of such protocol are obvious.
.
DISSECTING THE CENTRE EFFECT
l.A. Bradley, W.R. Glks, S. Gore, N.H. Seiwood
• U.K. Transplant Service, Bristol, UK
The variation in transplant survival results
between centres is the single most potent factor
affecting graft outcome and as such warrants in-
tensive investigation. 3653 first cadaver trans—
plants in Non—Diabetic recipients over the age of
15, that had been carried out in 30 UK centres
between 1978 and 83,were analysed.A significant
difference was observed between the centres in the
overall survival figures at 100 days post trans-
plant. In an attempt to identify which of the re-
cipient, operative or donor variables might in-
fluence these differences a multifactorial statis-
tical technique known as the Stratified Propor-
tional Hazards Regression Model was used. One of
the most significant influences was the duration
of pretransplant dialysis - the longer the
dialysis the lower the risk of graft failure,
particularly in later past operative times
> 100 days). This effect was thought to be inde-
pendent of the protection afforded by blood trans-
fusion nd was probably associated with the well
documented acquired immunodeficiency associated
with chronic haemodialysis. Good HLA-B locus
matching enhanced graft survival but HLA-A locus
matching showed no significant effect. High sen-
sitization ( > 75% panel reactivity), graft anoxia
time (, 10 mins.) and recipient age ( .45) were
associated with poor survival. When the results
of individual centres were compared before and
after correction for these undoubtedly signifi-
cant variables the differences between centres
remained substantially unaltered. This suggests
that the major causes of the effect were to be
found in the 2 operative therapeutic environ-
ment unique to each centre.
(0)
(18)
(24)
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THE USE OF FINE NEEDLE ASPIRATION BIOPSY (FNAB) IN
THE FOLLOW-UP OF KIDNEY TRANSPLANT RECIPIENTS.
Campos H., Droz D., Debure A., Ballarin J., Chkoff
H., Adafer E., Noel N., Kreis H.
Renal Transplant Unit — Hopital Necker - Paris.
Serial FNABs were performed in the follow—up of
82 cadaveric kidney recipients either as a routine
procedure in the post-operative follow-up or when
required by clinical events. 94 rejections epi-
sodes were observed in this group of patients. 39
of them (41.5 %) were dectected by FNAB before any
clinical evidence of renal failure (median 24
days). In 18 cases (19.1 %) diagnosis of rejection
by FNAB coincided with clinical evidence of rejec-
tion. In another 20 patients (21.3 %) a plasma
creatinine level increment < 25 % was the only sign
observed. In 17 rejection episodes (18.1 %) FNAB
did not confirm the diagnosis surgical biopsy
was performed in 12 of these patients and showed
predominantly vascular lesions and interstitial fi-
brosis in 9 cases. Diffuse cellular infiltration
was present in 3 cases, accounting for a false ne-
gative FNAB diagnosis. In 9 patients whose renal
function remained normal, cell counts from FNAB
were identical to blood counts. In 7 patients pre-
senting postoperative olygoanuria tubular cell Va—
cuolization and the absence of cellular infiltra-
tion sustained the diagnosis of acute tubular nec-
rosis. In 18 patients the persistance of FNAB in
flanisatory patterns while on rejection treatment
was indicative of the further evolution to chronic
rejection. 5 irreversible acute rejection episodes
were documented by extremely rich FNAB specimens
showing massive graft infiltration and intense nec-
rosis of parenchymal cells. FNAB is therefore con-
sidered an extremely valuable tool in the follow—up
of renal transplant recipients.
GLOMERULAR EPITHELIAL CELL ABNORMALITIES IN
EXPERIMENTAL KIDNEY ISOGRAFTS
H. Carro1, M.A. Henry ,* B.O. Howden, P. Jablonski,
R.M. Laribert,5 V.C. Marshall, B. Rae, G. Rigol andtJ.D. lange
Department of Surgery, Monash University
Departments of Ophthalmology and Pathology5
University of Melbourne, Melbourne, Australia.
Changes in rat glomerular permeability induced
by preservation led to the study of glornerular
morphology and function in renal isografts, 4 wk
after transplantation.
Urinary protein excretion (24 hr) was 40—200 mg
compared with C 20 ng in control rats. Glomerular
lesions were focal and not diffuse, throughout the
kidney and within individual glomeruli. Giomerular
epithelial cells appeared to contain large thin
walled cysts under light and transmission electron
microscopy. However, colloidal iron staining
polyanion was present on both surfaces of the cyst
wall. Scanning electron microscopy confirmed that
the cyst-like appearances were due to enlargement
and spreading of epithelial cells and their major
processes. The thin blown up epithelial cytoplasm
was stretched over intact foot processes, and
covered then like a tent. In other glomeruli the
malformation was associated with loss of foot
processes and aggregates of intracellular droplets.
Groups of capillaries were obsolescent and
epithelial cells no longer covered the loops.
Because of the background against which these
changes developed, some of tbem should be
interpreted as manifestations of glomerular
epithelial cell regeneration and repair. The
experiment indicates the existence of another
possible component in the glomerular response in
clinical renal transplantation.
c lTiS B 13( Aar-N
33 Cannata, Mr Allande, J Paniagua, M Serrano, ? Tevar,
V Cuesta, V Peral, J Herrera. HOspital Ganeral de Asturias.
kiiversidad de OviedO. Scam.
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Deri.ng last 10 years the blcxd (Sd) transfusiCa% (T) policy
in hasendialysis (HO) patiants (pts) have had crucial changes.
We rtved fros restrictive ad T schaies to sore liberal. pre-
transplant (Tx) ad T policies siDling to lnçrOve the kidney aliOgraft survival. Iwr, in manyccuntries,before to adhere to
the new scheasa, it has not bean deeply cocsfs3erad the badly
non bet likely high incidance of hepatitis (HP) B carriers
ancrig 3d ors ad the lack of use of aetIs with high
sansibility and specificity to roctinely teat the ad, such as
the radioinmunoassey (RIA).
'fle aim of this study es to evaluate prospectively the risk
of exposing HO pta to HP B virus by transfusing *Kile ad as part
of ocr Tx protocol. We studied througt*Dut oce year 58 units of
HBs negative (—) Sd analysed by the uetld used roctinely in ocr
ad canter (heaaaglutinatiCm thhlbiticm (HAl)), sant tO the HO unit
to be transfused to 12 HO pta. Before transfusing the ad wa
stored it 48—72 hcura re-checking each ad unit by RI?. (The first
36 units (1) with NBa and the resaining 24 (2) with NSa and anti
. We interpreted as positive (+) result, either has or anti—
NBc theee in '.Elich the pt/thresI1d (thr) cocnt ratio s 5 to
avoid including borderline (+) reanits.
Despite all Rd had bean HBs (-) by HAl ,rechecking it with RIA
focnd a sean of 10.3% of HBs(4). In additmnn wa also discover
8,3% of Ba HBs(-) bit anti—NBc(S) (table). If wa had transfused
these units of ad withait re—testing them by RIA.wa iid have
administrated at least 18.6% of 'dangerocs' Bd(8 units to 12 pt
NBa(S) pt/thr cC*t NBs(-) anti-HBc(+) pt/thr
1 3/36(8.3%) L12.2 —
2 3/24(12,5%) L54,7 2/24(5.3%) 2O.6Total 6/58(10.3%) :33.5
Nowadays a progressive number of HO pta receive Sd as part of
Tx protocols, as wa have pro, tha real incidance of HP B
carViers mexig ad dcncrs have bean underestimated in ocr and
presumably in other cocntries. Therefore, wa believe that centeza
whe do not test rcutinely HBs and anti—HBc by RI?., shaild use it
to re-check pre-'rx progremed Sd(likewise all rka-urgant T) ,to
minimize the risk of HP B exposure,making safer the pre—Tx ad T
policy.
HYPERTENSION IN RENAL TRANSPLANT RECIPIENTS
S.L. Cohen, G. Boner, J.B. Rosenfeld, D. Shmueli,
A. Yussim, Z. Shapira
Renal and Transplantation Unit, Beilinson Medical
Center and Tel Aviv University Sackler School of
Medicine, Petah Tikva, Israel
This study was designed to define the incidence
of hypertension in patients with functioning renal
transplants. Hypertension was defined as a per-
sisting blood pressure of 150/95 mmHg or more at
least 3 months after transplantation, or the regu-
lar use of antihypertensive medications. Data was
obtained retrospectively.
Of 128 patients currently followed, 65 were
hypertensive (50%). Hypertension was more common
in recipients of cadaver kidneys 48/84 (57%) as
compared to living donor kidneys 17/44 (37%)
p<O.O2. Poor renal function - plasma creatinine
(P.Cr)>l.5 mg/lOO ml - was associated with
increased incidence of hypertension34/55 (61%)
compared to 31/73 (42%) of the patients with good
renal function - P.Cr'cl.S mg/100 ml p<O.OS. Age
of recipient, previous hypertension in the dialy-
sis period, diagnosis of glomerulonephritis,
duration of function of the transplant, use of
Cyclosporin as compared to Azathioprine, first or
later kidney transplant were not associated with
an increased incidence of hypertension. Recipi-
ents pretreated with donor specific transfusion
had an incidence of hypertension similar to other
living donor recipients. Only four transplant
recipients had been bilaterally nephrectomised
before transpiantationand renal artery stenosis
was also demonstrated in only 4 patients in this
study.
Incidence of hypertension after transplantation
is reduced in patients with good function and in
recipients of Uving donnr kidneys.
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URINARY RBP (RETINOL BINDING PROTEIN) AS
THE BEST VIABILITY TEST IN NECROKIDNEY
TRANSPLANTATION.
D.Costantino,L.Berardinelh,G.Fioni,A.Vegeto
Depart.of Kidney Transplantation,University
of Milan,Mi Ian, Italy.
Although the agonal vasospasm and corti-
cal ischemia are known to determine adverse
effects on the prompt functional recovery
after cadaver donor transplantation,there
is until now no reliable method of predi-
cting the damage of a necrokidney prior to
transplant.RRP,a protein with a low mole-
cular weight,fi ltered by the glomerulus and
completely reabsorbed by undamaged epithe—
hal cells 0f proximal tubulus,has been
measured by us in the urine of 12 cadaver
donors,whose renal function was considered
perfectly normal by usual laboratory examens.
In 5 of these cadaver donors no amount of
RBP was identified in the urine samples
prior removing kidneys and the recovery of
graft function after transplantation was
perfect in all 5 corresponding recipients.
7 cadaver donors showed RBP in their urine
and 6 of the corresponding recipients had
various degrees of ATM in the first post-
operative days. These preliminary results
let us to consider the presence of RBP in
the donor urine the best predictive test
of viability in cadaver donor transplanta—
t ion.
THE EFFECT OF PRE-TRANSPLANT TRANSFUSION ON IgG
SECRIION
D Degiannis, D Tsakiris, J D Brigga, A M Mowat,J A Bradley, B J R Junor,
Renal Unit and Department of Immunology and
Bacteriology, Western Infirmary, Glasgow, Scotland.The mechanism underlying the beneficial effect
of blood transfusion (BT) on subsequent allograft
survival is unclear. This study examined the
effect of third party ST on the in vitro secretion
of IgG by peripheral blood lymphocytes (PBL) from
dialysis patients. Twenty six previously
untransfused chronic dialysis patients undergoing
a programme of elective BT (one unit of packed red
cells every l4 days, total 5-10 units) were studied,
PBL were obtained before BT, nd then at 11+ day
intervals throughout ET, and the IgG secretion was
assessed by a protein A plaque assay incorporating
both T cell dependent and relatively T cell
independent systems. Spontaneous IgG production
was variable but overall in the group values
remained unchanged throughout the study (mean + SD
PFC/l06PBL pre-BT = 22 292, post ST 556 382
NS). Similarly, IgG production in response to the
B cell activator staphylococcus aureus Cowan I
(relatively T cell independent) remained unchanged
(Li,576 5,337 vs 1+,016 k,67, NS). However, IgU
production in response to the i cell dependent
activator pokeweed mitogen showed a progressive
decrease with BT (21,237 + 23,220 vs 14,729 +
23,336, p0.05). By contrast no change in either
spontaneous or stimulated IgO production was
observed in 13 non-transfused dialysis patiente
studied sequentially. These results indicate that
ST suppresses in vitro T cell dependent B cell
differentiation into IgG secreting cells, and this
may possibly contribute to the in vivo
immunosuppression of ST.
MONITORING THE RESPONSE TO TREATMENT OF RENAL
ALLOGRAFT REJECTION WITH FINE NEEDLE ASPIRATION
CYTOLOGY (FNAC)
G. Cooksey, R.S. Reeve, N. Nicolopoulos,
R.P. Burden, R.E. Cotton, R.W. Blarney, A.G. Morgan
City Hospital, Nottingham, England.
FNAC has been performed regularly during the
treatment of first acute rejection episodes in
order to ascertain the cytological changes which
occur and their potential as a basis for
modulating immunosuppressive therapy. Immuno—
suppression consisted of Azathioprine and
Prednisolone and rejection was treated with a 12
day course of oral Prednisolone.
Fifteen rejection episodes were successfully
treated. In only one of these was there
cytological evidence of rejection after 5 days'
treatment. In 19 cases cytological evidence of
rejection was present after 5 days of treatment;
in 13 of these there was early recurrence of
rejection. In 6 of these 19 cases additional
poor prognostic cytological features developed:
2 of these underwent irreversible rejection and
in 4 others graft function was salvaged after the
addition of ALG to steroid treatment.
Monitoring the response to trestment of acute
rejection with FNAC can accurately predict the
adequacy of immunosuppressive therapy. FNAC
could be used as the basis for modulation of the
dosage of steroids used to treat acute rejection
episodes in individual patients.
3ERUM ERYTHROI'OIETIN FOLLOWING KIDNEY
TRANSPLANTATION.
E.De Pooh Vitali,R.Farinellj,A.Farjijellj,
r4.Vedovatoo,G.C.RalboniO,G.Salvatoiehljo
Divisione di Nefrolo.cia-Arcispedale S.Anna
''Tstituto di Anatomia:omparata dell'Univer
sit,Ferrara, Italia.
Post transplant erythrocytosis(PTE) and
elevated peripheral erythropoietin(Ep) con-
centration occur at different time periods
following successful kidney transplantatn
Our observations, in 39 post transplant(PT)
pts. ,show:
PTE—pts.(12.8f) — non PTE-pts.
Ep* 165+30(120—200) — 159+23(130—190) %
Hct 53+ 5( 48— 61) — 39+ 8( 34— 47)
PT—rn ths 61+37(7—102)— 49÷37(3—112)
'Serum Ep concentration was measured using
the Guinea pig bone marrew cells culture
technique and expressed as:cpm9Fe—PT—se'um
xlOO. cpm59Fe-control
Mean serum Ep in PTE and in nori-PTE pts.is
significantly higher than the mean serum
Ep in healthy controls(l00÷15%).
No significant difference hasfnind between
the Ep values from both groups(PTE nd non
PTE pts.).Our results agree well with the
hypothesis of the deficient feedback regu-
lation and suggest further elucidation
about the differert bone marrow sensibility
and responsiveness to higher serum
erythropoietin.
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TRANSPLANTATION VERSUS -iEMODIALYSIS IN ESRF SECONDA-
RY TO FABRYS DISEASE (F.D.)
D.Donati,L.Barstelli ,D.Cassani,A.De Maio,GFrattini,
M.Martegani,O.Amatruda,L.Gastaldi.(Intr.by R.Rossi).
Ospedale di Circolo.-Div.di Nefrologia—Varese—Italy.
The treatment of ESRF secondary to F.D. is still
object of an open debate.Renal transplantation(RTX)
is believed to expose the patients to a high risk of
lethal infections and to be unable to control the
vascular symptoms of the disease.
We have collected the clinical events of 12 pta.
affected by F.D.(2 personal observations).Their mean
age at diagnosis(biochemical) was 33y.(r.19—62), at
the onset of uremia was 39y.(r.29—63). 8 of the pta.
underwent RTX.
In comprehensive 287 months of hemodialysis(HD)we
recorded: 3 deaths for cerebrovascular accidents, 1
race of transitory hemiparesis and 5 cases of cardi
ac complications (miocardial infarction an3 arrith-.
mias
In comprehensive 238 m.of RTX we recorded: no dec
th nor cerebral or cardiovascular complications. 3
of the 8 pta. experienced 11 major infectious episo
des(all medically treated). Graft survival was 50%
and 38% at 12 and 48 m. respectively.
RD would not slow the natural history of the dise
ase down(high rate of lethal vascular complications)
while RTX, revised the problem of infectious compli
rations, appears to guarantee a longer survival.
This ran be related to the urinary reaction of an
amoOnt of the metabolic product(ceramide trihexosi—
de) while is still in discussion the chance for RTX
to provide an enzymatic support(gal—hydrolase).
.
EFFECT ON LYMPHOCYTE FUNCTION OF TRANSFIJSION-
RELATED SERUM FACTORS
M A Forwell, J E Cocker, M G Peel, 2 D Briggm,
B J P Junor, P N M MacSween, G P Sandilands
Renal Unit and Department of Pathology, Western
Infirmary, Glasgow, Scotland
The enhancement renal allograft survival by
pre-transplant blood transfusion has been
attributed to Fc' -receptor (FcI -R) blockIng
antibody.1 'tee have previously shown that IgG
preparations from recipients of blood block the
Fc'R and inhibit phytohaemagglntinin (PHA)-
induced T cell blastogenesis (2). The aim of
this study was to find if other serum factors in
addition to IgG might affect lymphocyte function
similarly. Serum samples were taken from 6
controls, 28 transfused and 6 non-transfused
uraemic patients, 6 transfused non-uraemic
patients and 6 haemophiliacs previously given
Factor VIII. The samples were fractionated over
discontinuous sucrose gradients and the resulting
fractions of graded molecular weight tested for
their capacity to block the Fcl P (using an EA
rosette inhibition assay) and to inhibit PHA-
induced blastogenesia.
Subjects who had received blood or blood
products showed FcR blocking activity and
inhibition of PHA-induced blastogenesis not only
in the fraction containing IgG but also in higher
molecular weight fractions. The serum factors
responsible are probably immune complexes or
aggregated IgG, and may contribute to the
modulation of T cell function seen in transfused
subjects.
1 MacLeod All et al Lancet 1982 ii 68-47O
2 Forwell MA et al Scot Med 2 1985 30 62-6
THE EFFECT OF STEROIDS ON THE ENERGY TURNOVER IN
RENAL TRANSPLANT RECIPIENTS
H. Ebel , 8. Krautwald, E. Krautwald, H. Lange
DeptTf Nephrology, Univ. of Marburg, F.R.G.
The effect of steroids on the energy turnover
[Qmetab = Qrcc ÷ QevapJ was measured in 21 renal
transplant recipients (10 women, 11 men; aged
20-64, mean 40.1; Tx-function 13-2013, mean 598
days; imsunosuppressive drugs: 100 mg azathiopri—
ne, varying doses of prednisolone (P) or methyl-P
expressed as equivalent P—dose). The turnover was
assessed by direct calorimetry: heat loss due to
radiation, convection, and conduction (Qrcc) with
a temperature-measuring electronic device and
due to evaporation LQevap] with a metabolic scale.
An S-like P-dosage—dependent saturation curve was
found under resting conditions (half-logarithmic
diagram). The energy turnover exceeded that of 7
normal controls ( Qmetab = 26.6± 3.4 kcal/kgx day)
aven in patients who received P—doses low as 0.1
ig/kg b.w.. The energy turnover was greatest at
i P—dose of 7.1 mg/kg b.w. : 36.2 kcal/kg x day.
A further increase of steroids did not further in-
fluence Qmetab.
These results suggest that steroid doses exceeding
the cushingoid threshold cause an increased ener—
turnover.
A PR0SPECIIVE STUDY OF DIGITAL SUBSTRACTION ANGlO-
GRAPI-IY (DSA) IN EARLY RENAL TRANSPLANTATION COURSE
0. Fries, 2. Tessier, B. Charpentier, H. Teyssou,
S. Boiibnider, 2. dellaniy, G. Berioit
Services de Naphrologie at Radiologie, Hôpital Paul
Brousse, FacultO de Ilédecine Paris-Sud, Villejuif.
To better evaluate the incidence of arterial ste
nosis (AS) after renal transplantation (RI), we ha-
ve conducted a prospective study with DSA, systema-
tically performed by the end of the 1st (105 pts)
or 2d (59 pts) post RT month. In 32/164 (19.5 %)pts
DSA were non informative on technical grounds. A
decrease > 50 % of the arterial diameter, corres-
ponding to a 75 % decrease of the arterial lumen,
was considered as a significant AS (SAS).
Results : a) SAS were observed in 7/106 normo-
tensive pts and in 7/27 hypertensives pts (6.6 % vs
25.9 %, p < 0.01). In the 7 normotensive pts, 2 re-
mained asymptomatic and HBP developped in 5, requi-
ring surgery in 1. In the 7 hypertensive pts, 2 re-
quired surgery and 5 were controlled by medical
treatment. In these 132 pts, there is a close rela-
tionship between SAS and the occurence of HBP (12/
14 pts). b) SAS were observed in 9/103 pts with
plasma creatinine < 200 ljmol/l, and in 5/29 pts
with Cr > 200 mol/1 (8.7 % vs 17.2, NS). C) Durine
the 6 following months, 47 pts had a second 054,
allowing to observe the occurence of SAS it 7 pts
(4 remained asymptomatic, 3 developped HBP requi-
ring surgery) and the total disapearance of 1 SAS.
Conclusion : a 10.6 % incidence of SAS is affor-
ded by DSA when this non invasive procedure is sys-
tematically performed during the 2 first months
post-surgery. Half of these stenosis are asymptoma-
tic, but HBP developped furthermore in most cases.
DSA is a valuable technic to be used when hyperten-
sive pts are to be explored, but its high cost ma-
kes its systematic use in asymptomatic pts cno-
troversial
INTRARENAL PRESSURE MEASUREMENT IN RENAL
TRANSPLANTATION
C.P. Gibbons, C.B. Sunimerton, P.C. McNally, B. Kay,
C.B. Brown and A.T. Raftery
Renal Transplant Unit, Royal Hallamehire Hospital,
Sheffield, Fnglland and Department of Probability
and Statistics, University of Sheffield.
Fine needle intrarenal pressure was measured
serially in 38 rena] transplant recipients to
assess its value in the diagnosis of rejection.
32 intreoperative and 207 postoperative measure-
ments were made, and 39 clinical rejection episodes
(23 confirmed by biopsy) monitored. Intraoperatfve
pressues in grafts wish immediate function
(37.4 — 4.Omnlig, Mean — SFM) were not significantly
differnt from those with delayed function
(30.9 — 4.8mniig). Nevertheless postoperative
pressures were greater (p<O.O) in kidneys with
acute tubular necrosis (29.4+— l.9mnig) than
in functioning grafts (20.4 — 0.9mn1g). Pressures
reeordd during clinical rejection episodes
(44.3 — 2.3mnIlg) exceeded (p<O.Ol) those
during quiescent periods (23.6 — 1.Otnnig). Higher
pressures (pO.Ol) were recorde from tender or
palpably enlarged grafts (52.3k— 3.Omn*ig) than
other rejecting kidneys (36.3 — 3.1mn1g).
Those with cellular rejectfon+on biopsy tended to
have greater pressures (50.1 — 4.lmnilg) than when
concomitant vaaculopathy was present
(36.4 — 3.9mnilg) hut this did not reach
statistical significance. However, using a
diagnostic cut off point of 4OniuIig the
investigation failed to recognise 26% of acute
rejection episodes and wrongly categorised 21% of
nonreiectors in the presence of acute tubular
necrosis. It was therefore of lisited predictive
value.
LONG TERM GRAF'T $IJDVTVAL OF I MPORTED
CADAVER KIDNEYS
K. lateral, V. Drier, N. Cakmakci, M, Turen
Ilacehtepa Univ. Hasp. Ts. Center, Ankara,
TURKEY
Prom Jan. 1, 1983 to Jan. 1, 1985, 157
transplants wore performed in our center.
Of these, lEO (76.4%) were cadaver grafts.
lIe analyzed 65 cadaver grafts retrospec-tively according to donor and recipient
HLA as well as far graft survival.18(27.7%)
of the 65 patients ware females and 47(72.
3%) were mOles between the ages of 17 to 54
Imuran K Drednisone were used as immunnsupp
ressive ogonts and the patients ware foiios
ad far at least 3 months.
4 patients were 2 antigen compatible & theCold Ischemia Time(CIT) was an average of62:25hrs.(44:05 to 93:3Ohrs.) 20 pts. were
1 antigen compatible and their CIT averaged
at 70:40hrs. (48:20 to 102:06 hrs.) 41(63.07%) grafts were not compatible, withtheir CIT average being 69:22hrs. (42:00 to
91:llhrs.) 4(9.7%) of the 41 grafts did not
funct:ion at all. 6(14.6%) grafts function-
ed from 1—Imos., 9 (21.9%) from 4—6mos., 1
grafts functioned for 8 months & 21 (51.2%)
grafts are still functioning with 15 pts.
having a creetinine level of between 0.7 —
1.5mg, 2 pts' creatnine from 1.6—2mg & 4
pt' at 2.5—3mg. Patient survival in this
particular follow—up group was 82.9% with
51.2% as grafts survival.
Therefore, we can say that if the APO is
compatible & a negative crosamatch, the
9rafts can function at least 50% in non-
BLA matching cadaver kidney grafts with pro'
loned cold ishernia time.
VIRAL INFECTIONS cVD TN RtN KArlsrLAflTS (RI).
J. Girbau, J. Lloveras, J. Masramon, X. Cuevas, A.Orfila, J. Aubia, I. Calico, H. SalvadO, M. Llorach
Nephrology Dept. Hosp. L'Esperanca. Barcelona.Spain
Over a 4 years period we perfomed 82 RI, 51 cada
ver RT(RTC) and 31 living related RT(RTL) in 79 pa-
tients. 37(45.1%) of the 82 RT presented one or mo-
re VI epHodes by one or more viruses. 19 RT(23%)
presented clinical CMV VI confirmed in 5 by a four
fold increase of the serogicat titer, in 9 by hemo—
culture (HC), in 3 by uroculture(UC), in 1 by the
presence of CMV inclusions(CMVIC) in hepatic biopsy
and 1 by CMVIC in aspiration cytology of the graft.
1 has a chronic form of CMV. Besides, aLl 9 RI with.
CMV in NC and the 2 with CMVIC had also CMV in UC.
1 of the RI with CMV in NC had also CMV in a bone
marrow aspirate. 9(47.3%) of the 19 RI with CMV had
other VI of herpes group (NV): 8 simplex(HVS) of o—
ronasal mucosa. of whom 1 had also an herpetic que—
ratitis and 1 Zoster(IIVZ). 18 other RI(22%) presen
ted oronasal HVS alone diagnosed clinically in all
cases and cultured from the lesion in 5 of them.
VI affected 30(58.7%) of the 51 RIC: 14 HV(27.4%)+
10 CMV(19.6%)+ 6 CMV+HV(l1.7%) and 7(22.5%) of the
31 RIL: 4 HV(12.9%) + 3 CMV+HV(9.6%). VI affected
23(44.1%) of the 52 RI treated with Azathioprine
(Az): 12 HV(23%)+ OCMV(11.5%)e.5CMV+HV(9.6%) and 1
(46.6%) of the 30 RI treated with Cyclosporine(cy):
6 HV(20%)+4CMV(13.3%)+4CMV+HV(13.3%). 2 of the 82
RI(2.3%) died over this 4 years and lost their
graft( %).1 death was attributable to VI(CMV) but
none of graft losses. We conclude 1) VI should be
early detected and confirmed by viral culture. 2)the
low mortality is attributable to early diaanosis,im
alunossupression reduction, intensive care measures
and the use of Acyclovir for MV. 3) VI incidence was
significantly higher in RIC than RIL(p ). 4) VI
incidence was similar either for Az or Cy treated RI
COMPARISON OF MONOCLONAL ANTIBODIES TN TNNTJNOLOGIC
MONITORING OF RENAL T1ii\NSPLANT PATIENTS.
F.C. Benny, P.S. Olans*, N.J. Tankea, P.C. Paul
and L.A. van Es (Intr. by 1. Schicht).
Department of Nephroiogy and *Depflrtnient of
Histochemistry and Cytochemistry, University
hospital Leiden, The Netherlands.
Sequential, monitoring of peripheral blood T cell.
subpopulations was performed by flow cytometry in
360 blood samples obtained from 35 renal allograft
recipients using OKT and Leu monoclonal antibodies
(NoAh). Cells which were labeled with the Leu
antibodies were double labeled with an anti ElLA—DR
MoAb to identify activated cells in the different
suhpopulations. The percentage of T cells express-
ing the "cytotoxic— suppressor' phenotype stained
with th Leu2a MoAb was lower than the percentage
of OKT8 cells (14.5±9,1% and 18.358.0%;
respetive1y; mean±SD; p<O.0001). The percentage of
Leu3 cells was also lower than the percentage of
OKT4 cells (47.6±12.8 and 50.5±11.2 repectiveiy,.
Since the discrepancy between the Leu2a and OKT8
cells was+relative1 higher (21%) than that between
the Leu3a and OKT4 cells (6%), the mean Leu3a/2a
ratio was higher than the mean OKT4/8 ratio
(6.64±9.7 versus 3.60±2.82; p 0.0001).+A high
discrepancy between the Leu2a and OKT8 cells,
indicated by an OKT8/Leu2a rtio 1.5, correlated
with a high percentage of DR cells within the
Leu2a population (>6%), whereas an OKT8/Lu2a ratio
<1.5, correlated with a low percentage DR cells
(56%; p<0.000l). These observations suggest that
activation of some T cells with the 'cytotoxic—
suppressor' phenotype lesds to antigen modulation
in which the OET8 epitope remains unaffected but
the Leu2a epitope hss disappeared or become
undetectable with the present method.
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A TWO—YEAR FOLLOW—UP OF LONG—TERM RENAL ALLDGRAFT RE-
CIPIENTS CONVERTED FROM PREDNISOLONE/AZATHIOPRINE TO
CYCLOSPORINE A
I. Henriksen, B.L. Hansen, S.A. Birkeland
Department of Nephrology and Tissue Culture Labora-
tory, Odense University Hospital, DK—5000 Odense C,
Denmark
20 long—term necrokidney transplanted patients
(age 15-60 years) mere converted from conventional
immunosuppression (predriisolone/azathioprine) to
monotherapy with cyclosporine A (CyA). The patients
were converted 1—7 years (median 3 years) after
transplantation because of chronic rejection and
massive steroid sideeffects including osteoporose,
osteonecrose, diabetes and hypertension. Ihe conver-
sion was performed in the following stages: Addition
of CyA, approx. 4 weeks later withdrawal of azathio—
prine, approx. 4 weeks later slowly withdrawal of
prednisolone over 3-4 months with reductions from 10
to 8.75,7.5,6.7,5.0,4.1,3.8,2.5,1.3,0mg per day.
CyA was initially given in doses of 10 mg/kg (later
7 mg/kg) but had to be tapered down to about the
half during the conversion because of sideeffects
and toxic reoal effect. iesults: The 5 patients
with chronic rejection proceeded in decreasing
graftfunction; the remaining patients were all suc-
cessful converted to CyA and had now been out of
conventional therapy for up to 22 months. All had a
light increase in 5—creatinine (median 48(21—212)
umol/l). Most had gastrointestinal disturbances, a
few had tremor, one had gingival hypertrophy and
most had hirsutism hut those sideeffects were rever-
sible upon dose reduction. 10 patients were immune
monitored weekly with OKT 3, 4 and 8 monoclonal an-
tibodies and surface membrane immunoglobulin fluo—
rescens (SMIg). It was found, that using this con-
version scheme the lymphocyte subsets could be held
unchanged with an OKT 4/OKT B ratio between 1.5 and
1.8. A decrease in S—cretinine was observed 6—12
months atter the conversion in some patients.
SUCCESSFUL PLASMAPHERESIS FOR CICLOSPORIN (Cs)-
INDUCED HEMOLYTIC UREMIC SYNDROME (HUS) IN TWO
RENAL ALLOGRAFT RECIPIENTS
G. Keusch, D. Baumgartner, J. Gmiir, H.R. Burger,
F. Largiadêr, U. Binswanger
Departments of Internal Medicine, Surgery
and Pathology, University Hospital of Zurich,
Swi tzerl and
We report on two cases of de novo HUS in renal
transplant recipients treated with Cs, Prednison
(P) and Azathioprine (Aza). Case 1: A 53—year old
woman remained olicuric after third cadaveric
renal transplantation under inimunosuppression
including P, Aza and Cs (6 mg/kg/day). On the
fifth day after gafting the platelet count fell
from 582 to 5llO /1 and a microangiopathic hemo-
lytic anemia was disclosed. Transplant biopsy
revealed thrombotic microangiopathy, tubular
injury but no rejection. After plasmapheresis
without withdrawal of Cs HUS resolved two weeks
later. At 6 months, serum creatinine was 150
umol/l. Case 2: A 59 year old man developped 6
days after a second RI acute renal failure under
immunosuppression with P, Aza and Cs (5 mg/kg/
day). Thrombocytopenia and microangiopathic hemo-
lytic anemia were observed. Withdrawal of Cs
combined with plasmapheresis and hemodialysis
were followed by recovery of hernatological
abnormalities after 6 days and renal funcion
after 2 weeks.
Conclusions: Low dose Cs may cause de nove HUS
in renal allografts. Therapy with plasmapheresis
looks promising.
TOLERANCE OF RABBIT ANTI-THYMOCYTE-GLOBULIN (R-ATG)
IN RENAL TRANSPLANTATION
C. Hiesse, ii. Cantarovich, B. Charpentier, 0. Fries
Service de Ndphrologie, HOpital Paul Brousse, Fa—
culté de Médecine Paris—Sud, Villejuif, France.
ATG is a useful tool for treatment of kidney
graft rejection. Nevertheless, its clinical use is
restricted by serious side effects wich would de-
pend upon the source of globulin. In order to veri-
fy the potential better tolerance of R-ATG, an open
study was conducted from 1982 to 1984 by treating
2 groups of 25 patients (P) with acute cellular re-
jection, with R-ATG or horse (H) ATG. The mean du-
ration treatment was similar in both groups (10.9
and 11.1 day respectively),as the mean daily dosa-
ge (16.5 and 17.6 ml). Each ml contained 5 mg of R-
globulin, inducing experimentally a 23-24 day tole-
rance of skin graft in macaccus cynomolgus (con-
trols : 10 days), or 18 mg of H-globulin, inducing
a 16-17 day tolerance. Local and general reactions,
WBC and platelet counts were recorded during the
course of ATG. Mild fever (< 38°5) occured in the
first day of treatment in 9 P of the R-ATG group
i34.o I) aol in 1 P of the H-ATG group (48 %).
The incidence of leucopenia (< 3500 WBC) was simi-
lar in both groups. The most striking difference
consisted of a major incidence of thromboperia
(36 %) in the H—ATG group : 2 severe (< 50000 pla-
telets) and 7 mild (< 100000), whereas only 3
(11.2 %) episodes of mild thrombopenia occured in
the R-ATG group (difference significant : p < 0.05)
In 3 P receiving H-ATG, thrombopenia promptly re-
solved when R-ATG was introduced instead H—ATG. We
concluded that with a similar effectiveness, side
effects of R-ATG are minimal, and R-ATG must be
substitued to H-ATG when a thrombopenia impedes
its use. Reduced daily dosage of globulin would
account for the better tolerance of R-ATG.
• ERYTHROCYTOSIS (E) AFTER KIDNEY ALLOTRANSPLANT-
.
ATION (KT): HEMATOLOGICAL CHARACTERIZATION AND
COMPLICATIONS
G. Keusch, H. Jungbluth, J. Fehr, K. MUhlethaler,
U. Binswanger
Sections of Nephrology and Hematology, University
Hospital of Zurich, Switzerland
By means of a prospective study etiology and
thrombembolic events were evaluated in 15 patients
(pts) with E (Hct-50 %) after KT. For identificat
ion of mechanisms involved red cell mass (RCM) and
plasma volume (PV) were estimated. All values are
expressed as means SD. Results: E occurred 8,1
(range 1-30) months following KI. No pts had under-
gone bilateral nephrectomy before KT. The average
serum creatinine (S-Cr) at onset of E was 113+34
*imol/l. Hemoglobin (Hgb) and Hct amounted to
17.4±1.3 g/dl and 54.3 (range 50-72) %, respect-
ively. RCM was elevated in 14 of 15 pts amounting
to 35.2±8.4 ml/kg body weight, reflecting an in-
crease of 40.4 (range 7 to 109) % as compared to
normal values. PV was increased in 4 pts and de-
creased in 11. Peripheral thrombosis was observed
in 4 pts leading to pulmonary embolism in one.
Therapeutic phlebotomy maintaining Hct levels be-
low 55 % were able to prevent further thrombotic
complications. At the end of the follow-up period
(7 to 80 months after onset of E) E persisted
(Hgb: 16.1±0.9 g/dl; Hct: 50.8± 2.8 %) and S-Cr
was ll9+47,umo1/l. Conclusions: E after KT is due
to an increased RCM. E can be associated with
thromboembolic complications. In our series E was
associated with anexcellent allograft function.
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• THE SELECTION OF DONORS FOR HIGHLY SENSITIZED
PATIENTS
• P.T. Kiouda, B.A. Bradley, N.H. Seiwood
U.K. Transplant Service, UK
Sera from 126 highly sensitized patients
85% panel reactivity) suffering from end stage
renal failure were tested against a panel of
cells from 100 HLA typed individuals in an
attempt to discover the range of antigens with
which their sera did not react. This was termed
'the window of acceptanie antigens' and it was
used to predict the HLA type of potentially cross
match negative donors. The results showed that
the supertypic antigens Bw4 and Bw6 played an
important role in sensitization. However cross—
reactive antigens were not always acceptable, as
expemplified by HLA-A28 patients whose sera
reacted positively with the HLA-A2 antigen. Most
windows" included 2 to 8 acceptable lILA—A and B
antigens.
38 of these patients were transplanted during
1934. Their donors were selected purely
on the basis of negative cross—match tests and
without reference to the "windows". When the actual
mismatches between donor and recipient were
compared with those predicted by the windows some
discrepancies were discovered. Some mismatches
selected by the negative cross—match test were
not revealed in the windows. This suggested
that the most practical way of finding acceptable
donors for highly sensitized patients is a
negative cross-match test. The overall survival
of these patients at three months post operative
is 68%.
IS ;YPENTRICHOSIS (H) IN CYCLOSPORIN A
(CY-A) TREATED RENAL TRANSPLANT PATIENTS
(RTP) A HORMONAL1EFFECT? 2 3
H. KopsaP. baic ke , W4Gebha rt3J. Huber ,J. B1
E}flT,M.Schemper,3.Spona,J.Zaz9ornik
1. Dep. Med. din. UI. Dep. Dermatol. I. Dep. Gyn
1,Dep.Surg.University of Vienna, Austria
H is a frequent side effect of CY-A
treatment and seems to be a dose dependent
phenomenon.The predilection sites are face,
shoulders,back and lateral parts of proxi-
mal extremities.The aim of the study was to
investigate a possible correlation between
sexual steroids and increased hair growth
in CY-A medication.Serologically testoste-
rone ,androstendione(A) ,dehydroepiandroster
onsulfate(DHEA-S),l7-hydroxyprogesterone
(17-OH-P),prolactine(HPRL),17-beta-Estradi-
ole(17-b-E) ,sexual binding globul ine(SHBG)
and cortisol (F)were evaluated.Group 1(4
7 )received dY-A and low dose steroid th
rapy,group 11(4 ,7 )were under azathio-
prine and high dose prednisolone.Statisti—
cal data were obtained by variance analys-
is.Androgenes,HPRL and 17-b—E did not dif-
fer significantly in both groups.SHBG show
ed no significant difference in all 22 Ca—
ses.F levels in group 1 (4,03 + 1,03
,pg/dl)
were significantly lower than in group II
(14,6 + 1 ,9)due to the different cortisone
doses.HEA-S,A and 17-OH-P were below the
normal range in both groups and sexes.
Hormonal cause of CY-A induced H can be
excluded by the findings of a normal profile of relevant hormones in RIP. Dose de-
pendent effects of CY-A on the cell cycle
might contribute to the development of H
in RIP.
DEVELOPMENT OF RENAL OSTEODYSTROPHY AFTER
KIDNEY TRANSPLANTATION
M.Köber,H.Schneider,H.M.Reinold,H.Bockhorn,
G.Delling,E.Streicher.
Katharinenhospital Stuttgart, University
Hospital TDbingen,University Hamburg, FRG
We performed bone biopsies in 30 pats.
on hemodialysis(9—l2Omonths)at the time of
transplantation(TPL)and 9—17 months after-
wards. Parallel biochemical analyses(Ca,PO4,
AP,PTH,Vit.D)and bone X—ray were compared.
73% of patients received cyclosporin, 27%
azathioprin, mean daily dose of prednisone
was 9.1mg in both groups.
At time of TPL all pats.had renal osteodys—
trophy,in 70% fibroosteoclasia was detected
Severity of changes was positive correlated
to time on dialysis, in 30% osteomalacic
lesions were found.In 44% of biopsies Al—
staining was positive.After TPL 90% of pats
continued to have signs of osteodystrophy
in control biopsy despite mean creatinine
clearance of 6lml/min.28% developed former-
ly not existing osteopenia.Time on dialysis
was not different between osteopenic group
and others,but number of rejection episodes
requiring high dose steroid treatment was
significantly higher(75%) in osteopenic
group compared with pats without osteopenia
(37%),while mean steroid treatment was not
higher(8.7mg/day) than average. Treatment
with cyclosporin or azathioprin tend to
have no influence on development of osteo—
penia.Positive Al—staining in control biop—
sies reduced to 13.3%. PTH levels did not
normalize and showed no correlation to typo
of osteodystrophy in control biopsies.X—ray
and lab documentation revealed no hints for
early detection of osteopenia.
COMPARISON BE1WEEN CYCLOSPORIN A (CY-A)
AND CONVENTIONAL IMMUNOSUPPRESSION(CI)
AFTER KIDNEY TRANSPLANTATION IN REGARD TO
DERMATOLOGIC FINDINGS
H. Kopsa,J Zazgorni k,P. Baicke ,K.Derfler,
W.Gebhart*
I. Dep. Med. Clin. ,II. Dep. Dermatol. din.
University of Vienna, Austria
66 patients of group I(high dose pred—
nisolone and azathioprine,mean observation
time 12,2 months(1-48)and 41 recipients of
group 11(10w dose steroid therapy and CY-P,
mean observation time 13,4 months(1-34))
were checked for dermatologic findings af-
successful grafting.Cl inical dermatologic
investigation was done routinously at 3 to
6 weeks intervals and completed by viral,
bacterial and mycotic tests and skin biop—
sy.Vi ral infections ,mostly H.simplex,H.zo—
ster, were seen in 72p.c. of group I,but
only in 42p.c. of group II.The frequency
of mycotic infections,mainly due to Candi
da albicans,trichophyton and epidermophy-
ton was 6lp.c. in group I and 28p.c. in
group II.Comparison of bacterial skin in-
fections between the 2 groups revealed a
striking decrease from 54p.c. to llp.c.
Non infectious dermatologic complications
were evident in 84p.c. of group I and 91
p.c. of group II.In CY-A cases no malig-
nancies were seen in contrast to CLCY—A
induced hypertrichosis occured in 75p.c.
A normal pattern of relevant hormones
was found in both groups.Cy-A dose depen-
dent effects on the cell cycle might cont-
ribute to increased hair growth.Gingival
hyperplasia was seen in 34p.c. and decrea-
sed with dose reduction.Use of CY-A redu-
ced remarkable infectious skin disorders.
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COMPARISON BETWEEN CYCLOSPORIN A (CY-A)AND
CONVENTIONAL IMMUNOSUPPRESSION (CI)AFTER
KIDNEY TRANSPLANTATION IN REGARD TO OCULAR
FINDINGS.
H.KopsaH.BettelheimE.WinklerP.Balcke
K. DerflerlJ.Zazgorni ki
I. Dep. Med. Clin. UI. Dep. Ophthal. Clin.?
University of Vienna,Austria
In group I 41 cases(high dose prednisolone
and azathioprine medication, mean observa-
tion time 8,7 months(1-4o)and in group II
31 cases(low dose steroid therapy and CY-A
mean observation time 12.8 months(2—32)
were under ocular examinatign.Clinical in-
vestigation of the eye,slit-lamp,tonometry
visual acuity and fundoscopy were done.
Recurrent subconjuncti val haemorrhages
and calcium depotis in the conjunctival
tissue occured in 6lp.c.of group I and 40
p.c. of group II. The incidence of poster-
ior subcapsular cataract(PSC) was 61p.c.
in the patients under CI and 21p.c.under
CY-A.Visual acuity in cases with PSC was
not impaired except in 2 cases of group I.
Elevated intraocular pressure was measured
in 2 cases of group I.Fundoscopic findings
in groupl/lI were pigmentary irregularit-
ies(44/42p.c.),alterations of the foveolar
region(12/l7p.c.) and narrowing of arteri-
al vessels(35/54p.c.).Hypertensive fundus
changes were more frequent and pronounced
in CY-A cases caused by more severe syste-
mic arterial hypertension.Despite develop-
ment of steroid induced hyperglycaemia or
diabetes no diabetic retinopathy was evi-
dent.Under CA-A subconjunctival haemorrha—
ges and PSC occured less frequently than
under CI.
THE DONOR AFTER TEN YEARS: DID MAKING iri1
DECISION INFLUENCE THE PSYCHIC REACTION?
K.Kronqvist, R.SipilR, R.Rimón, B.Kuhlbhck
Psychiatric Clinic and Fourth Department of
Medicine, Helsinki University Central
Hospital, Helsinki, Finland
To explore how much psychic trauma persists
after a kidney donation, 63 living related
donors were interviewed by a psychiatrist
10 to 17 years post-transplant. 41 had
given their kidney to a sibling, 20 to a
child, and 2 to other close relatives. The
donors decision—making model was identi-
fied as a. moral decision—making model
(immediate volunteer), b. model of delibe-
ration (rational model) or c. postponement
model. In donors who had made an immediate
decision, moderate to severe psychic trauma
was observed in 4 (15.8%), mild trauma in
8 (29.6%), and 15 donors (55,6%) showed no
signs of trauma, regardless of the outcome
of the transplantation. None of the donors
who had made a type b. decision showed
signs of even moderate trauma, and in the
3 (of 9) cases of mild trauma the outcome
had been unsuccessful. 5 donors had let the
circumstances make the decision.
Even if the psychic trauma is not conscious-
ly experienced as severe (on the contrary
the donors stressed the benefits of this
experience), the results underline how
important the psychiatric examination of
the prospective donors and their motives
are. Supporting them to a decision based
on rat:Lonal facts rather than moral obliga-
tion may spare them the psychic trauma.
. PROLONGED ADMINISTRATION OF A MONOCLONAL ANTI
T3-CELL ANTIBODY (OKT3) TO KIDNEY ALLOGRAFT RECIPI-
ENTS.
Kreis H., Chkoff N., Campos H., Chatenoud L., La-
combe M., Debure A., Choquenet C., Goldstein G.,
Bach J.F., Crosnier J.
Renal Transplant Unit - Hopital Necker - Paris.
OKT3 is a powerful immunosuppressive agent;
its major problem is immunogenicity. In order to
preclude anti—OKT3 immunization a study was de-
signed associating OKT3 to other immunosuppressive
agents. 60 allograft recipients were enrolled in
the study. 4 patients were excluded from the
study. 19 were allocated to the experimental group
receiving OKT3 (5mg per day I.V. for a minimum of
15 days or up to 30 days provided that the T3 cell
marker remained <30 per cent of baseline value) +
conventional low dose steroid (LDS) treatment and
azathioprine (AZ) . 37 control patients were divid-
ed into two groups 19 were allocated to the con-
ventional high dose steroid (HDS) treatment and 18
were placed in the LOS group receiving AZ+LDS as in
the experimental group but without the monoclonal
antibody. The mean number of rejection episodes
was lower in the 0KT3 group than in the control
groups. One year graft survival was 90% in the
0KT3 group, 81% and 84% respectively inthe control
groups. Lower serum creatinine levels were also
observed in OKT3 treated patients. Rejection epi-
sodes jot the experimental group were related to
blood repopulation by T3+ cells as a consequence of
either an inadequate dose of OKT3 or the develop-
ment of anti—OKT3 immunization. Antigen modulation
was observed in all 0KT3 patients within days 2 to
5. Minimum side effects were observed in OKT3 tre-
ated patients. OKT3 can thus be administered for
at leat 30 days in most patients, reducing or abol-
ishing rejection episodes and favoring good graft
survival with a much lower dose of steroids.
.
IDENTIFICATION OF A HITHERTO )JNDESCRIBED LEU7—LEU3
LYMPHOCYTE SUBSET IN LONG-TERM RENAL ALLOTRANS—
PLANT RECIPIENTS.
Ch. Legendre, R.O. Guttmann.
Royal Victoria Hospital and McGill University,
Montreal , Canada.
In long—term renal allotranspiarit recipients,
the percent of peripheral blood lymphocytes (PRL)
reacting with the 1gM monoclonal antibody (mab)
Leu7, a marker of large granular lymphocytes
(LGL), is increased compared to normal controls.
To further define this subset, we used two—color
immunofluorescence staining and flow cytornetry.
We studied 22 renal allograft recipients at risk
for a mean of 78 months for relative and absolute
numbers of PBL reacting with the following combin-
ations of mab: Leu7—Leul, Leu7—Leu2, Leu7—Leu3,
Leu7-Leul5. The absolute number of doubly fluo-
rescent lymphocytes Leu7—Leul and Leu7—Leu2 is not
different in the transplant population compared to
a control population. In striking contrast, the
Leu7—Leu3 subset, normally a very minor one, is
significantly elevated both in relative (6.8 1.3
vs 1.0 0.1 %, p <0.005) and absolute (58 10 vs
21 4 /mm3, p <0.02) numbers. On the other hand,
the absolute number of Leu7—LeulS PRL (as a marker
of Natural Killer cell activity is significantly
decreased (40 7 vs 89 11 /mm3, p <0.001). The
relationship between the modification of these two
phenotypes within the Leu7 subpopulation may be an
important correlate of decreased natural killer
cell activity in long—term renal allograft recipi-
ents. This newly described Leu7—Leu3 subset, sha-
ring phenotypic characteristics of LGL and T help-
er/inducer cells, has no known functional activity
and may represent a pre—NK subpopulation.
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• EXPRESSION OF LILA-DR ANTIGEN ON ENDOTHELIAL CELLS
(PC) IN KIDNEY ALLCGRAFTS
G.Leimenstoll, M.Stitz, P.Zahei, P.fleltz,fTfdher
flepartJrtents of Nephrology and Surgery University
of Piel, iKiel, F.R.G.
The expression of HLA-DR antigen on PC is im-
portant in inducing rejection of renal allografts.
For example, glucocorticoids can suppress this
expression. The aim of this study was fo find out
a correlation between the expression of the anti-
gen and the stage of rejection. 46 fine needle
aspiration biopsies of 24 patients (immunosuppres-
sion: Ciclosporin A and corticoids) were analysed.
The aspirates were labeled with the monoclonal
anti-LILA-DR antibody Dako M 7o4, using the per-
oxidase—technic. Three stages of rejection were
formed, according to the composition of the mono-
nuclear infiltrates (i-Iayry et al.), (table).
n stage of LILA-DR + LILA-DR -'-7- LILA-DR -
rejection
9 0 () 3 6
32 I 15 6 11
5 II 3 2 0
(lILA-Dr +7+: positive and negative P.C in one
aspirat)
The results show, that the antigen was in no case
expressed on all ECs in the group without rejec-
tion; on the contrary, in the aspirates of allo-
grafts showing rejection according to stage II,
there was no PC expressing LILA-DR at all.
Further studies will show, whether the monitoring
of this antigen will allow a better control of
the immunosuppressive therapy.
IMMUNE COMPLEXES IN PRE- AND POSTTRANSFUSION SERA
OF DIALYSIS PATIENTS
V. Lenhard, E. Krapf, W.E. Brandeis, H.G. Manke,
Institute of Immunology, Childrens Hospital,
Department of Thorax Surgery, University of
Heidelberg, and Department of Clinical
Immunology, University of Erlangen, FRG
Pretransplant blood transfusions (BT) improve
kidney graft survival. The underlying immuno-
logical mechanism, however, remains unclear. We
studied in dialysis patients before and after BT
the levels of circulating irmnune complexes (IC),
and the inhibitory activity of patient sera on B
cell response. In patients receiving 3 BT in
weekly intervals IC were quantitated by the PEG
precipitation method and the Clq binding assay.
Peripheral mononuclear cells were preincubated
with pre- and posttransfusion sera, and the PWM
induced antibody response was measured in the
plaque—forming cell (PFC) assay using protein
A—coated SRBC as target cells. Compared to
healthy controls, dialysis patients sera exhi-
bited significantly increased levels of IC (PEG:
0.65 mg/dl vs. 1.12 mg/dl; Clq: 28.6 ig/ml vs.
42.6 g/ml, p 0.05). There was no significant
increase of IC following BT. However, when normal
mononuclear cells were preincubated with post-
transfusion sera the number of PFC was markedly
inhibited, PFC inhibition was correlated with the
number of BT (Pre—BT; 34 x 1O—, post1.BT: 26 x
1O—, post 3.BT: 14 x 10—i PFC). In conclusion,
increased IC levels were found in dialysis
patients. There was no significant difference
between patients with and without BT. In con-
trast, inhibition of PFC was clearly correlated
with the number of BT.
TWO DIFFERENT PATTERNS OF ABSORVUON OF CICLO-
SPORIN A (CS-A) IN PENAL FNDSTAGE FAILURE
G.Leimenstoli, H.Jessen, S.Rothgorrlt,P.Zahel,
Niedermayer
Department of Nephrology, university of Kiel,
l(iel, F.R.G.
To avoid nephrotoxicity or rejection in renal
allografts the monitoring of CS-A bloodlevels is
mandatory, because of the variability of ab-
sorption of this drug. Using the pharmakokinetic
model, the optimal dose can he calculated before
transplantation.
or this purpose we applicated orally 7,5 mg/kg
RN CS-A in 16 patients hecore transplantation.
The CS-A hloodlevels were measured over a period
of 24 hours (RIA-method). The total areas of the
hloodlerel-versus-time curves (ATIC) were ca]cu-
lated using the trapezoidal rule.
According to the AIICs two groups can he distin-
guished. The mean of the AUCs of the first group
was 84o4 + 3197 ng/h/ml versus 24735 + 2411 mg/hI
ml of the second group (p <o,ool).
Calculated from these areas, the steady-state con-
centrations of CS-A (dose: 2 x 7,5 mg/kg RN/day)
will he 7oo + 266 mg/mi versus 2060 + 2oo ng/mi.
These bloodlevels were confirmed now after trans-
plantation in 8 patients.
There is no explanation for this phenomenon, re-
garding clinical parameters. We conclude, that
the determination of the AUCs before transplan-
tation is helpful. This result underlines the
importance of the pharmacokinetic monitoring to
ptimuze the immunosuppression of this drug.
VENO-0CCL[JSIVE DISEASE OF THE LIVER (V0D). A
PROBLEM IN RENAL TRRNS PLANTATION ?
F. Liaño, A. Fernandez, A. Moreno, N. Badfa, .T.L.
Teruel, C. Quereda and 3. OrtuRo.
Servicio do NefrologIa.centro Ram6n y Cajai.MadrId.
VOD is marked clinically by hepatomegely and as
cites. Histologic findings are centrilobular con-
gestion and fibrosis involving the terminal veins.
This disease has bean described in association
with autologous bone marrow transplantation and
with the use of some cytostatic drugs. A case of
VOD has been described also in a patient who was
receiving immunosuppressive therapy with azathio—
prine (AZ) and prednisone (P) after kidney trans-
plantation.
We present 3 new cases of VOD developed in our
first hundred of renal transplants. They were ma-
les without ethylic antecedents; their age ranged
from 31 to 51 years. Two of them took AZ and P and
the third also alphamethyldopa. No other immunosu
pressive agent was used.
Severe intrahepatic cholestasis occurred 2 to 6
months following kidney transplant in the three
patients; however there was only a milder increase
of SGOT and SGPT. Over the next months patients
experienced progressive ascites and one died be-
cause of hepatic failure. Az was withdrawn in the
three patients without any improvement. A viral
involvement could not been proved.
VOD is a serious problem; its incidence in re-
nal transplantation could be higher than has been
previously described. Because Az has been generous
ly used in kidney transplantation the possible
etiologyc effect of this drug in VOD should be ob-
jected.
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DELIA AGCNT GAg) 1RA4ISSIC* n4RWGI REMAL TRANSPLANTI (RI)
WITH SEVERE HEPATITIS IM)UCTION IN 1l I-BsAq HEAL1HY CARRIERS.
J. Lioveras, J. tthteis, J.M. Sánchez—Tias, l. Brt,era, J.
Nesraidn, A. Orfila, X. cuevas, J. Athia, II. Llorach.
Hosp. LEsperança; Fbsp. r; Hosp. Clinico; BARCELC'IA. SPAIN.
IAgCdonors are relatively frequent ard their ki&ieys go
to }€sAg recipients. The increasing rurter ard the characteris
tics of drta&Jicts (DA) brings to the fact that IBsAg DA are
not a rarity as potential donors (PD).Ag affects 50% of IBsAg®
DA &vi with nuch less incidence to patiens with active chronic
hepatitis BOB) or cirrhosis post B bot not to healthy }EsAg ca
rriers or to patients with persistent chronic B. Ag needs the
lB virts to replicate ard to becane infectious. Acute hepatitis
occurs always after Aq transmission in lBsAg carriers ard usu-
ally leads to severe active chronic hepatitis, cirrhosis or ful—
.ninant forms. Ne transplanted a ki&iey fran a 24 years old heroi
Unan with acute lB aid post-traunatic brain death to a healthy
IBsAG carrier yoirig recipient on dialysis program over last 2 ye
are. F received Azathiqrine arid high doses of pre&iisone the
first naith post RI arid maintenance doses thereafter. Renal arid
hepatic test were normal u,til week 18 when he was hospitalized
óie to fever arid GOT 461; GPT 463; (31 269; Gil tot 4.5; jick
27%; platelets 145.CXX); leuc 51(X) Creat 1.0; lBsAg if); anti—lBsQ); anti IBc; BeAg(9; anti Be(). A transjtular li-
ver bicpsy (LBx) showed severe acute hepatitis.äantigen was do—
tected in liver tissue by inmsncperoxidase . He received Inter—
ferai 10.(XX).CX:O/day x 2 weeks plus 5.CXX)XD)/day x 3 ulterior
weeks. 3? days later was discharged with GOT 72; (PT 82;AGT 330;
pil tot 1.1; tjick 78%; platelets 2a).CXJ); creat 1.0. 7 nnths
later a LBx showed severely active chronic hepatitis. The othe
r ki&iey fran the sane donor was succesfully transplanted in a—
ther Center to an iBsAg healthy carrier ycrp recipient who
was there recovered 14 weeks post RT with the diagoosis of ful—
minant hepatitis arid died 48 horus later. Ne ca-iclide that
PftAg()Pt) either GA or with active chronic hepatitis shouLd be
discarde Lntil serological markers are at disposal so we could
routinely detect it
ON PRO0JB'ENT EFFICIENCY IN A 250 BED HOSPITAL IN C(XJ_ABORA—
fl WITH A TRANSPLANT CENTER (IC)
J. Lioveras, J. Itnteis, L. Oiler, P. Fossas, J.F. Solsona. J.
Llovet. F. Garcia-Palleiro, J. lsraincri, J. kbia, N. Llorach.
Hosp.GJ1.D. Mar. Hoso. G.M.D. L'Esperança. Barcelona—Spain.
We desigoed a protocol (P) to detect all potential donors
(PD) aid to carry out their evaluation, follcw—q, maintenance
arid surgical organ retrieval. This P assunes the participation
of the Intensive Care Lkuit (1W), Neurology, Neurosugery, Neuro-
physiology, Anesthesia, Urology, Bnergencies arid Horses Depts co
rdinated by the Dcrror arid Neurology Coordinators (DC) (NC). All
than with the transplant Coordinator fran the IC constitute the
Organ Procurement Canitee ((PC) that nuithly analyzes the record
s of each PD. All patients with bad progiosis neurological sings
(BSP) that may evolution to irreversible cana or brain death are
registered . All BSP are considered PD arid closely followed by
the NC arid DC. Over 14 months 52 PD were registered. They re-
present 9.2% of all patients then recovered at the ICU, staying
an average of 7.6 days, similar to the rest of the 1W patients
( 6.3 days) . 38 were males arid 1.4 females. Age average 46.9
years (range 19 to 65). 24 of the 52 PD develqDed GD aid 28 did
riot hot all 52 died. 19 were cerebrovascular accidents (10 90)
li5post cardiac arrest brain anoxies (1 GD); 10 Cranial tra&snas
(7 (30); 3 CNS ttmirs (3 ti) arid 5 miscelania of causes (3 80).
3 of the 24 (3D were discarded (1 IBsAg + drugadict, doe to the
pansibitity of delta Ag transmission; 1 nmlarona ; 1 severe hr
pertermion) arid 10 other were lost for donation (8 family refu-
sal, of which 3 fran foreig tourists; 1 judicial negative arid
1 cardiac arrest before retrieval). Fran the remaining 11 GD we
ravENed a) kitheys, 3 pancreas ard 1 liver, which were all trans
planted. 1) Relatively small Hospitals may play an iisportant
role in organ procurement if organisation is gxxi. 2) (PC arid co
'rdinators help the maintenance of collaboration. 3)Close follow
-tp of all BSPby NC arid DC avoids misleadings. 4) PD do riot in-
crease the general average stay of IW. 5)Cranial traunas were
19% of all PD arid 29% of all 90, so that Hospitals lacking casu
atties may also be relatively inportant donation centers 6) Post
cardiacarrest brain arioxy rarely leads to GD despite fatal
orogiosis.
FIRST REJECT1 PERCUTAE RENAL BI(PSY (Pf) LESIC* CORRELA—
TI4 WITH &BSE(JENT P NB RENAL TRANSPLANT (RT) WTCCtE.
J. Lioveras, A. F&rné, S. Serrarmo, A. Orfila, X. Cuevas, J. Has—
ra'mn, J. Ai.tiia, N. thiné, N. Llorach.
lbsp. G.M.D. L'Esoerança. rcelona—Spain.
1( P3 fran 54 RI were exanirded. 22 RI first presented ncxJe
rate interstitial (MI) acute rejection CAR): 18 have the graft f
nctimirg S m to 5 y later arid 4 lost their graft. 2 of these 4
'had 2 ulterior P3 each over the following iroith apoearing ncde—
rate vascular (f'TiI) AR arid finally severe vascular (5'!) AR; ann-
ther one develpoed SV chronic rejection (CR) rjrnr 14 m arid the
fourth rever fuicticned with recetead P with only ti..bjlar no—
crosis. 8 other RI first presented severe interstitial (SI) AR:
7 have the graft fu,ctioning 9 m to 4 y later. 3 of these 7 had
normal ulterior P; another one sibsequently had t4JAR arid PWCR
later. The 1 RT that lost his graft showed I'VAR next roith arid
SVAR in the last Pf.7 other RI first presented MVAR: 4 have the
graft fr.srctioning 6 m to 4 y later. 2 of these 4 had 2 ulterior
P each over next 9 m showing MVCR; the 2 other had normal sib—
segaint P. 2 of the 3 RI that lost their graft showed SVAR in
si±sequent PRB over a-re month arid the third showed only tibilar
necrosis in srbseqent PRE hot never fu-rcticned.6 other RI first
presented WAR. All 6 lost their graft over next 2 m. 4 other RI
first presented IWCR over first a) d post RI: 2 have the graft
fr.nctioning 13 arid 18 m later. The 2 other had I?CR in stbseqje-
nt .. hot one died of sepsis arid the other one recurred his he-
molytic-urrenic syiidrane. 7 other RI that received Cyclosporine
(Cy) first presented rieotirotoxicity. lbre received rejection
treatment. All 7 have the graft fu-ictioning 4 to 12 m later. Ho
graft losses, infection or sigoificait morbidity was doe to P!.
1) P is efective to give an accurate diagiosis arid progrn:r
sis arid helps to mciiulate irynmrioss&pression. 2) SVAR (presence
of fibrinoid necrosis in sane point of any artery vail) has all-
ways a short term poor prognosis 3) Pf is a simple arid safe teo
hoiqre. 4) The progresive appearence of all degrees of vascular
lesions a-i the sara rejection episcde initiated as pure intersti
tial,sports the idea that all different forms of acute rejec-
tion are part of the sane process. 5) PRE is very helpful to dis
tingiish rejection fran Cv neohrotoxicity.
COMPLEMENT ACTTVAT1ON DURING TREATMENT 11TH RABBIT
ANTITHYMOCYTF GLOBULIN (AlL) FOR RENA!. ALLOGRAFT
REJECTION EPISODES.
S Lohatto, Lc Paul, MR Daha and LA von Es (intr. Nv
i.M. Schicht). Nephrology Dept, Uriv Hospital,
leiden, The Netherlands.
To determine the effect of complement activation
and circulating immune complexes (GIG) on the out-
come of treatment of renal aliograft rejection epi-
sodes with rabbit—ATG, we analyzed the results of
serial measurements of CR50, C3, C4, Clq and de-
tection of CIC with the do—binding assay in 17
recipients of renal a]lografts. Maintenance therapy
consisted of low—dose prednisone, combined with
cvclosporine—A or azathioprine. Diagnosis of graft
rejection was made when an increase in serum crest—
mine could not be explained by other causes. 3—4mg
1kg body weight of ATO was given for 21 days, on
days that perpheral blood lymphocyte levels ex-
ceeded 3 x 10 /1. Samples for complement and CIC
determination were drawn on the first day of treat-
ment and thrice weekly until completion. Complement
activation was detected in nine patients as indica-
ted by decreases of CR50, C3 or C4 to subnormal
levels by the third week of treatment. CIC's were
present in only one patient. In the remaining eight
patients complement activation was not detected and
CIC were not present. In 15 of the patients AId
treatment was succesful as indicated by improvement
of graft function and graft survival at six months
after transplantation. Two patients, both with
complement activation, lost their grafts within six
months after transplantation (n.s., x test). We
conclude that complement activation does not appear
to have a significant influence on the outcome of
treatment of renal allograft rejection episodes
with ATG. Clq binding complexes were rare in our
group of patients, and appeared to be insignificant
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EFFECT OF RENAL TRANSPLANTATION AFTER A
BEFOREHAND ANALYSIS OF RECIPIENTS' IMMUNE
STATUS TYPE
Krassimir Metodiev (Intr. by D.Nenov)
Higher InstMedicine, Varna, Bulgaria
Based on their own previous conclusion
that the higher the immune activity befo-
re operation, the oftener the rejection
crises were after transplantatiom of rens.i
allografts, the authors studied 26 recipi-
ents with high immune activity only. The
patients were set to a regular haemodialy—
sis and a thorough immunologic monitoring
(IM) was done before operation by using
several methods: proliferative and enzyma-
tic activity of lymphocytes, predeceding
and antibasal antibodies, tissue typing,
T— and B—cell prevailing, immune comple-
xes, etc. After transplantation the reci-
pients were studied in dynamics for a pe-
riod of I year. The average number of rg—
jection crises for I patient was 3.2 (hi-
ghest 5, lowest 1). By means of 114 was -
suggested and corrected the actual immuno-
suppressive therapy. Nevertheless, from
26 recipients after 1 year only 14 (53.9%)
still preserved considerably normal clini—
coimmunologic status with their renal
grafts. The rest 12 (46.1%) had either a
heavy rejection with removal of the graft
and back to dialysis or died (4 patients).
The results shew that patients with high
immune activity must be considered as
risk contingents for transplantation.
.
NEOPTERIN IN SERUN AND URINE AFTER KIDNEY TRANS-
PLANTATION
Oh. Noel, J.L. Dhondt, N. Dracon, C. Lelievre, A.
Tscque t
HApital Calmette, Nephrology Dept., Lille, France.
Several recents reports have suggested that
immune responses are accompagnied by increased
levels of neopterin, s pteridine derivsting from
CTP. The aim of this work was to evaluate the
interest of monitoring neopterin concentration in
serum and urine as an indicator of immunological
complication like rejection episode or viral
infection.
Neopterin was measured in serum by a radio—
immunoassay and in urine by !IPLC, in 14 renal
transplant recipients. All patients were treated
with azathioprine and methylprednisolone;
rejectinn crisis were treated by corticoid bolus
therapy.
In uncomplicated post—transplant course,
urinary excretion of neopterin was higher (792
421 pmol/mol creatinine) than in controls (307
103). Rejection episodes have been in most of the
cases sccompagnied by an reincrease of neopterin
excretion. However, the test lost its diagnostic
value when the graft did not function initially
(ie: acute tubular necrosis). On the contrary,
viral infection (ie: cytomegalovirus) led to a
dramatic increases of both serum (116 — > 200
nmol/l, normal: 5.3 1.7) and urinary neopterin
(2100 — 26000 pmol/mol. creatinine)cnncentration.
We conclude that monitoring of neopterin con-
centration offers a valuable aid in the early
diagnosis of viral complication in immuno depressed
patients but did not improve significantly the
prediction of acute allogrsft rejection in contrary
to data recently published by Msrgreiter et al
(Transplantation 1983, 36 : 650—653).
FUGN. IMINARY ACT INFECTICIS (FIJI) IN RBIIAL IRA1CPLANTICII
(RT).
N. Nir J. Lioveras, J. r'sran&i, J. Athla, A. Orfila, X. Cuevas
N. Salvadó, I. Torrella, N. Liorach.
Nephrology Dep. Fbsp. 6.M.D. L'Esperança. rcelca,a— Spain.
(Ker 4 years period we performed 83 RI. 61 males ard 22 fema-
les. Age average 35 years (range 14 to 57). 19 (22.8%) of the
83 RI presented FIJI. 10 were males ad 9 females. 15 FIJI were
cased by Cardida (C) ard 4 FIJI by Torulcpsis Glabrata. All 83
RI carried a blackler catheter curing 24h post RT. 38 of the 83
RT, besides carried other urinary catheters (UC). 5 of the 19
FIJI presented a single urinoculture positive to ftsigus aid did
rot reqiiere treatsant; 5 other presented tcnccni tant firgal va-
ginitis ad resolved with vaginal antifcngals; the remaining 9
of the 19 nil carried UC: 5 ureteral UC free into the blacder,
3 ureteral exteriorized UC aid 1 rephrosta' UC. 1 of these 9
presented C in the urinoculture previous to RI. These 9 repre-
sent 23.6% of all 38 RT UC carriers. Their FIJI were sore severe
thai FIJI of the rest. 1 presented C sepsis aid need transplarr
tectai'. Arother me presented urinary cbstnictia, by a ball of
C that spmtaneusly eliminated. 7 of the 9 FIJI with tIC received
Mihotericin 8 (*8) ad the remaning 2 Ketoccnazole (K). All cit
red. 16 of the 19 FIJI occured on well fuctiming RI. All 19 had
Yiehied relatively high doses of pre&iiscne ad 12 of them 2
or sore courses. 11 received Azathioprine aid 8 Cycloorine
(Cy). 3 were diabetics. 5 had cytcsnegolovin.s infection aid 4
herpes sisplex. It ccncluie 1) Avoid as auth as possible UC
aid if they are necessary stablish a very close follow—i.p. 2)
In nil associated to UC or to viral infecticns irdicate early
systemic antift.ngals.. 3) High pre&iiscne doses aid diabetes are
risk factors. 4) It retcimnerd pre RI vaginal samars aid pericxii-
callypost RI. 5) If ASor Kane reqiired in Cy treated RI,
Cy doses should be redoced aid C)' blood levels ani GFR closely
.nonitored since Cy nephrotoxicity is severely potentiated by
antifuigals.
PREGNANCY (P) AFTER RENAL TRANSPLANTATION (T)
ARE GRAFT (G) AND FETUS (F) RISKS PREDICTABLE 7
Y. Pirson, N. Van Lierde, .1. Ghysen, J.P.
Squifflet, G.P.J. Alexandre, C. van Ypersele de
Strihou. University of Luuvain Medical School,
Cliniques Universitaires St—Luc, Bruxelles.
The predictive value of pre-? status in the
evaluation of C and F risk in transplanted
patients is not yet established. We review 20 p
(leading to a F weighing > 500 g) among 18
patients transplanted at our centre in order to
assess the incidence of C relection, F growth
retardatstion and pre—P risk factors. C originated
from a cadaver (9 cases) and from a living donor
(9 cases). The time interval between T end P
averages 43 months (range 5 —136 m, 9 cases > 24
m). Before P, serum creatinine was 1.4 mg/dl in
all cases, significant prnteinuria was present in
only 1 case, blood pressure waa normal in 11 cases
and mildly elevated or requiring treatment in 9
cases.
Acute rejection occurred in 25 % of P either
during the 3rd trimester (3 B) or the 1st month
post—partum (2 B). Intrauterine growth retarda-
tion, F hypoxia, oligoamnios and meconium emission
were obwerved respectively in 40, 25, 20 and 45 %
of the P, vs respectively 8, 2, 2 and 12 % in a
control population (CP) from the same hospital (P
<.001). Preterm delivery occurred in 40 % of the P
(vs 8 % in CP, F <.001). Infants were small for
gestational age in 40 % of the cases (vs 8 % in
CP; P <.001). Neither rejection episodes nor fetal
complications were related with S origin, time
interval T—P, number of pre—P rejection crises and
blood pressure status prior to P.
We conclude that 1° acute rejection complicates
25 % of the P; 2° F growth retardation is 5 times
more frequent than in CP; 3° no predictive factors
for these complications could be identified.
Abstracts 383
SERUM NEOPTERINE LEVELS (sNPT) AFTER KIDNEY TRANS-
PLANTATION — A USEFUL TOOL FOR GRAFT MONITORING?
E.Pohanka, M.Schwartz, G.Mayer, W.Woloszczuk,
J.Kovarik, H.K.Stummvoll
2nd Dept of Internal Medicine and Ludwig Boltzmann
Institute of Clinical Endocrinology, University of
Vienna, Austria
Neopterine measurements in urine have been used
for monitoring of immunological activities in
renal allograft recipients. In order to be indep-
endent of transplant function especially with
regard to post—operative anuria, sNPT levels were
measured by RIA(ng/ml) in 35 patients before graf-
ting (day 0) and daily after at least 35 days
or until graft loss, respectively. 4 groups of
patients were compared: 1)patients without any
complications, who never required steroid bolus
therapy(SB).sNPT decreased within 10 days to levels
comparable to controls (n8,48±29 day 0 to 7±3
day 1O).2)patients with rejection episodes diag-
nosed clinically,ie they received SB without
biopsy. Decrease of sNPT was delayed but reached
almost normal levels at demission (n'12,49±18
day 0 to 24±21 day 10 to 15±13 day3O).3) patients
with SB in histologically proven rejection.
Similar course as in group 2 but delay more pron-
ounced (n=10,52±24dayO to 36±I7day 10 to 12±9
day 3O).4) includes 5 patients having graft loss
due to rejection, 3 of them never had any graft
function. In this group normal sNPT levels were
never reached (n=5,76±25 day before graft loss.
In detail we could demonstrate that SB given in
reversible rejection episodes leads to a marked
decrease of sNPT independent of serum creatinine
and urine output whereas irreversible rejection
is accompanied by sNPT increase. The predictive
value of sNPT measurements during postoperative
graft monitoring will be discussed.
DOES TIlE IMMUNE RESPONSE TO HEPATITiS B IN
PATIENTS ON DIALYSIS ALLOW THE PREDICTION
OF THE IMMUNE RESPONSE TO A KIDNEY ALLO-
GRAFT?
D.Proppe, P.Jessen, P.Zabel, F.Westphal,
W. Niedermayer
Dept. oF Nephrolocy and Dept. of Immuno-
logy, University of Kid, Kid, F.R.G.
Following hepatitis B-vaccination, only
about 4o % of dialysis patients were HB5-
antibody positive, as opposed to more
than 9o I of IIB -antibody positive age-
matched non-ureTIic controlls. The reduced
immunolLogical responsiveness of uremic re-
cipients accounts in part for the success
)f renal transplantation. Preliminary data
(not yet published) indicate a close cor-
relation of DNCB-mediated immune response
to the incidence of renal graft rejection
in uremjc recipients. We therefore also
studied the incidence of graft rejections
following kidney allograft transplanta-
tions in pre-transpiant HB -antigen posi-
tive (rLo later antibody prduction) and
HB -antibody positive patients (n27 and
24
There was no difference in renal graft
acceptance between HB -antigen positive
(persistent antigenema) and FlB.-antibody
positive uremic recipients neither during
steroid-azathioprine standard immuno-
suppression nor under ciclosporine A
treatment. In conclusion, at present the
non-quantitative determination of simple
hepatitis B immune marker seems not to
allow any prognosis of renal allograft
acceptance in uremic recipients.
HLA-DR2 IN DIALYSIS PATIFNrS IS ASSXIATED WITH
IDN-CY'l\YlDXIC ALLOANTIBODY FORMATION
Power D, MacLeod A, Mason R, Stewart K, Catto GIlD,
Uoiversity Department of Medicine, Aberdeen, U.K.
The ability to form certain alloantibodies may
determine whether a given renal transplant recipiest
accepts or rejects an allograft. We have shown that
the presence of non—cytotoxic Fc receptor blocking
alloantibodies detected by the erythrocyte ant ibedy
inhibition (EAI) assay correlates with improved
allograft survival. Animal studies indicate that
alloantibcxiy responses are coded for by Ir geneslocated within the MHC. We therefore aimed to de-
termine whether EA inhibiting antibodies formed
mere readily in patients of a given HLP.-DR type.
The presence of lymphocytotoxic and MA rosette in-
hibiting (EAT) antibodies to leukaemic B cells(CLL cells) were assessed in 39 transfused uraemic
subjects. EM antibodies occurred in sera fran
13/17 DR2 positive, but only 6/22 who were DR2 neg-
ative subjects (p<O.OO8). HLA—DR2 was not assoc-
iated with an altered incidence of cytotoxic anti-
body formation (DR2 9/17; non-DR2 13/22) or a
difference in kidney graft survival at 1 year
(DR2 9/16;non-DR2 9/19). There were no significant
differences in age, sex or number of transfusions
between DR2 positive and negative groups. Titres
of lymphocytotoxic activity in ironoclonal anti-FlEA
ABC and DR antibodies were always higher than the
EAT titres suggesting that EAT activity was unlik-
ely to be due to low titre cytotoxic activity.
Additionally EM was absorbed out by platelets in
some but not all sera. These results indicate that
HLA DR2 was associated with the formation of non-
cytotoxic alloantibodies to several antigens. This
may represent an Ir gene effect in the human.
l'EOPERATIVE CAERULOPLASMIN, AGE AND THE OUTCOME
OF RENAL TRANSPLANTATION.
Radford SG, Banks RA and Black AMS.
Dept. of Reiir14edicine and Sir Humphry Davy Dept.
of Anaesthesia, Southmead Hospital, Bristol.
We have studied the perioperative plasma
concentrations of a number of acute phase proteins
in 40 patients who have undergone renal transplan-
tation, here in the last two years. The present
report suggests a predictive value of preoperative
caeruloplasmin concentration on renal function
in the first 2 months.
Two patients died of non-renal causes with
functioning grafts. A further 6 patients lost
their grafts within the first two weeks, probablyfor technical reasons.
For the remaining 32 patients, there were
significant correlations between the preoperative
caeruloplasmin concentrations and the creatinine
clearances at 3 weeks, (r =—0.54; p(O.Ol), and at
2 months, (r =-O.57; p<O.Ol).
Age of the recipient also correlated with
creatinine clearance, but less strongly than did
preoperative caeruloplasmi n concentration,
(r =-O.47; p.O.O5, at 3 weeks; r =—0.28; ,p<O.l
and >0.05, at 2 months).
High preoperative caeruloplasrnin concentration
seem to be associated with an increased risk to
graft survival. Whether the association is causal
or coincidental with some other feature of the
recipient, such as advancing age, is uncertain.
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RENAL GRAFTECTOMY (GE): WHEN AND HOW ?
I.Reneltová, J. Jirka, H. Hahn, J Bláha,
P. Rossmarni, t Kafková, V.Koandrle
Institute for Clinical & Experimental He..
dicjne and Institute for Microbiology
ëSAV, Prague, Czechoslovakia
Between 1966 and 1984, 189 allografta
(AG) wore removed, mostly by intracapsular
technique: 122 from "medical" (mostly ir-
reversible rejeotion), 67 from 'surgical"
(mostly irreparable urinary leakage or AG
rupture and vascular problems) reasons.
Following complications (c), usually in
combination(s), were encountered: wound
infection(49), local bleeding(44), septic—
aemia(24), gastrointestinal haemorrhage(13), pulmonary in.fection(8) and various(21). The majority of deaths (28=14.8%)
was due to infection (septiceemia 20, pul—
monary infection 4);they occurred in 7/122
oases indicated from "medical" and in 21/
67 ones indicated from "surgical" reasons.
The incidence of C in asymptomatic and
symptomatic 0 failure and in vascular pro-
blems was similar (44.2, 39.7 and 42.9%),
that in surgical problems higher (76.5%
all cases, with 81.3% in urinary leakage,
83.3% in wound infection and 65% in vari-
ous) Most fatalities (70%) followed GE
performed because of local infection.lii irreversible G failure GE is inevit-
able in early cases (irreversible ATN, ne-
crosis or rejection vasculopathy), while
it may be needless in a majority of late
ones (interstitial lesions). in local pro-blems surgery is the method of choice;
however, other methods (embolization)
might be a much better solution in reef-
piertts free of them.
ENHANCED ALLOCRAFT SURVIVAL RATES WITH THE ADJUNC—
TIVE USE OF A PREGNANCY SERUM DERIVATIVE: PAST EX-
PERIENCE AND PROPOSED USE WITH YCLOSPORINE
jiio, R.Haschemeyer, J.Cheigh, M.Suthanthirao,
L.Tapia, W.Stubenbord, and K.H.Stenzel, The Rogosin
Institute, Departments of Medicine and Biochemistry,
The New York Hospital—Cornell University Medical
College, New York, New York, U.S.A.
Immune Serum Globulin Fraction (ISCF; IMNUN0,Vieno,
a derivative of retroplacental blood, has been used
adjunctively with standard immunosuppressive thera(azathioprine and prednisone) for the purpose of
enhancing allograft survival rates. Its use in allo-
graft recipients was prompted by its potent inhibi-
tory effect on the MLC proliferative response of
recipient leukocytes that had been challenged with a
broad panel of stimulating cells. In our six year
experience with 170 transfused, non—diabetic, first
and second cadaver graft recipients treated with
ISGF, we found that actuarial graft survival ratas
had improved from a figure of 35% 5 to 57% 4 at
one year (p 0.0001). Recipient survival rates had
improved numerically (88% 3 to 94% 2, pO.l7l).
During the past year, cyclosporine has supplanted
the use of azathioprine at our Center and has yet to
be used with ISGF. The actuarial survival rate of
these latest grafts at one year is 74% 9. Of note,
however, was the mean discharge creatinine level of
these patients (N 2.3±1.0 mg/dL) and the incidence
of renal failure that had been encountered (79%). We
are presently embarking upon a trial of using ISGF
with reduced dosaging of cyclosporine (eliciting
serum levela < 100 ag/mi) to determine if lower
discharge creatiolne values and less renal failure
can be obtained while preserving or improving upon
the survival rates.
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RENAL HEMODYNAMICS & FUNCTION AFTER
CONVERTING ENZYME INHIBITION IN KIDNEY
TRANSPLANT RECIPIENTS
:i Ribstein, G Mourad*, A Mimran, C Mion*.
Depts of Medicine and Nephrology*, University Hospital.
Montpellier, France.
The activation of the renin angiotensin system (RAS)
is thought to be an important factor contributing to
post transplantation (Ix) hypertension (HI) and a major
mechanism in case of artery stenosis. We investigated
the acute response of mean arterial pressure (MAP) and
renal function (effective renal plasma flow (ERP),
glomerular filtration rate (GFR,in mI/min/1.73 m ),
electrolytes excretion rates) to angiotensin-converting-
-enzyme inhibition (CE!) by captopril in 21 HI and 9
normotensive (NT) renal transplant recipients. CE! indu-
ced in both HI and NT a decrease In MAP (-8+1.5 and
-3±1 mmHg respectively) and filtration fraction (FF:
-0.07+0.02 and -0.06+0.02) whereas ERPF and GFR
were not significantly changed. The decrease in renal
resistance was significant only in HI. Urinary Na cx—
cretion rate increased in both NT and NT. Changes in
MAP (r=-0.66), ERPF (r0.74) and FF (r=-0.88) were
correlated with the log of control PRA. Ix HT patients
could be divided according to the change in ERPF into
two subgroups: SQ+ (% changer +20%; miD) and SQ-
(% change —30 to +5%; n=1l).
SQ+ SQ-
Control CE! Control CE!
MAP 119±2 108±2 §(NS) 116±3 111÷2
ERPF 220±12 320±24 §(++) 385+29 3'4÷27 §
GFR 73±2 72+7 (+÷) 101÷7 83÷6 §(CE! vs C:._p<0.05; §=p<0.01; SQ+ vs SQ-: (++)rp.0.01)
PRA and aldosterone were higher in the SQ+ groups.
These results prove RAS participates in the regulation
of the renal vascular tone in Tx pts. In about half of
them, an activated RAS is associated with renal
vasoconstriction which i' reversible after CEI.
A STATISTICAL MODEL FOR THE PREDICTION OF RENAL
ALLOGRAFT FAILURE TIME IN LONG TERN SURVIVORS
gjo, R.Haschemeyer, M.Suthanthiran, J.Cheigh,
L.Tapia, W.Stubenbord, and K.1I.Stenzel
The Rogosin Institute, Departments of Medicine and
Biochemistry, The New York Hospital—Cornell ml—
versity Medical College, New York, New York, U.S.A.
Kidney transplants are at continuous risk for
failure: actuarial allograft survival rates for
l.,04l transplants performed at our Center at one,
LO and 20 years are 48%, 30% and 24%, respectively.
If late graft failure occurs at a constant rate (as
reported for many primary renal diseases), then
end—Stage function tine could be predicted. To test
this hypothesis, renal function was retrospectively
examined in a group of 63 transplant recipients who
had lost their allograft after a period of two
years. The least squared line of reciprocal cren—
tinine levels would reach 8mg/aL. In 58 of the 63
recipients studied, a negative Slope was observed
whost intercept time for the reciprocal creatinine
value of 0.125 fell within 100% of the time at
which renal failure actually occurred and, further,
within 25% of the observed time in 22 of these
grafts (38%). When this formula was applied to
recipients with functioning grafts (data available
on 194 recipients), we found that 94 grafts were at
risk for failure. Thirty five were predicted to
fail within 10 years and 21 within five years. We
therefore believe that bug—term graft failure can
be predicted and that experimental therapeutic
intervention may be ju.tlfied in such recipients at
a time when meaningful renal function still exists.
Retardation of predicted creatinine doubling time
would be a useful endpoint. The use of agents which
reduce capillary filtration pressure is under
consideration for this purpose.
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. RESCUE OR RESISTANT REjECTION WITH OKT3.PAN
.
E.Rivolta,A.Tarantino,A.)eVecChi,F.M.Egidi,A.Vegett
C .Ponticelli
Ospedale Maggiore,Milano,Italy.
OKT3.PAN (OKT3) is a monoclonal antibody direc-
ted against total peripheral T lymphocytes which
has proved to be very effective in reversing the
first acute rejection episode in previous studies.
In this study OKT3 has been given (5 mg iv dail3
for 10—22 days) as the only immunosuppressive agent
to 8 patients with acute rejection resistant to 3—6
iv high dose steroid pulses.Rerejection (5 cases)
was treated with 2—4 iv high dose steroid pulses.
Results are indicated in the table.
Pta. plasm a cre atinine (mg/dl)
pre—rejection peak post—OK present)months)
1 2.6 dialysis 9.4 3.4 (21)
2 0.9 dialysis 4.0 2.0 (12)
3 1.9 diaisis 40 2.0 (12)
4 1.7 9.8 7.7 2.8 (11)
5 1.5 dialysis 1.8 2.4 (5)
6 3.1 dialysis dialysis dialysis (4)
7 1.7 13.6 2.0 1.9 (1)
8 1.9 10.1 3.3 3.0 (1)
To reduce side effects in all the cases the
first OKT3 injection was preceeded by iv adminis-
tration of 0.5 g of prednisolone.Fever and chills
were observed hut in no case they were severe. At
present the first patient is on azathioprine and
the others on cyclosporine therapy.
It is concluded that in most steroid resistant
rejections OKT3 can rescue transplant function.
RENAL HANDLING OF NATtiER AND SODIUM CHLORIDE AF-
TER RENAL TRANSPLANTATION.
L.M.RUIZ MUR0Z;L.ALvAREZ*;s.SANZ DE CASTRO;M. G-
FUENTES*;C.G_ALAMILLO;J.A.ZUBIMENDI;J.ALVAREZ_
GRANDE;M.ARIAS.
Departments of Nephrology and *paediatrjc Nephro
1oy.
H.N."Marqués de Valdecilla".-Santander.-S P A IN
Renal tubular functional studies performed in
patients after kidney transplantation have demons
trated defects in renal acidification ability. —
This study was designed to examine the renal tu-
bular handling of water and sodium chloride in
patients with renal transplant.
Renal function was assessed by means of:
a) Hypotonic saline diuresis (Chaimovitz et al,-
1973) that gives an indirect estimation of distal
sodium and chloride delivery (CR20 + CNa, CH2O +
CCI) and sodium and chloride reabsorption at the
diluting segment (CR20 / CR20 + CHa, CR20 / CH2O
+ CC1) ; b) Mannitol induced diuresis (Oetliker —
et al, 1974) that shows renal concentrating capa
city by plotting the values of TR2O against uri-
nary volume.
Eleven patients (31-64 years) with cadaveric
renal transplants, functioning 5 to 50 months, —
were studied. The features of their follow—up af
ter transplantation were: a) Isolated acute tubu
lar necrosis (1 case) , b) Acute tubular necrosis
and acute irsaunological rejection (4 cases), c)
Isolated acute immunological rejections (4 cases).
d) No complications (2 cases) . The endogenous —
creatinine clearances at the time of the study —
were 51 to 102 ml/min/1.73 m2 ( : 77 15).
Fractional distal dNa delivery was normal in
all the subjects. The proportion of the load reab
sorbed distally was normal in nine patients ancF
slightly reduced in the two patients with the lo
west creatinine clearance. The renal concentra——
ting ability remained in the normal range in all
the patients.
It is possible to get a normal renal handling
of water and sodium chloride in spite of tubular
damage, immunological or isquemic, in renal trans
olant
SEOWENTAL TRANSPLANTATION OF THE PANCREAS
WITH DRAINAGE INTO THE ABDONINAL CAVITY
OR INTO THE URINARY BLADDER OR WITH DUCT
OCCLUSION WITH PROLAMINE
J.Rosenberger,M.Holland,A.HUbinger,R.Grund
mann
Chirurgische UniversitNtsklinik,Kbln,FRG
We conducted segmental trcnmplcntation
of the pancreas in 7 dogs with free drai-
nage into the abdominal cavity.14 days
after transplantation the pancreas was re—
moved.Three months later a glucose tole-
rance test along with the determination
of glucose and insulin and histological
investigation of the transplant was made.
In group II we drained the transplanted
organ with an anaatomosls between the uri-
nary bladder and the pancreas of the
donor.The protocol was then as in group I.
In group III we occluded the duct of the
transplanted pancreas with prolamine.The
protocol was then the same as in groupl.
The animals of group I showed a clearly
altered glucose tolerance along with a
restriktion of the insulin secretion.The
fasting blood glucose remained normal in
50%,in the rest of the dogs it was clearly
raised.Histologlcal investigation of the
transplants showed besides an exokrine
atrophy of the parenchyma a clear altera-
tion of islet strukture.
The animals of group II showed a nearly
normal glucose tolerance in 2 of seven
dogm,as well as minor alterations of the
exo— and endocrine pancreatic parenchyma.
The results of group III aren't yet
complete;they will be reported in Jur.
STUDY OF THE ADRENAL FUNCTION IN RENAL TRANSPLANI
RECIPIENTS.
L.M.RUIZ MUfiOZ;J.A.AMADO*;A.L.MARTIN DE FRANCISCO;
J.A.ZUBIMENDI;P.MORALES;J.ALVAREZ-ORANDE ;M.ARIAS
Department of Nephrology and *Endrocrinolgy.
N.M. "Marques de Valdecilla" .—Santander.—S P A I N
The study was undertaken to examine the hipo—
thalamic-pituitary-adrenocortical (HPA) axis in
21 renal transplant recipients (RT) treated with
steroid therapy. It was performed a mean 46.8
38 months postranspiant (range 1 to 120 months)
and included plasma ACTH and Cortisol, basal and
after stimulation with synthetic ACTH.
A supressed adrenal response )SAR) was consi-
dered if simultaneously ocurred: a basal plasma—
tic cortisol below 5 microgr/ml, and increment —
below 6 microgr/ml and a poststimulatiOn value —
below 20 microgr/ml. If only was given one or tai
of these conditions we evaluated results as bor-
derline adrenal response (BAR)
Seven of RT had normal adrenal function (NAF)
whereas nine patients had SAN. The total acumula
tive dose os steroids was significantly greater
(p.O.Ol) in NAF (26.4 15.2 grs) than SAR 5.5
5.2 gr) and longer the evolution of the graft:
77.9 44 vs 2.9 1.8 months respectively (p.c
0.001) . However the mean maintenance steroid do-
se at the moment of the study was significantly
lower in NAF than SAN (pO.OOl). Patients with
a SAN had been transplanted in a time no longer
than 7 months so that they received higher ste-
roid dose close to the test day. A further five
patients had a BAR between the two groups descri
bed above.
It is concluded that: 1) ACTH stimulation test
is useful in studing the HPA axis function in -
transplant recipients under steroid therapy. 2)
The normal response to this assay is related to
a maintenance steroid dosage. 3) The risk of acu
te adrenal insufficiency may be individually pr
dicted by the ACTH stimulation test.
—
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• CYTOMEGALOVIRLIS-INFECTIONS AFTER RENAL TRANSPLANTA-
TION: EFFECT OF PROPHYLACTIC HYPERIMMUNOGLOBIJLIN
E.-H.Scheuermann, P.-B.Bechstein, W. Fassbinder.
Dept.Nephrol.University 1-lospital, Frankfurt/M.,FRG
Incidenceand ci inical symptomatoiogy of Cytome—
galovirus(CMv)—infection was investigated in all 83
recipients of cadaveric renal transplants in 1982
and 1983. CMV—antibody status was determined using
ELISA—technique. 43of the 83 patients (52) were sero—
negative, and 40 (48%) seropositive for CMV before
transpLantation. Seroconversion (i.e. primaryCMV-in-
fection)oran increase in titre(i.e. reactivationor
re-infection) was found in l8cases (42% and 45%, re-
spectively) in both groups. 89°iof all infections
occurred within the first 3months. Clinical sympto—
matologywasmuchmoresevereinthegroupwithprimary
CMV—infection: All cases with atypical pneumonia (n=8)
and both fatal cases belonged to this group. Prefor-
med CMV-antibodies thus appeared to prevent severe
syndromes associated with CMV-infection. Therefore
a randomized controlled study was started in 1984
in order to investigate the efficacy of an Lv.
applicable CMV-hyperimmunog!obulin (HIG). 21 patients
received5000units HIG (lOg gO), .snd24control pa-
tients lOg unspecific gO immediately prior to trans-
plantation, and on the days 18, 38 and 58 thereafter.
Seroconversion or a significant increase in titre
occurred in 67% (HIG), and in 54 (unspecific IgG).
Clinical symptomatology of the infection was much
less severe in both groups particularly in patients
with HIG. Full blown CMV-syndromesor fatal cases were
no longer seen. Clinically asymptomatic seroconver—
sions were observed in 57% (HIG) and in 46% (unspe-
cific gO) of the infected cases. Thus both prepa-
rations were not capable of preventing CMV-intections
(Or reactivation), but prophylactic CMV—HIG — and to
a minor degree unspecific IgG - were able to protect
the patients against the occurrence of severe CMV-
syndromes post transplantation.
EARLY INDICAtORS IN KIDNEY TRANSPLANT REJECTION:
RESULTS DY STUDIES ON COMPONENTS 01' THE PLASMA
KAI.LIKREIN, COAEUI,ATION AND 1IBUINOIYSIS SYSTEMS IN
PATIENTS
J.Schraderl,T.Eisonhauerl,M.J.cellimore2,
N. Br000e5ann' ,E. Red tint, C. Sche icr1
'Dept.of Neo)iroloqy, University 05 Cöttinoen, Nest
':ernany, 2Cheijnel Diaqnostjcs Ltd.Deal, Kent U.K.
In attemots to obtain early indicators of kidney
transoiant rejection we have studied conponents o
the idS5a koiiikrein, coagulation and fibrinolytic
systems in olosma samples from 20 catients receivinq
donor kidneys. All natients were treated with cyclo-
sporin A. Samoics were taken before arid after the
first dose of cyclosoorin A, imoediateiv after
cranspiantation and nearly every day for the nest
six weeks.
The parameters measured included prekallikrein
(PIcK) , Kallikrein Inhibition (KId) , Kaliikreiri like
activity (RN) , factor XII (FXII) , inhibitors of ii—
tactor xii (SE XIIa I) , factor VIII (F Vhdl , anti-
thrombin III (AT III), piasminogen (p9), a,—anti—
olasmin (c. -aP) , o. —aacroglobulin (o. —ml , C11—anti—
trypsin (o.1-AT) , fibrinogen (fg) , fibrin monomers
(fE) , APTT and PT.
Evidence for rejection one or two days before
clinical symctoiis or parameters was shown by raised
levels of kallikrein inhibition, inhibitors of
)IFXIIa and factor VIII.
changes in plasma levels of other parameters were
detected during rejection but those were not early
indicators of kidney transplant rejection.
During successful therapy the changes in kallikrein
inhibition, inhibitors of BFXIIa and factor VIII
were normalized.
ROLE OF THE RENIN-ANGIOTENSIN SYSTEM IN THE POST RE-
NAL ALLOGRAFT HYPERTENSION.
0. Schohn, H. Jahn
Service de Néphrologie, CHU Strasbourg, France.
The recurrence or the appearance of hypertension
(NT/I) after renal transplantation occurs in 505, to
831 at all transplantations. In order to elucidate
an eventual participation of the renin-angiotensin
system in this NT/I, we studied the effect of a stan-
dardized Saralasin infusion in 7 patients (mean age:
37.1 - 51 years) with a permanent NT/I following re-
sal allograft (mean arterial pressure (liP): 142
9.7 mmHg). Following explorations were performed
neasurement of the plasma renin activity (PEA) in
the graft 's and in the own kidneys veins, and of the
hemodynamic parameters : cardiac index (CI), syste-
mic vascular resistances (SvR) and pulmonary capil-
lary pressure (Pap). In all patients anti-hyperten-
sive drugs have bean stopped. Results : when comia—
red to the hemodynamic status of normal subjects
(NS) the hemodynamic expl÷oration shows a significant
increase of the CI (4.11 — 0.6 versus 3.71 - 0.21
/min/m2 in NS, p(O.O1) despite of a normal PWp (9
— 5 versus 7 — 5 mmH in NS) and an imortant increaseof the StiR (1996 ' 352 versus 1112 — 214 dyn.sec.
cm 5 in NS, p (0.001). The PEA is significantly
highr in the own kidneys veins 18.7 — 9.7 versus
5.3 4.8 ng/ml/h (p<0.O1) in the renal graft vein.
All patients showed a positive response to the Sara-
lasin test and a close inverse relationship between
the decrease of the diastolic AP in response to the
infusion and the pre--infusion value,of PR/I in the
own kidneys veins (r = 0.89, p<0.01) and between
the StiR before the infusion and the pre-infusion va-
lues of PR/I in the own kidneys veins (r 0,79, v<
0.05). These results may imply an important partici-
pation of the renin—angiotensin system in the genesis
and maintenance of hypertension after renal graft.
COMBINED PLASMA-LYMPHAPHERESIS AS AN EFFECTIVE IM-
MUNOMODULATORY PROCEDURE WHEN FRESH FROZEN PLASMA
IS USED AS THE REPLACEMENT FLUID IN THE MANAGEMENT
OF KIDNEY GRAFT REJECTION
Z. Shapira, G. Lavie*, A. Yussim, D. Shmueli,
I. Shmueli, S. Cohen, and C. Servadio
Blood Bank*, Transplantation Unit, Dept. of Urology,
Beilinson Medical Center and Tel Aviv University
Sackler School of Medicine, Israel.
Plasma exchange is generally applied for removal
of soluble components which, in case of graft rejtt-
tion, believed to be cytotoxic antibodies. Little
emphasis was attributed to the nature of replacenmnt
fluids yielding contradictory reports in the liter-
ature on treatment efficacy and disregarding the
following: 1. The exchange of 1-1.5 total body plas-
ma volumes reduced antibody titre by 50-60% at most.
2. IgS type antibodies are found in extravascular
reservoirs. 3. Soluble immunosuppressive mediators
present in healthy donor plasma but absent in the
patient during rejection are deprived if albumin is
used for replacement. 4. Antibodies with immunore-
gulatory anti-idiotypes which may be present in the
plasma of healthy donors are, absent during recon-
stitution with albumin.
A comparison between 3 groups of patients exhibi-
ting renal allograft rejection, plasmapheresed and
reconstituted, the first with saline and outdated
and fresh frozen plasma, the second with 5% albumin
and the third with fresh frozen plasma combined with
lymphapheresis revealed the latter to be most ef-
fective. It seems that plasma of healthy donors
which contains essential immunoregulatory soluble
mediators helps the balancing of the patients' im-
mune system. Supplementation with lymphapheresls
removes the bulk of activated cytotoxic T-cells
creating the time interval necessary for this bal-
ance to take place avoiding a phase of irreversible
damage.
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THE LIVING DONOR AFTER TEN YEARS
R.SipilE, B.KuhlbEck, L.Laasonen, B.Lmdstrdm
Fourth Dept. of Medicine, Helsinki University
Helsinki, Finland
92 kidney transplantations from living donor
were carried out in Finland between 1965—74. All
donors were reinvestigated in 1984. 9 donors have
died, none from obvious renal disorder, and 16
refused control study. 67 donors came for clinical
re—examination. There were 27 males with nan age
of 36 years at donation and 40 females with maan
age of 44, respectively. The present generalhealth of each donor was checked. The renal function
was evaluated by maasuri creatinine, urea, urate,
creatinine clearance, Cr —ENTA—clearance, urin-
alysis and by performing plain renal radiography,
ultrasonography and DTPA-nephrography. A comparison
with relevant examinations before donation could
be made in onst cases.
All the studied donors were in good general
health. 13 had developed hypertension treated with
antihypertensives but otherwise their cardio-
vascular status was normal. Average increase of
weight was 9.7 kgs in males and 2.1 kgs in females.
Mean increase of creatinine was 6.1 unol/l (p<0.02)
in males and 6.8 (p<0.Ol) in females. Mean derease
of creatinine clearance was 16.9 ml/nün/1 .73m(p<0.02) in males and 27.7 (p<0.Ol) in females.
2 donors developed a mild proteinuria. Hypertrophy
of the remaining kidney waa observed in nost
donors.
We conclude that the donation of a kidney causes
certain deterioration in the renal function. This
deterioration has obviously, however, only minor
clinical laortance.
SERUM KARKERS OF HEPATITIS B VIRUS (HBV) AND
KIDNEY TRANSPLANT IN A LOW—DOSE STEROID REGIMEN.
G. Squiccimarro,G.__Triolo,M. Messina,M.Rossetti,
B. Malfi,P. Stratta,G.P.Segoloni ,A.Vercelione.
Division of Nephrology and Dialysis, University of
Turin, S. Giovanni Hospital, Turin, Italy.
The influence of HBV infection on renal
transplant outcome was analysed in 84 recipients
of cadaveric kidneys (November '81—April 84)
treated with low—dose steroids and azathioprine.
At transplant, Hepatitis B surface antigen (HBsAg)
was positive in 8 patients (a and delta antigens
negative in all),negative in 76; of these, 18 were
anti—HBs antibody (anti—HBsAb) positive. Mean age
was higher in HB5Ag positive than in the other
recipients (43,2±6,3 vs. 38,1±10,8 years; F'O,O5);
sex, pre—transpiant blood transfusions, HLA—AB and
OR mismatches showed no significative difference
in these two groups, as well as between antibody
postv and negative patients.
Actuarial graft survival was 100% at 2 years in
the 8 HBSAg positive recipients, 80,1% at I year
and 70,5% at 2 in the other 76 (P< 0,005 at both
intervals). Among these, survival rates were
higher in anti•-HBsAb positive patients: 88,8% at I
and 2 years vs. 77,4% at I year and 64,2% at 2 in
antibody-negative (pO,O5 at 2 years).
These results show that, in a low—dose steroid
regimen, HBV infection does not adversely affect
renal transplant outcome. The good graft survival
in the anti-HBsAb positive group is of particular
remark in relation to the possible use of ariti—HBV
vaccines,.
LATE ACUTE INTERSTITIAL CELLULAR REJECTION IN RENAL
TRANSPLANT RECIPIENTS
L.R.Solomon, S.Martin, C.D.Short, W.Lawler, R.Gokal,
N.P.Mallick, R.W.G.Johnson.
Manchester Royal Infirmary, Manchester, England.
Late graft deterioration is usually due to
chronic vascular rejection, for which there is no
treatment. Acute cell—mediated rejection in the
first 6 months after transplantation (tp) is
reversed by high dose corticosteroids. Eight
patients ( male, tf female, aged l9_Lf8) on
maintenance doses of prednisolone + azathioprine
(5 pta) or cyclosporin A (3 pta) developed sudden
decline of renal function 10 months to 10 years
(mean 55 months) after tp. Biopsies showed acute
interstitial cellular rejection. Intravenous
methyiprednisolone improved renal function in 7 of
8 patients and arrested decline in function in
1 patient.
Sequential sera were monitored for lymphocyto—
toxic antibodies. Five patients developed anti-
bodies —6O days prior to biopsy, one had fluct-
uating levels of antibodies in the preceding 9
months and 2 showed no antibody changes. In
patients the antibodies were active against donor
spleen cells. In contrast only of 19 matched
controls developed lyaphocytotoxic antibodies
(Fisher's Exact Test P=O.0li) at any time post-tp.
Premonitory events were urinary tract (3 pts),
suspected viral (2 pta) and primary CMV infections
(1 pt) and fluid overload (1 pt).
Interstitial cellular rejection may occur many
years after tp. Prompt treatment may prevent
permanent renal damage.
Weeks post biopsy
Plasma creatinine
(uaol/1)
—12
180
(97—202)
0
871
(187—1069)
270
(163—388)
• 99m Tc. Sn COIADID SCANS IN THE DIAGNOSIS OF
RENAL GRAFT REJECTION
F. X. Sundram, R. P. S. Edrrondson, E. S. Ang
(Intr. by A J Wing)
Department of Renal Medicine, Singapore General
Hospital, Singapore
Uptake of 99m Tc Sn colloid in renal transplants
was studied to evaluate its role in the diagnosis
of graft rejection. 2—3 mci of 99m Tc Sn colloid
were given IV and 2 static scans, one iimmediately
and one 15 mm after the injection were done using
a computer linked I camera. The % uptake of the
injected dose by the graft (PU, all scans) and
the 15 mm/initial uptake ratio (RU, 100 scans)
were calculated. Normal values were derived from
15 scans in 13 patients with stable normal graft
function. 131 scans were performed in 50 patients
clinically suspected of undergoing graft rejection.The results (positive or negative) were then
confirmed by comparison with clinical, biochemical,histological and radiological evidence. It was
impossible to confirm the results of 12 scans. Of
119 scans (using PU) there were 62 true positive
(TP), 26 true negative (TN), 13 false positive (FP),
18 false negative (FN) giving sensitivity 77.5%,
specificity 66.6% and accuracy 73.9%. Using RU
as an index the results improved to 67 TP, 28 TN,
11 FP, 13 TN, sensitivity 83.8%, specificity 71.8%
and accuracy 79.9%. The method appears to be
useful for the diagnosis of graft rejection and
the 15 mm/initial uptake ratio is superior as an
index to the 15 mm uptake alone.
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HUMAN T-CELL ACTIVATION: ABILITY TO INTERCEPT
ALLOIMMUNITY IS SIGNAL AND CELL-STATUS DEPENDENT
N. Suthanthiran and K.H. Stenzel, The Rogosin Inst-
itute, Departments of Medicine and Biochemistry,
The New York Hospital—Cornell Medical Center,
New York, N.Y., U.S.A.
Antigen—primed memory cells (memory cells) or Un—
grimed peripheral blood mononuclear cells (PEM)
were activated with alloantigens or with recombin-
ant Interleukin—2 (rIL—2) and the effects of cyc—
losporine (CSA), nnethylprednisolone (HP), or mono—
clonal antibodies (NAB) directed at rIL—2 or recep-
tors for IL—2 on such activation were examined. CSA
(50 ng/ml) or NP (500 ng/ml) mediated significant
inhibition of alloantigen induced proliferation and
lyxnphokine (IL—2 and Interferon, gamma) production.
Supplementation of primary MLCa with 50 ng/ml of
rIL—2 did not alter the inhibitory effect of GSA
or HP. rIL—2 failed to activate unpriuned cells but
successfully activated memory cells. CSA or HP
inhibited alloantigen associated activation of mem-
ory cells but not rIL—2 associated activatioo. rIL-
2 reversed the inhibitory effects of CSA or NP on
secondary MLCs. rIL—2 associated activation of
memory cells was inhibitable with NAB directed at
IL—2 or at receptors for IL—2. Multiparameter flow
cytometric analysis revealed the presence of recep-
tors for IL—2 on T3 antigen positive memory cells
and their absence on the T3 antigen positive sub—
population of unprimed PBM. Our findings, taken
together, indicate that successful interception
of alloimmunity can be accomplished with therapeu-
tic strategies that take into consideration cell
Status and triggering signals involved in T cell
activation.
COMPARISON OF ALO AND AIG FOR RENAL TRANSPLANTATION
LJLToledo-Pereyrg, C. Bergren, J. Whitten
Mount Carniel Mercy Hospital, Detroit, Michigan, LISA
The use of antilymphoblast globulin (ALG) and
antithymocyte globulin (ATG), given as prophylactic
and antirejection therapy, was compared in a pro-
spective and randomized manner. Fifty patients un-
dergoing 1st cadaver kidney transplants were given
either ALG (n25) or ATG (n—25) and followed for a
minimum of 1 yr. Each group was also given aza-
thioprine and prednisolone. Minnesota equine or
caprine ALG was given up to an ideal dose of 20 mgI
kg/day for 14 days, prophylactically and ATGam
(Upjohn) was given up to 15 mg/kg/day for 14 days.
1st, 2nd, and 3rd rejection episodes (RE) were
treated with ALG or ATG up to 10 days. Subsequent
RE were treated with ALG or ATG, respectively, 10-
20 mg/kg/day every 4th to 5th day. No significant
differences (Students t-test) were observed in the
mean # of hospital admissions—ALG(3.2+1.4),ATG(3.1±
1.2), initial hospital stay (days)—AL(21.2+15.1),
ATG(17.8+7.7), # RE-ALG (1.7÷l.9),ATG(1.4+r3), /
reversal of 1st RE (days)ALG(83%), ATG (80%), time
to onset of 1st RE (days)-ALG(27+10.2), ATG(25+9.7)
and 1 yr. graft survival-ALG(56%T,ATG(52%). The
only significant differences that were found were
in the cost of the initial prophylactic treatment/
patient—ALG($2767+702), ATG($3546+1274)(p< .01) and
the total cost of therapy/patient/yr. , ALG—($6636+
2319), ATG($5433+489)(p <.025). Mortality was mod-
erately higher uT the ATG group (4/25) versus (2/
25) in the ALG group. More side effects of in-
creased severity were observed with ATG than with
ALG, Both ALG and ATG appear to be equally effec-
tive for prolongation of graft survival, however,
minimally increased cost and side effects with ATO
may be disadvantageous factors for its use.
EVOLUTION OF MYOCARDIAL HYPERTROPHY AFTER
RENAL TRANSPLANTATION (RT)
]'.L. Teruel,C.Quereda,R.Matesanz,F,Ljano,
R.Marcén,L.Rodriguez,p.yuste,J.Ortufco.
Centro Raxuón y Calal. Madrid. Spain.
Thirty nine adult transplant recipients
.i1th good renal function were prospectively
studied at 0,3,6,9 and 12 months after RT
,iith M-MODE ECHOCARDIOGRAFY.
Left Ventricular Mass (LVM) (g/m2 body
surface) decreased rapidly along the first
3 months (p<0.Ol), with significatively
lower values in those patients which remai
ned norniotemsive (p< 0.05 at 6.9 and 12
months>:
LV.M.
M$NTN
• NSRISTENWE .NIPØTENSIVI 0*11 PATIENTS
Patients with early thrombosis of hemodia1
sis vascular access showed also a significa
tively lower LVM. —
CONCLUSSION: Myocardial hypertrophy impro-
ves rapidely after RT. Thereafter, hyperten
sion and persistence of a functioning vascu
lar access are the main conditioming fac-
tors.
IMMEDIATE AND LONG—TERM FUNCTIONAL BEHAVIOUR OF 80 KIDNEYS
TRANSPLANTED FROM 40 DONORS IN THE SAME INSTITUTION.
A. Triolo, G.P. Segeleni, M. Messina, M. Vaj, M. Maritano, R.
Ferrero, A. Vercellone.
Departments of Nephrelngy, Vascular Surgery and Anesthesiology,
S. Giovanni University Hospital, Turin, Italy.
The study compares the behaviour of 40 pairs of kidneys tran-
splanted into 80 recipients in our institution. No significant
difference existed between first (I) and second (II) sideey of
each pair as regards age, dialytic age, ALA—OR incompatibily.
Cold ischemia oman tine (CI) was l9.b--8.2 and 25*10 hours For
respectively (1) and (II). Ihe first 60 patients (recipients of
30 donors) were treated with Azathiuprine and low dose steroids
and the remaining 20 patients with CyA and steroids. A protocol
of 'maximal intro—surgical load" employing saline and albumin,,
with continuous monitoring of pulmonary arterial pressure (Lu—
ciani, Transplantation 1979) was adopted in the last 20 pairs.
The global incidence of acute tubular necrosis (ATM) was 25% in
(I) and 37.5% iv (ii). There is no difference between (I) and
(II) treated with avathiuorine without "maximal load" 14394 vs.
2894) — CI 17.9--V vs. lA.6+U respectioely For (I) and (II) —,
whereas with "maximal load" the incidence ef ATM was globally
inferior and less frequent in the (I) vs (II) of each pair (0 vs
22%) with azathioprine, — CT 21.4+g vs 31.5+6 6 - and (log vs
5094) with CyU, — CI 21.5+6 vs. 32.2*3.2 h —. Global creatinir,e
value was 1.9+0.8 vs 1.9+1.1 mgN (I and IT kidney respectively)
at 12 months. Patients survival rate was 94.6% vs 97.384 at 12
months; graft survival 84% vs 82% at 12 months; CI dvratinn did
not seem to influence ATM in patients treated with ozathieprine,
but may be important in patients treated with CyA specially if
abovw 30 hours. "Maximal—load" could significantly decrease ATN.
Patient and graft survival were not significantly different when
compairing I and II kidney transplant.
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• RISK FACTORS ASSOCIATED WITH ASEPTIC BONE
NECROSIS (ABN) FOLLOWING RAL TRANSPLANTATION
• D Tsakiris, T C Aitchison, J D Brigge, J K
B J R Junor
Renal Unit and Department of Radiology, Western
Infirmary and Department of Statistics,
University of Glasgow, Scotland
The risk factors associated with the
development of ABN in 161 consecutive renal
transplant recipients were looked for by comparing
the 38 patients who developed ABN (2k%) with the
remaining 123, using a proportional hazards model
with step-wise selection of 56 variables. There
was a higher incidence of ABN in females than
males (37% vs 15%, p.c O.0OI), and patients with
ABN had gained significantly more weight during
the six months post—transplant (9.5 + 5.0kg vs
6.3 # 4..14kg,p 0.006). The probability of
patints treated with high and low dose
prednisolone developing ABN was 28% and 6%
respectively at 3 years (p.cO.O1). HLA-B8 was
significantly associated with the development of
ABN in both males and remales (p..O.O5) (table),
whereas an association with HLA B12 was
significant only for males (pO.05).
Probability of developing A( at 3
years post-transplant
High dose
predn isolone
Male Female Male Female
!LA-B8+ve 20% +k% 12% 42%
1LA-B8-ve 8% 20% 1.% 18%These results suggest that variations in
prednisolone pharmacokinetics, possibly HLA—B8, 12
ssociated, may explain individual susceptibility
to the development_of steroid induced ABN.
DR-MATCHING AND SHARING FOR CADAVERIC RENAL
TRANSPLANT (TXS)
Ben A. VanderWerf, M.D.
Phoenix Tx Center, Phoenix, Arizona, U.S.A.
This study was done to find out (1) Is it
feasible to do only DR—matched cadaveric Txs; (2)
Is DR typing good enough for kidney sharing; (3) Is
the 6Y—Ag special; (4) Is DR—match equally
important for all pts. From 1/81 through 12/83, of
213 kidneys available, 95 were used for local and
58 for out of town DR compatible Txs and 60 for
non—DR matched Txs elsewhere. Risk factors were
comparable in both groups. Actuarial kidney
survival at one year and (two) years:
DR Non-DR DR/Non-DR
-
All pts 74 (73%) 58 (57%) P 0.05
High Risk 69 (68%) 47 (40%) P 0.01
Low Risk 80 (79%) 76 (76%) NS
PEA 50% 78 (64%) 40 (27%) p 0.01
50% 73 (73%) 70 (69%) NS
All non—DR Txs and most DR Txs had blood
transfusions. Repeat DR—typing of 40 imported
kidneys was different eight times. Half of these
were related to 6Y. Repeated typing on our
exported kidneys was different only 1/55 (2%). For
12 pts whos only DR mismatch was 6Y, one and two
year kidney survival was 75 & 69% resp., which is
not significantly better than 65 & 62% for one
DR-mismatch other than 6Y. Wait time for a
DR—compatible Txs was 6 mos. for 74%.
Conclusions are: (1) Exclusive DR—matched
cadaveric Txs are possible. (2) Waiting time for
DR—matched Tx is acceptable. (3) Consistent typing
results make DR—sharing possible. (4) The reduced
antigenicity of the 6Y—Ag is not significant. (5)
DR—matching is most advantagous for "high risk
and "high antibody" pta.
INFLUENCE OF DELAYED TYPE HYPERSENSITIVI-
TY (DTH) ON GRAFT S1JRVIVAL(GS).
F.VaIderrbano, F.Anaya, R.Prez Garcfa, R.Jofre,
M.S5nchez Heras.
Hospital Provincial de Madrid. Madrid. Spain.
In order to evaluate the influence of DTH on the
outcome of renal transplantation (Tx) we have made
serial skin tests to the patients awaiting Tx. The me-
thod used was multipuncture with seven antigens (MUL—
TITESTR). In previous studies, a single blood unit
induced anergy in responsive patients. According with
this fact our blood transfusion policy, during the last
3 years has been to transfuse to responsive patients.
After this time the percentage of anergic patients in-
creased from 46 % to 63 %.
62 pre—Tx tested patients were grafted (58 fromca
daver and 4 from related living donor). Two years GS
was 88 % in anergic patients (N=44), versus 50 % in
responsive ones(N=14). There were no relationship
between anergy and the concept of "non responder"
(polytransfused patient without lymphocytotoxic antibo-
dies) and GS in the later was not better than in the
total group. There were no differences in the mortali-
ty rate, incidence of rejection and infections, accor-
ding with the DTH response.GS was slighty higher in
patients that received more pre—Tx blood transfusions,
but without statistical significance, as repported in
other short series.
We conclude that DTH is a good predictive factor
for the outcome of renal Tx. Pre—Tx blood transfusion
policy might be to transfuse mainly responsive patients
in order to increase the "anergic population" awaiting
kidney Tx.
PROLACTINOMAS AFTER RENAL TRANSPLANTATION
S. Vasiliou, D. Grekas, A. Dimitriadis, A. Pharma—
kiotis, A. Lazarides, A. Tourkantonis.
1st Medical Department, University of Thessaloniki,
Thessaloniki—Greece
Elevated prolactin blood levels and gynecomastia
are common findings in male uremic patients receiv-
ing chronic hemodialysis therapy. Renal transplanta-
tion usualy restores the above abnormalities. 40 pa-
tients, 28 male and 12 female, aged from 19 to 40
years were included in the study. The duration of
renal transplantation was from 6 months to 8 years
after surgery. Hypothalamic—pituitary—gonadal axis
functional integrity was studied by the standard
tests. In 3 patients, two female and one male, high
levels of plasma prolactin were found (>l6Ong/ml),
while they were complained for headache and elevati.
on of blood pressure. The rest of the patients had
plasma prolactin levels within normal limits. The
above 3 patients had renal function up to 6Oml/min/
/l.73m2. Amenorrhea and gynecomastia with galactor—
rhea were main clinical findings in female and male
patients respectively. Celia turcica had marked le
sions in one case only, but in Computed Tomography
a large adenoma, presumably prolactinoina was found
in all 3 cases. Therapy with Bromocryptine —5mg/dai.
ly for 6 months showed marked improvement of Clini-
cal fildings and restoration of plasma prolactin
levels within normal limits.
Low dose
predn isolone
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IS TIlE POST—TPANSPLANI INCIDENCE OF LYMPHO
CELE INCREASED IN [HE RECIPIENIS ON CARl)?
A. Vegeto, L. Berarth ne H i, M.Rn teri,C. Caste I
OUOVO
Dcpart.of Kidney Transplantation,University
of M Ian,M Ian, Italy.
The aim of the present study s to des—
cribs the surgical complications and outcome
of 21 recipients,trented bt CARD in the pre
operative period,out of the total number of
861 kidney transplantations,performed in our
Institution over 15 years. The patients,12
males and 9 femals,received their graft
from 3 LD and 18 CD;2 of these recipients
had been transplanted for the second t i me.
2 grafts had been lost, one becouse of i rre—
vcrs i ble renal artery thrombosis and one for
not viable kidney.Other 4 patients returned
to CAPD after rejection crises.15 patients
have a funct inning graft from 3 to 40 months(mean range 13.7±l1.i);I additional patient
received a second successful tranep I anta—
t ion.
Surq i ca I re—operot ions tad to be perfor'-
mcd in 3 paticnts,consisting in 1 corre-
ction of urinary listula and 2 drainages of
per irene1 I yniph col lent inn_The incidence of
post —transplant I vrnphocr In, needi op of sur'p
cal correct inn, is about nine t tines higher
I n our 21 CAP!) pat I ents (9. 5) ,as compared
with that in our 840 tIP recipients (O.6C),
dcSp i te of the greater' cart' in I i pat i ny
the peru I i ac I phut. in channels.
MOLECULAR WEIGHT DEPENDENT ANALYSIS OF URINARY
PROTEINS IN THE FIRST WEEKS AFTER KIDNEY TRANS-
PLANTATION - A NEW RAPID TECHNIQUE OF SOS-PAGE
R. Wartha, K. Rddinger, D.-E. Muller-Wiefel, K.E.
Bonz&I, K. SchNrer, K. Dreikorn
Departments of Pediatrics and Urology, University
of Heidelberg, FRG
SDS-polyacrylamide gel electrophoresis (SDS-
PAGE) has been suggested to provide additional
information in early recognition of acute kidney
transplant rejection. As usual techniques of SOS-
PAGE are evaluated after destaining of the gels for
24-48 h results are too late for clinical use. In
this Study 0.24 mm thick slab gels on an horizontal
electrophoresis system as suggested by Görg et al.
were used. The polyacrylamide concentration was
4-22.5 % with an exponential gradient. Scanning of
the gels was performed with a laserdensitometer.
SDS-PAGE was done three times per week with au—
quots of 24-hours urine specimens of 20 patients
during their hospital stay (mean 47.6 days). The
age of the patients was 3-50 years.
Six episodes of acute transplant rejection could be
detected by SOS-PAGE. In 4 cases the increase of
low molecular weight protein excretion (LMWPE)
became manifest with the rise of creatinine, in 2
cases LMWPF increased 2 days before the creatinine
values changed. Two rejection episodes with a
significant increase of serum creatinine and de-
crease of urine production could not be recognized
by SOS-PAGE. Six patients without transplant re-
jection had continously a slightly increased LMWPE.
In 2 patients results of SDS-PAGE did not correlate
with the clinical data, they intermittently showed
a large LMWPE in the absence of any clinical
parameters of rejection. Rapid performed SOS-PAGE
seems to provide additional valuable information
itt the monitoring of kidney-transplanted patients.
BENEFICIAL ROLE OF POSTTRANSPLANT BLOOD TRANSFU-
SIGNS IN THE MANAGEMENT OF KIDNEY TRANSPLANT RECI-
PIENTS.
0. Villada, Ph. Lang, B. Charpentier, 0. Fries
Service de Néphrologie, Hôpital Paul Brousse,
94804 Villejuif, France
There is a general agreement that pretranspiant
blood transfusions significantly improve the out-
come of kidney transplants, although the precise
mechanisms remain unknown. In this preliminary
study, we decided to transfuse patients recently
transplanted for whom a standard rejection protocol
was indicated but seemed hazardous considering the
risk of overimunosuppression. Transfusions consis-
ted in 2 to 4 units of fresh packed red cells in 7
cases, and of frozen blood in 3 cases. The decrease
in creatininemia observed within 1 week varied
between 20 and 57 % and no further antirejection
therapy was necessary for these rejection episodes.
Six months later all kidney grafts were functional.
In no case and whatever was the type of blood,sen-
sitization could be detected. No major infectious
complication has been observed during that period.
We conclude that post—transplant blood transfusions
are safe, and can be of beneficial influence in
the mananement of rejection episodes in kidney
recipients at risk for over immunosuppression. A
randomised prospective study is needed to confirm
our preliminary results.
PROGNOSTIC VALUE OF A NEW DNCB SKIN TEST IN
RENAL TRANSPLANTATION
E.Westphal, G. Leimenstoll, W. Niedermayer
Dept. of Immunology and Dept. of Nephrology, University
of Kiel, Fed. Rep, of Germany
In spite of HLA matching and multiple pretransfusions to-
gether with Cyclosporin therapy (CyA), there remains much
need of a more precise individual rather than a statistical
prognosis for prediction of rejection episodes (RE) and graft
survival in renal transplantation. Therefore we determined
the status of cell mediated immunity of each patient on the
waiting list by a newly devised skin test against dinitroehlo-
robenzene (DNCB): substantial reduction of the usually re-
commended dose now allows us to discern unspecific skin
irritations from specific delayed type hypersensitivity. Even
after transplantation (under the Criteria of Eurotransplant)
the reactions of the skin tests were not forwarded to the cli-
nicians. (1) The proportion of DNCB low and high responses
was about 5o to 50%, whereas others report more than 8o%
of the patients as low responders. (2) Under CyA therapy,
serum levels of beta-2-microglobuljn in high responders
were significantly higher (p=o, ol) than in a group under aza-
thioprine plus prednisolone. Low responders in each thera-
peutic group generally produced low beta-2-microglobulin
levels. (3) Under CyA therapy, Ia transplanted low respon-
ders showed only 3 RE; in contrast, 16 high responders re-
presented as much as 21 RE. 5 of 6 graft losses were seen
in the group of DNCB high responders. - The above results
show that a DNCB responder status is not covered in pre-
transfused patients even under CyA. As the outcome of DNCB
skin testing apparently could allow a more individual predic-
tion of RE and graft loss in renal transplantation, these fin-
dings Should be confirmed in larger studies.
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TRANSPLANT ASPIRATION CYTOLOGY (TAC) IN
HYPERSENSITIZED RENAL GRAFT RECIPIENTS
A ZANNIER, MJ RAFFALI, N BLANC, J TRAEGER
Transplant Unit & INSERM 080 - Pavilion P
Hôpital Edouard Herriot - Lyon - France
As the number of patients waiting for renal Tx in
creases, so does the percentage of hypersensitized
ones. Different trials have been proposed in aim of
reducing cytotoxic antibodies titers wich could per-
mit hypersensitized patients to be grafted. That hi-
gh risk population needs a closest post—Tx monito-
ring. Though TAC has gained wide acceptance as a di-
agnosis and follow up procedure in Tx, the possibi-
lity to diagnose VR (vascular rejection) by this me-
thod was not yet described.
We report a TAC pattern that allowed us to diag-
nose 'JR in a 38—year-old male who received a 2nd Tx.
Due to cytotoxic antibodies titers negativation, the
patient was included in a Tx trial using only last
negative serum to cross—match purpose. Daily TACs
despicted an irreversible rejection at D4 (day 4) as
serum creatinine increased. In spite of anti-rejec-
tion treatment (high MP and plasmatic exchanges),
clinical course worsened. D6,endothelial morphologi-
cal changes included vacuolization and inclusions,
but those alteration are not sufficient clues to se-
ttle 'JR diagnosis. That diagnosis was made 07 beca-
use of a high percentage of endothelial cells sho-
wed mitosis, which would be in accordance with a pro-
liferative endothelitis. A necrotic specimen was ob-
tained D9while there was a lack of graft vasculari-
zation at scintigraphy. Transplantectomy, performed
DiD, showed thromboses of different arteries, endo-
thelial proliferation in some vessels and extended
lytic changes.
We want to stress the possibility to recognize VR
using TAG and its importance in monitoring hyperse—
nsitized patients on Tx trials.-
CMV INFECTIONS IN RENAL ALLOTRANSPLANT RECIPIENTS
TREATED WITH CYCLOSPORINE AND PREDNISONE.
J. Arnfred, H.K. Andersen, E.S. Spencer.
flTTInic of Internal Medicine and Institute
of Medical Microbiology, University of Aarhus,
Denmark.
The incidence of CMV infection in renal allo-
graft recipients treated with azathioprine and
prednisone has previously been reported in the
range 60 to 96%. With the introduction of Cyclo-
sporine a lower susceptibility to infection could
be anticipated, owing to the different immuno—
suppression properties of this agent compared to
azathioprine.
In a prospective study, nine renal transplant
recipients treated with Cyclosporine and Predni-
sone were followed for 6 months after transplan-
tation. The one patient who was seronegative con-
verted to seropositive, and i 5 there were a sig-
nificant (4-fold) increase in CF-titer. CMV virus
could be found in the blood in 7 patients and
from all it could be cultud from the throat
and/or urine before the 12 week after trans-
plantation. Only one patient, however, developed
clinical illness.
Taking the isolation of virus as evidence of
infection, the incidence is 100% (63-100%, 95%
confidence limits) and thus not lower than the
incidenco in transplant recipients treated with
prednisone and azathioprine.
CVCLOSPORIN IN TRANSPLANTATION
TRIPLE DRUG IMMUNOSUPPRESSION AT LOW DOSE IN HIGH
RISK RENAL GRAFT RECIPIENTS.
E .Alexopoulos, M.Daniilidis, G.Sakellariou, C.Ha-
djidimitriou, P.Anaeis, A.Vyzantiadis, M.Papadimi-
triou.
2nd Prop.Dept of Medicine, Aristotelian University
of Thessaloniki, Greece.
There are quite a few reports comparing the re-
sults of conventional immunosuppression with. those
of cyclosporin (Cs) but little attention has been
paid on triple therapy at low dose of Cs, predniso—
lone (PDN) and azathioprine (Aza). During the last
3 years, 20 out of 56 kidney graft recipients pre-
sented with steroid resistant rejection (15) or va-
rious complications due to immunosuppression (5).
Therefore they were changed to Cs (1-8mg/kg BW) ,PDN
(0.2—1mg/kg BW) and Aza (0.2—1.6mg/kg BW). The do-
sage of Cs was modulated according to the blood le-
vels and the determination of OKT4/OKT8 ratio. 13/15
patients with steroid resistant rejection presented
a complete (9) or a partial (4) recovery after
treatment with Cs. The mean serum creatinine (Scr)
(*SD) decreased from 4.O1(±1.47) to 2.73(tl.10)mg%
(p<O.05). In 2 patients no response was observed.
Major complications were unusual except of de novo
or aggravated hypertension in 12 cases, which re-
sponded to antihypertensive treatment. Nephrotoxi—
city was found to be related to blood levels of
Cs>500 ng/ml and to low OKT4/OKT8 ratio (<0.8). Scr
decreased after reduction of the Cs dosage in all
cases.
In conclusion, the combination of Cs with low do-
ses of PDN and Aza seems to be effective for the
treatment of steroid resistant rejection, provided
that whole blood levels of Cs and lumphocyte sub-
sets are regularly monitored to avoid serious side
effects of immunosuppression.
CYCLOSPORINE A FOR STEROID RESISTANT ACUTE VASCULAR
RZJECTION OF RENAL CADAVER GRAFTS
F.W._Ballardie,. E.J. Clutterbuck, 0.3. EvanS, A.J.
Rees, G. Williams
)Intr. by G. Williams)
Royal Postgraduate Medical School, London
We have used cyclosporine A to treat acute
vascular rejection not controlled by repeated high
dose steroids, in renal transplant recipients
immunosuppressed initially with azathioprine and
prednisolone. The outcome is compared with our
earlier experience of patients with transplant
rejection similarly refractory to this treatment.
Morphological changes and prognostic features of
rejection were assessed by biopsy in each group.
Group I (1983—4) 10 patients )ll grafts) were
given cyclosporine A, initially 15 to 17mg/kg/day,
orally, after failure to respond to methyl-
prednisolone intravenously, mean dose 8.1 grams.
Azathioprine was discontinued in each. 8 grafts
recovered function and 3 failed. Group II (1902-
3): 13 patients )14 grafts) received no further
high dose steroids after continuing deterioration
in graft function following a mean dose of 6.9
grams of bolus steroids; 11 grafts failed, but 3
recovered. (Group I vs II, P(0.O5, 2 tailed
Fisher's exact test). Each recipient in Group I
had evidence of vascular rejection, as did 9 of 10
biopsied in Group II. Scoring of biopsies for
unfavourable prognostic indices )Herbertson, 1977)
showed no differences between the groups. Assess-
ment of patient characteristics and rejection
severity revealed no other factors to account for
the improvement.
Our findings suggest that cyclosporine A is a
useful treatment option for acute vascular reject-
ion refractory to conventional immunoSuppreSsion,
and that its advantages may be achieved when it is
not used as primary imniunosuppressant.
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SIGNIFICANCE OF VASCULAR LESIONS 1N CYCLOSPORYNE(Cy)
TREATED RENAL TRANSPLANTS.
G.Banfi ,A.Tarantino,GB.Fogazzi,*M.J.Mihatsch,C.Pon_
ticeili.
Renal Unit—Ospedale Maggiore—Miiario—Italy.
wlnstitute of Pathology—University of Base] (Sw).
Out of 72 renal biopsies (RB) performed in trari—
plant (tx) patients treated by Cy,17 showed an arte
riolopathy (CyAA) characterized in 1 case by throm..
bothic microangiopathy, in 13 cases by scattered
and in 3 by diffuse parietal nodular hyalinosis as—
soeiated in 4 with thrombosis, in the absence of
any singns of rejection. The pts were divided in 3
groups: (A) early renal insufficiency, (B) late re-
nal insufficiency, (c) stable renal function in the
late folios—up. Clinical data are summarized below:
Ftc Interval Cy Bl. Follow—up P1asm Crest.
Tx—RB level (Months) mg/di
rig/mi at RB Actual
(a) 0 ooi 126 6.3+3.7 1.6+0.7
(B) 5 13 mo 1096 2.8 2.6÷0.3 1.6+0.3
(C) 9 10 mo 801 2.0 1.7+0.5 1.6÷1.6
In a]l the 9 pts(3 in group A,5 in B and 1 in C)
switched from Cy to Azathioprine the renal function
improved.Only 1 patient had a reversible rejection.
These data suggest that CyAA may develop at any
time after tx and also in ebmence of any renal fun-
ction deterioration.Although a longer period of ob-
servation is needed,the stable renal function in(C),
in spite of continued Cy treatment, makes the impact
of CyAA on renal function uncertain.
CYCLOSPORIN A AND LOW- rZ)SE PP'"DNISOLONE rn RENAL
RE-TRANSPLANTATION
P.S. Bonser, R.J.S. McGonig].e. M Crovon,
1. Michael, B. Mu, A.D. Barnes, P. McMater.
Departments of Surgery and Medicine, Queen
Elizabeth Hoapit..l, Birmirighas, England.
In a single centre prospective study 35
patients who had previouSly undergone failed
renal transplantation using conventional iinmuno—
suppression with azathioprine and prednisolone
received Cyclosporin A and prednisolone treatment
for eecond cadaverjc rena]. transplants. After 5
meSn follow up period of 13.7 montha (2-35 monthe
5 grafts have been lost due to rejection if 1,1,
2, 6 and 31 months. One graft was bat for
technical reasons and 2 patients died from
Pneumocystia carinii pneumonia with functioning
grafts.
The overall one year actuarial graft
survival was 84%. In patients with pretranspiant
positive cytotoxie antibodiee the one year graft
survival was 80%. rly bee of the first
eraft, time intervalbetweeii.grfts &n4 ag gf
donor did not affect second graft survival.
These results hov that cycboeporin A is more
effective than conventional immunoaupprerieion in
cadaveric renal re—transplantation sad inst an
aggressive policy of regrafting may be adopted
with a highly successful one year graft
survival.
CYCLOSPORIN A (CyA) IN THE TREATh1ENT OF RENAL GRAFT
REJECTION.
V.Bonornini, A.Vangelista, G.N.Frascà, F.Fatone, L.C.
Borgnino.
Institute of Nephrology,University of Bologna-Italy
In recent years CyA has been largely used as a
new irrlnunosuppressive agent in renal transplanted
patients from surgery. Until today, however, few
data exist on its effectiveness, if any, in the
treatment of graft rejection.
The present stuy reports on the results observed
in 15 transplanted patients treated with CyA becan—
se of rejection. 7 patients (group A) had an acute
rejection unresponsive to high dose steroids; 8 pa-
tients (group B) presented chronic graft rejection
with progressive decline in renal function. All pa-
tients had been treated with azathioprine and ste-
roids before rejection. CyA was administered orally
at the initial dosage of 7—12 mg/Kg/day, than tape-
red according to the thugh blood levels
In group A CyA was stopped in 2 patients because
of severe side effects. 5 patients showed iriprove—
sent in renal function which remained stable after
2-10 months. Miong group .8 the CyA treatment was
ineffective in 4 patients who returned to ROT within
2 to 9 months; the other 4 patients showed a stable
renal function after 3—7 months.
Our results suggest that CyA may be effective in
acute graft rejection. In chronic rejection the re-
sults are not univocal and further studies are nee-
ded to clsrify whether CyA has a beneficial effect
in this patients.
FACTOR VIII RELATED ANTIGEN(F.VIIIRAg) LEVELS IN
RENAL ALLOGRAFT RECIPIENTS TAKING
CYCLOSPORINE(Cs).
Z.Srown; G.H.Neild; J.J.lilloughby; N.V.Somia;
J.S .Cameron.
Renal Unit, Cuys Hospital, London, U.K.
To examine whether Cs is implicated in renal
vascular injury in renal allografts, we measured
plaSma concentrations of F.VIIIRAg in renal
allograft reclpients(Tx) at weekly intervals by
both Rocket Eleetropheresis and ELISA; whole
blood Cs concentrations were assayed by RIA.
Twelve Cs treated recipients ware studied
serially, seven both when toxic(Toxic), as
defined by allograft biopsy and response to
reduction in Cs dosage, and again In the most
recent sample when no longer toxic(ExToxlc), and
five in whom nephrotoxicity never
occurred(Nnntoxfc) Twenty five allograft
recipients taking azathioprine(Aza) and
Prednisolorie(Pred) were also studied.
F.VIIIR.Ag
_________(n) (IUfml)
Controls (23) l.01( 0.34)
Ca+Pred.Toxie (7) 6.06( + 2.08)
Cs+Pred.Extox (7) 2.62( 0.95
Cs+Pred.Nntox(5) l.55( 0.40)
Pred+Aza (25) 1.67( + 0.48)
The increased F,VIIIRAg suggests stimulation
f the endothelium by Cs, and its measurement may
useful in the diagnosis and management of Cs
?phrotoxicity.
-—Mean + SEM--
Cs levels
(ugIL)
1608
540
520
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HERPESVIRUS INFECTION INCIDENCE IN RENAL IRAN—
SPLNJT RECIPIENTS TREATED WITH CYCLOSPORINE (Cs)
AFD LOW-DOSE STEROIDS.
Brunori G., Scolari F., Sancirini S., Savoldi S.,
Scaini P., Setti 6., Prati E., Cristineili L.,
riaiorca R., *1anca N. Dept. of Nephrology anc
*Inst. of Microbiology, Spedali Civili and Uni-
versity of Brescia, Italy.
Cytornegalo (CMV), herpes simplex (HSV) and
varicella—zoster (VZV) virus infection was
prospectively evaluated by complement fixation
test in 33 renal transplant recipients treated
with Cs and low-dose steroids. Cs was given with
a starting dose of. 14 mg/Kg, then adjusted to
achieve trough blood levels (TI3L) (RIA-method) of
200-500 ng/ml. The mean follow-up was 10 3
months. The cumulative incidence (life—table
analysis) of active infection (seroconversion) at
3,6,12 months was 63% - 94% - 100% for CMV; 76% -
85% - 96% for HSV; 25% - 35% - 54% for VZV. The
total number of active infection episodes was 47
(1.4/pt) for CMV; 48 (1.4/pt) for HSV; 16
(0.5/pt) for VZV. Mild symptomatic active in-
fection was observed in 4 patients (12%) for CMV;
in 6 patients (18%) for HSV; in 2 patients (6%)
for VZV. In Cs-treated patients, the herpes virus
active infection is usually asymptomatic. The
incidence of symptomatic infection, particularly
for CMV, is lower (12%) than in our patients
treated with azathioprine and low-dose steroids
(28%).
LOW STARTING AND FOLLOWING DOSES OF CYCLOSPORINE IN
KIDNEY TRANSPLANTATION.
G.Civati ,M.L.Broggi ,G.Busnach,B.Brando,M.L.Perrino,
M.Seveso,C.Guastoni,E.Del Favero,L.Belli,L.Minetti.
Renal Transpl .Unit,Niguarda Hospital ,Milano Italy.
In order to evaluate the fittest therapeutic re-
gimen for grafted subjects, 53 necrokidney transpl-
ants hav.e been treated with Cyclosporine (Cy)+stero
ids two-protocol study. In the first group, Cy was
administered at l5mg/Kg,reduced to 10mg on 30th and
5mg on 90th day.The second group received a Cy star
ting dose of 10mg/Kg, soon after reduced to reach
blood trough levels (BTL) between 200-400rncg/ml. Me
tyiprednisolone (MP) 16mg/die was given for 90 days
in both groups, then tapered. Only noninvasive tech
niques were used to watch the graft status
—
The total and pro kilo doses at 90 days were hg
hter in the group II,while the lenght of primary an
uria was shorter.Furthermore,no significative diffe
rent need of MP pulses(500mg) was seen;therefore te
risk of steroids side effects was not increased,whi
he an earlier and better diagnosis of rejection cri
sis could be made.
URINARY INTLEUKIN-l ACTIVITY IN ACUTE K]INEY
ALTXX3RAFT REJEX2TIcN.
S.Carozzi S.Lanperi F.Manca**
Divisions of Nephrology* and Inwunology**, St.I'4ar-
tin Hospital, Genoa, Italy.
Low doses of interleukin 1 (ILl) were found in
the urine (u) of normal subjects (NS) and in higher
aimunt in patients with infectious, flmtunological,
and neoplastic disorders. In this study the u-ILl
activity in 28 kidney allograft recipients (I<AR)was
dosed in order to evaluate the tohavior of this pa-
rarreter out side of and during acute rejection (AR).
Eighteen KAR underwent Cyclosrx)rine-A plus Pred-
nisone (Cya+P) treatmant and 10 Azathioprine plus
Prednisone (AZA-i-P) as prophylactic larnunosuppressi-
ye agents. These data were compared to those obser-
ved in 47 NS for control.
Results shcwed that in KPR, out side of AR evi-
dence, u—ill levels were lcxer both in Cya+P and
in AZA-? patients, in corrpauisca to those observ€+
in NS, 97% and 54% respectively. Ci the contrary,
u—ill showed a remarkable increase in values ob-
served in basal conditions, precocious when the
clinical and hunoral synptctns of AR occurred. This
rise was particularly evident when fine needle bio-
psy aspiration shcMed a blast-cell dominated pictu—
re, but less evident when the prophylactic and an-
rejection therapy was perforrred by CyA.
In conclusion, our data demonstrate that the
u-ill dosage can be particularly useful in the pre-
cocious diagnosis of AR and in follcming the evolu-
tion of the acute phase durinq various treatments.
CYCLOSPORIN A IN THE TREATMENT OF STEROID
RESISTANT RJ%XTION IN RENAL ALLOGRAFT
RECIPIENTS.
M.C. Crowson, R.J.S. McGoni&le, G. Hopkinson,
R. Bonser, I. Wilson, D. Adu, J. Michael,
A.D. Barnes.
DepaLrtment8 of Surgery and Medicine, Queen
Elizabeth Hospital, Birmingham, England.
Graft failure in rena]. allograft recipients
treated with prednisolone (P) and azathioprine
(A) is often caused by irreversible (i.e.
steroid resistant) rejection. In 50 consecutive
first renal allograft recipients treated with
P and A we prospectively studied the effect of
conversion from azathioprine to cyclosporin A
in patients with biopsy proven, steroid
resistant (after 5—9 Grams of intravenous
methyiprednisolone) rejection. Of 10 patients
converted in this way graft rejection was
reversed in 9 giving an overall actual graft
survival of 8%.
In contrast, in 50 consecutive first renal
allograft recipients treated with P and A prior
to this study 10 grafts were lost because of
steroid resistant rejection and the three month
actual graft survival was 66%.
These data indicate that the selective use of
cyclosporin A to treat steroid resistant re—
lection in renal allograft recipients treated
initially with P and A is effective and the
results are comparable to those in patients
treated throughout with cyclosporin A. Finally
the majority of patients treated in this way
escape the consequences of cyclosporin toxicity.
group
actuarial one — graft
year survival — pt
mean OsA duse/3outi Lhs
mg/Kg on 90th day
MP pulses/pt/3 months
lenght of primary (is
chemic ) anuria, days
one year PCreat(mg/dl)
I(l9tx) P
84,2% <0,01
100
42,30y+6,4 0,O5
6,09 +1,5 <0,001
2,11
31,16 +12, <0,01
(6 pt)
1.52 ÷O,51
II(34tx)
96,9%
96,9%
30,48g-i-5,U7
4,35 +1 ,05
2,44
16,7
(10 pt)
1.50 +0,57
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CYCLOSPORIN A INDUCED HYPERTENSION IN BONE MARROW
TRANSPLANTATION.
J.F. De Plaen, A. Ferrant, M. Uteri, A.Uyttebrouck,
J.L. Michaux, C. van Ypersele de Strihou.
University of Louvain Medical School, Cliniques
Universtaires St—Luc, Bruxelles.
Hypertension is a well documented but poorly
understood side effect of Cyclosporin A (CyA)
therapy. In order to delineate possible
etiological factors, we have prospectively
followed renal function, fluid status, renin
angiotensin a].dosterone levels and prostacyclin
production in 10 bone marrow transplant patients
(BMT) during the first 3 weeks of CyA therapy.
Blood pressure remained normal in 6 (Or. I) and
increased in 4 (Gr. II) subjects. At the end of 3
weeks, plasma renin activity (PRA) and plasma
aldosterone (PA) were significantly lower in Gr II
than in Gr I patients (PRA 0.66 0.16 vs 1.19 +
0.22 ng/ml.hour, PA : 0.16 + 0.02 vs 0.24 0.03
nM/i). Serum creatinine increased significantly in
Cr. II but not in Or. I (Gr. II 0.70 + 0.04 to
0.99 + 0.07 mg/dl, Gr. I 0.74 0.06 to 0.81 +
0.03). The increases in serum creatinine and in
diastolic blood pressure were significantly
correlated (r = .97 p <.02). Proteinurja was
similar in both groups. Body weight gain was
slightly but not significantly higher in Gr II
than in Cr I. CyA dose and plasma levels were
identical in both groups. Determinations of 6 keto
PGP 1o( plasma levels are still in progress.
We conclude that CyA induced hypertension is
not related to activation of the renin angiotensin
aldosterone system but well to an impaired renal
function.
LACK OF RELATIONSHIP BETWEEN BLOOD CYCLOSPORINS
LEVELS AND NEP1-IROTOXICITY AT"FINE NEEDLE BIOPSY"
Egidi F.,De Vecchi A.,Pa,gliari 8. ,Moriggi M. and
Ponticelli C.
Nephrology Division,Oapedale Maggiore—Milano,Italy
In order to evaluate whether trough Cyclosporine
(Cy) blood levels (BL) monitoring could assess the
Cy nephrotoxicity,a correlation between BL and ccl—
lular toxicity detected at"Fine needle aspi.ration
biopsy"(FNAB) was searched for in 64 Cy treated re-
nal transplant patients. Cy BL were measured in who-
le blood with a commercially available RIA kit. The
average value of at least 3 determinations made in a
period of 7—10 days was compared to the results at
FNABs performed in the same period.The severity of
Cy tubular—endothelial cell damage detected at FNAB
was semiquantitatively scored from 0 to ++÷,while
the imaunoactivation status was proved by the presen
Ce of imm mpetent cells.
++.- 3 4 3 1
++ 2 10 7 8
+1+ 5 12 15 11
0 [3 l6 20 14
Hedian BL(ng/ml)lO—300 300—600 600-1000 1000
Signs of marked inflammation were seen in 6/13 pta
with BL between 0—OOng/ml,in 8/42 pta with BL bet-
ween 300—600ng/ml,in 10/45 pts with BL between 600—
l000ng/ml and in 6/34 pta with BL higher than 1000.
In conclusion Cy BL are not related to the degree of
pephrotoxicity as assessed by FNAB; low Cy BL do not
protect from renal Cy toxicity while expose to a hi—
gher risk of acute rejection; high Cy BL do not seem
to expose to an increased nephrotoxicity.
NEED FOR STEROID IN CYCLOSPORINE(Cy) TREATED
CADAVERIC RENAL TRANSPLANT RECIPIENTS (pts).
Dc Vecchi A.,Tarantino A. ,Rlvolta E.,Egidi F.and
Ponticelli C.
Nephrology Division,Ospedale Maggioce—Milano Italy
A controlled trial was made to assess if steroidu
are needed in Cy—treated cadsveric renal transplant
pta. 50 consecutive pta were randomly allocated to
receive Cy and steroids(Group A:26 pts) or Cy alone
(Group B:24 pts).l5 Group A and 20 Group B had
rejections.17 pta of Group B had to be definitively
switched to Cy and steroids, so that only 7 Group B
pta are still on Cy alone(Group Bb). The nusber of
iv steroid pulses was similar in the two Groups
(2.5+2.6 and 3.2+2.2 in
2 Group A and 1 Group B
transplant failure.
GROUP B Rb
Pl.crest.(mg/dl) 1 so
Pl.creat.(mg,'dl) 3 moe
Hypertension
1.7+0.8
1,5÷0.5
16 61%
2.0±1.0
1.5±0.5
7 29%
1.7+0.9
1.5+0.3
1 14%
Viral infections 9 35% 1 4% 0
Bacterial infections 7 27% 2 8% 1 14%
Follow—up sos 3.4+1.6 3.4÷1.9 2.9+1.9
These data suggest that a small number of Cy treated
pts can tolerate cadaverjc transplant without
steroids. Due to the small risk of irreversible
rejections,immunosuppression could be started by Cy
alone in all the pta, both to identify pta not
requiring steroids and to reduce the incidence of
early infections and hypertension.
.
CYCLOSPOIdIN AOl) URINE GLUTATHIOIIE—S—TNANSFERASE
0. Fainfeith A. %envcnlaty, V. £"Agatis U. Hardy.
Harlem and Presbyteri an Hospitals, Columbi a Uni-
versity Collepe of Physicians C Surgeons, New
York, NY, USA
Glutethione—S—transforaae (GST) is art enzyme
found In the cytoscl of proximal tubular cells.
It is nornally undetocteble In urine but appears
in the urine following proximal tubular injury
with a nur;ber cf nohrotoxins. Since a najor
side affect of cyclce.porin is renal tubular
toxicity, we looked for urinary GSI in rats
given varying toxic doses of cyclosporin by
injection and in renal transplant patients
treated with this druc, in order to eveluet
OST as an indicator of tubular injury fror;
CyOl ospori n,
During the control period and for 40 hours
after beginning cyclusporin, all urine samples
eere negetive. However, 83% of all rats haddetectable GST in the urine followino 3 to 6
days on cyclospcrln. Pats cjiveri a high daily
dose (50 mg/kg) of the drug dovoloped early en—
zymuria and many died at 6 days. rats given 20
mg/kg of cyclosporin developed urinary OST be-
tween 3 and 5 days after starting injoctions.
This preceded the nadir of urine osrnclality,
which occurred at day 5.
Two of eight renal transpl ant patients had
elevated urinary GST while being treated with
cyclosporin. These findings were correlated
the clinical findings and cyclosporin levels.
Th appearance of GST in th urine at the
tine of early renal tubular toxicity suggests
that this enzyme may be a good marker for proxi—
mal tubular injury from cyclosporin. Further
investigations of urine GST in allograft pa-
tients receiving cyclosporin are continuing.
Group A and B respectively).
pta had irreversible
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SUCCESSFUL CONVERSION F1JM CSA EO AZATHIOPRINE IN
PENAL ALL(X3RAFPS WITH SEERELY IMPAIRED FUNCTION
U.Frei
,T.Block,G.Riechers,K.Wonigeit,B.Ringe,
R.Pichlmayr and K.M.Koch
Depts. Nephrology and Transplant Surgery,Hannover
f,dical School, Hannover, F1
Cyclosporin A (CSA) has improved results in kidney
transplantation,but acute and chronic CSA nephroto—
xicity remains aproblem to be solved. CSA treated pts
tend to have elevated serum creatinine levels as
compared to pts with conventional inmiunosuppression.
Since some pts develop progressive deterioration of
graft function ,which does not respond to anti—re-jection treatment and CSA dose reduction,we wanted
to evaluate whether these pts could benefit from
conversion from CSA to azathioprine treatment.
From 1981 to 1984 n=224 transplant recipients were
treated with CSA and low dose steroids. During the
maintenancephase the CSAdosagewas adjusted to ob-
tain through levels of 300-600ng/ml inwhole blood.
This imnsmosuppressive regimenwas changed in 11
pts 12.3 nonths (mean; range 2—37) after transplanta-
tion to azathioprine 2 og/kg.(riteria for conver-
sion were a) serum creatinine) 25oprmsl/l, b)rapid
deterioration of graft function, c)biopsy proven
signs of CSA toxicity.No graft was lostduring the
observation period of 2—15 menths (mean 4.1) after
conversion. Function improved in 8 pts, remained
unchanged in 2 and deteriorated in 1 .In the 8 pts
with improvement the serum creatinine level fell
from 483(range 235—734) to 281 (179—350))i5ol/lwith—
in 1 nonth and remained stable during the obser-
vation period. The results indicate that those pts
with rapid deterioration of function in the later
posttransplant phase may benefit from conversion.
These pts represent a subgroup of CSA treated pts,
since the majority treated with CSA according to
blood levels maintained stable graft function.
CYCLOSPORINE-A AS THE SOLE IMMUNOSUPPRESSI-
VE TREATMENT IN RENAL TRANSPLANTATIONS.
B.Lund Hansen, I.Henriksen, N.Rohr,
V.Svendsen, S.A.Birkeland.
University Hospital of Odense, Denmark
Cy—A as the sole immunosuppressive
treatment was used in the first 50 trans-
plantations performed in 1983—1985. This
protocol was used to improve graft— and pa-
tient survival, and to avoid side effects
observed in prednisolone—azathioprine
treated patients. 16 patients were given 17
mg/kg as the initially dose, 19 were given
15 mg/kg and 15 were given 12 mg/kg. One
year graft survival was 50.9%. Median we—
rum-creatinine for the three groups was
compared after 1,2,3,4 weeks and 2,3,4,5,6
months respectively. Median values for
creatinine at these intervals were much lo-
wer for the patients given 15 mg/kg and 12
mg/kg. All patients given 15 mg/kg had a
serum—creatinine less than 200 umol/l 2
months after transplBntation whIlst the
group given 17 mg/kg did not reach this
value till 6 months after transplantation.
Median day of onset for the group given 17
mg/kg was 3 (1-88), for the group given 15
mg/kg 1 (1-38), and the group given 12 mg/
kg 1 (1-8) . Symptomatically side effects
as tremor, gingival hypertrophy and gastro-
intestinal symptoms was observed in 36% of
the patients. Biochemically liver affec-
tion was observed in 31% for patients gi-
ven 17 mg/kg and 42% for patients given
15%. Our conclusion is that Cy—A as the
sole immunosuppressive treatment is po-
tent and safe. Graft function commences
more rapidly with the lower dosis of Cy-A
and one year graft survival is the same.
. INDIIJM-11l-OXINE LABELLED PLATELETS IN THE DIAGNO-
SIS OF RENAL ALLOGRAFT REJECTION UNDER CYCLOSPORI—
• NE THERAPY.
J.M. GriOb, J. Torras, J. MartIn—ComIn, J. flora,
I. Sabaté, A.M. Castelao, M. Roca, J. Alsina.
(Intr. by X. Sarrias)
Hospl do Bellvitge. Barcelona. Spain.
In —oxine autologous labelled platelets has
been useful in the diagnosis of renal allograft re-
jection (R) under conventional immunosupression.
Treatment with cyclosporine (Cy) raises the ques-
tion of differentiation betmeen R and Cy nephroto-
xicity and particularly so in the postoperative a—
cute tubular necrosis (AIN). We have studiedthe
usefulness of this method in the diagnosis of R
based on the image of the gra1area secondary to
the trapping of autologous In labelled platelets.
The trapping index (TI) mas calculated according to
the graft activity versus contralateral fossa ilia
ca ratio.
Nineteen patients treated with Cy were studied
In 10 patients with acute R the mean TI was 1,9 —
0,4 vs 1,1 0,2 in 9 patients without R (P(O,001)
Mean Cy rough whole blood levels (RIA) w?S -
248 ng/ml in the patients with R vs 596 - 319 ng/ml
in the patients without R (p<O,O25). Among 9 pa-
tients with postoperative ATM, 5 suffered from R,
and all 9 but 1 (arterial trombosis) recovered re-
nal function. In the last follow—up 17 grafts
are functioning. One graft failed due to acute vas
cular rejection on diuretic phase.
These preliminary results suggest that this me-
thod may be useful in the management of kidney a-
llOgraft recipients treated with Cy.
THE INFLUENCE OF DONOR AND RECIPIENT AGE AND SEX ON
GRAFI SURVIVAL: A COMPARISON OF AZATHIOPRINE (AZA)
AND CYCLOSPORIN A (CYA)
K.Harris, NDigard, C. Gosling, K.Athersmith,
B Gardner, M.Slapak.
Wessex Regional Transplant Unit, Portsmouth, U.K.
Previous statistics have suggested significant
differences in the DR matching and pre—transpiant
transfusion requirements of patients treated with
Aza and CyA if optimal graft survival (G.S.) rates
are to be attained. The influence of donor and
recipient age and sex on 1 year G.S. rates was
compared in 165 patients on CyA and 132 patients on
Aza, transplanted in a single centre, 1978—1985.
Results showed that overall recipients of grafts
from donors 4O yrs old did better on either drug,
1 year G.S. being 58.54% cf 44.5%. Patients on
Aza who had a donor of the opposite sex (OS) did
less well (34.97%) than those whose donor was of
the same sex (SS), (55.77%). For CyA the effect
was less pronounced and opposite (SS 58.79%,
OS 67.3%). Overall the sex of the donor, irres-
pective of that of the recipient, had little effect
in CyA or Aza treated recipients. Recipients <40
did better than those>.40, this effect being more
pronounced for patients on Aza (58.16% cf 30.16%)
than for CyA (67.24% Cf 56.97%). There was no
influence of recipient sex overall in patients on
Aza, recipient male (RH) 45.64%, recipient female
(RF) 49.97%, but for patients on CyA female reci-
pients did far better overall (RM 55.37% RF 76.41%)
In conclusion, optimal results on Aza were seen
where donor and recipient were under 40 and of the
same sex, with no significant influence of recipi-
ent sex being seen. In contrast, for patients on
cyA results were better if the donor and recipient
were both under 40 and of the opposite sex, and
female recipients did significantly better overall
than did males.
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. PHARMACOKINETICS AND NEPHROTOXICITY OF CYCLOSPORIN
A (CsA) IN RENAL TRANSPLANT RECIPIENTS.
F.C. Henny, C.H. Kleinbloesem, A.J, Moolenaar, L.C.
Paul, D.D. Brei,ner, L.A. van Es (Intr. by I.
Schicht).
Departments of Nephrology, Chemical Pathology and
Pharmacology, University of Leiden, The
Netherlands.
The pharmacokinetics of CeA were studied in 14
renal transplant patients on low doses of
prednisone during a three—months treatment period.
Three and 15 days after transplantation, 12—hour
blood level studies of the drug were performed to
calculate the elimination half—life, area under the
curve (AUC) and total blood clearance; trough
levels were measured twice weekly. In 10 patients
terminal half—lives as well as the change in renal
function were calculated after discontinuation of
CaA treatment. The CsA levels were measured in
whole blood by radioimmunoaseav. In the course of
CsA treatment, a significant prolongation of the
half—life was found (6.3 3.2 hr on day 3 versus
8.7 4.3 on day 15; mean SD) with a significant
deereae in clearance (46 17 i/hr on day 3 versus
28 10 1/hr on day 15; p < 0.02). The terminal
half—life varied considerably (24—93 hr). A good
correlation (rO.9589) was observed between CsA
trough levels before discontinuation of CsA and the
percent increment in endogenous creatinine
clearance after two weeks, From this study we
conclude that during chronic CsA therapy a gradual
increase in the CsA blond level occurs with a
decrease in clearance which suggests ron—linear
kinetics of the drug. Whole blood trough levels
correlate with reversible nephrotoxicity and, in
the absence of relection, allows to predict the
renal allograft function after discontinuation of
CaA therapy.
CYCLOSPORIN A: LESS REJECTION VASCULOPATiJY?
J.Jirka,P.Rossmaun,I.Matl, V.Zstava,
V. Kodandrie
Institute for Clinical & Experimental Medi-
cine and Institute for Microbiology SAV,
Prague, Czechoslovakia
In recipients (Rc) with aza÷pr iminuno—
supression the early rejection vascular
lesion (obliterative anglopathy, OA) ap-
pears in about 20/100 first and recurs in
more than 90/100 second renal allografts
(AG), manifesting itself usually in the
first trimestre and destroying the AG wi-
thin a few weeks or months. Reports on
90/100 and more one-year first AG survi-
val and on improved outcome of secondary
transplantations (Tx) in Rc treated by
CyA or CyA+pr suggest a decreased frequ-
ency of OA; however, pertinent data have
not been published.
Our preliminary experience shows that
this may be true: 1. , in a randomized
study (up to now 6 pairs of Ec, each pair
grafted from one donor, first Tx, one Rc
CyA+pr, the other one aza+pr), after a
follow—up of at least one year, there was
not a sin1e case of OA in, CyA+pr Rc as
compared to 2/6 cases in aza4.pr Rc; 2.,
in a non-randomized trial (7 Re with OA
in first AG while on aza÷pr, second Tx,
this time on CyA+pr), 2 AG were lost due
to renal artery thrombosis while 5 have
been surviving 1-20 mom. , with o/4 inci-
dence of OA in AG examined by needle bio-
psy 2_14 weeks after TX.
Thus the incidence of OA (0/6 first
and 0/It second AG) was definitely lower
than might have been expected, especially
as far as the second AG were conoerrsed.
THE MEASUREMENT OF CYCLOSPORIN A (CYA) IN WHOLE
BLOOD BY H.P.L.C. IN RENAL ALLOGRAFT RECIPIENTS.
HILLIS,A.N., STEVENS.D. ,TOMPSON.P. ,ROBERTS.N.B.,
TAYLOR.1H.,SELLS.R.A., BONE.J.M.
ROYAL LIVERPOOL HOSPITAL LIVERPOOL L7 8XP
The measurement of CyA levels in plasma by RIA
is affected by the temperature at which the RBC's
are separated, by metabolites of CyA, and by
steroids. We therefore measured CyA in whole
blood using HPLC. Between batch variation was
5.5-12.5%, n=8, with a concentration range of
125—1250ng/ml , and a mean recovery from whole
blood of 104.9% (range 86-128%, n=1O). CyA
was given 12 hourly and samples taken immediat-
ely before, 2 and 4 hours after the morning
dose. Sixty-three observations in 41 patients
were differentiated into graft rejection and CyA
nephrotoxicity retrospectively using clinical,
biochemical, histopathologkal data and measure-
ment of interstitial renal pressure and response
to therapy, without knowledge of CyA levels.
In eight rejecting patients the trough Cy1
concentrations,wcçe dower, (219 s.d.173uM4,'l'
vs 469s.d242 tj/I.74' p<O.OO1) when compared to
18 patients with nephrotoxicity. In nephro—
toxic patients, plasma creatinine correlates
positively with the CyA level at 2hrs and neg-
atively with the haetnatocrit (p<O.OO1,p<O.OO3,
respectively. The dosage of CyA correlates with
'the trough CyA level (p<0.OO1), but not with
plasma creatinine.
From these results it appears necessary to
assay whole blood since the haematocrit may
be an important determinant of CyA levels and
resultant toxicity. Furthermore, the trough
CyA level is able to differentiate between graft
rejection and toxicity in moderate to severe
renal failure.
.
CYCLOSPORIN A (CyA) NEPEIROTOXICITY: COMPARISON
OF BIOPSY HISTOLOGICAL FINDINGS 1N RENAL TRANS-
PLANT PATIENTS TREATED EITH CyA AND AZATHIOPRINE
(AZ)
S Kabalan. F Dische, C Neild, M Bewick, V Parsons
King's College Hospital and St Philip's Hospital,
London, UK.
CyA has now largely replaced AZ in transplanta-
tion. Nephrotoxicity of CyA is the main
lianagement problem. Nephrotoxicity has recently
been shown to cause vascular changes associated
with hyalinization of small arteries. In order to
establish that these lesions are found more
frequently with CyA toxicity than with rejection,
59 renal biopsies taken because of diminished
graft function from patients being treated with
CyA (36) or AZ (23), were examined blind and the
results assessed under light microscopy. The
indications for biopsy were not changed during
the course of the study; the two groups of
patients were therefore comnarable.
On morphological grounds, it was possible to
ident'Lfymany of the patients being treated with
CyA, as against those on AZ. It was also possible
to distinguish acute rejection from CyA toxicity
confirmed clinically by the response to anti-
rejection therapy. The histology of chronic
rejectnn was more difficult to distinguish.
It is concluded that CyA nephrotoxicity is
associated with vascular lesions that differ from
those of acute rejection and which are recognis-
able in renal biopsy specimens.
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IMMUNOSUPPRESSION IN PRESERVED HUMAN CADAVERIC
GRAFTS - AZAT}iIOPRINE VERSUS CYCLOSPORIN A. —
M.S.A.Kumar, A.G. white and G.M.Abouna,
Department of Organ Transplantation,
(Kuwait University) ,Faculty of Medicine, KUWAIT.
Cyclosporin (CyA), is currently regarded as the
powerful immunosuppressent, has serious toxicity,
particularly in human cadaveric kidneys with prolo-
nged ischaemia. During a 3 year period we have comp-
ared the effects of CyA with Azathioprine (Aza.)and
Prednisone(Pred.) in 52 cadaveric kidneys transpla-
nted after preservation for 12—76 hours.In 30 grafts
(Group 1) immunosuppression was with Aza.& Pred.,
while in 22 (Group 2) CyA and low dose Pred.were used
The two groups were similar with regard to HLA mat-
ching age, warm ischaemia and mean total preservat-
ion times. Post transplant dialysis requirment for
ATN was similar in both the groups but in Group 2,
85% of such recipients did not resume function at 1
month where as all such grafts in Group 1 recovered.
All the grafts(100%) in Group 1 were functioing com-
pared to 72% in Group 2.(P=0.01). During the first
year after transplantation loss of grafts due to
rejection was 50% in Group 1 and only 4% in Group 2
(P=0.01) . However ultimate graft survival at 1 and
2 years was 50% & 47% for group 1 and 68% and 68%
for Group 2(P=NS). In 5 recipients who, required
post transplant dialysis Aza.& Pred.were used init-
ially and converted to CyA. after resumption of
graft function, and all these grafts have survived
and continue to have excellent function.
These results indicate in cadaveric kidneys with
long Ischemia initial immunosuppression with CyA
may be detrimental because, toxicity of CyA and
Ischaemia damage are additive. However, when init-
ial therapy is with Aza.& Pred. which is then conv-
erted to CYA, early graft failure can be avoided and
long term graft survival greatly improved.
SDS-ELECrROPHOPESIS OF URrNARY PROTEINS IN RENAL
TRANSPLPNr RECIPIENTS TEATED BY CICLOSPORINE OR BY
O3NVENPIONPL INMUNOSUPRESSION +
A.Lapil1i, H.Gaisl, H.J.Zyman, F.Gabl,H.Kopsa ,J.Zaz-
gornik
Insituteoflinical Chemistry and La]xratory Dia-gnosis, t ?Wdical Clinic
University of Vienna, Austria
In 49 kidney transplant patients urine samples
were analyzed weekly by SDS—electrophoresis. Agroup of 26 cases was treated by ciclosporine A and
prednisolone, the other 23 by azathioprine and pred-
nisolone. The oman observation tine was 6 mDnths
and oman tiom after transplantation was 7 years and
one year respectively for first and the second
group. The basic renal disease of all subjects was
chronic glorrerulo-nephritis. The type of protein-
uria was evaluated according the protein pattern in
the SDS-electrophoresis, using the "Boesken Classi-
fication'. Each SDS—electrophoresis result was cor-
related to the total urinary protein concentration
and serum creatinine.
The types of proteinuria representing minor damage
of the glorrerulo-tubular apparatus, the tubular (IV
and selective glomarular (III) proteinuria, as well
the type of physiological proteinuria were nore fre-
quently found in the group of ciclosgorine treated
patients, compared to the group with conventional
iitffruinOsupression:
- tubular (IV) in 5 vs 1 patient
— gloirerular selective (III) in 15 vs 9 patients
— physiological (0) in 21 vs 10 patientsIn the class of selective gloomrular proteinuria(III) the serum creatinine was significantly higher
in the ciclosporine treated patients group (p 0,02).
We found that SDS-electrophoresis permits a conven-
ient, non—invasive nonitoring of nephrotoxic side
effects of ciclosrorine treatrrent.
CYCLOSPORINE-A IN THE TREAThENT OF .CUI'E KIDNEY
ALTXXRAFT REJECTICt STEROID PEFR(CTORY.
S.Lairr, S.Carozzi.
Division of Nephrology,St.Martin Hospital,Genoa,
Italy.
In this research we studied the effects of Cy-
closporine-A (CyA) in acute kidney rejection not
responsive to omthylprednisolone pulses.
In 12 allograft recipients treated by prednisone
and azathioprine as prophylactic irrrnumosuppressive
agents, in whom renal fine needle biopsy aspiration
(FNBA) showed a blast-cell dominated picture, CyA
was administered intravenously li-i the daily dosage
of 5 in/Kg/b.w. for five days,after a total dose of
3 g. steroid pulses without any favourable effect
was seen, to maintain serum trough levels of shout
1.000 ng/mL. Thereafter Cya was contind orally
and the dose of azathioprine was decreased.
In all patients this treateent was folld by
a reversal of clinical and humoral rejection fin-
dings and by the disappearance of blast cells from
the FNBA. In 10 patients no further rejection epi-
sodes occurred in 12 months; in 2 patients , howe-
ver, a releapse was observed within 33 days on the
average.
The conclusion drawa from this study is that the
steroid pulse refractory acute rejection where
blast-cells are predominant in the FNBA, can be
treated effectively and safely by CyA.
CYCLOSPORIN AND URIC ACID
K.M.L. Leunissen, J.P. van Hooff
Department of Nephrology, University of Limburg,
Maastricht (The Netherlands)
(Intr: J.M.V. Mooy)
We are studying prospectively the influence of the-
rapy with CyA on serum uric acid (UA) levels in
cadaveric kidney graft recipients. So far the data
of 19 patients have been analysed.
The conclusions reached so far are:
1. UA is significant higher for a given serum crea-
tinin level during CyA therapy than in a controi
group without CyA.
2. CyA concentrations (whole blood, HPLC) correla-
ted neither with creatinin nor with tiP, levels.
3. The high UA levels are due to a low excretion
of UA in the urine.
4. After conversion to azathioprine and predniso—
lone UA levels decreased within 2 to 4 weeks to
normal levels.
5. 5 out of 19 patients had a normal UA level. The-
se patients had the same serum creatinin and/or
CyA levels as patients with a raised UA level.
6. One patient with very high levels of UA (0.75-
1.05 mmol/l) showed arteriolopathy.
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DOES CYCLOSPORIN A WORSEN PNEUMOCYSTTS CARINII
INFECTION?
R.J.S. McGonigle, 3. Stone, M. Crowson,
3. Young, 3. Michael, D. Mu.
Departments of Medicine, Surgery and Pathology,
Queen Elizabeth Hospital, Birmingham, England.
Fourteen immunosuppressed patients with
Pneumocystis carinii infection presented in two
clusters of six months that were separated by
two years. The diagnosis in all cases was made
early hy alveolar lavage with cytology. The
first group of 7 patients wan treated with
cyclophosphamide or azathioprine and
prednisolone. All recovered with high dose
co-trimoxszole. The second group again of 7
patients was treated with prsdnisolone and
cyclosporin A. Despite identical treatment
three patients died and a further two who
survived lost their grafts from rejection.
Our data suggests that cyclosporin A worsens
the prognosis from Pneumocystic carinii
infection and raises the question of prophy-
lactic co—trimoxamole in these patients. The
clustering of Pneunocvatis carinii infection
raises suspicion of nosocomial transmission
altho':h in this study we were unable to
implicate person—to—person spread of infection.
HIGHER CYCLOSPORIN LEVELS IN THE FIRST THREE DAYS
POG'J'-THANSPLANTATIOH ARE ASSOCIATED WITH FEWER
REULCILON EPISODES, LOWER SERuM CREATININES AND
SIGNIFLCAIJTI.Y IMPROVED uRAFT SURVIVAL AT 12 MONTHS
O'DunovanR, Compton F, Verhi V, Sowjck N, Parsons V
Renul tnit, King's College Hospital, London SES, UK
tletseen March '03 and December '04, 96
corrective transplants were carried out. Immune—
supureusion was with cyclosporin A (GSA) 10/Kg 1/
Day - n 2 divided doses reducing at three days to
maintain whoLe blood trough GSA levels at 200-400
ngiiul - , and prednisolone 20 mg/day reducing at 3
weeks le i0mg/day. (Population: 70 male, 26
female age 17—70, mean 41iJ6 diabetics, 00 nun—
diabetics; 59 let, 32 2nd, 4 3rd and 1 4th graft)
Overall graft survival was 771 at 6/12, 691 at 12
months. In those patients with high initial mean
trough CSA levels ever the first 3 days, there were
fewer rejection episodes, lower serum creatinine
levels and significantly (Pc0.0S( improved graft
survival ever the period of this study.
Oreph: I graft survival vs. days peat transplant. 3
groups according to mean trough CSA levels over let
3 days CSA levels) . CSA levels l-3S0ng/m1-
(n=27) n CSA levels 351—640ng/mrl (n=37)
CSA levels 641—2000+ (n32)
Abstracts
ANALYSIS OF PRESERVATION METHOD AND FUNCTION IN THE
CYCLOSPORINE (Cy) ERA
VK Mittal, L.H. Toledo-Pereyra, tIP Kaplan
Transplantation Society of Michigan, Ann Arbor,
Michigan, USA
A retrospective review of 375 kidneys harvested
and transplanted in our state between January 1983
and August 1984 was performed to determine whether
hypothermic pulsatile perfusion (HPP) or hypother—
sic storage (HS) was used and whether Cy was given
after transplantation. Function in the immediate
post—surgical period and at 30—days was considered
only if no dialysis was required. Immediate renal
function (11(1) and 30—day renal function (30—RI)
for the entire group were 52% and 73%, respective-
ly. For HS kidneys (n=164), IRF was 45% and 30-RF
was 68%. No significant difference in IRF and 30—
RF were seen in the HPP group (n211) (IRFS6%, 30—
RF=75%). HS kidneys in the pre-Cy era (n=100)
with a mean preservation time of 25.4 hrs, showed
an IRF of 38% and a 30-RF of 60%. This was not
significantly different from HPP kidneys in the
pre-C,y era (n=106), preserved a mean of
25.3 hrs., IRF=43% and 30_RF=69%. In the Cy—era,
HPP kidneys (n=105) functioned significantly bet-
ter (p<.025) than HS kidneys (n64),HPP_IRF=75%
HS-lRF=53%, HPP-30-RF=83%, HS_30_RF=68%. Mean
preservation times for kidneys in the Cy-era were
22.0 hrs. for HS kidneys and 27.4 hrs. for HP
kidneys. No significant differences were obser-
ved in the function of kidneys preserved either
by HS or HPP when all kidneys were condidered
or in the pre—Cy era. However, a significant
improvement in function was seen in the HPP kid-
neys over the HS kidneys in the Cy era. These
results indicate that the use of Cy may necessi-
tate more caution in choosing appropriate preser-
vation methods.
.
CYCLOSPDRINA(CSA)OR AZATHIOPRIME(AZA) COMBINED
WITH PREDNISONE(PRED) IN RENAL ALLOTRANSPLANTA—
TIDN WITH A CONVERSION PROTOCOL FRON CSA TO AZA
AT FOUR MONThS. National Eidney Foundation of ti;e
rhilippines Transplant Teem, Clever P.Ramow,M.D.
The outcome of living related donor (LRD)and
cadaveric donor(CAD) allogrsfts in 46 patients
of the NEFP followed up for 3 months—24 months
(median of 8 months)after transplantation are
tabulated as follows:
TREA1I DO DR NO.f NO OF PATIENTS WITH EATH
MENT ( NOR MITCH c 'Chr Graft Elev Nephru
eI.FJ Loss SOFT toxicit
AZA LRD2 5(0 0 00 0 0
AZA LRD 1 lD 4 1 1 2 0 1
CSA LRD 1 l4 3 , 1 0 5 1 0
CSA CAD 1 12. 2 1 U 2 1 1
CSA CAD 0 5i3!lO 3 0 1
CSA was shifted in a gradually decreasing
and overlapping manner to AZA in 21 patients
at 4 months except in 3 in whom conversion was
done at 8 months; the remaining CSA patienta are
awaiting conversion.There was no case of acute
rejection following conversion.Serum creatinine
did not change by more than 0.3 mgsZ in 10 hut
decreased byO.4 mgs% to 1.8 us%(nedian of 0.5
mga%) in 11 within one month after conversion.
One patient had an SOFT rise after conversion
to AZA.
The causea of death were pulmonary thrombo —
embolism in the CSA—CAD group,urdetected aplas—
tic anemia which became apparent after an acute
rejection in the AZA—LRD group and lymphoma in
one case in the CSA—CAD—ODR group who had chro-
nic rejection and received aggressive immuno—
suppression including a triple therapy withCSA,
FRED and AZA 6 months after transplant and died
at 9 months,
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S RENAL FUNCTION AND BLOOD PRESSURE IN HEART TRANS-
PLANT RECIPIENTS TREATED WITH CYCLOSPORINE.
J. Rottembourg , M.F. Mattei,A.Cabrol,J.C.Gluckman,
H. Beaufils, I.Gandjbakhch, C.Cabrol.
Depts.of Nephrology,Cardio-vascular Surgery and
INSERM U.27. Hôpital de la Pitié.Paris. France.
Cyclosporine (A) (CyA) is widely used to suppress
allograft rejection. Its potential nephrotoxicity
is however obviously difficult to assess in kidney
transplant recipients.We therefore investigated the
renal function of heart transplant recipients (HR)
treated with low doses of steroids and CyA started
at dose of 12.5 mg/kg/day and reduced thereafter to
maintain trough plasma levels (To) around 150 ng/
ml.Actuarial survival was 89% at 6 months and 85%
at 1,2 and 3 years.Serum creatinine and blood pres-
sure were regularly assessed in the 34 HR who have
been followed more than 6 months (M)
Period (M) Pre 6 12 24
Nb of pts. 34 34 25 10
Steroids mg/d 480 20±5 155 12.52.5
CyA mg/kg/d - 7.5±1.2 7.6-1.0 8-1.2
To ng/ml 16075 130±60 13030
Creat. j.jmol/l 117—35 156—75 165±57 174—77
Hypertens.pts. 0 4 6 5
Eight HR received potentially nephrotoxic antibio-
tics between the first and the third month post-
transplant and their creatinine level significntly
increased thereafter from 100±20 umol/l to 200-80
mol/l (p<O.01).Only one HR had to stop CyA becau-
se of renal failure (serum creatinine>,450 pmol/l).
Renal biopsy in this case showed interstitial fibro-
sis and tubular lesions but no glornerular damage.
Three M after stopping CYA serum creatinine retur-
ned to 120 jimol/l. Thus CyA gives excellent results
in heart transplantation but lower doses of CyA
might be required to avoid nephrotoxicity.
5 ARE CYCLOSPORINE (Cs) DEPOSITS (DPS) IN RENAL
ALLOGRAFTS OF CLINICAL SIGrlFICANCE?
Scaini_P.,*Tardanico R.,*Favret N. , Scolari F.,
Savoldi S., Prati E., Sandrini S., Brunori 6.,
Cristinelli L., Maiorca R.
Dept. of flephrology, *1st Dept. of Pathology-Spe-
dali Civili-Brescia-Italy
94 FIrE NEEDLE ASPIRATION BIOPSIES (FNAB) were
obtained from 32 renal transplant recipients
treated with Cs and steroid. 67 FNAB were perfor-
med in the first 3 months, 27 between the 4th and
10th. An indirect immunoperoxidase technique was
used to detect cellular Cs BPS. Cs DPS in tubular
and/or endothelial cells were found in 44 FAB
from 22 patients (pts) (group A) (A). in 50 FNAB
from 10 pts there was no evidence of Cs DP (group
B) (B). When FIAB were perforned, Cs blood trough
levels (BTL) were 424 234 in A and 346 321
ng/nl in B (p=n.sj; the Cs mean dose was 10.4 *
4 in A and 11.2 4 mg/Kg/die in B (p=n.s.). At
6th month in 9/21 pts Cs BPS were seen in renal
parenchiral cells. Their Cs mean cumulative dose
was 11.0 3.4 while it was 9.1 2.9 mg/Kg/die
in the pts without Cs BPS (p=n.s.) In the first 3
months Cs BTL > 300 ng/ml were associated with a
hiyher incidence of Cs DPS positivity (21; 65.6%)
compared to Cs BTL 300 ng/nil (10; 28.5%) (Pc
0.02—Chi—square test). Clinical nephrotoxicity
was seen in only 2 pts with Cs DPS and BTL>500
ng/nil. Our results cast doubts on the clinical
significance of Cs presence in renal cells.
Further studies are needed in order to understand
their real value.
CYCLOSPORINE (Cs)—INDUCED GINGIVAL HYPERPLASIA: CLI-
NICAL AND PATHOLOGICAL FINDINGS.
Sandrini S. ,Savoldi S.,Scolari F. ,Brunori G.,Scaini
P. ,Prati E.,Cristinelli L.,Maiorca R.,Facchetti F.
Callea F.*,Zanetti U.—Dept. of Nephrology,l° Dept
of Pathoiogy and Dept. of Maxillar Surgery,Speda
ii Clviii Brescia,Italy.
Among 28 renal transplanted recipients receiving Cs
at a dosage adjusted to achieve blood trough levels
(BTL) of 200—500 ng/ml (follow—up 10±3 months),ll—
group A— (A) developed a marked gingival enlarge-
ment during the first 3 months,whilst the remaining
17—group B—(B) did at a minimal degree or not at al)
Cs—BTL were measured daily before discharge and at
each clinical visit later on.Histopathological and
immunohistochemical changes were evaluated on biop—
syspecimens at 6 months (4 cases) and 1 year (7 ca—
ses).In addition to previously reported findings
achantosis,plasma cell infiltration,fibrosis) a pie
omorphic inflammatory process with two main patterns
was observed in all biopsies at the interfacie epi—
thelium—chorion: l)lichenoid type (helper/suppressor
T lymphocytes) ,2)herpetiform type (polymorphonucle—
ar leucocytes,C3,IgA—M).Fibroblast activation was
impressive in adjent areas;fibrosis was most marked
at 1 year biopsies.At the 3rd month,the number of
BTL determination for patient was 37±13 (A),33±lO(B)
(P=NS)At the same time the mean BTL value turned
out to be 337±270 ng/ml (A),436±325 ng/ml (B) (P<3D1
);the mean Cs dose administered was 13,5±3,4 mg/Kg/
die (A) and 10±2,1 mg/Kg/die (B) (P<O.05).These resJ
its appear to indicate that:l)hyperplaatic gingivi—
tis,in contrast to other side Cs effect (hepato—ne
phrotoxicity),is not related to high BTL but rather
to the total Cs dose administered during the first
months;2)an inflammatory (—immunological)interaction
occursat the interfacie epithelium—chorion.
CYCLOSPORINE (Cs) BLOOD TROUGH LEVELS (BTL) ARE A
USEFUL CLINICAL TOOL IN ACHIEVING ADEQUATE
IP'1UNOSUPPRESSION AND AVOIDING DRUG-TOXICITY.
Scolari F., Savoldi S., Sandrini S., Scaini P.,
Brunori G., Prati E., Cristinelli L., Maiorca R.,
Tonini G.*, Salerni B*. Dept. of Nephrology and
*Inst. of Surgical Pathology, Spedali Civili and
University of Brescia, Italy.
Acute rejection (AR), symptomatic herpesvirus
infection and pneumonia, nephrotoxicity and
hepatotoxicity were retrospectively related to. Cs
— BTL (RIA) in 33 renal transplant recipients
(mean follow-up 10 3 months) treated with Cs
and low-dose steroids. The starting dose of Cs
was 14 mg/Kg, then adjusted to achieve Cs-BTL of
200-500 ng/ml. The mean Cs daily dose was 5.3
mg/Kg at 1 year. 1601 Cs-BTL were measured.
Cs-BTL( 200 ng/rnl were associated with a higher
incidence of AR (6.2%; 22 AR) compared with
Cs-BTL> 200 ng/nl (1.4%; 18 AR) (p <0.01;
chi-square test). Mild drug-toxicity (4 nephro-,
3 hepato-toxic episodes) was observed in 7 pts
(21%), always with Cs-BTL>500 ng/ml.
Cs-BTL > 500 ng/ml were also associated with a
greater rate of infection (2.3%; 9 episodes)
compared with Cs-BTL 500 ng/ml (0.4%; 5 epi-
sodes) (p < 0.01; chi-square test). One-year
patient and graft survivals were 97% and 88%. The
mean creatinine value at one year was 1.3 mg/dl.
Monitoring of Cs-BTL and dose-adjustment to
achieve Cs-BTL of 200-500 ng/ml provide an
adequate immunosuppression with a low rate of
drug-toxicity.
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THE USE OF LOW DOSE CYCLOSFORIN A (CYA) IN
COMBINATION WITH AZATHIOPHINE (AZA) AND STEROIDS
IN RENAL TRANSPLANTATION
M. S].apak, T. Geoghegan, N. Digard, K. Ahmed,
V.L. Sharman, G. Qerchi, R. Crockett
Wessex Regional Transplant Unit and International
Kidney Organization, Portsmouth, U.K.
The new drug CYA is the most potent clinical
immunosuppressive agent available. Nephrotoxicity
and high cost are its two major drawbacks. Both
are dose dependent. The purpose of this study is
to achieve results as good as those reported with
full doses of CYA. 53 patients from 12 different
countries received 33 cadaveric and 20 related
living allografta. HLA—DR mismatching in the cad—
averic transplants were 3.01 for A and B and 1.47
for DR. All patients had been blood transfused.
Donor kidneys had a mean cold ischaemic time of
38.3 hours. All patients received a commencing
dose of 12 mg/kg CYA, 1 mg/kg AZA and 30 mg Pred—
nisolone. At 1 month patients were on maintenance
therapy of 3 mg/kg CYA, 0.75 — 1 mg/kg AZA and
15 ag Prednisolone. The latter drug was discon-
tinued at 6 months.
Results Of the 20 living related recipients 17
are alive with functioning grafts 4 — 18 months
after transplantation — actuarial survival 91%.
Of the 33 cadaveric recipients 26 are alive 2 — 42
months after transplantation — actuarial survival
78%. The incidence of septic complications
(bacterial, viral or fungal) were not increased
compared to historical controls. There were no
malignancies, We conclude that treatment with a
mixture of AZA and CYA at a dosage rate below
marrow suppressive effect of the former and the
nephrotoxic effect of the latter has produced
results which equal that produced by CYA alone.
We believe this form of therapy merits further
evaluation.
R3JlN-ANGIOTE1'JS1N-Aln05I'r3ONE 5YSTEII IN CYCLOSPO-
RIME A TFiEATED RfNAL ALLOGRAIT RECIPIENTS
B.Stanek,J.Kovarik,S.Rasoul—Rockenschaub,H.K.Stumci-
VRàl
2 Dept.of Internal Nedicirie nd Ludui Boltamanri-Instltute for CIlnicCi Endocrioology,University of
Vianna,Auatris
There is still an ongoino dabate whether hyper-
tension erising in renal alI.3areft recipients trse—
ted with Cyclosporine A (CY-A) for irrmuresuDprewelo3
relates to stimulation of the renin-aniotonain—iL—
closterone system (R-IAS) as suagested by ariral e
penmen te.
Therefore we measured supine plasma renire activity(PRA)elA ph 7,4)anc] plasma aldosttcone (RIA) in
11 CY—A treated renal allograft recipients at weekly
inteials up to 3 weeks after transplantation,when
plasma creatinine was 2,2+0,1 mgJlOOml and blood
pressure 141+4/80+3 csnHg.l0 of 11 patients were
hypertensive and placed on labetalol,nifedipine,
dihydralazine and diuretics.
Resu].tu;
Weeks after tpl. First Second Third
Pte (mg/el/h) 0,31+0,05 0,30+0,03 0,32+0,05
A1dosterone/n1) 114±27 72-l8 72-ll
All patients were followed up after six to nine
months CY-A therapy.Plasma room activity was un-
changed in 10 but increased in 1 patient without
Symptoms of transplant rejection or deterioration
of renal fuoction.Stenosis of the transplant artery
was confirmed by anmiography in this patient.
Conctusion:Whereas in rats CY-A is known to induce
increases in redo storage and release, we could
not find respective changes in PRA (and aldosterone)
In CY-A treated patients.Alt'nough therapy with
B-blockers has to be taken into account,it is con-
cluded that there is no overall stimulation of the
R/AS by Cf-A early after renal transplantation.
CYCLOSPORINE A (CsA) IN THE TREATMENT OF STEROID
RESISTANT REJECTION EPISODES IN LIVING DONNOR KID-
NEY TRANSPLANTS.
M.Sobh (M.D.), F.El-Husseini (M.Sc.), A.Shehab El-
Din (M.D.) M.Ghoneim (M.D.).
Urology & Nephrology Center, Mansoura University,
Mansoura, Egypt.
The therapeutic value of CsA as a prophylactic
immunosuppressive in man has been established(Calne
eta], 1979). The drug has been shown to be unable
to reverse established skin graft rejection in mice
(Bore], 1981). On this basis Wagner (1983) suggest-
ed that C5A should be used to prevent rather than
to treat established graft rejection.
Here in we report our experience in the use of
Cyclosporine for the treatment of established ste-
roid resistant rejection episodes in twenty one
patients maintained previously on azathioprine and
prednisone. Ninteen of these rejection episodes
were steroid resistant, in one case the rejection
episode was associated with leukopenia and in the
last case there was a poor wound healing. Steroid
resistance was considered when there was no res-
ponse to 750 rng methyl prednisolon and 400 mg Cycl—
ophosphamide daily for at least five days. CsA was
given orally in a dose of 12.5 mg/kg, predisolon
was gradually tapered to 20 mg/d. The rejection
episodes as well as their response to CsA were doc-
umented by graft biopsies.
There was complete reversal of the rejection
episodes in nine cases, partial in six cases, arr-
est of the crisis in three cases and failure in
other three.
We have concluded that CsA can reverse an esta-
blished acute rejection episode even when sever
and steroid resistant.
ELdC2IVZ Coy 310N FRCM CYCLOSPORIN A (CyA) fO
AZAT8IOPRINE (azA) A f fHREE MONTHS
J. Tuylor, T. Horsburgh, J. Feehally, P.S. Veitch,2. Wal], 1'.M.F. Bell.
Departments of Surgery nod Nephro1oy, Leicester
General Honpital, U.K.
Converojon protocols from CyA to AZA an renal
transplant patiente have been developed due to con-
cern for the long term toxicity of CyA. This study
reviews an' elective convcreion protocol from CyA
steroid to AZ; + steroid three months poet trans-
plant.
Patient and craft survival of 54 consecutive
cadaveric transplants was 94% ad 87% respectively
(7—20 mona). 42 pta with stable function entered
conversion (4 grafte lost and 3 pta unsuitable).
17 (l4Of) ptu were convertec successfully with a
mean decrease in aerum creatjnjne from 179 to 115
umol/l, There were 14 ZARLY failures (< 21 days).The cause was rejection (12) and CMV diseao (2).
Pulsed ateroid therapy failed to control rejection
in 5 pta and GyA was re—introduced. In 7 pta the
immediate re—introduction of CyA was successful.
11 patients failed conversion ITE — (2l daym)duo to rejection. 7 were treated with pulsed ster-
oid, with success in two. CyA was re—introduced to
the remainder, including steroid failures. One
graft wam lost, and 2 have poor function. Two pta
died, one from CMV disease and one malignancy.
It was concluded that in conversion there is
a significant improvement in renal function. Rej-
ection post conversion is asaociated with steroid
resistance. In view of the experiences with late
failure it is no longer justified to convert at
three months.
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. MAGNETIC RESONANCE IMAGING IN RENAL TRANSPLANTSL. te Strake (1), L. Schultze KCx)l jJ L.C.
Paul (2), A.M. Tegzess (3), J.L. Bloem (1), J.
Doorribos (1)(Intr. by I. Schicht).
Depts. of Rd1o1ogy(1) and Nephrology (2), State
University Leiden, The Netherlands.
Dept. of NeThroIogy (3), State University
Groningen, The Netherlands.
Magnetic Resonance Imaging (MRI) of renal
transplants was performed to establish the
sensitivity and specificity in the detection of
rejection and cyclosporinenephrotoxicity.
MRI was performed with a 0.5 T superconducting
Gyror can S5, applying both Ti and T2 weighted
pulse sequences (IR: TI 400 msec. and SE with
various PR: 250 — 2000; TB 50 msec., multiple
echotechnique).
Sofar ten patients were examined with various
postransplant complications including acute
rej ection and cyclosgorinenephrotoxicity.
In acute rejection we observed an increase in
renal volume and either a loss of cortex-medulla
differentiation or enlargement of the pyramids.
In cyclosporinenephrotoxicity a normal renal
volume and a preserved cortex-medulladifferentiation was seen.
The early results of this prospective study
indicate that MRI is a prasising technique in the
diagnosis and differentiation of acute rejection
and cyclosporinenephrotoxicity.
Low—aose cyclosporine therapy allows to
avoid nephrotoxicity.
J.P. Wauters, M. Burnier, N. Gilliard,
J.C. Stauffer.
Division of Nephrology, University
Hospital, Lausanne, Switzerland.
To avoid nephrotoxicity, a very low
cyclosporine (cyA) dosage, aiming at
trough blood levels between 100—400 ng/
ml, was applied in 27 renal transplanted
patients. They were treated with the as-
sociation of CyA and decreasing low—dose
prednisone (0.7 mg/kg/day). At the time
of the study (mean follow—up period 8
months, range 1—17 months) the trough
blood CyA levels ranged between 125—460
ng/ml (mean 278 68 ng/ml, mean 1
SD). Five graft failures occured, 1 due
to immediate necrosis of the graft, the
other due to acute rejection. Twenty—
four episodes (range 0—3) of acute re-
jection occurred in 16 of the 27 pa-
tients. One year actuarial graft survi-
val vas at 83 % (67 % in the conventio-
nal therapy control group). Mean serum
creatinine was at 135 39 umol/l in the
CyA group and 127 12 in the control
group. Only 3 patients taking CyA had
creatinine levels above 150 jimol/l. The
reciprocal of serum creatinine remained
stable at 0.7 during the first 9 months
(n=11) and was comparable to the conven-
tional therapy group. In the 9 patients
in whom a renal biopsy was performed up
to 16 months after grafting, no lesions
of CyA toxicity were observed.
PPBIBN CF LThJ-OiS CF CY0ICHIN (Cs)
(PCs) WITH D3$iENTIWPL II111ffPtSSI[f'J [lRIr 1l-E FIRST
S (tNTI-15 IF KIFIMY TRffLPNTATIW
P. \ierserstrseten, P. Kirrrt, E. Elpnt aid C. Icussaint
Cliniqes Uiirersitaires c Bruxelles, -ital Erases,
Lhirersit4 Libre ds Bruxeiles, Bruxellea.
The early ccusse of kidey grafts sag arelyzed in 2 grcaps
of patients rratcF-ed for sex, aç, origin of ti-e thor, orthr of
ti-a graft, origirs]. kici-ey disease, rurter of bl trsnsfu-
sims, F-LA presa-aitizatim ard I-es status prior to trareplan—
tatim, F-LA-PB aid -4)1 rTmtchirg, uarm arc]
cold iseF-airia tines. Patients of grtip 1 sara treated with
azathiqjrire (P29) aid P35, uhile patients of grccp 2
raceiasd lcw-cbses of CS aid :113. In each grop of 15 patieits
ti-a saie JTnurm&4pressire req ires rims used throufcut ti-a
str4i ad, at ti-a erd of each rrcrrth, all patients rare evalLa-
ted for lady ueiit, systolic aid diastolic blcod pressore,
senin creatinire ccrcentratim, cbily cbses of PCS aid of ALA
or CS. Ti-a cleta riera arsiyzed accordirg the 2-say arelysis of
variarce. Bcdy rreiit ircreased in toth qrccpa at ti-a sate
extent : 6 kg fruit tI-a 1st to the 9th nuith. Systolic aid
diastolic bln pressuses sara similar in tech grctps as sail
as ti-a r,jrr of patients recairiirg antihparterrsiva dnxjs.
Seruli creatinire cacentratim rias hier (P (.ijii) in grccp
2 ti-en in grap 1 throumut the sttdy I-ut the differerce ras
mail (sean : 0.2 rrq/dl) aid did ret chsrqn with tine. 1Wan
idily of PIE rare stril<ir-qly lcaer in grasp 2 then in
grasp 1 patients, thia-atratirq the corticrateroid-Masrirq
effect of CS
Pratcp.rroiths 1 2 3 4 5 6 7 8 9
Grasp 1 .89 .66 .49 .37 .29 .25 .28 .37 .33
Grasp 2 .48 .33 .23 .17 .12 .12 .12 .15 .15
In toth graga, the ircicbrco of carplicatims rims similar
tot re,ctim eqiaWs rare nose fragrant in grasp 1 (N = 17)
ti-an in grasp 2 (N = in). In ccrclusim, lujj-±mes of IS
aid P05 cmstitute a safe iimrrusapressive regirren at
miniirel cast for ti-a graft firctim, at least diring the
first 9 rrcnths of traieqlantatim.
RANITIDINE DOES NOT INFLUENCE THE BLOOD CICLOSPO—
RIN LEVELS IN RENAL TRANSPLANT PATIENTS (RTP)
J.Zazgornik, J.Schindler, F.Gremmel, P.Balcke,
H.Kopsa, K.Derfler, E.Minar.
I.Medical Clinic, Laboratory Institute, Vienna
Austria.
Ranitidine and cimetidine a H2—receptor antago-
nists were widely used in treatment and prevention
of peptic ulcer disease. However, the combined
use of ciclosporin and cimetidine is harmful in
RTP. The aim of the study was to investigate whe-
ther ranitidine influences the blood ciclosporin
levels in RTP. Five RTP mean age of 40(21—50),
mean observation time after surgery of 11 (2—45)
weeks, were investigated. The ciclosporin doses
were: 4 mg/kg in one, 9 mg/kg in one and 11 ag/kg
in three patients. The daily ciclosporin dose
was divided in two equal parts given in an inter-
val of 12 hours. The investigations were perfor-
med on 2 consecutive days, the doses of ciclospo—
nfl were the same in both days. On the second day
together with the ciclosporin morning dose, rani—
tidine was coadministen-ed in an oral dose of 150
mg. In whole bloodciclosporin concentrations were
measured before, 2,o,6,8,1O and 12 hours after the
ciclosporin morning dose by RIA method.
Mean blood ciclosporin levels without(I) and with
ranitidine (li),ng/ml.
I.(b) 0 2 4 6 8 10 12
703 1492 1641 1669 1235 849 583
SD 168 932 1328 608 300 295 356
II - 669 888 1230 1743 1540 1033 600
SD 308 739 763 920 834 593 282
p NS NS NS NS NS NS NS
Conclusion. The results of this study emphasize
that combined ciclosporin ranitidine therapy can
be used without risk in RTP.
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PREVENTION OF NEPHROTOXIC CICLOSPORIN PEAK CONCEN-
TRATIONS BY DAILY DRUG DIVISION IN 3 EQUAL PORTIONS
J.Zazgornik, J.Schindler, P.Balcke, H.Kopsa,
F.Gremmel, K.Derfler, G.Kretschmer, F.Piza
I.Medical Clinic, I.Surgical Clinic, Laboratory In-
stitute University of Vienna, Vienna, Austria
Ciclosporin induced nephrotoxicity is an impor-
tant diagnostic and clinical problem in the early
period after kidney transplantation. In this study
2 groups, both consisting of 6 kidney transplant
recipients were investigated. Ciclosporin regime:
5 mg/kg i.v. continuously during 5 days, thereafter
starting oral dose of 15 mg/kg, reducing to 5—7 mg
per kg. The investigations were performed in the
second week after kidney transplantation. The oral
ciclosporin daily dose was in the first group 13 mg
per kg, in the second 11 mg/kg, respectively. In
both groups the daily dose was divided on the first
day of the investigation in 2 equal portions given
with an interval of 12 h (A), on the second day the
same dosis was divided in 3 equal portions given
with an interval of 8 h (B). In whole blood ciclo—
sporin was measured by RIA method before and 2,4,6
and 8 hours after ciclosporin administration.
A time(h) 0 2 4 6 8
x ng/ml 738 1718 2531 1911 1036
SD 201 409 725 541 210
B x rig/mI 660 1058 1186 10/3 725
SD 184 451 405 480 180
P NS .O.O5 .O.O25 <0.05 .O.01
In the second group the differences were similar
(4hvalues: I 1851 ng/ml, II 977 ng/rnl, p0.O05.
Conclusions: Potential nephrotoxic very high blood
ciclosporin peak concentrations could be prevented
by ciclosporin application in 3 equal portions.
A reduction f the daily ciclosporin dose in the ear
iy period after kidney transplantation can be recom
men1ed with s starting dose of 12 mg/kg or lower.
